Citrus Sinensis ID: 006125
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 660 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M0X5 | 675 | Cysteine-rich receptor-li | yes | no | 0.886 | 0.866 | 0.423 | 1e-135 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.9 | 0.887 | 0.427 | 1e-135 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.854 | 0.834 | 0.436 | 1e-131 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.901 | 0.889 | 0.401 | 1e-125 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.866 | 0.912 | 0.407 | 1e-125 | |
| Q8H199 | 658 | Cysteine-rich receptor-li | no | no | 0.859 | 0.861 | 0.397 | 1e-125 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.889 | 0.881 | 0.428 | 1e-125 | |
| Q9LDT0 | 700 | Putative cysteine-rich re | no | no | 0.880 | 0.83 | 0.414 | 1e-124 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.816 | 0.799 | 0.429 | 1e-124 | |
| O65472 | 690 | Putative cysteine-rich re | no | no | 0.906 | 0.866 | 0.387 | 1e-122 |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 483 bits (1242), Expect = e-135, Method: Compositional matrix adjust.
Identities = 271/640 (42%), Positives = 382/640 (59%), Gaps = 55/640 (8%)
Query: 29 YNICSTSTAGSARASTIDDNLQNVLTSLAS--NANAAKFSNASFG--NDSDRVYGLYMCL 84
Y+IC +T S R S+ NL+ VL+SL+S A A+ F NA+ G NDS+RVYG+++C
Sbjct: 31 YHICPNTTTYS-RNSSYLTNLRTVLSSLSSPNAAYASLFDNAAAGEENDSNRVYGVFLCR 89
Query: 85 NYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNR 144
+SAE C DC+ A+ + + CP + A++W + C +RY+ Q+ GQ+ + + N+
Sbjct: 90 GDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQSIVGQMRIRPGVFLTNK 149
Query: 145 LNISEPERYRSVVNNTLSDLITKLSAFDPF--EMYATDEVPFTNSDTFYALVQCTKDLPA 202
NI+E + R N +L L+ ++ +AT++ FT T Y+LVQCT DL
Sbjct: 150 QNITENQVSR--FNESLPALLIDVAVKAALSSRKFATEKANFTVFQTIYSLVQCTPDLTN 207
Query: 203 DDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFY--------------KGATE 248
DC +CL + CC S G R+++ +C RYELY FY T
Sbjct: 208 QDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTA 267
Query: 249 PSILAGNQASGGGKQRKMWMIIVLASV-VALLLVVFASTGYFFATKKITRKRKGTARKQI 307
P + N S GK + + +I+ +V V++ +++ + + A + R K +A +
Sbjct: 268 PPL---NIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARR---RNNKLSAETE- 320
Query: 308 QLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYK 367
L + G + +Q + AT+ FS+SN LG GGFG VYK
Sbjct: 321 DLDEDGITSTETLQFQ-----------------FSAIEAATNKFSESNKLGHGGFGEVYK 363
Query: 368 GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427
G L G+ VA+KRLS S QG EF NEV ++ KLQH+NL KLLG+C+DG+EK+LVYEF+
Sbjct: 364 GQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFV 423
Query: 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487
PN SLD LFD KR +L W++R I+ GIA+G+LYLH DSRL I+HRDLKASN+LLD+D
Sbjct: 424 PNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDAD 483
Query: 488 MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
M+ KISDFGMARIF + +ANT RIVGTYGYM+PEYA+ G YS KSDV+SFGVL++E+I
Sbjct: 484 MHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELI 543
Query: 548 TGRRNA------GSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQ 601
TG++N+ G L+ Y W LW E + LELVD + +F +E R IHI LLCVQ
Sbjct: 544 TGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRG-NFQTNEVIRCIHIALLCVQ 602
Query: 602 EDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSIGRVTDGH 641
ED+ +RP+M + M+ T TLP P++ F + + D
Sbjct: 603 EDSSERPSMDDILVMMNSFTVTLPIPKRSGFLLRTMKDSR 642
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 481 bits (1238), Expect = e-135, Method: Compositional matrix adjust.
Identities = 285/667 (42%), Positives = 395/667 (59%), Gaps = 73/667 (10%)
Query: 29 YNICSTSTAGSARASTIDDNLQNVLTSLAS-NAN-AAKFSNASFGNDSDRVYGLYMCLNY 86
Y+ C +TA ST ++NL+ +L SL+S NA+ + F NA+ G DRV GL+ C
Sbjct: 41 YHTCQ-NTANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGD 99
Query: 87 ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
+S E C C++ A D CPN+ EA ++ + C LRY+ QN L +G + N N
Sbjct: 100 VSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTGGVILVNTRN 159
Query: 147 ISEPERYRSVVNNTLSDLI------TKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDL 200
++ + + LSDL+ A + + + T + FT +FY LVQCT DL
Sbjct: 160 VTSNQL------DLLSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDL 213
Query: 201 PADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSIL-------- 252
DC CL I + GAR+++ +C RYE+YAFY TE ++
Sbjct: 214 TRQDCSRCLQLVINQIPT---DRIGARIINPSCTSRYEIYAFY---TESAVPPPPPPPSI 267
Query: 253 ------AGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQ 306
A ++ G + + + IV+ +VA+LL + GY F T++ ARK
Sbjct: 268 STPPVSAPPRSGKDGNSKVLVIAIVVPIIVAVLLFI---AGYCFLTRR--------ARKS 316
Query: 307 IQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVY 366
++ D+ A +D T+ AT +F +SN +GQGGFG VY
Sbjct: 317 -------------YYTPSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVY 363
Query: 367 KGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426
KG LSDG EVAVKRLS S QG EF NEV+L+ KLQH+NLV+LLGFC+DG+E++LVYE+
Sbjct: 364 KGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEY 423
Query: 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
+PN SLD LFDP K+G L W +R I+ G+A+G+LYLH+DSRL I+HRDLKASN+LLD+
Sbjct: 424 VPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDA 483
Query: 487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546
DMN KI+DFGMARIF + E NT RIVGTYGYM+PEYAM G YS KSDV+SFGVL++EI
Sbjct: 484 DMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEI 543
Query: 547 ITGRRNA------GSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCV 600
I+G++N+ G++ L++YAW LW+ G LELVDP + + +E R +HIGLLCV
Sbjct: 544 ISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENC-QRNEVVRCVHIGLLCV 602
Query: 601 QEDAFDRPTMSSVAPMLKGETGTLPQPQKPA-FSIGRV------TDGHCNNNNCSANGLT 653
QED +RPT+S++ ML T TLP P++P F R+ TD + S + +
Sbjct: 603 QEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDAS 662
Query: 654 ISNLSPR 660
I+++ PR
Sbjct: 663 ITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 468 bits (1205), Expect = e-131, Method: Compositional matrix adjust.
Identities = 269/616 (43%), Positives = 368/616 (59%), Gaps = 52/616 (8%)
Query: 43 STIDDNLQNVLTSLAS-NAN-AAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTAS 100
ST NL+ +L+S AS NA+ + F N G DRV GL++C +S E C++C+ +
Sbjct: 54 STYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSV 113
Query: 101 QDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNT 160
+ CPN+ EA+ + E C LRY+++NF + G + N NIS + R +
Sbjct: 114 NESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDL 173
Query: 161 LSDLITKLS--AFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILS 218
+ + + + A + ++T + T+ T Y LVQCT DL DC +CL ++ ++
Sbjct: 174 VQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMP 233
Query: 219 CCYFSRGARLLSRNCYLRYELYAFY--------------KGATEPSILAGNQASGGGKQR 264
F GAR +C RYELYAFY G+T P G
Sbjct: 234 --LFRIGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTV 291
Query: 265 KMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQH 324
+ I+VLA ++ + LV GY F ++ T+K TA ++GD T
Sbjct: 292 LVVAIVVLAVLLFIALV-----GYCFLAQR-TKKTFDTASAS----EVGDDMAT------ 335
Query: 325 VQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC 384
A +D T+ AT++F++SN +G+GGFG VYKG S+GKEVAVKRLS
Sbjct: 336 ---------ADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKN 386
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
S QG AEF EV+++ KLQH+NLV+LLGF + G+E++LVYE+MPN SLD +LFDP K+
Sbjct: 387 SRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQ 446
Query: 445 LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
L W +R NI+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+D+N KI+DFGMARIF
Sbjct: 447 LDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLD 506
Query: 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA------GSNQL 558
+ + NT RIVGTYGYMAPEYAM G +S KSDV+SFGVL++EII+GR+N+ G+ L
Sbjct: 507 QTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDL 566
Query: 559 LAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
L + W LW L+LVDPL+ + + E R IHIGLLCVQED RPT+S+V ML
Sbjct: 567 LTHTWRLWTNRTALDLVDPLIANNC-QNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLT 625
Query: 619 GETGTLPQPQKPAFSI 634
T TLP P++P F I
Sbjct: 626 SNTVTLPVPRQPGFFI 641
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 451 bits (1159), Expect = e-125, Method: Compositional matrix adjust.
Identities = 264/657 (40%), Positives = 380/657 (57%), Gaps = 62/657 (9%)
Query: 43 STIDDNLQNVLTSLASNANAAK-FSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQ 101
ST D N + +L++L+SN + F N+ FG +RV+ MC+ ETC+DCI AS
Sbjct: 36 STYDLNRRQILSTLSSNVTSHNGFFNSKFGQAPNRVFINGMCIPGTKPETCSDCIKGASD 95
Query: 102 DISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTL 161
IS+ CPNKT+A W + C +RY+ +F G L + + Y+ +I + +V +
Sbjct: 96 KISESCPNKTDAYTWPDCCMVRYSNVSFSGSLVMEPSETLYHTGDIEDTGTNLTVFDRIW 155
Query: 162 SDLITK-LSAFDPF---------EMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHN 211
+L+ + ++A + +A + T T YA++QCT D+ + DC CL
Sbjct: 156 EELMLRTITAASLSSSNGSSFGQKYFAAEVASLTTFQTMYAMMQCTPDVSSKDCEFCLKT 215
Query: 212 ATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQRKMWMI-- 269
+ D SCC +G ++ +C++R++LY Y GA E ++ Q + +I
Sbjct: 216 SVGDYESCCRGKQGGAVIRPSCFVRWDLYP-YAGAFE-NVTFPPPPPQSLPQPPVSLIPP 273
Query: 270 --------IVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQ-LHKIGDANDTDF 320
+ +VA+++ + + R++K ++Q +I + F
Sbjct: 274 PVSDRANTTIKGIIVAIVVPIIVILVSLVVLLVVCRRKKSYKTTEVQATDEITTTHSLQF 333
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR 380
++ ++ A D F D SN++G+GGFG VY+G LS G EVAVKR
Sbjct: 334 SFKTIEA------ATDKFSD-------------SNMIGRGGFGEVYRGKLSSGPEVAVKR 374
Query: 381 LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
LS S QG EF NE +L+ KLQHKNLV+LLGFC++G+EK+LVYEF+PN SLD LFDP
Sbjct: 375 LSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPA 434
Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
K+G L W +R NI+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGMARI
Sbjct: 435 KQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 494
Query: 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN-------- 552
F + +ANT RI GT+GYM+PEYAM G +S KSDV+SFGVL++EII+G++N
Sbjct: 495 FGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDD 554
Query: 553 AGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSS 612
+GSN L+ +AW LW G+ LELVDP + + S+ E +R IHI LLCVQED DRP + +
Sbjct: 555 SGSN-LVTHAWRLWRNGSPLELVDPTIGE-SYQSSEATRCIHIALLCVQEDPADRPLLPA 612
Query: 613 VAPMLKGETGTLPQPQKPAFSI-GR--------VTDGHCNNNNCSANGLTISNLSPR 660
+ ML T TL P+ P F + GR T+ + S N +I+ PR
Sbjct: 613 IIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-125, Method: Compositional matrix adjust.
Identities = 257/630 (40%), Positives = 369/630 (58%), Gaps = 58/630 (9%)
Query: 30 NICSTSTAGSARASTIDDNLQNVLTSL-ASNAN-AAKFSNASFGNDSDRVYGLYMCLNYI 87
+IC +T S R S NL+ +L+SL A NA+ + F +A G DRV GL++C +
Sbjct: 29 HICPNTTTYS-RNSPYLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDV 87
Query: 88 SAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYN---R 144
S C +C+ + D CP++ +++ + + C LRY+ QN L G + N
Sbjct: 88 SPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIRMNGNIS 147
Query: 145 LNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
++ ++ R++ V++T++ K +A P + Y T + +T T Y LVQCT DL D
Sbjct: 148 IDQNQMNRFKDFVSSTMNQAAVK-AASSPRKFY-TVKATWTALQTLYGLVQCTPDLTRQD 205
Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILA--------GNQ 256
C +CL ++ I + G R L +C RYEL+AFY T + A
Sbjct: 206 CFSCLESS---IKLMPLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPL 262
Query: 257 ASGGGKQRKMW------MIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLH 310
+ K W + IVL +VA LL++ GY FA
Sbjct: 263 VTSPSLPGKSWNSNVLVVAIVLTILVAALLLI---AGYCFA------------------K 301
Query: 311 KIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL 370
++ +++D + +D+ + +D + AT+ FS++N +GQGGFG VYKG
Sbjct: 302 RVKNSSDNAPAFD-----GDDITTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTF 356
Query: 371 SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430
S+G EVAVKRLS S QG EF NEV+++ KLQH+NLV+LLGF + G E++LVYE+MPN
Sbjct: 357 SNGTEVAVKRLSKSSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNK 416
Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
SLD LFDP K+ L W +R ++ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN
Sbjct: 417 SLDYFLFDPAKQNQLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNP 476
Query: 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
K++DFG+ARIF + + NT RIVGT+GYMAPEYA+ G +S KSDV+SFGVL++EII+G+
Sbjct: 477 KLADFGLARIFGMDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGK 536
Query: 551 RNA------GSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDA 604
+N G++ L+ +AW LW+ G L+LVDP++ D E R IHI LLCVQED
Sbjct: 537 KNNSFYETDGAHDLVTHAWRLWSNGTALDLVDPIIIDNC-QKSEVVRCIHICLLCVQEDP 595
Query: 605 FDRPTMSSVAPMLKGETGTLPQPQKPAFSI 634
+RP +S++ ML T TLP P +P F +
Sbjct: 596 AERPILSTIFMMLTSNTVTLPVPLQPGFPV 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-125, Method: Compositional matrix adjust.
Identities = 261/657 (39%), Positives = 368/657 (56%), Gaps = 90/657 (13%)
Query: 52 VLTSLASNANA-AKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNK 110
+L+SL SN +A F N+S G DRVY L MC+ + C+DCI AS + C N+
Sbjct: 44 LLSSLPSNVSARGGFYNSSIGQGPDRVYALGMCIEGAEPDVCSDCIEYASNLLLDTCLNQ 103
Query: 111 TEAIVWEE---VCQLRYAYQNFFGQL------------DVSGNIPKYNRLNISEPERYRS 155
TE + W E +C +RY+ +FFG L D++ N+ +++++ E R
Sbjct: 104 TEGLAWPEKRILCMVRYSNSSFFGSLKAEPHFYIHNVDDITSNLTEFDQV---WEELARR 160
Query: 156 VVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATAD 215
++ +T S + + YA D T YAL+QCT DL +DC CL + D
Sbjct: 161 MIASTTSPSSKR-------KYYAADVAALTAFQIIYALMQCTPDLSLEDCHICLRQSVGD 213
Query: 216 ILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQ--------ASGGGKQRK-- 265
+CC +G + +C R+EL+ F + + S+ Q A +K
Sbjct: 214 YETCCNGKQGGIVYRASCVFRWELFPFSEAFSRISLAPPPQSPAFPTLPAVTNTATKKGS 273
Query: 266 -------MWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDT 318
+W II+ +V+ + LV+ A G+ + R+RK
Sbjct: 274 ITISIGIVWAIII-PTVIVVFLVLLA-LGFV-----VYRRRKS----------------- 309
Query: 319 DFHYQHVQGRDNDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVA 377
QG D+ D + + AT+ FS+SNI+G+GGFG V+ GVL +G EVA
Sbjct: 310 ------YQGSSTDITITHSLQFDFKAIEDATNKFSESNIIGRGGFGEVFMGVL-NGTEVA 362
Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF 437
+KRLS S QG EF NEV+++ KL H+NLVKLLGFC++G+EK+LVYEF+PN SLD LF
Sbjct: 363 IKRLSKASRQGAREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVPNKSLDYFLF 422
Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
DP K+G L W KR NI+ GI +G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGM
Sbjct: 423 DPTKQGQLDWTKRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGM 482
Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557
ARIF + ANT +I GT GYM PEY +G +S +SDV+SFGVL++EII GR N +Q
Sbjct: 483 ARIFGIDQSGANTKKIAGTRGYMPPEYVRQGQFSTRSDVYSFGVLVLEIICGRNNRFIHQ 542
Query: 558 -------LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTM 610
L+ YAW LW + LELVDP +++ +E +R IHI LLCVQ + DRP++
Sbjct: 543 SDTTVENLVTYAWRLWRNDSPLELVDPTISENC-ETEEVTRCIHIALLCVQHNPTDRPSL 601
Query: 611 SSVAPMLKGETGTLPQPQKPAFSIGRVT-------DGHCNNNNCSANGLTISNLSPR 660
S++ ML + LP PQ+P F ++ D +N + N +TI++ PR
Sbjct: 602 STINMMLINNSYVLPDPQQPGFFFPIISNQERDGLDSMNRSNPQTINDVTITDFEPR 658
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 449 bits (1156), Expect = e-125, Method: Compositional matrix adjust.
Identities = 265/619 (42%), Positives = 363/619 (58%), Gaps = 32/619 (5%)
Query: 29 YNICSTSTAGSARASTIDDNLQNVLTSLAS-NAN-AAKFSNASFGNDSDRVYGLYMCLNY 86
Y+ CS +T S+ ST NL+ +L+SL+S NA+ + F NA+ G D V GL++C
Sbjct: 30 YHNCSITTTYSSN-STYSTNLKTLLSSLSSRNASYSTGFQNATAGQAPDMVTGLFLCRGN 88
Query: 87 ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
+S E C CI + + CPN+ EA+ + E C LRY+ +N L+ G + N N
Sbjct: 89 VSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILSTLNTDGGVFMQNARN 148
Query: 147 -IS-EPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
IS + +R+R +V N ++ + + A + +A + + Y +VQCT DL D
Sbjct: 149 PISVKQDRFRDLVLNPMN--LAAIEAARSIKRFAVTKFDLNALQSLYGMVQCTPDLTEQD 206
Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYK--GATEPSILAGNQASGGGK 262
C+ CL + I Y G R +C RY+ Y FY P + GG
Sbjct: 207 CLDCLQQS---INQVTYDKIGGRTFLPSCTSRYDNYEFYNEFNVGTPQDSSPRPGKGGNS 263
Query: 263 QRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHY 322
+ ++V +V+ LL V F F+ ++ RK+ A I L K+ +T+
Sbjct: 264 SVIVIAVVVPITVLFLLFVAF------FSVRRAKRKKTIGA---IPLFKV-KRKETEVTE 313
Query: 323 QHVQGRDND--LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR 380
+ D D A D + + AT F N LGQGGFG VYKG G +VAVKR
Sbjct: 314 PPAETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSGVQVAVKR 373
Query: 381 LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
LS S QG EF NEV+++ KLQH+NLVKLLG+C++G+EK+LVYEF+PN SLD LFDP
Sbjct: 374 LSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDYFLFDPT 433
Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
+G L W +R I+ GIA+G+LYLH+DSRL I+HRDLKA N+LLD+DMN K++DFGMARI
Sbjct: 434 MQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARI 493
Query: 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--- 557
F + EANT R+VGTYGYMAPEYAM G +S KSDV+SFGVL++EI++G +N+ +Q
Sbjct: 494 FGMDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEIVSGMKNSSLDQMDG 553
Query: 558 ----LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613
L+ Y W LW+ G+ ELVDP D ++ E +R IHI LLCVQEDA DRPTMS++
Sbjct: 554 SISNLVTYTWRLWSNGSPSELVDPSFGD-NYQTSEITRCIHIALLCVQEDANDRPTMSAI 612
Query: 614 APMLKGETGTLPQPQKPAF 632
ML + L P+ P F
Sbjct: 613 VQMLTTSSIALAVPRPPGF 631
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LDT0|CRK30_ARATH Putative cysteine-rich receptor-like protein kinase 30 OS=Arabidopsis thaliana GN=CRK30 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 447 bits (1149), Expect = e-124, Method: Compositional matrix adjust.
Identities = 262/632 (41%), Positives = 359/632 (56%), Gaps = 51/632 (8%)
Query: 31 ICSTSTAGSARASTIDDNLQNVLTSLASNANAAK-FSNASFGNDSDRVYGLYMCLNYISA 89
+CS T D N + +L+SL S A F NAS G D D++Y + MC+
Sbjct: 26 LCSEKFGTFTPGGTFDKNRRIILSSLPSEVTAQDGFYNASIGTDPDQLYAMGMCIPGAKQ 85
Query: 90 ETCNDCITTASQDISKLCPNKTEAIVW----EEVCQLRYAYQNFFGQLDVSGNIPKYNRL 145
+ C DCI ++ + + CPN+T AI W + VC RY Q LD+ YN
Sbjct: 86 KLCRDCIMDVTRQLIQTCPNQTAAIHWSGGGKTVCMARYYNQPSSRPLDLESVSIGYNVG 145
Query: 146 NISEP-ERYRSVVNNTLSDLITKLSA-------FDPFEMYATDEVPFTNSDTFYALVQCT 197
N+S + + ++ ++TK S+ FD YA DE TNS YAL+QCT
Sbjct: 146 NLSTNLTDFDRLWERLIAHMVTKASSASIKYLSFDNSRFYAADETNLTNSQMVYALMQCT 205
Query: 198 KDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKG------ATEPSI 251
D+ +C TCL + D + CC+ +G + +C R++LY F A PS
Sbjct: 206 PDVSPSNCNTCLKQSVDDYVGCCHGKQGGYVYRPSCIFRWDLYPFNGAFDLLTLAPPPSS 265
Query: 252 LAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHK 311
+ K K I +++ +++VV ++ R +RK+ Q
Sbjct: 266 QLQSPPPVTNKDEK---TIHTGTIIGIVIVVAMVIIMALLALGVSVCR---SRKKYQAFA 319
Query: 312 IGDAND-TDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL 370
A+D T Y +D + ATSNF SN +GQGGFG VYKG L
Sbjct: 320 SETADDITTVGYLQFDIKD--------------IEAATSNFLASNKIGQGGFGEVYKGTL 365
Query: 371 SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430
S+G EVAVKRLS S+QG EF NEVLL+ KLQH+NLV+LLGF + G+EK+LV+EF+PN
Sbjct: 366 SNGTEVAVKRLSRTSDQGELEFKNEVLLVAKLQHRNLVRLLGFALQGEEKILVFEFVPNK 425
Query: 431 SLDAILF---DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487
SLD LF +P K+G L W +R NI+ GI +G+LYLH+DSRL I+HRD+KASN+LLD+D
Sbjct: 426 SLDYFLFGSTNPTKKGQLDWTRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDAD 485
Query: 488 MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
MN KI+DFGMAR F + + E +T R+VGT+GYM PEY G +S KSDV+SFGVL++EI+
Sbjct: 486 MNPKIADFGMARNFRDHQTEDSTGRVVGTFGYMPPEYVAHGQFSTKSDVYSFGVLILEIV 545
Query: 548 TGRRNAGSNQ-------LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCV 600
+GR+N+ Q L+ Y W LWN + LELVDP ++ S+ DE +R IHIGLLCV
Sbjct: 546 SGRKNSSFYQMDGSVCNLVTYVWRLWNTDSSLELVDPAISG-SYEKDEVTRCIHIGLLCV 604
Query: 601 QEDAFDRPTMSSVAPMLKGETGTLPQPQKPAF 632
QE+ +RP +S++ ML + TL PQ P F
Sbjct: 605 QENPVNRPALSTIFQMLTNSSITLNVPQPPGF 636
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1148), Expect = e-124, Method: Compositional matrix adjust.
Identities = 259/603 (42%), Positives = 355/603 (58%), Gaps = 64/603 (10%)
Query: 65 FSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRY 124
F NA+ G DRV GL++C +S E C +C+ + LCP EA+ + E C LRY
Sbjct: 68 FQNATAGKAPDRVTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQCILRY 127
Query: 125 AYQNFFGQ-LDVSGNIPKYNRLNISEPER----YRSVVNNTLSDLITKLSAFDPFEMYAT 179
+++N + G N IS ++ + S V++T+S+ K +A ++Y T
Sbjct: 128 SHKNILSTAITNEGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGK-AANSSRKLY-T 185
Query: 180 DEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSR-GARLLSRNCYLRYE 238
T Y L+QCT DL DC++CL ++ ++ SR GARL +C RYE
Sbjct: 186 VNTELTAYQNLYGLLQCTPDLTRADCLSCLQSS----INGMALSRIGARLYWPSCTARYE 241
Query: 239 LYAFYKGA---------------------TEPSILAGNQASGGGKQRKMWMIIVLASVVA 277
LY FY + + P I + + G + + +V+ +V+
Sbjct: 242 LYPFYNESAIETPPLPPPPPPPPPRESLVSTPPISSSSLPGKSGNSTVLVVAVVVLAVLL 301
Query: 278 LLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDF 337
+ +V GY F KK +K TA ++GD T A
Sbjct: 302 FIALV----GYCFLAKK-KKKTFDTASAS----EVGDDMAT---------------ADSL 337
Query: 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVL 397
+D T+ AT++F++SN +G+GGFG VYKG S+GKEVAVKRLS S QG AEF EV+
Sbjct: 338 QLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVV 397
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
++ KLQH+NLV+LLGF + G+E++LVYE+MPN SLD +LFDP K+ L W +R NI+ GI
Sbjct: 398 VVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQIQLDWMQRYNIIGGI 457
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
A+G+LYLH+DSRL I+HRDLKASN+LLD+D+N KI+DFGMARIF + + NT RIVGTY
Sbjct: 458 ARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTY 517
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA------GSNQLLAYAWHLWNEGNV 571
GYMAPEYAM G +S KSDV+SFGVL++EII+GR+N+ G+ LL +AW LW
Sbjct: 518 GYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGESDGAQDLLTHAWRLWTNKKA 577
Query: 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPA 631
L+LVDPL+ + + E R IHIGLLCVQED RP +S+V ML T TLP P++P
Sbjct: 578 LDLVDPLIAENC-QNSEVVRCIHIGLLCVQEDPAKRPAISTVFMMLTSNTVTLPVPRQPG 636
Query: 632 FSI 634
F I
Sbjct: 637 FFI 639
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65472|CRK12_ARATH Putative cysteine-rich receptor-like protein kinase 12 OS=Arabidopsis thaliana GN=CRK12 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 440 bits (1132), Expect = e-122, Method: Compositional matrix adjust.
Identities = 262/677 (38%), Positives = 363/677 (53%), Gaps = 79/677 (11%)
Query: 43 STIDDNLQNVLTSLASNANAA-KFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQ 101
ST D N + +L+ L SN + F N S G +RVY + MCL E+C C+ +AS
Sbjct: 34 STYDTNRRVILSLLPSNVTSHFGFFNGSIGQAPNRVYAVGMCLPGTEEESCIGCLLSASN 93
Query: 102 DISKLCPNKTEAIVW---EEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVN 158
+ + C + A++W +C +RY+ +F G ++ P L+I + + N
Sbjct: 94 TLLETCLTEENALIWIANRTICMIRYSDTSFVGSFELE---PHREFLSIHGYKTNETEFN 150
Query: 159 NTLSDLITKL---------SAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCL 209
S L ++ + + + Y D +S T YA++QCT DL +C CL
Sbjct: 151 TVWSRLTQRMVQEASSSTDATWSGAKYYTADVAALPDSQTLYAMMQCTPDLSPAECNLCL 210
Query: 210 HNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGAT----------EPSILAGNQASG 259
+ + SCC +G ++ +C R ELY F T PS++ +
Sbjct: 211 TESVVNYQSCCLGRQGGSIVRLSCAFRAELYPFGGAFTVMTARPLSQPPPSLIKKGEFFA 270
Query: 260 ---GGKQRKMWMIIVLASVVALLLVVFASTGYF------------------FATKKITRK 298
Q + MI L VV L+ F +G F F + +
Sbjct: 271 KFMSNSQEPVKMIQNLYVVV--LIFYFLDSGKFSTETIAAIVVPIIVVAIIFLVLLVLSR 328
Query: 299 RKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILG 358
RK Q + + T H+Q +D +T+ +AT NF+ +N LG
Sbjct: 329 LFARRRKSYQEIDLDQSGITTLHFQQ--------------LDFKTIEVATENFAKTNKLG 374
Query: 359 QGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418
QGGFG VYKG L +G EVAVKRLS SEQG EF NEV+L+ KLQH+NLVKLLG+C++ +
Sbjct: 375 QGGFGEVYKGTLVNGTEVAVKRLSKTSEQGAQEFKNEVVLVAKLQHRNLVKLLGYCLEPE 434
Query: 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK 478
EK+LVYEF+PN SLD LFDP K+G L W KR NI+ GI +G+LYLH+DSRL I+HRDLK
Sbjct: 435 EKILVYEFVPNKSLDYFLFDPTKQGQLDWTKRYNIIGGITRGILYLHQDSRLTIIHRDLK 494
Query: 479 ASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFS 538
ASN+LLD+DM KI+DFGMARI + ANT RI GT+GYM PEY + G +S KSDV+S
Sbjct: 495 ASNILLDADMIPKIADFGMARISGIDQSVANTKRIAGTFGYMPPEYVIHGQFSMKSDVYS 554
Query: 539 FGVLLIEIITGRRNAGSNQ-------LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSR 591
FGVL++EII G++N Q L+ Y W LW G+ LELVD +++ +E R
Sbjct: 555 FGVLILEIICGKKNRSFYQADTKAENLVTYVWRLWTNGSPLELVDLTISENC-QTEEVIR 613
Query: 592 YIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSI--GRVTDGHCNNN---N 646
IHI LLCVQED DRP +S++ ML + L PQ P F + + D ++
Sbjct: 614 CIHIALLCVQEDPKDRPNLSTIMMMLTNSSLILSVPQPPGFFVPQNKERDSFLSSQFTMG 673
Query: 647 CSA---NGLTISNLSPR 660
C++ N +TI+NL PR
Sbjct: 674 CTSQTKNDVTITNLDPR 690
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 660 | ||||||
| 302144055 | 698 | unnamed protein product [Vitis vinifera] | 0.984 | 0.931 | 0.592 | 0.0 | |
| 255555023 | 648 | ATP binding protein, putative [Ricinus c | 0.959 | 0.976 | 0.581 | 0.0 | |
| 359483378 | 678 | PREDICTED: cysteine-rich receptor-like p | 0.984 | 0.958 | 0.587 | 0.0 | |
| 224076497 | 591 | predicted protein [Populus trichocarpa] | 0.881 | 0.984 | 0.589 | 0.0 | |
| 356540317 | 647 | PREDICTED: cysteine-rich receptor-like p | 0.913 | 0.931 | 0.587 | 0.0 | |
| 224113911 | 657 | predicted protein [Populus trichocarpa] | 0.956 | 0.960 | 0.551 | 0.0 | |
| 357480739 | 644 | Cysteine-rich receptor-like protein kina | 0.933 | 0.956 | 0.558 | 0.0 | |
| 359477817 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.965 | 0.950 | 0.461 | 1e-154 | |
| 147776074 | 815 | hypothetical protein VITISV_005300 [Viti | 0.909 | 0.736 | 0.480 | 1e-153 | |
| 359496581 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.922 | 0.914 | 0.443 | 1e-152 |
| >gi|302144055|emb|CBI23160.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/677 (59%), Positives = 483/677 (71%), Gaps = 27/677 (3%)
Query: 2 VHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNAN 61
V KAIQL+ I + + DL D PPYN+CST+T S NL+N+L SL S A
Sbjct: 31 VSKAIQLLFISSVLSGFPDLVCAD-PPYNVCSTTTTYGLN-SLFQSNLENLLDSLPSKAF 88
Query: 62 AAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQ 121
+ F N S GN DRV G ++CLNY++ + C +CI+TA+ + KLCPN EAIVWE+ CQ
Sbjct: 89 VSHFDNTSIGNGLDRVNGAFLCLNYVANDQCRNCISTAAYHVKKLCPNMNEAIVWEDECQ 148
Query: 122 LRYAYQNFFGQLDVSGNIPKYNRLNISEPE----RYRSVVNNTLSDLITKLSAFDPFEMY 177
+ Y+ + F G L +GNIP N N+S+ E R+RSVVN+TL +LI + + +MY
Sbjct: 149 ILYSNETFLGHLSTTGNIPLDNMKNVSDLESEQLRFRSVVNDTLQNLIKQAAFNSSTDMY 208
Query: 178 ATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRY 237
AT V FT+ D YALVQCT DL D+C CL AT +IL+ YFSRGARLLSR+CYLRY
Sbjct: 209 ATKPVVFTDVDILYALVQCTPDLSPDNCSICLQTATTEILAVYYFSRGARLLSRSCYLRY 268
Query: 238 ELYAFYKGATEPSILAGNQASGGGK--QRKMWMIIVLASV-VALLLVVFASTGYFFATKK 294
E Y FY+ ATEP Q G K +RK MI+++ SV V+L++ A Y AT+
Sbjct: 269 EFYPFYEVATEPQAPVSPQNPGTRKDGRRKTGMILIITSVSVSLVVATLAFYVYCLATRN 328
Query: 295 ITRK-RKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDF-FIDLETLNLATSNFS 352
+K RK +++QL I D + T + H GR + L +Q+F FIDL T++ AT NFS
Sbjct: 329 GKKKERKQYLNREVQLPDIDDPSYTGPYQFH--GRKS-LNSQEFLFIDLATIHEATDNFS 385
Query: 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+ N LGQGGFGPVYKGVL DGKEVAVKRLSS SEQG+ EFTNEVLLI+KLQHKNLV+LLG
Sbjct: 386 ELNKLGQGGFGPVYKGVLRDGKEVAVKRLSSDSEQGSEEFTNEVLLIMKLQHKNLVRLLG 445
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
FCVD +E++LVYE+MPN SLD LFDPR+R L W +R NI+ GIA+G+LYLHEDSRLRI
Sbjct: 446 FCVDREERMLVYEYMPNSSLDVFLFDPRRRAQLDWSRRLNIIGGIARGILYLHEDSRLRI 505
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
+HRDLKASNVLLD DM KISDFGMARIF SEGEANT IVGT+GYMAPEYAMEGLYS
Sbjct: 506 IHRDLKASNVLLDCDMKPKISDFGMARIFGGSEGEANTATIVGTHGYMAPEYAMEGLYSV 565
Query: 533 KSDVFSFGVLLIEIITGRRNAG------SNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586
KSDVFSFGVLL+EIITGRRN+G + L++YAW LWNEG EL+DPLLTD S
Sbjct: 566 KSDVFSFGVLLLEIITGRRNSGFHLSKRAPSLISYAWQLWNEGKGSELMDPLLTD-SCCQ 624
Query: 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSIGRVTDGHCNNNN 646
+EF R HIGLLCVQEDAFDRPTMSSV MLK ET TL QP++PAFSIGR TD C+ N
Sbjct: 625 NEFLRCYHIGLLCVQEDAFDRPTMSSVV-MLKSETVTLRQPERPAFSIGRFTD--CDEKN 681
Query: 647 ---CSANGLTISNLSPR 660
CS NGLT+SN+ PR
Sbjct: 682 ACGCSVNGLTVSNIGPR 698
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555023|ref|XP_002518549.1| ATP binding protein, putative [Ricinus communis] gi|223542394|gb|EEF43936.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/664 (58%), Positives = 474/664 (71%), Gaps = 31/664 (4%)
Query: 4 KAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAA 63
K + +L+ L + D A+ D PPY +C +A +NL+N+L SL SNA+
Sbjct: 9 KIFEFLLLCFLVGSFLDFAYAD-PPYLLCPNINNQAANI-PFQNNLKNLLLSLPSNASGL 66
Query: 64 KFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLR 123
K ++S GN++D+VY YMCLNY++++ C+ CI TAS+DI + C N EAIVWEEVCQLR
Sbjct: 67 KVFDSSIGNNTDKVYSQYMCLNYVTSDKCSSCIQTASEDIKQSCANSAEAIVWEEVCQLR 126
Query: 124 YAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVP 183
Y+ Q+F G LDVSGN N NIS P+++RS+VN T+S LI K + + MYAT E
Sbjct: 127 YSNQSFLGHLDVSGNQFYDNEKNISNPDQFRSLVNQTVSGLIKKAAFNNSVNMYATGEAA 186
Query: 184 FTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFY 243
FT+++ YALVQCT DL +DDC TCL A A++ SCCYFSRGARLLSR+CYLRYELYAFY
Sbjct: 187 FTSTEKLYALVQCTTDLSSDDCSTCLQVALANLSSCCYFSRGARLLSRSCYLRYELYAFY 246
Query: 244 KGATEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTA 303
KG A NQ +G KQ K WMI L + A+L+V+ S+ F ++ + +
Sbjct: 247 KGENGDPASAQNQGTGKSKQTKTWMIAFLTATTAILVVLALSS--FIYSRSMKK------ 298
Query: 304 RKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFG 363
++ F Q G+D + F+D +++ AT NF +SN+LGQGGFG
Sbjct: 299 ------------DNPAFQNQSFHGKDGLSAKESGFMDFASIHAATDNFCESNLLGQGGFG 346
Query: 364 PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423
PVYKG+LSDGKE+AVKRL++CSEQG EF E+ LI+KLQHKNLV+LLGFC DG+EKLLV
Sbjct: 347 PVYKGILSDGKEIAVKRLATCSEQGIEEFKTEIQLIMKLQHKNLVRLLGFCFDGEEKLLV 406
Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
YEFMPN SLD ILFDPRKR L W KR NI+NGIAKG+LYLHEDSRLRI+HRDLK SN+L
Sbjct: 407 YEFMPNSSLDVILFDPRKRAQLDWCKRINIINGIAKGILYLHEDSRLRIIHRDLKPSNIL 466
Query: 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
LD++MN KISDFG ARIF SEGEANT R+VGTYGYMAPEYAMEGLYS KSDVFSFGVLL
Sbjct: 467 LDNEMNPKISDFGTARIFG-SEGEANTCRVVGTYGYMAPEYAMEGLYSTKSDVFSFGVLL 525
Query: 544 IEIITGRRNAGSNQ------LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGL 597
+EIITGR+N GS++ L AYAWHLWN GN LEL+DPLL+D S DEFSRY+HIGL
Sbjct: 526 LEIITGRKNTGSHKSKNAPNLSAYAWHLWNRGNELELMDPLLSD-SCCPDEFSRYMHIGL 584
Query: 598 LCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSIGRVTDG-HCNNNNCSANGLTISN 656
LC+QEDA DRPTMS V ML+ E LPQP KPAFS+GR T+ N N+ S N LT S+
Sbjct: 585 LCLQEDACDRPTMSYVVLMLRSEAAALPQPGKPAFSVGRFTNNIEANYNDSSTNYLTTSD 644
Query: 657 LSPR 660
+S R
Sbjct: 645 VSAR 648
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483378|ref|XP_002265659.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/682 (58%), Positives = 483/682 (70%), Gaps = 32/682 (4%)
Query: 2 VHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNAN 61
V KAIQL+ I + + DL D PPYN+CST+T S NL+N+L SL S A
Sbjct: 6 VSKAIQLLFISSVLSGFPDLVCAD-PPYNVCSTTTTYGLN-SLFQSNLENLLDSLPSKAF 63
Query: 62 AAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQ 121
+ F N S GN DRV G ++CLNY++ + C +CI+TA+ + KLCPN EAIVWE+ CQ
Sbjct: 64 VSHFDNTSIGNGLDRVNGAFLCLNYVANDQCRNCISTAAYHVKKLCPNMNEAIVWEDECQ 123
Query: 122 LRYAYQNFFGQLDVSGNIPKYNRLNISEPE----RYRSVVNNTLSDLITKLSAFDPFEMY 177
+ Y+ + F G L +GNIP N N+S+ E R+RSVVN+TL +LI + + +MY
Sbjct: 124 ILYSNETFLGHLSTTGNIPLDNMKNVSDLESEQLRFRSVVNDTLQNLIKQAAFNSSTDMY 183
Query: 178 ATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRY 237
AT V FT+ D YALVQCT DL D+C CL AT +IL+ YFSRGARLLSR+CYLRY
Sbjct: 184 ATKPVVFTDVDILYALVQCTPDLSPDNCSICLQTATTEILAVYYFSRGARLLSRSCYLRY 243
Query: 238 ELYAFYKGATEPSILAGNQASGGGK--QRKMWMIIVLASV-VALLLVVFASTGYFFATKK 294
E Y FY+ ATEP Q G K +RK MI+++ SV V+L++ A Y AT+
Sbjct: 244 EFYPFYEVATEPQAPVSPQNPGTRKDGRRKTGMILIITSVSVSLVVATLAFYVYCLATRN 303
Query: 295 ITRK-RKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDF-FIDLETLNLATSNFS 352
+K RK +++QL I D + T + H GR + L +Q+F FIDL T++ AT NFS
Sbjct: 304 GKKKERKQYLNREVQLPDIDDPSYTGPYQFH--GRKS-LNSQEFLFIDLATIHEATDNFS 360
Query: 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+ N LGQGGFGPVYKGVL DGKEVAVKRLSS SEQG+ EFTNEVLLI+KLQHKNLV+LLG
Sbjct: 361 ELNKLGQGGFGPVYKGVLRDGKEVAVKRLSSDSEQGSEEFTNEVLLIMKLQHKNLVRLLG 420
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
FCVD +E++LVYE+MPN SLD LFDPR+R L W +R NI+ GIA+G+LYLHEDSRLRI
Sbjct: 421 FCVDREERMLVYEYMPNSSLDVFLFDPRRRAQLDWSRRLNIIGGIARGILYLHEDSRLRI 480
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY-----GYMAPEYAME 527
+HRDLKASNVLLD DM KISDFGMARIF SEGEANT IVGT+ GYMAPEYAME
Sbjct: 481 IHRDLKASNVLLDCDMKPKISDFGMARIFGGSEGEANTATIVGTHFSLDSGYMAPEYAME 540
Query: 528 GLYSKKSDVFSFGVLLIEIITGRRNAG------SNQLLAYAWHLWNEGNVLELVDPLLTD 581
GLYS KSDVFSFGVLL+EIITGRRN+G + L++YAW LWNEG EL+DPLLTD
Sbjct: 541 GLYSVKSDVFSFGVLLLEIITGRRNSGFHLSKRAPSLISYAWQLWNEGKGSELMDPLLTD 600
Query: 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSIGRVTDGH 641
S +EF R HIGLLCVQEDAFDRPTMSSV MLK ET TL QP++PAFSIGR TD
Sbjct: 601 -SCCQNEFLRCYHIGLLCVQEDAFDRPTMSSVV-MLKSETVTLRQPERPAFSIGRFTD-- 656
Query: 642 CNNNN---CSANGLTISNLSPR 660
C+ N CS NGLT+SN+ PR
Sbjct: 657 CDEKNACGCSVNGLTVSNIGPR 678
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076497|ref|XP_002304952.1| predicted protein [Populus trichocarpa] gi|222847916|gb|EEE85463.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/633 (58%), Positives = 445/633 (70%), Gaps = 51/633 (8%)
Query: 8 LILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSN 67
++L+Y ANL DLA+ D PPY +CS + S +NL+ ++ SL+SNA+ +K N
Sbjct: 1 ILLLYFSIANLLDLAYAD-PPYRLCSNKS-NYIDNSPFQNNLETLMASLSSNASVSKIFN 58
Query: 68 ASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQ 127
S G D DRVY YMCLNY++ E+C C+ ASQDI +LCP +A+VWEE+CQLRY+ Q
Sbjct: 59 TSTGIDPDRVYAQYMCLNYVTNESCRTCVAAASQDIRQLCPGDKKAVVWEELCQLRYSNQ 118
Query: 128 NFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDP-FEMYATDEVPFTN 186
F G LDVSGN+P+YN NIS PE VVN LS LI K +AFDP MYAT + PFT+
Sbjct: 119 RFLGHLDVSGNVPQYNPKNISNPEHLSLVVNKILSSLIKK-AAFDPSANMYATRDEPFTD 177
Query: 187 SDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGA 246
SD+F++LVQC+ DL +DC TCL A ++ +CCYFSRGAR+LSR+CYLRYELY FY GA
Sbjct: 178 SDSFFSLVQCSTDLSPNDCYTCLEVAVKNVTTCCYFSRGARVLSRSCYLRYELYDFYDGA 237
Query: 247 TEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQ 306
TE S + +G G LL I + R G R
Sbjct: 238 TESS---KSPVTGKGTN---------------LL--------------IDQLRHGKFRV- 264
Query: 307 IQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVY 366
N DF Q Q RD + +DL ++N AT NFS++N+LGQGGFGPVY
Sbjct: 265 -----FDHPNHNDFQNQDFQ-RDGLNDRESAIMDLASINAATDNFSETNLLGQGGFGPVY 318
Query: 367 KGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426
KG+LSDGKEVAVKRLS SEQG EFTNEVLLI+KLQHKNLVKLLGFCVDG+EKLLVYEF
Sbjct: 319 KGILSDGKEVAVKRLSDSSEQGKNEFTNEVLLIMKLQHKNLVKLLGFCVDGEEKLLVYEF 378
Query: 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
MPN SLD +LFDPRK L WR R +I+NGIAKG LYLHEDSRLRI+HRDLKASN+LLD+
Sbjct: 379 MPNNSLDVVLFDPRKGAQLSWRSRIHIINGIAKGTLYLHEDSRLRIIHRDLKASNILLDN 438
Query: 487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546
+MN KISDFGMARI +EGEANTVRI GTYGYMAPEYAMEGLYS KSDVFSFGV+L+EI
Sbjct: 439 NMNPKISDFGMARIMEANEGEANTVRIAGTYGYMAPEYAMEGLYSTKSDVFSFGVILLEI 498
Query: 547 ITGRRNAGSNQ------LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCV 600
ITGR+N+G ++ LLAYAW LWN G LE++DP+L D+ S DEFSR +HIGLLCV
Sbjct: 499 ITGRKNSGFHKSKRAPSLLAYAWELWNNGKELEMIDPVLVDSCCS-DEFSRCVHIGLLCV 557
Query: 601 QEDAFDRPTMSSVAPMLKGETGT-LPQPQKPAF 632
QEDA +RP MSSV MLK + LPQPQ+PA
Sbjct: 558 QEDASERPAMSSVVLMLKSDNSIDLPQPQRPAI 590
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356540317|ref|XP_003538636.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1841), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/648 (58%), Positives = 469/648 (72%), Gaps = 45/648 (6%)
Query: 21 LAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSN-ASFGNDSDRVYG 79
+ F D PPY ICSTS++ A+ S+ ++NL N+L+SL+S A+ KF N +S+G DRVYG
Sbjct: 37 VVFAD-PPYYICSTSSS-FAKGSSFENNLTNLLSSLSSIASNYKFYNTSSYGIGPDRVYG 94
Query: 80 LYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNI 139
LYMCL+YI+ E+C CITTA++DI KLCP TEA+VWEE+CQLRY+ NF G L+V+GNI
Sbjct: 95 LYMCLDYITNESCKTCITTATEDIVKLCPRATEAVVWEELCQLRYSNSNFMGMLNVTGNI 154
Query: 140 PKYNRLNISEPERYRSVVNNTLSDLITKLSAFD-PFEMYATDEVPFTNSDTFYALVQCTK 198
N+ N+SEPE++ S VN T+S+L TK+++F MYAT EVPF + +T YALVQCT+
Sbjct: 155 GLDNKQNLSEPEKFESAVNQTISNL-TKVASFGVSANMYATGEVPFED-ETIYALVQCTR 212
Query: 199 DLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQAS 258
DL A DC CL +A DI CCY S G R+LSR+CYLRYE YAFY GAT P+ + +
Sbjct: 213 DLTASDCSRCLQSAIGDIPGCCYASIGGRVLSRSCYLRYEFYAFYHGATGPTDSSIGKKE 272
Query: 259 GGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDT 318
G K+W+I + VV L++V F F + KRK ++ I H+I
Sbjct: 273 GENNSSKIWVITGIIVVVGLVIVFF-----IFGLYLVRNKRKRQSKNGIDNHQI------ 321
Query: 319 DFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAV 378
+L +L +AT+NFSD N LGQGGFGPVYKG LSDG+EVA+
Sbjct: 322 ---------------------NLGSLRVATNNFSDLNKLGQGGFGPVYKGKLSDGQEVAI 360
Query: 379 KRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD 438
KRLS+CSEQG+ EF NEVLLI++LQHKNLVKLLGFCVDG+EKLLVYEF+PNGSLD +LFD
Sbjct: 361 KRLSTCSEQGSEEFINEVLLIMQLQHKNLVKLLGFCVDGEEKLLVYEFLPNGSLDVVLFD 420
Query: 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
P +R L W KR +I+NGIA+G+LYLHEDSRL+I+HRDLKASN+LLD DMN KISDFGMA
Sbjct: 421 PNQRERLDWTKRLDIINGIARGILYLHEDSRLKIIHRDLKASNILLDYDMNPKISDFGMA 480
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG---- 554
RIFA SEGEANT IVGTYGYMAPEYAMEGLYS KSDVF FGVLL+EII G+RNAG
Sbjct: 481 RIFAGSEGEANTATIVGTYGYMAPEYAMEGLYSIKSDVFGFGVLLLEIIAGKRNAGFYHS 540
Query: 555 --SNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSS 612
+ LL+YAWHLWNEG +EL+DPLL D S DEF RY+HIGLLCVQEDA+DRPTMSS
Sbjct: 541 KNTPSLLSYAWHLWNEGKEMELIDPLLVD-SCPGDEFLRYMHIGLLCVQEDAYDRPTMSS 599
Query: 613 VAPMLKGETGTLPQPQKPAFSIGRVTDGHCNNNNCSANGLTISNLSPR 660
V MLK E+ L QP++P FS+GR + S N LT+S++ P+
Sbjct: 600 VVLMLKNESAMLGQPERPPFSLGRFNANEPGCEDYSLNFLTLSDIVPQ 647
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113911|ref|XP_002316612.1| predicted protein [Populus trichocarpa] gi|222859677|gb|EEE97224.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/664 (55%), Positives = 450/664 (67%), Gaps = 33/664 (4%)
Query: 8 LILIYCLTANL--HDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKF 65
L+L+Y A L H F PPY CS ++ A S +NLQ +++ LASNA+ +
Sbjct: 15 LLLLYFSIATLSQHSSNFLTHPPYKFCSNTSLYEAN-SPFQNNLQTLMSYLASNASVSNQ 73
Query: 66 SNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYA 125
+A GND D VY YMC NYI E C+ CI ASQDI +LCPN A VWEE+CQLR++
Sbjct: 74 YHAYAGNDPDIVYAQYMCYNYI--ENCSACIYAASQDIMQLCPNNRNATVWEELCQLRFS 131
Query: 126 YQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFE-MYATDEVPF 184
+NF GQLD+SGNI N I P +Y SVVN S+L TK +AFDP + MYAT ++
Sbjct: 132 NKNFIGQLDISGNIIVANTETIENPGQYISVVNENFSNL-TKKAAFDPTQNMYATGKLAL 190
Query: 185 TNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYK 244
++ DT Y L QCT DL + DC TCL A +I SCCY RG RLLS++CY RYELY FY+
Sbjct: 191 SDIDTLYTLGQCTTDLSSHDCSTCLQVAIQNISSCCYIGRGQRLLSQSCYFRYELYPFYE 250
Query: 245 GATEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTAR 304
G + SG + + IVL + + +++ F ++I+RK +
Sbjct: 251 GTAD---------SG---ETLTILKIVLGTCIPAVVLAFLIASCIIYFRRISRKETDEEK 298
Query: 305 KQIQ-LHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFG 363
+ L ++ ++ + +G + + +DL + AT NFS SN LGQGGFG
Sbjct: 299 SHLDFLQELRKSSGSTL----AEGNKVSSEELPWMMDLSVIRAATDNFSVSNKLGQGGFG 354
Query: 364 PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423
VYKG+LSDG EVAVKRLS SEQG EF EVLLI+KLQHKNLV+LLGFCV+G+EKLLV
Sbjct: 355 SVYKGILSDGSEVAVKRLSRSSEQGVKEFKTEVLLIMKLQHKNLVRLLGFCVEGEEKLLV 414
Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
YEFMPN SLD LFDP KR L W R +I+NGIAKGMLYLHEDSRLRI+HRDLKASNVL
Sbjct: 415 YEFMPNSSLDVFLFDPTKRAELDWSSRIDIINGIAKGMLYLHEDSRLRIIHRDLKASNVL 474
Query: 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
LD++MN KISDFGMARIF+ +E EANT RIVGTYGYMAPEYAMEGLYS KSDVFSFGVLL
Sbjct: 475 LDNEMNPKISDFGMARIFSSNEDEANTARIVGTYGYMAPEYAMEGLYSTKSDVFSFGVLL 534
Query: 544 IEIITGRRNAGSNQ------LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGL 597
+EII+GR+ AG +Q LLAYAW LWNEGN EL+D +L+D S + DEFSRY+HIGL
Sbjct: 535 LEIISGRKKAGYHQSKCAPSLLAYAWQLWNEGNKAELIDSMLSD-SCNADEFSRYMHIGL 593
Query: 598 LCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSIGRVTDG-HCNNNNCSANGLTISN 656
LCVQEDA DRPTMSSV MLK + LPQP++PAF +GR D +N S N +T+S+
Sbjct: 594 LCVQEDASDRPTMSSVVLMLKSQNSFLPQPERPAF-VGRFMDNLEATASNFSVNEMTLSD 652
Query: 657 LSPR 660
+ PR
Sbjct: 653 VGPR 656
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357480739|ref|XP_003610655.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355511990|gb|AES93613.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 673 bits (1736), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/681 (55%), Positives = 460/681 (67%), Gaps = 65/681 (9%)
Query: 1 MVHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASN- 59
+V K IQ L+ L LA D PPY ICST A S+ D+NL N+L SL N
Sbjct: 6 IVFKFIQFFLVLYTLDFLSYLALAD-PPYEICSTRNI-YANGSSFDNNLSNLLLSLPFND 63
Query: 60 -ANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEE 118
+ +KF N S G DRVYGLYMCL+++S ETC C+T A D KLCP EA+V+EE
Sbjct: 64 SNSISKFGNTSSGIGLDRVYGLYMCLDFVSNETCLKCVTNAIADTVKLCPQSKEAVVYEE 123
Query: 119 VCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFD-PFEMY 177
CQ+RY+ +NF G L+V+GNI K N NISEP ++ + VN L+ L TK+++F+ MY
Sbjct: 124 FCQVRYSNKNFIGSLNVNGNIGKDNVQNISEPVKFETSVNKLLNGL-TKIASFNVSANMY 182
Query: 178 ATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRY 237
AT EVPF + T YALVQCT+DL A+DC CL +A DI CCY S GAR++SR+CYLRY
Sbjct: 183 ATGEVPFEDK-TIYALVQCTRDLAANDCSRCLLSAIGDIPGCCYASIGARVMSRSCYLRY 241
Query: 238 ELYAFYKGATEPSILAGNQASGGGKQR--------KMWMIIVLASVVALLLVVFASTGYF 289
E Y FY G E + + N GGK + K+WMI V+A V L++++F F
Sbjct: 242 EFYPFYLGEKEQTKSSTNL---GGKSKHFSSYNSSKIWMITVIAVGVGLVIIIFICYLCF 298
Query: 290 FATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDF-FIDLETLNLAT 348
R R+ + N ++DF FIDL +L +AT
Sbjct: 299 L------RNRQSN-------------------------KGNGKISKDFPFIDLASLRVAT 327
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
NF+DSN LG+GGFGPVYKG+LSDG+EVA+KRLS CSEQG+ EF NEV+LILKLQHKNLV
Sbjct: 328 RNFTDSNKLGEGGFGPVYKGILSDGQEVAIKRLSICSEQGSEEFINEVMLILKLQHKNLV 387
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
KLLGFCVDG+EKLLVYE++PNGSLD +LF+ + L W KR +I+NGIA+G+LYLHEDS
Sbjct: 388 KLLGFCVDGEEKLLVYEYLPNGSLDVVLFEQHAQ--LDWTKRLDIINGIARGILYLHEDS 445
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
RL+I+HRDLKASNVLLD+DMN KISDFGMARIFA SEGEANT IVGTYGYMAPEYAMEG
Sbjct: 446 RLQIIHRDLKASNVLLDNDMNPKISDFGMARIFAGSEGEANTTTIVGTYGYMAPEYAMEG 505
Query: 529 LYSKKSDVFSFGVLLIEIITGRRNAG------SNQLLAYAWHLWNEGNVLELVDPLLTDT 582
LYS KSDVF FGVLL+EIITG RNAG + LLAYAWHLWN+G LEL DPLL
Sbjct: 506 LYSIKSDVFGFGVLLLEIITGIRNAGFCYSKTTPSLLAYAWHLWNDGKGLELRDPLLLCP 565
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSIGRVTDGHC 642
D+F RY++IGLLCVQEDAFDRPTMSSV ML E+ L QP KP FS+GR+
Sbjct: 566 G---DQFLRYMNIGLLCVQEDAFDRPTMSSVVLMLMNESVMLGQPGKPPFSVGRLNFIDQ 622
Query: 643 N----NNNCSANGLTISNLSP 659
N S N LT+S++ P
Sbjct: 623 NELDLEEEYSVNFLTVSDILP 643
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477817|ref|XP_003632027.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 552 bits (1423), Expect = e-154, Method: Compositional matrix adjust.
Identities = 315/683 (46%), Positives = 422/683 (61%), Gaps = 46/683 (6%)
Query: 8 LILIYCLTANLHDLAFGDSPP-------YNICST-STAGSARASTIDDNLQNVLT-SLAS 58
+I+ C+ LA+ +P Y C+ S AGS + NL +L+ SL +
Sbjct: 4 VIVFLCIFLYSLPLAWSQTPANYQPGFLYTFCNNNSHAGSTK---FQSNLGALLSRSLNN 60
Query: 59 NANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEE 118
+ FS G D D+VYGL++C +S C CI A+ I ++C +K EAI+W
Sbjct: 61 EGGISSFSMVYEGEDPDKVYGLFLCRPDVSKHICQSCIDAATLKIVQVCQHKKEAIIWYN 120
Query: 119 VCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYA 178
C LRY+ ++FF L++ + +N N S P+++ + +L + ++ D +MYA
Sbjct: 121 ECFLRYSNRSFFSNLEMKPTLYMWNTQNASAPDKFDQKLGEMFQNLTAQATSSD--DMYA 178
Query: 179 TDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYE 238
+V +N Y +VQCT+DL C CL I + +G R+L+ +CY+RYE
Sbjct: 179 IGQVEVSNFLNLYGIVQCTRDLRMSYCRRCLDEVVGYIPNFMEGKQGGRVLAPSCYIRYE 238
Query: 239 LYAFYKGATEPSILAGNQASG----GGKQRKMWMIIVLASVVALLLVVFASTGYFFATKK 294
+Y F A E ++ S G K RK I S+ +++V F Y+
Sbjct: 239 VYPF--AAVEDPVVEAQVPSSISPRGRKGRKTKWIATGTSLSGIVVVAFCV--YY----- 289
Query: 295 ITRKRKGT------ARKQIQLHKIGDA--NDTDFHYQHVQGRDNDLKAQDF-FIDLETLN 345
+ R+RKG ++ + L +G + D+ + +QG D K+++F I + +
Sbjct: 290 VIRRRKGADPEEKESKGDLCLLDLGGGRLDAEDYSSETLQG-DMLAKSKEFPVIGFDIVY 348
Query: 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK 405
AT +FS+ N LG+GGFGPVYKG LSDGKE+AVKRLSS S QG EF NEV+LI KLQH+
Sbjct: 349 EATQHFSNDNKLGEGGFGPVYKGTLSDGKEIAVKRLSSTSGQGLQEFKNEVILIAKLQHR 408
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
NLV+LLG C++G+E LL+YE+MPN SLD LFD + L W+ R +I+NGIA+G+ YLH
Sbjct: 409 NLVRLLGCCLEGNELLLIYEYMPNKSLDFFLFDSTRGLELDWKTRFSIINGIARGISYLH 468
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
EDSRLRI+HRDLK SN+LLD DMN KISDFG+ARIFA SE NT +IVG+YGYMAPEYA
Sbjct: 469 EDSRLRIIHRDLKPSNILLDGDMNPKISDFGLARIFAGSENGTNTAKIVGSYGYMAPEYA 528
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRRNAGSN------QLLAYAWHLWNEGNVLELVDPLL 579
MEGLYS KSDVFSFGV+L+EIITGR+NAG + LL+YAW LWNEG LEL+DPLL
Sbjct: 529 MEGLYSNKSDVFSFGVVLLEIITGRKNAGFHLSGMGLSLLSYAWQLWNEGKGLELMDPLL 588
Query: 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSIGRVTD 639
D S DEF R HIGLLCVQEDAFDRPTMSSV ML+ E+ TL QP++PAFS+GR +
Sbjct: 589 GD-SCCPDEFLRCYHIGLLCVQEDAFDRPTMSSVIIMLRSESLTLRQPERPAFSVGRFAN 647
Query: 640 GH--CNNNNCSANGLTISNLSPR 660
+ ++ S NGLT S PR
Sbjct: 648 NQEIASGSSSSVNGLTASTTVPR 670
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776074|emb|CAN65425.1| hypothetical protein VITISV_005300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1415), Expect = e-153, Method: Compositional matrix adjust.
Identities = 305/635 (48%), Positives = 402/635 (63%), Gaps = 35/635 (5%)
Query: 48 NLQNVLT-SLASNANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKL 106
NL +L+ SL + + FS G D D+VYGL++C +S C CI A+ I ++
Sbjct: 194 NLGALLSRSLNNEGGISSFSMVYEGEDPDKVYGLFLCRPDVSKHICQSCIDAATLKIVQV 253
Query: 107 CPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLIT 166
C +K EAI+W C LRY+ ++FF L++ + +NR N S P+++ + +L
Sbjct: 254 CQHKKEAIIWYNECFLRYSNRSFFSNLEMKPTLYMWNRQNASAPDKFDQKLGEMFQNLTA 313
Query: 167 KLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGA 226
K ++ D MYA +V +N Y +VQCT+DL C CL I + G
Sbjct: 314 KATSSDG--MYAIGQVEVSNFLNLYGIVQCTRDLRMSYCRQCLDEVVGYIPNFMEGKEGG 371
Query: 227 RLLSRNCYLRYELYAFYKGATEPSILAGNQASG----GGKQRKMWMIIVLASVVALLLVV 282
R+L+ +CY+RYE+Y F A E I+ S G K RK I S+ +++V
Sbjct: 372 RVLAPSCYIRYEIYPF--AAVEDPIVEAQVPSSISPRGRKGRKTKWIATGTSLSGIVVVA 429
Query: 283 FASTGYFFATKKITRKRKGT------ARKQIQLHKIGDA--NDTDFHYQHVQGRDNDLKA 334
F Y+ + R+RKG ++ + L +G + D+ + +QG D K+
Sbjct: 430 FCV--YY-----VIRRRKGADPEEKESKGDLCLLDLGGGRLDAEDYSSETLQG-DMLAKS 481
Query: 335 QDF-FIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFT 393
++F I + + AT +FS+ N LG+GGFGPVYKG LSDGKE+AVKRLS S QG EF
Sbjct: 482 KEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGKEIAVKRLSRTSGQGLQEFK 541
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
NEV+LI KLQH+NLV+LLG C++G+E LL+YE+MPN SLD LFD + L W+ R +I
Sbjct: 542 NEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFFLFDSTRGLELDWKTRFSI 601
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
+NGIA+G+ YLHEDSRLRI+HRDLK SN+LLD DMN KISDFG+ARIFA SE NT +I
Sbjct: 602 INGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDFGLARIFAGSENGTNTAKI 661
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN------QLLAYAWHLWN 567
VG+YGYMAPEYAMEGLYS KSDVFSFGV+L+EIITGR+NAG + LL+YAW LWN
Sbjct: 662 VGSYGYMAPEYAMEGLYSNKSDVFSFGVVLLEIITGRKNAGFHLSGMGLSLLSYAWQLWN 721
Query: 568 EGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQP 627
EG LEL+DPLL D S DEF R HIGLLCVQEDAFDRPTMSSV ML+ E+ +L QP
Sbjct: 722 EGKGLELMDPLLGD-SCCPDEFLRCYHIGLLCVQEDAFDRPTMSSVIIMLRSESLSLRQP 780
Query: 628 QKPAFSIGRVTDGH--CNNNNCSANGLTISNLSPR 660
++PAFS+GR + + ++ S NGLT S PR
Sbjct: 781 ERPAFSVGRFANNQEIASGSSSSVNGLTASTAVPR 815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496581|ref|XP_002270035.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1405), Expect = e-152, Method: Compositional matrix adjust.
Identities = 293/660 (44%), Positives = 396/660 (60%), Gaps = 51/660 (7%)
Query: 29 YNICSTSTAGSARASTIDDNLQNVLTSLASNA---NAAKFSNASFGNDSDRVYGLYMCLN 85
Y+ C T + ST +L +LTSL+S+A N KF N + G D VYGLY+C
Sbjct: 30 YSFC-TENSNYVPNSTYQSSLNVLLTSLSSDATILNGRKFHNTTAGQAPDMVYGLYLCRG 88
Query: 86 YISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRL 145
++ C DC+ TASQ+I CPN+ EA+ W + C LRY+ ++ F ++ + N L
Sbjct: 89 DVTDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLTMSNSL 148
Query: 146 NISEPERYRSVVNNTLSDLITKLSA-FDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
++ +P+R+ +VN T+ LI K + +M+ T E F S Y LVQCT DL +
Sbjct: 149 DMDDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNASTKIYGLVQCTPDLSGSN 208
Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFY------KGATEPSILAGNQAS 258
C TCL N + I +CC +GAR+L +C RYELY FY +
Sbjct: 209 CSTCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYGDLAAATPPAPAPSPLSLLSP 268
Query: 259 GGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDT 318
G K ++I + VA+ +V+F+ Y F +K +K T ++++
Sbjct: 269 PGKKGNSSQLLIAIIVPVAVSVVIFSILCYCFICRKAKKKYSSTEEEKVE---------- 318
Query: 319 DFHYQHVQGRDNDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVA 377
ND+ Q D TL AT+NFSD N +G+GGFG VYKG LS GKE+A
Sbjct: 319 -----------NDITTVQSLQFDFGTLEAATNNFSDDNKIGEGGFGDVYKGTLSSGKEIA 367
Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF 437
+KRLS S QG EF NEV+L+ KLQH+NLV+LLGFC++G+EK+LVYE++PN SLD LF
Sbjct: 368 IKRLSRSSAQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDCFLF 427
Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
DP K+G L W +R I+ GIA+G+LYLHEDS+L+++HRDLKASNVLLD DMN KISDFGM
Sbjct: 428 DPDKQGQLDWSRRYKIIGGIARGILYLHEDSQLKVIHRDLKASNVLLDGDMNPKISDFGM 487
Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR------ 551
ARIF + +T R+VGTYGYM+PEYAM G +S KSDV+SFGVL++EII+G++
Sbjct: 488 ARIFGGDQTRGSTKRVVGTYGYMSPEYAMRGHFSAKSDVYSFGVLVLEIISGKKISHFYE 547
Query: 552 NAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMS 611
+ + LL YAW LW +G LEL+DP++ D S++ +E R IH+GLLCVQED DRP+M+
Sbjct: 548 SDQTEDLLGYAWKLWRDGTPLELMDPIMRD-SYARNEVIRCIHMGLLCVQEDPDDRPSMA 606
Query: 612 SVAPMLKGETGTLPQPQKPAFSIGRVT-----------DGHCNNNNCSANGLTISNLSPR 660
SV ML + TLP PQ+PAF IG T + S N +IS L PR
Sbjct: 607 SVVLMLSSYSVTLPLPQQPAFFIGSGTQSGFPIKAESDQSTSKSTPWSVNETSISELYPR 666
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 660 | ||||||
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.469 | 0.463 | 0.573 | 7.5e-120 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.913 | 0.901 | 0.411 | 3.7e-119 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.906 | 0.885 | 0.406 | 5.4e-118 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.853 | 0.832 | 0.423 | 2.7e-116 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.493 | 0.494 | 0.522 | 3.7e-116 | |
| TAIR|locus:2123116 | 700 | CRK30 "cysteine-rich RLK (RECE | 0.442 | 0.417 | 0.567 | 1.6e-115 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.518 | 0.505 | 0.506 | 3.8e-114 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.5 | 0.511 | 0.530 | 8.9e-113 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.469 | 0.464 | 0.537 | 7.9e-112 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.5 | 0.486 | 0.533 | 1e-111 |
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 7.5e-120, Sum P(2) = 7.5e-120
Identities = 184/321 (57%), Positives = 232/321 (72%)
Query: 325 VQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC 384
VQ D +T+ AT FSDSN++G+GGFG VY+G LS G EVAVKRLS
Sbjct: 319 VQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKT 378
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
S QG EF NE +L+ KLQHKNLV+LLGFC++G+EK+LVYEF+PN SLD LFDP K+G
Sbjct: 379 SGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGE 438
Query: 445 LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
L W +R NI+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGMARIF
Sbjct: 439 LDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVD 498
Query: 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA--------GSN 556
+ +ANT RI GT+GYM+PEYAM G +S KSDV+SFGVL++EII+G++N+ GSN
Sbjct: 499 QSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSN 558
Query: 557 QLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616
L+ +AW LW G+ LELVDP + + S+ E +R IHI LLCVQED DRP + ++ M
Sbjct: 559 -LVTHAWRLWRNGSPLELVDPTIGE-SYQSSEATRCIHIALLCVQEDPADRPLLPAIIMM 616
Query: 617 LKGETGTLPQPQKPAFSI-GR 636
L T TL P+ P F + GR
Sbjct: 617 LTSSTTTLHVPRAPGFCLSGR 637
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1173 (418.0 bits), Expect = 3.7e-119, P = 3.7e-119
Identities = 271/658 (41%), Positives = 372/658 (56%)
Query: 29 YNICXXXXXXXXXXXXIDDNLQNVLTSLXXXXXXXXXXX--XXXGNDSDRVYGLYMCLNY 86
Y+ C ++NL+ +L SL G DRV GL+ C
Sbjct: 41 YHTCQNTANYTSNSTY-NNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGD 99
Query: 87 ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
+S E C C++ A D CPN+ EA ++ + C LRY+ QN L +G + N N
Sbjct: 100 VSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTGGVILVNTRN 159
Query: 147 IS--EPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
++ + + +V TL+ T A + + + T + FT +FY LVQCT DL D
Sbjct: 160 VTSNQLDLLSDLVLPTLNQAATV--ALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQD 217
Query: 205 CITCLHNATADILSCCYFSR-GARLLSRNCYLRYELYAFYKGAT------EPSILAGNQA 257
C CL I + R GAR+++ +C RYE+YAFY + PSI +
Sbjct: 218 CSRCLQLVINQIPT----DRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVS 273
Query: 258 SG--GGKQRKMWMIIXXXXXXXXXXXXXXXTGYFFATKKITRKRKGTARKQIQLHKIGDA 315
+ GK +++ GY F T++ ARK
Sbjct: 274 APPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRR--------ARKS--------- 316
Query: 316 NDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE 375
++ D+ A +D T+ AT +F +SN +GQGGFG VYKG LSDG E
Sbjct: 317 ----YYTPSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTE 372
Query: 376 VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI 435
VAVKRLS S QG EF NEV+L+ KLQH+NLV+LLGFC+DG+E++LVYE++PN SLD
Sbjct: 373 VAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYF 432
Query: 436 LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495
LFDP K+G L W +R I+ G+A+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DF
Sbjct: 433 LFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADF 492
Query: 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA-- 553
GMARIF + E NT RIVGTYGYM+PEYAM G YS KSDV+SFGVL++EII+G++N+
Sbjct: 493 GMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSF 552
Query: 554 ----GSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT 609
G++ L++YAW LW+ G LELVDP + + +E R +HIGLLCVQED +RPT
Sbjct: 553 YQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENC-QRNEVVRCVHIGLLCVQEDPAERPT 611
Query: 610 MSSVAPMLKGETGTLPQPQKPA-FSIGRV------TDGHCNNNNCSANGLTISNLSPR 660
+S++ ML T TLP P++P F R+ TD + S + +I+++ PR
Sbjct: 612 LSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1162 (414.1 bits), Expect = 5.4e-118, P = 5.4e-118
Identities = 262/645 (40%), Positives = 363/645 (56%)
Query: 29 YNICXXXXXXXXXXXXIDDNLQNVLTSLXX--XXXXXXXXXXXXG--NDSDRVYGLYMCL 84
Y+IC + NL+ VL+SL G NDS+RVYG+++C
Sbjct: 31 YHICPNTTTYSRNSSYLT-NLRTVLSSLSSPNAAYASLFDNAAAGEENDSNRVYGVFLCR 89
Query: 85 NYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNR 144
+SAE C DC+ A+ + + CP + A++W + C +RY+ Q+ GQ+ + + N+
Sbjct: 90 GDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQSIVGQMRIRPGVFLTNK 149
Query: 145 LNISEPE--RYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPA 202
NI+E + R+ + L D+ K + +AT++ FT T Y+LVQCT DL
Sbjct: 150 QNITENQVSRFNESLPALLIDVAVKAALSS--RKFATEKANFTVFQTIYSLVQCTPDLTN 207
Query: 203 DDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKG-------ATEPS--ILA 253
DC +CL + CC S G R+++ +C RYELY FY A PS + A
Sbjct: 208 QDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTA 267
Query: 254 G--NQASGGGKQRKMWMIIXXXXXXXXXXXXXXXTGYFFATKKITRKRKGTARKQIQLHK 311
N S GK + + +I+ + ++ R K +A
Sbjct: 268 PPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARR--RNNKLSA-------- 317
Query: 312 IGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLS 371
+ D D D + + AT+ FS+SN LG GGFG VYKG L
Sbjct: 318 --ETEDLD--------EDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLI 367
Query: 372 DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431
G+ VA+KRLS S QG EF NEV ++ KLQH+NL KLLG+C+DG+EK+LVYEF+PN S
Sbjct: 368 TGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKS 427
Query: 432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491
LD LFD KR +L W++R I+ GIA+G+LYLH DSRL I+HRDLKASN+LLD+DM+ K
Sbjct: 428 LDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPK 487
Query: 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
ISDFGMARIF + +ANT RIVGTYGYM+PEYA+ G YS KSDV+SFGVL++E+ITG++
Sbjct: 488 ISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKK 547
Query: 552 NA------GSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAF 605
N+ G L+ Y W LW E + LELVD + +F +E R IHI LLCVQED+
Sbjct: 548 NSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRG-NFQTNEVIRCIHIALLCVQEDSS 606
Query: 606 DRPTMSSVAPMLKGETGTLPQPQKPAFSIGRVTDGHCNNNNCSAN 650
+RP+M + M+ T TLP P++ F + + D + SA+
Sbjct: 607 ERPSMDDILVMMNSFTVTLPIPKRSGFLLRTMKDSRDPRSGGSAS 651
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
Identities = 257/607 (42%), Positives = 354/607 (58%)
Query: 48 NLQNVLTSLXXXXXXXXXXXXX--XGNDSDRVYGLYMCLNYISAETCNDCITTASQDISK 105
NL+ +L+S G DRV GL++C +S E C++C+ + +
Sbjct: 59 NLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESLT 118
Query: 106 LCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLI 165
CPN+ EA+ + E C LRY+++NF + G + N NIS + R + + +
Sbjct: 119 RCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDLVQSNM 178
Query: 166 TKLS--AFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFS 223
+ + A + ++T + T+ T Y LVQCT DL DC +CL ++ ++ F
Sbjct: 179 NQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPL--FR 236
Query: 224 RGARLLSRNCYLRYELYAFYK----GA-TEPSILAGN-----QASGGGKQRKMWMIIXXX 273
GAR +C RYELYAFY G + P + G+ S GK +++
Sbjct: 237 IGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTVLVVAI 296
Query: 274 XXXXXXXXXXXXTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLK 333
GY F ++ T+K TA ++GD T
Sbjct: 297 VVLAVLLFIAL-VGYCFLAQR-TKKTFDTASAS----EVGDDMAT--------------- 335
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFT 393
A +D T+ AT++F++SN +G+GGFG VYKG S+GKEVAVKRLS S QG AEF
Sbjct: 336 ADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFK 395
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
EV+++ KLQH+NLV+LLGF + G+E++LVYE+MPN SLD +LFDP K+ L W +R NI
Sbjct: 396 TEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNI 455
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+D+N KI+DFGMARIF + + NT RI
Sbjct: 456 IGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRI 515
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA------GSNQLLAYAWHLWN 567
VGTYGYMAPEYAM G +S KSDV+SFGVL++EII+GR+N+ G+ LL + W LW
Sbjct: 516 VGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTWRLWT 575
Query: 568 EGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQP 627
L+LVDPL+ + + E R IHIGLLCVQED RPT+S+V ML T TLP P
Sbjct: 576 NRTALDLVDPLIANNC-QNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTLPVP 634
Query: 628 QKPAFSI 634
++P F I
Sbjct: 635 RQPGFFI 641
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 901 (322.2 bits), Expect = 3.7e-116, Sum P(2) = 3.7e-116
Identities = 175/335 (52%), Positives = 235/335 (70%)
Query: 329 DNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG 388
D+ + +D + AT++FS++N +G+GGFG VYKG S+G EVAVKRLS SEQG
Sbjct: 314 DDKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQG 373
Query: 389 TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
EF NEV+++ L+HKNLV++LGF ++ +E++LVYE++ N SLD LFDP K+G L W
Sbjct: 374 DTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWT 433
Query: 449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
+R +I+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGMARIF + +
Sbjct: 434 QRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQ 493
Query: 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG------SNQLLAYA 562
NT RIVGTYGYM+PEYAM G +S KSDV+SFGVL++EII+GR+N + L+ +A
Sbjct: 494 NTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHA 553
Query: 563 WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622
W LW G L+LVDP + D S E R HIGLLCVQED RP MS+++ ML T
Sbjct: 554 WRLWRNGTALDLVDPFIAD-SCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTM 612
Query: 623 TLPQPQKPAFSI-GRVTDGHCNNNNCSAN-GLTIS 655
LP PQ+P F + R +++ + N +T+S
Sbjct: 613 ALPAPQQPGFFVRSRPGTNRLDSDQSTTNKSVTVS 647
|
|
| TAIR|locus:2123116 CRK30 "cysteine-rich RLK (RECEPTOR-like protein kinase) 30" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 1.6e-115, Sum P(2) = 1.6e-115
Identities = 172/303 (56%), Positives = 223/303 (73%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLI 399
D++ + ATSNF SN +GQGGFG VYKG LS+G EVAVKRLS S+QG EF NEVLL+
Sbjct: 335 DIKDIEAATSNFLASNKIGQGGFGEVYKGTLSNGTEVAVKRLSRTSDQGELEFKNEVLLV 394
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF---DPRKRGILCWRKRTNIVNG 456
KLQH+NLV+LLGF + G+EK+LV+EF+PN SLD LF +P K+G L W +R NI+ G
Sbjct: 395 AKLQHRNLVRLLGFALQGEEKILVFEFVPNKSLDYFLFGSTNPTKKGQLDWTRRYNIIGG 454
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I +G+LYLH+DSRL I+HRD+KASN+LLD+DMN KI+DFGMAR F + + E +T R+VGT
Sbjct: 455 ITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRDHQTEDSTGRVVGT 514
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-------LLAYAWHLWNEG 569
+GYM PEY G +S KSDV+SFGVL++EI++GR+N+ Q L+ Y W LWN
Sbjct: 515 FGYMPPEYVAHGQFSTKSDVYSFGVLILEIVSGRKNSSFYQMDGSVCNLVTYVWRLWNTD 574
Query: 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQK 629
+ LELVDP ++ S+ DE +R IHIGLLCVQE+ +RP +S++ ML + TL PQ
Sbjct: 575 SSLELVDPAISG-SYEKDEVTRCIHIGLLCVQENPVNRPALSTIFQMLTNSSITLNVPQP 633
Query: 630 PAF 632
P F
Sbjct: 634 PGF 636
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 3.8e-114, Sum P(2) = 3.8e-114
Identities = 183/361 (50%), Positives = 246/361 (68%)
Query: 318 TDFHYQHVQGRDNDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV 376
T++ + + +D+ A D + + AT+ F ++N LGQGGFG VYKG+ G +V
Sbjct: 317 TNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQV 376
Query: 377 AVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL 436
AVKRLS S QG EF NEV+++ KLQH+NLV+LLGFC++ DE++LVYEF+PN SLD +
Sbjct: 377 AVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFI 436
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
FD + +L W +R I+ GIA+G+LYLH+DSRL I+HRDLKA N+LL DMN+KI+DFG
Sbjct: 437 FDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFG 496
Query: 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
MARIF + EANT RIVGTYGYM+PEYAM G +S KSDV+SFGVL++EII+G++N+
Sbjct: 497 MARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVY 556
Query: 557 Q--------LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP 608
Q L+ Y W LW+ G+ LELVDP D ++ +E SR IHI LLCVQE+A DRP
Sbjct: 557 QMDGTSAGNLVTYTWRLWSNGSPLELVDPSFRD-NYRINEVSRCIHIALLCVQEEAEDRP 615
Query: 609 TMSSVAPMLKGETGTLPQPQKPAF--------SIGRVTDGHCNNNN-CSANGLTISNLSP 659
TMS++ ML + L PQ+P F +G V N + CS + +I+N++P
Sbjct: 616 TMSAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVDDASITNVTP 675
Query: 660 R 660
R
Sbjct: 676 R 676
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 884 (316.2 bits), Expect = 8.9e-113, Sum P(2) = 8.9e-113
Identities = 182/343 (53%), Positives = 234/343 (68%)
Query: 330 NDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG 388
ND+ A D + + AT+ F N LGQGGFG VYKG LS G +VAVKRLS S QG
Sbjct: 304 NDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQG 363
Query: 389 TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
EF NEV+++ KLQH+NLVKLLG+C++G+EK+LVYEF+PN SLD LFD + L W
Sbjct: 364 EKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWT 423
Query: 449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
+R I+ GIA+G+LYLH+DSRL I+HRDLKA N+LLD DMN KI+DFGMARIF + EA
Sbjct: 424 RRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEA 483
Query: 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-------LLAY 561
T R+VGTYGYM+PEYAM G +S KSDV+SFGVL++EII+G +N+ Q L+ Y
Sbjct: 484 MTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTY 543
Query: 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621
W LW+ G+ ELVDP D ++ E +R IHI LLCVQEDA DRPTMSS+ ML
Sbjct: 544 TWRLWSNGSPSELVDPSFGD-NYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSL 602
Query: 622 GTLPQPQKPAFSIGRVTD--GHC--NNNNCSANGLTISNLSPR 660
L +P+ P F + G ++ +CS + +I+ ++PR
Sbjct: 603 IALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEASITRVTPR 645
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 7.9e-112, Sum P(2) = 7.9e-112
Identities = 173/322 (53%), Positives = 229/322 (71%)
Query: 322 YQHVQGR-DNDLKAQDFFI-DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVK 379
YQ + ++D+ D + D +T+ AT+ FS SN LG+GGFG VYKG LS+G +VAVK
Sbjct: 319 YQRTKTESESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVK 378
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
RLS S QGT EF NE +L+ KLQH+NLV+LLGFC++ +E++L+YEF+ N SLD LFDP
Sbjct: 379 RLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDP 438
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
K+ L W +R I+ GIA+G+LYLH+DSRL+I+HRDLKASN+LLD+DMN KI+DFG+A
Sbjct: 439 EKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLAT 498
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-- 557
IF + + NT RI GTY YM+PEYAM G YS KSD++SFGVL++EII+G++N+G Q
Sbjct: 499 IFGVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMD 558
Query: 558 -------LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTM 610
L+ YA LW + LELVDP ++ +E +R IHI LLCVQE+ DRP +
Sbjct: 559 ETSTAGNLVTYASRLWRNKSPLELVDPTF-GRNYQSNEVTRCIHIALLCVQENPEDRPML 617
Query: 611 SSVAPMLKGETGTLPQPQKPAF 632
S++ ML T TLP P+ P F
Sbjct: 618 STIILMLTSNTITLPVPRLPGF 639
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 903 (322.9 bits), Expect = 1.0e-111, Sum P(2) = 1.0e-111
Identities = 185/347 (53%), Positives = 238/347 (68%)
Query: 329 DNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG 388
D + + ETL AT NFS N LG+GGFG VYKGV G+E+AVKRLS S QG
Sbjct: 335 DEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQG 394
Query: 389 TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
EF NE+LL+ KLQH+NLV+L+GFC+ G+E+LLVYEF+ N SLD +FD KR +L W
Sbjct: 395 DNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWV 454
Query: 449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
R ++ GIA+G+LYLHEDSR RI+HRDLKASN+LLD +MN KI+DFG+A++F +
Sbjct: 455 VRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMT 514
Query: 509 N--TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN--AGSN------QL 558
+ T RI GTYGYMAPEYAM G +S K+DVFSFGVL+IEIITG+RN GSN L
Sbjct: 515 HRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDL 574
Query: 559 LAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
L++ W W E +L ++DP LT + S +E R IHIGLLCVQE A RPTM++V+ ML
Sbjct: 575 LSWVWRSWREDTILSVIDPSLT--AGSRNEILRCIHIGLLCVQESAATRPTMATVSLMLN 632
Query: 619 GETGTLPQPQKPAFSIGRVT-DGHCNNNN----CSANGLTISNLSPR 660
+ TLP P +PAF + V + +++ S+N +T+S SPR
Sbjct: 633 SYSFTLPTPLRPAFVLESVVIPSNVSSSTEGLQMSSNDVTVSEFSPR 679
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9M0X5 | CRK25_ARATH | 2, ., 7, ., 1, 1, ., - | 0.4234 | 0.8863 | 0.8666 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00006934001 | SubName- Full=Chromosome chr10 scaffold_179, whole genome shotgun sequence; (654 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 660 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-57 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-57 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-57 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-43 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-37 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-36 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-35 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-34 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-34 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-33 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-33 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-33 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-31 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-31 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-28 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-28 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-28 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-27 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-25 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-25 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-25 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-24 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-24 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 5e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-24 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-23 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-23 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-22 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-22 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-20 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 5e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-57
Identities = 80/200 (40%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 356 ILGQGGFGPVYKGVLSDGK-----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG VYKG L EVAVK L SEQ EF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
LLG C + + +V E+M G L + L R + L + IA+GM YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE---S 120
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV-GTYGYMAPEYAMEG 528
+HRDL A N L+ ++ KISDFG++R + + R +MAPE EG
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 529 LYSKKSDVFSFGVLLIEIIT 548
++ KSDV+SFGVLL EI T
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 5e-57
Identities = 100/288 (34%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 355 NILGQGGFGPVYKGVLSDGK----EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG VYKG L EVAVK L SE+ +F E ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL------FDPRKRGILCWRKRTNIVNGIAKGMLY 463
LLG C + + LV E+M G L L F ++ L + + IAKGM Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT-----VRIVGTY 517
L + VHRDL A N L+ D+ KISDFG++R ++ + T +R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-------GRRNAGSNQLLAYAWHLWNEGN 570
+MAPE +G+++ KSDV+SFGVLL EI T G N ++L Y +G
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYL----RKGY 224
Query: 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
L P DE + L C Q D DRPT S + L+
Sbjct: 225 RLP--KPEYC-----PDELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 8e-57
Identities = 79/200 (39%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 356 ILGQGGFGPVYKGVLSDGK-----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG VYKG L EVAVK L SEQ EF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
LLG C + + ++V E+MP G L L R + + + IA+GM YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEYLE---S 121
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGYMAPEYAMEG 528
+HRDL A N L+ ++ KISDFG++R ++ + + ++ +MAPE EG
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179
Query: 529 LYSKKSDVFSFGVLLIEIIT 548
++ KSDV+SFGVLL EI T
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 3e-54
Identities = 76/199 (38%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLG 412
LG G FG VYK GK VAVK L SE + E+ ++ +L H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
D D LV E+ G L L + G L + I I +G+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEGLYS 531
+HRDLK N+LLD + KI+DFG+A+ +S T VGT YMAPE Y
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYG 177
Query: 532 KKSDVFSFGVLLIEIITGR 550
K DV+S GV+L E++TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 6e-54
Identities = 95/280 (33%), Positives = 127/280 (45%), Gaps = 47/280 (16%)
Query: 357 LGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG VYKG L E VAVK L SE+ EF E ++ KL H N+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
LG C G+ +V E+MP G L L + L + + IAKGM YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES---K 121
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT-----VRIVGTYGYMAPEY 524
VHRDL A N L+ ++ KISDFG++R I+ + ++ +MAPE
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK------WMAPES 175
Query: 525 AMEGLYSKKSDVFSFGVLLIEIIT-------GRRNAGSNQLLAYAWHLWNEGNVLELVDP 577
+G ++ KSDV+SFGVLL EI T G N ++L +G L P
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE---EVLELL----EDGYRLPR--P 226
Query: 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617
+ + L C D DRPT S + L
Sbjct: 227 ENCPDELYE--------LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 2e-51
Identities = 76/194 (39%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFC 414
LG+GGFG VY GK+VA+K + E E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
D + LV E+ GSL +L G L + I+ I +G+ YLH I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 475 RDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEGLYSK 532
RDLK N+LLDSD K++DFG++++ + T IVGT YMAPE +G YS+
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 533 KSDVFSFGVLLIEI 546
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 3e-50
Identities = 73/202 (36%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLV 408
+ LG+G FG VY GK VA+K + ++ E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+L D D+ LV E+ G L +L +KRG L + + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
IVHRDLK N+LLD D + K++DFG+AR E + T VGT YMAPE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTF--VGTPEYMAPEVLLGK 171
Query: 529 LYSKKSDVFSFGVLLIEIITGR 550
Y K D++S GV+L E++TG+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 71/205 (34%), Positives = 110/205 (53%), Gaps = 17/205 (8%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
+LG+G FG VY + D G+ +AVK LS SE+ E+ ++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 412 GFCVDGDEK-LLVY-EFMPNGSLDAILFDPRKRGILCWRKRTNI---VNGIAKGMLYLHE 466
G D ++ L ++ E++ GSL ++L +K G L I I +G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKL---PEPVIRKYTRQILEGLAYLH- 118
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
IVHRD+K +N+L+DSD K++DFG A+ + E T + GT +MAPE
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR 551
Y + +D++S G +IE+ TG+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 9e-39
Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 6/200 (3%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
F+ LG G FG V++G+ + VA+K L S +F EV + +L+HK+L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
L C G+ ++ E M GSL A L P + +L ++ +A+GM YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
+HRDL A N+L+ D+ K++DFG+AR+ E ++ +I Y + APE A G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179
Query: 529 LYSKKSDVFSFGVLLIEIIT 548
+S KSDV+SFG+LL E+ T
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 69/205 (33%), Positives = 108/205 (52%), Gaps = 17/205 (8%)
Query: 351 FSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
F +G+GGFG VYK GKEVA+K + S++ + NE+ ++ K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML----YLH 465
G + DE +V EF GSL +L + + + I + K +L YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTL----TESQIAY-VCKELLKGLEYLH 115
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
I+HRD+KA+N+LL SD K+ DFG++ ++++ +VGT +MAPE
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVI 169
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
Y K+D++S G+ IE+ G+
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 71/205 (34%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKN 406
N+ +++G+G FG VYKG+ L G VA+K++S E+ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+VK +G D ++ E+ NGSL I+ +K G V + +G+ YLHE
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YA 525
++HRD+KA+N+L D K++DFG+A + + +V VGT +MAPE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV--VGTPYWMAPEVIE 172
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
M G S SD++S G +IE++TG
Sbjct: 173 MSGA-STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 71/200 (35%), Positives = 104/200 (52%), Gaps = 17/200 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V+ G + +VAVK L + S F E ++ KL+H LV+L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ + +V E+M GSL L + + + ++ IA+GM YL +H
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL-PQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAMEGLYS 531
RDL A N+L+ ++ KI+DFG+AR+ + E A G + APE A G ++
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFT 182
Query: 532 KKSDVFSFGVLLIEIIT-GR 550
KSDV+SFG+LL EI+T GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 71/217 (32%), Positives = 114/217 (52%), Gaps = 25/217 (11%)
Query: 355 NILGQGGFGPVYKGVLS-DGKE---VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G G FG V +G L GK+ VA+K L + S++ +F E ++ + H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L G +++ E+M NGSLD L G + ++ GIA GM YL S
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT------VRIVGTYGYMAPE 523
+ VHRDL A N+L++S++ K+SDFG++R +SE T +R + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------WTAPE 178
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAG--SNQ 557
++ SDV+SFG+++ E+++ G R SNQ
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 74/196 (37%), Positives = 108/196 (55%), Gaps = 14/196 (7%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFCV 415
+G+G FG V G G++VAVK L + A+ F E ++ L+H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKD--DSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
G+ +V E+M GSL L R R ++ ++ + +GM YL E VHR
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSD 535
DL A NVL+ D+ +K+SDFG+A+ A ++ + + T APE E +S KSD
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKE-ASQGQDSGKLPVKWT----APEALREKKFSTKSD 181
Query: 536 VFSFGVLLIEIIT-GR 550
V+SFG+LL EI + GR
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 73/211 (34%), Positives = 113/211 (53%), Gaps = 29/211 (13%)
Query: 356 ILGQGGFGPVYKGV-LSDGK----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+LG G FG VYKGV + +G+ VA+K L S + E +E ++ + H ++V+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
LLG C+ + L+ + MP G L + + + +L W + IAKGM YL
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE----GEANTVRIVGTYGYMA 521
E R+VHRDL A NVL+ + + KI+DFG+A++ E E V I +MA
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI----KWMA 179
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
E + +Y+ KSDV+S+GV + E++T G +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 71/205 (34%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 354 SNILGQGGFGPVYKGVL-----SDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNL 407
LG+G FG V + G++VAVK L+ S EQ ++F E+ ++ L H+N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 408 VKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
VK G C + L+ E++P+GSL L R R + ++ + I KGM YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG--EANTVRIVGTYGYMAPE 523
R +HRDL A N+L++S+ KISDFG+A++ E + + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
+S SDV+SFGV L E+ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 6e-34
Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G FG VY SDGK +K LS+ SE+ + NEV ++ KL H N++K
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRG-------ILCWRKRTNIVNGIAKGMLYLHE 466
+ + +V E+ G L + +K G IL W V + + YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-----FVQ-LCLALKYLHS 121
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
+I+HRD+K N+ L S+ K+ DFG++++ + + A TV VGT Y++PE
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV--VGTPYYLSPELCQ 176
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR 551
Y+ KSD++S G +L E+ T +
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVK 409
LGQG FG VY+G+ VA+K ++ + EF NE ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDPRKRGILCWRKRTNIVNGIAKGML 462
LLG G L+V E M G L + L + G +K + IA GM
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE------GEANTVRIVGT 516
YL + VHRDL A N ++ D+ KI DFGM R E++ VR
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE +G+++ KSDV+SFGV+L E+ T
Sbjct: 187 --WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 86/264 (32%), Positives = 121/264 (45%), Gaps = 38/264 (14%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LG G FG V++G+ ++ VAVK L + +F E ++ KL+H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
+ +V E M GSL L L + ++ +A GM YL + +HRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAMEGLYSKK 533
L A NVL+ + K++DFG+AR+ E EA G + APE A+ +S K
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIK 184
Query: 534 SDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVD-------PLLTDTSFS 585
SDV+SFG+LL EI+T GR + Y VL+ VD P
Sbjct: 185 SDVWSFGILLTEIVTYGR--------MPYPG--MTNAEVLQQVDQGYRMPCPPGCPKELY 234
Query: 586 DDEFSRYIHIGLLCVQEDAFDRPT 609
D I L C +ED DRPT
Sbjct: 235 D--------IMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 74/215 (34%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG V+ G + VAVK L + S +F E L+ QH+N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLD----------AILFDPR-KRGILCWRKRTNIVNGIA 458
G C +GD ++V+E+M +G L+ A L P G L + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANTVRIVGT- 516
GM+YL + VHRDL N L+ D+ KI DFGM+R ++ + R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT-----TDYYRVGGHT 184
Query: 517 ---YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+M PE M ++ +SDV+SFGV+L EI T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 48/279 (17%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKN 406
S+ +LGQG G VYK GK A+K++ E+ + E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 407 LVKLLG-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---------G 456
+VK G F +G+ + V E+M GSL +L K+ +
Sbjct: 61 VVKCYGAFYKEGEISI-VLEYMDGGSLADLL------------KKVGKIPEPVLAYIARQ 107
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I KG+ YLH ++ I+HRD+K SN+L++S KI+DFG++++ + + NT VGT
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGT 163
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR------RNAGSNQLLAYAWHLWNEGN 570
YM+PE YS +D++S G+ L+E G+ +L+
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--------- 214
Query: 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT 609
+ + P L FS EF +I C+Q+D RP+
Sbjct: 215 ICDGPPPSLPAEEFS-PEFRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 75/202 (37%), Positives = 106/202 (52%), Gaps = 22/202 (10%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQHKNLVKLLG 412
+G+G FG VYKGVL EVAVK +C + F E ++ + H N+VKL+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVK---TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
CV +V E +P GSL + F +K+ L +K + A GM YL +S+
Sbjct: 60 VCVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NC 114
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMAR-----IFAESEGEANTVRIVGTYGYMAPEYAME 527
+HRDL A N L+ + KISDFGM+R I+ S+G + I T APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG-LKQIPIKWT----APEALNY 169
Query: 528 GLYSKKSDVFSFGVLLIEIITG 549
G Y+ +SDV+S+G+LL E +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 91/280 (32%), Positives = 123/280 (43%), Gaps = 47/280 (16%)
Query: 357 LGQGGFGPVYKGV--LSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
LG G FG V KGV + GKE VAVK L G EF E ++ +L H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
G C G+ +LV E P G L L +KR + + + +A GM YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLESK---H 115
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAPEYAM 526
VHRDL A NVLL + +KISDFGM+R + G + T G + APE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSR----ALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 527 EGLYSKKSDVFSFGVLLIEIIT-------GRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579
G +S KSDV+S+GV L E + + A +L G L
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-------ESGERLP------ 218
Query: 580 TDTSFSDDEFSRYIH-IGLLCVQEDAFDRPTMSSVAPMLK 618
+E + I+ I L C + DRPT S + +
Sbjct: 219 -----RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 77/219 (35%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 355 NILGQGGFGPVYKGVLS--DGK----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LG G FG VY+G+ DG +VAVK L SCSEQ ++F E L++ K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLY 463
V+L+G + + ++ E M G L + L + R R L + +AKG Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 464 LHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
L E+ +HRD+ A N LL +KI+DFGMAR + R + +M
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEII-------TGRRN 552
PE ++G+++ K+DV+SFGVLL EI GR N
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 7e-32
Identities = 84/271 (30%), Positives = 124/271 (45%), Gaps = 22/271 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE---FTNEVLLILKLQH-KNLVKLLG 412
LG+G FG VY D K VA+K L+ E + E F E+ ++ L H N+VKL
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
F D LV E++ GSL+ +L ++G L + I+ I + YLH I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122
Query: 473 VHRDLKASNVLLDSDMN-SKISDFGMARIFAE----SEGEANTVRIVGTYGYMAPEYAM- 526
+HRD+K N+LLD D K+ DFG+A++ + S A VGT GYMAPE +
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 527 --EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT---D 581
S SD++S G+ L E++TG + + +LEL P L
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTPSLASPLS 240
Query: 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSS 612
S + + + +D +R + SS
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 25/219 (11%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEV 396
D+ + + + +G+G G VYK + GKEVA+K RL +++ NE+
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEI 66
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN---- 452
L++ +H N+V + GDE +V E+M GSL I I R N
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI--------ITQNFVRMNEPQI 118
Query: 453 --IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ + +G+ YLH ++HRD+K+ N+LL D + K++DFG A + + + N+
Sbjct: 119 AYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
V VGT +MAPE Y K D++S G++ IE+ G
Sbjct: 176 V--VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 26/260 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA-----EFTNEVLLILKLQHKNLVKL 410
LG G FG VY+G+ L DG AVK +S + T + E+ L+ KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
LG + D + E +P GSL +L +K G I G+ YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLHDR--- 121
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGL 529
VHRD+K +N+L+D++ K++DFGMA+ + + G+ +MAPE +G
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 530 YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589
Y +D++S G ++E+ TG+ + +A + + + + D L DE
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHL-------SDEA 231
Query: 590 SRYIHIGLLCVQEDAFDRPT 609
+I L C+Q D RPT
Sbjct: 232 KDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 81/217 (37%), Positives = 115/217 (52%), Gaps = 32/217 (14%)
Query: 355 NILGQGGFGPVYKG----VLSDGKE---VAVKRLSSCS-EQGTAEFTNEVLLILKLQHKN 406
N LG G FG VY+G +L G VAVK L + +Q EF E L+ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGML 462
+VKLLG C+ + + ++ E M G L + L D R +L ++ +I +AKG +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 463 YLHEDSRLRIVHRDLKASNVLL-----DSDMNSKISDFGMARIFAES-----EGEAN-TV 511
YL ++ +HRDL A N L+ D+D KI DFG+AR +S EGE V
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
R +MAPE ++G ++ +SDV+SFGVL+ EI+T
Sbjct: 178 R------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 86/267 (32%), Positives = 137/267 (51%), Gaps = 29/267 (10%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLS-SCSEQGTAE-----FTNEVLLILKLQHKNLV 408
+LG+G +G VY G+ + G+ +AVK++ S AE EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+ LG C+D + + EF+P GS+ +IL F P + C + I++G+A YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVA----YLHN 120
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA---ESEGEANTVRIV-GTYGYMAP 522
+ +VHRD+K +NV+L + K+ DFG AR A +N ++ + GT +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582
E E Y +KSD++S G + E+ TG+ S LA +++ G L+ L
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI---GAHRGLMPRL--PD 232
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPT 609
SFS ++ C+ D +RP+
Sbjct: 233 SFSAAAID-FVT---SCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 85/267 (31%), Positives = 126/267 (47%), Gaps = 39/267 (14%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK----NLVKLL 411
LG G G V K + GK +AVK + E A ++L L + HK +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRL--EINEAIQ-KQILRELDILHKCNSPYIVGFY 65
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
G + + + E+M GSLD IL +G + R I + KG+ YLHE +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEK--HK 121
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
I+HRD+K SN+L++S K+ DFG++ S + VGT YMAPE YS
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF----VGTSSYMAPERIQGNDYS 177
Query: 532 KKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG--NVLELVD-------PLLTDT 582
KSD++S G+ LIE+ TGR + + N+ + EL+ P L
Sbjct: 178 VKSDIWSLGLSLIELATGR----------FPYPPENDPPDGIFELLQYIVNEPPPRLPSG 227
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPT 609
FS D F +++ LC+ +D +RP+
Sbjct: 228 KFSPD-FQDFVN---LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 79/269 (29%), Positives = 115/269 (42%), Gaps = 45/269 (16%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V+ G +VA+K R + SE +F E +++KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+V E+M NG L L ++G L ++ + + + M YL + +H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 475 RDLKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGL 529
RDL A N L+ D K+SDFG+AR + S+G V+ + PE
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK------WAPPEVFDYSR 177
Query: 530 YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLE-------LVDPLLTDT 582
+S KSDV+SFGVL+ E+ + + ++ V+E L P L T
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYER---------FSNSEVVESVSAGYRLYRPKLAPT 228
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMS 611
I C E DRP
Sbjct: 229 EVYT--------IMYSCWHEKPEDRPAFK 249
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 21/199 (10%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
+G G FG V+ G + ++VA+K R + SE+ +F E +++KL H LV+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ LV+EFM +G L L +RG + + +GM YL + ++H
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 475 RDLKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGL 529
RDL A N L+ + K+SDFGM R + S G V+ + +PE
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEVFSFSK 177
Query: 530 YSKKSDVFSFGVLLIEIIT 548
YS KSDV+SFGVL+ E+ +
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 72/205 (35%), Positives = 103/205 (50%), Gaps = 26/205 (12%)
Query: 357 LGQGGFGPVYKGV--LSDGKEVAVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLL 411
LG+G FG V V GK A+K L ++ E T E ++ ++ H +VKL
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 412 GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRT-----NIVNGIAKGMLYLH 465
+ +EKL LV E+ P G L + L K G +R IV + YLH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALE----YLH 110
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
L I++RDLK N+LLD+D + K++DFG+A+ + NT GT Y+APE
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVL 165
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
+ Y K D +S GVLL E++TG+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 69/207 (33%), Positives = 115/207 (55%), Gaps = 15/207 (7%)
Query: 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKN 406
+F N +G+G FG V+K V +D + A+K+ LS + + E +E ++ KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI---LCWRKRTNIVNGIAKGMLY 463
+++ +D + +V E+ NG L +L R R + WR I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
LH +I+HRD+K+ N+ LD+ N KI D G+A++ +++ ANT IVGT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITGR 550
+ Y++KSDV++ GV+L E TG+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 75/198 (37%), Positives = 109/198 (55%), Gaps = 14/198 (7%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LG G FG V+ G + +VA+K L S A F E L+ +LQH LV+L V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+ ++ E+M NGSL L P GI L K ++ IA+GM ++ R +HR
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLYSKK 533
DL+A+N+L+ + KI+DFG+AR+ ++E T R + + APE G ++ K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 534 SDVFSFGVLLIEIIT-GR 550
SDV+SFG+LL EI+T GR
Sbjct: 184 SDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 84/275 (30%), Positives = 116/275 (42%), Gaps = 36/275 (13%)
Query: 357 LGQGGFGPVYKG--VLSDGK--EVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLL 411
LG G FG V +G S GK VAVK L S +F E ++ L H+NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLHED 467
G + ++V E P GSL L LC + IA GM YL
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLC-----DYAVQIANGMRYLESK 116
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV----RIVGTYGYMAPE 523
R +HRDL A N+LL SD KI DFG+ R A + E + V V + + APE
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMR--ALPQNEDHYVMEEHLKV-PFAWCAPE 170
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582
+S SDV+ FGV L E+ T G W + +L+ +D
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEE----------PWAGLSGSQILKKIDKEGERL 220
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617
+ ++ L C + DRPT +++ L
Sbjct: 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 73/218 (33%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 349 SNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLSSCSEQGT-AEFTNEVLLILK 401
SN + LG+G FG V+ KG+ +G E V VK L ++ +EF E+ + K
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL------FDPRKRGILCWRKRTNIVN 455
L HKN+V+LLG C + + ++ E+ G L L + K L +++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANT--- 510
IA GM +L S R VHRDL A N L+ S K+S +++ SE N
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+R ++APE E +S KSDV+SFGVL+ E+ T
Sbjct: 182 LR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG+G +G VYK + G+ VA+K + E+ E E+ ++ + +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ +V E+ GS+ I+ K L + I+ KG+ YLH + +H
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLH---SNKKIH 122
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
RD+KA N+LL+ + +K++DFG++ ++ + NTV +GT +MAPE E Y+ K+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV--IGTPFWMAPEVIQEIGYNNKA 180
Query: 535 DVFSFGVLLIEIITGR 550
D++S G+ IE+ G+
Sbjct: 181 DIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 357 LGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG V+ D VAVK L SE +F E L+ LQH+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 411 LGFCVDGDEKLLVYEFMPNGSL---------DAILFDPRKR---GILCWRKRTNIVNGIA 458
G C +G L+V+E+M +G L DA + + G L + I + IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
GM+YL + L VHRDL N L+ + KI DFGM+R ++ R +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+M PE + ++ +SD++SFGV+L EI T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 79/202 (39%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 357 LGQGGFGPVYK---GVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
LG+G FG V L D G+ VAVK+L + + +F E+ ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 412 GFCVD-GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
G C G L LV E++P GSL L R+R L RK + I KGM YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYL---GS 126
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG---TYGYMAPEYAM 526
R VHRDL N+L++S+ KI DFG+ ++ + + E VR G + Y APE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLT 184
Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
E +S SDV+SFGV+L E+ T
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 356 ILGQGGFGPVYKGVLS--DGK--EVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
ILG+G FG V +G LS DG +VAVK +L + EF +E + H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 410 LLGFCVDGDEK------LLVYEFMPNGSLDAILFDPRKRGI---LCWRKRTNIVNGIAKG 460
L+G C + +++ FM +G L + L R G+ L + + IA G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAES---EGEANTVRIVGT 516
M YL S +HRDL A N +L DM ++DFG+++ I++ +G + +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
++A E + +Y+ KSDV++FGV + EI T
Sbjct: 180 -KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 70/212 (33%), Positives = 108/212 (50%), Gaps = 25/212 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE-----FTNEVLLILKLQ 403
N+ +LGQG FG VY D G+E+AVK++ + + E+ L+ LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 404 HKNLVKLLGFCVDGDEKLLVY-EFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-----I 457
H+ +V+ G C+ DE L ++ E+MP GS+ L + G L T V I
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGAL-----TETVTRKYTRQI 113
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAESEGEANTVRIVGT 516
+G+ YLH + IVHRD+K +N+L DS N K+ DFG + R+ + GT
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+M+PE Y +K+DV+S G ++E++T
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT----NEVLLILKLQHKNLVK 409
+G+G +G VYK G+ VA+K++ E F E+ L+ KL+H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLY 463
L + +V+E+M + L +L P + I C+ K+ + +G+ Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQ------LLEGLQY 115
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
LH + I+HRD+K SN+L+++D K++DFG+AR + + T R++ T Y PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171
Query: 524 YAM-EGLYSKKSDVFSFGVLLIEIITGR 550
+ Y + D++S G +L E+ G+
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 72/209 (34%), Positives = 117/209 (55%), Gaps = 20/209 (9%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAE-------FTNEVLLILKLQHK 405
++G G FG VY G+ S G+ +AVK+ L S S E+ L+ +LQH+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
N+V+ LG +D D + E++P GS+ A+L G N V I KG+ YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES--EGEANTVR--IVGTYGYMA 521
+R I+HRD+K +N+L+D+ KISDFG+++ + + N R + G+ +MA
Sbjct: 124 --NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
PE + Y++K+D++S G L++E++TG+
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 72/201 (35%), Positives = 113/201 (56%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LG G FG V+ G + +VAVK L + + F E ++ KL+H LV+L + V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---GIAKGMLYLHEDSRLRI 472
+E + +V E+M GSL L D R + K N+V+ +A GM Y+ R+
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRAL----KLPNLVDMAAQVAAGMAYIE---RMNY 123
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLY 530
+HRDL+++N+L+ + KI+DFG+AR+ ++E T R + + APE A+ G +
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180
Query: 531 SKKSDVFSFGVLLIEIITGRR 551
+ KSDV+SFG+LL E++T R
Sbjct: 181 TIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 78/275 (28%), Positives = 120/275 (43%), Gaps = 32/275 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL----QHK 405
+ + LG+G G V K L + + + + + ++L L++ +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSP 59
Query: 406 NLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRT-NIVNGIAKGML 462
+VK G +D + E+ GSLD+I +KRG K I + KG+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
YLH +I+HRD+K SN+LL K+ DFG++ S A T GT YMAP
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTSFYMAP 172
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR--------RNAGSNQLLAYAWHLWNEGNVLEL 574
E YS SDV+S G+ L+E+ R G +LL+Y ++ EL
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPEL 228
Query: 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT 609
D +S +EF +I C+++D RPT
Sbjct: 229 KDEPGNGIKWS-EEFKDFIKQ---CLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 69/210 (32%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 357 LGQGGFGPVYKGVL------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG VYKG L VA+K L + + EF E L+ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILF-------------DPRKRGILCWRKRTNIVNG 456
LLG C +++E++ +G L L D + L +I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
IA GM YL S VHRDL A N L+ + KISDFG++R ++ + +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546
+M PE + G ++ +SD++SFGV+L EI
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
+ +LG+G +G VY LS +A+K + + E+ L L+H+N
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--IAKGMLYL 464
+V+ LG + + E +P GSL A+L K G L ++T I I +G+ YL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
H+ +IVHRD+K NVL+++ KISDFG ++ A T GT YMAPE
Sbjct: 125 HD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAPE 179
Query: 524 YAMEGL--YSKKSDVFSFGVLLIEIITGR 550
+G Y +D++S G ++E+ TG+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 72/267 (26%), Positives = 124/267 (46%), Gaps = 33/267 (12%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNL 407
F+ +G+G FG VYK + + VA+K L +E + E+ + + + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYI 61
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
K G + G + ++ E+ GS D K G L I+ + G+ YLHE+
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
+HRD+KA+N+LL + + K++DFG++ + + NT VGT +MAPE +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172
Query: 528 GLYSKKSDVFSFGVLLIEIITGRR-NAGSNQLLAYAWHLWNEGNVLELVD----PLLTDT 582
Y +K+D++S G+ IE+ G + + + VL L+ P L
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----------RVLFLIPKNNPPSLEGN 221
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPT 609
FS F ++ LC+ +D +RP+
Sbjct: 222 KFS-KPFKDFVS---LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 33/227 (14%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKL-Q 403
+F I+G+G F V KE A+K L E+ E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 404 HKNLVKLLGFCVDGDEKL-LVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
H ++KL + +E L V E+ PNG L I RK G L + I +
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLAL 115
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF---------------AESEG 506
YLH I+HRDLK N+LLD DM+ KI+DFG A++ +S+
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 507 EANTVR---IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
E N R VGT Y++PE E K SD+++ G ++ +++TG+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 75/211 (35%), Positives = 111/211 (52%), Gaps = 22/211 (10%)
Query: 357 LGQGGFGPVYKGV---LSDGKE---VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG V+ LS K+ VAVK L + +F E L+ LQH+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDA----------ILFD--PRK-RGILCWRKRTNIVNGI 457
G C DGD ++V+E+M +G L+ IL D PR+ +G L + +I + I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
A GM+YL + VHRDL N L+ +++ KI DFGM+R ++ +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+M PE M ++ +SDV+SFGV+L EI T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 67/211 (31%), Positives = 116/211 (54%), Gaps = 14/211 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKE---VAVKRLSS-CSEQGTAEFTNEVLLILKLQ 403
S+ + ++G G FG V++G+L G++ VA+K L +E+ +F +E ++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
H N+++L G +++ E+M NG+LD L D G + ++ GIA GM Y
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKY 122
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMA 521
L S + VHRDL A N+L++S++ K+SDFG++R+ E + E G + A
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTA 178
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
PE ++ SDV+SFG+++ E+++ G R
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 80/221 (36%), Positives = 117/221 (52%), Gaps = 33/221 (14%)
Query: 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV 396
+ ++L+ L L I+G+G FG V +G + G++VAVK + C A F E
Sbjct: 1 WLLNLQKLTLGE-------IIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQA-FLEET 50
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN- 455
++ KL HKNLV+LLG + + +V E M G+L L R RG R +++
Sbjct: 51 AVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFL---RTRG----RALVSVIQL 102
Query: 456 -----GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+A+GM YL ++VHRDL A N+L+ D +K+SDFG+AR S G N+
Sbjct: 103 LQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNS 157
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GR 550
V + APE +S KSDV+S+GVLL E+ + GR
Sbjct: 158 KLPV---KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 71/198 (35%), Positives = 110/198 (55%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LGQG FG V+ G + VA+K L + A F E ++ KL+H+ LV+L + V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+E + +V E+M GSL L L + ++ IA GM Y+ R+ VHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLYSKK 533
DL+A+N+L+ ++ K++DFG+AR+ ++E T R + + APE A+ G ++ K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 534 SDVFSFGVLLIEIITGRR 551
SDV+SFG+LL E+ T R
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE----QGTAEFTNEVLLILKLQHKNLVKL 410
LG+G +G VYK G+ VA+K++ +E TA E+ L+ +L+H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHPNIVKL 63
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA----KGMLYLHE 466
L + LV+E+ L L D R + N++ I +G+ Y H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPL-----SPNLIKSIMYQLLRGLAYCH- 115
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
S RI+HRDLK N+L++ D K++DFG+AR F T +V T Y APE +
Sbjct: 116 -SH-RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILL 171
Query: 527 -EGLYSKKSDVFSFGVLLIEIITGR 550
YS D++S G + E+ITG+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 91/273 (33%), Positives = 138/273 (50%), Gaps = 39/273 (14%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LGQG FG V+ G + +VA+K L + A F E ++ KL+H LV L + V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---GIAKGMLYLHEDSRLRI 472
+E + +V EFM GSL D K G + K +V+ IA GM Y+ R+
Sbjct: 71 SEEPIYIVTEFMGKGSL----LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNY 123
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLY 530
+HRDL+A+N+L+ ++ KI+DFG+AR+ ++E T R + + APE A+ G +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180
Query: 531 SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVD-----PLLTDTSFS 585
+ KSDV+SFG+LL E++T R + Y + E VLE V+ P S
Sbjct: 181 TIKSDVWSFGILLTELVTKGR-------VPYPGMVNRE--VLEQVERGYRMPCPQGCPES 231
Query: 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
E + LC ++D +RPT + L+
Sbjct: 232 LHELMK------LCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 74/213 (34%), Positives = 116/213 (54%), Gaps = 20/213 (9%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRLSSCS-EQGTAEFTNEVLLI 399
L + +LG G FG VYKG+ + +G+ V A+K L+ + + EF +E L++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVN 455
+ H +LV+LLG C+ +L V + MP+G L + + + + +L W +
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ----- 117
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
IAKGM+YL E R+VHRDL A NVL+ S + KI+DFG+AR+ E E N
Sbjct: 118 -IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MA E ++ +SDV+S+GV + E++T
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 72/224 (32%), Positives = 105/224 (46%), Gaps = 41/224 (18%)
Query: 357 LGQGGFGPVYK----GVLSDGKE--VAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
+GQG FG V++ G+L VAVK L S A+F E L+ + H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFD-------------------PRKRGILCWRKR 450
LLG C G L++E+M G L+ L L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAE-----S 504
I +A GM YL E + VHRDL N L+ +M KI+DFG++R I++ S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
E +A +R +M PE Y+ +SDV+++GV+L EI +
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 71/195 (36%), Positives = 105/195 (53%), Gaps = 12/195 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LG G FG V+ G ++ +VAVK L + A F E L+ LQH LV+L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 417 GDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+ ++ E+M GSL D + D + +L K + IA+GM Y+ R +HR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLYSKK 533
DL+A+NVL+ + KI+DFG+AR+ ++E T R + + APE G ++ K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 534 SDVFSFGVLLIEIIT 548
SDV+SFG+LL EI+T
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
+G+G FG V K SDGK + K + + +E+ + +EV ++ +L+H N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 412 GFCVDGDEKLL--VYEFMPNGSLDAILFDPRK-RGIL----CWRKRTNIVNGIAKGMLYL 464
+D + L V E+ G L ++ +K R + WR T ++ L L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL-------LAL 118
Query: 465 HE-----DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
+E D ++HRDLK +N+ LD++ N K+ DFG+A+I A T VGT Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYY 176
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
M+PE Y +KSD++S G L+ E+
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 76/202 (37%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG V Y G+ VAVK L C +Q T+ + E+ ++ L H+N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 411 LGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
G C + K L+ E++P GSL L P+ + L + I +GM YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHK--LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAM 526
+HRDL A NVLLD+D KI DFG+A+ E E VR G + A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWYAVECLK 183
Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
E +S SDV+SFGV L E++T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 71/206 (34%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
LGQG FG VY KGV+ D E VA+K ++ + S + EF NE ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-------GILCWRKRTNIVNGIAKGML 462
LLG G L++ E M G L + L R +K + IA GM
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
YL+ + + VHRDL A N ++ D KI DFGM R E++ + + +M+P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
E +G+++ SDV+SFGV+L EI T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 73/198 (36%), Positives = 106/198 (53%), Gaps = 16/198 (8%)
Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFC 414
+G+G FG V G G +VAVK + + TA+ F E ++ +L+H NLV+LLG
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 415 VDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
V+ L +V E+M GSL L R R +L + + M YL ++ V
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
HRDL A NVL+ D +K+SDFG+ + E+ +T ++ + APE E +S K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTK 179
Query: 534 SDVFSFGVLLIEIIT-GR 550
SDV+SFG+LL EI + GR
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 70/202 (34%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQHKNLVKLL 411
+LG+G FG V+KG L D VAVK +C E E F +E ++ + H N+VKL+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVK---TCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
G C +V E +P G D + F +K+ L ++ A GM YL +
Sbjct: 59 GVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--- 113
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMAR-----IFAESEGEANTVRIVGTYGYMAPEYAM 526
+HRDL A N L+ + KISDFGM+R I++ S + ++ + APE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPEALN 167
Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
G YS +SDV+S+G+LL E +
Sbjct: 168 YGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-24
Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLI 399
L + F +LG G FG VYKG+ + +G++ VA+K L + S + E +E ++
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
+ + ++ +LLG C+ +L + + MP G L + + + + + N IAK
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 120
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
GM YL E R+VHRDL A NVL+ + + KI+DFG+A++ E E + +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
MA E + +Y+ +SDV+S+GV + E++T
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 72/203 (35%), Positives = 106/203 (52%), Gaps = 12/203 (5%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
++G G VY + L + ++VA+KR L C E EV + + H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
V GDE LV ++ GSL I+ RG L ++ + KG+ YLH + +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGTYGYMAPEYAMEGL 529
+HRD+KA N+LL D + KI+DFG++ A+ VR VGT +MAPE ME +
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQV 181
Query: 530 --YSKKSDVFSFGVLLIEIITGR 550
Y K+D++SFG+ IE+ TG
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 71/209 (33%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKE----VAVKRLSSCSEQGT-AEFTNEVLLI 399
L + +LG G FG V+KG+ + +G VA+K + S + T E T+ +L +
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
L H +V+LLG C G LV + P GSL + + R L ++ N IAK
Sbjct: 64 GSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
GM YL E R+VHR+L A N+LL SD +I+DFG+A + + + +
Sbjct: 121 GMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
MA E + G Y+ +SDV+S+GV + E+++
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 71/221 (32%), Positives = 104/221 (47%), Gaps = 31/221 (14%)
Query: 356 ILGQGGFGPVYKGVLSDGK------EVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLV 408
LG+G FG V K K VAVK L + + +E L+ ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-----RGILCWRKRTNIVNG------- 456
KL G C LL+ E+ GSL + L + RK G R + + N
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 457 ---------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
I++GM YL E +++VHRDL A NVL+ KISDFG++R E +
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+ +MA E + +Y+ +SDV+SFGVLL EI+T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 69/199 (34%), Positives = 99/199 (49%), Gaps = 21/199 (10%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V+ G +VA+K + SE+ +F E +++KL H LV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+V EFM NG L + + +++G L ++ + +GM YL +S +H
Sbjct: 69 TQQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 475 RDLKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGL 529
RDL A N L+ S K+SDFGM R + S G V+ + PE
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK------WSPPEVFNFSK 177
Query: 530 YSKKSDVFSFGVLLIEIIT 548
YS KSDV+SFGVL+ E+ T
Sbjct: 178 YSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 357 LGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG V+ D VAVK L S+ +F E L+ LQH+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 411 LGFCVDGDEKLLVYEFMPNGSL---------DAILF---DPRKRGILCWRKRTNIVNGIA 458
G CV+GD ++V+E+M +G L DA+L + L + +I IA
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQMLHIAQQIA 130
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
GM+YL + VHRDL N L+ ++ KI DFGM+R ++ +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+M PE M ++ +SDV+S GV+L EI T
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 82/284 (28%), Positives = 140/284 (49%), Gaps = 33/284 (11%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKE---VAVKRLSS-CSEQGTAEFTNEVLLIL 400
+ S ++G G FG V G L GK VA+K L + +E+ +F +E ++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
+ H N++ L G ++V E+M NGSLDA L + G + ++ GIA G
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASG 118
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-- 518
M YL S + VHRDL A N+L++S++ K+SDFG++R+ + A T R G
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGK 170
Query: 519 ----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLE 573
+ APE ++ SDV+S+G+++ E+++ G R Y W + N+ +V++
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER--------PY-WEMSNQ-DVIK 220
Query: 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617
++ + D + + + L C Q+D +RP + +L
Sbjct: 221 AIEEGYRLPAPMDCPAALH-QLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS--CSEQG-TAEFTNEVLLILKLQHK 405
+F ++G+G FG V D K++ A+K ++ C E+G NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 406 NLVKL-LGFCVDGDEKLLVYEFMPNGSLDAILFDPRK------RGILCWRKRTNIVNGIA 458
LV L F D + LV + + G L L K + +C I
Sbjct: 61 FLVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC---------EIV 110
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
+ YLH I+HRD+K N+LLD + I+DF +A + T GT G
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPG 164
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
YMAPE YS D +S GV E + G+R
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 356 ILGQGGFGPVYKGVLS-DGKE---VAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKL 410
++G G FG V +G L GK VA+K L S +E+ +F +E ++ + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
G +++ EFM NG+LD+ L + G + ++ GIA GM YL E +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG---TYGYMAPEYAME 527
VHRDL A N+L++S++ K+SDFG++R + + +G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 528 GLYSKKSDVFSFGVLLIEIIT-GRR 551
++ SDV+S+G+++ E+++ G R
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 36/229 (15%)
Query: 349 SNFSDSNI---LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKL 402
S D I LG+G FG VYK + G+ VA+K++ +E+ T E+ ++ KL
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 403 QHKNLVKLLGFCVD-----GDEKLLVYEFMP--NGSLDAILFDPRKR----GILCWRKRT 451
+H N+V L+ V+ ++ VY P + L +L +P + I C+ +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQ- 123
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES------- 504
+ +G+ YLHE+ I+HRD+KA+N+L+D+ KI+DFG+AR +
Sbjct: 124 -----LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 505 --EGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
G +V T Y PE + E Y+ D++ G + E+ T R
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-24
Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 5/106 (4%)
Query: 29 YNICSTSTAGSARA--STIDDNLQNVLTSLASNA---NAAKFSNASFGNDSDRVYGLYMC 83
+++CS++T+G+ ST + NL +L+SL+SNA + F+ + G D VYGL C
Sbjct: 1 FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQC 60
Query: 84 LNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNF 129
+SA C C+ TA ++ + CPNK +W + C LRY F
Sbjct: 61 RGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 67/199 (33%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V G +VA+K + S SE EF E +++KL H+ LV+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+V E+M NG L L + KR + + + +GM YL + +H
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 475 RDLKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGL 529
RDL A N L+D K+SDFG++R + S G VR + PE +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLLYSK 177
Query: 530 YSKKSDVFSFGVLLIEIIT 548
+S KSDV++FGVL+ E+ +
Sbjct: 178 FSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 19/209 (9%)
Query: 350 NFSDSNILGQGGFGPVYK-GVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKN 406
+F LG+G +G VYK LSD + A+K L S S++ + NE+ ++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAKGM 461
++ +DG++ +V E+ P G L + +K+ L WR I + +G+
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
LHE +I+HRDLK++N+LL ++ KI D G++++ + A T +GT YMA
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQ--IGTPHYMA 169
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
PE YS KSD++S G LL E+ T
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
LGQG FG VY+G D VAVK ++ S S + EF NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILF-------DPRKRGILCWRKRTNIVNGIAKGML 462
LLG G L+V E M +G L + L + R ++ + IA GM
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
YL+ + VHRDL A N ++ D KI DFGM R E++ + + +MAP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
E +G+++ SD++SFGV+L EI +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 67/199 (33%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLG 412
LG+GGFG V + GK A K+L +G NE IL+ + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKK-ILEKVSSRFIVSLA 59
Query: 413 FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
+ + + L LV M G L +++ + G R I G+ +LH + R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QRR 115
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
IV+RDLK NVLLD N +ISD G+A E +G GT GYMAPE +Y
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 532 KKSDVFSFGVLLIEIITGR 550
D F+ G L E+I GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 31/211 (14%)
Query: 355 NILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVK 409
++G+G FG VY G L SDG+++ AVK L+ ++ + +F E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 410 LLGFCVDGD-EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-------IAKGM 461
LLG C+ + L+V +M +G L + V +AKGM
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGM 111
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE----GEANTVRIVGTY 517
YL + VHRDL A N +LD K++DFG+AR + E ++
Sbjct: 112 EYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PV 166
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MA E ++ KSDV+SFGVLL E++T
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 57/200 (28%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQH---KNLVKL 410
++G+G +G VY+G + G+ VA+K ++ + ++ EV L+ +L+ N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
G + G ++ E+ GS+ ++ K G + + + I+ + + Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-L 529
++HRD+KA+N+L+ + N K+ DFG+A + ++ + +T VGT +MAPE EG
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKY 178
Query: 530 YSKKSDVFSFGVLLIEIITG 549
Y K+D++S G+ + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 68/203 (33%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+ LG G +G VY+GV VAVK L EF E ++ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGIAKGMLYLHED 467
C ++ EFM G+L L + C R+ N V I+ M YL +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYA 525
+ +HRDL A N L+ + K++DFG++R+ G+ T + + APE
Sbjct: 124 N---FIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESL 177
Query: 526 MEGLYSKKSDVFSFGVLLIEIIT 548
+S KSDV++FGVLL EI T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 78/274 (28%), Positives = 120/274 (43%), Gaps = 38/274 (13%)
Query: 354 SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHKNLVKL 410
N +G G FG VY V L G+ +AVK + E +E+ ++ L+H NLVK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
G V ++ + E+ G+L+ +L R R T + +G+ YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL---QLLEGLAYLHSH--- 118
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAES-----EGEANTVRIVGTYGYMAPEYA 525
IVHRD+K +N+ LD + K+ DFG A + E + GT YMAPE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL---AGTPAYMAPEVI 175
Query: 526 MEGLYSKK---SDVFSFGVLLIEIITGRRNAGSNQLLAYAWH-LWNEGNVLELV----DP 577
G +D++S G +++E+ TG+R W L NE ++ V P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR----------PWSELDNEFQIMFHVGAGHKP 225
Query: 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMS 611
+ D+ E ++ C++ D RPT S
Sbjct: 226 PIPDSLQLSPEGKDFLD---RCLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 71/267 (26%), Positives = 127/267 (47%), Gaps = 25/267 (9%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK----------RLSSCSEQGTAEFTNEVLLILKLQH 404
++G+G +G VY + ++ G+ +AVK R S + +E+ + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
N+V+ LGF + + E++P GS+ + L R G + + +G+ YL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE- 523
H I+HRDLKA N+L+D+D KISDFG+++ + + + G+ +MAPE
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 524 -YAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582
++ YS K D++S G +++E+ GRR + +A + L N+ + + + +
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPT 609
S +F C + +RPT
Sbjct: 242 SPVALDFLNA------CFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 7e-23
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 24/208 (11%)
Query: 356 ILGQGGFGPVYKGVLS-DGKE---VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
ILG G FG + +G L K VA+ L + CS++ F E L + + H N+V+L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
G G+ ++V E+M NG+LD+ L + G L + ++ G+A GM YL E +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFG------MARIFAESEGEANTVRIVGTYGYMAPEY 524
VH+ L A VL++SD+ KIS F I+ G++ + + APE
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-------WAAPEA 179
Query: 525 AMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
+S SDV+SFG+++ E+++ G R
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVKRLSSCS-EQGTAEFT-NEVLLILKLQHKNLVKLLGF 413
+G+G G V+K G+ VA+K+++ E G E+ + QH +VKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGMLYLHE 466
G +LV E+MP L +L D + + + ++ G+A Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYM-----RMLLKGVA----YMHA 117
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
I+HRDLK +N+L+ +D KI+DFG+AR+F+E E + + V T Y APE
Sbjct: 118 ---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPEL-- 171
Query: 527 EGLYSKKS-----DVFSFGVLLIEIITGR 550
LY + D+++ G + E++ G
Sbjct: 172 --LYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 70/201 (34%), Positives = 112/201 (55%), Gaps = 16/201 (7%)
Query: 356 ILGQGGFGPVYKGV-LSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+LG G FG VYKG+ + DG+ VA+K L + S + E +E ++ + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
LLG C+ +L V + MP G L + + + R + + N IAKGM YL E
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE--- 127
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIF--AESEGEANTVRIVGTYGYMAPEYAME 527
+R+VHRDL A NVL+ S + KI+DFG+AR+ E+E A+ ++ +MA E +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESILH 185
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
++ +SDV+S+GV + E++T
Sbjct: 186 RRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 356 ILGQGGFGPVYKGVLSD------GKEVAVKRL-SSCSEQGTAEFTNEVLLILKL--QHKN 406
LG+G FG V K VAVK L +E+ ++ +E + ++K+ +HKN
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE-MEMMKMIGKHKN 77
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---------- 456
++ LLG C +V E+ +G+L L R G
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA-SPDDPRPPEETLTQKDLVS 136
Query: 457 ----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
+A+GM +L S+ + +HRDL A NVL+ D KI+DFG+AR + T
Sbjct: 137 FAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE + +Y+ +SDV+SFGVLL EI T
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 70/220 (31%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 347 ATSNFSD---SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA-EFTNEVLLILK 401
A + S+ N +G G G VYK + G+ A+K + E + E+ ++
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128
Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT------NIVN 455
+ H N+VK E ++ EFM GSL+ G ++ I++
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE---------GTHIADEQFLADVARQILS 179
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
GIA YLH R IVHRD+K SN+L++S N KI+DFG++RI A++ N+ VG
Sbjct: 180 GIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VG 230
Query: 516 TYGYMAPEYA----MEGLYSKKS-DVFSFGVLLIEIITGR 550
T YM+PE G Y + D++S GV ++E GR
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-22
Identities = 75/203 (36%), Positives = 112/203 (55%), Gaps = 18/203 (8%)
Query: 357 LGQGGFGPVY------KGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG V +G + G++VAVK L S A+ E+ ++ L H+N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 410 LLGFCV-DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G C DG + L+ EF+P+GSL L PR + + +++ I KGM YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--G 126
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGTYGYMAPEYA 525
SR + VHRDL A NVL++S+ KI DFG+ + E++ E TV+ + + APE
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 526 MEGLYSKKSDVFSFGVLLIEIIT 548
++ + SDV+SFGV L E++T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC----SEQGTA--EFTNEVLLILKL 402
+ LG G F Y+ + G +AVK+++ SEQ E+ L+ +L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGILCWRKRTNIVNGIAKG 460
H +++++LG + L E+M GS+ +L + K ++ N + +G
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVR--IVGTY 517
+ YLHE+ +I+HRD+K +N+L+DS +I+DFG A A A + ++GT
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
+MAPE Y + DV+S G ++IE+ T +
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQ 403
NF +G+G F VYK + L DG+ VA+K++ + + E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGILCWRKRT--NIVNGIAK 459
H N++K L ++ +E +V E G L ++ F +KR I +RT +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLI---PERTIWKYFVQLCS 117
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
+ ++H RI+HRD+K +NV + + K+ D G+ R F+ A++ +VGT Y
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEI 546
M+PE E Y+ KSD++S G LL E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 60/196 (30%), Positives = 107/196 (54%), Gaps = 14/196 (7%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLVKLLGFC 414
+GQG G VY + ++ G+EVA+K+++ +Q E NE+L++ + +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 415 VDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+ GDE +V E++ GSL D + G + + + + +LH + +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-----AAVCRECLQALEFLHSN---QVI 137
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
HRD+K+ N+LL D + K++DFG + + +T +VGT +MAPE Y K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195
Query: 534 SDVFSFGVLLIEIITG 549
D++S G++ IE++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 71/215 (33%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVYK----GVLSDGKE----VAVKRLS-SCSEQGTAEFTNEV-LLILKLQHKN 406
LG+G FG V + G+ + VAVK L + +++ A+ +E+ L+ L +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-----------FDPRK--RGILCWRKRTNI 453
++ LLG C ++ E+ G+L L FD K L ++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
+A+GM YL +SR R +HRDL A NVL+ D KI+DFG+AR + + T
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE + +Y+ +SDV+SFG+L+ EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-22
Identities = 71/198 (35%), Positives = 108/198 (54%), Gaps = 14/198 (7%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LG G FG V+ + +VAVK + S A F E ++ LQH LVKL V
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 417 GDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+ ++ EFM GSL D + D + L K + IA+GM ++ + + +HR
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIHR 126
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLYSKK 533
DL+A+N+L+ + + KI+DFG+AR+ ++E T R + + APE G ++ K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 534 SDVFSFGVLLIEIIT-GR 550
SDV+SFG+LL+EI+T GR
Sbjct: 184 SDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 356 ILGQGGFGPVYKGVLSDGK----EVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKL 410
+G+G FG VY+GV + VAVK +C+ E F E ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+G + + +V E P G L + L + L ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-GEANTVRIVGTYGYMAPEYAMEGL 529
R VHRD+ A NVL+ S K+ DFG++R + +A+ ++ +MAPE
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRR 184
Query: 530 YSKKSDVFSFGVLLIEII 547
++ SDV+ FGV + EI+
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
S + +G+G G V S G++VAVK++ +Q NEV+++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--KRGILCWRKRTNIVNGIAKGMLYLH 465
V++ + GDE +V EF+ G+L I+ R + I + + K + +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLAVLKALSFLH 132
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEY 524
++HRD+K+ ++LL SD K+SDFG A++ S+ +VGT +MAPE
Sbjct: 133 AQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEV 186
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
Y + D++S G+++IE++ G
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN-----EVLLILKLQHKNLVKL 410
LG+G + VYK G+ VA+K++ + + N E+ L+ +L+H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLHE 466
L LV+EFM L+ ++ D I + T +G+ YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLEYLH- 119
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
I+HRDLK +N+L+ SD K++DFG+AR F S T ++V T Y APE
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TRWYRAPELLF 175
Query: 527 EG--LYSKKSDVFSFGVLLIEIITGR 550
G Y D++S G + E++
Sbjct: 176 -GARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 9e-22
Identities = 67/197 (34%), Positives = 110/197 (55%), Gaps = 15/197 (7%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG-FC 414
LG G FG VYK + G A K + + SE+ ++ E+ ++ H +VKLLG F
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
DG +++ EF P G++DAI+ + RG+ + + I + + + YLH ++I+H
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGL 529
RDLKA NVLL D + K++DFG++ ++ ++ +GT +MAPE M +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTP 191
Query: 530 YSKKSDVFSFGVLLIEI 546
Y K+D++S G+ LIE+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLV 408
F+ +G+G FG VYKG+ + KEV ++ +E + E+ ++ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ G + G + ++ E++ GS D K G L I+ I KG+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
R +HRD+KA+NVLL + K++DFG+A +++ + NT VGT +MAPE +
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
Y K+D++S G+ IE+ G
Sbjct: 177 AYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLLGF 413
+G+G +G VYK G+ VA+K++ E T E+ L+ +L H N++KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+ LV+EFM I R+RG L + + + +G+ + H I+
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLI--KDRQRG-LPESLIKSYLYQLLQGLAFCH---SHGIL 120
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE--YAMEGLYS 531
HRDLK N+L++++ K++DFG+AR F S T +V T Y APE +G YS
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVV-TRWYRAPELLLGDKG-YS 177
Query: 532 KKSDVFSFGVLLIEIITGR 550
D++S G + E+++ R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 19/207 (9%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC-SEQGTAEFT-NEVLLILKLQ---H 404
+ + +G+G +G VYK L+ G+ VA+K++ SE+G T E+ L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 405 KNLVKLLGFC--VDGDEKL---LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
N+V+LL C D +L LV+E + + L L K G+ + +++ + +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
G+ +LH RIVHRDLK N+L+ SD KI+DFG+ARI++ E +V T Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMALTSVVVTLWY 172
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEI 546
APE ++ Y+ D++S G + E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 357 LGQGGFGPVY---KGVLSDGKEVAVKRLSSCSEQGTAEFTN---EVLLILKLQHKNLVKL 410
+ +G +G V+ K S G A+K + + E ++ + Q +VKL
Sbjct: 1 ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
+ G + L LV E++P G L ++L G L + I + YLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIAEIVLALEYLH---S 111
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFG------MARIFAESEGEANTVRIVGTYGYMAPE 523
I+HRDLK N+L+DS+ + K++DFG + R ++ E RIVGT Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITG 549
+ +SK D +S G +L E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 356 ILGQGGFGPVYKGVL----SDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+LG+G FG + L D V K L+ SE+ + NE++++ LQH N++
Sbjct: 7 VLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+D + L+ E+ G+L LF+ ++ IV+ ++
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ----IVSAVS---- 115
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
Y+H+ I+HRD+K N+ L K+ DFG+++I A TV VGT YM+P
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV--VGTPYYMSP 170
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRN-AGSNQL 558
E Y+ KSD+++ G +L E++T +R +N L
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-21
Identities = 69/210 (32%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRL-----SSCSEQGTAEFTNEVLLILKLQ 403
N+ +LGQG FG VY D G+E+A K++ S + + + E+ L+ LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 404 HKNLVKLLGFCVDGDEKLLV--YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
H+ +V+ G D EK L E+MP GS+ L + G L I +GM
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGM 119
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYM 520
YLH + IVHRD+K +N+L DS N K+ DFG ++ +R + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
+PE Y +K+DV+S G ++E++T +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 15/211 (7%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRL-----SSCSEQGTAEFTNEVLLILKL 402
+N+ +LGQG FG VY +D G+E+AVK++ S + + E+ L+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 403 QHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
H+ +V+ G D E+ L E MP GS+ L + G L I +G
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEG 118
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAESEGEANTVRIVGTYGY 519
+ YLH + IVHRD+K +N+L DS N K+ DFG + R+ + GT +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
M+PE Y +K+D++S G ++E++T +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL-GFC 414
LG G FG VYK G A K + SE+ +F E+ ++ + +H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ +L+ EF G+LD+I+ +RG+ + R + + + + +LH +++H
Sbjct: 73 YENKLWILI-EFCDGGALDSIM-LELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGL 529
RDLKA N+LL D + K++DFG++ + + +T +GT +MAPE +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNP 184
Query: 530 YSKKSDVFSFGVLLIEIITGR 550
Y K+D++S G+ LIE+
Sbjct: 185 YDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 27/213 (12%)
Query: 354 SNILGQGGFGPVYKGVLSDGK-----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNL 407
S++L +G FG ++ G+L D K EV VK + SE E L+ L H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 408 VKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRKRGI-----LCWRKRTNIVNGIAKGM 461
+ +L C+ DG+ ++Y +M G+L L R L ++ ++ IA GM
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAES-----EGEANTVRIVG 515
YLH + ++H+D+ A N ++D ++ KI+D ++R +F + E V+
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK--- 184
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MA E + YS SDV+SFGVLL E++T
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 50/131 (38%), Positives = 72/131 (54%), Gaps = 19/131 (14%)
Query: 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
EFM GSLD I +K G + I + +G+ YL+ RI+HRD+K SN+L+
Sbjct: 83 EFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILV 137
Query: 485 DSDMNSKISDFGMARIFAESEGE-----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSF 539
+S K+ DFG++ GE A+T VGT YM+PE G Y+ KSDV+S
Sbjct: 138 NSRGQIKLCDFGVS-------GELINSIADT--FVGTSTYMSPERIQGGKYTVKSDVWSL 188
Query: 540 GVLLIEIITGR 550
G+ +IE+ G+
Sbjct: 189 GISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 63/187 (33%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 376 VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA 434
VAVK L S+ +F EV ++ +L N+ +LLG C ++ E+M NG L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 435 IL--FDPRKRGILCWRK---RTNIVN---GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
L G+ C K + ++ IA GM YL L VHRDL N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165
Query: 487 DMNSKISDFGMARIFAES-----EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGV 541
+ KI+DFGM+R S +G R +MA E + G ++ KSDV++FGV
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQG-----RAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 542 LLIEIIT 548
L EI+T
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-21
Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 357 LGQGGFGPVY----KGVLS---------DGKE--VAVKRL-SSCSEQGTAEFTNEVLLIL 400
LG+G FG V+ +G+ DG+ VAVK L + ++ +F E+ ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI------- 453
+L++ N+++LLG CV D ++ E+M NG L+ L NI
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT--HANNIPSVSIAN 130
Query: 454 ----VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
IA GM YL + L VHRDL N L+ + KI+DFGM+R +
Sbjct: 131 LLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
R V +MA E + G ++ SDV++FGV L E+ T
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 1e-20
Identities = 58/198 (29%), Positives = 107/198 (54%), Gaps = 18/198 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+GQG G V+ + ++ G+EVA+K+++ + NE+L++ +L++ N+V L +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
GDE +V E++ GSL ++ D + +C + + +LH + +
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVC--------RECLQALEFLHAN---Q 135
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
++HRD+K+ NVLL D + K++DFG + + +T +VGT +MAPE Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 193
Query: 532 KKSDVFSFGVLLIEIITG 549
K D++S G++ IE++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 73/217 (33%), Positives = 114/217 (52%), Gaps = 34/217 (15%)
Query: 355 NILGQGGFGPVYKGVLS-DGKEV--AVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVK 409
+++G+G FG V + ++ DG ++ A+K L SE +F E+ ++ KL H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDP---RKRGI---LCWRKRTNIVNG 456
LLG C + + E+ P G+L L DP ++ G L ++ +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+A GM YL E + +HRDL A NVL+ ++ SKI+DFG++R GE V + T
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR------GE--EVYVKKT 176
Query: 517 YG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
G +MA E +Y+ KSDV+SFGVLL EI++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-20
Identities = 87/395 (22%), Positives = 162/395 (41%), Gaps = 62/395 (15%)
Query: 246 ATEPSILAGNQASGGG------------KQRKMWMIIVLASVVALLLVVFASTGYFFATK 293
A S +AGN GG ++ W + ++ A L++ + G+ F
Sbjct: 595 AINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVF--- 651
Query: 294 KITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSD 353
R R K+++ D + Q + T+N S+ +
Sbjct: 652 --IRGRNNLELKRVE------NEDGTWELQFFDSK---------VSKSITINDILSSLKE 694
Query: 354 SNILGQGGFGPVYKG-VLSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVK 409
N++ +G G YKG + +G + VK ++ S A+ KLQH N+VK
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG-------KLQHPNIVK 747
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L+G C L++E++ +L +L R L W +R I GIAK + +LH
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVL-----RN-LSWERRRKIAIGIAKALRFLHCRCS 801
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
+V +L +++D + + + + Y+APE
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKD 854
Query: 530 YSKKSDVFSFGVLLIEIITGRRNA-----GSNQLLAYAWHLWNEGNVLELVDPLLT-DTS 583
++KSD++ FG++LIE++TG+ A ++ +A + +++ ++ +DP + D S
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914
Query: 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ +E +++ L C D RP + V L+
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 57/198 (28%), Positives = 106/198 (53%), Gaps = 18/198 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+GQG G VY + ++ G+EVA+K+++ + NE+L++ + ++ N+V L +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
GDE +V E++ GSL ++ D + +C + + +LH + +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALDFLHSN---Q 135
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
++HRD+K+ N+LL D + K++DFG + + +T +VGT +MAPE Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 193
Query: 532 KKSDVFSFGVLLIEIITG 549
K D++S G++ IE++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 74/211 (35%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGV---LSDGK---EVAVKRLSSCSEQGTAE-FTNEVLLILKL 402
N S LG G FG V + LS +VAVK L + E +E+ ++ L
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 403 -QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNGIAKG 460
H+N+V LLG C G L++ E+ G D + F RKR L + +AKG
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYG--DLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESE--GEANTVRIVGTY 517
M +L + +HRDL A NVLL KI DFG+AR I +S + N V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE +Y+ +SDV+S+G+LL EI +
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGF 413
++G+G +G VYK G+ VA+K + ++ E E ++ K H N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYGA 71
Query: 414 ------CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----IVNGIAKGMLY 463
+ D+ LV E GS+ ++ RK+G R + I+ +G+ Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG---KRLKEEWIAYILRETLRGLAY 128
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
LHE+ +++HRD+K N+LL + K+ DFG++ + G NT +GT +MAPE
Sbjct: 129 LHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGTPYWMAPE 183
Query: 524 -----YAMEGLYSKKSDVFSFGVLLIEIITG 549
+ Y +SDV+S G+ IE+ G
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLS-SCSEQGTAEFTN----EVLLILKLQ 403
N+ +LG+G FG VY +D G+E+AVK++ Q T++ N E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 404 HKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
H +V+ G D +EK L E+MP GS+ L + G L I +G+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGV 119
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAESEGEANTVRIVGTYGYM 520
YLH + IVHRD+K +N+L DS N K+ DFG + RI + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+PE Y +K+DV+S ++E++T
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 34/217 (15%)
Query: 355 NILGQGGFGPVYKGVLS-DGKEV--AVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVK 409
+++G+G FG V K + DG + A+KR+ S+ +F E+ ++ KL H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDP---RKRGI---LCWRKRTNIVNG 456
LLG C L E+ P+G+L L DP L ++ +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+A+GM YL + + +HRDL A N+L+ + +KI+DFG++R G+ V + T
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQ--EVYVKKT 169
Query: 517 YG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
G +MA E +Y+ SDV+S+GVLL EI++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 69/198 (34%), Positives = 94/198 (47%), Gaps = 21/198 (10%)
Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE----QGTAEFTNEVLLILKLQHKNLVKLL 411
+G+G FG V+ G L +D VAVK SC E A+F E ++ + H N+V+L+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK---SCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
G C +V E + G L R L ++ +V A GM YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH--- 114
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAE----SEGEANTVRIVGTYGYMAPEYAME 527
+HRDL A N L+ KISDFGM+R + S G + + T APE
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT----APEALNY 170
Query: 528 GLYSKKSDVFSFGVLLIE 545
G YS +SDV+SFG+LL E
Sbjct: 171 GRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 59/199 (29%), Positives = 108/199 (54%), Gaps = 20/199 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+GQG G VY + ++ G+EVA+++++ + NE+L++ + ++ N+V L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
GDE +V E++ GSL ++ D + +C + + +LH + +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALEFLHSN---Q 136
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
++HRD+K+ N+LL D + K++DFG A+I E ++ +VGT +MAPE Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 531 SKKSDVFSFGVLLIEIITG 549
K D++S G++ IE+I G
Sbjct: 194 GPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-20
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 153 YRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNA 212
+ S +N LS L + +A + +A DT Y L QC DL A DC +CL A
Sbjct: 19 FESNLNALLSSLSSN-AASSSGKGFAAGTSG-AAPDTVYGLAQCRGDLSASDCRSCLATA 76
Query: 213 TADILSCCYFSRGARLLSRNCYLRYELYAF 242
+++ CC +G R+ +C+LRYE Y F
Sbjct: 77 VSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 61/195 (31%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 357 LGQGGFGPV-YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G+G G V V S GK VAVK++ +Q NEV+++ QH+N+V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
GDE +V EF+ G+L I+ R + + + + K + LH ++HR
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG---VIHR 140
Query: 476 DLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
D+K+ ++LL D K+SDFG A++ E + +VGT +MAPE Y +
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS---LVGTPYWMAPELISRLPYGPEV 197
Query: 535 DVFSFGVLLIEIITG 549
D++S G+++IE++ G
Sbjct: 198 DIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 56/178 (31%), Positives = 96/178 (53%), Gaps = 11/178 (6%)
Query: 373 GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
GK+VAVK++ +Q NEV+++ H+N+V + + GDE +V EF+ G+L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492
I+ R + + + + + + YLH ++HRD+K+ ++LL SD K+
Sbjct: 107 TDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159
Query: 493 SDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
SDFG A++ E + +VGT +MAPE Y + D++S G+++IE+I G
Sbjct: 160 SDFGFCAQVSKEVPKRKS---LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 81/291 (27%), Positives = 133/291 (45%), Gaps = 44/291 (15%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG-VLSDG--KEVAVKRLSS-CSEQGTAEFTNEVLLILK 401
L ++ +++G+G FG V K + DG + A+KR+ S+ +F E+ ++ K
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 63
Query: 402 L-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDP------RKRGILCW 447
L H N++ LLG C L E+ P+G+L L DP L
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
++ + +A+GM YL S+ + +HRDL A N+L+ + +KI+DFG++R
Sbjct: 124 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------- 172
Query: 508 ANTVRIVGTYG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYA 562
V + T G +MA E +Y+ SDV+S+GVLL EI++ A
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232
Query: 563 WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613
+ +G LE PL DDE + C +E ++RP+ + +
Sbjct: 233 YEKLPQGYRLE--KPL-----NCDDEVYDLMR---QCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 35/230 (15%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQG-TAEFTNEV 396
+NL+T F + LG+ FG VYKG L + VA+K L +E EF +E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF-------------DPRKRG 443
++ +LQH N+V LLG +++ + + L L D +
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFA 502
L +IV IA GM +L S +VH+DL NVL+ +N KISD G+ R ++A
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 503 ESEGEANTVRIVGT----YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
A+ +++G +M+PE M G +S SD++S+GV+L E+ +
Sbjct: 177 -----ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
+NF +G+G F VY+ L D K VA+K++ + + E+ L+ +L H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGI---LCWRKRTNIVNGIAK 459
N++K L ++ +E +V E G L ++ F +KR I W+ + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE- 120
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
H SR R++HRD+K +NV + + K+ D G+ R F+ A++ +VGT Y
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEI 546
M+PE E Y+ KSD++S G LL E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 32/218 (14%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
LG+G FG V V+++ +VAVK L S +E+ ++ +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKR 450
HKN++ LLG C ++ E+ G+L L R G+ L ++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ +A+GM YL + + +HRDL A NVL+ D KI+DFG+AR + T
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE + +Y+ +SDV+SFGVLL EI T
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSDGK---EVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
LG+G FG V +G L+ +VAVK +++ C+ +F +E + + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 412 GFCVDGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGML 462
G C+ E +++ FM +G L + L R L + + IA GM
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
YL S +HRDL A N +L+ +MN ++DFG+++ + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
E + +Y+ KSDV+SFGV + EI T
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 357 LGQGGFGPV------YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+GGFG V G + K++ KRL S + A E IL+ + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE---ILEKVNSPFIVN 57
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L + + L LV M G L +++ +RG+ R + I G+L+LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV-IHYSAQITCGILHLHS--- 113
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
+ IV+RD+K NVLLD N ++SD G+A E + + GT GYMAPE E
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 530 YSKKSDVFSFGVLLIEIITGR 550
YS D F+ G + E++ GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 19/198 (9%)
Query: 357 LGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHKNLVKLL 411
LG G FG V KG+ K VAVK L + + E E ++ +L + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
G C + + +LV E G L+ L +K + + T +V+ ++ GM YL E +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN--- 115
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-- 529
VHRDL A NVLL + +KISDFG+++ E N + + YA E +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMNY 172
Query: 530 --YSKKSDVFSFGVLLIE 545
+S KSDV+SFGVL+ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 11/193 (5%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G +G VYK ++ G+ VA+K + E+ ++ + +H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
D+ +V E+ GSL I RG L + + KG+ YLHE +HR
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHR 125
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA---MEGLYSK 532
D+K +N+LL D + K++DFG++ + + + +GT +MAPE A +G Y
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGYDG 183
Query: 533 KSDVFSFGVLLIE 545
K D+++ G+ IE
Sbjct: 184 KCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 17/209 (8%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQ 403
+ ++G+G FG V+ + +D K V +K++ EQ T + NE ++ L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPV--EQMTKDERLAAQNECQVLKLLS 57
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
H N+++ ++ ++V E+ P G+L A R +L I++ + +L
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTL-AEYIQKRCNSLL---DEDTILHFFVQILLA 113
Query: 464 LHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
LH I+HRDLK N+LLD M KI DFG+++I + S+ +A TV VGT Y++P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTV--VGTPCYISP 170
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
E Y++KSD+++ G +L E+ + +R
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHK 405
+ +G+G FG +Y K SD + +K L+ + EV+L+ K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRKRGILCWRKRTNIVNGIA 458
N+V + +V E+ G L +LF + IL W + I+
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSWFVQ------IS 111
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVRIVGTY 517
G+ ++H+ +I+HRD+K+ N+ L + M +K+ DFG+AR +S A T VGT
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTP 166
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL 558
Y++PE Y+ K+D++S G +L E+ T + N L
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 54/178 (30%), Positives = 96/178 (53%), Gaps = 11/178 (6%)
Query: 373 GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
G++VAVK + +Q NEV+++ QH+N+V++ + G+E ++ EF+ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492
I+ R L + + + + + YLH ++HRD+K+ ++LL D K+
Sbjct: 106 TDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158
Query: 493 SDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
SDFG A+I S+ +VGT +MAPE Y + D++S G+++IE++ G
Sbjct: 159 SDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 11/201 (5%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLV 408
F+ +G+G FG V+KG+ + ++V A+K + +E + E+ ++ + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
K G + G + ++ E++ GS D + G + ++ I KG+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
+ +HRD+KA+NVLL + K++DFG+A +++ + NT VGT +MAPE +
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
Y K+D++S G+ IE+ G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 357 LGQGGFGPVY------------KGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLL 398
LG+G FG V+ K D VAVK L ++ +F E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-- 456
+ +L+ N+++LL C+ D ++ E+M NG L+ L + I
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 457 ------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
IA GM YL S L VHRDL N L+ + KI+DFGM+R +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
R V +M+ E + G ++ SDV++FGV L EI+T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 36/215 (16%)
Query: 358 GQGGFGPVYKGVL---SDGKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQHKNLVKLL 411
G+G +G VYK DGKE A+K+ EQ T E+ L+ +L+H+N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 412 GFCVDGDEKL--LVYEFMPNGSLDAILFDPRKRGI---------LCWRKRTNIVNGIAKG 460
++ +K L++++ + I F + + + L W+ I+NG+
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----ILNGVH-- 122
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNS----KISDFGMARIF-AESEGEANTVRIVG 515
YLH + ++HRDLK +N+L+ + KI D G+AR+F A + A+ +V
Sbjct: 123 --YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 516 TYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIIT 548
T Y APE + G Y+K D+++ G + E++T
Sbjct: 178 TIWYRAPELLL-GARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 77/280 (27%), Positives = 134/280 (47%), Gaps = 28/280 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
+NF +G+G F VY+ L DG VA+K++ + A+ E+ L+ +L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGI---LCWRKRTNIVNGIAK 459
N++K ++ +E +V E G L ++ F +KR I W+ + + +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE- 120
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
H SR R++HRD+K +NV + + K+ D G+ R F+ A++ +VGT Y
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVD-PL 578
M+PE E Y+ KSD++S G LL E+ A + +L++ +E D P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMA-----ALQSPFYGDKMNLYSLCKKIEQCDYPP 227
Query: 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
L +S +E + ++ +C+ D RP ++ V + K
Sbjct: 228 LPSDHYS-EELRQLVN---MCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-19
Identities = 79/267 (29%), Positives = 128/267 (47%), Gaps = 31/267 (11%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
F+D +G G FG VY EV A+K++S +Q ++ + EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
++ G + LV E+ + D L + K+ L + I +G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAITHGALQGLAYLHS 143
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
+ ++HRD+KA N+LL K++DFG A I + AN+ VGT +MAPE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANS--FVGTPYWMAPEVIL 194
Query: 527 ---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL-WNEGNVLELVDPLLTDT 582
EG Y K DV+S G+ IE+ + + ++ +H+ NE P L
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------SPTLQSN 247
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPT 609
+S D F ++ C+Q+ DRPT
Sbjct: 248 EWS-DYFRNFVDS---CLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 42/213 (19%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--------EVLLILKLQ-HKN 406
LG G FG VY G+ VA+K++ +F + EV + KL H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRK-RGILCWRKRTNIVNGIA 458
+VKL + DE V+E+M G+L F R +I+ I
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR---------SIIYQIL 109
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
+G+ ++H + HRDLK N+L+ KI+DFG+AR E V T
Sbjct: 110 QGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRW 163
Query: 519 YMAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
Y APE + YS D+++ G ++ E+ T R
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 69/208 (33%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 357 LGQGGFGPV----YKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILK-LQHKNLVK 409
LG G FG V +KG GK A+K LS + E IL+ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK--------GM 461
L G D LV E++P G L + L RK +A+ +
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYAAQVVLAL 114
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
YLH L IV+RDLK N+LLDSD KI+DFG A+ T + GT Y+A
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLA 166
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
PE + Y K D ++ G+L+ E++ G
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 42/214 (19%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G +G VYKG G+ VA+K RL S E + E+ L+ +LQH N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 414 CVDGDEKLLVYEFM------------PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
+ L++EF+ +DA L IL +G+
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL-------------QGI 114
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTY 517
L+ H R++HRDLK N+L+D+ K++DFG+AR F VR+ V T
Sbjct: 115 LFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP------VRVYTHEVVTL 165
Query: 518 GYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGR 550
Y APE + YS D++S G + E+ T +
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 357 LGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKL 410
LG+ FG +YKG L + VA+K L + Q EF E L+ +L H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILF--------------DPRKRGILCWRKRTNIVNG 456
LG +++E++ G L L D + L +I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
IA GM YL S VH+DL A N+L+ ++ KISD G++R ++ + +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+M PE M G +S SD++SFGV+L EI +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 31/267 (11%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
F+D +G G FG VY E VA+K++S +Q ++ + EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
++ G + LV E+ + D + + K+ L + I +G +G+ YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKP-LQEVEIAAICHGALQGLAYLHS 133
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE--Y 524
R +HRD+KA N+LL K++DFG A + + AN+ VGT +MAPE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVIL 184
Query: 525 AM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL-WNEGNVLELVDPLLTDT 582
AM EG Y K DV+S G+ IE+ + + ++ +H+ N+ P L+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-------SPTLSSN 237
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPT 609
+S D F ++ C+Q+ DRP+
Sbjct: 238 DWS-DYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 80/267 (29%), Positives = 128/267 (47%), Gaps = 31/267 (11%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
FSD +G G FG VY + + + VA+K++S +Q ++ + EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
++ G + LV E+ + D L + K+ L + + +G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAVTHGALQGLAYLHS 133
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
+ ++HRD+KA N+LL K+ DFG A I A AN VGT +MAPE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANX--FVGTPYWMAPEVIL 184
Query: 527 ---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL-WNEGNVLELVDPLLTDT 582
EG Y K DV+S G+ IE+ + + ++ +H+ NE P L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------SPALQSG 237
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPT 609
+S + F ++ C+Q+ DRPT
Sbjct: 238 HWS-EYFRNFVDS---CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 58/166 (34%), Positives = 93/166 (56%), Gaps = 23/166 (13%)
Query: 394 NEVLLILKLQHK----NLVKLLG-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
N+++ LK+ H+ +V G F DG+ + + E M GSLD +L +K G R
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAG----R 95
Query: 449 KRTNIVNGIA----KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
NI+ I+ +G+ YL E + +I+HRD+K SN+L++S K+ DFG++ +S
Sbjct: 96 IPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153
Query: 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
AN+ VGT YM+PE Y+ +SD++S G+ L+E+ GR
Sbjct: 154 M--ANS--FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 67/205 (32%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNL 407
NF LG+G + VYKG + G+ VA+K + +E+GT + E+ L+ +L+H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
V+L ++ +LV+E+M + L + RG L + + KG+ + HE+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI-VGTYGYMAPEYAM 526
R++HRDLK N+L++ K++DFG+AR F NT V T Y AP+ +
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---VNTFSNEVVTLWYRAPDVLL 173
Query: 527 EG-LYSKKSDVFSFGVLLIEIITGR 550
YS D++S G ++ E+ITGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 357 LGQGGFGPVYKGVLSDGK---EVAVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLVKLLG 412
LG G FG V KGV K +VA+K L + +E+ E E ++ +L + +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
C + + +LV E G L+ L K+ + +++ ++ GM YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN---F 116
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLY 530
VHRDL A NVLL + +KISDFG+++ ++ R G + + APE +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 531 SKKSDVFSFGVLLIE 545
S +SDV+S+G+ + E
Sbjct: 176 SSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLV 408
F+ +G+G FG V+KG+ + ++V ++ +E + E+ ++ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGS-LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
K G + + ++ E++ GS LD L +P G L + I+ I KG+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 120
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
+ +HRD+KA+NVLL K++DFG+A +++ + N VGT +MAPE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQ 175
Query: 528 GLYSKKSDVFSFGVLLIEIITG 549
Y K+D++S G+ IE+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVYK----GVLSDG-KE---VAVKRLS-SCSEQGTAEFTNEVLLILKL-QHKN 406
LG+G FG V G+ D KE VAVK L +E+ ++ +E+ ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
++ LLG C ++ E+ G+L L R G+ + ++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
+A+GM YL + + +HRDL A NVL+ + KI+DFG+AR + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE + +Y+ +SDV+SFGVL+ EI T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 29/204 (14%)
Query: 357 LGQGGFGPVYKGVLSDGKEV----AVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL- 411
LG G FG VYK + KE A K + + SE+ ++ E+ ++ H N+VKLL
Sbjct: 13 LGDGAFGKVYK---AQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
F + + +L+ EF G++DA++ + + L + + + + YLHE+ +
Sbjct: 70 AFYYENNLWILI-EFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---K 123
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR----IVGTYGYMAPEYAM- 526
I+HRDLKA N+L D + K++DFG+ S T++ +GT +MAPE M
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGV------SAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 527 ----EGLYSKKSDVFSFGVLLIEI 546
+ Y K+DV+S G+ LIE+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 37/225 (16%)
Query: 357 LGQGGFGPVYKGVLSDGKE-----------------VAVKRL-SSCSEQGTAEFTNEVLL 398
LG+G FG V+ + + ++ VAVK L ++ +F EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA-----ILFDPRKRG---------- 443
+ +L+ N+++LLG CVD D ++ E+M NG L+ L D + G
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 444 -ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
+ + ++ IA GM YL S L VHRDL N L+ ++ KI+DFGM+R
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
+ R V +MA E + G ++ SDV++FGV L EI+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 72/278 (25%), Positives = 128/278 (46%), Gaps = 35/278 (12%)
Query: 357 LGQGGFGPVYKGVLSDG-------KEVAVKRLS-----SCSEQGTAEFTNEVLLILK-LQ 403
LG G FG VYK + KE+ V + ++ + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGML 462
H N+V+ ++ D +V + + L + K+ + NI + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
YLH++ R IVHRDL +N++L D I+DFG+A+ + + E+ +VGT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582
E Y +K+DV++FG +L ++ T + S +L+ A + V + +P L +
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-----VEAVYEP-LPEG 236
Query: 583 SFSDDEFSRYIHIGLL---CVQEDAFDRPTMSSVAPML 617
+S+D + + C+ DA RP + V+ M+
Sbjct: 237 MYSED-------VTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G +G VYK G+ VA+K RL + E + E+ L+ +L H N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 414 CVDGDEKL-LVYEFMP---NGSLDAILFDPRKRGILCWRKRTN-IVNGIAKGMLYLHEDS 468
V + KL LV+EF+ +D+ ++ + ++ GIA Y H S
Sbjct: 67 -VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI--KSYLYQLLQGIA----YCH--S 117
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG---EANTVRIVGTYGYMAPEYA 525
R++HRDLK N+L+D + K++DFG+AR F G T +V T Y APE
Sbjct: 118 H-RVLHRDLKPQNLLIDREGALKLADFGLARAF----GVPVRTYTHEVV-TLWYRAPEIL 171
Query: 526 MEG-LYSKKSDVFSFGVLLIEIITGR 550
+ YS D++S G + E++ R
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
LG+G FG V K + VAVK L +++ ++ +E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
++ LLG C ++ E+ G+L L R G+ L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
+A+GM YL + + +HRDL A NVL+ D KI+DFG+AR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE + +Y+ +SDV+SFGVLL EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 357 LGQGGFGPVYKGVLSDGKEVA---VKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G G FG V G G A VK L +S + F EV +L H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT--NIVNGIAKGMLYLHEDSRL 470
C++ LLV EF P G L L R +K + +A G+L+LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMAR------IFAESEGEANTVRIVGTYGYMAPEY 524
+H DL N L +D++ KI D+G+A + + A +R ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAPE- 172
Query: 525 AMEGLYS--------KKSDVFSFGVLLIEIIT 548
+E KKS+++S GV + E+ T
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-18
Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 29/266 (10%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
F + +G G FG VY S E VAVK++S +Q ++ + EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
++ G + LV E+ + D L + K+ L + I +G +G+ YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAITHGALQGLAYLHS 139
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
+ ++HRD+KA N+LL K++DFG A + AN+ VGT +MAPE +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANS--FVGTPYWMAPEVIL 190
Query: 527 ---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583
EG Y K DV+S G+ IE+ + + ++ +H+ + P L
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS------PTLQSNE 244
Query: 584 FSDDEFSRYIHIGLLCVQEDAFDRPT 609
++ D F ++ C+Q+ +RP
Sbjct: 245 WT-DSFRGFVD---YCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKN 406
NF +G+G +G VYK G+ VA+K RL + +E + E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 407 LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG----IAKGM 461
+VKLL + + KL LV+EF+ + L + GI ++ + +G+
Sbjct: 61 IVKLLD-VIHTENKLYLVFEFL-HQDLKKFMDASPLSGI-----PLPLIKSYLFQLLQGL 113
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTY 517
+ H R++HRDLK N+L++++ K++DFG+AR F VR V T
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYTHEVVTL 164
Query: 518 GYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
Y APE + YS D++S G + E++T R
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 1e-17
Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 18/204 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRL-SSCSEQGTAEFT-NEVLLILKL-QHKNLVKLLG 412
LG+G +G V+K + KE VA+K++ + A+ T E++ + +L H N+VKLL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 413 -FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ D+ + LV+E+M L A++ + IL + I+ + K + Y+H S
Sbjct: 75 VIKAENDKDIYLVFEYMET-DLHAVI----RANILEDVHKRYIMYQLLKALKYIH--SG- 126
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI---VGTYGYMAPEYAME 527
++HRDLK SN+LL+SD K++DFG+AR +E E + V T Y APE +
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG 186
Query: 528 G-LYSKKSDVFSFGVLLIEIITGR 550
Y+K D++S G +L E++ G+
Sbjct: 187 STRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 67/223 (30%), Positives = 114/223 (51%), Gaps = 27/223 (12%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLL 411
+G+G +G VYK D G+ VA+K++ +E+ T E+ ++ +L H+N+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 412 GFCVDGDEKL----------LVYEFMPN---GSLDAILFDPRKRGILCWRKRTNIVNGIA 458
D + L LV+E+M + G L++ L + I + K+ +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ------LL 126
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
+G+ Y H+ + L HRD+K SN+LL++ K++DFG+AR++ E T +++ T
Sbjct: 127 EGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLW 182
Query: 519 YMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA 560
Y PE + E Y DV+S G +L E+ T + +NQ LA
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 75/271 (27%), Positives = 124/271 (45%), Gaps = 47/271 (17%)
Query: 355 NILGQGGFGPVYKG-VLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
ILG G G VYK L + +AVK + + + + +E+ ++ K ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 413 -FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA----KGMLYLHED 467
F V+ + + EFM GSLD + + +++ IA KG+ YL
Sbjct: 67 AFFVE-NRISICTEFMDGGSLD-----------VYRKIPEHVLGRIAVAVVKGLTYLWS- 113
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
L+I+HRD+K SN+L+++ K+ DFG++ S + VGT YMAPE
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAPERISG 167
Query: 528 GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLEL------VD---PL 578
Y SDV+S G+ +E+ GR Y N+G+++ L VD P+
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR--------FPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219
Query: 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT 609
L FS+ +++H C+++ +RP
Sbjct: 220 LPVGQFSE----KFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKLQHKNLV 408
LG+G FG VY ++ D K VA +RL E T + E L+ KL H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHED 467
K ++ D ++ E+ LD L + + G L + + G+ Y+H+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
RI+HRDLKA N+ L +++ KI DFG++R+ S A T GT YM+PE
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALKH 179
Query: 528 GLYSKKSDVFSFGVLLIEI 546
Y KSD++S G +L E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEV-------LLILK-LQHKNL 407
+G+G +G V K + G+ VA+K+ +E +V + +L+ L+H+N+
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFK------ESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT-NIVNGIAKGMLYLHE 466
V L LV+E++ L+ + P R ++ IA Y H
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIA----YCH- 117
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
I+HRD+K N+L+ K+ DFG AR + V T Y APE +
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR-PASPLTDYVATRWYRAPELLV 174
Query: 527 -EGLYSKKSDVFSFGVLLIEIITGR 550
+ Y K DV++ G ++ E++ G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLLG 412
LG GGFG V V S + A+K + E G E +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 413 FCVDGDEKLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
+ D+K +Y E+ G L IL R RG+ + + YLH
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIACVVLAFEYLH---N 111
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
I++RDLK N+LLDS+ K+ DFG A+ + T GT Y+APE +
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 530 YSKKSDVFSFGVLLIEIITGR 550
Y D +S G+LL E++TGR
Sbjct: 169 YDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 351 FSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQH 404
F+ +LG+G FG V + L ++VAVK L + S EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 405 KNLVKLLGFCVDGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVN 455
N++KL+G + K +++ FM +G L L R + L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAES---EGEANTV 511
IA GM YL S +HRDL A N +L+ +M ++DFG+++ I++ +G A+ +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+ ++A E + +Y+ SDV++FGV + EI+T
Sbjct: 178 PV----KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 43/219 (19%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV--------LLILK-LQH 404
+G G +G V V G++VA+K++S+ F + + + +L+ L+H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRH 58
Query: 405 KNLVKLLGFCVDGD----EKL-LVYEFMPNGSLDAILFDPRK------RGILCWRKRTNI 453
+N++ LL + +V E M L ++ P+ + L
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLY------- 110
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV-R 512
I +G+ YLH + ++HRDLK SN+L++S+ + KI DFG+AR E E +
Sbjct: 111 --QILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 513 IVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
V T Y APE + Y+K D++S G + E++T +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 67/210 (31%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
F +LG+GGFG V V + GK A K+L +G + NE ++ K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD------PRKRGILCWRKRTNIVNGIAKG 460
+V L D LV M G L ++ R + I G
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-------YAAEICCG 114
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
+ LH++ RIV+RDLK N+LLD + +ISD G+A EG+ R VGT GYM
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYM 168
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
APE Y+ D ++ G LL E+I G+
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 69/202 (34%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLSS--CSEQGTAEFT--NEVLLILKLQHKNLVKL 410
+LG+G FG V L E A+K L E E T +L L +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 411 LGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
FC ++ L V E++ G L +F + G + I G+ +LH+
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
I++RDLK NVLLD D + KI+DFGM + EG+A+T GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQ 171
Query: 529 LYSKKSDVFSFGVLLIEIITGR 550
Y++ D +SFGVLL E++ G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 82/283 (28%), Positives = 129/283 (45%), Gaps = 50/283 (17%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQH-K 405
+ D +G+G FG V K + G +AVKR+ S E+ ++ ++++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLD---AILFDPRKRGILCWRKRTNIVNGIA---- 458
+VK G + + E M + SLD +++ K I I+ IA
Sbjct: 64 YIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVI-----PEEILGKIAVATV 117
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
K + YL E+ L+I+HRD+K SN+LLD + N K+ DFG++ +S A T R G
Sbjct: 118 KALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--IAKT-RDAGCRP 172
Query: 519 YMAPE----YAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLEL 574
YMAPE A +G Y +SDV+S G+ L E+ TG+ + + WN +V +
Sbjct: 173 YMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK----------FPYPKWN--SVFDQ 219
Query: 575 V------DP--LLTDTSFS-DDEFSRYIHIGLLCVQEDAFDRP 608
+ DP L F +I+ LC+ +D RP
Sbjct: 220 LTQVVKGDPPILSNSEEREFSPSFVNFIN---LCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE--FTNEVLLILKLQHKNLVKLLG 412
++G+G +G V K + G+ VA+K+ + + E+ ++ +L+H+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
LV+EF+ + LD + P RK + I +G+ + H + I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK---YLFQILRGIEFCHSHN---I 121
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYS 531
+HRD+K N+L+ K+ DFG AR A + GE T V T Y APE + + Y
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYT-DYVATRWYRAPELLVGDTKYG 179
Query: 532 KKSDVFSFGVLLIEIITG 549
+ D+++ G L+ E++TG
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
I G+ +LHE I++RDLK NVLLDS+ + KI+DFGM + E T G
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCG 158
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
T Y+APE Y D ++ GVLL E++ G+
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 20/206 (9%)
Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILK----LQHKNLVK 409
+G+G +G V+K + + G+ VA+KR+ E+G T + +L+ +H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 410 LLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
L C D + KL LV+E + + L L + G+ +++ + +G+ +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT-ETIKDMMFQLLRGLDFL 126
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
H R+VHRDLK N+L+ S K++DFG+ARI++ + +V T Y APE
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 180
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGR 550
++ Y+ D++S G + E+ +
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 357 LGQGGFGPVYKGVLSDG---KEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G G FG V G ++ G +V VK L S S Q +F E LQH NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT--NIVNGIAKGMLYLHEDSRL 470
C + LLV EF P G L L RK ++ T + IA G+L+LH+++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME--- 527
+H DL N LL +D+ KI D+G++ + + ++ ++APE E
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 528 ----GLYSKKSDVFSFGVLLIEII----TGRRNAGSNQLLAY 561
+K+S+V+S GV + E+ R+ Q+L Y
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY 221
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 71/218 (32%), Positives = 97/218 (44%), Gaps = 39/218 (17%)
Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
F +LG+GGFG V V + GK A K+L +G A NE ++ K+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 407 LVKLL-------GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
+V L C+ GD K +Y G FD +R +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FD-EERAVF-------Y 107
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR- 512
I G+ LH R RIV+RDLK N+LLD + +ISD G+A E E T+R
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRG 160
Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
VGT GYMAPE Y+ D + G L+ E+I G+
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN--EVLLILKLQHK 405
+ F N +G+G +G VY+ + E VA+K++ +E+ ++ E+ L+L L+H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 406 NLVKLLGFCVDG--DEKLLVYEFMPNGSLD-AILFDPRKR-----GILCWRKRTNIVNGI 457
N+V+L V D LV E+ D A L D + C ++ +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQ---DLASLLDNMPTPFSESQVKC------LMLQL 117
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
+G+ YLHE+ I+HRDLK SN+LL KI+DFG+AR + + T ++V T
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TL 172
Query: 518 GYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
Y APE + Y+ D+++ G +L E++ +
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 22/225 (9%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
IDL L F ++G G +G VYKG ++A ++ +E E E+ +
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 399 ILKL-QHKNLVKLLGFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR- 450
+ K H+N+ G + D+ LV EF GS+ ++ + + ++
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN---ALKEDW 122
Query: 451 -TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
I I +G+ +LH +++HRD+K NVLL + K+ DFG++ + G N
Sbjct: 123 IAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 179
Query: 510 TVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITG 549
T +GT +MAPE + Y +SD++S G+ IE+ G
Sbjct: 180 T--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 359 QGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTAEFTN----EVLLILKLQHKNLVKLLG 412
+G FG VY K + G A+K L + TN +++++ + + KL
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC--WRKR--TNIVNGIAKGMLYLHEDS 468
D LV E++ G +++ + G L W K+ +V G+ LH+
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLGVE----DLHQRG 117
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
I+HRD+K N+L+D + K++DFG++R E++ + VGT Y+APE +
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGV 168
Query: 529 LYSKKSDVFSFGVLLIEIITGRR 551
K SD +S G ++ E + G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 356 ILGQGGFGP--VYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL-G 412
++G+G FG + + V SD K + S + E +L+ K++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKR-----GILCWRKRTNIVNGIAKGMLYLHED 467
F DG +V E+ G L + R + IL W + + G+ ++HE
Sbjct: 67 FEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK 119
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
R++HRD+K+ N+ L + K+ DFG AR+ A T VGT Y+ PE
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPPEIWEN 174
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
Y+ KSD++S G +L E+ T
Sbjct: 175 MPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 38/214 (17%)
Query: 357 LGQGGFGPVYK------GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK----N 406
LG+G +G VYK GV KE+ RL E ++F N++++ L + HK
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI---RL----ELDESKF-NQIIMELDILHKAVSPY 60
Query: 407 LVKLLG-FCVDGDEKLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+V G F ++G VY E+M GSLD + + I + KG+
Sbjct: 61 IVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
+L E+ I+HRD+K +NVL++ + K+ DFG++ S + N +G YMAP
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAP 170
Query: 523 EY------AMEGLYSKKSDVFSFGVLLIEIITGR 550
E Y+ +SDV+S G+ ++E+ GR
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 356 ILGQGGFGPV----YKGVLSDGKEVAVKRL----SSCSEQGTAEFTNEVLLILKLQHKNL 407
++G+G +G V ++ +DGK+ +K+L +S E+ AE E L+ +L+H N+
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNI 61
Query: 408 VKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
V D L +V F G L L +K +L + IA + YLHE
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
I+HRDLK NV L K+ D G+AR+ A+T ++GT YM+PE
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFS 175
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR--NAGSNQLLAY 561
Y+ KSDV++ G + E+ T + NA L Y
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNE--VLLILKLQHKNLVK 409
I+G+GGFG VY +D GK A+K L +QG NE +L ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ + +KL + + M G L L + G+ + I G+ ++H +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMH--N 115
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
R +V+RDLK +N+LLD + +ISD G+A F++ + A+ VGT+GYMAPE +G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170
Query: 529 L-YSKKSDVFSFGVLLIEIITG 549
+ Y +D FS G +L +++ G
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKN 406
+ + + +G+G +G V G +VA+K++S Q + T E+ ++ + +H+N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 407 LVKLLGFCVDGD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
++ +L + +V E M I + + + I +G+
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQY-----FLYQILRGL 119
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA-ESEGEANTVRIVGTYGYM 520
Y+H + ++HRDLK SN+LL+++ + KI DFG+ARI E + V T Y
Sbjct: 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 521 APEYAMEG-LYSKKSDVFSFGVLLIEIITGR 550
APE + Y+K D++S G +L E+++ R
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHK 405
S + +GQG FG V+K + VA+K++ +E+ T E+ ++ L+H+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 406 NLVKLLGFCVDGDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
N+V L+ C LV+EF + L +L + + L K+ ++ +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKML 128
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN---TVRIV 514
G+ Y+H R +I+HRD+KA+N+L+ D K++DFG+AR F+ S+ T R+V
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 515 GTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIIT 548
T Y PE + E Y D++ G ++ E+ T
Sbjct: 186 -TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 71/231 (30%), Positives = 110/231 (47%), Gaps = 33/231 (14%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL---SSCSEQGTAEFTN 394
+ LE+L T + +G+G +G VYK DG AVK L S E+ AE+
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN- 70
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKL-----LVYEFMPNGSLDAILFDPRKRGILCWRK 449
+L L H N+VK G D+ + LV E GS+ ++ +G+L +
Sbjct: 71 -ILQSLP-NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQ 123
Query: 450 RTN------IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
R + I+ G G+ +LH + RI+HRD+K +N+LL ++ K+ DFG++
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 504 SEGEANTVRIVGTYGYMAPEY-----AMEGLYSKKSDVFSFGVLLIEIITG 549
+ NT VGT +MAPE + Y + DV+S G+ IE+ G
Sbjct: 181 TRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN----EVLLILKLQHKNLVKLL 411
+G G +G V + VA+K+LS + +A E+ L+ + H+N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 412 G-FCVDG-----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
F + LV M L+ I+ K L +V I +G+ Y+H
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
I+HRDLK SN+ ++ D KI DFG+AR + E V T Y APE
Sbjct: 136 S---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDE----MTGYVATRWYRAPEIM 187
Query: 526 MEGL-YSKKSDVFSFGVLLIEIITGR 550
+ + Y++ D++S G ++ E++TG+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 68/205 (33%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
F +LG+GGFG V V + GK A K+L +G A NE ++ K+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+V L D LV M G L +++ G + A+ L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF----DEQRAIFYAAELCCGLED 117
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYMAPEYA 525
R RIV+RDLK N+LLD + +ISD G+A E E TVR VGT GYMAPE
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTVGYMAPEVI 173
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
Y+ D + G L+ E+I G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTNEVLLILK-------LQHKNLV 408
+GQGG+G V+ D E VA+KR+ + NEV +L + + LV
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK----KSLLFKLNEVRHVLTERDILTTTKSEWLV 64
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-- 466
KLL D + L E++P G +L + G+L A+ Y+ E
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNN---LGVLS--------EDHAR--FYMAEMF 111
Query: 467 ---DS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
D+ L +HRDLK N L+D+ + K++DFG+++ AN+V VG+ YMA
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSV--VGSPDYMA 166
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
PE Y D +S G +L E + G
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 67/204 (32%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
F +LG+GGFG V V + GK A KRL +G + NE ++ K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+V L D LV M G L +++ G R I G+ LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHR 120
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
++ V+RDLK N+LLD + +ISD G+A EGE+ R VGT GYMAPE
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEVLN 174
Query: 527 EGLYSKKSDVFSFGVLLIEIITGR 550
Y+ D + G L+ E+I G+
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKN--LVK 409
I+G+GGFG VY +D GK A+K L +QG NE +++ + + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ + +KL + + M G L L + G+ ++ I G+ ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--N 115
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
R +V+RDLK +N+LLD + +ISD G+A F++ + A+ VGT+GYMAPE +G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170
Query: 529 L-YSKKSDVFSFGVLLIEIITG 549
Y +D FS G +L +++ G
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLG 412
LG+GGFG V + + GK A K+L+ +G E ++ K+ + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFD--------PRKRGILCWRKRTNIVNGIAKGMLYL 464
+ LV M G L +++ P R I G+ +L
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF-------YTAQIISGLEHL 113
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
H+ RI++RDLK NVLLD+D N +ISD G+A +G++ T GT G+MAPE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK--DGQSKTKGYAGTPGFMAPEL 168
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGR 550
Y D F+ GV L E+I R
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 356 ILGQGGFGPVYKGVL-SDGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQHKNLVKL 410
+LG+G FG V L G+ AVK L + T + +L L H L +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 411 LGFCVDGDEKLL-VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
C ++L V EF+ G L +F +K + I +++LH+
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN---TVRIVGTYGYMAPEYAM 526
I++RDLK NVLLD + + K++DFGM + EG N T GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 527 EGLYSKKSDVFSFGVLLIEIITG 549
E LY D ++ GVLL E++ G
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 17/210 (8%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK 405
L +F + LG G G V+K + ++L + N+++ L++ H+
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHE 59
Query: 406 -NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
N ++GF DG E + E M GSLD +L +K G + + + + KG
Sbjct: 60 CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKG 115
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
+ YL E + +I+HRD+K SN+L++S K+ DFG++ +S AN+ VGT YM
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRSYM 169
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
+PE YS +SD++S G+ L+E+ GR
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
F ++G G +G VYKG ++A ++ + E E+ ++ K H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 410 LLGFCVD------GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
G + D+ LV EF GS+ ++ + K L I I +G+ +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSH 126
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
LH+ +++HRD+K NVLL + K+ DFG++ + G NT +GT +MAPE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPE 181
Query: 524 YAM-----EGLYSKKSDVFSFGVLLIEIITG 549
+ Y KSD++S G+ IE+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 40/96 (41%), Positives = 56/96 (58%), Gaps = 9/96 (9%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR--IFAESEGEANTVRIV 514
IA G+ +LH I++RDLK NV+LD++ + KI+DFGM + IF G T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF----GGKTTRTFC 162
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
GT Y+APE Y K D ++FGVLL E++ G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 350 NFSDSNILGQGGFGPVY----KGVLSDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL 402
NF +LG G +G V+ G GK A+K L + + TAE T +L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 403 QHKN--LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
+ LV L + D KL L+ +++ G L L+ R+ + IA+
Sbjct: 61 VRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTE---SEVRVY--IAE 113
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
+L L +L I++RD+K N+LLDS+ + ++DFG+++ F E E GT Y
Sbjct: 114 IVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEY 172
Query: 520 MAPEYAM--EGLYSKKSDVFSFGVLLIEIITG 549
MAPE G + K D +S GVL E++TG
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKN 406
+ N + +G +G VY+ G+ VA+K+L E+ T+ E+ ++LKLQH N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 407 LVKLLGFCV--DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
+V + V + D+ +V E++ + L +++ ++ + K ++ + G+ +L
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVK--CLMLQLLSGVAHL 122
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
H++ I+HRDLK SN+LL++ KI DFG+AR + ++V T Y APE
Sbjct: 123 HDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPEL 177
Query: 525 AM-EGLYSKKSDVFSFGVLLIEIITGR 550
+ YS D++S G + E++T +
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 41/103 (39%), Positives = 59/103 (57%), Gaps = 11/103 (10%)
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
I I K + YLH +L ++HRD+K SNVL++ + K+ DFG++ +S A T+
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTID 163
Query: 513 IVGTYGYMAPE-----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
G YMAPE +G Y KSDV+S G+ +IE+ TGR
Sbjct: 164 A-GCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKL 410
+G G +G VYK G VA+K R+ + + EV L+ +L+ H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 411 LGFC----VDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ C D + K+ LV+E + + L L G L +++ +G+ +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFLH 125
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
+ IVHRDLK N+L+ S K++DFG+ARI++ + +V T Y APE
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVL 179
Query: 526 MEGLYSKKSDVFSFGVLLIEI 546
++ Y+ D++S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 39/216 (18%)
Query: 357 LGQGGFGPVYKGVLS--DGKEVAVKRLS---SCSEQGTAEFTNEVLLILKL--QHKNLVK 409
+G+G +G V+K VL+ +G + AVK L E+ AE+ ILK H N+VK
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYN-----ILKALSDHPNVVK 79
Query: 410 LLGF-----CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN------IVNGIA 458
G +GD+ LV E GS+ ++ KRG +R I++
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG-----ERMEEPIIAYILHEAL 134
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
G+ +LH + + +HRD+K +N+LL ++ K+ DFG++ + NT VGT
Sbjct: 135 MGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPF 189
Query: 519 YMAPEY-----AMEGLYSKKSDVFSFGVLLIEIITG 549
+MAPE ++ Y + DV+S G+ IE+ G
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 70/255 (27%), Positives = 106/255 (41%), Gaps = 45/255 (17%)
Query: 305 KQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGP 364
K +QLHK D++ T R N +K +DF NF + LG G FG
Sbjct: 5 KNLQLHKKKDSDSTK-----EPKRKNKMKYEDF------------NFIRT--LGTGSFGR 45
Query: 365 VYKGVLSDGK--EVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419
V + VA+KR ++ +E ++ + H V L G D
Sbjct: 46 VILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105
Query: 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI-----AKGMLYLHEDSRLRIVH 474
LV EF+ G L R+ N + A+ +L L IV+
Sbjct: 106 LYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
RDLK N+LLD D K++DFG A++ + T + GT Y+APE + + K +
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHGKAA 209
Query: 535 DVFSFGVLLIEIITG 549
D ++ G+ + EI+ G
Sbjct: 210 DWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 356 ILGQGGFGPVYKGVLS-DGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQHKNLVKL 410
+LG+G FG V L G+ AVK L + + +L L ++ L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ V EF+ G L +F + +G + T I G+ +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG-- 116
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
I++RDLK NV+LD D + KI+DFGM + + A+T GT Y+APE Y
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKY 173
Query: 531 SKKSDVFSFGVLLIEIITGR 550
+ D +SFGVLL E++ G+
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 55/164 (33%), Positives = 91/164 (55%), Gaps = 19/164 (11%)
Query: 394 NEVLLILKLQHK-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRK--RGILC 446
N+++ L++ H+ N ++GF DG E + E M GSLD +L + ++ IL
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKRIPEEIL- 105
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
+ + +G+ YL E + +I+HRD+K SN+L++S K+ DFG++ +S
Sbjct: 106 ----GKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158
Query: 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
AN+ VGT YM+PE YS +SD++S G+ L+E+ GR
Sbjct: 159 -ANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPV----YKGVLSDGKEVAVKRLSS---C 384
+KA F +T + S+F LG G FG V +KG G+ A+K L
Sbjct: 1 MKAAYMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREIL 57
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
+ E ++++L H +V ++ D + + EF+ G L L
Sbjct: 58 KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-------- 109
Query: 445 LCWRKRTNIVNGIAK--------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
RK N +AK YLH I++RDLK N+LLD+ + K++DFG
Sbjct: 110 ---RKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFG 163
Query: 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
A+ + T + GT Y+APE + K D ++ GVLL E I G
Sbjct: 164 FAKKVPD-----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 27/229 (11%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
S + D LG G G V+ V SD K VAVK++ Q E+ +I +L H N+
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI 64
Query: 408 VKLLGFCVDGDEKL--------------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
VK+ L +V E+M + L + ++G L
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLF 119
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIF-AESEGEANTV 511
+ + +G+ Y+H + ++HRDLK +NV +++ D+ KI DFG+ARI +
Sbjct: 120 MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 512 RIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRR-NAGSNQL 558
+ T Y +P + Y+K D+++ G + E++TG+ AG+++L
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 350 NFSDSNILGQGGFGPVY---KGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLILKL 402
NF +LG G +G V+ K D GK A+K L + + T E T +L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 403 --QHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
Q LV L + + KL L+ +++ G + L+ +R + I
Sbjct: 61 VRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIIL 116
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
+ +LH +L IV+RD+K N+LLDS+ + ++DFG+++ F E E T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEY 172
Query: 520 MAPEYAM-EGLYSKKSDVFSFGVLLIEIITG 549
MAPE +G + K D +S G+L+ E++TG
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 356 ILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLLG 412
++G+G +G V K + KE VA+K+ E + T E+ ++ L+ +N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
+ LV+E++ L+ L + G+ + R+ I I K + + H++ I
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKND---I 121
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
VHRD+K N+L+ + K+ DFG AR +E AN V T Y +PE + Y K
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGK 180
Query: 533 KSDVFSFGVLLIEIITGR 550
D++S G +L E+ G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G G +G V + G++VA+K+LS SE E+ L+ +QH+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 414 ---CVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
V GDE Y MP D + G L K +V + G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDL----QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG- 137
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
I+HRDLK N+ ++ D KI DFG+AR +A V T Y APE + +
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWM 190
Query: 530 -YSKKSDVFSFGVLLIEIITGR 550
Y++ D++S G ++ E++TG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 356 ILGQGGFGPVY---KGVLSD-GKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+LGQG FG V+ K D G+ A+K L ++ + E ++ ++ H +VK
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 410 L-LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
L F +G KL L+ +F+ G L L K + + +A + +LH
Sbjct: 63 LHYAFQTEG--KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLH-- 115
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES-EGEANTVRIVGTYGYMAPEYAM 526
L I++RDLK N+LLD + + K++DFG+++ ES + E GT YMAPE
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 527 EGLYSKKSDVFSFGVLLIEIITG 549
+++ +D +SFGVL+ E++TG
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 357 LGQGGFGPVYKGVL----SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKL 410
+G+G FG K +L DGK+ +K ++ S + E EV ++ ++H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 411 LGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
+ +V ++ G L +LF + IL W + I + +
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ--ILDWFVQ------ICLALKH 116
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
+H+ +I+HRD+K+ N+ L D K+ DFG+AR+ + A T +GT Y++PE
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--IGTPYYLSPE 171
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
Y+ KSD+++ G +L E+ T
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 356 ILGQGGFGPVYKGVLS-DGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQHKNLVKL 410
+LG+G FG V+ L + A+K L + + +L L +H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ V E++ G L +F + + T I G+ +LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG-- 116
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
IV+RDLK N+LLD+D + KI+DFGM + G+A T GT Y+APE + Y
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 531 SKKSDVFSFGVLLIEIITGR 550
+ D +SFGVLL E++ G+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 350 NFSDSNILGQGGFGPVY---KGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLILK- 401
NF +LG G +G V+ K D GK A+K L + + T E T +L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 402 LQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
++ + L + D KL L+ +++ G L L +R ++ I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
+ +LH +L I++RD+K N+LLDS+ + ++DFG+++ F E E E GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 521 APEYAM--EGLYSKKSDVFSFGVLLIEIITG 549
AP+ +G + K D +S GVL+ E++TG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 18/197 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G +G VYK ++ G+ A+K + + A E++++ +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 416 DGDEKLLVYEFMPNGSLDAI--LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
D+ + EF GSL I + P + + R + +G+ YLH ++
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGKM--- 128
Query: 474 HRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAM---EGL 529
HRD+K +N+LL + + K++DFG+ A+I A A +GT +MAPE A +G
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 530 YSKKSDVFSFGVLLIEI 546
Y++ D+++ G+ IE+
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 71/283 (25%)
Query: 357 LGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEVLL---ILKLQH--KNLVKL 410
+G G G VYK G +AVK++ G E +L+ ++ H +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 411 LG-FCVDGD------------EKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
G F D D +KLL + +P + IL +
Sbjct: 80 YGYFITDSDVFICMELMSTCLDKLLKRIQGPIP----EDIL--------------GKMTV 121
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
I K + YL E ++HRD+K SN+LLD+ N K+ DFG++ +S +A T R G
Sbjct: 122 AIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS--KAKT-RSAG 176
Query: 516 TYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE--- 568
YMAPE Y ++DV+S G+ L+E+ TG+ + +
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ----------FPYKNCKTEFE 226
Query: 569 --GNVLELVDPLLT-DTSFSDDEFSRYIHIGLLCVQEDAFDRP 608
+L+ P L + FS D F ++ LC+ +D RP
Sbjct: 227 VLTKILQEEPPSLPPNEGFSPD-FCSFVD---LCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 49/231 (21%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE------------FT--NEVLLI 399
LG+G +G V K GK VA+K++ FT E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI------LFDPRKRGILCWRKRTNI 453
+++H+N++ L+ V+GD LV + M L + L + + + IL I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-----LQI 128
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA----------- 502
+NG+ LH+ +HRDL +N+ ++S KI+DFG+AR +
Sbjct: 129 LNGLNV----LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 503 --ESEGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
E T ++V T Y APE M Y D++S G + E++TG+
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKR-LSSCSEQGTAEFT-NEVLLILKLQHKN-LVKLL 411
+G+G +G VYK + GK VA+K+ E+G E+ L+ L +V+LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 412 GFCVDGDEK-------LLVYEFMPNGSLDAILFDPRKRGILCWRKR-----TNIVNG--- 456
V+ E+ LV+E++ + D +K R +
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDS--------DLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 457 -IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIV 514
+ KG+ + H + ++HRDLK N+L+D KI+D G+ R F+ + T IV
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIV 173
Query: 515 GTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITG 549
T Y APE + YS D++S G + E+
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
+ +G G FG V+ + A+K ++ + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 405 KNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+++L F + D++ L + E++P G L + L R G + I +
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL---RNSGRFSNSTGLFYASEIVCALE 115
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
YLH IV+RDLK N+LLD + + K++DFG A+ + T + GT Y+AP
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAP 167
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITG 549
E ++K D ++ G+L+ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHK 405
S + +G G +G V + GK+VA+K++ + T A+ T L IL+ +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 406 NLVKLLGFCV----DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
N++ + D + +V + M + L I+ L + + +G+
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMES-DLHHII---HSDQPLTEEHIRYFLYQLLRGL 120
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV--RIVGTYGY 519
Y+H + ++HRDLK SN+L++ D +I DFGMAR + S E V T Y
Sbjct: 121 KYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177
Query: 520 MAPE--YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
APE ++ Y+ D++S G + E++ GRR
Sbjct: 178 RAPELLLSLPE-YTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 31/235 (13%)
Query: 337 FFIDLETLNLATSNFSDSNILGQGGFGPV-YKGVLSDGKEVAVK--RLSSCSEQGTAEFT 393
F D T + S +LG G G V +SDG+ AVK + SE
Sbjct: 20 FAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ 79
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
EV +L ++VK D + N + A++ D G L R I
Sbjct: 80 AEVCCLLNCDFFSIVKCHEDFAKKDPRNPE-----NVLMIALVLDYANAGDL----RQEI 130
Query: 454 VNGIAK----------GMLYL-------HEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
+ AK G+L++ H S+ ++HRD+K++N+LL S+ K+ DFG
Sbjct: 131 KSR-AKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFG 188
Query: 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
++++A + + GT Y+APE YSKK+D+FS GVLL E++T +R
Sbjct: 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRLSSC----SEQGTAEFTNEVLLILKLQHKNL 407
+LG+GG+G V++ G + A+K L +++ TA E ++ ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 408 VKLL-GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
V L+ F G KL L+ E++ G L L + GI ++ I+ + +LH
Sbjct: 63 VDLIYAFQTGG--KLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLH 117
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES-EGEANTVRIVGTYGYMAPEY 524
+ I++RDLK N+LLD+ + K++DFG+ + ES T GT YMAPE
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK---ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
M + K D +S G L+ +++TG
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 40/213 (18%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G +G VYK E +A+K RL E + E+ L+ ++QH N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD- 68
Query: 414 CVDGDEKL-LVYEFMPNGSLDAILF---------DPRKRGILCWRKRTNIVNGIAKGMLY 463
V +++L LV+E++ LD +PR ++ I+ GIA Y
Sbjct: 69 VVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----Y 117
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRI----VGTYG 518
H S R++HRDLK N+L+D N+ K++DFG+AR F VR V T
Sbjct: 118 CH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP------VRTFTHEVVTLW 168
Query: 519 YMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
Y APE + YS D++S G + E++ +
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
E +L+ + H +++++ V G +V +P+ S D + ++ L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
I +G+ YLH RI+HRD+K N+ ++ I D G A+ + +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
GT APE Y+ K+D++S G++L E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 55/234 (23%)
Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLSSC----SEQGTAEFTNEVLLILKLQHKNLVKL 410
++G+G FG V+ D +V A+K L Q A E ++ +VKL
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL 66
Query: 411 LGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG------IAKGML 462
+ DE+ L V E+MP G L +L R ++ IA+ +L
Sbjct: 67 --YYSFQDEEHLYLVMEYMPGGDL---------MNLLI---RKDVFPEETARFYIAELVL 112
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-------RIFAESEGEANTVR--- 512
L +L +HRD+K N+L+D+D + K++DFG+ N +
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 513 -----------------IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
VGT Y+APE Y + D +S GV+L E++ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 40/97 (41%), Positives = 59/97 (60%), Gaps = 13/97 (13%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESE----GEANTV 511
+A+GM +L SR + +HRDL A N+LL + KI DFG+AR I+ + + G+A
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE + +Y+ +SDV+SFGVLL EI +
Sbjct: 238 ----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
I+ G+ +LH I++RDLK NV+LDS+ + KI+DFGM + E + T R G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
T Y+APE Y K D +++GVLL E++ G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 12/194 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G +G VYK L G+ AVK + + E+ ++ + +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
++ + E+ GSL I G L + + +G+ YLH ++ HR
Sbjct: 77 SREKLWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLAYLHSKGKM---HR 130
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSK 532
D+K +N+LL + + K++DFG+A + + + +GT +MAPE A G Y++
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 533 KSDVFSFGVLLIEI 546
D+++ G+ IE+
Sbjct: 189 LCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQ 403
A +++ + LG+G + VYKG+ +G+ VA+K +S +E+G FT E L+ L+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61
Query: 404 HKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
H N+V LL + E L V+E+M ++ P G+ + R + + +G+
Sbjct: 62 HANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQ-LLRGLA 117
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
Y+H I+HRDLK N+L+ K++DFG+AR A+S V T Y P
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPP 172
Query: 523 EYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
+ + YS D++ G + IE++ G+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 54/222 (24%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G +G V+K + E VA+KR L E + E+ L+ +L+HKN+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD- 66
Query: 414 CVDGDEKL-LVYEFMP----------NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+ D+KL LV+E+ NG +D + + + + KG+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK-------------SFMFQLLKGLA 113
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF--------AESEGEANTVRIV 514
+ H ++HRDLK N+L++ + K++DFG+AR F AE V
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE----------V 160
Query: 515 GTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGS 555
T Y P+ LYS D++S G + E+ NAG
Sbjct: 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL----ANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQHKNLVKL 410
++G+G FG V +DGK AVK L + E +L+ ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
+ +KL V +++ G L L R+R R R IA + YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS--- 114
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
L I++RDLK N+LLDS + ++DFG+ + E T GT Y+APE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 530 YSKKSDVFSFGVLLIEIITG 549
Y + D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 39/95 (41%), Positives = 57/95 (60%), Gaps = 7/95 (7%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
IA G+ +LH I++RDLK NV+LDS+ + KI+DFGM + E+ + T + G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
T Y+APE Y K D ++FGVLL E++ G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 357 LGQGGFGPVYKGV---LSDGK-----EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
LGQG F ++KG+ + D EV +K L + F ++ +L HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
G CV GDE ++V E++ GSLD L + + W + + +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 469 RLRIVHRDLKASNVLL--DSDMNS------KISDFGMARIFAESEGEANTVRIVGTYGYM 520
+ H ++ A NVLL + D + K+SD G++ E RI ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI----PWV 171
Query: 521 APEYAMEGLY-SKKSDVFSFGVLLIEIITG 549
PE S +D +SFG L EI +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNL 407
+ D +G G +G V + G +VA+K+L SE E+ L+ ++H+N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 408 VKLLG-FCVDG--DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
+ LL F D D Y MP D L K L + +V + KG+ Y+
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
H I+HRDLK N+ ++ D KI DFG+AR +SE V T Y APE
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEMTGYVV----TRWYRAPEV 186
Query: 525 AMEGL-YSKKSDVFSFGVLLIEIITGR 550
+ + Y++ D++S G ++ E++TG+
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 41/226 (18%)
Query: 356 ILGQGGFGPVYKGVLSD---GKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G+GG G VY D + VA+K++ S + F E + L H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 410 LLGFCVDGDEKLLVYEFMP---NGSLDAILFDPRKRGILC--WRKRTN------IVNGIA 458
+ C DGD VY MP +L ++L ++ L ++T+ I + I
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEAN-------- 509
+ Y+H S+ ++HRDLK N+LL I D+G A E E +
Sbjct: 124 ATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 510 -----TV--RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
T+ +IVGT YMAPE + S+ +D+++ GV+L +++T
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 357 LGQGGFGPVYKGVLSDG---KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG- 412
+G+G +G VYK DG ++ A+K++ +A E+ L+ +L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66
Query: 413 FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY-----LHE 466
F D K+ L++++ + I F R +K + G+ K +LY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKF---HRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 467 DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARIF-AESEGEANTVRIVGTYGYMA 521
++HRDLK +N+L+ + KI+D G AR+F + + A+ +V T+ Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIIT 548
PE + Y+K D+++ G + E++T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKL 410
+LG+G FG V L EV A+K L + T + +L L +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
D V E++ G L +F R R R R + +++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLHRHG- 116
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN---TVRIVGTYGYMAPEYAM 526
+++RDLK N+LLD++ + K++DFGM + EG N T GT Y+APE
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK-----EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 527 EGLYSKKSDVFSFGVLLIEIITGR 550
E Y D ++ GVL+ E++ G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 48/217 (22%)
Query: 356 ILGQGGFGPV----YKGVLSDGKEVAVKRL------------SSCSEQGTAEFTNEVLLI 399
+LG+G FG V YK G+ A+K L S E+ E N
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN----- 57
Query: 400 LKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSL-----DAILFDPRKRGILCWRKRTNI 453
+H LV L C ++ + V E+ G L + +PR
Sbjct: 58 -SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAA------- 108
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-TVR 512
+ G+ YLHE+ +IV+RDLK N+LLD++ KI+DFG+ + E G + T
Sbjct: 109 --CVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTST 160
Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
GT ++APE E Y++ D + GVL+ E++ G
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNE 395
+ L + +F ++G+G FG V K+V A+K LS +A F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFD---PRKRGILCWRKR 450
++ + +V+L D+K L V E+MP G L ++ + P K W +
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----WARF 146
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
A+ +L L + +HRD+K N+LLD + K++DFG + ++ G
Sbjct: 147 Y-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRC 200
Query: 511 VRIVGTYGYMAPEYAM----EGLYSKKSDVFSFGVLLIEIITG 549
VGT Y++PE +G Y ++ D +S GV L E++ G
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 356 ILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVK 409
++G+G FG V SDG AVK L + EQ VLL L+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL-KNLKHPFLVG 60
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
L + EKL V +++ G L R+R L R R +A + YLH
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS-- 114
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
L I++RDLK N+LLDS + ++DFG+ + E E +T GT Y+APE +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST--FCGTPEYLAPEVLRKE 171
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
Y + D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 18/191 (9%)
Query: 373 GKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMP 428
G EVA+K L + + + A F E L +L H N+V LL L V+E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---D 485
+L +L G L + ++ + + H IVHRDLK N+++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 486 SDMNSKISDFGMARIFAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFG 540
++K+ DFG+ + T ++GT Y APE + SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 541 VLLIEIITGRR 551
++ +E +TG+R
Sbjct: 177 LIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 45/206 (21%), Positives = 81/206 (39%), Gaps = 20/206 (9%)
Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+ K VAVK+ L SCS++ E++ +LQH N++ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT---NIVNGIAKGMLYLHEDSRL 470
+ E +V M GS + +L G+ I+ + + Y+H
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGL----PELAIAFILKDVLNALDYIH---SK 120
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAPEYA 525
+HR +KAS++LL D +S + + V +++PE
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 526 MEGL--YSKKSDVFSFGVLLIEIITG 549
+ L Y++KSD++S G+ E+ G
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 348 TSNFSDSNILGQGGFGPV--YKGVLSDGKEVAVKRL-SSCSEQGTAEFT-NEVLLILKLQ 403
T+ + D +G G FG V + L+ G+ VA+K++ S A+ T E+ L+ L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 404 HKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
H+N++ L + E + V E + L +L L + + I +G+
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGT-DLHRLL----TSRPLEKQFIQYFLYQILRGLK 122
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
Y+H +VHRDLK SN+L++ + + KI DFG+ARI + V T Y AP
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAP 174
Query: 523 EYAME-GLYSKKSDVFSFGVLLIEIITGR 550
E + Y + D++S G + E++ G+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I +G+ YLH I+HRD+K N+L++S+ KI DFG+AR+ E + T +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 517 YGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
Y Y APE M Y+ D++S G + E++ R
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 44/128 (34%), Positives = 64/128 (50%), Gaps = 10/128 (7%)
Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
Y+ + + +L D G L + +A+GM +L + VHRDL A NVL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEG-LTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269
Query: 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTY---GYMAPEYAMEGLYSKKSDVFSFG 540
L KI DFG+AR ++N V T+ +MAPE + LY+ SDV+S+G
Sbjct: 270 LAQGKIVKICDFGLARDIMH---DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYG 326
Query: 541 VLLIEIIT 548
+LL EI +
Sbjct: 327 ILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLLGF 413
+G G +G V G VAVK+LS + A+ T L +LK ++H+N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
F P SL+ L I+ +K T+ ++ I +G
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
+ Y+H I+HRDLK SN+ ++ D KI DFG+AR + V T Y
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 184
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
APE + + Y++ D++S G ++ E++TGR
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 39/94 (41%), Positives = 59/94 (62%), Gaps = 7/94 (7%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEG-EANTVRIV 514
+A+GM +L SR + +HRDL A N+LL + KI DFG+AR I+ + + + R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE + +Y+ +SDV+SFGVLL EI +
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLLGF 413
LG+G + VYKG +GK VA+K + E+GT FT E L+ L+H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP-FTAIREASLLKGLKHANIVLLHDI 71
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+ LV+E++ D + + G L + + +G+ Y+H+ I+
Sbjct: 72 IHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---IL 125
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSK 532
HRDLK N+L+ K++DFG+AR A+S V T Y P+ + YS
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 533 KSDVFSFGVLLIEIITG 549
D++ G + +E+I G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 357 LGQGGFGPVYKGVLSDG---KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG- 412
+G+G +G VYK DG KE A+K++ +A E+ L+ +L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 413 FCVDGDEKL-LVYEFMPNGSLDAILF----DPRKRGILCWRKRT-NIVNGIAKGMLYLHE 466
F D K+ L++++ + I F K+ + R +++ I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 467 DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARIF-AESEGEANTVRIVGTYGYMA 521
+ ++HRDLK +N+L+ + KI+D G AR+F + + A+ +V T+ Y A
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIIT 548
PE + Y+K D+++ G + E++T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 41/97 (42%), Positives = 59/97 (60%), Gaps = 13/97 (13%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESE----GEANTV 511
+AKGM +L SR + +HRDL A N+LL + KI DFG+AR I+ + + G+A
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE + +Y+ +SDV+SFGVLL EI +
Sbjct: 244 ----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 56/225 (24%)
Query: 357 LGQGGFGPV----YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLI-----LKL----- 402
LGQG +G V S+ + VA+K++++ F+ ++L LKL
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNV-------FSKKILAKRALRELKLLRHFR 59
Query: 403 QHKNLVKLLGFCV---DGDEKLLVYEFMPNGSLDAILFDPRKRG----------ILCWRK 449
HKN+ L + +L +YE + L I+ + ILC
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC--- 116
Query: 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
G+ Y+H + ++HRDLK N+L+++D KI DFG+AR F+E+ GE N
Sbjct: 117 ----------GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-N 162
Query: 510 TVRI---VGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
+ V T Y APE + Y+K DV+S G +L E++ +
Sbjct: 163 AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 21/191 (10%)
Query: 371 SDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429
SD KE V + +++ A + +E+ + H +VK D+ LL+ E+
Sbjct: 90 SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 430 GSLDAIL---------FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480
G L+ + F + G+L ++ IV L L E +++HRDLK++
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQ----IV-------LALDEVHSRKMMHRDLKSA 198
Query: 481 NVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFG 540
N+ L K+ DFG ++ +++S GT Y+APE YSKK+D++S G
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 541 VLLIEIITGRR 551
V+L E++T R
Sbjct: 259 VILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE----QGTAEFTNE 395
+ L + ++ ++G+G FG V ++V +L S E +A F E
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFD---PRKRGILCWRKR 450
++ +V+L FC D+K L V E+MP G L ++ + P K W K
Sbjct: 94 RDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKF 146
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
A+ +L L + ++HRD+K N+LLD + K++DFG E+ G
Sbjct: 147 YT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMVRC 200
Query: 511 VRIVGTYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITG 549
VGT Y++PE +G Y ++ D +S GV L E++ G
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLGF 413
LG+G + VYKG L+D VA+K + E+G EV L+ L+H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---------GIAKGMLYL 464
LV+E++ + L L D C N +N + +G+ Y
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDD-------C----GNSINMHNVKLFLFQLLRGLNYC 120
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
H R +++HRDLK N+L++ K++DFG+AR A+S V T Y P+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDI 175
Query: 525 AMEGL-YSKKSDVFSFGVLLIEIITGR 550
+ YS + D++ G + E+ TGR
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILK-LQHKNLVKL 410
++G+G FG V ++ K AVK L ++ +E ++LK ++H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
D+ V +++ G L L R+R L R R IA + YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---L 115
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
IV+RDLK N+LLDS + ++DFG+ + E G +T GT Y+APE + Y
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST--FCGTPEYLAPEVLHKQPY 173
Query: 531 SKKSDVFSFGVLLIEIITG 549
+ D + G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 39/95 (41%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+A GM +L + VHRDL A NVL+ KI DFG+AR ++N + T
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMR---DSNYISKGST 301
Query: 517 Y---GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+ +MAPE LY+ SDV+SFG+LL EI T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 356 ILGQGGFGPVYKGVL----SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLV 408
+LG+G FG V +L + GK A+K L ++ A E ++ +H L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHED 467
L D V E++ G L F R + RT I + YLH
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGEL----FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYMAPEYAM 526
+IV+RDLK N++LD D + KI+DFG+ + E +A T++ GT Y+APE
Sbjct: 115 ---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLE 168
Query: 527 EGLYSKKSDVFSFGVLLIEIITGR 550
+ Y + D + GV++ E++ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 20/185 (10%)
Query: 373 GKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLLGFCV------DGDEKLLVY 424
G VAVK+LS + T A+ L++LK + HKN++ LL + + LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
E M I + L + + ++ + G+ +LH I+HRDLK SN+++
Sbjct: 106 ELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 485 DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLI 544
SD KI DFG+AR T +V Y Y APE + Y + D++S G ++
Sbjct: 157 KSDCTLKILDFGLAR--TACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 545 EIITG 549
E++ G
Sbjct: 214 ELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 52/244 (21%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQ 403
+F ++G+G FG V D G A+K+L EQ A E ++ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59
Query: 404 HKNLVKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
+ +VKL + DE L+ E++P G + +L K+ + T IA+ +
Sbjct: 60 NPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFT-EEETRFY--IAETI 111
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM------------ARIFAESEGEAN 509
L + +L +HRD+K N+LLD+ + K+SDFG+ RI + +
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 510 TVRI------------------------VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIE 545
I VGT Y+APE ++ Y+K+ D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 546 IITG 549
++ G
Sbjct: 232 MLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLGF 413
LG+G + V+KG L++ VA+K + E+G EV L+ L+H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
V D+ L LV+E++ + L + D I+ + I +G+ Y H R ++
Sbjct: 73 -VHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYS 531
+HRDLK N+L++ K++DFG+AR A+S V T Y P+ + YS
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 532 KKSDVFSFGVLLIEIITGR 550
+ D++ G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 37/210 (17%)
Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLLGF 413
LG+G + VYKG G+ VA+K + E+G A FT E L+ L+H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIV-TLHD 70
Query: 414 CVDGDEKL-LVYEFM-----------PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
+ + L LV+E++ G + ++ + +G+
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGG------LSMHNVRLFLFQ--------LLRGL 116
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
Y H + R++HRDLK N+L+ K++DFG+AR A+S V T Y
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR--AKSVPSKTYSNEVVTLWYRP 171
Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
P+ + YS D++ G + E+ TGR
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 357 LGQGGFGPVYKGVL---SDGK--------EVAVKRLSSCSEQGTAEFTNEVLLILKLQHK 405
LGQG F +YKGVL SD V +K L S + + F L+ +L HK
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+LVKL G CV DE ++V E++ G LD L + L W + ++ +A + YL
Sbjct: 62 HLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 466 EDSRLRIVHRDLKASNVLL--DSDMNS-----KISDFGMAR-IFAESEGEANTVRIVGTY 517
+ ++VH ++ N+L+ K+SD G+ + + E RI
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---RI---- 168
Query: 518 GYMAPEYAMEGLYSKKS---DVFSFGVLLIEI 546
++APE + + + D +SFG L+EI
Sbjct: 169 PWIAPEC-IRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 64/248 (25%), Positives = 108/248 (43%), Gaps = 24/248 (9%)
Query: 314 DANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDG 373
D + H D + ++ ID + ++ NI+G G FG VY+ + D
Sbjct: 32 DKKLDEEERSHNNNAGED-EDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDT 90
Query: 374 KE-VAVKRLSSCSEQGTAEFTNEVLLILK-LQHKNLVKLLGF----CVDGDEKLL----V 423
E VA+K++ ++ N LLI+K L H N++ L + C +EK + V
Sbjct: 91 SEKVAIKKVLQ-----DPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
EF+P + R L + + + Y+H I HRDLK N+L
Sbjct: 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLL 202
Query: 484 LDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGV 541
+D + ++ K+ DFG A+ +V + + Y APE + Y+ D++S G
Sbjct: 203 IDPNTHTLKLCDFGSAKNLL---AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGC 259
Query: 542 LLIEIITG 549
++ E+I G
Sbjct: 260 IIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 59/201 (29%), Positives = 86/201 (42%), Gaps = 50/201 (24%)
Query: 373 GKEVAVKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLLGFCVDGDEKL-- 421
G+ VA+K+LS F N E++L+ + HKN++ LL + L
Sbjct: 41 GQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKNIIGLLN-VFTPQKSLEE 92
Query: 422 -----LVYEFMPNGSLDAILFD-PRKR------GILCWRKRTNIVNGIAKGMLYLHEDSR 469
LV E M I D +R +LC G+ +LH
Sbjct: 93 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC-------------GIKHLHSAG- 138
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
I+HRDLK SN+++ SD KI DFG+AR T +V Y Y APE +
Sbjct: 139 --IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMG 193
Query: 530 YSKKSDVFSFGVLLIEIITGR 550
Y + D++S G ++ E+I G
Sbjct: 194 YKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLGFC 414
LG+G + V+KG VA+K + E+G EV L+ L+H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
LV+E++ + D + ++ + + +G+ Y H + +I+H
Sbjct: 73 HTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILH 126
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSKK 533
RDLK N+L++ K++DFG+AR A+S V T Y P+ + YS
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 534 SDVFSFGVLLIEIITGR 550
D++ G +L E+ TGR
Sbjct: 185 IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 357 LGQGGFGPVYKGVLSDGKEVA---VKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
+G G FG V + VA VK L +S EQ + IL QH N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL--QHPNILQC 60
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILF---DPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
LG CV+ LLV+E+ G L + L R+ L +R + IA G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHMH-- 116
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI-FAESEGEANTVRIVGTYGYMAPEYAM 526
+ +H DL N L SD+ K+ D+G+ + E E + V ++APE
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174
Query: 527 E---GLYS----KKSDVFSFGVLLIEI 546
E GL + K S+V++ GV L E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAEFTN-----EVLLILKLQHKNLVKL 410
+G+G FG VY+ D + + A+K LS E + +L+ L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L F D L LV ++M G L + +K G + + + + +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD- 116
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EG 528
IV+RDLK N+LLD+ + + DFG+++ A T GT Y+APE + E
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
Y+K D +S GVL+ E+ G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 38/209 (18%)
Query: 357 LGQGGFGPVYKG-VLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQ-HKNLVKLL 411
+G+G F V K GK A+K + EQ E+ + +L H N+++L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFD---PRKRGILCWRKRTNIVNGIAKGMLYLHE 466
D LV+E M D L++ RKR L ++ + + + K + ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKR-PLPEKRVKSYMYQLLKSLDHMH- 117
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI------FAESEGEANTVRIVGTYGYM 520
R I HRD+K N+L+ D K++DFG R + E + T Y
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE---------YISTRWYR 165
Query: 521 APEYAM-EGLYSKKSDVFSFGVLLIEIIT 548
APE + +G Y K D+++ G + EI++
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 72/274 (26%), Positives = 118/274 (43%), Gaps = 33/274 (12%)
Query: 329 DNDL-KAQDFFIDLETLNLATSNFSDSNILGQGGFGPV----YKGVLSDGKEVAVKRLSS 383
DN L + +D + L + ++ ++G+G FG V +K S K A+K LS
Sbjct: 22 DNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSK 78
Query: 384 CS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFD-- 438
++ + F E I+ + V L + D L +V E+MP G L ++ +
Sbjct: 79 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 138
Query: 439 -PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
P K W + A+ +L L + +HRD+K N+LLD + K++DFG
Sbjct: 139 VPEK-----WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188
Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITGRRNA 553
+ EG VGT Y++PE +G Y ++ D +S GV L E++ G
Sbjct: 189 C-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
Query: 554 GSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587
++ L+ + N N L D D S +
Sbjct: 248 YADSLVGTYSKIMNHKNSLTFPD----DNDISKE 277
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 11/96 (11%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+A+GM +L + +HRD+ A NVLL +KI DFG+AR + ++N V + G
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---DIMNDSNYV-VKGN 273
Query: 517 ----YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE + +Y+ +SDV+S+G+LL EI +
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 67/204 (32%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 356 ILGQGGFGPVYKGVLS-DGKEVAVKRLS-----SCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G+G FG V DGK AVK L + EQ VLL ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLL-KNVKHPFLVG 60
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
L + EKL V +F+ G L R+R R R IA + YLH
Sbjct: 61 L-HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS-- 114
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA---NTVRIVGTYGYMAPEYA 525
+ IV+RDLK N+LLDS + ++DFG+ + EG A T GT Y+APE
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK-----EGIAQSDTTTTFCGTPEYLAPEVI 168
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
+ Y D + G +L E++ G
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 11/96 (11%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+AKGM +L + +HRDL A N+LL +KI DFG+AR + ++N V + G
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR---DIRNDSNYV-VKGN 275
Query: 517 ----YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MAPE +Y+ +SDV+S+G+LL EI +
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
A+ + L + +++RDLK N+LLD + + DFG+ ++ + + + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
Y+APE + Y+K D ++ GVLL E++TG
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 43/163 (26%), Positives = 79/163 (48%), Gaps = 19/163 (11%)
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLV--------YEFMPNGSLDAILFDPRKRGIL 445
NE+L + +L H+N++K+ ++ Y FM + + D K L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW------KDRPL 265
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ R I+ + + Y+H+ +++HRD+K N+ L+ D + DFG A F E E
Sbjct: 266 LKQTRA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKE 320
Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
EA VGT +PE Y + +D++S G++L+++++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 7/89 (7%)
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYMA 521
+LHE I++RDLK NVLLD++ + K++D+GM + E +T GT Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIA 164
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
PE Y D ++ GVL+ E++ GR
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE--FTNEVLLILKLQHKNLVKLLGF 413
+G+G +G V+K + G+ VA+K+ + + E+ ++ +L+H NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+ LV+E+ + L+ + +PR +K I+ + + + H + +
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCH---KHNCI 122
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSK 532
HRD+K N+L+ K+ DFG ARI + + V T Y APE + Y
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPELLVGDTQYGP 180
Query: 533 KSDVFSFGVLLIEIITG 549
DV++ G + E++TG
Sbjct: 181 PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
+G G G V Y VL + VA+K+LS + T E++L+ + HKN++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ + LV E M I + L + + ++ + G+ +LH
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 136
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
I+HRDLK SN+++ SD KI DFG+AR S T +V Y Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 190
Query: 526 MEGLYSKKSDVFSFGVLLIEII 547
+ Y + D++S G ++ E++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
I + YLH +V+RDLK N++LD D + KI+DFG+ + E + T++ G
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
T Y+APE + Y + D + GV++ E++ GR
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG---EANTVRI 513
I + YLH +V+RD+K N++LD D + KI+DFG+ + EG A
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTF 155
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
GT Y+APE + Y + D + GV++ E++ GR
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD---GKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQH 404
+F +++G+G FG V V+ + G A+K + S Q T F E IL + +
Sbjct: 2 DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 405 KNLVKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
+ L + D D LV E+ P G L ++L R +A+ +L
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQF---DEDMAQFYLAELVLA 114
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
+H ++ VHRD+K NVL+D + K++DFG A + N+ VGT Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPE 173
Query: 524 Y--AMEG----LYSKKSDVFSFGVLLIEIITGR 550
M G Y + D +S GV+ E+I GR
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLLGF 413
+G G +G V + ++ VAVK+LS + A T L +LK ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
F P S++ L I+ +K ++ ++ + +G
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
+ Y+H I+HRDLK SNV ++ D +I DFG+AR + + V T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYR 182
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
APE + + Y++ D++S G ++ E++ G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
+G G G V Y +L + VA+K+LS + T E++L+ + HKN++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ + +V E M I + L + + ++ + G+ +LH
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
I+HRDLK SN+++ SD KI DFG+AR S T +V Y Y APE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
+ Y + D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGT-AEFT-NEVLLILKLQHKNLVKLLGF 413
+G+G +G V S+ ++VA+K++++ + A+ T E+ L+ L H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71
Query: 414 CVDGDEK------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
+ + +VYE M + L I+ R L + + +G+ Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELM-DTDLHQII---RSSQTLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
+ ++HRDLK SN+LL+++ + KI DFG+AR SE V T Y APE +
Sbjct: 128 N---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 528 -GLYSKKSDVFSFGVLLIEIITGR 550
Y+ DV+S G + E++ +
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
I + YLH S +V+RDLK N++LD D + KI+DFG+ + E + T++ G
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCG 158
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
T Y+APE + Y + D + GV++ E++ GR
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI-FAESEGEANTVRIVGTY 517
+ + Y+H + + HRDLK N+L ++D KI DFG+AR+ F ++ V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 518 GYMAPEY--AMEGLYSKKSDVFSFGVLLIEIITGR 550
Y APE + Y+ D++S G + E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 35/89 (39%), Positives = 51/89 (57%), Gaps = 7/89 (7%)
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYMA 521
+LHE I++RDLK NVLLD+D + K++D+GM + E G +T GT Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIA 164
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
PE Y D ++ GVL+ E++ GR
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG---EANTVRI 513
I+ + YLHE I++RDLK NVLLDS+ + K++D+GM + EG T
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTF 156
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
GT Y+APE Y D ++ GVL+ E++ GR
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 43/237 (18%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHK 405
+F ++G+G FG V D G A+K L ++ A E ++++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+VK+ D L+ EF+P G + +L K+ L + T IA+ +L +
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLS-EEATQFY--IAETVLAID 115
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE---------------------- 503
+L +HRD+K N+LLD+ + K+SDFG+ +
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 504 --SEGEANTVR---------IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
S+ +A T + VGT Y+APE M+ Y+K D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 43/237 (18%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHK 405
+F ++G+G FG V D G A+K L ++ E ++++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+VK+ D L+ EF+P G + +L K+ L + T IA+ +L +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLT-EEETQFY--IAETVLAID 115
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE---------------------- 503
+L +HRD+K N+LLDS + K+SDFG+ +
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 504 --SEGEANTVR---------IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
S+ +A T + VGT Y+APE M+ Y+K D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 6/98 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
IA+ +L +H +L VHRD+K NVLLD + + +++DFG + +G + VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGT 166
Query: 517 YGYMAPEY--AME---GLYSKKSDVFSFGVLLIEIITG 549
Y++PE AME G Y + D +S GV + E++ G
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 8/99 (8%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAESEGEANTVRIVG 515
+A+ +L + +L VHRD+K NVLLD + + +++DFG R+ A+ ++N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 516 TYGYMAPEY--AME---GLYSKKSDVFSFGVLLIEIITG 549
T Y++PE AME G Y + D +S GV + E++ G
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI--------FAESEGEANT---- 510
YLH IVHRDLK N+L+ S + K++DFG+++I E E +T
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 511 -VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
++ GT Y+APE + Y K D ++ G++L E + G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 50/189 (26%), Positives = 91/189 (48%), Gaps = 17/189 (8%)
Query: 373 GKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430
G V V+ L +C+E+ NEV+L +H N++ G ++ FM G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
S +++L G+ NI+ G +G+ YLH++ +HR++KAS++L+ D
Sbjct: 85 SANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLV 140
Query: 491 KISDFGMARIFA-ESEGEANTVRI------VGTYGYMAPEYAMEGL--YSKKSDVFSFGV 541
+S G++ +++ G+ V +++PE + L Y+ KSD++S G+
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 542 LLIEIITGR 550
E+ TGR
Sbjct: 199 TACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 44/223 (19%)
Query: 357 LGQGGFGPVYKGVL-----------------------SDGKE--VAVKRLSSCSEQGTAE 391
LGQG +Y G L ++G+E V +K L
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 392 FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
F L+ ++ H +L + G CV G E ++V EF+ +G LD L + R + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD----SDMNS---KISDFGMARIFAES 504
+ +A + YL ED L VH ++ A N+LL ++ S K+SD G++ F
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 505 EGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEI 546
E RI ++APE G S +D +SFG L+EI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEVLLILKLQHK 405
+F ++G+G FG V L + +V A+K L+ TA F E +++ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ L D + LV ++ G L +L R + +A+ YL
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR----------LPEDMAR--FYLA 109
Query: 466 E-----DS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
E DS +L VHRD+K N+L+D + + +++DFG E +G + VGT
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPD 168
Query: 519 YMAPEY--AME---GLYSKKSDVFSFGVLLIEIITG 549
Y++PE AME G Y + D +S GV + E++ G
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 357 LGQGGFGPVYKGVLSDGKE-------------VAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
LG+G +Y G+L+ + V +K L + F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
HK++V L G CV E ++V EF+ G LD LF RK +L + + +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 464 LHEDSRLRIVHRDLKASNVLL-----DSDMNS--KISDFGMARIFAESEGEANTVRIVGT 516
L ED L VH ++ N+LL D + K+SD G+ I S E V
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQEC-----VER 171
Query: 517 YGYMAPEYAMEG-LYSKKSDVFSFGVLLIEI 546
++APE + S +D +SFG L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 60/257 (23%), Positives = 101/257 (39%), Gaps = 71/257 (27%)
Query: 350 NFSDSNILGQGGFGPVYKGV--LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
+F ++G+G FG V + V GK A+K L + F + L +K + L
Sbjct: 2 DFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLK-----SEMFKKDQLAHVKAERDVL 55
Query: 408 --------VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--I 457
V L D L+ EF+P G L +L + + V +
Sbjct: 56 AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--------YDTFSEDVTRFYM 107
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES----------EGE 507
A+ +L + +L +HRD+K N+L+D + K+SDFG++ F + +G+
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167
Query: 508 ANTVRI-----------------------------------VGTYGYMAPEYAMEGLYSK 532
+N RI VGT Y+APE ++ Y +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227
Query: 533 KSDVFSFGVLLIEIITG 549
+ D +S G ++ E + G
Sbjct: 228 ECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 21/195 (10%)
Query: 372 DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYEFMPNG 430
K+V VK ++ G E+ ++ + H+ ++ L + K V MP
Sbjct: 118 QRKKVIVKAVTGGKTPGR-----EIDILKTISHRAIINL----IHAYRWKSTVCMVMPKY 168
Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
D + R G L + I + + + YLH I+HRD+K N+ LD N+
Sbjct: 169 KCDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENA 224
Query: 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
+ DFG A GT +PE Y K+D++S G++L E+
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
Query: 551 R-------NAGSNQL 558
+ S+QL
Sbjct: 285 VTLFGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 53/247 (21%), Positives = 94/247 (38%), Gaps = 51/247 (20%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS---EQGTAEFTNEVLLILKLQH 404
S F +G G FG V D + A+K L A E ++ + +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
+ +VKL D D V +++P G + ++L + GI + + + +
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESV 117
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF----------------------- 501
H ++ +HRD+K N+L+D D + K++DFG+ F
Sbjct: 118 H---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 502 ----AESEGEANTVR--------------IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
+ +VGT Y+APE + Y++ D +S GV+L
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234
Query: 544 IEIITGR 550
E++ G+
Sbjct: 235 YEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 13/165 (7%)
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-L 445
GTA E ++ + H ++++L G L+ +P D + KR I +
Sbjct: 128 GGTA---TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAI 181
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
C I + + + YLHE+ RI+HRD+KA N+ ++ + + DFG A F
Sbjct: 182 C--DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDI 235
Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
GT APE Y D++S G++L E+ T
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 44/198 (22%), Positives = 93/198 (46%), Gaps = 26/198 (13%)
Query: 365 VYKGVLSDGKEVAVKRLSSCSEQGTA----EFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420
+YKG+ + KEV ++ +G NE+ + ++ N++K+ GF +D +
Sbjct: 36 IYKGIF-NNKEVIIRTFK-KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 421 L----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHR 475
L L+ E+ G L +L K L ++ + ++ KG+ L++ ++ ++
Sbjct: 94 LPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYK 147
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK--- 532
+L + + L+ + KI G+ +I + + V Y + + + ++S+
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKM-LNDIFSEYTI 201
Query: 533 KSDVFSFGVLLIEIITGR 550
K D++S GV+L EI TG+
Sbjct: 202 KDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 32/150 (21%), Positives = 58/150 (38%), Gaps = 15/150 (10%)
Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV--KLLGF 413
+L G VY + + ++ +K S + A+ EV ++ L K L K+L
Sbjct: 5 LLKGGLTNRVYL-LGTKDEDYVLKINPS--REKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
L+ E++ +LD + + ++ + +AK LH+ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKED------IAEQLAELLAK----LHQLPLLVLC 111
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAE 503
H DL N+L+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 49/192 (25%), Positives = 89/192 (46%), Gaps = 31/192 (16%)
Query: 386 EQGTAEFTNEVLLILKLQHKNLVKLLG-FCVDGDEKL-LVYEFMPNGSLDAILFDPRKR- 442
E+ ++ EV ++ +L+HKN+V+ + F ++KL ++ EF G L + K
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 443 GILCWRKRTNIVNGIAKGMLYLHE----DSRLRIVHRDLKASNVLLDSDMN--------- 489
G + +I + + Y H + R++HRDLK N+ L + +
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 490 --------SKISDFGMAR-IFAESEGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFS 538
+KI DFG+++ I ES + VGT Y +PE + Y KSD+++
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIESMAHS----CVGTPYYWSPELLLHETKSYDDKSDMWA 228
Query: 539 FGVLLIEIITGR 550
G ++ E+ +G+
Sbjct: 229 LGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 57/251 (22%), Positives = 98/251 (39%), Gaps = 55/251 (21%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS---EQGTAEFTNEVLLILKLQH 404
S F LG G FG V D K + A+K L A E ++ + +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
+ +V+L D D V +++P G + ++L + GI IA+ +
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIF---PEDLARFYIAELTCAV 114
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM----------------------ARIFA 502
++ +HRD+K N+L+D D + K++DFG+ + F+
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 503 ESEGEANTVR-----------------------IVGTYGYMAPEYAMEGLYSKKSDVFSF 539
G+ R +VGT Y+APE + Y++ D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 540 GVLLIEIITGR 550
GV+L E++ G+
Sbjct: 235 GVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 55/251 (21%), Positives = 97/251 (38%), Gaps = 55/251 (21%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
S F LG G FG V D A+K L + A E ++ + +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
+ +VKL D D V +++P G + ++L + + IA+ L +
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFY---IAELTLAI 114
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG-----EANTVR------- 512
++ +HRD+K N+L+D D + K++DFG+ F + + + +R
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 513 ---------------------------------IVGTYGYMAPEYAMEGLYSKKSDVFSF 539
+VGT Y+APE + Y++ D +S
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234
Query: 540 GVLLIEIITGR 550
GV+L E++ G+
Sbjct: 235 GVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 54/236 (22%), Positives = 84/236 (35%), Gaps = 57/236 (24%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS-----SCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G G V+ L ++ A+K L ++ E+L L H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD--HPFLPTL 66
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK--------GML 462
LV ++ P G L +L + L +A+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLS--------EEVARFYAAEVLLALE 117
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA------------------------ 498
YLH L IV+RDLK N+LL + +SDF ++
Sbjct: 118 YLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 499 ----RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
F+E + VGT Y+APE + D ++ G+LL E++ G
Sbjct: 175 SIPSETFSEEPS-FRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 17/149 (11%)
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGML 462
+ N +KL +L+ +++ +G L FD +K G L + I+ + + +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIF-AESEGEANTVRIVGTYGYM 520
LH + I+H D+K NVL D + + D+G+ +I S + GT Y
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-------GTLDYF 173
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
+PE Y D ++ GVL E++TG
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 17/188 (9%)
Query: 373 GKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430
G+ V V+R L +C+ + E+ + H N+V + +E +V FM G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
S ++ G + I+ G+ K + Y+H + VHR +KAS++L+ D
Sbjct: 85 SAKDLICTHFMDG-MSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVD--G 138
Query: 491 KISDFGMARIFAE-SEGEANTV------RIVGTYGYMAPEYAMEGL--YSKKSDVFSFGV 541
K+ G+ + + G+ V V +++PE + L Y KSD++S G+
Sbjct: 139 KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198
Query: 542 LLIEIITG 549
E+ G
Sbjct: 199 TACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 32/181 (17%)
Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL- 436
+K L SE T I+ N+V L + V D LV + G L + +
Sbjct: 23 LKGLRKSSEYSRERLT-----IIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77
Query: 437 --FDPRKRGILCWRKRTNIVNGIAKGMLY----LHEDSRLRIVHRDLKASNVLLDSDMNS 490
+ + + W A M+ LH + IV RDL +N+LLD +
Sbjct: 78 KFLNIPEECVKRW----------AAEMVVALDALHREG---IVCRDLNPNNILLDDRGHI 124
Query: 491 KISDFGMARIFAES-EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
+++ F +S +GEA + Y APE ++ D +S G +L E++TG
Sbjct: 125 QLTYFSRWSEVEDSCDGEA-VENM-----YCAPEVGGISEETEACDWWSLGAILFELLTG 178
Query: 550 R 550
+
Sbjct: 179 K 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 42/182 (23%), Positives = 68/182 (37%), Gaps = 44/182 (24%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSCSEQGTAE-FTNEVLL----- 398
+F LG+G FG VYK L + + +K+ +E G E + NE +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK---ATEYGAVEIWMNERVRRACPN 189
Query: 399 -ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL--------------DAILFDPRK-- 441
+ L + DE LV+ + +L +L +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 442 RGILCWRKRTNIVNGIAKGMLY----LHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFG 496
+G+ + I+ I + +L+ LH IVHRD+K N++ S KI D G
Sbjct: 248 KGL---ERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLG 301
Query: 497 MA 498
A
Sbjct: 302 AA 303
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 15/38 (39%), Positives = 27/38 (71%), Gaps = 3/38 (7%)
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
YLH I+HRDLK N+L+ ++ + K++DFG++++
Sbjct: 119 YLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 454 VNGIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
V +A+ +L Y+H + I+HRD+K NVL++ + + DFG A S
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIE 545
I GT APE Y+ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 32/85 (37%), Positives = 39/85 (45%), Gaps = 8/85 (9%)
Query: 356 ILGQGGFGPVYKGV-LSDGKE-----VAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNL 407
LG G FG V + GKE VAVK L + + E L IL QHKN+
Sbjct: 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSL 432
V LLG C G L++ E+ G L
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 660 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.33 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.18 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.1 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.05 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.73 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.68 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.66 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.63 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.5 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.45 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.25 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.19 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.12 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.08 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.08 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.07 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.02 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.83 | |
| PLN02236 | 344 | choline kinase | 96.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.53 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.39 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.36 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.05 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.85 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.82 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.77 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.45 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.43 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.38 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.33 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.2 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.05 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.59 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.46 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-54 Score=450.90 Aligned_cols=283 Identities=49% Similarity=0.828 Sum_probs=250.5
Q ss_pred ccccChHHHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEE
Q 006125 336 DFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415 (660)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 415 (660)
...++++++..+|++|...++||+|+||.||+|.+.+|+.||||++.........+|.+|+.++.+++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34578999999999999999999999999999999999999999987644431556999999999999999999999999
Q ss_pred eCC-eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 416 DGD-EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 416 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
+.+ +.+||||||++|+|+++|+..... .++|.+|++|+.++|+||+|||+...++|+||||||+|||||+++++||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 999 599999999999999999765443 799999999999999999999999988999999999999999999999999
Q ss_pred ccccccccccCCccceeee-eccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCC------CcHHHHHHHHHh
Q 006125 495 FGMARIFAESEGEANTVRI-VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS------NQLLAYAWHLWN 567 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~------~~~~~~~~~~~~ 567 (660)
||+++..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+. ..+.+|++..+.
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999655431 1111112 799999999999999999999999999999999999987663 348899999999
Q ss_pred cCcccccccccCCCCCCCH-HHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 568 EGNVLELVDPLLTDTSFSD-DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 568 ~~~~~~~~d~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
++++.+++|+.+....+.. +++.++..++.+|++.+|.+||+|.||+++|+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999999999987435554 68899999999999999999999999999996654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=394.91 Aligned_cols=258 Identities=32% Similarity=0.504 Sum_probs=215.3
Q ss_pred CCcccccCCcccEEeeeecCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC-eeEEEEEecCC
Q 006125 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLVYEFMPN 429 (660)
Q Consensus 353 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~ 429 (660)
..+.||+|+||+||+|.+.....||||++.... ....+.|.+|+.+|.+++|||||+++|+|.+.. ..+|||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 346699999999999999544449999997532 222668999999999999999999999999988 79999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-CEEEeeccccccccccCCcc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~ 508 (660)
|+|..+++.. ....+++..+++|+.|||+||.|||+.++ ||||||||+||||+.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999653 45679999999999999999999999874 99999999999999997 99999999998765432 1
Q ss_pred ceeeeeccCCcCCHhhhh--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 509 NTVRIVGTYGYMAPEYAM--EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~--~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
......||+.|||||++. ...|+.|+|||||||++|||+||+.||......+.+......+... ..+.
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp----------~~p~ 269 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP----------PIPK 269 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC----------CCCc
Confidence 122257999999999999 5689999999999999999999999999877766666555444322 2223
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCC
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLP 625 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 625 (660)
.....+..|+.+||+.||.+||++.|++.+|+.......
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 355668888889999999999999999999986544333
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=387.94 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=216.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC---CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
.+|...+.||+|+|+.||+++. ..|+.||+|++.+ ......+.+.+||++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999995 8899999999975 35566778999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
|+|++++|..+++ .++.+++.+++.+++||+.||.|||+.+ |+|||||..|+||++++++||+|||||..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999994 5567999999999999999999999998 999999999999999999999999999988755
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
... ..+.+|||.|+|||++.....+..+||||+|||||-||.|++||+...+.+....+...+- .+
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------------~~ 237 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------------SM 237 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc------------cc
Confidence 333 2357999999999999999999999999999999999999999998877666555443321 11
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhc
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLK 618 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~ 618 (660)
+......-.+||..+|+.||.+|||+++|+ .+++
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 112223356788899999999999999998 4553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=382.65 Aligned_cols=263 Identities=35% Similarity=0.474 Sum_probs=219.2
Q ss_pred cccccChHHHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEE
Q 006125 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (660)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 414 (660)
..+.++.+++.+ .+.||+|.||.||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|
T Consensus 199 d~wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~ 270 (468)
T KOG0197|consen 199 DPWEIPREELKL-------IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVC 270 (468)
T ss_pred CCeeecHHHHHH-------HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEE
Confidence 345666666665 5789999999999999987779999999874 34556788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
..++..+||||||+.|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|
T Consensus 271 ~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsD 346 (468)
T KOG0197|consen 271 TKQEPIYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISD 346 (468)
T ss_pred ecCCceEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcc
Confidence 999999999999999999999965 34566999999999999999999999998 99999999999999999999999
Q ss_pred ccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccc
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
|||++...++..... ....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+.+..+-+..+
T Consensus 347 FGLAr~~~d~~Y~~~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR--- 422 (468)
T KOG0197|consen 347 FGLARLIGDDEYTAS-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR--- 422 (468)
T ss_pred cccccccCCCceeec-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc---
Confidence 999995544333222 11234678999999999999999999999999999999 7777776666555544444332
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
+.. +..++..+.+|+..||+.+|++|||++.+...|++..
T Consensus 423 -----lp~---P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 423 -----LPR---PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred -----CCC---CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 222 2334556788889999999999999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=363.01 Aligned_cols=245 Identities=30% Similarity=0.452 Sum_probs=204.8
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC-eeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 426 (660)
+++..+.||+|..|+|||+.++ +++.+|+|.+.. .++...+++.+|+++++..+||+||.++|.|.+.. +..|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4445688999999999999965 688999999954 35566788999999999999999999999999998 59999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|++|+|+.++. ..+.+++...-+|+.+|++||.|||+ .+ |+||||||+||||+..|.+||+|||.+..+.+.
T Consensus 160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999994 33669999999999999999999996 54 999999999999999999999999999887665
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHHhcCcccccccccCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN-----QLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~-----~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+-|+... ...+....+..+.. +.+.
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp------P~lP 303 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP------PRLP 303 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC------CCCC
Confidence 223468999999999999999999999999999999999999998653 22232222222211 2222
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
...+ ..++.+++..||++||.+||++.|++
T Consensus 304 ~~~f----S~ef~~FV~~CL~Kdp~~R~s~~qLl 333 (364)
T KOG0581|consen 304 EGEF----SPEFRSFVSCCLRKDPSERPSAKQLL 333 (364)
T ss_pred cccC----CHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 2123 34478888899999999999999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=363.88 Aligned_cols=216 Identities=31% Similarity=0.506 Sum_probs=189.4
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.+|...+.||+|+|++||+|++ +++..||||.+... .....+.+..|+.+|+.++|||||+++++++..+..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5677788899999999999995 46899999999764 55667778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC------CCEEEeeccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD------MNSKISDFGMAR 499 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~------~~~kl~DfGla~ 499 (660)
||.+|+|..++ +..+.+++..+..++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+++
T Consensus 90 yC~gGDLs~yi---~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYI---RRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999 45557999999999999999999999998 9999999999999765 458999999999
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccc
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
.+....... +.+|++-|||||++...+|+.|+|+||+|+|||||++|+.||......+....+........
T Consensus 164 ~L~~~~~a~---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~ 234 (429)
T KOG0595|consen 164 FLQPGSMAE---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP 234 (429)
T ss_pred hCCchhHHH---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC
Confidence 887544332 46999999999999999999999999999999999999999997777666654444444333
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=398.18 Aligned_cols=269 Identities=30% Similarity=0.454 Sum_probs=223.3
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCChh-cHHHHHHHHHHHhhcCCCCcceEeEEE
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFC 414 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~ 414 (660)
...++...+....+.||+|.||+||+|+.. +.+.||||.++...+. ..++|++|++++..++|||||+|+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 334455667777889999999999999843 3457999999876555 788999999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCChhhhhcCCC----------C-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceE
Q 006125 415 VDGDEKLLVYEFMPNGSLDAILFDPR----------K-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 483 (660)
.+++..++|+|||.+|+|.+||.... . ..+|+..+.+.|+.|||.||+||-++. +|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence 99999999999999999999995311 1 344889999999999999999999988 999999999999
Q ss_pred eCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q 006125 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYA 562 (660)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~ 562 (660)
|.++..|||+||||++.....+.........-..+||+||.++.++||.+||||||||+|||+++ |+.|+..-.-.+ +
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-V 714 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-V 714 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-H
Confidence 99999999999999998766555443323345789999999999999999999999999999999 888876544333 3
Q ss_pred HHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 563 WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 563 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
....+.+.++ +.+..++.++..|+..||+.+|.+||+++||-..|+.-.+..
T Consensus 715 Ie~i~~g~lL----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 IECIRAGQLL----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHcCCcc----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 3444444432 234556777999999999999999999999999998755443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=363.91 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=201.5
Q ss_pred cCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCCh-------hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE-------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
.+.|...+.||+|+||.|-+|. .++|+.||||++++... .......+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3456778999999999999998 56899999999974211 122346799999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC---CCEEEeecc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFG 496 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfG 496 (660)
.||||||+++|+|.+.+- .++.+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ -.+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999984 4455777778889999999999999999 9999999999999766 779999999
Q ss_pred ccccccccCCccceeeeeccCCcCCHhhhhcCC---CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccc
Q 006125 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGL---YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
+++..... ..+.+.+||+.|.|||++.++. +..|+|+||+||+||-+++|.+||.+..-.....+....++...
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 99977532 2234579999999999998654 34588999999999999999999975432221222333332211
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.+....+..++.+++|.+||+.||++||+++|++
T Consensus 402 -------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 402 -------GPLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred -------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 1112234455678999999999999999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=346.47 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=212.6
Q ss_pred CCCCCcccccCCcccEEeee-ecCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEE-EEeCCe-eEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGF-CVDGDE-KLLVY 424 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~ 424 (660)
+|.+.++||.|.||+|||+. +.+|..+|.|.++- .+....++...|+.+|++|+|||||+++++ +.+..+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45667899999999999998 67999999999873 355667789999999999999999999994 444444 78999
Q ss_pred EecCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCC-CCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 425 EFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSR-LRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||+..|+|..+++..+ ....+++..+|+++.|+++||.++|+.-+ ..|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999996533 34569999999999999999999999431 249999999999999999999999999999887
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
...... ...+|||-||+||.+.+..|+.||||||+||++|||..-++||.+..+.+.-.++-.. +. +.++.
T Consensus 180 s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~-----~~~p~- 250 (375)
T KOG0591|consen 180 SKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DY-----PPLPD- 250 (375)
T ss_pred chhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CC-----CCCcH-
Confidence 654443 3468999999999999999999999999999999999999999988777665554433 21 11111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.-....+.+||..|+..||+.||+...++..+.+.
T Consensus 251 ---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 251 ---EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred ---HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 22234578889999999999999977666666553
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=352.41 Aligned_cols=243 Identities=25% Similarity=0.358 Sum_probs=208.3
Q ss_pred hcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
..++|+..++||+|+||+|+.++. ++++.+|+|++++. ...+.+...+|..+|.+++||.||+++..|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 356789999999999999999984 56899999999763 33456788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
|+||+.||.|...| +..+.+++..+.-++..|+.||.|||+.+ |+||||||+|||||++|+++|+||||++...
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999 45677999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
..... +..++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+...+...+.... ....+
T Consensus 177 ~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------~~~~p 246 (357)
T KOG0598|consen 177 KDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------LPLPP 246 (357)
T ss_pred cCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--------CCCCC
Confidence 43322 334799999999999999999999999999999999999999999888777766665543 11111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRP 608 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RP 608 (660)
.... ....+++.+.|+.||++|.
T Consensus 247 ~~ls---~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 GYLS---EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ccCC---HHHHHHHHHHhccCHHHhc
Confidence 2122 2356778899999999996
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=376.73 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=216.5
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec----CCcEEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
++.+...+.++||.|.||.|++|.++ ....||||.++. ..+.+..+|..|..+|.+++||||++|.|+.......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 45566677899999999999999975 234799999985 4677788999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
+||.|||++|+|+.||.. +.+++++.+...|+++||.||.||-+.+ +|||||.++||||+.+..+|++||||++.
T Consensus 706 MIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999954 4567999999999999999999999988 99999999999999999999999999998
Q ss_pred ccccCCcccee-eeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 501 FAESEGEANTV-RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 501 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
+.++.....+. .-.-+.+|.|||.+...++|.++|||||||+|||+++ |.+|+.+-.-.+.+..+..+-+
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR-------- 852 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR-------- 852 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC--------
Confidence 86655322221 1122578999999999999999999999999999998 8888765443333333322211
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
+ ..+.+++..|.+|++.|||+|-.+||.+.+|+..|..
T Consensus 853 L---PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 853 L---PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred C---CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 2 2245677789999999999999999999999988865
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=385.27 Aligned_cols=262 Identities=34% Similarity=0.536 Sum_probs=217.1
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC--Cc----EEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD--GK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--g~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
+...+.+....||+|.||.||+|...+ |. .||||.+++ .+.++..+|.+|..+|++++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 335556667899999999999999643 33 489999976 46677889999999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCC----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
..+|++|||++|+|..+|.+.+. ...++..+.+.++.|||+|+.|||+++ +|||||.++|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999976432 345899999999999999999999998 99999999999999999999999
Q ss_pred ccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccc
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
||+++.+...+.......-.-...|||||.+.++.||.|+|||||||+|||++| |..|+...+-.+........++
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR--- 922 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR--- 922 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc---
Confidence 999996655544433322233568999999999999999999999999999999 7788876655554444444442
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
+.. +..++..+.+|+..||+.+|++||++..|++.+..+.
T Consensus 923 -----L~~---P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 923 -----LDP---PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred -----cCC---CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 212 3334556789999999999999999999999887653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=355.55 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=215.7
Q ss_pred CCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
..|...++||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.+..++++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457778899999999999998 5678999999998766666677999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.+++. ...+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+......
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 9999999983 344999999999999999999999999 999999999999999999999999999887665543
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
. ...+||+-|||||++....|..|.||||||++++||+-|.+||-.+......+.+...+.. .+..++.
T Consensus 426 R--~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P------~lk~~~k--- 494 (550)
T KOG0578|consen 426 R--STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP------KLKNPEK--- 494 (550)
T ss_pred c--ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC------CcCCccc---
Confidence 3 3469999999999999999999999999999999999999999877777777777666542 2322222
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....|.+++.+||+.|+.+||++.|+|+
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 2234666677999999999999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=349.63 Aligned_cols=251 Identities=28% Similarity=0.393 Sum_probs=211.7
Q ss_pred hcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 421 (660)
...+|...+.||+|+|++|++++ ...++.+|||++.+. .+.-.+-+..|-+.|.+| .||.|++|+--|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 45678889999999999999999 557999999998642 233344577899999999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+|+||+++|+|-++| .+.+.|++...+.++.+|+.+|+|||+.| ||||||||+|||||+||++||+|||-++.+
T Consensus 151 FvLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999 45678999999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCc---------cce--eeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc
Q 006125 502 AESEGE---------ANT--VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 502 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 570 (660)
...... ... ..++||..|.+||++..+..+..+|+|+||||||+|+.|++||...+..-...++..-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-- 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-- 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--
Confidence 643322 111 3479999999999999999999999999999999999999999877765555544432
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+-.+. +.++ ....+|+.+.|..||.+|+|.+||-+
T Consensus 303 -----~y~fp-~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 303 -----DYEFP-EGFP----EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred -----cccCC-CCCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence 11111 1333 44678888999999999999999974
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=357.18 Aligned_cols=263 Identities=29% Similarity=0.438 Sum_probs=206.6
Q ss_pred hhcCCCCCCcccccCCcccEEeeee------cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 417 (660)
+..++|...++||+|+||.||++.. .+++.||+|+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4566788899999999999999973 235689999997532 33456789999999999 899999999998764
Q ss_pred C-eeEEEEEecCCCChhhhhcCCCC-------------------------------------------------------
Q 006125 418 D-EKLLVYEFMPNGSLDAILFDPRK------------------------------------------------------- 441 (660)
Q Consensus 418 ~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 441 (660)
+ ..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 57899999999999999854211
Q ss_pred ----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccC
Q 006125 442 ----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517 (660)
Q Consensus 442 ----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 517 (660)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 134788899999999999999999988 9999999999999999999999999998654332222222234567
Q ss_pred CcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHH
Q 006125 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIG 596 (660)
Q Consensus 518 ~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li 596 (660)
.|+|||++.+..++.++||||||+++|||++ |..||...............+.... . +......+.+|+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~-----~~~~~~~l~~li 310 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-----A-----PENATPEIYRIM 310 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-----C-----CCCCCHHHHHHH
Confidence 8999999999999999999999999999997 9999876443333333333222111 0 112234578899
Q ss_pred hhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 597 LLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 597 ~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.+||+.||.+||++.||+++|++..
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=337.99 Aligned_cols=262 Identities=26% Similarity=0.357 Sum_probs=212.3
Q ss_pred hcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
..++|+..+.||.|.-++||+|. .+.++.||||++.- ......+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45678889999999999999999 66789999999963 22333788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
.||.+|++.+++...-..+ +++..+..|++++++||.|||.+| .||||||+.||||+++|.+||+|||.+-.+...
T Consensus 104 pfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999996544443 899999999999999999999999 999999999999999999999999988665543
Q ss_pred CCccc-e-eeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 505 EGEAN-T-VRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 505 ~~~~~-~-~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
..... . ...+|++.|||||+++. ..|+.|+|||||||...||.+|..||..-...........+....-. -..+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-t~~~- 257 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-TSGL- 257 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-cccC-
Confidence 32111 1 34689999999999654 45999999999999999999999999877666555444444322111 0011
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
+.+-.....+.+.+++..||++||++|||+++++
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 1011112234678899999999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.34 Aligned_cols=263 Identities=27% Similarity=0.414 Sum_probs=222.5
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|...+.||+|.||.||||+. .+.+.||+|.+.+ ..+.+.+.+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4577778999999999999994 4788999999975 345567789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+.+ +|..+| ...+.++++.+..|+.+++.||.|||+.+ |+|||+||.|||++.++.+|++|||+++....
T Consensus 82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 9977 999999 45566999999999999999999999998 99999999999999999999999999987654
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.......+.||+-|||||++.+..|+..+|+||+|||+||+++|++||....+.+.+..+..+.. .++
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v------------~~p 220 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV------------KPP 220 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC------------CCc
Confidence 23334457899999999999999999999999999999999999999988888777777665532 122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhcCCCCCCCCCCCCce
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGETGTLPQPQKPAF 632 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~~~~~~~p~~p~~ 632 (660)
......+.+++...|++||.+|.+..+++ .++++.......|..|++
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~ 269 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF 269 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence 34445578888899999999999999998 355554444444444444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=325.94 Aligned_cols=258 Identities=21% Similarity=0.319 Sum_probs=204.9
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+...++|+|+||+|||++.+ +|+.||||++.... +.-.+-..+|+++|++++|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677789999999999999965 69999999997533 3334567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|++..-|+++-. ....++.+.+.+++.|+++|+.|+|+++ ++||||||+||||+.++.+||+|||+|+.+....
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 999987777763 3344889999999999999999999998 9999999999999999999999999999886321
Q ss_pred CccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-Ccc----cccc----
Q 006125 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-GNV----LELV---- 575 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~~~----~~~~---- 575 (660)
...+..+.|.+|.|||.+.+ .+|...+|||++||++.||++|.+.|.+.+..+....+... +.+ .+++
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 12223578999999999987 78999999999999999999999998766655554443321 110 0111
Q ss_pred ------cccCCCCCC----CHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 576 ------DPLLTDTSF----SDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 576 ------d~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
-|....++. -+....-+++++..||+.||.+|++-+|++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 011111110 112233578999999999999999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=342.16 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=203.8
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC--eeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 425 (660)
.++...+.||+|+||.||++... +|...|||.+...+....+.+.+|+.+|.+++|||||+.+|...... ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45666789999999999999964 58999999987543333677999999999999999999999855444 6889999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEEeeccccccccc-
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAE- 503 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~- 503 (660)
|+++|+|.+++..... .+++..+..+.+||++||.|||+++ |+|+||||+||||+. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999954322 6999999999999999999999998 999999999999999 79999999999987663
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCC-CCcchhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHHhcCcccccccccCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGS-NQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwslGvll~elltG~~p~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
...........||+.|||||++..+. ...++|||||||++.||+||++||.. ....++...+...... |.+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~-----P~i-- 244 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL-----PEI-- 244 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC-----CCC--
Confidence 11112233468999999999998643 34599999999999999999999986 4555555554444321 122
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
+........+++.+|++.||++|||++|+++---
T Consensus 245 ---p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 245 ---PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 2222233556777999999999999999996553
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.06 Aligned_cols=271 Identities=27% Similarity=0.390 Sum_probs=218.0
Q ss_pred cChHHHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe
Q 006125 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416 (660)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 416 (660)
...++.++..+.+...+.||+|.||+||+|.+. -.||||++.. -.....+.|++|+..+++-+|.||+-+.|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344556666666777899999999999999984 3599999974 345577889999999999999999999999998
Q ss_pred CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecc
Q 006125 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 496 (660)
... .||..+|++.+|..+|+..+ ..|+..+.+.|++||++||.|||.++ |||||||.+||++.++++|||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 877 99999999999999997654 44899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCccceeeeeccCCcCCHhhhhc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccc
Q 006125 497 MARIFAESEGEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
|+................|...|||||++.. .+|++.+||||||+++|||++|..|+......+.+|..-+.. -
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~---l 610 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGY---L 610 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccc---c
Confidence 9976554433333344568889999999964 469999999999999999999999998444333333222221 1
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
..|... ......+.+.+|+..||..++++||.+.+|+.+|+.....+
T Consensus 611 ~pd~s~----~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 611 MPDLSK----IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred Cccchh----hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 111111 12344556777888999999999999999999988775544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=339.26 Aligned_cols=260 Identities=30% Similarity=0.423 Sum_probs=204.1
Q ss_pred CCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhh--cCCCCcceEeEEEEeCC----eeEEEE
Q 006125 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDGD----EKLLVY 424 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~ 424 (660)
....++||+|.||.||||++. ++.||||++.. .+.+.|.+|.++.+. ++|+||+++++.-..+. +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 334578999999999999994 59999999964 455677788777764 58999999999987666 889999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS------RLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
||.+.|+|.++| +...++|....+|+..+++||+|||+.- +++|+|||||++||||.+|+++.|+||||+
T Consensus 288 ~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999 4567999999999999999999999863 678999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCC-C-----CcchhHHHHHHHHHHHHhCCCCCC--CCc-------------
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGL-Y-----SKKSDVFSFGVLLIEIITGRRNAG--SNQ------------- 557 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----t~ksDVwslGvll~elltG~~p~~--~~~------------- 557 (660)
..+............+||.+|||||++++.. + -.+.||||+|.|||||++.-.... ...
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 9988766666566679999999999998643 2 247999999999999999654331 111
Q ss_pred -HHHHHHHH-HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCC
Q 006125 558 -LLAYAWHL-WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGT 623 (660)
Q Consensus 558 -~~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 623 (660)
-.+..+.. .++.....+.+.+. ....+..+.+.+..||+.||+-|.|+.=|-+++......
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~-----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWR-----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhh-----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11112221 11111122222222 224566788999999999999999999998888775433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=337.96 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=205.1
Q ss_pred CCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV 423 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 423 (660)
+.|+..++||+|.||.||+++ ..+|+.||+|+++.. .+.......+||.+|++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456677899999999999999 678999999999753 345566788999999999999999999999876 689999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
+|||++ +|.-++.. ..-.+++.++..++.||++||+|+|+.+ |+|||||.+|||||.+|.+||+||||++++..
T Consensus 197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999988 78777743 3345999999999999999999999999 99999999999999999999999999998766
Q ss_pred cCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc------Cccc--cc
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE------GNVL--EL 574 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~------~~~~--~~ 574 (660)
..... .+..+-|..|.|||++.+ ..|+.++|+||.||||.||++|++.+.+....+....+++- ..+. ++
T Consensus 271 ~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 271 SGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 55443 334577999999999986 46999999999999999999999998866655544433321 0011 11
Q ss_pred ccccCCCC--CCCH-------HHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 575 VDPLLTDT--SFSD-------DEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 575 ~d~~~~~~--~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.......+ .+.. ......++|+..+|..||.+|.|+.+++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 11011110 1110 1123457788899999999999999887
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.41 Aligned_cols=236 Identities=29% Similarity=0.369 Sum_probs=202.9
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||.|+||.|.+++.+ +|..+|+|++++. ...+.+...+|..+|+.+.||+++++.+.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56777899999999999999954 6889999999763 2345667889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|.|.++| ++.+.+++..++.++.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+++....
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999999 56677999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.+.+.+||+.|+|||++....+..++|+|+|||++|||+.|.+||...+......++... ++ .+
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-~v-----------~f 260 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-KV-----------KF 260 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-cc-----------cC
Confidence 356789999999999999999999999999999999999999999887765554444432 21 11
Q ss_pred CHHHHHHHHHHHhhcccCCCCCC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDR 607 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~R 607 (660)
+.-....+.+|+...|+.|-.+|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhh
Confidence 11122236678888999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=313.53 Aligned_cols=260 Identities=27% Similarity=0.370 Sum_probs=207.6
Q ss_pred CCCCCCcccccCCcccEEeee-ecCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.+|...++||+|.||.||+|. ..+|+.||||+++. ..+.......+|++.|+.++|+||+.++++|-+.+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 356777899999999999999 56899999999974 333445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
||+. +|+..+++ +...++-.++..++.++++||+|||++. |+||||||+|+||+++|.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 89999965 4456899999999999999999999998 9999999999999999999999999999887654
Q ss_pred CccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh---c---Ccccc---cc
Q 006125 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN---E---GNVLE---LV 575 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~---~---~~~~~---~~ 575 (660)
..... .+-|..|.|||++.+ ..|+..+||||.|||+.||+.|.+-+.+....+....+.+ - +.+.+ +.
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 44332 267899999999986 5699999999999999999999987765544443333222 1 11111 11
Q ss_pred c-------ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 576 D-------PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 576 d-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
| +.......-.......++++..|+..||.+|++++|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1 0001101223344556899999999999999999999854
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=346.95 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=209.1
Q ss_pred hhcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCC----Ch-hcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC----SE-QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGD 418 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 418 (660)
...++|...+.||+|.||+|+++. ..+++.||+|++... .. ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345688889999999999999998 457899999977652 11 34556778999999998 999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-CCEEEeeccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGM 497 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGl 497 (660)
..++||||+.+|+|.+++. ..+.+.+.++..+++||+.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999994 3567999999999999999999999998 9999999999999999 9999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YS-KKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELV 575 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 575 (660)
+..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++........++....-
T Consensus 168 s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~----- 240 (370)
T KOG0583|consen 168 SAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF----- 240 (370)
T ss_pred ccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-----
Confidence 987741 112233469999999999999876 75 899999999999999999999998777766665433221
Q ss_pred cccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 576 DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 576 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.+.. ... ...+..++.+|++.||.+|+++.||+
T Consensus 241 --~~p~-~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 --KIPS-YLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred --cCCC-CcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0110 110 34477889999999999999999998
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=355.65 Aligned_cols=270 Identities=29% Similarity=0.405 Sum_probs=217.5
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeeecC--C--cE-EEEEEccC---CChhcHHHHHHHHHHHhhcCCCCcceEe
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSD--G--KE-VAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLL 411 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--g--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~ 411 (660)
.....++..++....++||+|+||.||+|.+.. + .. ||||..+. .......+|.+|.++|++++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 344455566677777999999999999999643 2 23 89999874 3466788999999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEE
Q 006125 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 412 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
|++......+||||+|.||+|.++|.... ..++..++..++.+.|+||+|||+++ ++||||.++|+|++.++.+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence 99999999999999999999999995432 25999999999999999999999998 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCc
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 570 (660)
|+|||+++......... ....-+..|+|||.+..+.|+.++|||||||++||+++ |..|+.+....+...++...+.
T Consensus 303 ISDFGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~ 380 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY 380 (474)
T ss_pred eCccccccCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc
Confidence 99999987543111111 01134678999999999999999999999999999999 8889887776655555434332
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCC
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQ 626 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 626 (660)
... .+...+..+..+...||+.+|++||+|.++.+.|+........
T Consensus 381 r~~----------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 RMP----------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred cCC----------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 211 1123344456677799999999999999999999887655443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=343.53 Aligned_cols=260 Identities=26% Similarity=0.346 Sum_probs=210.3
Q ss_pred cCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcH-HHHHHHHHHHhhcC-CCCcceEeEEEEeCC-eeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQ-HKNLVKLLGFCVDGD-EKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv 423 (660)
-++|...++||.|.||.||+|+ ..+|+.||||++++.-..+. ..-.+|+..|++|+ ||||+++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 3567778999999999999999 56799999999986433322 23458999999998 999999999999988 99999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
||||+. +|.+++++. +..++++.+..|+.||++||+|+|.+| +.||||||+|||+.....+||+|||+|+....
T Consensus 89 fE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 999955 999999764 667999999999999999999999999 99999999999999899999999999997654
Q ss_pred cCCccceeeeeccCCcCCHhhhh-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc------Ccccc---
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE------GNVLE--- 573 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~------~~~~~--- 573 (660)
.. ..+..+.|.+|.|||++. .+.|+.+.|||++|||++|+.+-++.|.+.+..+..+++..- ..+.+
T Consensus 163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 33 233458899999999875 678999999999999999999999999888877777765431 11111
Q ss_pred ---ccc---ccCCC---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 574 ---LVD---PLLTD---TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 574 ---~~d---~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
.+. +...+ ....+....++++++.+|+..||.+|||+.|.++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 11111 01122345678899999999999999999999864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.68 Aligned_cols=262 Identities=28% Similarity=0.392 Sum_probs=202.7
Q ss_pred cCCCCCCcccccCCcccEEeeeecC-----------------CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcce
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSD-----------------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 409 (660)
.++|...++||+|+||.||++.+.+ +..||+|.+... ......++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4567888999999999999997532 336999998753 3344567999999999999999999
Q ss_pred EeEEEEeCCeeEEEEEecCCCChhhhhcCCC----------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 006125 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473 (660)
Q Consensus 410 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 473 (660)
+++++.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885321 1134788899999999999999999998 99
Q ss_pred ecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh--CCC
Q 006125 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT--GRR 551 (660)
Q Consensus 474 H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt--G~~ 551 (660)
||||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986544332222222345788999999998899999999999999999997 455
Q ss_pred CCCCCcHHHHH---HHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 552 NAGSNQLLAYA---WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 552 p~~~~~~~~~~---~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
|+......+.. ........... .. ..++.....+.+++.+||+.||.+||++.||.+.|++
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQV----YL---FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccc----cc---cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 66543322221 11111111000 00 0111223457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.25 Aligned_cols=245 Identities=21% Similarity=0.320 Sum_probs=200.4
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhc---HHHHHHHHHHHhhcCCCCcceEeEEEEe----CCeeEEEEEe
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVYEF 426 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 426 (660)
...||+|+++.||+|.+ +|+.||||+++...... .+.+.+|+.++.+++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 78999999997543322 5678899999999999999999999977 3467899999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
+++|+|.+++.. ...+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999943 34689999999999999999999985 5 7899999999999999999999999987654321
Q ss_pred CccceeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...+... .
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------~ 242 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL----------K 242 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC----------C
Confidence 12367889999999976 679999999999999999999999998766544433332222110 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1112334577889999999999999999999998753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.42 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=213.3
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
+-|+.++.||+|+-|.|-+|++ .+|+.+|||++.+. +......+.+|+.+|+.+.||||+++++++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3466789999999999999994 58999999999764 3444667899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|.|.+++ ...+.+++.++.++++||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999 56678999999999999999999999998 999999999999999999999999999764433
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.- ..+.||+++|.+||++.+..| ..++||||.|||||.||+|+.||+++++.....+..++. . +
T Consensus 166 kl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-f-----------~ 230 (786)
T KOG0588|consen 166 KL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-F-----------E 230 (786)
T ss_pred cc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-c-----------c
Confidence 22 223599999999999999887 689999999999999999999999888777665544332 1 2
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
++.....+..+|+.+|+..||++|.|++||++ +|.+
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 22333344778889999999999999999986 4444
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=337.25 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=209.5
Q ss_pred HHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 343 TLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
..++..++|+..+.||+|+||.||+++. .+|+.+|+|++++. ...+.+.+..|..+|...++|+||+|+-.|.+.+
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 3356778999999999999999999994 57999999999863 4456778899999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
.+||||||++||++..+| ...+.|++..+...+.+++-|++-||+.| +|||||||+|+|||..|++||+||||+
T Consensus 215 ~LYLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred eeEEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccccc
Confidence 999999999999999999 56678999999999999999999999999 999999999999999999999999999
Q ss_pred cccccc----------------------CCcc----ce-------------------eeeeccCCcCCHhhhhcCCCCcc
Q 006125 499 RIFAES----------------------EGEA----NT-------------------VRIVGTYGYMAPEYAMEGLYSKK 533 (660)
Q Consensus 499 ~~~~~~----------------------~~~~----~~-------------------~~~~gt~~y~aPE~~~~~~~t~k 533 (660)
.-+... +... .. ...+|||.|||||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 643210 0000 00 11479999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCC---H
Q 006125 534 SDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT---M 610 (660)
Q Consensus 534 sDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~ 610 (660)
+|+||||||+||||.|-+||..+...+...++..-.......+.. .. ..+..+||.+|+. ||++|.. +
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~----~~----s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV----DL----SDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC----cc----cHHHHHHHHHHhc-CHHHhcCcccH
Confidence 999999999999999999998877665544443322211111110 11 1446678888888 9999986 5
Q ss_pred HhHH
Q 006125 611 SSVA 614 (660)
Q Consensus 611 ~evl 614 (660)
+||-
T Consensus 440 ~EIK 443 (550)
T KOG0605|consen 440 EEIK 443 (550)
T ss_pred HHHh
Confidence 5553
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.59 Aligned_cols=261 Identities=28% Similarity=0.399 Sum_probs=206.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeee------cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 417 (660)
+..++|+..++||+|+||.||+++. .++..||||+++.. .....+.+.+|+.++..+ +||||+++++++..+
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3455788899999999999999973 23568999999753 233456788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCCCC--------------------------------------------------------
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRK-------------------------------------------------------- 441 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 441 (660)
+..++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999998854211
Q ss_pred ----------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 442 ----------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 442 ----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 124788999999999999999999988 9999999999999999999999999998654332
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.........++..|+|||++.+..++.++||||||+++|||++ |..||..........+....+.... .+..
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~ 341 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-------SPEC 341 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-------CCCC
Confidence 2211112234667999999999999999999999999999998 8888865443333344433322110 0111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
....+.+|+.+||+.||++||++.||+++|+.
T Consensus 342 ---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 342 ---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 12357789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=345.14 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=210.0
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCChh
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 433 (660)
.+-||.|+.|.||+|++ .++.||||+++... ..+|+-|++|+|+||+.+.|+|.....++||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 56799999999999999 47889999886432 35788899999999999999999999999999999999999
Q ss_pred hhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeee
Q 006125 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513 (660)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 513 (660)
++|+ ....++-.....|..+||.||.|||.+. |||||||.-||||..+..+||+|||-++...+.. ....+
T Consensus 201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSF 271 (904)
T KOG4721|consen 201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSF 271 (904)
T ss_pred HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhh
Confidence 9994 4556888899999999999999999998 9999999999999999999999999998765442 22346
Q ss_pred eccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Q 006125 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYI 593 (660)
Q Consensus 514 ~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~ 593 (660)
.||..|||||++.+...++|+|||||||||||||||.-|+.+.+-...+|..-.+ .+. -..+..++..|.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN--sL~--------LpvPstcP~Gfk 341 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN--SLH--------LPVPSTCPDGFK 341 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC--ccc--------ccCcccCchHHH
Confidence 8999999999999999999999999999999999999999877766555543221 111 123445566677
Q ss_pred HHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCCCCCCcee
Q 006125 594 HIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFS 633 (660)
Q Consensus 594 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~ 633 (660)
-|++.||+..|..||++.+|+.-|.=...++=.-....||
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf 381 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYF 381 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHH
Confidence 8888999999999999999999887554444333334444
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=326.69 Aligned_cols=257 Identities=28% Similarity=0.400 Sum_probs=205.5
Q ss_pred hcCCCCCCcccccCCcccEEeeeec----CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
+.++|+..+.||+|+||.||+|.++ .+..||+|.++.. +......+.+|+..+.+++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3456778899999999999999853 3568999999764 3344567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.....
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999999532 346899999999999999999999988 999999999999999999999999987653
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
..... .......++..|+|||++.+..++.++||||||+++||+++ |+.||......+....+ .++...
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~-------- 227 (266)
T cd05064 158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRL-------- 227 (266)
T ss_pred cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCC--------
Confidence 22111 11111234678999999999999999999999999999875 99998765544433222 211110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+......+.+++..||+.+|.+||+++||++.|++.
T Consensus 228 --~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01122344577889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=334.18 Aligned_cols=244 Identities=22% Similarity=0.259 Sum_probs=201.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999964 6899999998642 2234556889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999984 3446899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...........+..... .+
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~------------~~ 217 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL------------EF 217 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc------------CC
Confidence 1234689999999999988899999999999999999999999987665444333322210 11
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCC-----HHhHHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPT-----MSSVAP 615 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 615 (660)
+......+.+++.+||+.||.+||+ ++|+++
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1111234778999999999999995 777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=329.55 Aligned_cols=249 Identities=36% Similarity=0.572 Sum_probs=196.4
Q ss_pred CcccccCCcccEEeeeec-----CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 354 SNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~-----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.+.||+|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+.+++||||++++|++.+.+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 478999999999999976 3568999999653 3445788999999999999999999999999888899999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.++|... ....+++.++..|+.||++||+|||+.+ ++|+||+++||++++++.+||+|||+..........
T Consensus 84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999643 2356899999999999999999999988 999999999999999999999999999876322222
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
...........|+|||.+....++.++||||||+++|||++ |+.|+......+....+ .++..... +.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~----------~~ 228 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPI----------PD 228 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTS----------BT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccee----------cc
Confidence 11122356778999999999999999999999999999999 67888766555544444 33322111 11
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
.....+.+++..||..||.+||++.||++.|
T Consensus 229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1234477899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=345.77 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=205.5
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 417 (660)
...++|...+.||+|+||.||++... +++.||+|+++.. .......+.+|+.+++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44567888999999999999998732 3457999999753 333456788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCCC---------------------------------------------------------
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPR--------------------------------------------------------- 440 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 440 (660)
+..++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999884321
Q ss_pred ----------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccce
Q 006125 441 ----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510 (660)
Q Consensus 441 ----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (660)
....+++.++++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 1124788999999999999999999988 999999999999999999999999999765433221111
Q ss_pred eeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 511 ~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
....++..|+|||++.+..++.++|||||||++|||++ |+.||...............+. ..... .. ..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-----~~~~~--~~---~~ 341 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-----QMSRP--DF---AP 341 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-----CccCC--CC---CC
Confidence 12234567999999999999999999999999999997 9999875443322233322211 00010 11 12
Q ss_pred HHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+.+++.+||+.||.+||++.+|+++|++.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.25 Aligned_cols=241 Identities=24% Similarity=0.267 Sum_probs=197.5
Q ss_pred cccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCC
Q 006125 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 430 (660)
+.||+|+||.||++.. .+|+.||+|+++.. .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 47899999998752 2334456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccce
Q 006125 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510 (660)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (660)
+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 9999884 3456899999999999999999999998 99999999999999999999999999875322211 12
Q ss_pred eeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHH
Q 006125 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFS 590 (660)
Q Consensus 511 ~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 590 (660)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..... .++.....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------------~~p~~~~~ 220 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------RFPRTLSP 220 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC------------CCCCCCCH
Confidence 235799999999999999999999999999999999999999976654433332222110 11112233
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 591 RYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 591 ~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
.+.+++.+||+.||++|| ++.|+++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 477888999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.45 Aligned_cols=257 Identities=30% Similarity=0.456 Sum_probs=207.1
Q ss_pred CCCCCCcccccCCcccEEeeeecC------CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
++|+..+.||+|+||.||+|.... ...|++|.++.. .......+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467778999999999999998532 257999998753 3334567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC
Q 006125 422 LVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~ 488 (660)
++|||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999854211 145889999999999999999999998 99999999999999999
Q ss_pred CEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHh
Q 006125 489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWN 567 (660)
Q Consensus 489 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~ 567 (660)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.. ..+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~-~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI-EMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHH
Confidence 999999999976543332222223356788999999998899999999999999999998 99998765443332 2222
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 568 EGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 568 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.+... ..+......+.+|+.+||+.||.+||++.||++.|++
T Consensus 241 ~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 SRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 22111 1122334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.54 Aligned_cols=252 Identities=29% Similarity=0.394 Sum_probs=205.3
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
++|+..+.||+|+||.||++.++++..+|+|.+... .....++.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 456677899999999999999888889999988643 3345678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+|+|.+++... .+.+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999998532 245899999999999999999999988 9999999999999999999999999987654322211
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....++..|+|||++....++.++||||||+++|||++ |+.||......+....+...... ..+. .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--------~~~~---~ 225 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL--------YRPK---L 225 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC--------CCCC---C
Confidence 111234568999999988889999999999999999999 88898766655444443332111 0111 1
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
....+.+++.+||+.+|++||++.|+++.|.
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1245788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=337.30 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=205.0
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++... +++.||+|+++.. .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36788899999999999999965 5889999998742 2234557889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999994 3456899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+......... +.... .
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~--~ 225 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--PVYDD--P 225 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC--CCCCc--c
Confidence 122347899999999999999999999999999999999999999876554433332221111110 11000 0
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
.......+.+++.+||+.+|.+||++.|+++.
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01123457788889999999999999999854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=334.32 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=203.7
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
..++|+..+.||+|+||.||+++.. ++..+|+|.+... .......+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3567888999999999999999964 6889999998753 3334567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 83 EHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999999943 345889999999999999999999853 3999999999999999999999999998765432
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc------c------
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV------L------ 572 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~------~------ 572 (660)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+... ....... .
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-IFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HhcccccccccCCccccCcc
Confidence 2 122468999999999998899999999999999999999999997554333221 1110000 0
Q ss_pred ----------------------cccc---ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 573 ----------------------ELVD---PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 573 ----------------------~~~d---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+..+ ...............+.+++.+||+.||++|||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000000001112345889999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=334.54 Aligned_cols=241 Identities=22% Similarity=0.283 Sum_probs=196.5
Q ss_pred cccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 357 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
||+|+||.||++... +++.||+|+++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 6889999998642 334456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceee
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (660)
.+++. ..+.+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 99984 3446899999999999999999999998 99999999999999999999999999875433222 1223
Q ss_pred eeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 513 ~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
..||+.|+|||++.+..++.++|||||||++|||++|+.||................. .++......+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~------------~~~~~~~~~~ 220 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL------------RFPDGFDRDA 220 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC------------CCCCcCCHHH
Confidence 5789999999999999999999999999999999999999987665554444332211 1111122346
Q ss_pred HHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 593 IHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 593 ~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
.+++.+||+.||.+||++..+.+.|
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 7888899999999998654444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=338.33 Aligned_cols=243 Identities=26% Similarity=0.340 Sum_probs=200.8
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56778899999999999999964 6889999998642 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999984 3456889999999999999999999998 999999999999999999999999999765332
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||...........+.. +.. .+.. ..
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-~~~------~~p~-~~ 238 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-GRL------KFPN-WF 238 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-CCc------CCCC-CC
Confidence 1 234789999999999999999999999999999999999999976654443333222 111 0111 11
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCC-----HHhHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPT-----MSSVA 614 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl 614 (660)
...+.+++.+||+.||.+||+ +.+++
T Consensus 239 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 239 ----DGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred ----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 234678899999999999997 57766
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.41 Aligned_cols=258 Identities=31% Similarity=0.444 Sum_probs=207.1
Q ss_pred cCCCCCCcccccCCcccEEeeeecC------CcEEEEEEccCCChh-cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
.++|...+.||+|+||.||+|...+ ++.||+|.++..... ..+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3457778999999999999998633 478999999764433 456899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC-----------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC
Q 006125 421 LLVYEFMPNGSLDAILFDPR-----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~ 489 (660)
++||||+++++|.+++.... ....+++..+..++.||+.+|.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999995421 2345889999999999999999999998 999999999999999999
Q ss_pred EEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhc
Q 006125 490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNE 568 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 568 (660)
+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||......+...... .
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-Q 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-c
Confidence 99999999876533222111122345778999999999999999999999999999999 999986555444333222 2
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
+.... ........+.+++.+||+.||++||++.||++.|++
T Consensus 240 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 240 GRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111 111223457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.26 Aligned_cols=260 Identities=30% Similarity=0.457 Sum_probs=205.9
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
+.+++|+..+.||+|+||.||++... +++.||+|++... ......++.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678899999999999999998753 3567999998643 2334557889999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCC-------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEE
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
..++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999999854221 234678899999999999999999987 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCc
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 570 (660)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.......... ...+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR-FVMEGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHcCC
Confidence 999999876543322221112245778999999998899999999999999999999 678886554433222 222221
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
... .+......+.+++.+||+.||++||++.|+++.|++
T Consensus 239 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 239 LLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111 111223457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.11 Aligned_cols=256 Identities=31% Similarity=0.457 Sum_probs=211.3
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
...+|+..++||+|+||.||++...+++.+++|.+..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34567788999999999999999888999999999876665677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++.... ...+++.+++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996532 345899999999999999999999988 99999999999999999999999999976543222
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
... ...++..|++||.+.+..++.++||||||+++++|++ |+.|+......+.......... . ..+
T Consensus 160 ~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------~-----~~~ 226 (261)
T cd05148 160 LSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR------M-----PCP 226 (261)
T ss_pred ccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc------C-----CCC
Confidence 111 2245678999999998899999999999999999998 7888876554333322221111 0 111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
......+.+++.+||+.||.+|||+.++++.|++
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 2233457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=321.54 Aligned_cols=257 Identities=31% Similarity=0.428 Sum_probs=208.2
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+..++|+..+.||+|++|.||++...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3456788889999999999999998778899999987533 345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999995422 345899999999999999999999988 9999999999999999999999999998765322
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
... ......+..|+|||++.+..++.++||||||+++|||++ |+.|+.......... ........ ..
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~----------~~ 225 (261)
T cd05068 158 YEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-QVDQGYRM----------PC 225 (261)
T ss_pred ccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHHcCCCC----------CC
Confidence 111 111123457999999998899999999999999999999 888887654333222 22211100 01
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.......+.+++.+|++.+|.+||++.++++.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11223458889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=328.39 Aligned_cols=261 Identities=31% Similarity=0.434 Sum_probs=210.6
Q ss_pred CCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
.+|...+.||+|+||.||+++.. ++..+++|.++.......+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45677789999999999999742 345789999887666666789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC
Q 006125 423 VYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~ 489 (660)
||||+++++|.+++.... ..+.+++..++.++.||+.+|+|||+.+ ++||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985422 2245899999999999999999999998 999999999999999999
Q ss_pred EEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhc
Q 006125 490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNE 568 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 568 (660)
++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.|+......... .....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~ 240 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-ECITQ 240 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhC
Confidence 99999999976543322211222356788999999999999999999999999999999 99998665543322 22222
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCC
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGT 623 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 623 (660)
+...+. .......+.+++.+||+.+|.+||++.+|+++|+++..+
T Consensus 241 ~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 241 GRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 221111 111234578999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.08 Aligned_cols=247 Identities=27% Similarity=0.334 Sum_probs=197.7
Q ss_pred CCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
|+..+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 56678999999999999985 579999999986422 22334678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999998887532 2335899999999999999999999998 99999999999999999999999999976533221
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHHHhcCcccccccccCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA---YAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... .......... . .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~---~ 223 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--------E---E 223 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------c---c
Confidence 123468999999999999999999999999999999999999997543211 1111111100 0 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC-----HHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPT-----MSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 615 (660)
+.......+.+|+.+||+.||.+||+ ++|+++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11112334778899999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=333.74 Aligned_cols=266 Identities=27% Similarity=0.403 Sum_probs=217.1
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCCh-hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
.++..+.+.+.++||+|-||.|.++....+..||||+++.... ....+|.+|+++|.+++||||++++|+|..++..++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 3456677788899999999999999998889999999997543 445899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
|+|||++|+|.+++....... +..+...+|+.||+.||+||.+.. +|||||.++|+|+|.++++||+|||+++.+.
T Consensus 613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999996533222 455667789999999999999988 9999999999999999999999999999877
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh--CCCCCCCCc---HHHHHHHHHhcCcccccccc
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT--GRRNAGSNQ---LLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt--G~~p~~~~~---~~~~~~~~~~~~~~~~~~d~ 577 (660)
..+......+.+-+.+|||||.+..+++|.++|||+||+.+||+++ ..+|++... ..+......+.+... -
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~----~ 764 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ----V 764 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc----e
Confidence 6666555555667899999999999999999999999999999976 567775332 222222222221110 0
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.+ ..+..++..+.+++++||..|-++||+++++...|.+.
T Consensus 765 ~l---~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VL---SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ec---cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 12334556688999999999999999999999988754
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=327.42 Aligned_cols=261 Identities=30% Similarity=0.443 Sum_probs=209.8
Q ss_pred cCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
..+|...+.||+|+||.||++... ++..+++|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 456788899999999999999742 34568999998766666778999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC----------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEE
Q 006125 422 LVYEFMPNGSLDAILFDPR----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
+||||+++++|.+++.... ....+++..++.++.|++.+|+|||+.+ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999985321 2235899999999999999999999988 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCc
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 570 (660)
|+|||++................++..|+|||++.+..++.++||||||++++||++ |+.||...........+ ..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i-~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-TQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCC
Confidence 999999976543322111122345778999999998899999999999999999998 88888765543332222 2222
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
... ... .. ...+.+|+.+||+.||.+||++.||++.|++...
T Consensus 240 ~~~-----~~~-~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 240 VLQ-----RPR-TC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred cCC-----CCC-CC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 111 111 12 2347889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=377.57 Aligned_cols=258 Identities=25% Similarity=0.496 Sum_probs=210.7
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
..+...+.||+|+||.||+|+. .+++.||||+++..... ..+|++.+++++||||++++++|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999996 57899999998753322 235688999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.++++ .++|.++.+|+.||++||+|||....++|+||||||+||+++.++.+++. ||........
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999994 28999999999999999999997655679999999999999999988875 6655432211
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCC-----CcHHHHHHHHHhcCcccccccccCCCC
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS-----NQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~-----~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
....+++.|+|||++.+..++.++|||||||++|||++|+.|++. .....|.............+|+.+...
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 112578999999999999999999999999999999999999853 235555554444444455566655331
Q ss_pred -CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCC
Q 006125 583 -SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGT 623 (660)
Q Consensus 583 -~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 623 (660)
....++..++.+++.+||+.||++||+|.||+++|+.....
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 33556777899999999999999999999999999987543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=321.46 Aligned_cols=256 Identities=31% Similarity=0.451 Sum_probs=207.9
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
..++|+..++||+|+||.||+|...+++.|++|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345778889999999999999998888899999987532 3456889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999998542 3345889999999999999999999987 99999999999999999999999999987643222
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. .....++..|+|||++....++.++||||||+++|||++ |+.||...........+. ..... +. .
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~----~~------~ 226 (261)
T cd05072 159 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRM----PR------M 226 (261)
T ss_pred ec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCC----CC------C
Confidence 11 112245678999999988889999999999999999998 888886554433332222 11110 00 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
......+.+++.+|++.+|++||+++++.++|++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.88 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=208.3
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEe
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVD 416 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 416 (660)
....++|...++||+|+||.||+|+.. .+..||||+++.. .....+.+.+|+.++.++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 345677888999999999999999842 2347999999753 3344567999999999995 9999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhcCCCC-------------------------------------------------------
Q 006125 417 GDEKLLVYEFMPNGSLDAILFDPRK------------------------------------------------------- 441 (660)
Q Consensus 417 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 441 (660)
.+..+|||||+++|+|.+++.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998853210
Q ss_pred --------------------------------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceE
Q 006125 442 --------------------------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (660)
Q Consensus 442 --------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 483 (660)
...+++..+..++.||++||.|||+.+ |+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 124788889999999999999999988 999999999999
Q ss_pred eCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q 006125 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYA 562 (660)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~ 562 (660)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 99999999999999986543322222222356788999999998899999999999999999997 88888654332333
Q ss_pred HHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 563 WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 563 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
+.....+... .........+.+++.+||+.||++||++.+|+++|++..
T Consensus 350 ~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 YNKIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 3322222110 111223345788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.38 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=206.3
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
..|+..+.||+|.||.||+|.. ..++.||+|++.- ..+.+.+++.+|+.++.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566778999999999999994 5789999999974 4556678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
|.+|++.++| +....+++....-|++++..||.|||.++ .+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999 34445588888889999999999999998 99999999999999999999999999987765544
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
.. ..++||+-|||||++....|+.|+||||||++.+||.+|.+|+....... +.-++..... |....
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------vlflIpk~~P-P~L~~ 233 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------VLFLIPKSAP-PRLDG 233 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------EEEeccCCCC-Ccccc
Confidence 43 45799999999999998899999999999999999999999987554322 2222211111 11122
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.....+.+++..||++||+.||++.+++
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 2233477788899999999999999998
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=348.41 Aligned_cols=251 Identities=22% Similarity=0.255 Sum_probs=206.0
Q ss_pred CCCCcccccCCcccEEeeeec-C-CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-D-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
|...+.||+|+||.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 777899999999999999843 3 67889998766555556678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 429 NGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 429 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
+|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999888542 23456889999999999999999999988 999999999999999999999999999876543322
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......... .+ . +..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-----~~-~-----~~~ 294 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-----DP-F-----PCP 294 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CC-C-----Ccc
Confidence 223345799999999999999999999999999999999999999986665444433332211 00 0 111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....+.+++.+||+.||++||++.+++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 2235778899999999999999999863
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=321.25 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=211.8
Q ss_pred CCCCCCcccccCCcccEEeee-ecCCcEEEEEEccC---CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
.+|++.++||+|.||.|-++. ...|+.||||.+++ .++++.-.+.+|+++|..|+||||+.++.+|++.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 467778999999999999998 57899999999975 35566667899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||..+|.|.+++ ...+.|++.++.++++||..++.|+|.++ ++|||||.+|||+|+++++||+||||+-++...
T Consensus 133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999 45667999999999999999999999998 999999999999999999999999999877654
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.. ..+++|++-|.+||++.+..| .+.+|.|||||+||-|+.|.-||++.+....+.++-+.. ..+ +.
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga-YrE--------P~ 274 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA-YRE--------PE 274 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc-ccC--------CC
Confidence 33 234799999999999999887 589999999999999999999999887766665544332 111 11
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
.+....-||+|||..||++|.|+.+|..-+
T Consensus 275 ----~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 275 ----TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 122244688899999999999999998543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=325.95 Aligned_cols=260 Identities=21% Similarity=0.297 Sum_probs=201.1
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..+.||+|+||.||+++.+ +++.+|+|+++.. .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999965 6889999998743 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987776652 2345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh---------------cCc
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN---------------EGN 570 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~---------------~~~ 570 (660)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....... ...
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 21 12234689999999999988899999999999999999999999975443222211110 000
Q ss_pred ccccccccCCCCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VLELVDPLLTDTS-----FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~~~~d~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+...... ........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 00112345889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.74 Aligned_cols=241 Identities=23% Similarity=0.271 Sum_probs=196.2
Q ss_pred cccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCC
Q 006125 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 430 (660)
+.||+|+||.||++.. .+|+.||+|+++.. .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 47899999998742 2334556788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccce
Q 006125 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510 (660)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (660)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......... .
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--c
Confidence 9998884 3346899999999999999999999998 999999999999999999999999998753222211 1
Q ss_pred eeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHH
Q 006125 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFS 590 (660)
Q Consensus 511 ~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 590 (660)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+............. .+.. .. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~-------~~p~-~~----~~ 220 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------RFPR-TL----SP 220 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------CCCC-CC----CH
Confidence 234689999999999999999999999999999999999999976654433333222111 1111 22 23
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 591 RYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 591 ~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
.+.+++.+||+.||.+|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 467888899999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.73 Aligned_cols=241 Identities=24% Similarity=0.271 Sum_probs=196.8
Q ss_pred cccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCC
Q 006125 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 430 (660)
+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46899999999752 2334567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccce
Q 006125 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510 (660)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (660)
+|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence 9998884 3346899999999999999999999998 99999999999999999999999999875332211 12
Q ss_pred eeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHH
Q 006125 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFS 590 (660)
Q Consensus 511 ~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 590 (660)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ..+.. .. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------~~~p~-~~----~~ 220 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-------IKFPR-TL----SA 220 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-------ccCCC-CC----CH
Confidence 23478999999999998899999999999999999999999997665443332222111 01111 22 23
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 591 RYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 591 ~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
.+.+++.+||+.||++|| ++.|+++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 467888899999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.91 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=207.0
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCe
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 419 (660)
.+.-++|...++||+|.||+|+++.++ +++.+|||.+++. ...+.+..+.|..++... +||.++.++..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345578999999999999999999965 6889999999874 345677788898888877 59999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
++.||||+.||++..+. ..+.+++..+..++..|+.||.|||+++ ||+||||.+|||||.+|.+||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954443 4466999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
...... ..+.+++||+.|||||++.+..|+.++|+|+|||+|||||.|+.||..++..+..-.+..++. .
T Consensus 517 e~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-------~- 586 (694)
T KOG0694|consen 517 EGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-------R- 586 (694)
T ss_pred ccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-------C-
Confidence 654222 234568999999999999999999999999999999999999999998877666555554432 1
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 610 (660)
++.-...+.+.|+.++|.++|++|.-+
T Consensus 587 ----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 ----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111223346678889999999999977
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.00 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=205.8
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHh--hcCCCCcceEeEEEEeC----CeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLIL--KLQHKNLVKLLGFCVDG----DEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~----~~~~ 421 (660)
.......+.||+|.||.||+|.+ .|+.||||++...+ ...+.+|.++.+ .|+|+||+.+++.-..+ .+++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 34567789999999999999999 58999999997533 344556666666 45999999999886544 3579
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCceEeCCCCCEEEeecc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-----SRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~DLkp~NILl~~~~~~kl~DfG 496 (660)
||.+|.++|||.++| .+..++.+..++++..+|.||+|||.. |+|.|.|||||++||||..++.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999 346699999999999999999999964 78999999999999999999999999999
Q ss_pred ccccccccCCc--cceeeeeccCCcCCHhhhhcCC----C--CcchhHHHHHHHHHHHHhC----------CCCCCCCcH
Q 006125 497 MARIFAESEGE--ANTVRIVGTYGYMAPEYAMEGL----Y--SKKSDVFSFGVLLIEIITG----------RRNAGSNQL 558 (660)
Q Consensus 497 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--t~ksDVwslGvll~elltG----------~~p~~~~~~ 558 (660)
|+......... ......+||.+|||||++.+.. + -..+||||||.++||+... +.||.+...
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99876654322 1223458999999999997543 1 2479999999999999753 234432111
Q ss_pred HHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 559 LAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 559 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.+.-....++--..+.+.|.+++...+.+.+..+.+|++.||..+|.-|.|+--|-+.|.+..
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 111111122222233445566665667788999999999999999999999999988887654
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=319.58 Aligned_cols=257 Identities=31% Similarity=0.460 Sum_probs=206.7
Q ss_pred cCCCCCCcccccCCcccEEeeeecC----CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
.++|+..+.||+|+||.||+|.+.. ...|++|.++.. ......++.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4578888999999999999998642 457999998753 34445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
+|||+++++|.+++... .+.+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998542 346899999999999999999999988 9999999999999999999999999998775
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+......... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~-------- 228 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDGYRLP-------- 228 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-HHHHcCCCCC--------
Confidence 3222222222244678999999998899999999999999999998 98888654433322 2222211100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
........+.+++.+||+.+|++||++.||++.|++.
T Consensus 229 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 --PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112234578999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.49 Aligned_cols=257 Identities=30% Similarity=0.424 Sum_probs=203.8
Q ss_pred CCCCCCcccccCCcccEEeeee-----cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
++|+..+.||+|+||.||+|.. .+++.+++|.++.. .......+.+|+.+++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567778999999999999984 24578999999753 33345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC--------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC
Q 006125 423 VYEFMPNGSLDAILFDPR--------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~ 488 (660)
+|||+++++|.+++.... ....+++.+...++.|++.||.|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999984221 1234789999999999999999999998 99999999999999999
Q ss_pred CEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHh
Q 006125 489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWN 567 (660)
Q Consensus 489 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~ 567 (660)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||........ .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-IEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHH
Confidence 999999999986543322222222345678999999988889999999999999999999 8888865443222 22222
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 568 EGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 568 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
...... ........+.+++.+||+.||.+||++.+|++.|+.
T Consensus 241 ~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 221111 111123457788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=323.42 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=209.9
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC-----CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe-CC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GD 418 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 418 (660)
+..++|...+.||+|+||.||+|...+ +..|++|++... .......+.+|+.++++++|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456778888999999999999999755 688999998753 34456678899999999999999999999876 46
Q ss_pred eeEEEEEecCCCChhhhhcCCCCC-----CccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEe
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKR-----GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 493 (660)
..++++||+++++|.+++...... ..+++.+++.++.||+.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998543222 45899999999999999999999988 9999999999999999999999
Q ss_pred eccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccc
Q 006125 494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVL 572 (660)
Q Consensus 494 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 572 (660)
|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+......+...........
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 238 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL- 238 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC-
Confidence 9999986544332211112345678999999998889999999999999999999 99999765544433222221110
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.. .......+.+++.+||+.||++||++.||++.|++..
T Consensus 239 -------~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 239 -------AQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred -------CC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00 1112345788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.89 Aligned_cols=257 Identities=29% Similarity=0.447 Sum_probs=203.9
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCc----EEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
..+|+..+.||+|+||.||+|++. +++ .||+|+++.. .....+++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 456888999999999999999853 344 4899998753 334566789999999999999999999999765 567
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+++||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999998542 345889999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
.............++..|+|||++.+..++.++||||||+++|||++ |+.|+......+. .......... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~------~~ 232 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL------PQ 232 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCC------CC
Confidence 54332222112234668999999999999999999999999999998 9999876554332 2222221110 00
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.+. ....+.+++.+||+.+|.+||++.+++..|....
T Consensus 233 ~~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 233 PPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 2234778999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=319.26 Aligned_cols=256 Identities=29% Similarity=0.395 Sum_probs=206.1
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
..+|...++||+|+||.||++... .++.+++|++... .....++.+|+++++.++|+||+++++++......+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345677789999999999999954 5889999998753 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999998542 2345899999999999999999999988 99999999999999999999999999976543322
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......+.. ........ . ..+
T Consensus 160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~-----~-----~~~ 227 (263)
T cd05052 160 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKGYR-----M-----ERP 227 (263)
T ss_pred ec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCC-----C-----CCC
Confidence 11 111223567999999998899999999999999999998 88888765544332 22222110 1 111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
......+.+++.+||+.||++||++.+++++|+..
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12234578899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.62 Aligned_cols=262 Identities=28% Similarity=0.409 Sum_probs=205.1
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 417 (660)
+..++|+..+.||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34457888999999999999999632 3478999998743 233455688899999999 899999999988754
Q ss_pred -CeeEEEEEecCCCChhhhhcCCCC-------------------------------------------------------
Q 006125 418 -DEKLLVYEFMPNGSLDAILFDPRK------------------------------------------------------- 441 (660)
Q Consensus 418 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 441 (660)
...++++||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 567899999999999998853211
Q ss_pred ---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCC
Q 006125 442 ---RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518 (660)
Q Consensus 442 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 518 (660)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 125899999999999999999999988 99999999999999999999999999987644332222222355778
Q ss_pred cCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHh
Q 006125 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGL 597 (660)
Q Consensus 519 y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~ 597 (660)
|+|||++.+..++.++|||||||++|||++ |+.||......+........+.... .+......+.+++.
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~ 310 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR----------APEYATPEIYSIML 310 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC----------CCccCCHHHHHHHH
Confidence 999999999999999999999999999998 9988865433222223322221110 01112345788999
Q ss_pred hcccCCCCCCCCHHhHHHHhcCC
Q 006125 598 LCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 598 ~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
+||+.+|++||++.||++.|++.
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.34 Aligned_cols=263 Identities=24% Similarity=0.296 Sum_probs=209.5
Q ss_pred cCCCCCCcccccCCcccEEeeeecC--CcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSD--GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
.++|...+.||+|+||.||++...+ +..||+|++... .....+.+.+|+.++..++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568888999999999999998543 368999998642 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999994 3446899999999999999999999998 9999999999999999999999999997653
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... .+ ..
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-------~~-p~ 249 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-------YF-PK 249 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-------CC-CC
Confidence 21 1235789999999999988899999999999999999999999987654433333322110 01 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHHHH--hcCC------CCCCCCCCCCcee
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAPM--LKGE------TGTLPQPQKPAFS 633 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~--L~~~------~~~~~~p~~p~~~ 633 (660)
..+ ..+.+++.+||+.||++|+ +++|+++. +++. ...++.|..|.+.
T Consensus 250 ~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~ 309 (340)
T PTZ00426 250 FLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK 309 (340)
T ss_pred CCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 222 2367888999999999995 88888753 3322 2344556666654
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=324.07 Aligned_cols=256 Identities=29% Similarity=0.384 Sum_probs=203.4
Q ss_pred CCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCCh-hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
+|...+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4556788999999999999853 247899999975432 234568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCC-------------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC
Q 006125 423 VYEFMPNGSLDAILFDP-------------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~ 489 (660)
++||+++++|.+++... .....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998421 11235888999999999999999999998 999999999999999999
Q ss_pred EEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhc
Q 006125 490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNE 568 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 568 (660)
+||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..|+......+....+. .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~-~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR-N 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999886543322222222345778999999998889999999999999999998 777877655444332222 2
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.... .........+.+++..||+.+|.+||++.||+..|+.
T Consensus 242 ~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 242 RQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2111 1112233447789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=348.22 Aligned_cols=260 Identities=26% Similarity=0.320 Sum_probs=209.7
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
.+.+...++|...+.||+|+||.||++.. .+|+.||||++... +......+.+|+..+..++|+|++++...+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 44455667899999999999999999984 57999999998642 3445567889999999999999999988775432
Q ss_pred --------eeEEEEEecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC
Q 006125 419 --------EKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (660)
Q Consensus 419 --------~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~ 489 (660)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 357999999999999998542 23356899999999999999999999988 999999999999999999
Q ss_pred EEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC
Q 006125 490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG 569 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~ 569 (660)
+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 99999999987654332222334579999999999999999999999999999999999999998776555444333221
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
. .+ + +......+.+++.+||+.||.+||++.+++.
T Consensus 262 -~----~~-~-----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 262 -Y----DP-L-----PPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred -C----CC-C-----CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 1 11 1 1122345778899999999999999999975
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=317.61 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=203.4
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
++|...+.||+|+||.||++...++..+|+|.++.. .....++.+|+.++.+++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 456677899999999999999877778999998753 2345678999999999999999999999999888999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+|+|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998542 235899999999999999999999998 9999999999999999999999999987654322111
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....++..|++||.+....++.++||||||+++|||++ |+.|+.................. .. ...
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------~~-----~~~ 225 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL------YR-----PHL 225 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC------CC-----CCC
Confidence 111234567999999988889999999999999999999 99898755543333322221110 00 111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2345788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=330.11 Aligned_cols=202 Identities=29% Similarity=0.419 Sum_probs=175.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
..++|+..++||+|+||.||++... +++.+|+|+++.. .......+.+|++++++++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4578889999999999999999965 6888999988753 3344567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.|+++||.|||+.. +++||||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999994 3345889999999999999999999753 3999999999999999999999999998755332
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~ 557 (660)
.. ....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 MA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred cc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 11 22468899999999998889999999999999999999999987544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.18 Aligned_cols=258 Identities=29% Similarity=0.402 Sum_probs=206.5
Q ss_pred cCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
..++...++||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 456777899999999999999632 35689999988767677778999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC
Q 006125 422 LVYEFMPNGSLDAILFDPRK------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~ 489 (660)
++|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999854221 135889999999999999999999988 999999999999999999
Q ss_pred EEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhc
Q 006125 490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNE 568 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 568 (660)
+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |++||...............
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 99999999875543222111112245678999999998899999999999999999998 88888655443333222211
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.. . . .+......+.+++.+||+.||.+||++.||++.|+.
T Consensus 241 ~~-~-----~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 241 RE-L-----E-----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cc-C-----C-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11 0 0 011123447789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=330.90 Aligned_cols=241 Identities=25% Similarity=0.334 Sum_probs=196.6
Q ss_pred cccccCCcccEEeeee----cCCcEEEEEEccCC----ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 355 NILGQGGFGPVYKGVL----SDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+.||+|+||.||++.. .+++.||+|+++.. .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999984 35789999998742 223345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999984 3456888999999999999999999998 99999999999999999999999999875432221
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||...........+..... .+ +.
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-------~~-----~~ 221 (323)
T cd05584 156 V--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-------NL-----PP 221 (323)
T ss_pred c--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------CC-----CC
Confidence 1 2234689999999999988899999999999999999999999987665544433332211 01 11
Q ss_pred HHHHHHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
.....+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1223477889999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=325.64 Aligned_cols=263 Identities=29% Similarity=0.411 Sum_probs=209.8
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEE
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 415 (660)
+++..++|+..+.||+|+||.||++... ....+|+|.+... .......+.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3455667888899999999999999853 2367999998753 334456788999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCC-------------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDP-------------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 482 (660)
..+..+++|||+++|+|..++... .....+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999998532 23456899999999999999999999988 99999999999
Q ss_pred EeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q 006125 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAY 561 (660)
Q Consensus 483 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~ 561 (660)
|+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+......+.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999987654332222222234678999999998899999999999999999998 8888876554433
Q ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 562 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
... ...+... ..+......+.+++.+|++.||.+|||+.|+++.|++.
T Consensus 244 ~~~-~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 FKL-LKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHH-HHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 322 2221111 11112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.82 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=202.7
Q ss_pred CCCCcccccCCcccEEeeeecC----CcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe-----
Q 006125 351 FSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE----- 419 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 419 (660)
|...+.||+|+||.||+|.... +..||+|+++.. .......+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 367999998742 33445678999999999999999999999876554
Q ss_pred -eEEEEEecCCCChhhhhcCCC---CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeec
Q 006125 420 -KLLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (660)
Q Consensus 420 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 495 (660)
.++++||+++|+|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999885432 2345899999999999999999999988 999999999999999999999999
Q ss_pred cccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccc
Q 006125 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLEL 574 (660)
Q Consensus 496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 574 (660)
|+++...............++..|+|||++....++.++||||||+++|||++ |..|+......+........ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~-- 234 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRL-- 234 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC--
Confidence 99986654332222222234678999999988889999999999999999999 88888665544333222221 111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+......+.+++.+||+.||.+||++.||++.|++.
T Consensus 235 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 --------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11122334688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=319.37 Aligned_cols=274 Identities=26% Similarity=0.335 Sum_probs=212.1
Q ss_pred HhhcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCC--------------hhcHHHHHHHHHHHhhcCCCCcce
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS--------------EQGTAEFTNEVLLILKLQHKNLVK 409 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~ 409 (660)
...-+.|+..+.||+|.||.|-++. ..+++.||||++.+.. ....+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3445779999999999999999999 4579999999986421 122457899999999999999999
Q ss_pred EeEEEEe--CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC
Q 006125 410 LLGFCVD--GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487 (660)
Q Consensus 410 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~ 487 (660)
|+.+..+ .+..|||+|||..|.+.+.= .....++..+++++++++..||+|||.++ |+||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9999876 45789999999988875542 22223999999999999999999999999 9999999999999999
Q ss_pred CCEEEeeccccccccccCCc---cceeeeeccCCcCCHhhhhcCC----CCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 006125 488 MNSKISDFGMARIFAESEGE---ANTVRIVGTYGYMAPEYAMEGL----YSKKSDVFSFGVLLIEIITGRRNAGSNQLLA 560 (660)
Q Consensus 488 ~~~kl~DfGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwslGvll~elltG~~p~~~~~~~~ 560 (660)
|++||+|||.+..+...... ......+||+.|+|||...++. .+.+.||||+||.||.|+.|+.||..+...+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999999866332111 1122358999999999987633 3679999999999999999999998877766
Q ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC-CCCCCCCCCCCceec
Q 006125 561 YAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG-ETGTLPQPQKPAFSI 634 (660)
Q Consensus 561 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~-~~~~~~~p~~p~~~~ 634 (660)
...++..+ .+.-+. .++....+.+||.++|++||++|.+..+|..-.=- .....+.+..|-.+.
T Consensus 327 l~~KIvn~---------pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~~c~ 391 (576)
T KOG0585|consen 327 LFDKIVND---------PLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPSSCS 391 (576)
T ss_pred HHHHHhcC---------cccCCC-cccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcccce
Confidence 65555433 222112 12445668899999999999999999999754422 122334444444443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.17 Aligned_cols=266 Identities=21% Similarity=0.352 Sum_probs=197.8
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC-----eeE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL 421 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 421 (660)
+|+..++||+|+||.||++.. .+++.||+|+++.. .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 467789999999999999995 47899999998642 2234456889999999999999999999986432 479
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+. ++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888884 3345899999999999999999999998 999999999999999999999999999765
Q ss_pred cccCCcc-ceeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH-------------
Q 006125 502 AESEGEA-NTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL------------- 565 (660)
Q Consensus 502 ~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~------------- 565 (660)
....... ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3322211 1123468999999999876 67899999999999999999999999755432211110
Q ss_pred -HhcCcccccccccCCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCC
Q 006125 566 -WNEGNVLELVDPLLTDTSFS-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETG 622 (660)
Q Consensus 566 -~~~~~~~~~~d~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 622 (660)
+......+.+.......... ......+.+++.+||+.||++||+++|+++ ++++...
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00000000000000000000 011234678999999999999999999984 4554433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.04 Aligned_cols=248 Identities=28% Similarity=0.367 Sum_probs=196.8
Q ss_pred cccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
+.||+|+||.||++.. .+++.+|+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999996 47899999988643 334456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceee
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (660)
.+++.. ....+++..++.++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999853 2345899999999999999999999988 99999999999999999999999999875443211111111
Q ss_pred eeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHH
Q 006125 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSR 591 (660)
Q Consensus 513 ~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 591 (660)
...+..|+|||.+.++.++.++||||||+++|||++ |..|+................. . .........
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~------~-----~~~~~~~~~ 224 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------L-----PCPELCPDA 224 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC------C-----CCcccCCHH
Confidence 123456999999998899999999999999999998 8888764433222111111100 0 111222345
Q ss_pred HHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 592 YIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 592 l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
+.+++.+|++.+|++||++.||+++|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=321.17 Aligned_cols=262 Identities=27% Similarity=0.354 Sum_probs=201.8
Q ss_pred cCCCCCCcccccCCcccEEeeeecC---------------CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSD---------------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLL 411 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 411 (660)
.++|+..++||+|+||.||++...+ ...||+|+++.. .......+.+|++++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578888999999999999987532 225899998753 334456789999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCChhhhhcCCCC---------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 006125 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRK---------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (660)
Q Consensus 412 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 482 (660)
+++......++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999854221 123788999999999999999999998 99999999999
Q ss_pred EeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh--CCCCCCCCcHHH
Q 006125 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT--GRRNAGSNQLLA 560 (660)
Q Consensus 483 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt--G~~p~~~~~~~~ 560 (660)
++++++.+||+|||++................++..|+|||++.++.++.++||||||++++||++ |..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976543322211122345678999999998899999999999999999998 556665443322
Q ss_pred HHHHH---HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 561 YAWHL---WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 561 ~~~~~---~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
..... +......... .........+.+|+.+|++.||++||++.+|++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 22111 1111000000 0011123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.87 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=199.2
Q ss_pred CCCcccccCCcccEEeeeecC-Cc--EEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------Cee
Q 006125 352 SDSNILGQGGFGPVYKGVLSD-GK--EVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DEK 420 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 420 (660)
...++||+|+||.||+|+..+ ++ .+|+|.++.. +....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999654 33 6899988643 345567789999999999999999999987542 246
Q ss_pred EEEEEecCCCChhhhhcCCC---CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 421 LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
++++||+++|+|.+++.... ....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874221 2345899999999999999999999987 99999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
++...............+++.|++||++.+..++.++||||||+++|||++ |+.||........ +.....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~-- 235 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI-YDYLRQGNRLKQ-- 235 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHcCCCCCC--
Confidence 987643322111112245678999999999999999999999999999999 7888865544332 232332221110
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.......+.+++.+||+.||++||++.||++.|++.
T Consensus 236 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 --------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111233478899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.41 Aligned_cols=252 Identities=28% Similarity=0.393 Sum_probs=202.4
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
.+|+..+.||+|+||.||++..+++..+|+|++... ......+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 356778899999999999999877778999998643 2334578889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999998532 236899999999999999999999998 9999999999999999999999999987654322111
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....... .. .... +..
T Consensus 158 ~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~-----~~~~-----~~~ 225 (256)
T cd05059 158 S-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GY-----RLYR-----PKL 225 (256)
T ss_pred c-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CC-----cCCC-----CCC
Confidence 1 11123457999999998899999999999999999999 7888875544333322221 11 1111 111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
....+.+++.+||+.+|++||++.|+++.|.
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 2345888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.97 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=198.9
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|...++||+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999854 68899999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++ +|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 88888843 2334789999999999999999999998 99999999999999999999999999876433221
Q ss_pred ccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC---------------c
Q 006125 507 EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG---------------N 570 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~---------------~ 570 (660)
. .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.... .
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 T--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred c--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1 122467899999999875 568999999999999999999999997665444332222110 0
Q ss_pred ccccccccCCCCC---CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VLELVDPLLTDTS---FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~~~~d~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+...+...... ..........+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 00011234678999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.90 Aligned_cols=258 Identities=29% Similarity=0.455 Sum_probs=203.7
Q ss_pred hcCCCCCCcccccCCcccEEeeeecC------CcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
.+++|...+.||+|+||.||++...+ +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678888999999999999999643 5689999887433 3344578999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC---CEEE
Q 006125 420 KLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKI 492 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~---~~kl 492 (660)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999854321 235899999999999999999999998 99999999999998754 5999
Q ss_pred eeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcc
Q 006125 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNV 571 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 571 (660)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||..................
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999986633222111112233567999999999999999999999999999997 88888765543332222211110
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
..+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 241 -----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 -----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111122345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.62 Aligned_cols=240 Identities=26% Similarity=0.334 Sum_probs=191.9
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
++||+|+||.||++... +++.||+|+++.. .....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5789999998742 223344556676666654 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~ 152 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence 99999884 3345899999999999999999999988 99999999999999999999999999975433221 2
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.... +.+ +....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------~~~-----~~~~~ 220 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-------PHF-----PRWIS 220 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------CCC-----CCCCC
Confidence 223578999999999998899999999999999999999999998766544443332211 111 11122
Q ss_pred HHHHHHHhhcccCCCCCCCCHH-hHH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMS-SVA 614 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~-evl 614 (660)
..+.+++.+||+.||.+||++. +++
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3467788899999999999876 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=301.08 Aligned_cols=269 Identities=22% Similarity=0.272 Sum_probs=213.7
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC--
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-- 418 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 418 (660)
.++.+..++|.+.+.||+|+|+.||+++ +.+++.+|+|++.-.+..+.+..++|++..++++||||++++++...+.
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 3445677899999999999999999999 6789999999998767778889999999999999999999998876443
Q ss_pred ---eeEEEEEecCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 419 ---EKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 419 ---~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
+.||+++|...|+|.+.+.... ++..+++.+.++|+.+|.+||.+||+.. ++++||||||.|||+.+++.++|.|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEe
Confidence 4899999999999999886533 3447999999999999999999999986 5899999999999999999999999
Q ss_pred ccccccccccCCccc-------eeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 006125 495 FGMARIFAESEGEAN-------TVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWH 564 (660)
Q Consensus 495 fGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~ 564 (660)
||.++...-...... -.....|..|.|||.+. +...++++|||||||+||+|+.|..||+.. ..
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~------~~ 246 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI------YQ 246 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH------hh
Confidence 999875432111100 01124688999999985 445789999999999999999999998521 11
Q ss_pred HHhcCccc-ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 565 LWNEGNVL-ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 565 ~~~~~~~~-~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
+.+.+. ......+.-+. .......+.+++.+|++.||.+||++.|++..+...
T Consensus 247 --~GgSlaLAv~n~q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 --QGGSLALAVQNAQISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --cCCeEEEeeeccccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 222221 22232332222 122456688999999999999999999999988653
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.75 Aligned_cols=244 Identities=25% Similarity=0.319 Sum_probs=194.7
Q ss_pred CCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHH---hhcCCCCcceEeEEEEeCCeeEEE
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLI---LKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
|+..+.||+|+||.||++.. .+++.||||+++.. .....+.+.+|+.++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45678999999999999985 46899999999742 223345566676655 566899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999998883 245899999999999999999999998 99999999999999999999999999865332
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
... ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+..... ... ..
T Consensus 154 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-------~~p-~~ 223 (324)
T cd05589 154 FGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-------RYP-RF 223 (324)
T ss_pred CCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------CCC-CC
Confidence 211 12235789999999999999999999999999999999999999987665544433332211 111 12
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC-----HHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPT-----MSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 615 (660)
. ...+.+++.+||+.||.+||+ +.++++
T Consensus 224 ~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 224 L----SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred C----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 2 234678899999999999994 555553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.68 Aligned_cols=259 Identities=31% Similarity=0.456 Sum_probs=206.0
Q ss_pred hcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
..++|+..+.||+|+||.||++..+ ++..+|+|+++.. ......++.+|+.++++++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4567888999999999999999853 4678999998753 33445678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCC-------------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 006125 420 KLLVYEFMPNGSLDAILFDPR-------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~ 480 (660)
.++++||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999995321 1234788999999999999999999988 999999999
Q ss_pred ceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHH
Q 006125 481 NVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLL 559 (660)
Q Consensus 481 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~ 559 (660)
||++++++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543322111112234667999999998899999999999999999998 77787655444
Q ss_pred HHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 560 AYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 560 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
+....+ ..+.... .+......+.+++.+||+.+|.+||++.|+++.|++
T Consensus 240 ~~~~~~-~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIYYV-RDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHH-hcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 333222 2222111 111223458889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.22 Aligned_cols=256 Identities=31% Similarity=0.429 Sum_probs=201.0
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCc----EEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
++|+..+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+..+.+++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46777899999999999999853 454 47788875432 233467888888999999999999999875 455789
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
++||+++|+|.+++.. ..+.+++..+..|+.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999953 2345899999999999999999999988 9999999999999999999999999998664
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
............++..|++||.+.++.++.++||||||+++|||++ |+.|+........ .+....+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~-------~ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLA-------Q 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCC-------C
Confidence 4332222223456778999999998899999999999999999998 9989876543322 22222222111 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
+.. ....+.+++.+||..||++||++.|+++.|+...
T Consensus 233 ~~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 233 PQI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 011 1234677888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.61 Aligned_cols=240 Identities=21% Similarity=0.294 Sum_probs=195.4
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
++||+|+||.||+++.. +++.||+|+++.. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 5789999998752 233445677888888866 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|...+. ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-- 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc--
Confidence 99998884 3445899999999999999999999998 999999999999999999999999998754322221
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...........+...... . .... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~-------~-p~~~----~ 220 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-------Y-PVWL----S 220 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------C-CCCC----C
Confidence 22346899999999999989999999999999999999999999877655544443332210 0 1011 2
Q ss_pred HHHHHHHhhcccCCCCCCC-------CHHhHH
Q 006125 590 SRYIHIGLLCVQEDAFDRP-------TMSSVA 614 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RP-------t~~evl 614 (660)
..+.+++.+||+.||++|| ++.+++
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 3467888999999999999 777776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=332.32 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=192.7
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+|+..++||+|+||.||+++. .+++.||||++... .......+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 455578899999999999995 46899999998653 3334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.... ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999986532 3567778899999999999999998 999999999999999999999999999865432211
Q ss_pred cceeeeeccCCcCCHhhhhc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 508 ANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.....|+..|+|||++.. ...+.++|||||||++|||++|+.||......++......... . .. .
T Consensus 225 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~---~~----~ 294 (353)
T PLN00034 225 --CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-S---QP----P 294 (353)
T ss_pred --ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-c---CC----C
Confidence 123478999999998743 2345799999999999999999999974332222211111000 0 00 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
.........+.+++.+||+.||++||++.||++.
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112233457889999999999999999999853
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=319.07 Aligned_cols=258 Identities=30% Similarity=0.427 Sum_probs=204.6
Q ss_pred CCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
+|...+.||+|+||.||+|+.. ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667789999999999999852 23578999887533 3445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC---------------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 006125 423 VYEFMPNGSLDAILFDPR---------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~N 481 (660)
++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885321 1235889999999999999999999988 9999999999
Q ss_pred eEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 006125 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLA 560 (660)
Q Consensus 482 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~ 560 (660)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976543322211222345678999999988889999999999999999998 888886554332
Q ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 561 YAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 561 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.+......... .........+.+++.+||+.+|++||++.|+++.|++..
T Consensus 238 -~~~~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 -LFNLLKTGYRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -HHHHHhCCCCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 33333222110 011122345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=330.30 Aligned_cols=241 Identities=23% Similarity=0.268 Sum_probs=195.4
Q ss_pred cccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCC
Q 006125 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 430 (660)
+.||+|+||.||++.. .+|+.||+|+++.. .......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 47899999998752 2334556788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
+|..++. ....+++..+..++.||+.||.|||+ .+ |+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence 9998884 33468999999999999999999997 56 999999999999999999999999998754322211
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...........+..... .+.. .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~-------~~p~-~~----~ 220 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------RFPR-TL----S 220 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-------CCCC-CC----C
Confidence 1234689999999999999999999999999999999999999976554433332221110 1111 22 2
Q ss_pred HHHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 590 SRYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
..+.+++.+||+.||++|+ ++.++++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 3467888999999999996 8999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.41 Aligned_cols=259 Identities=31% Similarity=0.454 Sum_probs=207.3
Q ss_pred hcCCCCCCcccccCCcccEEeeeecC------CcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
..++|...+.||+|+||.||++...+ +..|++|.+.... ......+.+|+.++..++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34577788999999999999998642 3689999987532 3445678899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCC-------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEE
Q 006125 420 KLLVYEFMPNGSLDAILFDPR-------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl 492 (660)
.++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999985422 1234789999999999999999999988 999999999999999999999
Q ss_pred eeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcc
Q 006125 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNV 571 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 571 (660)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......... .......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK-FVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH-HHhcCCC
Confidence 99999876554332222223356788999999998889999999999999999998 888886555433332 2222211
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.. . +......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 240 LD-----L-----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CC-----C-----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11 1 11124457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=318.41 Aligned_cols=265 Identities=28% Similarity=0.333 Sum_probs=204.5
Q ss_pred cCCCCCCcccccCCcccEEeeeecC-----------------CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcce
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSD-----------------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 409 (660)
.++|+..+.||+|+||.||++...+ +..||+|++... .....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678889999999999999988542 246899998753 3345667899999999999999999
Q ss_pred EeEEEEeCCeeEEEEEecCCCChhhhhcCCC--------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 006125 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (660)
Q Consensus 410 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~N 481 (660)
+++++..++..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1225899999999999999999999988 9999999999
Q ss_pred eEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh--CCCCCCCCcHH
Q 006125 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT--GRRNAGSNQLL 559 (660)
Q Consensus 482 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt--G~~p~~~~~~~ 559 (660)
|++++++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976544332222223356778999999998889999999999999999998 56677543322
Q ss_pred HHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 560 AYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 560 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.............. ...... ........+.+++.+||+.||.+||++.||++.|+.
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 QVIENAGHFFRDDG-RQIYLP---RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHhcccccc-ccccCC---CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 22111111100000 000000 111123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.54 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=196.9
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.|+..+.||+|+||.||++.. .+++.||+|++... .......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999985 56889999999652 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999984 3345889999999999999999999988 9999999999999999999999999976432100
Q ss_pred Cc---------------------------------------------cceeeeeccCCcCCHhhhhcCCCCcchhHHHHH
Q 006125 506 GE---------------------------------------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFG 540 (660)
Q Consensus 506 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslG 540 (660)
.. ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 001124699999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhh--cccCCCCCCCCHHhHHH
Q 006125 541 VLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLL--CVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 541 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl~ 615 (660)
|++|||++|+.||...........+......... + .....+. .+.+++.+ |+..+|..||++.|++.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~~~~~s~----~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHI--P--PQVKLSP----EAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCC--C--CCCCCCH----HHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999999765544333333221111110 0 0001222 34555555 56677777999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.90 Aligned_cols=237 Identities=26% Similarity=0.302 Sum_probs=190.7
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHH-HHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||++... +|+.||+|++... .......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 7899999998642 1223344555554 56788999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++........ .
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T 152 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence 99999884 3446889999999999999999999998 99999999999999999999999999875332221 1
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..... .+ .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------~~-~~~~----~ 220 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-------RL-KPNI----S 220 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-------CC-CCCC----C
Confidence 2234789999999999999999999999999999999999999987665544433332211 01 1122 3
Q ss_pred HHHHHHHhhcccCCCCCCCCHH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMS 611 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~ 611 (660)
..+.+++.+||+.||.+||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCC
Confidence 4477889999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.23 Aligned_cols=260 Identities=23% Similarity=0.288 Sum_probs=195.9
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.++|...++||+|+||.||++... +++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999964 78999999987532 2234467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|++ ++|.+++.. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 577777643 2345889999999999999999999998 9999999999999999999999999987543222
Q ss_pred CccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHH---hcCc---ccc----
Q 006125 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQL-LAYAWHLW---NEGN---VLE---- 573 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~-~~~~~~~~---~~~~---~~~---- 573 (660)
.. .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........ .... +..
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 HT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred cc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 11 122467899999999875 4588999999999999999999999975322 11111111 0000 000
Q ss_pred -ccccc-CC--CCCCCH------HHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 574 -LVDPL-LT--DTSFSD------DEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 574 -~~d~~-~~--~~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+. .. .+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 000000 01134678999999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.75 Aligned_cols=236 Identities=26% Similarity=0.316 Sum_probs=192.1
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||+++.+ +++.||+|+++.. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 6889999998742 233455677888888876 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........ .
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 99999884 3346899999999999999999999998 99999999999999999999999999875322211 1
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... .. +....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-------~~-----~~~~~ 220 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-------VY-----PTWLS 220 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-------CC-----CCCCC
Confidence 2234789999999999988999999999999999999999999987665544433332211 00 11122
Q ss_pred HHHHHHHhhcccCCCCCCCCH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~ 610 (660)
..+.+++.+||+.||.+||++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCC
Confidence 346788899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=312.34 Aligned_cols=246 Identities=30% Similarity=0.424 Sum_probs=196.9
Q ss_pred ccccCCcccEEeeee---cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCC
Q 006125 356 ILGQGGFGPVYKGVL---SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 430 (660)
.||+|+||.||+|.+ .+++.+|+|+++... ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357889999986432 334567899999999999999999999885 45678999999999
Q ss_pred ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc-
Q 006125 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN- 509 (660)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~- 509 (660)
+|.+++. ....+++..+..++.|++.+|+|||+.+ ++||||||+||++++++.+||+|||++...........
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999984 3345899999999999999999999988 99999999999999999999999999986644332211
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 588 (660)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...........+ ..+.... .+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~----------~~~~~ 223 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-ESGERME----------CPQRC 223 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCC----------CCCCC
Confidence 111234578999999988889999999999999999998 99999766544433332 2221111 11112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 589 FSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 589 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
...+.+++.+||+.||++||++.+|++.|++
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 3457789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.76 Aligned_cols=242 Identities=24% Similarity=0.257 Sum_probs=193.0
Q ss_pred cccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHH-HHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||++.. .+|+.+|+|++... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 47899999998642 2223345555554 46778999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence 99998884 4456899999999999999999999998 99999999999999999999999999875322211 1
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+............. ...+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--------~~~~~~----~ 220 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--------VLRPGA----S 220 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--------cCCCCC----C
Confidence 2235789999999999999999999999999999999999999987665544433332211 011122 2
Q ss_pred HHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
..+.+++.+|++.+|.+||++.+.++.
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 346788899999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.87 Aligned_cols=261 Identities=30% Similarity=0.438 Sum_probs=206.2
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
+..++|+..++||+|+||.||+|..+ .+..||+|.++... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678888999999999999999743 24579999886432 233456788999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCC-------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEE
Q 006125 419 EKLLVYEFMPNGSLDAILFDPR-------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999995422 1234677888999999999999999988 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCc
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 570 (660)
|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..|+......+........+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999876543322222222245678999999998899999999999999999999 6778876554433222221111
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.. ........+.+++.+|++.||++||++.++++.|++.
T Consensus 240 -~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 240 -LD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -CC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 10 1112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.96 Aligned_cols=238 Identities=24% Similarity=0.291 Sum_probs=194.7
Q ss_pred cccccCCcccEEeeee----cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 355 NILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
+.||+|+||.||++.. .+|+.+|+|+++... ......+.+|++++.+++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999997522 2234567789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+|+|.+++. +...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999999984 3456899999999999999999999998 99999999999999999999999999876543221
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 588 (660)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...........+..... ..+...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~------------~~p~~~ 221 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL------------GMPQFL 221 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC------------CCCCCC
Confidence 22235789999999999988899999999999999999999999987665444433332211 011112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHh
Q 006125 589 FSRYIHIGLLCVQEDAFDRPTMSS 612 (660)
Q Consensus 589 ~~~l~~li~~cl~~dP~~RPt~~e 612 (660)
...+.+++.+||+.||++||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 234678889999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=334.41 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=200.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++... +++.||||++... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999954 6899999999642 2234456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999984 3446899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCcc------------------------------------ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh
Q 006125 505 EGEA------------------------------------NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548 (660)
Q Consensus 505 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt 548 (660)
.... .....+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100 0012368999999999999999999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHhHHH
Q 006125 549 GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT---MSSVAP 615 (660)
Q Consensus 549 G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~ 615 (660)
|+.||...........+........... .... ...+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~----~~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETLQFPD----EVPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCccCCCC----CCCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999987665544433332111111100 0011 2245677778886 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=330.98 Aligned_cols=261 Identities=18% Similarity=0.219 Sum_probs=197.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
+...+|+..++||+|+||.||++.. .+++.||+|.... ..+.+|+.++++++||||+++++++......++|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 3456799999999999999999995 5788999997542 34678999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
|++. ++|..++.. ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 163 e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 163 PRYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred ecCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9985 688888743 345899999999999999999999998 999999999999999999999999999754322
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHHHh-cCc------
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-------LLAYAWHLWN-EGN------ 570 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~-------~~~~~~~~~~-~~~------ 570 (660)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+.... .......+.. .+.
T Consensus 236 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 NAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 111 1223479999999999999899999999999999999999997753211 0000000000 000
Q ss_pred ------ccccc----c----ccCCCCCC--CHHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhcCC
Q 006125 571 ------VLELV----D----PLLTDTSF--SDDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGE 620 (660)
Q Consensus 571 ------~~~~~----d----~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~ 620 (660)
..+.. . .....+.+ .......+.+|+.+||+.||++|||++|++ .++++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00000 0 00000000 012345688899999999999999999998 455543
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.53 Aligned_cols=241 Identities=24% Similarity=0.287 Sum_probs=195.0
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCC-CCcceEeEEEEeCCeeEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 424 (660)
+|+..+.||+|+||.||++... +++.||+|+++.. .....+.+..|+.++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677899999999999999954 5789999998742 23345667889999999976 46888999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999884 3445899999999999999999999988 999999999999999999999999998643221
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... .+.. ..
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-------~~~~-~~ 224 (324)
T cd05587 155 GK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-------SYPK-SL 224 (324)
T ss_pred CC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------CCCC-CC
Confidence 11 22345789999999999999999999999999999999999999986665444433332110 1111 12
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~ 610 (660)
...+.+++.+||+.||.+||+.
T Consensus 225 ----~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 225 ----SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CHHHHHHHHHHhhcCHHHcCCC
Confidence 2346788899999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=312.93 Aligned_cols=254 Identities=29% Similarity=0.437 Sum_probs=204.3
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.++|...++||+|+||.||++...++..+|+|.++... ...+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 34677789999999999999998888899999987533 23567899999999999999999999875 45689999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++... ....+++.++..++.|++.+|.|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998542 2345899999999999999999999998 999999999999999999999999999765432211
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
. .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+...... ....
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~ 226 (260)
T cd05070 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-----------PCPQ 226 (260)
T ss_pred c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------CCCC
Confidence 1 111234668999999988889999999999999999999 88888765544333322211110 1112
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.....+.+++.+|++.+|.+|||+.+++++|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223458889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=328.68 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=196.3
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++.. .+++.||+|+++... ......+.+|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688889999999999999985 468899999997532 233456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999994 3456899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCc---------------------------------cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCC
Q 006125 505 EGE---------------------------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551 (660)
Q Consensus 505 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~ 551 (660)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123479999999999999999999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcc--cCCCCCCCCHHhHHH
Q 006125 552 NAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCV--QEDAFDRPTMSSVAP 615 (660)
Q Consensus 552 p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl--~~dP~~RPt~~evl~ 615 (660)
||...........+........ +.+. ...+.+ +.+++.+++ ..++..||+++||++
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~-~p~~---~~~s~~----~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLI-FPPE---VPISEK----AKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCccc-CCCc---CCCCHH----HHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 9987665444433332111111 1110 012222 334444433 334456799999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=312.89 Aligned_cols=255 Identities=28% Similarity=0.402 Sum_probs=203.9
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
..++|+..++||+|+||.||+++..+...||+|+++... ...+.+.+|+.+++.++||||+++++.+. ....++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 345688889999999999999998777789999997532 23467899999999999999999999874 4567999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++|+|.+++... ....+++..+..++.|++++|+|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999999542 2345789999999999999999999988 99999999999999999999999999976643322
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. .....++..|+|||+..+..++.++||||||+++|||++ |+.||................. . ...
T Consensus 158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------~-----~~~ 225 (262)
T cd05071 158 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------M-----PCP 225 (262)
T ss_pred cc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC------C-----CCc
Confidence 11 112345678999999988899999999999999999999 7778865543322222211110 0 112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.+....+.+++.+|++.||++||++.+++++|+.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 2344568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=313.89 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=207.0
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC---CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||+++. .+++.||+|.++. ........+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688889999999999999995 4789999998754 23344557889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 425 EFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
||+++++|.+++.... ....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 2345889999999999999999999988 99999999999999999999999999876543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHHhcCcccccccccCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL--LAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..... ...... .+.
T Consensus 159 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~-~~~~~~-----~~~--- 227 (267)
T cd08228 159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ-KIEQCD-----YPP--- 227 (267)
T ss_pred hhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH-HHhcCC-----CCC---
Confidence 32211 123578899999999988899999999999999999999999864432 22221 111111 111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.........+.+++.+||+.+|++||++.||++.|++.
T Consensus 228 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 -LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11223345688899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=314.76 Aligned_cols=258 Identities=29% Similarity=0.482 Sum_probs=206.3
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CC---cEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DG---KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
..++|+..+.||+|+||.||++... ++ ..+++|.++.. .....+.+.+|++++.+++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 3456778899999999999999964 33 37999998754 3445667899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+++++|.+++.. ..+.+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999999853 2356899999999999999999999988 999999999999999999999999999766
Q ss_pred cccCCccce-eeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 502 AESEGEANT-VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 502 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
......... .....+..|+|||++....++.++||||||+++|||++ |+.|+...........+. .... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~-------~ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFR-------L 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCC-------C
Confidence 433222111 11123457999999998889999999999999999998 999986554433332222 1110 0
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
....+....+.+++.+||+.+|++||++.+|++.|++.
T Consensus 230 ---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ---PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112334578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=326.10 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=215.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe-eEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-KLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 424 (660)
++|...+++|+|+||.++..+.+ +++.+++|.+.- ..+.......+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46777899999999999999854 678999999864 344455578899999999999999999999999888 89999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
+|++||+|.+.+...+ ...++++++..++.||+.|+.|||+.. |+|||||+.||+++.+..+||+|||+++.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996533 456999999999999999999999877 999999999999999999999999999988766
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.... ...+||+.||.||++.+..|..|+|||||||++|||.+-+++|...+....+.++.+.- +. ..
T Consensus 160 ~~~a--~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-----~~------Pl 226 (426)
T KOG0589|consen 160 DSLA--STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-----YS------PL 226 (426)
T ss_pred hhhh--heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----CC------CC
Confidence 5333 24589999999999999999999999999999999999999999988887776665432 11 12
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
+......+..++..|++++|+.||++.+++.+
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33344557888899999999999999999854
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=294.23 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=207.4
Q ss_pred hcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
+-++|+..+.||+|-||.||.|.. +++-.||+|++.+. ..+...++.+|+++-..|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 346788899999999999999995 46778999998642 22335578999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
++||.++|.|...|.+ +....+++.....++.|+|.||.|+|... ++||||||+|+|++.++..||+|||-+..-.
T Consensus 100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999964 34456899999999999999999999988 9999999999999999999999999986433
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.......+||..|.+||...+...+.++|+|++|++.||++.|.+||......+...++.+- + +.+
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-~---~~~------ 241 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-D---LKF------ 241 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-c---ccC------
Confidence 22233569999999999999999999999999999999999999999876643333333221 1 111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+........++|.+|+..+|.+|.+..|++.
T Consensus 242 --p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 --PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1222334678899999999999999999875
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=334.48 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=203.9
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
.+..++|+..++||+|+||.||++... +++.||+|+++.. .....+.+.+|+.+++.++||||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345678888999999999999999954 6889999998642 223345678899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999999843 34788889999999999999999998 99999999999999999999999999976
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcC----CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccc
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEG----LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.........
T Consensus 192 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~-- 268 (370)
T cd05596 192 MDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF-- 268 (370)
T ss_pred ccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCC--
Confidence 5432211 11234789999999998653 4789999999999999999999999877665544444332211111
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHhHHH
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFD--RPTMSSVAP 615 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~ 615 (660)
.. .......+.+++.+||+.+|.+ ||++.|++.
T Consensus 269 ---~~---~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 269 ---PD---DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred ---CC---cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00 0012234678888999999988 999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.05 Aligned_cols=261 Identities=27% Similarity=0.394 Sum_probs=207.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec--------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 415 (660)
+...+|...+.||+|+||.||++... ++..+|+|.+... .......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44566778899999999999999731 2457999998753 334566799999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 482 (660)
.....+++|||+++|+|.+++..... ...+++.++..++.||++||.|||+.+ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999964321 235788999999999999999999998 99999999999
Q ss_pred EeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q 006125 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAY 561 (660)
Q Consensus 483 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~ 561 (660)
|+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999986644332222222345678999999998889999999999999999998 7777766555444
Q ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 562 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
...+. .+.... ........+.+++.+||+.+|.+||++.||++.|+++
T Consensus 249 ~~~~~-~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 249 FKLLK-EGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHH-cCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 33332 221110 1112234577889999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=308.32 Aligned_cols=247 Identities=29% Similarity=0.402 Sum_probs=199.7
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCChh
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 433 (660)
++||+|+||.||++...+++.+|+|+++... ......+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998889999999987543 333456889999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeee
Q 006125 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513 (660)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 513 (660)
+++.. ....+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.+||+|||++.......... ....
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 99853 2345889999999999999999999988 9999999999999999999999999987543322111 1112
Q ss_pred eccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 514 ~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
.++..|+|||++.+..++.++||||||+++|||++ |..||............. ..... .........+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~ 223 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRM----------SCPQKCPDDV 223 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCC----------CCCCCCCHHH
Confidence 34567999999998899999999999999999998 888987655443322222 11110 1111223468
Q ss_pred HHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 593 IHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 593 ~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
.+++.+|++.+|++||++.|+++.|.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHhc
Confidence 88999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=332.33 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=204.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|...+.||+|+||.||++... +++.||+|+++.. .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36788899999999999999964 6899999998742 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++++|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999953 356899999999999999999999988 999999999999999999999999999865543
Q ss_pred CC---------------------------ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 006125 505 EG---------------------------EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557 (660)
Q Consensus 505 ~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~ 557 (660)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 20 011123468999999999999999999999999999999999999998766
Q ss_pred HHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCC-HHhHHHH
Q 006125 558 LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT-MSSVAPM 616 (660)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 616 (660)
.......+........ +. ... .....+.+++.+|++ ||.+||+ +.|+++.
T Consensus 235 ~~~~~~~i~~~~~~~~-----~p--~~~-~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQETYNKIINWKESLR-----FP--PDP-PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHHhccCCccc-----CC--CCC-CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4444333332111000 00 000 023447788889997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=312.17 Aligned_cols=255 Identities=31% Similarity=0.460 Sum_probs=205.7
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
..++|...++||+|+||.||++..++++.+|+|.+.... ....++.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 456788889999999999999998889999999987533 34567899999999999999999999874 4568999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++... ....+++.++..++.|++.+|+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999998542 3346899999999999999999999988 99999999999999999999999999976643222
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. .....++..|+|||++....++.++||||||++++||++ |+.||............ ....... . .
T Consensus 158 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~-----~-----~ 225 (260)
T cd05067 158 TA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRMP-----R-----P 225 (260)
T ss_pred cc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-HcCCCCC-----C-----C
Confidence 11 112245678999999998889999999999999999999 99998765543333222 1111100 1 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
......+.+++.+|++.+|++||+++++++.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1123458889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=318.61 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=194.5
Q ss_pred CCCCCcccccCCcccEEeeee-c-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhc---CCCCcceEeEEEEe-----C
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-S-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL---QHKNLVKLLGFCVD-----G 417 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~ 417 (660)
+|+..+.||+|+||.||++.. . +++.||+|+++.. .......+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 678889999999999999985 3 4688999988642 222334566777777665 69999999999863 3
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
...++||||++ ++|.+++... ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 45789999996 6898888542 2345899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC------cc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG------NV 571 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~------~~ 571 (660)
++...... ......|++.|+|||++.+..++.++|||||||++|||++|++||......+....+.... ..
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 97654321 1223468999999999998899999999999999999999999998665444333332210 00
Q ss_pred cc---cccccCC-CC-----CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 572 LE---LVDPLLT-DT-----SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 572 ~~---~~d~~~~-~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. .....+. .+ .........+.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0000000 00 000112245678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=316.73 Aligned_cols=262 Identities=26% Similarity=0.373 Sum_probs=202.8
Q ss_pred cCCCCCCcccccCCcccEEeeeec-----------------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcce
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-----------------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 409 (660)
.++|+..++||+|+||.||++... ++..+|+|+++.. ......++.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457888999999999999997532 2446899999753 3344568999999999999999999
Q ss_pred EeEEEEeCCeeEEEEEecCCCChhhhhcCCCC--------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 006125 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK--------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (660)
Q Consensus 410 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~N 481 (660)
+++++...+..+++|||+++++|.+++..... ...+++.++..++.||+.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999854221 134788899999999999999999998 9999999999
Q ss_pred eEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh--CCCCCCCCcHH
Q 006125 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT--GRRNAGSNQLL 559 (660)
Q Consensus 482 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt--G~~p~~~~~~~ 559 (660)
||+++++.++|+|||++..+.............++..|++||....+.++.++||||||+++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999976543322211122234678999999988899999999999999999998 66777644433
Q ss_pred HHHHH---HHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 560 AYAWH---LWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 560 ~~~~~---~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
+.... ....... .. .... .......+.+++.+||+.||.+||++.||++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~-~~---~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGEFFRDQGR-QV---YLPK---PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHhhccc-cc---cCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 32211 1111100 00 0111 11123567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.87 Aligned_cols=241 Identities=25% Similarity=0.288 Sum_probs=195.8
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||++... +++.||+|+++.. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 5789999998752 233455677888888887 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T 152 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence 99998884 3346899999999999999999999998 99999999999999999999999999865322221 1
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..... .. +....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-------~~-----~~~~~ 220 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-------RY-----PRWLS 220 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-------CC-----CCcCC
Confidence 2234789999999999999999999999999999999999999986664443333322211 11 11122
Q ss_pred HHHHHHHhhcccCCCCCCCCH-----HhHHH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTM-----SSVAP 615 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~-----~evl~ 615 (660)
..+.+++.+||+.||.+||++ .++++
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 347788999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=325.57 Aligned_cols=241 Identities=24% Similarity=0.286 Sum_probs=194.6
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 424 (660)
+|...+.||+|+||.||++... +++.||+|+++.. .......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677899999999999999854 5789999998753 223344567788888777 6899999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|..++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999998884 3345899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..... .+
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------~~ 220 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------AY 220 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------CC
Confidence 11 12234789999999999999999999999999999999999999987665444433332211 11
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~ 610 (660)
+......+.+++.+||+.||.+|++.
T Consensus 221 p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11123357788999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.47 Aligned_cols=261 Identities=28% Similarity=0.395 Sum_probs=206.2
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec--------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 415 (660)
+..++|...+.||+|+||.||++... ++..+|+|.++.. ......++.+|+.++..+ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33467888999999999999999742 2356999999753 234456788999999999 7999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 482 (660)
..+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 99999999999999999999964321 235899999999999999999999988 99999999999
Q ss_pred EeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q 006125 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAY 561 (660)
Q Consensus 483 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~ 561 (660)
|+++++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.|+......+.
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 999999999999999876543222111111234568999999998889999999999999999998 7888866554333
Q ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 562 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
... ....... ..+......+.+++.+||+.+|.+||++.||++.|+.+
T Consensus 252 ~~~-~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 FKL-LKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHH-HHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 322 2222111 11112234577889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=309.59 Aligned_cols=250 Identities=28% Similarity=0.387 Sum_probs=205.6
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..+.||+|++|.||+++.. +++.|++|.+.. ........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4667789999999999999964 689999999863 2345567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++... ....+++..++.++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999643 2346899999999999999999999988 99999999999999999999999999886654322
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
.. ....|++.|+|||++.+..++.++||||||+++|||++|+.||.............. +... ....
T Consensus 157 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~----------~~~~ 223 (256)
T cd08529 157 FA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFP----------PVSQ 223 (256)
T ss_pred hh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCC----------CCcc
Confidence 21 224678899999999999999999999999999999999999976654333322221 1110 1111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
.....+.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 234558889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.04 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=197.9
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|...++||+|+||.||++.. .+++.||||++... .....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3678889999999999999985 47899999998642 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999984 3356889999999999999999999998 999999999999999999999999998643211
Q ss_pred CCc------------c---------------------------------ceeeeeccCCcCCHhhhhcCCCCcchhHHHH
Q 006125 505 EGE------------A---------------------------------NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSF 539 (660)
Q Consensus 505 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwsl 539 (660)
... . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0001368999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCC---CCHHhHHHH
Q 006125 540 GVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDR---PTMSSVAPM 616 (660)
Q Consensus 540 Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~ 616 (660)
||++|||++|+.||...........+........+ .... .....+.+++.+|++ +|.+| |++.|++..
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----p~~~---~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYF-----PDDI---HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCC-----CCCC---CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999999766544433333321111111 1100 112346678888997 66665 599888753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=322.15 Aligned_cols=240 Identities=25% Similarity=0.324 Sum_probs=192.3
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||++... +++.||+|+++.. .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5789999998753 123345566777777764 999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++........ .
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 99999984 3345889999999999999999999998 99999999999999999999999999875322221 2
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... +.... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-------~~~~~-~----~~ 220 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-------PCYPR-W----LT 220 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------CCCCc-c----CC
Confidence 233578999999999999899999999999999999999999997665443332222111 11111 1 12
Q ss_pred HHHHHHHhhcccCCCCCCCCHH-hHH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMS-SVA 614 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~-evl 614 (660)
..+.+++.+||+.||++||++. ++.
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHHH
Confidence 3467888999999999999997 664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=332.05 Aligned_cols=263 Identities=28% Similarity=0.395 Sum_probs=206.5
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEe
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVD 416 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 416 (660)
.+..++|...++||+|+||.||++.+. .++.||+|+++.. .....+.+.+|+.++.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344556777899999999999999853 3468999999753 2333457889999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhcCCCC-------------------------------------------------------
Q 006125 417 GDEKLLVYEFMPNGSLDAILFDPRK------------------------------------------------------- 441 (660)
Q Consensus 417 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 441 (660)
.+..++|+||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999854211
Q ss_pred ----------------------------------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 006125 442 ----------------------------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (660)
Q Consensus 442 ----------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~N 481 (660)
...+++..+..++.||++||.|||+.+ ++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 123678888999999999999999987 9999999999
Q ss_pred eEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 006125 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLA 560 (660)
Q Consensus 482 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~ 560 (660)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986543222111122356788999999998889999999999999999998 888886544433
Q ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 561 YAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 561 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
........+.... . +......+.+|+.+||+.+|.+||++.||++.|+..
T Consensus 350 ~~~~~~~~~~~~~-------~---p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 QFYNAIKRGYRMA-------K---PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHHcCCCCC-------C---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3333332221110 0 111234577888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.03 Aligned_cols=241 Identities=24% Similarity=0.282 Sum_probs=194.2
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 424 (660)
+|+..+.||+|+||.||++.. .+|+.||+|+++.. .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 366778999999999999985 46889999998742 2233456778888888885 577888999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|..++. ..+.+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999884 3456899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... ..
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-------~~----- 220 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-------SY----- 220 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------CC-----
Confidence 11 12234689999999999988899999999999999999999999987665444433332211 01
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~ 610 (660)
+......+.+++.+||+.+|.+|++.
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11122346788899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.12 Aligned_cols=250 Identities=36% Similarity=0.499 Sum_probs=204.7
Q ss_pred cccccCCcccEEeeeecC----CcEEEEEEccCCChh-cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLSD----GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||++.... +..+++|.++..... ..+.+.+|+..+..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 789999999764333 367899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCC------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 430 GSLDAILFDPRK------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 430 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965321 366999999999999999999999988 99999999999999999999999999987665
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
...........++..|+|||.+....++.++||||||++++||++ |..|+.............. +...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~---------- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRL---------- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCC----------
Confidence 432222233457889999999988899999999999999999999 5888876654433332222 1110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
..+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122345888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=311.72 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=208.1
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccC---CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++... +|+.+++|.++. ......+.+.+|++++++++|+|++++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999965 789999998863 22334667899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 425 EFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
||+++++|.+++.... ....+++.+++.++.++++||.|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999885432 2345899999999999999999999998 99999999999999999999999999876543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHHhcCcccccccccCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--LLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..+... ....+.. +...
T Consensus 159 ~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~-----~~~~- 229 (267)
T cd08224 159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIEKCDY-----PPLP- 229 (267)
T ss_pred CCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh-hhhcCCC-----CCCC-
Confidence 32221 22467889999999998889999999999999999999999986443 111111 1111110 0111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.......+.+++.+||+.+|++||++.+|+++|++.
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 112334578899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=325.98 Aligned_cols=244 Identities=25% Similarity=0.299 Sum_probs=192.6
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHH-HHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEV-LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||++... +++.+|+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 67889999986421 22233444444 456788999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 99999984 3445788889999999999999999998 99999999999999999999999999875432222 1
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+..... . ..+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------~-~~~~~----~ 220 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-------Q-LKPNI----T 220 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-------C-CCCCC----C
Confidence 2235789999999999999999999999999999999999999987665544433332211 0 01122 2
Q ss_pred HHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
..+.+++.+||+.||.+||++.+.+..+.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 34678888999999999999876544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=329.85 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=202.9
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|...+.||+|+||.||++.. .+|+.||+|+++.. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3678889999999999999985 47899999999753 2234556889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999532 246899999999999999999999998 999999999999999999999999999866433
Q ss_pred CCccceeeeeccCCcCCHhhhh------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 505 EGEANTVRIVGTYGYMAPEYAM------EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...........+..........+
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-- 232 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE-- 232 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCC--
Confidence 222 122346899999999986 45678999999999999999999999987665554444433222111100
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+. ....+.+++..|++ +|.+||++.+++.
T Consensus 233 --~~~----~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 233 --DPK----VSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --CCC----CCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 001 22346778888998 9999999999983
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=319.35 Aligned_cols=260 Identities=29% Similarity=0.427 Sum_probs=207.3
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 417 (660)
+..++|...+.||+|+||.||++... .+..+|+|+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44567888999999999999999731 34579999987542 34456789999999999 799999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
+..+++|||+++|+|.+++.... ...+++.++..++.||+.||+|||+.+ |+|+||||+|||+++++.+||+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999985422 234899999999999999999999988 99999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
+................++..|+|||.+.+..++.++||||||+++|||++ |+.|+...............+...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---- 263 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM---- 263 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC----
Confidence 976543322111112245678999999999999999999999999999998 899987655433333333222110
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
. . .......+.+++.+||+.+|++||++.||++.|++
T Consensus 264 -~-~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 -A-Q----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred -C-C----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0 0 11123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=314.36 Aligned_cols=257 Identities=30% Similarity=0.427 Sum_probs=202.6
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCc----EEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGK----EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
..+|+..++||+|+||.||+|.+ .+++ .||+|+++.. .......+.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 45678889999999999999984 3554 4899998753 344456788999999999999999999999754 578
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+++||+++|+|.+++.. ..+.+++..++.++.||++||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999853 2345899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~------- 231 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLP------- 231 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCC-------
Confidence 43322211111234678999999998899999999999999999998 88888754433222 2222211100
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
........+.+++.+||+.||++||++.|+++.|+...
T Consensus 232 ---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 232 ---QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01112345778999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.46 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=197.1
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++.. .+++.||+|++... .......+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688899999999999999995 46899999998642 2234566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999994 3456889999999999999999999998 999999999999999999999999997533100
Q ss_pred CC-----------------------------------------ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHH
Q 006125 505 EG-----------------------------------------EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543 (660)
Q Consensus 505 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll 543 (660)
.. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001124699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCC---CHHhHHH
Q 006125 544 IEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP---TMSSVAP 615 (660)
Q Consensus 544 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~ 615 (660)
|||++|+.||...........+......... +. ....+ ..+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~--~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTLHI--PS--QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCccccC--CC--CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999999876654443333221111110 00 00122 23455666665 5999999 8888873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.43 Aligned_cols=259 Identities=24% Similarity=0.314 Sum_probs=201.0
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCCh--hcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV 423 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 423 (660)
++|+..++|++|.||.||+|+. ++++.||+|+++...+ .-.-.-.+||.+|.+.+|||||.+..+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4577789999999999999994 5789999999985332 2233467999999999999999999988754 568999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
||||++ +|.+++..-. .++...++.-++.|+++|+.|||+.. |+|||||++|+|+++.|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 8999995432 46899999999999999999999999 99999999999999999999999999998865
Q ss_pred cCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-CcccccccccC--
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-GNVLELVDPLL-- 579 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~d~~~-- 579 (660)
... ..+..+-|..|.|||++.+ ..|+...|+||+|||+.||+++++.|.+....+...+++.. +...+.+-+.+
T Consensus 230 p~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 230 PLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred Ccc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 532 2344678999999999986 46999999999999999999999998766555544443331 11111111100
Q ss_pred ---------CC-------CCCCHH-HHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 580 ---------TD-------TSFSDD-EFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 580 ---------~~-------~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. ..+... ....=.+|+...+..||.+|.|++|.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 001000 1133456777899999999999999874
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.86 Aligned_cols=246 Identities=26% Similarity=0.330 Sum_probs=193.6
Q ss_pred cccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 357 lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
||+|+||+||++.. .+++.+|+|++.... ....+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 478899999986422 22335677899999999999999999999999999999999999999
Q ss_pred hhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcccee
Q 006125 433 DAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511 (660)
Q Consensus 433 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 511 (660)
..++... .....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 9887432 23456899999999999999999999998 999999999999999999999999999765433222 22
Q ss_pred eeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHH
Q 006125 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSR 591 (660)
Q Consensus 512 ~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 591 (660)
...|++.|+|||++.+..++.++||||||+++|||++|+.||............... ...... .........
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~---~~~~~~~~~ 227 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR-----ILNDSV---TYPDKFSPA 227 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh-----hcccCC---CCcccCCHH
Confidence 346899999999999999999999999999999999999998754321111111100 001111 111223345
Q ss_pred HHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 592 YIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 592 l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
+.+++.+||+.||++|| +++|+++
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 77888999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=324.92 Aligned_cols=241 Identities=23% Similarity=0.303 Sum_probs=192.5
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
++||+|+||.||++... +++.||+|+++.. .......+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999954 6889999999752 223445678899999988 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence 99998884 3356999999999999999999999998 99999999999999999999999999874322111 1
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHHHhcCcccccccccCCC
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--------LLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~--------~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence 223578999999999999999999999999999999999999996211 12222222222111 1111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCC------HHhHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPT------MSSVA 614 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl 614 (660)
.. ...+.+++.+||+.||.+||+ +.|++
T Consensus 227 -~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 227 -SL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -CC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 22 234778889999999999997 56776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=333.59 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=195.6
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+|+..++||+|+||.||++.. .+++.+|+|++.... ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 577889999999999999995 468899999987532 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999843 346889999999999999999999998 9999999999999999999999999975332100
Q ss_pred C---------------------------------------------ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHH
Q 006125 506 G---------------------------------------------EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFG 540 (660)
Q Consensus 506 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslG 540 (660)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001124689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHhHHH
Q 006125 541 VLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT---MSSVAP 615 (660)
Q Consensus 541 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~ 615 (660)
|++|||++|+.||......+....+......... + .....++ ...+++.+++ .+|.+|++ +.|+++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p--~~~~~s~----~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI--P--PQAKLSP----EASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCC--C--CcccCCH----HHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999999876554443333321111111 0 0112222 2445555555 49999997 777763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.03 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=203.1
Q ss_pred CCCCCCcccccCCcccEEeeeecC-Cc--EEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSD-GK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 423 (660)
++|+..+.||+|+||.||++...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998643 33 4788888742 334456789999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCE
Q 006125 424 YEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~ 490 (660)
+||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1135889999999999999999999988 9999999999999999999
Q ss_pred EEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC
Q 006125 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEG 569 (660)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 569 (660)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |+.||......+....... +
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~ 234 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-G 234 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-C
Confidence 9999999864321111 111123457999999988889999999999999999998 9999976654443322221 1
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 570 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
. .... .......+.+|+.+||+.+|.+||+++++++.|++.....
T Consensus 235 ~-----~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 235 Y-----RMEK-----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred C-----CCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 0011 1112245778999999999999999999999988765433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=324.66 Aligned_cols=237 Identities=23% Similarity=0.300 Sum_probs=189.0
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||++... +++.+|+|+++.. .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 6889999998752 233445677888888777 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence 99998884 3346899999999999999999999998 99999999999999999999999999875322211 1
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHHHHhcCcccccccccCCC
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN--------QLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~--------~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||... ....+.+........ .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC--
Confidence 22357899999999999999999999999999999999999998521 112222222222111 11
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 610 (660)
+......+.+++.+||+.||.+||+.
T Consensus 225 ---p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 ---PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11223346788899999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=322.41 Aligned_cols=240 Identities=26% Similarity=0.319 Sum_probs=192.1
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
++||+|+||.||++... +|+.||+|+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999964 68899999987521 23345567777777754 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence 99999884 3356899999999999999999999998 99999999999999999999999999874322111 1
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.... +.+.. . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-------~~~~~-~----~~ 220 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-------PHYPR-W----IT 220 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------CCCCC-C----CC
Confidence 233578999999999999999999999999999999999999997665443332222111 11111 1 12
Q ss_pred HHHHHHHhhcccCCCCCCCCHH-hHH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMS-SVA 614 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~-evl 614 (660)
..+.+++.+||+.||++||++. +++
T Consensus 221 ~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 221 KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3467888899999999999985 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=310.32 Aligned_cols=257 Identities=30% Similarity=0.434 Sum_probs=208.3
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+..++|...++||+|+||.||++..++++.+++|.+.... ...+++.+|+.++++++|+||+++++++......+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4456788899999999999999998888899999987532 345678999999999999999999999999889999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++... ....+++..+..++.+|+.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999542 2345899999999999999999999998 9999999999999999999999999987664322
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
... .....++..|+|||.+.+..++.++||||||++++||++ |+.|+................. .. .
T Consensus 158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~------~~-----~ 225 (261)
T cd05034 158 YTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR------MP-----R 225 (261)
T ss_pred hhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------CC-----C
Confidence 111 111234568999999998889999999999999999999 8988865543333222221110 00 0
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.......+.+++.+|++.+|++||++.|+++.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11123457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.14 Aligned_cols=253 Identities=30% Similarity=0.421 Sum_probs=202.1
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
++|...+.||+|++|.||++...++..+++|++.... ...+.+.+|+.+++.++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577778999999999999998777789999887532 33467889999999999999999999875 456889999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999999542 2345889999999999999999999988 9999999999999999999999999997654332211
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.......... . .....
T Consensus 160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------~-----~~~~~ 227 (260)
T cd05069 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR------M-----PCPQG 227 (260)
T ss_pred -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------C-----CCCcc
Confidence 111245678999999998899999999999999999999 8888876543332222211111 0 11122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
....+.+++.+||+.||.+||++++|+++|++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 34557889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.51 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=203.6
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 417 (660)
..+....++|+..+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 344556678999999999999999999964 6889999998642 223345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999999842 24788999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcC----CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEG----LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
+......... ......||+.|+|||++... .++.++|||||||++|||++|+.||...........+........
T Consensus 189 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 267 (370)
T cd05621 189 CMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN 267 (370)
T ss_pred ceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC
Confidence 9865432211 11234799999999999753 378999999999999999999999987765554444433221111
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHhHHHH
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFD--RPTMSSVAPM 616 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 616 (660)
+ .. .......+.+++..|++.++.+ ||++.|+++.
T Consensus 268 ~-----p~---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 F-----PE---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-----CC---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1 00 0111234567777888765544 8899999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=311.59 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=206.4
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++.. .+++.++||.+... ......++.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999994 58899999987642 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 425 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
||+++++|.+++... .....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 23456899999999999999999999998 99999999999999999999999999876543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHHHhcCcccccccccCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAY-AWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~d~~~~~~ 582 (660)
..... ....++..|+|||.+.+..++.++||||||+++|||++|..||........ ..+... ....+...
T Consensus 159 ~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~-- 229 (267)
T cd08229 159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-----QCDYPPLP-- 229 (267)
T ss_pred CCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh-----cCCCCCCC--
Confidence 32211 224688899999999988899999999999999999999999864332111 111111 11111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.......+.+++.+||+.||++||||.+|++++++.
T Consensus 230 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 230 --SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 112334578889999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.37 Aligned_cols=249 Identities=24% Similarity=0.428 Sum_probs=204.3
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.+|+..+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677889999999999999985 478899999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999842 34789999999999999999999998 999999999999999999999999998765432211
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||................. +.+. ....
T Consensus 173 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~------~~~~---~~~~ 241 (296)
T cd06654 173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT------PELQ---NPEK 241 (296)
T ss_pred --cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC------CCCC---Cccc
Confidence 1223678899999999988899999999999999999999999976554333222221111 1111 1122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....+.+++.+||+.+|++||++.||++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 3345778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.12 Aligned_cols=249 Identities=32% Similarity=0.439 Sum_probs=202.0
Q ss_pred cccccCCcccEEeeeecC--Cc--EEEEEEccCCCh-hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLSD--GK--EVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~--g~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
++||+|++|.||++.+.+ ++ .+|+|.++.... ...+.+.+|+.++++++||||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 33 689999987554 556789999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
++|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++..+........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999965332 46899999999999999999999998 99999999999999999999999999987654322111
Q ss_pred -eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 510 -TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 510 -~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+........... . ..+..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------~---~~~~~ 225 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-------L---ERPEA 225 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-------C---CCCcc
Confidence 112356788999999998899999999999999999999 99998765544443333321111 0 01112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
....+.+++.+|++.+|++||++.||++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 2345888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=305.28 Aligned_cols=273 Identities=24% Similarity=0.337 Sum_probs=209.9
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe-----CCe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-----GDE 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 419 (660)
...|...+.||+|+||.|..+.. .+|+.||||++.. ......+.-.+|+.+|+.++|+||+.+++++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 44566678999999999999994 5789999999973 455667788999999999999999999999865 346
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.|+|+|+| ..+|..+++ .+..|+......++.||++||.|+|+.+ ++||||||+|+|++.+..+||+|||+++
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 79999999 669999993 4444999999999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh-----------
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN----------- 567 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~----------- 567 (660)
...........+..+.|..|.|||++.. ..|+.+.||||.|||+.||++|++.|.+.+.......+..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8765433333455688999999999864 5799999999999999999999999876554433322221
Q ss_pred ---cCcccccccccCCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCCCCCC
Q 006125 568 ---EGNVLELVDPLLTDTSFS-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGTLPQP 627 (660)
Q Consensus 568 ---~~~~~~~~d~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~p 627 (660)
.+.....+......+..+ +..-...++|+.+||..||.+|+|++|.++ .|+.-.....+|
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 111111111111110000 011234678888999999999999999983 455555555555
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=319.86 Aligned_cols=262 Identities=28% Similarity=0.413 Sum_probs=206.1
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec--------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 415 (660)
...++|...++||+|+||.||++... ....+|+|.++.. .......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34457778899999999999999742 2457899998753 334456788999999999 6999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCC-------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 482 (660)
..+..+++|||+++|+|.+++.... ....+++.++..++.||+.||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 9999999999999999999995422 1245899999999999999999999988 99999999999
Q ss_pred EeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q 006125 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAY 561 (660)
Q Consensus 483 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~ 561 (660)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999986543222211111234567999999998899999999999999999999 8888865544333
Q ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 562 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.. ........+ .+......+.+++.+||+.+|++||++.|+++.|+...
T Consensus 246 ~~-~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 FK-LLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HH-HHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 22 222221111 11122345778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.10 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=203.4
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC-----hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
++|...+.||+|++|.||++.. .+++.+++|.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688889999999999999985 468999999886422 2234578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
|+||+++++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999884 3345889999999999999999999998 9999999999999999999999999987654
Q ss_pred ccCCccc-eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 503 ESEGEAN-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 503 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||...+.............. .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~---- 226 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-----P---- 226 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-----C----
Confidence 3221111 02235778999999999888999999999999999999999998765444333332222111 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
..+......+.+++.+||+.+|.+||++.|+++.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1112223457788999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.88 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=196.3
Q ss_pred ccccCCcccEEeeeec---CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCC
Q 006125 356 ILGQGGFGPVYKGVLS---DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 431 (660)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 35579999987543 334567899999999999999999999885 457899999999999
Q ss_pred hhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc-e
Q 006125 432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-T 510 (660)
Q Consensus 432 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~ 510 (660)
|.+++.. ....+++..++.++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++........... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999853 2346899999999999999999999988 99999999999999999999999999976543322111 1
Q ss_pred eeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 511 ~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+... ....+... ..+....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~----------~~~~~~~ 224 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-FIEQGKRL----------DCPAECP 224 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-HHHCCCCC----------CCCCCCC
Confidence 11123568999999988889999999999999999996 999987655443322 22222111 1111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 4577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=311.97 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=201.4
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|+..+.||+|+||.||+|+. .+++.+|+|++..........+.+|+.++++++||||+++++++..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35688889999999999999995 57889999999765445556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++. ....+++..+..++.|+++||.|||+.+ |+||||+|+||++++++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999884 3346899999999999999999999988 99999999999999999999999999986543221
Q ss_pred ccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
. .....++..|+|||.+. ...++.++||||||+++|||++|+.|+.............. .. ...+...
T Consensus 162 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~-~~---~~~~~~~--- 232 (267)
T cd06646 162 K--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK-SN---FQPPKLK--- 232 (267)
T ss_pred c--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec-CC---CCCCCCc---
Confidence 1 12246788999999884 34578899999999999999999998854332111111100 00 0001110
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
........+.+++.+||+.+|++||++++|++.|
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0112234678899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=315.39 Aligned_cols=265 Identities=29% Similarity=0.394 Sum_probs=201.8
Q ss_pred cCCCCCCcccccCCcccEEeeeec-----CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--Cee
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 420 (660)
..+|+..+.||+|+||.||++..+ +++.|++|+++.......+.+.+|++++++++||||+++++++... ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 346777899999999999999742 5789999999876666677899999999999999999999987643 457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 8999999999999998532 345899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCccce-eeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc--------
Q 006125 501 FAESEGEANT-VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV-------- 571 (660)
Q Consensus 501 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~-------- 571 (660)
.......... ....++..|+|||++.+..++.++||||||+++|||++|..++..... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hhhhhcccccccccchHHH
Confidence 6433221111 111234459999999988999999999999999999998876542211 11111111100
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.+.+...... .........+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0001100000 11112234588899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=312.12 Aligned_cols=255 Identities=28% Similarity=0.447 Sum_probs=202.7
Q ss_pred CCCCCcccccCCcccEEeeeec-CC---cEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DG---KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
+|+..+.||+|+||.||+|... ++ ..|++|.++.. ......++..|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4667789999999999999964 33 36999998753 4445678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++++|.+++... .+.+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998542 346899999999999999999999988 999999999999999999999999998765433
Q ss_pred CCccceeeee---ccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 505 EGEANTVRIV---GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 505 ~~~~~~~~~~---gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
.......... .+..|+|||++....++.++||||||+++|||++ |..||......+....+..... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~--------~- 230 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR--------L- 230 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--------C-
Confidence 2221111111 2357999999998899999999999999999987 9999876554332222211100 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
....+.+..+.+++.+||+.+|.+||++.+|+..|+..
T Consensus 231 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 --PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01112234577899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.50 Aligned_cols=261 Identities=24% Similarity=0.288 Sum_probs=211.4
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeeecCC-cEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEE-EEe----
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDG-KEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGF-CVD---- 416 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~---- 416 (660)
+.+...++++.+.|.+|||+.||++....+ .++|+|++-..++...+.+.+||++|++|+ |+|||.+++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 345566677789999999999999997655 999999987778888999999999999996 9999999993 321
Q ss_pred --CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 417 --GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 417 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
.-+.+|.||||++|.|-+++..... ..|++.++++|+.|+++|+++||... ++|||||||-+||||..+++.||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 1357899999999999999954333 34999999999999999999999985 7899999999999999999999999
Q ss_pred ccccccccccCCccc-------eeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 006125 495 FGMARIFAESEGEAN-------TVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWH 564 (660)
Q Consensus 495 fGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~ 564 (660)
||.+.-......... .....-|+.|.|||.+. +...++|+|||+|||+||-|.....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 999874332221111 01124689999999985 56789999999999999999999999975421
Q ss_pred HHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 565 LWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 565 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+++....-+. .+....++.+||..||++||.+||++.+|+..+-..
T Consensus 264 -------laIlng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 -------LAILNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred -------eeEEeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 233443333322 246677899999999999999999999999877543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=324.51 Aligned_cols=248 Identities=25% Similarity=0.290 Sum_probs=195.4
Q ss_pred CCCCCcccccCCcccEEeeee----cCCcEEEEEEccCC----ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCee
Q 006125 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 420 (660)
+|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467789999999999999874 35789999998642 223345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999984 3445899999999999999999999998 99999999999999999999999999976
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCccccccc
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ---LLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~---~~~~~~~~~~~~~~~~~~d 576 (660)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ........... .+
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~~ 227 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------CD 227 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------CC
Confidence 5433222 12235799999999999865 47899999999999999999999986322 11111111111 11
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
+.+ +......+.+++.+||+.||++|| +++++++
T Consensus 228 ~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 PPF-----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111 111233467888999999999999 6667763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.47 Aligned_cols=250 Identities=32% Similarity=0.463 Sum_probs=205.5
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.++|+..+.||+|+||.||++.. .|+.|++|.++.... ..+++.+|+.+++.++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45677889999999999999987 478999999976443 5678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999998542 2235899999999999999999999998 99999999999999999999999999986632221
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
....+..|+|||.+....++.++||||||+++|||++ |+.|+............ ...... ..+.
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~----------~~~~ 222 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-EKGYRM----------EAPE 222 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hcCCCC----------CCcc
Confidence 1234567999999998899999999999999999998 99888765543322222 111110 1111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.....+.+++.+||+.+|++||++.|++++|++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 223457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.76 Aligned_cols=253 Identities=27% Similarity=0.358 Sum_probs=190.8
Q ss_pred ccccCCcccEEeeeecC---CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCC
Q 006125 356 ILGQGGFGPVYKGVLSD---GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~~~---g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 431 (660)
.||+|+||.||+|...+ ...+++|.+... .......+.+|+..++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 346888887643 23345678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 432 LDAILFDPRK--RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 432 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999965332 233567888999999999999999998 99999999999999999999999999865432221111
Q ss_pred eeeeeccCCcCCHhhhhc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 510 TVRIVGTYGYMAPEYAME-------GLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
.....++..|+|||++.. ..++.++||||||+++|||++ |..|+......+.......... ..+..+.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~-- 235 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD-IKLPKPQL-- 235 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-ccCCCCcc--
Confidence 122345678999999753 356889999999999999999 6777765543333333332221 11212221
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
.......+.+++..|+ .||++||+++||+++|.
T Consensus 236 ---~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 236 ---DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ---cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1222334556777788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=316.11 Aligned_cols=251 Identities=27% Similarity=0.320 Sum_probs=199.2
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+|+..++||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 366778999999999999995 468999999986422 2223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888532 3345899999999999999999999998 9999999999999999999999999987653322
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||............... +.... ....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~------~~~~~--~~~~ 225 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR------VKEDQ--EEYS 225 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH------hhhcc--cccC
Confidence 1 12246899999999999888999999999999999999999999754432211111110 00000 0112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
......+.+++.+||+.||.+|| +++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 22334577899999999999999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=304.11 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=202.6
Q ss_pred CCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCC-cceEeEEEEeCC------e
Q 006125 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGD------E 419 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~ 419 (660)
.|...++||+|+||+||+|+ ..+|+.||+|+++-.. +.......+|+.+++.++|+| |+++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45556789999999999999 5578999999997532 334556789999999999999 999999999877 7
Q ss_pred eEEEEEecCCCChhhhhcCCCCC-CccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
++||+||++. +|..++...... ..++...+..++.||++||+|||+++ |+||||||.||||+++|.+||+|||++
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 8899999954 899999543321 34666889999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc------Ccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE------GNV 571 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~------~~~ 571 (660)
+.+.-.... ....++|..|.|||++.+. .|+...||||+|||+.||+++++.|......+....+.+- ..+
T Consensus 168 ra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 966533222 2334789999999999876 7999999999999999999999988766655554444331 111
Q ss_pred ccc-----ccccCCCC----CCCHHHH---HHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 572 LEL-----VDPLLTDT----SFSDDEF---SRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 572 ~~~-----~d~~~~~~----~~~~~~~---~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
... .+...... ....... ....+++.+||+.+|.+|.++..++..
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111 01111100 1111111 357789999999999999999999875
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.05 Aligned_cols=250 Identities=20% Similarity=0.300 Sum_probs=205.0
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+|+..+.||+|+||.||++... +++.+++|.++. ......+.+.+|+.+++.++|+||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4667789999999999999954 688999998864 23445667889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++... ....+++.....++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999988532 3345889999999999999999999998 999999999999999999999999998765432221
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||...+............ ... + +..
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-----~-----~~~ 223 (255)
T cd08219 157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS-YKP-----L-----PSH 223 (255)
T ss_pred --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC-CCC-----C-----Ccc
Confidence 123468889999999998889999999999999999999999998766555444433221 110 1 111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
....+.+++.+||+.||++||++.||+..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22347788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=324.89 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=202.8
Q ss_pred hcCCCCCCcccccCCcccEEeeee------cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC-
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG- 417 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 417 (660)
..++|+..+.||+|+||.||++.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456788899999999999999973 357789999997532 33456788999999999 789999999988654
Q ss_pred CeeEEEEEecCCCChhhhhcCCCC--------------------------------------------------------
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRK-------------------------------------------------------- 441 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 441 (660)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 457899999999999999853210
Q ss_pred --------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeee
Q 006125 442 --------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513 (660)
Q Consensus 442 --------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 513 (660)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 124788899999999999999999988 999999999999999999999999999765432221111122
Q ss_pred eccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 514 ~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
.++..|+|||.+.+..++.++||||||+++|||++ |..|+..............++..... +... ...+
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~---~~~~ 311 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-------PDYT---TPEM 311 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC-------CCCC---CHHH
Confidence 45678999999998899999999999999999997 88888654332222222222221110 1111 2347
Q ss_pred HHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 593 IHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 593 ~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.+++.+||+.||.+||++.||++.|+...
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 78889999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.31 Aligned_cols=257 Identities=30% Similarity=0.456 Sum_probs=203.8
Q ss_pred cCCCCCCcccccCCcccEEeeeec-C---CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-D---GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~---g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
..+|+..+.||+|+||.||+|... + +..+|+|.++.. .....+.+.+|+.++.+++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356777899999999999999853 2 337999998753 23445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999953 2345899999999999999999999988 9999999999999999999999999998664
Q ss_pred ccCCccce-eeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 503 ESEGEANT-VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 503 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
........ ....++..|++||++.+..++.++||||||+++||+++ |+.||......+....+ .+... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~-------~- 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYR-------L- 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH-hCCCc-------C-
Confidence 43221111 11123567999999998899999999999999999887 99998755433322222 11110 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.........+.+++.+|++.+|.+||+|.++++.|+..
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 --PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01112234577899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=322.84 Aligned_cols=237 Identities=24% Similarity=0.314 Sum_probs=189.6
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHH-HHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
++||+|+||.||+++.. +++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 68899999986421 223344555554 67888999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|...+. ....+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 99988884 3345888999999999999999999988 99999999999999999999999999875322221 1
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.... + ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------~---~~~~~~~ 220 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP---------L---QLPGGKT 220 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC---------C---CCCCCCC
Confidence 223578999999999998899999999999999999999999998776554433333211 1 1111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMS 611 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~ 611 (660)
..+.+++.+||+.||.+||+..
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCC
Confidence 3577889999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.19 Aligned_cols=262 Identities=28% Similarity=0.385 Sum_probs=207.3
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec--------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 415 (660)
+...+|...+.||+|+||.||++... .+..+|+|.++.. .....+++.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 33456788899999999999999742 1236899988753 334466889999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCC-------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 482 (660)
+.+..++++||+++|+|.+++.... ....+++.++..++.||++||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence 9999999999999999999985422 2235889999999999999999999988 99999999999
Q ss_pred EeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q 006125 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAY 561 (660)
Q Consensus 483 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~ 561 (660)
|+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999976543322222222234567999999999999999999999999999998 7888876655444
Q ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 562 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
...+... ...+ ........+.+++.+||+.+|.+||++.|+++.|+.+.
T Consensus 246 ~~~~~~~-~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 246 FKLLKEG-HRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHcC-CCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 3333221 1111 11122345778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=309.42 Aligned_cols=254 Identities=28% Similarity=0.352 Sum_probs=192.1
Q ss_pred cccccCCcccEEeeeecC---CcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCC
Q 006125 355 NILGQGGFGPVYKGVLSD---GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 430 (660)
+.||+|+||.||+|...+ +..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998543 4579999987533 334457889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 431 SLDAILFDPR--KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 431 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999985422 2234677888899999999999999988 9999999999999999999999999987543322211
Q ss_pred ceeeeeccCCcCCHhhhhcC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 509 NTVRIVGTYGYMAPEYAMEG-------LYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
......++..|+|||++... .++.++||||||+++|||++ |+.||......+........ ......++.+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-QQLKLPKPRLK 236 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc-ccCCCCCCccC
Confidence 11223567889999998642 35789999999999999996 99998654433322211211 11122222221
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
. .....+.+++..|+ .+|++||++.||+..|+
T Consensus 237 ~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 L-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred C-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 12234666778898 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.40 Aligned_cols=252 Identities=29% Similarity=0.456 Sum_probs=204.0
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
.+|+..+.||+|+||.||++...+++.+++|+++... ....++.+|++++++++|||++++++++......++++||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4566778999999999999998778899999987532 334578899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+++|.+++.. ..+.++++.+..++.+++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999853 2345889999999999999999999988 9999999999999999999999999987654322111
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
. ....++.+|+|||++.++.++.++||||||+++|||++ |+.|+................. ...+ ..
T Consensus 158 ~-~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~-----~~--- 225 (256)
T cd05112 158 S-TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR---LYKP-----RL--- 225 (256)
T ss_pred c-CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC---CCCC-----CC---
Confidence 1 11234678999999998899999999999999999998 8899876655444333321111 1111 11
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
....+.+|+.+||+.+|++||++.|++++|.
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1245888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=327.80 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=205.2
Q ss_pred hHHHHhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe
Q 006125 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416 (660)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 416 (660)
..++.+..++|+..+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455666789999999999999999999964 6889999998642 22334567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecc
Q 006125 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 496 (660)
+...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999842 34788899999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCccceeeeeccCCcCCHhhhhcC----CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccc
Q 006125 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEG----LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVL 572 (660)
Q Consensus 497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 572 (660)
++......... ......||+.|+|||++... .++.++|||||||++|||++|+.||...+.......+.......
T Consensus 188 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (371)
T cd05622 188 TCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 266 (371)
T ss_pred ceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 99865432211 12234799999999999753 37899999999999999999999998777655554444322211
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHhHHHH
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFD--RPTMSSVAPM 616 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 616 (660)
.+.+ . ......+.+++..|++.++.+ ||++.|+++.
T Consensus 267 ~~~~----~----~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 TFPD----D----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCCC----c----CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111 0 112234667888899844443 7889988863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.62 Aligned_cols=248 Identities=30% Similarity=0.393 Sum_probs=201.0
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe-CCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 427 (660)
.+|...+.||+|+||.||++.. .|+.+++|.++.. ...+.+.+|+.++++++|+|++++++++.. ++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4677789999999999999987 4788999998643 235678899999999999999999998654 45689999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++... ....+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 157 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence 999999998542 2335889999999999999999999988 99999999999999999999999999875433221
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
...++..|+|||++.+..++.++||||||+++|||++ |+.|+...........+... ... ....
T Consensus 158 ----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~----------~~~~ 222 (256)
T cd05082 158 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKM----------DAPD 222 (256)
T ss_pred ----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCC----------CCCC
Confidence 1234567999999998889999999999999999998 88888766554443332221 110 1112
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.....+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 223457788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=304.80 Aligned_cols=249 Identities=31% Similarity=0.394 Sum_probs=199.7
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCCh-hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCChh
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 433 (660)
++||+|+||.||++...+++.|++|+++.... .....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999976799999999875433 35567999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeee
Q 006125 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513 (660)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 513 (660)
+++... ...+++..+..++.+++.+|.|||+.+ ++||||+|+|||++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998542 335889999999999999999999998 999999999999999999999999999765422221111112
Q ss_pred eccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 514 ~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
..+..|+|||.+.++.++.++||||||+++|||++ |..|+................. . ..+......+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~ 224 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR--------M---PAPQLCPEEI 224 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC--------C---CCCccCCHHH
Confidence 33567999999988899999999999999999999 7788765543332222211110 0 1112223468
Q ss_pred HHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 593 IHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 593 ~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.+++.+|++.+|.+||++.||++.|+.
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.05 Aligned_cols=257 Identities=26% Similarity=0.352 Sum_probs=201.9
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
++.+++++.....||+|+||.||+|.. .++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345677777788999999999999995 4678899999887666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEEeeccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIF 501 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~ 501 (660)
|+||+++++|.+++.........++..+..++.||++||+|||+.+ |+||||||+||+++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999964322212278888999999999999999988 999999999999986 679999999998765
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCC--CCcchhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHHhcCccccccccc
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGSNQLLA-YAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwslGvll~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~d~~ 578 (660)
...... .....++..|+|||++.... ++.++||||||+++|||++|+.|+....... ..+...... ..+
T Consensus 160 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~- 231 (268)
T cd06624 160 AGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-----IHP- 231 (268)
T ss_pred ccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc-----cCC-
Confidence 432221 12235788999999986543 7899999999999999999999986432111 111110000 011
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+......+.+++.+||+.+|.+||++.|+++
T Consensus 232 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 232 ----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 112223345778899999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.45 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=200.4
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
++|...+.||+|+||.||++.. .+++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4666778999999999999985 468899999987655555567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++. ..+.+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 9999999984 3456899999999999999999999998 99999999999999999999999999876543221
Q ss_pred cceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 508 ANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
......|+..|+|||++. ...++.++|||||||++|||++|+.|+.................. .+....
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~~~--- 233 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ----PPKLKD--- 233 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC----CCcccc---
Confidence 122346899999999985 456889999999999999999999998644332222222111110 011100
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.......+.+++.+||+.+|++||++++|++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0011234778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=315.65 Aligned_cols=262 Identities=31% Similarity=0.384 Sum_probs=199.1
Q ss_pred CCCCcccccCCcccEEeeee-----cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEE
Q 006125 351 FSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 422 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 422 (660)
|...+.||+|+||+||++.. .+++.||+|.++... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 36778999999999988652 357889999987532 33456788999999999999999999998764 35789
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
+|||+++++|.+++.. ..+++.+++.++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 34899999999999999999999998 9999999999999999999999999998664
Q ss_pred ccCCccc-eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHH---HHhcCccccccc
Q 006125 503 ESEGEAN-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL--LAYAWH---LWNEGNVLELVD 576 (660)
Q Consensus 503 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~--~~~~~~---~~~~~~~~~~~d 576 (660)
....... .....++..|+|||.+.+..++.++||||||+++|||++|..|+..... ...... ........+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 3322111 1112345679999999888899999999999999999999988753221 100000 000001111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..... ..+......+.+++..||+.+|++||++++|+++|+..
T Consensus 239 ~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111 11222345688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.00 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=201.3
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCc--EEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 422 (660)
.++|+..+.||+|+||.||++... ++. .+++|.++.. .......+.+|+.++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457788899999999999999964 454 4578877643 334456788999999999 89999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC
Q 006125 423 VYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~ 489 (660)
||||+++++|.+++.... ....+++.+++.++.||++||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999985422 1235889999999999999999999988 999999999999999999
Q ss_pred EEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhc
Q 006125 490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNE 568 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 568 (660)
+||+|||++....... ......++..|+|||++....++.++||||||+++|||+| |..||......+...... .
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~ 238 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 238 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-c
Confidence 9999999986432111 1111134567999999988889999999999999999998 999987555443332221 1
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.... .........+.+++.+||+.+|++||++.+++..|++.
T Consensus 239 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 239 GYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1000 00111223477899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.43 Aligned_cols=255 Identities=21% Similarity=0.262 Sum_probs=198.2
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36788899999999999999954 6899999998642 2334556889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999943 2345899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCccceeeeeccCCcCCHhhhhc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....+........+.. .
T Consensus 156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~- 232 (331)
T cd05597 156 GTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP-D- 232 (331)
T ss_pred CCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC-c-
Confidence 2211 122468999999999863 4578899999999999999999999987766555444443222111110 0
Q ss_pred CCCCCCHHHHHHHHHHHhhcccC--CCCCCCCHHhHHHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQE--DAFDRPTMSSVAPM 616 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~ 616 (660)
.... ...+.+++.+|+.. ++..||++.+++.-
T Consensus 233 -~~~~----~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 -VTDV----SEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -cCCC----CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0011 22355666666644 44458899888744
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=306.92 Aligned_cols=255 Identities=28% Similarity=0.420 Sum_probs=205.3
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
..++|...+.||+|+||.||++...++..+++|.++.. ......+.+|+.+++.++|+||+++.+++.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 45678888999999999999999877888999988753 3345678899999999999999999999887 678999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999999542 3445889999999999999999999987 99999999999999999999999999976543322
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. .....++..|+|||++....++.++||||||++++||++ |+.||........... ...+.... ..
T Consensus 158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~----------~~ 225 (260)
T cd05073 158 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMP----------RP 225 (260)
T ss_pred cc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhCCCCCC----------Cc
Confidence 11 111245677999999998889999999999999999999 8888875543332222 22211110 11
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
......+.+++.+|++.+|++||++.+++++|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.33 Aligned_cols=248 Identities=34% Similarity=0.470 Sum_probs=197.1
Q ss_pred cccccCCcccEEeeeec--C--CcEEEEEEccCCCh-hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS--D--GKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~--~--g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
++||+|+||.||+|+.. + +..+|+|.+..... ...+++.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999843 2 26899999875433 34567899999999999999999999876 4567999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|.+++.. ...+++..+..++.|++.+|+|||+.+ ++|+||||+|||+++++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999953 236899999999999999999999988 99999999999999999999999999986644332211
Q ss_pred -eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 510 -TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 510 -~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ........ .+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~----------~~~~ 222 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-LESGERLP----------RPEE 222 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCcCC----------CCCC
Confidence 111223567999999998899999999999999999998 9999876554333222 22221111 1111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
....+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 234577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=307.31 Aligned_cols=240 Identities=24% Similarity=0.381 Sum_probs=190.7
Q ss_pred cccccCCcccEEeeeecC-------------CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 355 NILGQGGFGPVYKGVLSD-------------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
+.||+|+||.||+|++.. ...+++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258999887655556667889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC-------EEEee
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-------SKISD 494 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~-------~kl~D 494 (660)
++|||+++|+|..++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999998853 2345899999999999999999999988 999999999999987664 89999
Q ss_pred ccccccccccCCccceeeeeccCCcCCHhhhh-cCCCCcchhHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHHhcCccc
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEII-TGRRNAGSNQLLAYAWHLWNEGNVL 572 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwslGvll~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 572 (660)
||++....... ...++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+.. .......
T Consensus 156 ~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~-- 226 (262)
T cd05077 156 PGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQC-- 226 (262)
T ss_pred CCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCc--
Confidence 99986543221 235778899999887 467899999999999999998 577777654433221 1111110
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
... ......+.+|+.+||+.||.+||++.+|++.|+
T Consensus 227 -----~~~-----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 -----MLV-----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -----cCC-----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 001 111245778999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=308.00 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=196.1
Q ss_pred cccccCCcccEEeeeec-CCc--EEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS-DGK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||++... ++. .+++|.++.. .......+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999964 343 4688888753 344556788999999999 899999999999999999999999999
Q ss_pred CChhhhhcCCC-------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecc
Q 006125 430 GSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 430 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 496 (660)
|+|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985422 1234789999999999999999999987 9999999999999999999999999
Q ss_pred ccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccc
Q 006125 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELV 575 (660)
Q Consensus 497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 575 (660)
++....... .......+..|+|||++....++.++||||||+++|||++ |+.||......+....... +...+
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~-- 231 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLE-- 231 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCC--
Confidence 985322111 1111123567999999988889999999999999999997 9999876554433322221 11100
Q ss_pred cccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 576 DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 576 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
........+.+++.+|++.||.+||++.|++..|++.
T Consensus 232 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 232 --------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0111223577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.83 Aligned_cols=261 Identities=28% Similarity=0.418 Sum_probs=215.6
Q ss_pred hHHHHhhcCCCCCCcccccCCcccEEeeeecC-CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
.++.+....+....++||-|.||.||.|.|+. .-.||||.++. +....++|..|..+|+.++|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 35566667777788999999999999999864 56899999987 55678899999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.|||.|||.+|+|-++|... ++..++.--.+.|+.||+.||+||..+. +|||||.++|+||.++..+||+||||++
T Consensus 338 FYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999653 3345777778899999999999999988 9999999999999999999999999999
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
+...+..... ..-.-.+.|.|||-+.-..++.|+|||+|||+||||.| |-.|+.+.++.+. +.++.++-.
T Consensus 414 lMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEkgyR------- 484 (1157)
T KOG4278|consen 414 LMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEKGYR------- 484 (1157)
T ss_pred hhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhcccc-------
Confidence 8765543322 11123678999999999999999999999999999999 6677777776554 344433321
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
+.+ +..++..+.+|++.||+.+|.+||++.|+-+.++
T Consensus 485 M~~---PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 485 MDG---PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred ccC---CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 112 2334556888999999999999999999876554
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=323.04 Aligned_cols=258 Identities=23% Similarity=0.322 Sum_probs=196.7
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC-----eeE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL 421 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 421 (660)
+|+..++||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467789999999999999995 47899999998642 2334567889999999999999999999998776 789
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+|+||+. ++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777773 3456899999999999999999999998 999999999999999999999999999765
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh---cCccc-----
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN---EGNVL----- 572 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~---~~~~~----- 572 (660)
....... .....++..|+|||++.+. .++.++|||||||++|||++|+.||...........+.. .....
T Consensus 154 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 4322211 1223578899999998764 579999999999999999999999975543322211111 00000
Q ss_pred -----ccc-cccCCCC------CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 573 -----ELV-DPLLTDT------SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 573 -----~~~-d~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+ ......+ .........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000 0000000 001112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=314.24 Aligned_cols=256 Identities=32% Similarity=0.481 Sum_probs=200.4
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCc----EEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
.++|+..+.||+|+||.||++... +|+ .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456777899999999999999853 444 47889887532 23344688999999999999999999998754 467
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+++||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999999853 2335889999999999999999999988 999999999999999999999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
.............++..|++||++.+..++.++||||||+++|||++ |+.|+........ ......+... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~-------~ 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERL-------P 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCC-------C
Confidence 53332222222345678999999998899999999999999999998 8888865443322 2222222111 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
. .......+.+++..||..+|++||++.|+++.|+..
T Consensus 232 ~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 Q---PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 111223577889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.64 Aligned_cols=251 Identities=33% Similarity=0.517 Sum_probs=199.1
Q ss_pred cccccCCcccEEeeeecC-------CcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 355 NILGQGGFGPVYKGVLSD-------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+.||+|+||.||+|+..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2578999886532 34466788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC----CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-----CEEEeeccc
Q 006125 427 MPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-----NSKISDFGM 497 (660)
Q Consensus 427 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-----~~kl~DfGl 497 (660)
+++++|.+++.... ....+++.+++.++.||+.||.|||+.+ ++|+||||+||+++++. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996422 2234789999999999999999999987 99999999999999877 899999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
+................++..|+|||++.++.++.++||||||+++|||++ |+.||......+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR------ 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc------
Confidence 976543322222222345678999999999999999999999999999998 9999875544333222211111
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
. .........+.+++.+||+.+|.+||++.+|++.|++
T Consensus 232 --~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 --L---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --c---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 1112233457789999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.31 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=192.8
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-------
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------- 417 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 417 (660)
....+|...++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3456799999999999999999995 468899999886422 2345799999999999999999887532
Q ss_pred -CeeEEEEEecCCCChhhhhcC-CCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-CEEEee
Q 006125 418 -DEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISD 494 (660)
Q Consensus 418 -~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~D 494 (660)
...++||||+++ +|.+++.. ......+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 235689999985 66665532 234456899999999999999999999998 99999999999999664 799999
Q ss_pred ccccccccccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---Cc
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---GN 570 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~~ 570 (660)
||+++.+...... ....||+.|+|||++.+. .++.++|||||||++|||++|.+||......+....+... ..
T Consensus 215 FGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 215 FGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred cccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9999866433221 224679999999998754 6899999999999999999999999765543333222210 00
Q ss_pred c----------cccccccCCCC----CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 571 V----------LELVDPLLTDT----SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 571 ~----------~~~~d~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
. .+..-+..... .++......+.+++.+||+.||.+|||+.|++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 00000000000 01111234678899999999999999999998
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.14 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=200.3
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
|+..+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 445678999999999999964 5778899998766666677889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
++|..++.. ....+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-- 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-- 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccccc--
Confidence 999998743 2346899999999999999999999998 999999999999999999999999998765432211
Q ss_pred eeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 510 TVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.....++..|+|||++. +..++.++|||||||++|||++|++|+.................. .+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~--- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP------TLAQ--- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC------CCCC---
Confidence 12246889999999984 345788999999999999999999998765544433333222110 1111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+......+.+++.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112245778999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=306.37 Aligned_cols=249 Identities=30% Similarity=0.494 Sum_probs=199.9
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChh---------cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQ---------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
+|...+.||+|++|.||+|.. .+++.+++|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 356678999999999999985 46889999988643221 23568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++++||+++++|.+++. ..+.+++..+..++.|++.+|+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999994 3356889999999999999999999988 9999999999999999999999999998
Q ss_pred cccccCCcc----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccc
Q 006125 500 IFAESEGEA----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELV 575 (660)
Q Consensus 500 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 575 (660)
......... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||............... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~ 228 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN------A 228 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc------C
Confidence 765321111 111235788999999999888999999999999999999999999765433332222110 1
Q ss_pred cccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 576 DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 576 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+ ..+......+.+++.+||+.||.+||++.||++
T Consensus 229 ~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 SP-----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CC-----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11 112223345778889999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=304.37 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=203.9
Q ss_pred cCCCCCCcccccCCcccEEeeeecC-CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|+..++||+|+||.||++...+ ++.+++|.++.... .+++.+|++++++++|+||+++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578888999999999999999754 78999999875432 67899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++.. ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999843 2346899999999999999999999998 99999999999999999999999999886654322
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
. .....++..|+|||++.+..++.++||||||+++|||++|+.|+............... ....+ ....
T Consensus 155 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~---~~~~ 223 (256)
T cd06612 155 K--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK------PPPTL---SDPE 223 (256)
T ss_pred c--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC------CCCCC---Cchh
Confidence 1 12235788999999999889999999999999999999999998754432222111110 00111 1112
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.....+.+++.+||+.||.+||++.||++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 22345788999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.23 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=199.9
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|+..++||+|+||.||++... ++..+++|.++.. ......++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36788899999999999999854 6888999988653 333456688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
+++++|.+++.. .+.+++..+..++.||++||.|||+. + ++|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999943 35689999999999999999999984 5 9999999999999999999999999987543321
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccc-----------
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLEL----------- 574 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 574 (660)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.|+...+.................
T Consensus 155 ~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 A----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred c----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1 2246889999999998888999999999999999999999998654432221111100000000
Q ss_pred ------------ccccCC--CCCCC-HHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 575 ------------VDPLLT--DTSFS-DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 575 ------------~d~~~~--~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
.+.... .+..+ ......+.+++.+||+.+|++||++.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00000 0122357899999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.35 Aligned_cols=248 Identities=27% Similarity=0.332 Sum_probs=192.0
Q ss_pred cccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 357 lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
||+|+||.||++.. .+|+.+|+|++.... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 468999999986421 12234456799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceee
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (660)
.+++... ....+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++........ ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 9888542 2334889999999999999999999988 99999999999999999999999999876543221 123
Q ss_pred eeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 513 ~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
..|+..|+|||++.+..++.++|||||||++|||++|+.||............... .....+. .....+ ...+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~----~~~~ 226 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR-TLEDEVK--FEHQNF----TEES 226 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH-hhccccc--cccccC----CHHH
Confidence 46889999999999888999999999999999999999998643211111111111 0000000 001112 2346
Q ss_pred HHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 593 IHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 593 ~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
.+++.+||+.||++||++.|+++.+.
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhhh
Confidence 78899999999999999987764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.50 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=199.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC------C
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG------D 418 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 418 (660)
+++.|+..+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999854 68899999986532 3456788999999998 799999999998753 4
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..+++|||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 578999999999999998542 2345899999999999999999999988 999999999999999999999999998
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
......... .....|+..|+|||++. +..++.++|||||||++|||++|+.|+................
T Consensus 159 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~---- 232 (272)
T cd06637 159 AQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---- 232 (272)
T ss_pred eeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC----
Confidence 765432221 22346889999999986 3457889999999999999999999987544333222222111
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
........ ....+.+++.+||+.||.+||++.|+++
T Consensus 233 --~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 --APRLKSKK----WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --CCCCCCCC----cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111111 2235778999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=305.30 Aligned_cols=250 Identities=29% Similarity=0.411 Sum_probs=193.5
Q ss_pred cccccCCcccEEeeeec----CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe-CCeeEEEEEecC
Q 006125 355 NILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYEFMP 428 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 428 (660)
+.||+|+||.||+|... ++..+|+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998643 33456678899999999999999999998764 556789999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+|+|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999532 234678888999999999999999987 9999999999999999999999999997554321111
Q ss_pred --ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 509 --NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR-RNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 509 --~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
......++..|+|||.+.+..++.++||||||+++|||++|+ +|+................. ... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~----~ 224 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-------LLQ----P 224 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-------CCC----C
Confidence 111224567899999998889999999999999999999964 55654444333322222111 000 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
......+.+++.+||+.+|++||++.||++.|++.
T Consensus 225 ~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11224577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.03 Aligned_cols=237 Identities=23% Similarity=0.290 Sum_probs=189.8
Q ss_pred cccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||++.. .+++.+|+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 46789999999753 223455688899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++........ .
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 99998884 3346999999999999999999999998 99999999999999999999999999875322111 1
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCC------cHHHHHHHHHhcCcccccccccCCCCC
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN------QLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~------~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||... ......+........ .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~---- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RI---- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CC----
Confidence 22357899999999999999999999999999999999999999521 122233333322111 01
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~ 610 (660)
+......+.+++.+||+.||.+||++
T Consensus 223 -p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 -PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11112346788889999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=304.75 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=200.9
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe-----eEEEE
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-----KLLVY 424 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~ 424 (660)
|...+++|.|+||.||+|++. +++.||||++-.... --.+|+++|+.++|||||+++-+|....+ ..|||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 455689999999999999954 578999999865333 22479999999999999999999875432 34899
Q ss_pred EecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-CCEEEeecccccccc
Q 006125 425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFA 502 (660)
Q Consensus 425 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~~~~ 502 (660)
|||+. +|..++... ..+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 788888531 22445788888889999999999999988 9999999999999977 999999999999887
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh---cCc---c----
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN---EGN---V---- 571 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~---~~~---~---- 571 (660)
..+... ....|.-|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+..+....+.+ -.. +
T Consensus 178 ~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 KGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred cCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 655442 34568889999999874 699999999999999999999999986654444333322 111 0
Q ss_pred ---cccccccCCCCC----CCHHHHHHHHHHHhhcccCCCCCCCCHHhHH-----HHhcCCCCCCC
Q 006125 572 ---LELVDPLLTDTS----FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA-----PMLKGETGTLP 625 (660)
Q Consensus 572 ---~~~~d~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl-----~~L~~~~~~~~ 625 (660)
.+.-.+.+.... +......+.++++.++|+.+|.+|.++.|++ +.|++....+|
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~ 320 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLP 320 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCc
Confidence 011112121111 2233445688899999999999999999987 55666555554
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.02 Aligned_cols=252 Identities=29% Similarity=0.428 Sum_probs=198.6
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHH--HHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
|+..+.||+|+||+||++... +++.+|+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 345689999999999999965 5678999999865433322 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++. ....+++..+..++.||++||.+||+.+ ++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999995 4566899999999999999999999998 99999999999999999999999999875411 11
Q ss_pred cceeeeeccCCcCCHhhhh-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 508 ANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
.......++..|+|||++. +..++.++||||||+++|+|++|+.|+......+.......... .. +...... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~---~~ 227 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK-RP-LPSSSQQ---SR 227 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH-TH-HHHHTTS---HT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc-cc-ccccccc---cc
Confidence 2222346789999999998 88899999999999999999999999986622222111111100 00 0000000 00
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.....+.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11266889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=303.44 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=207.0
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..+.||+|+||.||.+.. .+++.+++|.+... +.....++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477789999999999999884 56889999987642 345567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++.... ...+++.++..++.|++++|.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999995432 356899999999999999999999988 99999999999999999999999999976644332
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
......+++.|+|||++.+..++.++||||||+++|||++|+.|+......+....+.... ... ...
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~----------~~~ 223 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTP----------VVS 223 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCC----------Ccc
Confidence 1223468899999999988889999999999999999999999998766555544443221 111 011
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
.....+.+++.+||+.+|.+||++.|+++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2234577888899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.71 Aligned_cols=248 Identities=25% Similarity=0.452 Sum_probs=204.1
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.+|...+.||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4578889999999999999984 578999999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|..++.. ..+++.++..++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999998842 35899999999999999999999998 999999999999999999999999998765433221
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+............. +.+.. ...
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~------~~~~~---~~~ 240 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT------PELQN---PEK 240 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------cccCC---ccc
Confidence 1223678899999999988899999999999999999999999976654443332222111 01111 112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
....+.+++.+||+.||.+||++.+|+
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 233477889999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.73 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=204.6
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688889999999999999995 579999999997655555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++.. ..+++.++..++.|++.+|.|||+.+ ++||||||+|||++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999842 34789999999999999999999988 999999999999999999999999998765433221
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+...........+ .+.. ..+..
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~------~~~~---~~~~~ 240 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG------TPEL---QNPER 240 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC------CCCC---CCccc
Confidence 122367889999999999889999999999999999999999996544322111111110 0111 11122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
....+.+++.+||+.+|++||++.+|++ +++.
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 2344678889999999999999999986 4443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=305.18 Aligned_cols=251 Identities=31% Similarity=0.483 Sum_probs=200.5
Q ss_pred CCCCCcccccCCcccEEeeeecCCcEEEEEEccCCC------hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
+|...+.||+|+||.||+|...+++.+|+|.++... ......+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366788999999999999998789999999886421 22345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
+||+++++|.+++. ....+++..+..++.|++.+|+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999994 3345889999999999999999999988 99999999999999999999999999876532
Q ss_pred cCC----ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 504 SEG----EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 504 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
... ........++..|+|||++.+..++.++||||||++++||++|+.||...+.............. .+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~ 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL----MPRL 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----CCCC
Confidence 111 11112245788999999999888999999999999999999999999755433322222111111 1111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.......+.+++.+||+.+|.+||++.|+++
T Consensus 231 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 -----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122344778899999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.77 Aligned_cols=251 Identities=34% Similarity=0.478 Sum_probs=207.3
Q ss_pred CCCcccccCCcccEEeeee-cCCc----EEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 352 SDSNILGQGGFGPVYKGVL-SDGK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~-~~g~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
...++||+|+||+||+|.+ ++|+ +||+|++.. ...+...++.+|+.+|.+++|||+++|+|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3468999999999999994 5554 689999865 34556788999999999999999999999998876 889999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
||+.|+|.++++. .++.+-.+..+.|..|||+||.|||++. ++||||..+||||.+-..+||.|||+++.+....
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999975 3445888899999999999999999987 9999999999999999999999999999887766
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.........-.+.|||-|.+....|+.++|||||||.+||++| |..|+......+.. +.++.+. . +. -
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-dlle~ge------R-Ls---q 921 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-DLLEKGE------R-LS---Q 921 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-HHHhccc------c-CC---C
Confidence 5554444445778999999999999999999999999999999 88888776654433 3333322 1 11 1
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
++-....+..++.+||..|+..||+++++...+.+
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 23344557778889999999999999999876654
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.71 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=204.4
Q ss_pred hcCCCCCCcccccCCcccEEeeeecC----CcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
...+|...++||+|+||.||+|...+ ...+++|...... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34567778999999999999998543 2468999887644 4556689999999999999999999999875 4578
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999532 235899999999999999999999988 999999999999999999999999998765
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
........ ....++..|+|||.+....++.++||||||+++|||++ |..||......+....+...... .
T Consensus 158 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~------- 228 (270)
T cd05056 158 EDESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-P------- 228 (270)
T ss_pred ccccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-C-------
Confidence 44322111 11234568999999988889999999999999999996 99999766544433332221111 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
........+.+++.+|+..+|.+||++.|+++.|++...
T Consensus 229 ---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 ---MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111223457788999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=310.41 Aligned_cols=252 Identities=27% Similarity=0.377 Sum_probs=203.0
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|+..++||+|+||.||++... +++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 356788899999999999999964 5889999999876666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|..++.. ....+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999999988743 2345899999999999999999999988 99999999999999999999999999875433221
Q ss_pred ccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
. .....++..|+|||++. ...++.++||||||+++|||++|+.|+................. +...
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------~~~~- 236 (292)
T cd06644 166 R--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP------PTLS- 236 (292)
T ss_pred c--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC------ccCC-
Confidence 1 12346788999999884 34578899999999999999999999876554333322221111 1110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
........+.+++.+||+.||++||++.|+++
T Consensus 237 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 --QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11122335778999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=309.68 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=199.0
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..+.||+|++|.||+|... +++.||+|+++.. .......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999964 6899999998642 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
++ ++|.+++........+++..+..++.||++||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888855444467899999999999999999999988 99999999999999999999999999875533221
Q ss_pred ccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc---------------
Q 006125 507 EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN--------------- 570 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~--------------- 570 (660)
. .....+++.|+|||++.+. .++.++||||||++++||++|+.|+.................
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 V--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred c--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1 1123568899999988654 578999999999999999999999976554433332221100
Q ss_pred ccccccccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VLELVDPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~~~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....+...... .........++.+++.+||+.||.+|||+.||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0000012234678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=342.76 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=202.1
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|...++||+|+||.||+|... +|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999954 6899999998742 2233557899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC--------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecc
Q 006125 425 EFMPNGSLDAILFDPR--------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 496 (660)
||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234667788999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCc----------------cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 006125 497 MARIFAESEGE----------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA 560 (660)
Q Consensus 497 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~ 560 (660)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99866211100 00112468999999999999999999999999999999999999997543222
Q ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCC-CHHhHHHHhcCC
Q 006125 561 YAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP-TMSSVAPMLKGE 620 (660)
Q Consensus 561 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 620 (660)
...... . .++.-.. ...+....+.+++.+|++.||++|| +++++++.|+..
T Consensus 239 i~~~~~----i---~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISYRDV----I---LSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhhhh----c---cChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 211110 0 0000000 0112234577899999999999995 677777776654
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=308.51 Aligned_cols=239 Identities=25% Similarity=0.368 Sum_probs=187.7
Q ss_pred ccccCCcccEEeeeecC-------------------------CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceE
Q 006125 356 ILGQGGFGPVYKGVLSD-------------------------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 410 (660)
+||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998421 13589999876544455678899999999999999999
Q ss_pred eEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC--
Q 006125 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-- 488 (660)
Q Consensus 411 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-- 488 (660)
++++......++||||+++|+|..++.. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999853 2346889999999999999999999987 99999999999997643
Q ss_pred -----CEEEeeccccccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCcHHHH
Q 006125 489 -----NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEII-TGRRNAGSNQLLAY 561 (660)
Q Consensus 489 -----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~ell-tG~~p~~~~~~~~~ 561 (660)
.+||+|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 37999999876432211 1246788999998865 56899999999999999995 68888865432221
Q ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 562 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
. ....... .... . ....+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~-~~~~~~~-------~~~~-~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 E-RFYEKKH-------RLPE-P----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H-HHHHhcc-------CCCC-C----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 1111110 0111 1 1234788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=307.97 Aligned_cols=257 Identities=30% Similarity=0.440 Sum_probs=204.6
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCc----EEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
..+|...+.||+|+||.||+|..+ +|+ .+++|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356777899999999999999854 333 58999887543 3445678899999999999999999999987 7889
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+|+||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999998542 334899999999999999999999987 999999999999999999999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
.............++..|+|||.+....++.++||||||+++||+++ |+.||......+.......... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~ 231 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER--------LP 231 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC--------CC
Confidence 53322211111223567999999988899999999999999999999 9999976655443332221111 00
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
. +......+.+++.+||..+|.+||++.++++.|++..
T Consensus 232 ~---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 232 Q---PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred C---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 1112234778889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.49 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=208.3
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC---Cc--EEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD---GK--EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~---g~--~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
+..+.....+.||+|.||.||+|+..+ |+ .||||..+. +.....+.|..|..+|++++||||++++|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 334445556889999999999999532 33 589999886 5556688899999999999999999999999765 6
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.|||||.++.|.|.++|+. +...|+......++.||..+|+|||+.. +|||||..+|||+.+..-+||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 7999999999999999964 3445899999999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
...+....... ...-++.|||||.+.-..+|.++|||-|||.+||+++ |.+||....-.+.+..+.+++ .
T Consensus 540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe--------R 610 (974)
T KOG4257|consen 540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE--------R 610 (974)
T ss_pred hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC--------C
Confidence 88766544433 2344778999999999999999999999999999987 888986432221111111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
...++.++..+..|..+||..||.+||.+.|+...|.++
T Consensus 611 ---lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 611 ---LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred ---CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 134556677788999999999999999999998776543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=306.85 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=200.7
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCCh----------hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE----------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
+|...+.||+|+||.||+|.. .+|+.+|+|.++.... ...+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 456678999999999999985 4689999998753110 11346788999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+++++|.+++.. .+.+++..+..++.||+.+|.|||+.+ ++||||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999943 356899999999999999999999988 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCC--CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
................++..|+|||.+.... ++.++||||||+++|||++|+.|+....................+ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 234 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI-P 234 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC-C
Confidence 7654322222222346788999999987654 889999999999999999999999765544443333222111111 1
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
. .........+.+++.+||+.+|.+||++.+|++
T Consensus 235 ~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 235 P-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred c-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1 111122356788889999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.05 Aligned_cols=258 Identities=22% Similarity=0.244 Sum_probs=208.9
Q ss_pred CCCCCCcccccCCcccEEeeeecC-CcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
+.|+..+.||.|.-|+||++.+++ +..+|+|++.+.. .........|.+||+.++||.++.|+..++..+..+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456667899999999999999754 5899999997632 334456778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
|||+||+|..+++. +....+++..+..++..|+-||+|||-.| ||.|||||+||||.++|++.|+||.|+......
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999854 56667999999999999999999999998 999999999999999999999999988643210
Q ss_pred --------------------------------CCc----------------------cceeeeeccCCcCCHhhhhcCCC
Q 006125 505 --------------------------------EGE----------------------ANTVRIVGTYGYMAPEYAMEGLY 530 (660)
Q Consensus 505 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 530 (660)
... .....++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 00112579999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCC-
Q 006125 531 SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT- 609 (660)
Q Consensus 531 t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt- 609 (660)
+.++|+|+|||++|||+.|+.||.+.+-.+-...++... +.-++. +.....+.+||++.|.+||++|..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~---------l~Fp~~-~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP---------LKFPEE-PEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC---------CcCCCC-CcchhHHHHHHHHHhccChhhhhcc
Confidence 999999999999999999999998776555444444332 211111 134456889999999999999998
Q ss_pred ---HHhHH--HHhcCC
Q 006125 610 ---MSSVA--PMLKGE 620 (660)
Q Consensus 610 ---~~evl--~~L~~~ 620 (660)
+.||- ...++.
T Consensus 383 ~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 383 KRGAAEIKRHPFFEGV 398 (459)
T ss_pred ccchHHhhcCccccCC
Confidence 77775 344554
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.18 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=196.6
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++... +++.||+|+++.. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36778899999999999999854 6899999998642 2334567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCc---------------------------------cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCC
Q 006125 505 EGE---------------------------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551 (660)
Q Consensus 505 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~ 551 (660)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00112468999999999999999999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHhHH
Q 006125 552 NAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT---MSSVA 614 (660)
Q Consensus 552 p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl 614 (660)
||...........+........ +.+.. ..+ ..+.+++.+++ .||.+|++ +.|++
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~-~p~~~---~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLV-FPPEV---PIS----EKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCcee-cCCCC---CCC----HHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 9987665544433332111111 01000 112 23556666766 49999996 45554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=304.04 Aligned_cols=258 Identities=29% Similarity=0.421 Sum_probs=207.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|+..+.||+|+||.||++.. .++..+++|++... .......+.+|++.++.++|+||+++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3678889999999999999995 46889999998643 233567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++........+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999965433356899999999999999999999988 99999999999999999999999999977654433
Q ss_pred cc--ceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 507 EA--NTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.. ......|+..|++||++... .++.++||||||+++|||++|+.||................. +.+....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~ 231 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP------PSLETGA 231 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC------CCcCCcc
Confidence 21 12234688999999999877 789999999999999999999999976554443333332211 1111100
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
........+.+++.+||+.||++||++.||++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01122355788999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=302.77 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=206.1
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|+..+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.++++++||||+++++.+.++...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35788889999999999999996 46788999999865555677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999998532 245899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccceeeeeccCCcCCHhhhhcC---CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEG---LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
. .....++..|+|||.+... .++.++||||||+++|||++|+.|+...............+. ....+ .
T Consensus 157 ~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~---~ 227 (262)
T cd06613 157 K--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF----PPPKL---K 227 (262)
T ss_pred c--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----CCccc---c
Confidence 1 1224678889999999776 789999999999999999999999876553333222221110 00011 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
........+.+++.+||+.+|.+||++.+|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12233456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.90 Aligned_cols=245 Identities=31% Similarity=0.454 Sum_probs=203.9
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCChh
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 433 (660)
-+||+|.||+||-|... +...+|||.+........+.+++||.+.+.|+|.|||+++|.+.+++..-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36999999999999954 55679999998877788888999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCcc--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEEeeccccccccccCCccce
Q 006125 434 AILFDPRKRGIL--CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESEGEANT 510 (660)
Q Consensus 434 ~~l~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~ 510 (660)
++|. .+-+++ ++.+.-...+||++||.|||+.. |||||||-+||||+- .|.+||+|||-++.+..-. +.+
T Consensus 661 sLLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~T 733 (1226)
T KOG4279|consen 661 SLLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCT 733 (1226)
T ss_pred HHHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--ccc
Confidence 9995 345566 77888889999999999999998 999999999999974 5899999999998775432 334
Q ss_pred eeeeccCCcCCHhhhhcCC--CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHH
Q 006125 511 VRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588 (660)
Q Consensus 511 ~~~~gt~~y~aPE~~~~~~--~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 588 (660)
.++.||..|||||++..+. |..++|||||||.+.||.||++||..-...+.+.- +-+. ....+..+.+.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--kVGm-------yKvHP~iPeel 804 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--KVGM-------YKVHPPIPEEL 804 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--hhcc-------eecCCCCcHHH
Confidence 4568999999999998654 88999999999999999999999965433322211 1111 11123445666
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 589 FSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 589 ~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+...+|++|+.+||.+||++.++++
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 677889999999999999999999984
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=305.48 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=200.4
Q ss_pred CCCCcccccCCcccEEeeeec----CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC------
Q 006125 351 FSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 418 (660)
|...++||+|+||.||++.+. +++.+|+|+++.. .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 3678999998653 3345667889999999999999999999987543
Q ss_pred eeEEEEEecCCCChhhhhcCCC---CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeec
Q 006125 419 EKLLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 495 (660)
..++++||+++|+|..++.... ....+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988874321 2234789999999999999999999988 999999999999999999999999
Q ss_pred cccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccc
Q 006125 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLEL 574 (660)
Q Consensus 496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 574 (660)
|+++...............++..|++||.+....++.++||||||+++|||++ |++|+......+....+...... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~- 235 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL-K- 235 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC-C-
Confidence 99986644332222222345678999999998889999999999999999999 88888765543332222221110 0
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 236 ---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 ---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112234688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=324.05 Aligned_cols=258 Identities=19% Similarity=0.214 Sum_probs=197.6
Q ss_pred hcCCCCCCcccccCCcccEEeeeec---CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
...+|...+.||+|+||.||++... .++.|++|.+... ....+|+.++++++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3457999999999999999999743 3578999988642 2356899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
||++. ++|.+++ .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99985 6788887 33456999999999999999999999998 99999999999999999999999999986655
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHHh---cCccc--c--
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL---LAYAWHLWN---EGNVL--E-- 573 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~---~~~~~~~~~---~~~~~--~-- 573 (660)
...........||+.|+|||++....++.++|||||||++|||++|+.||..... ......+.. ..... .
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 4433333345799999999999999999999999999999999999999854321 111111111 00000 0
Q ss_pred ---------cccccCCCCCCCH------HHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 574 ---------LVDPLLTDTSFSD------DEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 574 ---------~~d~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
........+...+ .....+.+++.+||+.||++||++.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 112346788999999999999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=323.40 Aligned_cols=247 Identities=33% Similarity=0.447 Sum_probs=205.4
Q ss_pred CCcccccCCcccEEeeeec--CCc--EEEEEEccCCChh-cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 353 DSNILGQGGFGPVYKGVLS--DGK--EVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 353 ~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
..++||+|.||.|++|.|. +|+ .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3588999999999999975 454 6899999876555 67899999999999999999999999988 6788999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
+.|+|.+.|+. .....|-......++.|||.||.||.+++ +|||||..+|+||-....+||+||||.+.+...+..
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999976 56677889999999999999999999998 999999999999999999999999999988766554
Q ss_pred cceee-eeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 508 ANTVR-IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 508 ~~~~~-~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
..... ..-.+.|+|||.+....|+.++|||+|||.||||+| |..||-+-.-.+....+- ++. .+.+ +
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~e-------rLpR---P 337 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGE-------RLPR---P 337 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccc-------cCCC---C
Confidence 43221 223668999999999999999999999999999999 556776554443332222 211 2333 3
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+.+++.+++..||..+|.+||++..|.+
T Consensus 338 k~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 338 KYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 345667899999999999999999999973
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.64 Aligned_cols=240 Identities=24% Similarity=0.396 Sum_probs=189.8
Q ss_pred cccccCCcccEEeeeecC--------CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 355 NILGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888888765555567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC--------EEEeecccc
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--------SKISDFGMA 498 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~--------~kl~DfGla 498 (660)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999542 235899999999999999999999988 999999999999987765 699999988
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHHHhcCccccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGR-RNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+......... ......
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~------- 221 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDR------- 221 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHcc-------
Confidence 654321 12357888999999976 45799999999999999999995 555433322211 111110
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
..+ +......+.+++.+||+.||++||+++++++.|+
T Consensus 222 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQL-----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccC-----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011 1112245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.19 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=203.0
Q ss_pred CCCCCcccccCCcccEEeeeecC--CcEEEEEEccCC----------ChhcHHHHHHHHHHHhh-cCCCCcceEeEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLSD--GKEVAVKRLSSC----------SEQGTAEFTNEVLLILK-LQHKNLVKLLGFCVD 416 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 416 (660)
+|+..+.||+|+||.||++.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777899999999999999654 688999987531 22234557778888875 699999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeec
Q 006125 417 GDEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (660)
Q Consensus 417 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 495 (660)
.+..+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887432 23345899999999999999999999632 3999999999999999999999999
Q ss_pred cccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccc
Q 006125 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELV 575 (660)
Q Consensus 496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 575 (660)
|++....... ......|+..|++||.+.+..++.++||||||+++|||++|+.|+................. .
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--- 231 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY-E--- 231 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC-C---
Confidence 9998654432 22234688899999999988899999999999999999999999976665544433322111 1
Q ss_pred cccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 576 DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 576 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
+. .. ......+.+++.+||+.||++||++.||..++++
T Consensus 232 -~~-~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 232 -PL-PE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -cC-Cc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 10 00 1122457788899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=312.80 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=199.3
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|...+.||+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46788899999999999999854 67889999987432 23344678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++ +|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 78777743 2345889999999999999999999998 99999999999999999999999999875433222
Q ss_pred ccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---Cc---c------cc
Q 006125 507 EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---GN---V------LE 573 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~~---~------~~ 573 (660)
.. ....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+... .. + .+
T Consensus 160 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 TY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 11 12357889999999865 46899999999999999999999999765543332222110 00 0 00
Q ss_pred ccc---ccCCCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 574 LVD---PLLTDT---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 574 ~~d---~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
..+ +..... .........+.+++.+||+.||.+|||+.|+++ +++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 000 000000 000112234678999999999999999999985 4444
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=305.73 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=202.6
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+|+..+.||.|++|.||++... +++.+++|++.... ......+.+|+.+++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777889999999999999954 68899999987532 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 99999999843 26899999999999999999999988 999999999999999999999999999876543211
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+...+.......+... . .+.+....
T Consensus 155 --~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~-----~~~~~~~~---- 222 (274)
T cd06609 155 --RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-N-----PPSLEGNK---- 222 (274)
T ss_pred --cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-C-----CCCCcccc----
Confidence 22346788999999999888999999999999999999999999765533332222211 1 11111101
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....+.+++.+||+.+|++||+++++++
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2335778899999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=307.01 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=204.0
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|...+.||+|+||.||++... +++.+++|.++.......+.+.+|++++++++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 346778899999999999999964 6889999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++... ...+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999998532 345899999999999999999999998 99999999999999999999999999876543222
Q ss_pred ccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
. .....++..|++||++. ...++.++||||||+++|||++|+.|+...+............. +.+..
T Consensus 159 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~ 230 (280)
T cd06611 159 K--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP------PTLDQ 230 (280)
T ss_pred c--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC------CCcCC
Confidence 1 12346889999999985 34467899999999999999999999976654443333222111 11111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+......+.+++.+||+.+|.+||++.+|++
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 231 ---PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ---cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1112234678888999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.66 Aligned_cols=247 Identities=30% Similarity=0.456 Sum_probs=202.0
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-----hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
+|...+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999965 78999999886432 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
+||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999943 345889999999999999999999998 99999999999999999999999999876543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.. ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.........+.........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 221 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---------- 221 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCC----------
Confidence 32 112346788999999998766 8999999999999999999999997665444443332211111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+......+.+++.+||+.+|.+||++.++++
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111122345678889999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=318.25 Aligned_cols=256 Identities=24% Similarity=0.277 Sum_probs=194.2
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC------
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 418 (660)
.++|...+.||+|+||.||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46788899999999999999985 46899999998642 3344567889999999999999999999986543
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+++ +|...+. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 46899999976 5555552 23788999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc----------
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---------- 568 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---------- 568 (660)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...........
T Consensus 171 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 75433221 12246899999999999999999999999999999999999999755432211111100
Q ss_pred ------------Cc------ccccccccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 569 ------------GN------VLELVDPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 569 ------------~~------~~~~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. ..+........ ..........+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000000000 0000111245788999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=302.25 Aligned_cols=238 Identities=26% Similarity=0.415 Sum_probs=189.1
Q ss_pred cccccCCcccEEeeeecCCc-----------EEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 355 NILGQGGFGPVYKGVLSDGK-----------EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975432 5788877654333 6788999999999999999999999988 778999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-------CEEEeecc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-------NSKISDFG 496 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-------~~kl~DfG 496 (660)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999995422 26899999999999999999999988 99999999999999887 79999999
Q ss_pred ccccccccCCccceeeeeccCCcCCHhhhhcC--CCCcchhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhcCcccc
Q 006125 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITG-RRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwslGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
++...... ....++..|+|||++... .++.++||||||+++|||++| ..|+.......+. ..+....
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-~~~~~~~--- 223 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-RFYQDQH--- 223 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-HHHhcCC---
Confidence 98765431 123467789999999876 789999999999999999995 6666544322211 1111110
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
....+. ...+.+++.+||+.+|.+||++.||++.|+
T Consensus 224 ----~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 ----RLPMPD-----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----CCCCCC-----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011101 156788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=308.02 Aligned_cols=257 Identities=28% Similarity=0.389 Sum_probs=200.2
Q ss_pred CCCCCCcccccCCcccEEeeee-----cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--Cee
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 420 (660)
..|...+.||+|+||.||++.. .++..||+|.++... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4467788999999999999974 357889999987543 34456799999999999999999999998875 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++++|.+++... ...+++..+..++.||+.+|+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998432 235899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--------------HHHHHHHH
Q 006125 501 FAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--------------LLAYAWHL 565 (660)
Q Consensus 501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~--------------~~~~~~~~ 565 (660)
+....... ......++..|+|||++.+..++.++||||||+++|||++++.|..... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 65432211 1112346678999999988889999999999999999999876543210 00001111
Q ss_pred HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 566 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
...+.. . .........+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 239 ~~~~~~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR-------L---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc-------C---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 0 11112345688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=305.29 Aligned_cols=257 Identities=29% Similarity=0.397 Sum_probs=203.7
Q ss_pred CCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCChh-cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
++|.....||+|+||.||+++.+ +.+.+++|.+...... ....+.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56788899999999999999853 3467999988754433 4677999999999999999999999999989999
Q ss_pred EEEEecCCCChhhhhcCCCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeec
Q 006125 422 LVYEFMPNGSLDAILFDPRKR------GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 495 (660)
+||||+++|+|.+++...... ..+++..+..++.||+++|+|||+.+ |+||||||+||++++++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999643322 25899999999999999999999998 999999999999999999999999
Q ss_pred cccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccc
Q 006125 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLEL 574 (660)
Q Consensus 496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 574 (660)
|++......... ......++..|+|||.+.+..++.++||||||++++||++ |..||........... .........
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~-~~~~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-LQAGKLELP 239 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH-HHcCCcCCC
Confidence 998754322211 1112356778999999988889999999999999999999 7778764433332222 221111100
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
........+.+++.+||+.+|++||++.|++..|+.
T Consensus 240 ---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 240 ---------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 011123457889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=307.17 Aligned_cols=244 Identities=26% Similarity=0.368 Sum_probs=195.1
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+|...++||+|+||.||++.. .+++.+|+|++... .......+.+|+.++.+++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567788999999999999984 57889999998643 3334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999996553 3678889999999999999999998 9999999999999999999999999997654322
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHHHhcCcccccccccCCC
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL------AYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~------~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||...... ........... .+.+..
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 222 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPV 222 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCC
Confidence 12246889999999999888999999999999999999999998532110 00011111110 111111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
.. ....+.+++.+|++.+|++||+++|+++.
T Consensus 223 ~~----~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQ----FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred Cc----CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11 22347788999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.74 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=202.3
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-CeeEEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYE 425 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 425 (660)
+|+..+.||+|++|.||++... +++.+++|++... .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4677899999999999999954 5789999998642 234456788999999999999999999987644 45789999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++... ....+++.++..++.+++.+|++||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998542 3345899999999999999999999998 9999999999999999999999999997664322
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. .....+++.|+|||++.+..++.++||||||++++||++|+.|+...+........... .. + ...
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~-----~-----~~~ 223 (257)
T cd08223 157 DM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-KL-----P-----PMP 223 (257)
T ss_pred Cc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CC-----C-----CCc
Confidence 21 22346889999999999999999999999999999999999999876655544433322 11 0 111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.+++.+|++.||++||++.|+++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 223345788999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=324.73 Aligned_cols=257 Identities=23% Similarity=0.240 Sum_probs=194.6
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
...|...+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 456888899999999999999965 578899996432 2456899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+. ++|.+++.. ....+++.+++.|+.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 688888743 2336999999999999999999999998 99999999999999999999999999986643322
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCC-C------cHHHHHHHHHhcCccc--ccc--
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS-N------QLLAYAWHLWNEGNVL--ELV-- 575 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~-~------~~~~~~~~~~~~~~~~--~~~-- 575 (660)
........||..|+|||++.+..++.++|||||||+||||++|..++.. . .......++....... +..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 2222235799999999999999999999999999999999998765321 1 1111122222211100 000
Q ss_pred -----------------cccCCCCCCC--HHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 576 -----------------DPLLTDTSFS--DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 576 -----------------d~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
.+......+. ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 0111257789999999999999999999863
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=307.75 Aligned_cols=250 Identities=28% Similarity=0.336 Sum_probs=196.5
Q ss_pred CCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
|+..+.||+|+||+||++.. .+++.+|+|.+.... ......+.+|+.+++.++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55668899999999999985 478899999986432 22344578899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888542 2345899999999999999999999988 99999999999999999999999999876533221
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||.............. ...+.. . .+..
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~--~~~~~~-~-----~~~~ 226 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR--RVLETE-E-----VYSA 226 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hhhccc-c-----ccCc
Confidence 1224689999999999988999999999999999999999999975443222111111 000000 0 0111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCC-----HHhHHH
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPT-----MSSVAP 615 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 615 (660)
.....+.+|+.+|++.||++||+ +.|++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 12234678888999999999999 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.55 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=191.4
Q ss_pred ccccCCcccEEeeeecCCc---EEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCC
Q 006125 356 ILGQGGFGPVYKGVLSDGK---EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~~~g~---~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 431 (660)
.||+|+||.||++...++. .+++|.++.. .....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999854433 4567766543 23456689999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccce
Q 006125 432 LDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510 (660)
Q Consensus 432 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (660)
|.+++..... ...+++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999964322 234677788899999999999999988 999999999999999999999999998643222111112
Q ss_pred eeeeccCCcCCHhhhhc-------CCCCcchhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 511 VRIVGTYGYMAPEYAME-------GLYSKKSDVFSFGVLLIEIITG-RRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 511 ~~~~gt~~y~aPE~~~~-------~~~t~ksDVwslGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
....++..|+|||++.. ..++.++||||||+++|||+++ ..|+......+.......+.. ....++.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~- 236 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ-VKLFKPQLEL- 236 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc-cccCCCccCC-
Confidence 23467889999999753 2457899999999999999974 667765554444444333322 2233333322
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
.+ ...+.+++..|| .+|++||+++||++.|.
T Consensus 237 ~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 PY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22 234667778899 67999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=308.46 Aligned_cols=245 Identities=26% Similarity=0.436 Sum_probs=199.0
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++......++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445678999999999999854 5789999998743 23445678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+++|.+++. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06642 86 GGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchh-
Confidence 999999883 245889999999999999999999988 999999999999999999999999998765432211
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 588 (660)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+...........+. ... .+ ......
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~-----~~-----~~~~~~ 225 (277)
T cd06642 158 -RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNS-----PP-----TLEGQY 225 (277)
T ss_pred -hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCC-----CC-----CCCccc
Confidence 122357889999999998889999999999999999999999986543322222111 110 01 112223
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 589 FSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 589 ~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+.+++.+||+.+|++||++.||++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 455788999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.57 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=195.7
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC-----hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--Cee
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 420 (660)
.+|...+.||+|+||.||++.. .+++.+++|++.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688889999999999999985 468899999886321 23345688999999999999999999998753 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++++||+++++|.+++. ....+++...+.++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999984 3345889999999999999999999988 99999999999999999999999999876
Q ss_pred ccccCCc-cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 501 FAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 501 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
....... .......++..|+|||++.+..++.++||||||+++|||++|+.||................. .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-----~~-- 228 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-----NP-- 228 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-----CC--
Confidence 5332111 111223578899999999988899999999999999999999999976544333332221111 11
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+......+..++ +||..+|++||++.||++
T Consensus 229 ---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 ---QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11222223344555 688899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.27 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=200.8
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh-----hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-----QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
+|+..+.||+|+||.||+|... +++.|++|+++.... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667789999999999999954 689999999975332 2345577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999995422 36999999999999999999999998 99999999999999999999999999986654
Q ss_pred cCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC------------c
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG------------N 570 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~------------~ 570 (660)
..... ....++..|+|||.+.+ ..++.++||||||++++||++|.+++...............- .
T Consensus 155 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 155 PNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 32211 12245778999999865 467899999999999999999987776444322222221100 0
Q ss_pred ccccccccCCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH--hcCCC
Q 006125 571 VLELVDPLLTD----TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM--LKGET 621 (660)
Q Consensus 571 ~~~~~d~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 621 (660)
........... ..........+.+++.+||+.||++||++.||++. +++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 00000000000 00111224567899999999999999999999974 65543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=302.05 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=205.0
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..+.||+|+||.+|++.. .+|+.+++|++... ......++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477789999999999999985 47889999998642 344556889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++... ....+++.++..++.|++.+|.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988532 2235789999999999999999999988 99999999999999999999999999976543222
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
.. ....|++.|+|||++.+..++.++||||||+++++|++|+.|+......+.......... + ..+.
T Consensus 157 ~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~------~-----~~~~ 223 (256)
T cd08218 157 LA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY------P-----PVSS 223 (256)
T ss_pred hh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC------C-----CCcc
Confidence 11 123578899999999988899999999999999999999999987665555444432211 0 1112
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.....+.+++.+||+.+|.+||++.||++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 22345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.83 Aligned_cols=250 Identities=35% Similarity=0.492 Sum_probs=201.5
Q ss_pred CCCcccccCCcccEEeeeecC-----CcEEEEEEccCCChh-cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 352 SDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+..+.||.|+||.||+++..+ +..+|+|+++..... ..+.+.+|+.++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999999653 388999999764433 56789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++..... ..+++.++..++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999853221 12899999999999999999999998 9999999999999999999999999998765442
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
..... ...+++.|+|||.+.+..++.++||||||++++||++ |+.|+............... .... .
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~----------~ 225 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-YRLP----------K 225 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCC----------C
Confidence 22211 1236789999999988889999999999999999998 77887655444333322221 1110 1
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
.......+.+++.+|++.||++|||+.|+++.|
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111334578899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.70 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=202.8
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999964 6889999998743 3445677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++.. +.+++.++..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999999842 35889999999999999999999988 999999999999999999999999999765433221
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+............... ..+.....
T Consensus 158 --~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~ 224 (277)
T cd06640 158 --RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-----------NPPTLTGE 224 (277)
T ss_pred --cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-----------CCCCCchh
Confidence 12235788899999998888999999999999999999999998755433222211100 01123344
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
....+.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 56678899999999999999999999743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=307.45 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=200.1
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+|+..+.||+|+||.||++... +++.+|+|.++.. .......+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677899999999999999965 7899999988643 3344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
++++|..++........+++..+..++.||+++|.|||+. + ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 9999999986543344689999999999999999999974 5 99999999999999999999999999876533221
Q ss_pred ccceeeeeccCCcCCHhhhhcC------CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEG------LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.............. ..+..
T Consensus 159 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~-- 226 (286)
T cd06622 159 ----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA------IVDGD-- 226 (286)
T ss_pred ----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH------HhhcC--
Confidence 123578899999998543 358899999999999999999999965443222211110 00000
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+.........+.+++.+||+.+|++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 01122234455778999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=308.19 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=193.0
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhc---CCCCcceEeEEEEe-----CC
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCVD-----GD 418 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 418 (660)
+|+..+.||+|+||.||++... +++.||+|.++... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4677889999999999999854 68899999986422 22234566777777665 79999999999864 24
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..+++|||+++ +|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999974 888887532 2345899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---C---ccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---G---NVL 572 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~---~~~ 572 (660)
......... ....++..|+|||++.+..++.++|||||||++|||++|++||......+....+... . .+.
T Consensus 156 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 865432211 2246789999999999889999999999999999999999998755433322222210 0 000
Q ss_pred c-------cccccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 573 E-------LVDPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 573 ~-------~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
. ...+.... ....++....+.+++.+||+.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000 0011122345778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.52 Aligned_cols=259 Identities=21% Similarity=0.303 Sum_probs=199.8
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36778899999999999999965 68999999986432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|..++. ....+++..+..++.||+.+|+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999999988873 3345899999999999999999999988 9999999999999999999999999998765432
Q ss_pred CccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc--C------------c
Q 006125 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE--G------------N 570 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~--~------------~ 570 (660)
.. .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+... . .
T Consensus 155 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 DD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 21 112356788999999876 56889999999999999999999999755433332221110 0 0
Q ss_pred cc-ccccccCCC-CC---CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VL-ELVDPLLTD-TS---FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~-~~~d~~~~~-~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. ....+.... .. ........+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 000000000 00 00112345788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.88 Aligned_cols=247 Identities=30% Similarity=0.441 Sum_probs=199.4
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
++|+..+.||+|+||.||++.. +++.+|+|+++... ....+.+|+.++++++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4577789999999999999985 67889999986532 345788999999999999999999998764 4799999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 99999999542 2345889999999999999999999988 99999999999999999999999999875432211
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
....+..|+|||.+.+..++.++||||||+++|||++ |+.||............. .+... .....
T Consensus 156 ---~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~----------~~~~~ 221 (254)
T cd05083 156 ---NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRM----------EPPEG 221 (254)
T ss_pred ---CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCC----------CCCCc
Confidence 1233567999999988899999999999999999998 888887666544332222 11110 01112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
....+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 23457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=309.53 Aligned_cols=245 Identities=27% Similarity=0.394 Sum_probs=199.0
Q ss_pred CcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
...||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 46799999999999985 46889999998765555567789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceee
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (660)
.+++.. +.+++.++..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++......... ...
T Consensus 107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~ 177 (292)
T cd06658 107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKS 177 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Cce
Confidence 998832 34889999999999999999999998 999999999999999999999999998755432221 123
Q ss_pred eeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 513 ~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||............... +...... .......+
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~---~~~~~~~~ 248 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN------LPPRVKD---SHKVSSVL 248 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------CCCcccc---ccccCHHH
Confidence 46889999999998888999999999999999999999998765543332222111 1111111 11122346
Q ss_pred HHHHhhcccCCCCCCCCHHhHHHH
Q 006125 593 IHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 593 ~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
.+++.+|++.||.+|||+.|+++.
T Consensus 249 ~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 249 RGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHccCChhHCcCHHHHhhC
Confidence 678889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=290.14 Aligned_cols=249 Identities=28% Similarity=0.406 Sum_probs=199.7
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-----Chh---cHHHHHHHHHHHhhc-CCCCcceEeEEEEeCC
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-----SEQ---GTAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 418 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 418 (660)
.+|...+.||.|..+.|-++.. .+|+++|+|++.-. ++. -.+.-.+|+.+|+++ .||+|+.+.++++...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4677788999999999999885 47889999988521 111 123345789999998 7999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++|+|.|+.|.|.++| ...-.++++...+|++|+.+|++|||..+ |+||||||+|||+|++.++||+|||++
T Consensus 97 F~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 999999999999999999 44556999999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhh------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAM------EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVL 572 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 572 (660)
..+.....- ...+|||+|+|||.+. ...|+..+|+|++|||+|.|+.|.+||....-.-.. +.+.+++.
T Consensus 171 ~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML-R~ImeGky- 245 (411)
T KOG0599|consen 171 CQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML-RMIMEGKY- 245 (411)
T ss_pred eccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH-HHHHhccc-
Confidence 988765433 3469999999999984 345889999999999999999999998533222111 22223321
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
....+++ .+......+||.+||+.||++|.|++|++
T Consensus 246 -----qF~speW-adis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 246 -----QFRSPEW-ADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred -----ccCCcch-hhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 1111111 22334567899999999999999999997
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.10 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=194.2
Q ss_pred CCcccccC--CcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 353 DSNILGQG--GFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 353 ~~~~lG~G--~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
..++||+| +|++||++.. .+|+.||+|+++.. .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 6889999985 57899999998743 2334556888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999998532 2234899999999999999999999988 999999999999999999999999865433211110
Q ss_pred c-----ceeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc--
Q 006125 508 A-----NTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL-- 578 (660)
Q Consensus 508 ~-----~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~-- 578 (660)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.............. +.....++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-CCccccccccch
Confidence 0 0111246778999999976 4589999999999999999999999975433322222211 1111110000
Q ss_pred -----------------CC---------C-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 579 -----------------LT---------D-------TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 579 -----------------~~---------~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. . ..........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0 0011122346788999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=315.77 Aligned_cols=254 Identities=21% Similarity=0.258 Sum_probs=198.8
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|...+.||+|+||.||+++.. +++.||+|++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46788899999999999999954 6789999998642 2233455888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999532 345889999999999999999999988 999999999999999999999999999765432
Q ss_pred CCccceeeeeccCCcCCHhhhhc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
... ......|++.|+|||++.+ +.++.++||||||+++|||++|+.||...+..+....+......... .
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-p--- 230 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF-P--- 230 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC-C---
Confidence 221 1123468999999999875 56789999999999999999999999876655544444332211110 0
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHhHHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFD--RPTMSSVAP 615 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~ 615 (660)
.........+.+++.+|+..++.+ |++++++++
T Consensus 231 ---~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 231 ---SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ---CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 111112345667788888765544 467887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.68 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=202.3
Q ss_pred hHHHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEE---
Q 006125 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV--- 415 (660)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 415 (660)
++.+....++|+..+.||+|+||.||++.. .+++.+++|+++... .....+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 345556788999999999999999999985 468899999886532 2345688899999999 7999999999885
Q ss_pred --eCCeeEEEEEecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEE
Q 006125 416 --DGDEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (660)
Q Consensus 416 --~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl 492 (660)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999987532 23346889999999999999999999988 999999999999999999999
Q ss_pred eeccccccccccCCccceeeeeccCCcCCHhhhhc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh
Q 006125 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN 567 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~ 567 (660)
+|||++.......... ....|+..|+|||++.. ..++.++|||||||++|||++|+.|+..............
T Consensus 166 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 166 VDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred ccCCceeecccCCCcc--ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 9999987654322211 22368999999999853 4578999999999999999999999875543322221111
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 568 EGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 568 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
. . .+....+. .....+.+++.+||+.||++||++.||++-
T Consensus 244 ~-~-----~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 244 N-P-----PPTLHQPE---LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c-C-----CCcccCCC---CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1 0 01111111 112347789999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.00 Aligned_cols=266 Identities=29% Similarity=0.384 Sum_probs=202.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-----CCcEEEEEEccCCChh-cHHHHHHHHHHHhhcCCCCcceEeEEEEe--CCee
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEK 420 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 420 (660)
+.|...+.||+|+||.||++++. +++.+|+|+++..... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45666789999999999999853 3678999999764443 46789999999999999999999999987 5578
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999542 235899999999999999999999988 99999999999999999999999999987
Q ss_pred ccccCCccc-eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHH--HHHH---hcCccccc
Q 006125 501 FAESEGEAN-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYA--WHLW---NEGNVLEL 574 (660)
Q Consensus 501 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~--~~~~---~~~~~~~~ 574 (660)
......... .....++..|++||.+.+..++.++||||||++++||++|+.|+......... .... ......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 653322111 11123456799999998889999999999999999999999887532211100 0000 00000001
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
+...... .........+.+++.+||+.+|++||++.||+++|+.+
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111100 11122235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=307.06 Aligned_cols=250 Identities=28% Similarity=0.379 Sum_probs=201.0
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|+..+.||+|+||.||++.. .+++.+|+|++... .....+.+.+|+++++.++||||+++++.+......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4667778999999999999995 46889999987643 234456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++. ..+.+++..+..++.+++.+|.|||+.. +++||||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 85 MDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred CCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 99999999884 3456899999999999999999999742 399999999999999999999999999865432211
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH-----------HHHHHHHhcCcccccc
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL-----------AYAWHLWNEGNVLELV 575 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~-----------~~~~~~~~~~~~~~~~ 575 (660)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... +.......+.
T Consensus 160 ----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 160 ----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred ----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 1346899999999998889999999999999999999999998743321 1111111110
Q ss_pred cccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 576 DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 576 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
.+.+. ..+....+.+++.+|++.||.+||++.|++++.
T Consensus 230 ~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00110 112334578899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=290.09 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=201.5
Q ss_pred cCCCCCCcccccCCcccEEeee-ecCCcEEEEEEcc--CCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++.|+..+.||+|.|+.|++.. ..+|+.+|+|++. +.+....+++.+|+.+-+.|+||||+++.+...+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3556677899999999999998 4579999999875 344557889999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC---CCEEEeeccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIF 501 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfGla~~~ 501 (660)
|+|.+++|..-+- .+-.+++..+-..++||+++|.|.|.++ |+|||+||+|+|+.+. .-+||+|||++..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999865442 3345788888999999999999999998 9999999999999643 45899999999877
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
..... -...+|||+|||||++...+|+..+|||+.||+||-|+.|.+||.+.+-.....++... .. + +++.
T Consensus 164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-~y-d-~~~~--- 234 (355)
T KOG0033|consen 164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-AY-D-YPSP--- 234 (355)
T ss_pred CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-cc-C-CCCc---
Confidence 62221 22358999999999999999999999999999999999999999876544444333322 11 1 1111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.+ +...+...+|+++||..||.+|.|+.|.+
T Consensus 235 -~w-~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 235 -EW-DTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred -cc-CcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 11 11122356788899999999999999987
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.92 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=198.7
Q ss_pred CcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
...||+|+||.||++.. .+++.||+|.+........+.+.+|+.++..++||||+++++++..++..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 45799999999999985 46899999998765555567788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceee
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (660)
..++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......... ...
T Consensus 106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~ 176 (297)
T cd06659 106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKS 176 (297)
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccc
Confidence 998732 45889999999999999999999998 999999999999999999999999998755432211 123
Q ss_pred eeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 513 ~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
..|+..|+|||++.+..++.++||||||++++||++|+.||...........+.. ... ..... .......+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~-----~~~~~---~~~~~~~l 247 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPP-----PKLKN---AHKISPVL 247 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCC-----CCccc---cCCCCHHH
Confidence 4688999999999988899999999999999999999999875554433332221 110 00000 11122346
Q ss_pred HHHHhhcccCCCCCCCCHHhHHH
Q 006125 593 IHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 593 ~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+++.+||+.+|.+||++.||++
T Consensus 248 ~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 248 RDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHHhcCCcccCcCHHHHhh
Confidence 78888999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.83 Aligned_cols=261 Identities=26% Similarity=0.353 Sum_probs=204.6
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 417 (660)
....+...+++|...+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3455556688899999999999999999995 468899999986532 2345678899999999 899999999998754
Q ss_pred -----CeeEEEEEecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEE
Q 006125 418 -----DEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 418 -----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
+..++|+||+++++|.+++... .....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3579999999999999988532 23346899999999999999999999988 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhhcC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-----LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLW 566 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~ 566 (660)
|+|||++.......... ....|+..|+|||++... .++.++||||||+++|||++|+.|+...........+.
T Consensus 169 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 169 LVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred Eeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 99999987654322211 123678899999998643 36899999999999999999999987655433333322
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 567 NEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 567 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.... . .+.. ..+....+.+++.+||+.+|++||++.|+++
T Consensus 247 ~~~~-~-----~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RNPP-P-----TLLH---PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCCC-C-----CCCc---ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2111 1 1111 1122345788999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=315.10 Aligned_cols=255 Identities=21% Similarity=0.268 Sum_probs=198.5
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..++||+|+||.||++..+ +++.+|+|++.+. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36788899999999999999965 5778999998642 2233445888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999953 2345899999999999999999999988 999999999999999999999999998755332
Q ss_pred CCccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.......+.........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----- 229 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF----- 229 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC-----
Confidence 21 1122347899999999986 346889999999999999999999999877766655554432211111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCC--CCCCCCHHhHHHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQED--AFDRPTMSSVAPM 616 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~d--P~~RPt~~evl~~ 616 (660)
. .........+.+++.+|+..+ +..||++.|+++.
T Consensus 230 p--~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 P--AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C--CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 101112234666777777554 4447899988754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=329.36 Aligned_cols=265 Identities=20% Similarity=0.255 Sum_probs=194.5
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCC------CCcceEeEEE
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH------KNLVKLLGFC 414 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 414 (660)
+++...+++|+..++||+|+||.||++.. ..++.||||+++... ....++..|+.++..++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34456678899999999999999999985 468899999996532 233455667777777654 4588898888
Q ss_pred EeC-CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCC----
Q 006125 415 VDG-DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDM---- 488 (660)
Q Consensus 415 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~---- 488 (660)
... ...++|||++ +++|.+++. +.+.+++..+..|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 764 4688999988 667888773 345699999999999999999999984 6 99999999999998765
Q ss_pred ------------CEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006125 489 ------------NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556 (660)
Q Consensus 489 ------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~ 556 (660)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998754221 122357899999999999999999999999999999999999999755
Q ss_pred cHHHHHHHHHhc-Cc-------------cccccc------ccCCC--------CC-C-CHHHHHHHHHHHhhcccCCCCC
Q 006125 557 QLLAYAWHLWNE-GN-------------VLELVD------PLLTD--------TS-F-SDDEFSRYIHIGLLCVQEDAFD 606 (660)
Q Consensus 557 ~~~~~~~~~~~~-~~-------------~~~~~d------~~~~~--------~~-~-~~~~~~~l~~li~~cl~~dP~~ 606 (660)
...+....+... +. ..++++ +.... .. . .......+.+|+.+||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 433222111000 00 000000 00000 00 0 0011245779999999999999
Q ss_pred CCCHHhHHH--HhcC
Q 006125 607 RPTMSSVAP--MLKG 619 (660)
Q Consensus 607 RPt~~evl~--~L~~ 619 (660)
|||++|+++ ++..
T Consensus 429 R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 429 RLNARQMTTHPYVLK 443 (467)
T ss_pred CCCHHHHhcCccccc
Confidence 999999985 5544
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=337.37 Aligned_cols=260 Identities=21% Similarity=0.302 Sum_probs=202.3
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKL 421 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 421 (660)
..++|...++||+|+||.||++... +++.+|+|.+... .......+..|+.++.+++||||+++++++.+. ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4467888999999999999999954 5778999988642 334456789999999999999999999988654 4689
Q ss_pred EEEEecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCceEeCCC---------
Q 006125 422 LVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSR----LRIVHRDLKASNVLLDSD--------- 487 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~DLkp~NILl~~~--------- 487 (660)
|||||+++|+|.++|... .....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999998542 223569999999999999999999998542 349999999999999642
Q ss_pred --------CCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 006125 488 --------MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557 (660)
Q Consensus 488 --------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~~~~~ 557 (660)
+.+||+|||++........ .....||+.|+|||++.. ..++.++|||||||+||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3489999999976543221 123468999999999864 458899999999999999999999997554
Q ss_pred HHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhcCC
Q 006125 558 LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGE 620 (660)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~ 620 (660)
............. .+..... ...+.+|+..||+.+|.+||++.|++ .+++..
T Consensus 248 ~~~qli~~lk~~p-------~lpi~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 248 NFSQLISELKRGP-------DLPIKGK----SKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cHHHHHHHHhcCC-------CCCcCCC----CHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 3333333332221 1111111 24477899999999999999999998 566544
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.67 Aligned_cols=195 Identities=27% Similarity=0.441 Sum_probs=159.2
Q ss_pred CcccccCCcccEEeeeec---CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe--CCeeEEEEEecC
Q 006125 354 SNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP 428 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 428 (660)
.++||+|+||.||++... +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999986532 23457889999999999999999999864 456789999986
Q ss_pred CCChhhhhcCC------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe----CCCCCEEEeecccc
Q 006125 429 NGSLDAILFDP------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMA 498 (660)
Q Consensus 429 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DfGla 498 (660)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 787776421 12235889999999999999999999998 9999999999999 45678999999999
Q ss_pred ccccccCCc-cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 006125 499 RIFAESEGE-ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAG 554 (660)
Q Consensus 499 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~ 554 (660)
+........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 866433221 11223578999999999876 458999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.15 Aligned_cols=256 Identities=24% Similarity=0.276 Sum_probs=196.2
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------C
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 418 (660)
.++|...+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46788899999999999999985 46889999998752 233456788999999999999999999987643 3
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+++ +|...+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 56999999975 6666662 23788999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc--c-----
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN--V----- 571 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~--~----- 571 (660)
+....... .....++..|+|||++.+..++.++|||||||++|||++|+.||...+.......+...-. .
T Consensus 174 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 174 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 76533221 1224689999999999999999999999999999999999999976554333222221000 0
Q ss_pred ---------------------cccccccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 572 ---------------------LELVDPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 572 ---------------------~~~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+........ ..........+.+++.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 0001112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.99 Aligned_cols=256 Identities=23% Similarity=0.284 Sum_probs=195.7
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC------
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 418 (660)
.++|...+.||+|+||.||++.. ..++.+|+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46888999999999999999985 46889999998742 3334567888999999999999999999986543
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+++ +|...+. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 96 ~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 46899999975 5666552 23788999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc----------
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---------- 568 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---------- 568 (660)
+....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+........
T Consensus 167 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 167 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 76533221 12246899999999999889999999999999999999999999765533322111110
Q ss_pred ------------C-ccccccccc-CCC------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 569 ------------G-NVLELVDPL-LTD------TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 569 ------------~-~~~~~~d~~-~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
. .......+. ... ..........+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0 000000000 000 0011112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.15 Aligned_cols=240 Identities=23% Similarity=0.272 Sum_probs=187.6
Q ss_pred cccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc---CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 357 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
||+|+||.||+++.. +++.||+|++... .......+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999954 6899999998642 122233455566666655 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|..++. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++.........
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 99998884 3456899999999999999999999998 999999999999999999999999998754322221
Q ss_pred eeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 588 (660)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||......+....+..... .+.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------~~~~~~~---- 221 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-------RFPKNVL---- 221 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-------CCCCccC----
Confidence 2234789999999998764 489999999999999999999999987665444333322211 1111112
Q ss_pred HHHHHHHHhhcccCCCCCCCC----HHhHHH
Q 006125 589 FSRYIHIGLLCVQEDAFDRPT----MSSVAP 615 (660)
Q Consensus 589 ~~~l~~li~~cl~~dP~~RPt----~~evl~ 615 (660)
...+.+++.+||+.||.+||+ +.|+++
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 234667888999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.20 Aligned_cols=247 Identities=28% Similarity=0.346 Sum_probs=196.1
Q ss_pred CCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 56678899999999999985 468899999986432 22234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988532 2235899999999999999999999988 99999999999999999999999999875433221
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHHhcCcccccccccCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL---AYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
. ....|+..|+|||++.+..++.++||||||+++|||++|+.||...... ......... .....
T Consensus 158 ~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------~~~~~---- 224 (285)
T cd05630 158 I---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------VQEEY---- 224 (285)
T ss_pred c---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------hhhhc----
Confidence 1 1236899999999999989999999999999999999999999753211 111111110 00011
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC-----HHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPT-----MSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 615 (660)
.......+.+++..||+.||++||+ ++|+++
T Consensus 225 -~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 -SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112234678889999999999999 888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.86 Aligned_cols=257 Identities=19% Similarity=0.244 Sum_probs=203.9
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||++... .++.|++|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36778899999999999999954 57899999987532 234557889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++++|.+++. ..+.+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999994 3356899999999999999999999988 999999999999999999999999998642111
Q ss_pred CC-------------ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc
Q 006125 505 EG-------------EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV 571 (660)
Q Consensus 505 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 571 (660)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.||......+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~- 233 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI- 233 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Confidence 00 0011123578889999999888899999999999999999999999976554443333322211
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+.. .......+.+++.+||+.||++||++.++.+.|+..
T Consensus 234 ---~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 234 ---EWPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred ---CCCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 01110 011233477899999999999999988888777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=308.11 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=199.5
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..++||+|+||.||++..+ +++.+|+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35777899999999999999975 58999999986432 2235578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|..+... ...+++.++..++.||+++|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887732 334899999999999999999999988 9999999999999999999999999987654432
Q ss_pred CccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-Cccc----c------
Q 006125 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-GNVL----E------ 573 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~~~~----~------ 573 (660)
.. .....++..|+|||++.+ ..++.++||||||+++|||++|++|+......+........ +... +
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 EV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 21 122457889999999875 45788999999999999999999988755433322222110 0000 0
Q ss_pred cc----cccCCCC----CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 574 LV----DPLLTDT----SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 574 ~~----d~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
++ .+..... .........+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 0000000 000112345888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.48 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=197.6
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|...+.||+|+||.||++... +++.||+|.++.. .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46788899999999999999854 6889999998643 233345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
++ ++|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888888532 335889999999999999999999998 99999999999999999999999999875433221
Q ss_pred ccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc------Cccccccc---
Q 006125 507 EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE------GNVLELVD--- 576 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~------~~~~~~~d--- 576 (660)
.. ....+++.|+|||++.+ ..++.++||||||+++|||++|+.||...+..+....+... ..+..++.
T Consensus 160 ~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 TY--SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred cc--cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 11 12356889999999875 45789999999999999999999999765543332211110 00000000
Q ss_pred ------ccCCCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 577 ------PLLTDT---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 577 ------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+..... .........+.+|+.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000112234678999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=303.96 Aligned_cols=271 Identities=21% Similarity=0.286 Sum_probs=220.8
Q ss_pred CCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+-|...+.||+|.|..|-+++ .-+|+.||||++.+. +......+.+|+..|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346677899999999999998 458999999999763 34455679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEEeecccccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAES 504 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~~ 504 (660)
.-++|+|.+++-.... .+++..+.+++.||+.++.|+|+.. +|||||||+||.+-+ -|-+||.|||++-.+.+.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999954333 3999999999999999999999988 999999999998755 588999999999877654
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCC-cchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYS-KKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.. ....+|+..|-|||++.+..|. +++||||||||||-|++|++||...+..+- +..++|-.. .
T Consensus 173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------LTmImDCKY---t 237 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------LTMIMDCKY---T 237 (864)
T ss_pred ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------hhhhhcccc---c
Confidence 33 2346999999999999988875 799999999999999999999975543322 222333222 3
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhcCCCCCCCCCCCCceeccccCCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGETGTLPQPQKPAFSIGRVTDG 640 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~~~~~~~p~~p~~~~~~~~~~ 640 (660)
.+.-...++.+||.+||+.||.+|.+.+||+ .+|+.....++. .-|-.......++
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT-~iPLvsr~~L~ee 295 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST-AIPLVSRHHLPEE 295 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc-cCceeehhhCChH
Confidence 4555667799999999999999999999998 577776555443 3555555555444
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.97 Aligned_cols=259 Identities=23% Similarity=0.348 Sum_probs=203.3
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..++||+|+||.||++... +++.|++|+++.. .....+.+.+|++++++++|+||+++++++...+..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778899999999999999965 6889999998642 333456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
++++.+..++. ....+++.++..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99888877663 3345899999999999999999999998 99999999999999999999999999987654432
Q ss_pred ccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC-ccc----cc--cccc
Q 006125 507 EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG-NVL----EL--VDPL 578 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~-~~~----~~--~d~~ 578 (660)
.. .....++..|+|||++.+. .++.++||||||+++|||++|+.||......+..+...... ... +. .++.
T Consensus 156 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 11 1224678899999999887 88999999999999999999999987655544443322100 000 00 0000
Q ss_pred -----CCCC--------CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 579 -----LTDT--------SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 579 -----~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.... .+.......+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 011112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.16 Aligned_cols=250 Identities=28% Similarity=0.340 Sum_probs=208.7
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh---hcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 422 (660)
...|+..+.||.|.||.||+++.+ +|+.+|+|.+.+... .....+.+|+.+|+++. |||||.+.+.++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456777899999999999999965 599999999975332 34568999999999998 9999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC----CCEEEeecccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD----MNSKISDFGMA 498 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~----~~~kl~DfGla 498 (660)
|||++.+|.|.+.+... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999998543 2999999999999999999999988 9999999999999643 57999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...........+..... .
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-------~ 256 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-------D 256 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-------C
Confidence 87765 2334457999999999999999999999999999999999999999987665444443333222 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
... ..-+.......+++..++..||.+|+|+.++++
T Consensus 257 f~~-~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 257 FTS-EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCC-CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111 111222445667888999999999999999997
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.80 Aligned_cols=247 Identities=26% Similarity=0.433 Sum_probs=207.1
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
|...++||+|+||.||++.++ .|+.+|+|++.- +.+.+++..|+.+|++.+.|++|+++|.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 455688999999999999965 699999999874 45678899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+..+++.. .+.+|++.++..+++..++||+|||... -+|||||+.|||++-+|.+||+|||.+-.+.+.....+
T Consensus 113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 999999954 4456999999999999999999999987 89999999999999999999999999987765444433
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
...||+.|||||++..-.|..++||||||+...||..|++|+.+.......+-+..+. -+.+.. +..-.
T Consensus 188 --TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~P------PPTF~K---PE~WS 256 (502)
T KOG0574|consen 188 --TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKP------PPTFKK---PEEWS 256 (502)
T ss_pred --ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCC------CCCCCC---hHhhh
Confidence 3589999999999999999999999999999999999999997665433222111111 111111 22334
Q ss_pred HHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+-++++.||-+.|++|-|+.++++
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 56888999999999999999998873
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.90 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=195.2
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------C
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 418 (660)
.++|...+.||+|+||.||++.. .+++.||+|++... .......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46788899999999999999985 57889999998752 223345678899999999999999999987643 3
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++++|++ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 468999987 778988873 345899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc--Ccccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE--GNVLELV 575 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~--~~~~~~~ 575 (660)
+...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+... ....+..
T Consensus 166 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 166 RQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred eecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 8654321 22468999999999876 56899999999999999999999999765544333222110 0000000
Q ss_pred ccc--------CC-CCCCCH--------HHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 576 DPL--------LT-DTSFSD--------DEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 576 d~~--------~~-~~~~~~--------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
... +. .+.... .....+.+++.+||+.||.+|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00 000000 01124678999999999999999999983
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=298.52 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=196.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-----ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--Cee
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 420 (660)
.+|+..++||+|+||.||++.. .+++.|++|.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4678889999999999999995 46899999987532 123345788999999999999999999998764 457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
+++|||+++++|.+++. ....+++....+++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999984 3345788999999999999999999998 99999999999999999999999999876
Q ss_pred ccccCCc-cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 501 FAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 501 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||................. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~--- 227 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-----N--- 227 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC-----C---
Confidence 5432111 111224578899999999888899999999999999999999999875443332222211110 1
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+..+......+.+++.+|+. +|.+||+++||++
T Consensus 228 --~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 --PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11223334557778888885 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=297.98 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=202.3
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|...+.||+|+||.||++.. .+++.+++|.+... .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 467788999999999999985 46889999998643 334466789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-CCEEEeeccccccccccC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESE 505 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~~~~~~~ 505 (660)
+++++|.+++... ....+++..+..++.+++++|.|||+.+ ++|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999542 2345899999999999999999999988 9999999999999865 468999999998664332
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...+............. .. ..
T Consensus 157 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~----------~~ 222 (256)
T cd08220 157 KA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-AP----------IS 222 (256)
T ss_pred cc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CC----------CC
Confidence 21 224678899999999988899999999999999999999999977665544433322111 11 11
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.+++.+||+.+|.+|||+.|+++
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.61 Aligned_cols=259 Identities=26% Similarity=0.434 Sum_probs=202.3
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEe-
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD- 416 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 416 (660)
++.++....+.|+..+.||+|+||.||++.. .+++.+|+|++... .....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4455556778899999999999999999995 46889999988653 33446788899999998 79999999999863
Q ss_pred -----CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEE
Q 006125 417 -----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 417 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
....+++|||+++|+|.+++... ....+++..+..++.||+++|.|||+.+ |+|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45679999999999999998542 2345788889999999999999999998 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLW 566 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~ 566 (660)
|+|||++......... .....|+..|+|||.+. ...++.++||||||+++|||++|+.||.............
T Consensus 162 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 162 LVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred EeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence 9999998755332211 12246889999999875 3457889999999999999999999986544322222111
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 567 NEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 567 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
... .+.... ......+.+++.+||+.||.+||++.||++
T Consensus 240 ~~~------~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 RNP------PPKLKS----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hCC------CCCCcc----cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 110 111111 112345888999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=304.62 Aligned_cols=243 Identities=29% Similarity=0.356 Sum_probs=199.5
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|...+.||+|+||.||++... +++.+|+|+++.. .....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36778899999999999999954 6899999998642 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++++|.+++. ....+++..+..++.||++||.|||+.+ ++|+||+|+|||+++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999984 3356899999999999999999999988 999999999999999999999999999876443
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...+......... .+.. .+
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~------~~----- 217 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGKV------RF----- 217 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCc------cC-----
Confidence 123468899999999988889999999999999999999999997665332222222 1110 11
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCC-----CHHhHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVA 614 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl 614 (660)
+......+.+++.+||+.||.+|| ++.|++
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 111234577889999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=297.40 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=202.4
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe--CCeeEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVY 424 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 424 (660)
+|+..+.||.|+||.||++.. .+++.+++|++.. ......+.+.+|+++++.++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467778999999999999984 4688999999864 234455678899999999999999999998764 44578999
Q ss_pred EecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 425 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
||+++++|.+++... .....+++..++.++.||++||.|||..+ ..+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 22456899999999999999999999332 233999999999999999999999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
....... ....++..|++||++.+..++.++||||||+++++|++|+.|+...+....... ...+.. +
T Consensus 161 ~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~-----~---- 228 (265)
T cd08217 161 GHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK-IKEGKF-----R---- 228 (265)
T ss_pred cCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH-HhcCCC-----C----
Confidence 5433211 224688999999999988899999999999999999999999986653333222 222111 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
..+......+.+++.+|++.+|.+||++.+|++.
T Consensus 229 -~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1222334568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=299.79 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=201.0
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC------hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
+|+..+.||+|++|.||++.. .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999984 578999999986422 1234678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-CEEEeeccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIF 501 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~ 501 (660)
|+||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 346889999999999999999999998 99999999999998776 5999999998766
Q ss_pred cccCCcc--ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 502 AESEGEA--NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 502 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
....... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+................. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~ 227 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-------AT 227 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc-------cC
Confidence 5432111 11224678899999999888899999999999999999999999864432221111111100 00
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+..+......+.+++.+|++.+|.+||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011223334456888999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=301.60 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=201.7
Q ss_pred CCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44467999999999999985 47889999998755555566788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
++|.+++.. ..+++..+..++.|++.+|+|||+.+ ++||||+|+||++++++.++|+|||++.........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-- 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-- 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence 999999843 45899999999999999999999998 999999999999999999999999988755432221
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...+........... . .+.... .....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~-----~~~~~~---~~~~~ 242 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-L-----PPKLKN---LHKVS 242 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-C-----CCCCcc---cccCC
Confidence 12246889999999998888999999999999999999999998765544433322221 1 011111 11123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+.+++.+||+.+|++||++.|+++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 45788999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.70 Aligned_cols=259 Identities=23% Similarity=0.325 Sum_probs=203.1
Q ss_pred CCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-C-----CCcceEeEEEEeCCeeEE
Q 006125 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-H-----KNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 422 (660)
+|+..+.||+|.||.|-++. .++++.||||++++. ..-..+-..|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78889999999999999999 567999999999873 344566778999999996 4 489999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC--CCEEEeecccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARI 500 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~--~~~kl~DfGla~~ 500 (660)
|+|.+. -+|.++|+..... .++...++.|+.||+.+|.+||+.+ |||+||||+||||.+- ..+||+|||.+..
T Consensus 266 VfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999984 5999999765444 4999999999999999999999998 9999999999999754 4699999999986
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc------------
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE------------ 568 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~------------ 568 (660)
...... ..+-+.-|.|||++.+.+|+.+.||||||||+.||++|.+.|.+++..+....+..-
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 543322 346788899999999999999999999999999999999888755544433222110
Q ss_pred Ccccccccc---------------------------------cCC-C-----CCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 006125 569 GNVLELVDP---------------------------------LLT-D-----TSFSDDEFSRYIHIGLLCVQEDAFDRPT 609 (660)
Q Consensus 569 ~~~~~~~d~---------------------------------~~~-~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt 609 (660)
.+....++. ... . .......-..+++++.+||+.||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 000000000 000 0 0011133467899999999999999999
Q ss_pred HHhHHH--HhcC
Q 006125 610 MSSVAP--MLKG 619 (660)
Q Consensus 610 ~~evl~--~L~~ 619 (660)
..|.++ +|.+
T Consensus 496 p~qal~Hpfl~~ 507 (586)
T KOG0667|consen 496 PAQALNHPFLTG 507 (586)
T ss_pred HHHHhcCccccc
Confidence 999983 4543
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.52 Aligned_cols=242 Identities=30% Similarity=0.457 Sum_probs=202.4
Q ss_pred CCCCcccccCCcccEEeee-ecCCcEEEEEEccC---CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
|...+.||.|+||.||-+. ..+.+.||||++.- .+...+.++..|+..|.+++|||++.+.|++..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4556789999999999999 45788999999864 3344467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
|- |+-.+++.- ...++-+.++..|+.+.+.||+|||+++ .||||||+.|||+.+.|.|||+|||.+....+.
T Consensus 108 Cl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred Hh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 94 566676632 2345888899999999999999999998 999999999999999999999999999765432
Q ss_pred ccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
..++|||-|||||++. .+.|+-|+|||||||...||.-.++|...-+.....+.+..++. |.+..
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes------PtLqs-- 247 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------PTLQS-- 247 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC------CCCCC--
Confidence 2468999999999985 68899999999999999999999999877777776666665543 33332
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.+....|.+++..||++-|.+|||.++++
T Consensus 248 --~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 248 --NEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred --chhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 22334477788899999999999999987
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.19 Aligned_cols=250 Identities=25% Similarity=0.433 Sum_probs=203.4
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
++|...+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999985 468899999987555555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999842 34789999999999999999999998 999999999999999999999999998765433222
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
. ....+++.|++||.+....++.++||||||+++||+++|+.||...............+. +.. .....
T Consensus 172 ~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~------~~~---~~~~~ 240 (293)
T cd06647 172 R--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT------PEL---QNPEK 240 (293)
T ss_pred c--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC------CCC---CCccc
Confidence 1 223678899999999888899999999999999999999999975543322221111110 001 11122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
....+.+++.+||+.+|++||++.+++..
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33457789999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=299.16 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=200.2
Q ss_pred CCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
|...+.||+|+||.||++.. .+++.+|+|.+... .......+.+|+.++.+++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 55678899999999999985 46889999988643 23445678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+++|.+++. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06641 86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh-
Confidence 999999984 235899999999999999999999988 999999999999999999999999998765432211
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 588 (660)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+...........+..... +......
T Consensus 158 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~ 225 (277)
T cd06641 158 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-----------PTLEGNY 225 (277)
T ss_pred -hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC-----------CCCCccc
Confidence 1223578899999999888899999999999999999999999875543333222211110 0111223
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 589 FSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 589 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
...+.+++.+||+.+|.+||++.++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3457788999999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=297.19 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=200.5
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCCh--hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|...+.||+|+||.||++.. .+++.+++|.++.... ...+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 467789999999999999985 4788999999875433 3677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++.. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999843 345889999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccce--eeeeccCCcCCHhhhhcCC---CCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCcccccccccCC
Q 006125 507 EANT--VRIVGTYGYMAPEYAMEGL---YSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 507 ~~~~--~~~~gt~~y~aPE~~~~~~---~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
.... ....++..|++||++.... .+.++||||||+++|||++|+.||...+ .......... .. .+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~-----~~~~~ 228 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH-----KPPIP 228 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC-----CCCCC
Confidence 2111 1235788999999998766 8899999999999999999999986442 1111111111 10 11111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
. .......+.+++.+||+.+|.+||++.|++.
T Consensus 229 ~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 D---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 0111344678889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=295.97 Aligned_cols=247 Identities=28% Similarity=0.426 Sum_probs=204.4
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh-hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+|+..+.||+|++|.||+++.. +++.+++|++..... .....+.+|+..+.+++|+||+++++++......++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5777899999999999999965 589999999876433 45678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
++++|.+++.. ...+++..++.++.|++++|+|||+ .+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 82 DGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999943 3568999999999999999999999 87 99999999999999999999999999986654333
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCcccccccccCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ---LLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~---~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..+....+. .... + .
T Consensus 156 ~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~-----~-----~ 222 (264)
T cd06623 156 QC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPP-----P-----S 222 (264)
T ss_pred cc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCC-----C-----C
Confidence 22 23467889999999999899999999999999999999999987553 222222222 1111 1 1
Q ss_pred CCHH-HHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 584 FSDD-EFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 584 ~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.... ....+.+++.+||+.+|++||++.|+++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1111 3356888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=302.65 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=200.0
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..+.||+|+||.||++.. .+|+.|++|++.... ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 467788999999999999995 478999999987533 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+ +++|.+++.... ..+++.+++.++.||+++|+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999985432 55899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---C------------c
Q 006125 507 EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---G------------N 570 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~------------~ 570 (660)
. ......++..|+|||.+.+. .++.++||||||++++||++|++++............... . .
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 R-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred C-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 1 11224688899999988654 4689999999999999999998877654432222111110 0 0
Q ss_pred ccccccccCCC---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VLELVDPLLTD---TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~~~~d~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.... .....+....+.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0001122366889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=300.08 Aligned_cols=247 Identities=25% Similarity=0.460 Sum_probs=200.2
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcC---CCCcceEeEEEEeCCeeEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 424 (660)
.|+..+.||+|+||.||+|.. .+++.+++|.++.. ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999995 57899999998653 3445667889999999996 999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++++|.+++.. ..+++..++.++.|++++|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999843 36899999999999999999999998 999999999999999999999999999876544
Q ss_pred CCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||............... ..+.+..
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------~~~~~~~-- 224 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------KPPRLED-- 224 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------CCCCCCc--
Confidence 322 1234688899999998754 4689999999999999999999999765543322111110 0111111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.+++.+||+.||++||++.|+++
T Consensus 225 --~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 --NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 013345778899999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.74 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=201.5
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCC------
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGD------ 418 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 418 (660)
.+++|+..+.||+|++|.||++... +++.+++|++.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999964 67899999987543 3456789999999999 7999999999997644
Q ss_pred eeEEEEEecCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999985422 2456899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVL 572 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 572 (660)
+......... .....++..|+|||++.. ..++.++||||||++++||++|+.||................
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--- 234 (275)
T cd06608 160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--- 234 (275)
T ss_pred ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---
Confidence 8765432221 122468889999998853 346789999999999999999999997544333322222111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+.+. ........+.+++.+||..||++|||+.|+++
T Consensus 235 ---~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 ---PPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---CCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 11223446788999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.74 Aligned_cols=252 Identities=22% Similarity=0.243 Sum_probs=201.7
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh---hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+|+..+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|++++..++|+||+++++.+.+....++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777899999999999999965 589999999875322 245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+.+++|.+++.. .....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999853 23356899999999999999999999988 9999999999999999999999999987543221
Q ss_pred Ccc---------------------------ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH
Q 006125 506 GEA---------------------------NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL 558 (660)
Q Consensus 506 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~ 558 (660)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 110 01123678899999999988899999999999999999999999976554
Q ss_pred HHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCC----HHhHHH
Q 006125 559 LAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT----MSSVAP 615 (660)
Q Consensus 559 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 615 (660)
............ ... . .......+.+++.+||+.||++||+ +.|++.
T Consensus 238 ~~~~~~~~~~~~-------~~~--~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFSNILKKEV-------TFP--G-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHhcCCc-------cCC--C-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 333322221111 010 0 1113456888999999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=297.47 Aligned_cols=246 Identities=31% Similarity=0.439 Sum_probs=200.3
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+|+..+.||+|++|.||++... +++.+++|++.... .....++.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999965 68899999987543 345567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
++++|.+++.... ..+++.....++.|++++|+|||+ .+ ++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999995422 568899999999999999999999 77 99999999999999999999999999876543221
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHHHhcCcccccccccCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-----LLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~-----~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
.. ..++..|+|||.+.+..++.++||||||+++|+|++|+.|+.... ..+......... .+
T Consensus 157 ~~----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~---- 222 (265)
T cd06605 157 KT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------PP---- 222 (265)
T ss_pred hc----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------CC----
Confidence 11 467889999999999999999999999999999999999986431 222221111111 01
Q ss_pred CCCCHH-HHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 582 TSFSDD-EFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 582 ~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..... ....+.+++.+||..||++||++.|++.
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 -RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11111 3345788999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=305.10 Aligned_cols=195 Identities=28% Similarity=0.442 Sum_probs=158.7
Q ss_pred CcccccCCcccEEeeeec---CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe--CCeeEEEEEecC
Q 006125 354 SNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP 428 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 428 (660)
..+||+|+||.||++... ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999964 35789999987532 23467899999999999999999999864 456789999987
Q ss_pred CCChhhhhcCC------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe----CCCCCEEEeecccc
Q 006125 429 NGSLDAILFDP------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMA 498 (660)
Q Consensus 429 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DfGla 498 (660)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 676665321 12235889999999999999999999998 9999999999999 56689999999999
Q ss_pred ccccccCCc-cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 006125 499 RIFAESEGE-ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAG 554 (660)
Q Consensus 499 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~ 554 (660)
+........ .......+|+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 866433221 11223468999999999876 458999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.63 Aligned_cols=193 Identities=23% Similarity=0.335 Sum_probs=164.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
....+|...+.||+|+||.||++... +++.||+|+.... ....|+.++++++||||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999964 5778999975432 2346899999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
|++. ++|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 588887743 3345899999999999999999999998 999999999999999999999999998753322
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA 553 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~ 553 (660)
. ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 122346899999999999999999999999999999999966554
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.63 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=193.4
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..+.||+|+||.||++... +|+.+++|+++.. .......+.+|+.++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677789999999999999964 6899999998642 222345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
++ ++|.+++.. ..+.+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 477777643 2345899999999999999999999998 99999999999999999999999999976543221
Q ss_pred ccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHHhc---Cc------ccccc
Q 006125 507 EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGS-NQLLAYAWHLWNE---GN------VLELV 575 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~-~~~~~~~~~~~~~---~~------~~~~~ 575 (660)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.|+.. .+.......+... .. ..+..
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1 1123568899999998764 478999999999999999999988542 2222221111110 00 00000
Q ss_pred cc----cCCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 576 DP----LLTD----TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 576 d~----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+. .... ..........+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0000 0001112345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.87 Aligned_cols=266 Identities=23% Similarity=0.340 Sum_probs=223.1
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeeecC------CcEEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeE
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLG 412 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 412 (660)
...++.+...++....++-+|.||.||+|.+.+ .+.|-+|.++. .++.+...+..|.-++..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 456788888899999999999999999997643 44677887764 56667778999999999999999999999
Q ss_pred EEEeC-CeeEEEEEecCCCChhhhhc-----CCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC
Q 006125 413 FCVDG-DEKLLVYEFMPNGSLDAILF-----DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (660)
Q Consensus 413 ~~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~ 486 (660)
++.+. +.++++|.++.-|+|..||. +......++..+...++.|++.||+|||.++ ++|.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 98764 56799999999999999997 4455566888889999999999999999998 999999999999999
Q ss_pred CCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 006125 487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHL 565 (660)
Q Consensus 487 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~ 565 (660)
..++||+|-.+++.+.+.+...-......+..||+||.+.+..|+.++|||||||+||||+| |+.|+.+.+..+..--+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 99999999999999888777665544556789999999999999999999999999999998 88898887766654433
Q ss_pred HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 566 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.++.++. . +..++.++..++.-||..+|++||++++++.-|.+
T Consensus 512 kdGyRla--------Q---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 512 KDGYRLA--------Q---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred hccceec--------C---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 3332221 1 22345568888999999999999999999987764
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=290.46 Aligned_cols=249 Identities=30% Similarity=0.477 Sum_probs=205.1
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999965 688999999987555566789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+++|.+++... ...+++..+..++.|++++|.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999998542 246899999999999999999999987 99999999999999999999999999876654332
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 588 (660)
.....++..|++||.+....++.++||||||+++++|++|+.|+...+.......... ..... ... ....
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~-----~~~---~~~~ 223 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPG-----LRN---PEKW 223 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCC-----cCc---cccc
Confidence 2234688999999999888899999999999999999999999876543333322221 11111 100 1111
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 589 FSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 589 ~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 345788999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=295.75 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=202.7
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..+.||+|+||.||++... +|..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999964 6889999998642 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-CEEEeeccccccccccC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAESE 505 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~~~ 505 (660)
+++++|.+++... ....+++..+..++.|++++|.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999998542 2335799999999999999999999988 99999999999999885 46999999987664332
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
... ....|++.|+|||++.+..++.++||||||++++||++|+.|+................ . .+ ..
T Consensus 157 ~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~----~~------~~ 223 (257)
T cd08225 157 ELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-F----AP------IS 223 (257)
T ss_pred ccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-C----CC------CC
Confidence 211 22357889999999988889999999999999999999999998766555554433221 1 11 11
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.+++.+|++.+|++||++.||++
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 112235778899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.14 Aligned_cols=260 Identities=26% Similarity=0.335 Sum_probs=201.5
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVYE 425 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 425 (660)
+|+..+.||.|++|.||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++... ...++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 577788999999999999996 468899999987532 23456789999999999999999999998654 36799999
Q ss_pred ecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 426 FMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 426 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
|+++++|.+++... .....+++..+..++.||+++|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999887432 23445889999999999999999999988 999999999999999999999999998755432
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHHHhcCcccccccccC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-----LLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~-----~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
... ...++..|++||.+.+..++.++||||||+++|||++|+.|+.... ..+.. ..........+.+...
T Consensus 159 ~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 LAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNPELKDEPG 233 (287)
T ss_pred ccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCchhhccCCC
Confidence 211 2356888999999998899999999999999999999999987541 11211 1111111111111110
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGET 621 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 621 (660)
. .......+.+++.+||+.+|++|||+.||++ ++++..
T Consensus 234 ~----~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 234 N----GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred C----CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 0 0112356789999999999999999999987 554443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.36 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=205.1
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.++.|+..+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|+++++.++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3556777889999999999999975 688999999976443 56678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999995422 36999999999999999999999988 9999999999999999999999999987554322
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. .....++..|++||++.+..++.++||||||+++|+|++|+.|+...........+..... .. ... .
T Consensus 171 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-----~~~---~ 239 (286)
T cd06614 171 SK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PP-----LKN---P 239 (286)
T ss_pred hh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CC-----Ccc---h
Confidence 21 1223578899999999888899999999999999999999999876554433332222111 00 100 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.+++.+||+.+|.+||++.+|++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 112345788999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=291.12 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=205.1
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVY 424 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 424 (660)
+|...+.||+|++|.||+|... +++.+++|++.... ....+.+.+|+..+++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999965 78999999987543 24567899999999999999999999999988 8899999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++++|.+++.. ...+++..++.++.|++++|+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999953 236899999999999999999999987 999999999999999999999999999876654
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCcccccccccCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
..........++..|++||.+.....+.++||||||+++++|++|+.|+.... .....+........ ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~ 224 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP----------PE 224 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCC----------cC
Confidence 33111223467889999999988889999999999999999999999987654 22222222211111 01
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+......+.+++.+|++.+|++||++.|++.
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 22223456888999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=300.63 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=197.4
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..+.||+|++|.||+++.. +++.|+||+++... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777899999999999999854 68999999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+. ++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 6888888542 3356899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccceeeeeccCCcCCHhhhhcCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc-cccc---------
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV-LELV--------- 575 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~~--------- 575 (660)
. .....++..|+|||++.+.. ++.++||||||+++|||++|+.||..........+....... .+.+
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1 11234678899999886544 688999999999999999999998765544333332221100 0000
Q ss_pred -----cccCCCC--CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 576 -----DPLLTDT--SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 576 -----d~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....... .........+.+++.+||+.||.+||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000 000111234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.35 Aligned_cols=259 Identities=23% Similarity=0.327 Sum_probs=194.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|+..+.||+|++|.||++..+ +++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56788899999999999999964 68999999986432 22334577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 898888532 236889999999999999999999988 99999999999999999999999999875432211
Q ss_pred ccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHh---cC---cccc-----
Q 006125 507 EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWN---EG---NVLE----- 573 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~---~~---~~~~----- 573 (660)
.. ....++..|+|||++.+ ..++.++||||||+++|||++|+.||.... ..+.....+. .. ....
T Consensus 159 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 TY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 11 11246788999999875 458899999999999999999999986543 1111111111 00 0000
Q ss_pred -cc---cccCCCCC----C-CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 574 -LV---DPLLTDTS----F-SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 574 -~~---d~~~~~~~----~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. ........ . .......+.+++.+||+.+|++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000000 0 0001245678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.00 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=194.2
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+++|...+.||+|+||.||+|.. .+++.+++|++.... ......+.+|+.+++.++|+||+++.+++..++..++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46788899999999999999985 468899999986532 2334467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+. ++|.+++.. ....+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 667666632 2345788889999999999999999998 9999999999999999999999999987543322
Q ss_pred CccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhc---C-----------
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLL-AYAWHLWNE---G----------- 569 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~-~~~~~~~~~---~----------- 569 (660)
... ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... +.....+.. .
T Consensus 158 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 QTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCC--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 111 123568899999998754 5788999999999999999999998644321 111111110 0
Q ss_pred -cccccccccCCCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 -NVLELVDPLLTDTSF-----SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 -~~~~~~d~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+........... .......+.+++.+|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0011345678899999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.80 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=200.5
Q ss_pred cccCCcccEEeeeec-CCcEEEEEEccCCCh---hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 357 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
||+|+||.||++... +|+.+++|++..... ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 489999999875332 4556788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC------
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG------ 506 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~------ 506 (660)
.+++.. .+.+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999953 236899999999999999999999988 99999999999999999999999999875443221
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
........++..|++||.......+.++||||||++++||++|+.||.............. +.. . .+.. .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~-~-------~~~~-~ 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GKI-E-------WPED-V 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCc-C-------CCcc-c
Confidence 1112234678899999999888899999999999999999999999976665444333322 111 0 0000 0
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.....+.+++.+||+.+|.+||++.++.+.|+..
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 0134578899999999999999998877777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.36 Aligned_cols=246 Identities=30% Similarity=0.448 Sum_probs=197.6
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
..|...+.||+|+||.||+++.. +++.|++|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778899999999999999964 6899999988642 2233457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||++ |+|.+++.. ....+++..+..++.||+.+|.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 567666632 2345899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
. ...++..|+|||++. ...++.++||||||+++|||++|+.|+...+............. +.+.
T Consensus 169 ~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~------~~~~- 235 (307)
T cd06607 169 N------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS------PTLS- 235 (307)
T ss_pred C------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC------CCCC-
Confidence 1 235788999999874 45688999999999999999999999876654444333322111 1111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
.......+.+++.+||+.+|++||++.+|+..
T Consensus 236 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 ---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11233458889999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.33 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=194.4
Q ss_pred CCCCCcccccCCcccEEeeeec---CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKL 421 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 421 (660)
+|...++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3667789999999999999964 47899999997632 34456788999999999999999999999988 7899
Q ss_pred EEEEecCCCChhhhhcCCC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC----CCCEEEeec
Q 006125 422 LVYEFMPNGSLDAILFDPR--KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDF 495 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~----~~~~kl~Df 495 (660)
+||||+++ +|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5666553222 2236899999999999999999999998 999999999999999 899999999
Q ss_pred cccccccccCC-ccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH------------H
Q 006125 496 GMARIFAESEG-EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA------------Y 561 (660)
Q Consensus 496 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~------------~ 561 (660)
|++........ ........++..|+|||++.+ ..++.++||||||++++||++|++||....... .
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986644322 111223467889999998876 458999999999999999999999986432111 0
Q ss_pred HHHHHh-----------c-Ccccccccc----cCCCCCCCH------HHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 562 AWHLWN-----------E-GNVLELVDP----LLTDTSFSD------DEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 562 ~~~~~~-----------~-~~~~~~~d~----~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...... + .......+. ......... .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 0 000000000 000000000 12245788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.36 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=192.0
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHH-HhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLL-ILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..+.||+|+||.||++... +|+.||+|+++... .....++..|+.. ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999964 69999999987532 2233445556554 566799999999999999999999999
Q ss_pred ecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 426 FMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 426 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|++ |+|.+++... .....+++..++.++.||+.||+|||++ + ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888777432 2335689999999999999999999986 6 99999999999999999999999999876543
Q ss_pred cCCccceeeeeccCCcCCHhhhhc----CCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCccccccccc
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAME----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~d~~ 578 (660)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.... ..+......... .+.
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~ 227 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP------SPQ 227 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC------CCC
Confidence 221 112357889999998864 456889999999999999999999986422 122222221111 111
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+.. ......+.+++.+||+.+|.+||++.+|++
T Consensus 228 ~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 112345788999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=296.52 Aligned_cols=260 Identities=26% Similarity=0.353 Sum_probs=199.0
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+|+..++||+|++|.||+|+.. +|+.||+|+++... ......+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4777899999999999999964 68899999987533 233556788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++ +|.+++........+++..+..++.||++||.|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 88888755444456899999999999999999999988 999999999999999999999999999755332211
Q ss_pred cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC------cc-----cccc
Q 006125 508 ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG------NV-----LELV 575 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~------~~-----~~~~ 575 (660)
. ....++..|++||.+.+ ..++.++||||||+++|||++|+.||...+..+......... .. ....
T Consensus 157 ~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 157 F--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred c--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1 12356889999999865 457899999999999999999999987554333222221110 00 0000
Q ss_pred cccCCC------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 576 DPLLTD------TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 576 d~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...... ....+.....+.+++.+|++.||.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0001122345778999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.78 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=196.8
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV 423 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 423 (660)
++|+..+.||+|+||.||+|... +++.+++|.++... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777899999999999999965 68899999987432 22334577899999999999999999999877 789999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
+||++ ++|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 4898888532 235899999999999999999999998 99999999999999999999999999987654
Q ss_pred cCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh--------------c
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN--------------E 568 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~--------------~ 568 (660)
..... ....+++.|+|||.+.+. .++.++||||||+++|||++|+.||..........++.. .
T Consensus 159 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32211 223578899999998754 468999999999999999999999875543332221111 0
Q ss_pred Cc------ccccccccCCCCCCCHH-HHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 569 GN------VLELVDPLLTDTSFSDD-EFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 569 ~~------~~~~~d~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
-. ........+. ..+... ....+.+++.+||+.||++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0000000000 011111 2345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.92 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=197.6
Q ss_pred CcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
..+||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+||+++++.+...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36799999999999986 47899999998755555667799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceee
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (660)
.+++. ...+++.....++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++......... ...
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~ 175 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence 99873 234889999999999999999999998 999999999999999999999999998755432211 122
Q ss_pred eeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 513 ~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
..++..|++||.+.+..++.++||||||+++|||++|+.|+............ .... ...+.. .......+
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-~~~~-----~~~~~~---~~~~~~~l 246 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNL-----PPKLKN---LHKVSPSL 246 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhC-----CcccCC---cccCCHHH
Confidence 46788999999998888999999999999999999999998755433322211 1110 011100 11123346
Q ss_pred HHHHhhcccCCCCCCCCHHhHHH
Q 006125 593 IHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 593 ~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+++.+||+.+|.+||++.++++
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhc
Confidence 77888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.08 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=196.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCe-----
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE----- 419 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~----- 419 (660)
++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788899999999999999954 68999999876432 22346788899999999 46999999999987665
Q ss_pred eEEEEEecCCCChhhhhcCCCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEEeecc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRK--RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFG 496 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfG 496 (660)
.++||||+++ +|.+++..... ...+++..++.++.||++||.|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78887754222 346899999999999999999999998 999999999999998 8999999999
Q ss_pred ccccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc--ccc
Q 006125 497 MARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN--VLE 573 (660)
Q Consensus 497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~--~~~ 573 (660)
++..+....... ....+++.|+|||++.+ ..++.++||||||+++|||++|..||...........+...-. ..+
T Consensus 157 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 987654322211 12256788999998865 4579999999999999999999999876655444433322100 000
Q ss_pred cc-----------cccCCCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 574 LV-----------DPLLTDT---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 574 ~~-----------d~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. .+..... ...+.....+.+++.+||+.||.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000000 000122345788999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=310.45 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=207.0
Q ss_pred CCCCcccccCCcccEEeeeecC-CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 351 FSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
|.+...||.|+||.||+++.++ +-..|.|++...++...+++.-||++|...+||+||+|++.+..++.+++..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3445679999999999999664 445577888888888999999999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|-.+.++.. -...|++.++..++.|++.+|.|||+.. |||||||+.|||++-+|.++|+|||.+-....... .
T Consensus 114 GAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q--k 186 (1187)
T KOG0579|consen 114 GAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ--K 186 (1187)
T ss_pred chHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHh--h
Confidence 999998853 4456999999999999999999999998 99999999999999999999999999865432222 2
Q ss_pred eeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 510 TVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
...+.|||-|||||+.+ ..+|..++||||||+.|.||..+.+|....+......++.+.+. |.+..
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP------PTLlq--- 257 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP------PTLLQ--- 257 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC------CcccC---
Confidence 23468999999999974 56799999999999999999999999887776666655554432 22222
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
+......|.+++.+||.+||..||++.+++
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 122334477888899999999999999987
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=289.17 Aligned_cols=247 Identities=30% Similarity=0.456 Sum_probs=203.6
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh--hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..+.||+|++|.||+++.. +++.+++|.+..... .....+.+|++++.+++|+|++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999854 678999999976443 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999843 356899999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
. .....++..|++||...+...+.++|||+||+++++|++|+.|+.........+...... .+. .+.
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~-----~~~ 221 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD------HPP-----LPE 221 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC------CCC-----CCC
Confidence 2 122467889999999988888999999999999999999999987554333333322111 011 111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.....+.+++.+||+.+|++||++.|++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 22345778889999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=295.24 Aligned_cols=245 Identities=25% Similarity=0.295 Sum_probs=199.9
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+|...+.||+|+||.||++... +++.+++|.+... .....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677899999999999999965 6899999998643 22456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++.. ...+++..+..++.||+++|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999943 356899999999999999999999988 9999999999999999999999999987654432
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHHhcCcccccccccCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL--LAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ........... ...
T Consensus 155 ~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~ 220 (258)
T cd05578 155 L---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA-----------DVL 220 (258)
T ss_pred c---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc-----------ccc
Confidence 1 1224678899999999988899999999999999999999999875542 22222211110 001
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCH--HhHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTM--SSVA 614 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 614 (660)
.+......+.+++.+||+.||.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 122233567889999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=297.82 Aligned_cols=260 Identities=24% Similarity=0.296 Sum_probs=196.1
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 422 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 422 (660)
.++|+..+.||+|+||.||++.. .+|+.||+|+++... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45788889999999999999996 468999999986432 22233567899999999999999999998765 46899
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+.+ +|.+++... ...+++.++..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999965 788887432 356899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc--ccc------
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN--VLE------ 573 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~--~~~------ 573 (660)
...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+...-. ...
T Consensus 160 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 432111 12245778999999875 4578999999999999999999999976554443332221100 000
Q ss_pred ------cccccCCCCCCC----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 574 ------LVDPLLTDTSFS----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 574 ------~~d~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+.-........ ......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000 011345678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=302.21 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=202.7
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEcc--CCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCee
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 420 (660)
+.+....|++.++||.||.+.||++...+.+.+|+|++. ..+.+...-|.+|+..|.+| .|.+|++|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 456677789999999999999999998788889988875 35666778899999999999 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
||||||- ..+|..+|... ...++...++.+..||+.++.++|+++ |||.||||.|+|+ -.|.+||+|||++..
T Consensus 436 YmvmE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcc
Confidence 9999976 55999999542 222333378889999999999999999 9999999999999 467999999999998
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCC-----------CCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhc
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGL-----------YSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNE 568 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~ 568 (660)
...+...-.....+||+.||+||.+.... .+.++||||||||||+|+.|+.||+... .....
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl------ 582 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKL------ 582 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHH------
Confidence 87776665556679999999999985322 5689999999999999999999996432 22211
Q ss_pred Cccccccccc--CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 569 GNVLELVDPL--LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 569 ~~~~~~~d~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+.++. +.-+..+.. ..+++++..||+.||.+||+..|+++
T Consensus 583 ---~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 583 ---HAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---HhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2222221 111111111 12888999999999999999999984
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.97 Aligned_cols=258 Identities=22% Similarity=0.318 Sum_probs=196.6
Q ss_pred CCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
|+..+.||+|++|.||++.. .+|+.|++|++.... ......+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678899999999999985 479999999986432 233456889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
+ ++|.+++.... ...+++..+..++.|++++|+|||+.+ ++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68998884322 235899999999999999999999987 999999999999999999999999999755332211
Q ss_pred cceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc-cc-----------cc
Q 006125 508 ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN-VL-----------EL 574 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~-~~-----------~~ 574 (660)
. ....++..|+|||++.+. .++.++||||||+++|||++|+.||...+............. .. +.
T Consensus 156 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 Y--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred c--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1 122568889999987654 578999999999999999999999876554433333222100 00 00
Q ss_pred ---ccccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 575 ---VDPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 575 ---~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+...... ..........+.+++.+|++.||.+||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 0001112245788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=293.88 Aligned_cols=240 Identities=27% Similarity=0.337 Sum_probs=184.9
Q ss_pred ccccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhh---cCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 356 ILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILK---LQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
.||+|+||.||++.. .+++.+|+|.+.... ......+.+|..++.. .+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 468899999886422 1222334455444433 479999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+|+|.+++. ..+.+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 999999884 3456999999999999999999999998 99999999999999999999999999875533221
Q ss_pred ceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHHHhcCcccccccccCCCCCCC
Q 006125 509 NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA--YAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||....... ....... .... ..+
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------~~~~-----~~~ 219 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------TVNV-----ELP 219 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh------cCCc-----CCc
Confidence 12368999999999864 558999999999999999999999986432111 1111110 0111 112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHhHHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAPM 616 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 616 (660)
......+.+++.+||+.||.+|| +++|+++.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 22334577888999999999999 59999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=287.86 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=206.2
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|...+.||.|+||.||++... +++.+++|++.... ......+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677789999999999999964 68899999987532 35566789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 427 MPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 427 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
+++++|.+++.... ....+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999985432 2366999999999999999999999998 9999999999999999999999999998665433
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
. ......|++.|+|||.+.+..++.++||||||+++++|++|+.|+...+........... ... .+ +
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-----~~-----~ 224 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-QYP-----PI-----P 224 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC-CCC-----CC-----C
Confidence 1 122246888999999999888999999999999999999999999776654444333221 111 11 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.+++.+||+.+|++||++.|+++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 122345788999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=290.87 Aligned_cols=240 Identities=26% Similarity=0.355 Sum_probs=194.6
Q ss_pred cccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 357 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
||+|++|.||+++.. +++.+++|++.... ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 58999999986422 23456799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceee
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (660)
.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999943 345899999999999999999999988 9999999999999999999999999998765432 1122
Q ss_pred eeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHHhcCcccccccccCCCCCCCHHHHH
Q 006125 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFS 590 (660)
Q Consensus 513 ~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 590 (660)
..++..|++||.+.+..++.++|+||||+++|||++|+.|+.... ............. .. ..+.....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~---~~~~~~~~ 221 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-------KL---EFPNYIDK 221 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-------CC---CCCcccCH
Confidence 467889999999988889999999999999999999999997554 3322222221111 00 11112245
Q ss_pred HHHHHHhhcccCCCCCCCC-----HHhHHH
Q 006125 591 RYIHIGLLCVQEDAFDRPT-----MSSVAP 615 (660)
Q Consensus 591 ~l~~li~~cl~~dP~~RPt-----~~evl~ 615 (660)
.+.+++.+||+.+|++||+ +.|+++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 6888999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=296.18 Aligned_cols=261 Identities=15% Similarity=0.150 Sum_probs=183.8
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC----CcEEEEEEccCCChhcH-----------HHHHHHHHHHhhcCCCCcceE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSCSEQGT-----------AEFTNEVLLILKLQHKNLVKL 410 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l 410 (660)
+..++|...++||+|+||.||+|...+ +..+++|+......... .....+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345678889999999999999999654 34566665432221110 112233345566789999999
Q ss_pred eEEEEeCC----eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC
Q 006125 411 LGFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (660)
Q Consensus 411 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~ 486 (660)
++++.... ..++++|++.. ++.+++.. ....++..+..|+.|+++||+|||+.+ |+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 99876543 33677777643 56666532 223578888999999999999999988 999999999999999
Q ss_pred CCCEEEeeccccccccccCCc-----cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHH
Q 006125 487 DMNSKISDFGMARIFAESEGE-----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLA 560 (660)
Q Consensus 487 ~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~ 560 (660)
++.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999876432211 11122468999999999999999999999999999999999999997542 111
Q ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 561 YAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 561 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
... ....+....+....+..+. ....+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIH-AAKCDFIKRLHEGKIKIKN----ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHH-HhHHHHHHHhhhhhhccCC----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111 1000000111111111111 1345778888999999999999999998774
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=290.19 Aligned_cols=245 Identities=22% Similarity=0.258 Sum_probs=191.3
Q ss_pred cccccCCcccEEeeee-cCCcEEEEEEccCCCh---hcHHHHHHHHHH-HhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE---QGTAEFTNEVLL-ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+.||+|+||.||++.. .+++.||+|.++.... .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999985 4689999999865321 222334445444 3455899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
++|.+++. ..+.+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 99999994 3345899999999999999999999988 999999999999999999999999998754331
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
....++..|++||.+.+..++.++||||||+++|||++|..|+............. ..... . .........
T Consensus 151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~----~---~~~~~~~~~ 221 (260)
T cd05611 151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL-SRRIN----W---PEEVKEFCS 221 (260)
T ss_pred -ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-hcccC----C---CCcccccCC
Confidence 12357889999999988889999999999999999999999997665443322221 11110 0 001111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
..+.+++.+||+.+|++||++.++.+.|+-
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 457889999999999999988777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=296.98 Aligned_cols=246 Identities=29% Similarity=0.439 Sum_probs=196.5
Q ss_pred CCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
|...+.||+|+||.||+++. .+++.+|+|++... .......+.+|+.++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 56678899999999999995 46889999998642 223345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++ +|.+++.. ....+++.++..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 974 77776642 2345899999999999999999999998 999999999999999999999999998654321
Q ss_pred ccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
....++..|+|||++. .+.++.++||||||+++|||++|+.|+...........+..... +...
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~------~~~~--- 245 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------PTLQ--- 245 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC------CCCC---
Confidence 1235788999999974 45689999999999999999999999876544333333332221 0111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
.......+.+++.+||+.+|.+||++.+|++.+-
T Consensus 246 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 246 -SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -CccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1122345788999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=301.05 Aligned_cols=268 Identities=22% Similarity=0.335 Sum_probs=200.2
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC-----ee
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EK 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 420 (660)
+++|+..++||+|+||.||+|.. .+|+.||+|+++.. .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46788899999999999999984 47899999998643 2334556888999999999999999999876543 57
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++++||+++ +|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999964 7877773 245899999999999999999999998 99999999999999999999999999876
Q ss_pred ccccCCcc-ceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH---hcCc---cc
Q 006125 501 FAESEGEA-NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLW---NEGN---VL 572 (660)
Q Consensus 501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~---~~~~---~~ 572 (660)
........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+......... .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 54322211 1122467899999998754 568999999999999999999999997554332221111 1100 00
Q ss_pred cccccc-------C-CCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH--hcCCCCC
Q 006125 573 ELVDPL-------L-TDTSF-----SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM--LKGETGT 623 (660)
Q Consensus 573 ~~~d~~-------~-~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~ 623 (660)
.+.+.. . ..+.. .+.....+.+++.+||+.||++||++.|+++. ++.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 000000 0 00000 01123457899999999999999999999865 6655433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=302.06 Aligned_cols=256 Identities=25% Similarity=0.293 Sum_probs=195.8
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------C
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 418 (660)
.++|+..+.||+|+||.||++.. .+++.||+|++... .......+.+|+.++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46788899999999999999995 47899999998642 333455678899999999999999999998643 3
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 4699999996 478777732 1888999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc----------
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---------- 568 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---------- 568 (660)
+....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 86543221 12235788999999999999999999999999999999999998755432221111110
Q ss_pred ------------Cc------ccccccccCCCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 569 ------------GN------VLELVDPLLTDT---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 569 ------------~~------~~~~~d~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. ..+.+...+... .........+.+++.+||+.||++||++.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000000000000 001123445788999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=288.72 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=204.0
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|+..++||+|+||.||+++. .+++.+++|.+... .......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 466778999999999999984 47889999998743 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 427 MPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 427 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
+++++|.+++.... ....+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999885421 2355899999999999999999999998 9999999999999999999999999998765441
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
. ....++..|++||.+.+..++.++|+||||+++|||++|+.|+...+......... ..... ...
T Consensus 158 ~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~----------~~~ 222 (256)
T cd08530 158 A----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYP----------PIP 222 (256)
T ss_pred c----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCC----------CCc
Confidence 1 12357889999999999899999999999999999999999998766543332221 11111 122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.+++.+|++.+|.+||++.|+++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 234456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=295.47 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=192.6
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|...+.||+|+||.||++.. .+++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455567899999999999995 468999999987432 344567889999999996 99999999999999999999999
Q ss_pred cCCCChhhhhcC--CCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 427 MPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 427 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
+.. +|.++... ......+++..+..++.++++||+|||+. + ++||||||+||++++++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 55544311 12235689999999999999999999975 5 99999999999999999999999999976543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcC---CCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCcccccccccC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEG---LYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
.... ....|+..|+|||++.+. .++.++||||||+++|||++|+.||.... ..+......... .+.+
T Consensus 161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------~~~~ 231 (288)
T cd06616 161 SIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD------PPIL 231 (288)
T ss_pred CCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC------CCcC
Confidence 2221 223578899999999766 68999999999999999999999986443 111111111111 1111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. .........+.+++.+||+.||++||++.||++
T Consensus 232 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 232 SN-SEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CC-cCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 111223445788999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.88 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=197.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-----ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--Cee
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 420 (660)
.+|...+.||+|+||.||++.. .+++.+++|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4678889999999999999995 46899999987531 223456788999999999999999999998764 457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++++||+++++|.+++. ..+.+++.....++.||+.+|.|||+.+ ++|+||||+||++++++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999984 3345889999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCCc-cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 501 FAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 501 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
....... .......++..|+|||++.+..++.++||||||++++||++|+.||.................. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~-- 228 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK-----P-- 228 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC-----C--
Confidence 5322111 1112245788999999998888999999999999999999999999765444333332221110 1
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+......+.+++.+|++ +|..||+..+++.
T Consensus 229 ---~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 229 ---MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1222233457788889999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.14 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=202.5
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 423 (660)
++|...+.||+|+||.||+++.. +++.+++|++... .......+.+|+.++++++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778899999999999999964 7899999998642 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999994 3446999999999999999999999998 99999999999999999999999999986644
Q ss_pred cCCc------------------cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 006125 504 SEGE------------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL 565 (660)
Q Consensus 504 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~ 565 (660)
.... .......++..|++||.+....++.++||||||++++++++|+.|+............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 3221 1112245788999999998888999999999999999999999999766533333222
Q ss_pred HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCH----HhHHH
Q 006125 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTM----SSVAP 615 (660)
Q Consensus 566 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~ 615 (660)
..... ..+......+.+++.+||+.+|.+||++ .++++
T Consensus 235 ~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 LKLEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HhcCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 21110 1112224457889999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=291.24 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=191.9
Q ss_pred CCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeC--CeeEEEEE
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDG--DEKLLVYE 425 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 425 (660)
|+..++||+|+||.||++.. .+++.+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45678899999999999995 468899999987532 222334557888888885 99999999999987 88999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|++ ++|.+++.. ....+++.+++.++.||++||+|||+.+ ++||||+|+||++++ +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 577777743 2346899999999999999999999998 999999999999999 999999999998664332
Q ss_pred CccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh--------------cCc
Q 006125 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN--------------EGN 570 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~--------------~~~ 570 (660)
.. ....++..|+|||++.. ..++.++|||||||++|||++|+.||...+..+....... ...
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 21 12357889999997654 5678999999999999999999999976543332222111 000
Q ss_pred ccccccccCCCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VLELVDPLLTDT---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~~~~d~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+..... .........+.+++.+||+.+|++||+++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 001123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=291.76 Aligned_cols=243 Identities=28% Similarity=0.325 Sum_probs=189.9
Q ss_pred cccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 357 lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
||+|+||+||++.. .+|+.+++|.+.... ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 468999999986422 22344567899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceee
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (660)
.+++.... ...+++..+..++.|++.+|.|||+.+ ++||||+|+||++++++.+||+|||++........ ...
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~ 153 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKG 153 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---ccc
Confidence 99985432 235899999999999999999999998 99999999999999999999999999876543211 112
Q ss_pred eeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 513 ~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
..++..|++||++.+..++.++||||||+++++|++|+.||...........+. ...... .. ..+......+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~--~~-----~~~~~~~~~~ 225 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-RRTLEM--AV-----EYPDKFSPEA 225 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-hccccc--cc-----cCCccCCHHH
Confidence 357889999999988889999999999999999999999986543211111111 110000 00 1111223457
Q ss_pred HHHHhhcccCCCCCCC-----CHHhHH
Q 006125 593 IHIGLLCVQEDAFDRP-----TMSSVA 614 (660)
Q Consensus 593 ~~li~~cl~~dP~~RP-----t~~evl 614 (660)
.+++.+||+.||.+|| ++.+++
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHH
Confidence 7889999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=293.58 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=195.2
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..+.||+|.+|.||++... +|+.|++|++.... ......+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46778899999999999999964 78899999986432 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEEeecccccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAES 504 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~~ 504 (660)
|++ ++|.+++.. .....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++ ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 477777633 22233678888999999999999999988 999999999999985 567999999999765432
Q ss_pred CCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc--Cccccccc-----
Q 006125 505 EGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE--GNVLELVD----- 576 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~--~~~~~~~d----- 576 (660)
.... ....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+........ ....+..+
T Consensus 157 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 VRTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred cccc--ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 2111 12356889999999876 45789999999999999999999999765544433332211 00000000
Q ss_pred -------ccCCCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 577 -------PLLTDT---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 577 -------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+..... .........+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 001112344778999999999999999999985
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=322.43 Aligned_cols=264 Identities=30% Similarity=0.428 Sum_probs=212.3
Q ss_pred HHHhhcCCCCCCcccccCCcccEEeeeec----C----CcEEEEEEccC-CChhcHHHHHHHHHHHhhc-CCCCcceEeE
Q 006125 343 TLNLATSNFSDSNILGQGGFGPVYKGVLS----D----GKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLG 412 (660)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~----g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 412 (660)
.+++..+++...+.||+|.||.|++|... . ...||||.++. ....+.+.+..|+++|..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 44555666666779999999999999843 1 34799999985 3446678899999999999 6999999999
Q ss_pred EEEeCCeeEEEEEecCCCChhhhhcCCC------C-----C--CccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 006125 413 FCVDGDEKLLVYEFMPNGSLDAILFDPR------K-----R--GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKA 479 (660)
Q Consensus 413 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp 479 (660)
+|...+..++|+||+.+|+|.++|...+ . . ..++....+.++.|||.||+||++.. ++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999996544 0 0 23889999999999999999999987 99999999
Q ss_pred CceEeCCCCCEEEeeccccccccccCCccceeeee--ccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 006125 480 SNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV--GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN 556 (660)
Q Consensus 480 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~ 556 (660)
+|||+.++..+||+|||+++............ .. -...|||||.+....|+.|+|||||||+||||+| |..|+...
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999998655443332111 11 2456999999999999999999999999999999 66777654
Q ss_pred cHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 557 QLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
......++..+++...+. +.-+..++.+|++.||+.+|++||++.|+++.++..
T Consensus 526 ~~~~~l~~~l~~G~r~~~----------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 PPTEELLEFLKEGNRMEQ----------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CcHHHHHHHHhcCCCCCC----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 423333555655543322 122244577889999999999999999999999884
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.97 Aligned_cols=255 Identities=20% Similarity=0.236 Sum_probs=191.6
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
+.+|.|+++.|+++.. +++.||+|+++.. .......+.+|+.+++.++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455555555555555 7899999998753 345567899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc-----
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE----- 507 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~----- 507 (660)
.+++... ....+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.+.........
T Consensus 87 ~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999543 2335889999999999999999999998 999999999999999999999999988755432211
Q ss_pred cceeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccc----------
Q 006125 508 ANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELV---------- 575 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 575 (660)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||................ ....+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT-VPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CccccccCchhhhcC
Confidence 11122356778999999876 358899999999999999999999997654333222221110 00000
Q ss_pred ----------cccC---CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 576 ----------DPLL---TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 576 ----------d~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
++.. ............+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 000111222346788999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.12 Aligned_cols=255 Identities=23% Similarity=0.292 Sum_probs=191.9
Q ss_pred cccccC--CcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQG--GFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G--~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
..||+| +||+||++.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 8899999995 47999999998642 334456789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
++|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++++||+.............
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999985432 234889999999999999999999988 99999999999999999999999986543322111110
Q ss_pred -----eeeeeccCCcCCHhhhhcC--CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccc---------
Q 006125 510 -----TVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLE--------- 573 (660)
Q Consensus 510 -----~~~~~gt~~y~aPE~~~~~--~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------- 573 (660)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||....................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0011345679999999763 478999999999999999999999975543332222221111000
Q ss_pred ---------------------------cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 574 ---------------------------LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 574 ---------------------------~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
..+..+.. .........+.+++.+||+.||++|||+.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT-PSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccc-hhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000000 11223445688999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.12 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=198.4
Q ss_pred CCCcccccCCcccEEeeee-cCCcEEEEEEc--c--CCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe--eEEEE
Q 006125 352 SDSNILGQGGFGPVYKGVL-SDGKEVAVKRL--S--SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE--KLLVY 424 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l--~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 424 (660)
+...+||+|+|-+||||.. .+|-.||=-.+ + ..++...+.|.+|+.+|+.|+||||++++.+..+... .-+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3457899999999999995 35666653222 1 1345566889999999999999999999999987665 66899
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-CCEEEeeccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAE 503 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~~~~~ 503 (660)
|.+..|+|..|+. +.+..+.+....|++||++||.|||++. |||+|||||-+||+|+.+ |.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999994 4556889999999999999999999986 799999999999999876 8999999999988765
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.... ...|||.|||||+.. ..|.+.+||||||+.++||+|+..|+..=.-...+++....+.....+...
T Consensus 199 s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV----- 268 (632)
T KOG0584|consen 199 SHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV----- 268 (632)
T ss_pred cccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc-----
Confidence 4332 258999999999887 789999999999999999999999987543334444444443322222211
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
. -..+.++|.+|+.. .++||++.|+|. +|..
T Consensus 269 -~---dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 269 -K---DPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -C---CHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1 23467788899999 999999999983 4544
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=293.29 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=197.7
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEEEEE
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVYE 425 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 425 (660)
|+..+.||+|+||.||++... +++.+++|++... .......+.+|+.+++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999965 5889999999764 234456788999999999999999999999988 78999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++ +|.+++... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888888432 246899999999999999999999988 9999999999999999999999999998665443
Q ss_pred CccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC------ccccc----
Q 006125 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG------NVLEL---- 574 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~------~~~~~---- 574 (660)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+.... .....
T Consensus 155 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred ccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 211 122356788999997764 457899999999999999999999987655433322222110 00000
Q ss_pred ----ccccCCC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 575 ----VDPLLTD-----TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 575 ----~d~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....... ..+.......+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 0000011456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=300.21 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=196.8
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC--CeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG--DEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~ 421 (660)
.++|+..+.||+|+||.||+|... +++.+|+|++... .......+.+|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 356788899999999999999964 6889999988542 233445677899999999 999999999998654 3679
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 589888843 26889999999999999999999988 999999999999999999999999999866
Q ss_pred cccCCc---cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--------
Q 006125 502 AESEGE---ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG-------- 569 (660)
Q Consensus 502 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~-------- 569 (660)
...... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 543322 12223468899999998764 567899999999999999999999986543322221111110
Q ss_pred ------cccccccccCCC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 570 ------NVLELVDPLLTD-----TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 570 ------~~~~~~d~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
...++++..... ..........+.+++.+||+.||++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000011100000 00011123457889999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=279.03 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=200.4
Q ss_pred cccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
+.||+|+++.|--++ +.+|.++|||++.+........+.+|++++.+- .|+||++|+++|++++..|||||.|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999988 789999999999987777788899999999998 699999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC---CEEEeecccccccccc-----
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIFAES----- 504 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DfGla~~~~~~----- 504 (660)
-..+ .++..+++.++.+++++|+.||.|||.+| |.||||||+|||..+.. -+||+||.|..-....
T Consensus 164 LshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 8888 45566999999999999999999999999 99999999999997654 4799999887643211
Q ss_pred CCccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH--------------HHHHHH
Q 006125 505 EGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL--------------AYAWHL 565 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~--------------~~~~~~ 565 (660)
.........+|+..|||||+.. ...|..+.|.||||||||-||+|.+||.+.--. +..+.-
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1122234468999999999874 345889999999999999999999999633211 112222
Q ss_pred HhcCcccccccccCCCCCCCHHHH----HHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCC
Q 006125 566 WNEGNVLELVDPLLTDTSFSDDEF----SRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGT 623 (660)
Q Consensus 566 ~~~~~~~~~~d~~~~~~~~~~~~~----~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~ 623 (660)
+.++.. ++++++. ..-.+++...+..|+.+|.++.+++. +..+...+
T Consensus 318 IQEGkY-----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 318 IQEGKY-----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HhccCC-----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 223221 2333322 23456777888899999999999986 44544433
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=293.97 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=193.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC-CcEEEEEEccCCC-hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 422 (660)
+.-++|+..+.||+|+||.||++...+ ++.||||+++... ......+..|+.++.+. .|+||+++++++......++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 344667888999999999999999764 8999999997532 23345566777767666 59999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+|||++ ++|.+++.. ....+++..+..++.||++||+|||+. + |+||||+|+||++++++.+||+|||++..+
T Consensus 92 v~e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 92 CMELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EeeccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999985 477777643 234689999999999999999999974 5 999999999999999999999999998765
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCC----CCcchhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHHhcCccccccc
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGL----YSKKSDVFSFGVLLIEIITGRRNAGSNQL-LAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwslGvll~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~d 576 (660)
...... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... .+..........
T Consensus 166 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 236 (296)
T cd06618 166 VDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP------ 236 (296)
T ss_pred cCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC------
Confidence 432221 1235778899999987543 78999999999999999999999865322 122222222110
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
+.... .......+.+++.+||+.||.+||++.++++.
T Consensus 237 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLPP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111 11123457889999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.02 Aligned_cols=252 Identities=29% Similarity=0.352 Sum_probs=200.3
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
..+..+.|..-++||+|+||.|+-++. .+|+.+|.|++.+. ......-..+|-.+|.+++.+.||.+--.++..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 345557788889999999999999985 47999999988542 23334457789999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
++||+..|.||+|.-+|.+... ..+++..+...+.+|+.||++||... ||.|||||+|||+|+.|+++|+|.||+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred eEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEE
Confidence 9999999999999999976443 56999999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
.+....... ..+||.+|||||++.+..|+...|+|||||+||||+.|+.||........ +..+ +.++.+ ++
T Consensus 336 ei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-~eEv-drr~~~--~~-- 406 (591)
T KOG0986|consen 336 EIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-REEV-DRRTLE--DP-- 406 (591)
T ss_pred ecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-HHHH-HHHHhc--ch--
Confidence 876554433 23899999999999999999999999999999999999999853211100 0000 000000 00
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 610 (660)
..+++.-.+....|....|++||.+|..-
T Consensus 407 --~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 407 --EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred --hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 12233333346667778999999999743
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=288.39 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=195.5
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhc---CCCCcceEeEEEEeCCe-----
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDGDE----- 419 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 419 (660)
|+..+.||+|+||.||+++.+ +++.+|+|+++... ......+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456788999999999999975 58999999997422 22234566787777666 69999999999988776
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.+++|||+.+ +|.+++... ....+++..++.++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 788887532 2235899999999999999999999988 9999999999999999999999999997
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc---cc---
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV---LE--- 573 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~---~~--- 573 (660)
........ ....++..|+|||++.+..++.++||||||+++|||++|++|+......+....+...-.. ..
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 76433221 1235788899999999989999999999999999999999998765544443333221100 00
Q ss_pred -------cccccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 574 -------LVDPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 574 -------~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
........ .....+....+.+++.+||+.||.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0111223456788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.23 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=205.4
Q ss_pred hcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
....|.+.++||+|.|+.|.++.. .++..||||.+.+. +....+.+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346788899999999999999994 47999999999763 233345689999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+.+|.+.+++ .+.+...+..+..++.|+.++++|||+++ |+|||||++||||+.++++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl---~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYL---VKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHH---HhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999 45566777899999999999999999998 99999999999999999999999999987763
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
... ....+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..+...-.+..... +.
T Consensus 208 ~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk---------~r-- 273 (596)
T KOG0586|consen 208 GLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK---------YR-- 273 (596)
T ss_pred ccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee---------ec--
Confidence 322 234699999999999998765 689999999999999999999998766543322211110 00
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+.-....+-++++++|..+|.+|++++++.+
T Consensus 274 -Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 274 -IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 01111234778889999999999999999963
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=300.45 Aligned_cols=268 Identities=22% Similarity=0.332 Sum_probs=201.0
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEe----CCeeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 421 (660)
++|+..+.||+|+||.||++.. .+|+.|++|++.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6788889999999999999995 469999999987532 2345667889999999999999999998763 34679
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+|+||+. ++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 68988884 3345899999999999999999999988 999999999999999999999999999765
Q ss_pred cccCCcc--ceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh-----------
Q 006125 502 AESEGEA--NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN----------- 567 (660)
Q Consensus 502 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~----------- 567 (660)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 4332211 1123468889999999865 4689999999999999999999999975543322211111
Q ss_pred ---cCcccccccccCCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCC
Q 006125 568 ---EGNVLELVDPLLTDTSFS-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGT 623 (660)
Q Consensus 568 ---~~~~~~~~d~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~ 623 (660)
.....+..+......... ......+.+++.+||+.+|++||++.+++. ++++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 001111111000000111 123456889999999999999999999885 44443333
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=290.11 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=199.3
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh--hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
|+..+.||+|++|.||++... +++.+++|+++.... .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455688999999999999954 788999999875322 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++ +|.+++.. ....+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 88887743 2256899999999999999999999998 999999999999999999999999999776543311
Q ss_pred cceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-C-----ccccccc----
Q 006125 508 ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-G-----NVLELVD---- 576 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~-----~~~~~~d---- 576 (660)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+........ + ......+
T Consensus 155 --~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 155 --YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred --ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 1123577889999998876 7899999999999999999999998765544333222111 0 0000000
Q ss_pred -----ccCCC---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 577 -----PLLTD---TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 577 -----~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+.... ....+.....+.+++.+||+.||.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 0111223456889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.81 Aligned_cols=261 Identities=24% Similarity=0.328 Sum_probs=192.3
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe------
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------ 419 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 419 (660)
++|+..++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999954 68999999886432 2233456789999999999999999999876543
Q ss_pred --eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 420 --KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 420 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
.++||||+.+ +|.+++.. ....+++.+++.++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4999999965 78777743 2235899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCc--cceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHH---HHHHhc---
Q 006125 498 ARIFAESEGE--ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYA---WHLWNE--- 568 (660)
Q Consensus 498 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~---~~~~~~--- 568 (660)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...+..... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866433222 111223578889999988664 4788999999999999999999998755432211 111100
Q ss_pred -----CcccccccccCCCCCC---------CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 569 -----GNVLELVDPLLTDTSF---------SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 569 -----~~~~~~~d~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....+..+........ .......+.+++.+||+.||.+||+++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000000000000 0001234678999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.69 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=197.8
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC----
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD---- 418 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 418 (660)
...++|+..+.||+|+||.||+|..+ +|+.|++|+++... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567888999999999999999965 68899999986432 233456788999999999999999999987655
Q ss_pred ------eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEE
Q 006125 419 ------EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (660)
Q Consensus 419 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl 492 (660)
..++|+||+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 66666643 2345899999999999999999999998 999999999999999999999
Q ss_pred eeccccccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc--C
Q 006125 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE--G 569 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~--~ 569 (660)
+|||++........... ....++..|+|||.+.+ ..++.++||||||+++|||++|++|+...........+... .
T Consensus 158 ~dfg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred CcccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999987654332111 12245778999998865 45789999999999999999999999765543332222111 0
Q ss_pred ccc----ccc--------ccc--CCCC--CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 NVL----ELV--------DPL--LTDT--SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 ~~~----~~~--------d~~--~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
... .+. +.. ..+. .........+.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 000 000 0000 000012345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.68 Aligned_cols=272 Identities=25% Similarity=0.351 Sum_probs=203.9
Q ss_pred hcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC-----
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----- 418 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 418 (660)
..++|...+.||+|+||.||++.. .+++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467788899999999999999984 57899999998642 2333456889999999999999999999987553
Q ss_pred -eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 419 -EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 419 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999998 778988873 245899999999999999999999988 99999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc------
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN------ 570 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~------ 570 (660)
+....... ....+++.|++||.+.+ ..++.++||||||+++++|++|+.||.................
T Consensus 165 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 165 ARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 87653321 12356889999999876 4588999999999999999999999976554333322221100
Q ss_pred --------cccccc--ccCCCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhcCCCCCCCCCCCCc
Q 006125 571 --------VLELVD--PLLTDT---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGETGTLPQPQKPA 631 (660)
Q Consensus 571 --------~~~~~d--~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~~~~~~~p~~p~ 631 (660)
....+. +..... .........+.+++.+|++.||++|||+.+++ .+++.......++..|.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~ 315 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP 315 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC
Confidence 000000 000000 00011223477899999999999999999998 55665544444444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=316.03 Aligned_cols=262 Identities=18% Similarity=0.291 Sum_probs=185.0
Q ss_pred cCCCCCCcccccCCcccEEeeeecC--CcEEEEE------------------EccCCChhcHHHHHHHHHHHhhcCCCCc
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSD--GKEVAVK------------------RLSSCSEQGTAEFTNEVLLILKLQHKNL 407 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~h~ni 407 (660)
.++|...+.||+|+||.||++..+. +...+.| .+. ........+.+|+.++++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999987532 2222222 111 122234568899999999999999
Q ss_pred ceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC
Q 006125 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK--RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD 485 (660)
Q Consensus 408 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~ 485 (660)
+++++++...+..++|+|++. ++|.+++..... ........+..|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 466666643211 222446677889999999999999998 99999999999999
Q ss_pred CCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCC-CCCC--cHHHHH
Q 006125 486 SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN-AGSN--QLLAYA 562 (660)
Q Consensus 486 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p-~~~~--~~~~~~ 562 (660)
.++.+||+|||+++.+....... .....|+..|+|||++.+..++.++|||||||++|||++|+.+ +... ......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999998765432211 2234789999999999999999999999999999999998854 3321 111111
Q ss_pred HHHHhcC-----cc-------ccccccc-CC-CCCCCHH------HHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 563 WHLWNEG-----NV-------LELVDPL-LT-DTSFSDD------EFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 563 ~~~~~~~-----~~-------~~~~d~~-~~-~~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+....- .. .+.++.. +. .+..... ....+.+++.+||+.||.+||++.|++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111100 00 0000000 00 0000000 1124667788999999999999999985
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.75 Aligned_cols=265 Identities=25% Similarity=0.348 Sum_probs=197.7
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC----------
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG---------- 417 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 417 (660)
.+|...+.||+|+||.||++.. .+|+.|++|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6788889999999999999995 46899999998765556667789999999999999999999776543
Q ss_pred ----CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEE
Q 006125 418 ----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKI 492 (660)
Q Consensus 418 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl 492 (660)
...++|+||++ ++|.+++. ...+++..+..++.||++||.|||+.+ ++||||||+||+++. ++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58888873 235889999999999999999999998 999999999999974 567899
Q ss_pred eeccccccccccCCcc-ceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc
Q 006125 493 SDFGMARIFAESEGEA-NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 570 (660)
+|||++.......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.................
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999997653221111 1112357888999998764 5678999999999999999999999975543333322221110
Q ss_pred cc------cc---cccc----CCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhcCCC
Q 006125 571 VL------EL---VDPL----LTDTSFS-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGET 621 (660)
Q Consensus 571 ~~------~~---~d~~----~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~~ 621 (660)
.. +. +... ......+ ......+.+++.+||+.||.+||++.|++ .+++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 00 00 0000 0000000 11224577899999999999999999998 5665443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=288.21 Aligned_cols=239 Identities=28% Similarity=0.335 Sum_probs=185.0
Q ss_pred ccccCCcccEEeeee-cCCcEEEEEEccCCCh---hcHHHHHHHHH---HHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 356 ILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE---QGTAEFTNEVL---LILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
.||+|+||.||++.. .+++.||+|.+..... .....+.+|.. .+....||||+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4688999999864321 11222334433 3444579999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+|+|..++. ..+.+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++..+.....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 999999884 3456999999999999999999999988 99999999999999999999999999876543221
Q ss_pred ceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHHHhcCcccccccccCCCCCCC
Q 006125 509 NTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA--YAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
....|+..|+|||++.++ .++.++||||||+++|||++|+.||....... ........ ....+ +
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~-----~ 219 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------MAVEL-----P 219 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc------cCCCC-----C
Confidence 123689999999999754 68999999999999999999999997542111 11111110 01111 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
......+.+++.+|++.+|.+|| ++.|+++
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11234578888999999999999 9999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=291.09 Aligned_cols=243 Identities=28% Similarity=0.446 Sum_probs=193.7
Q ss_pred CCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
|...+.||+|+||.||+|+. .+++.+++|++... .......+.+|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 45567899999999999985 46889999998642 223345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+. |+|.+++.. ....+++.++..++.||+.+|.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 96 567776642 2345899999999999999999999998 999999999999999999999999998643211
Q ss_pred ccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
....|+..|+|||++. ...++.++||||||+++|||++|+.|+...+............. +......
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~ 244 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS------PTLQSNE 244 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------CCCCccc
Confidence 1246788999999984 45688999999999999999999999876654444443332211 1111111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+ ...+.+++.+||+.+|.+||++.+++.
T Consensus 245 ~----~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 245 W----TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred c----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 234778889999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.68 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=197.8
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-----Ce
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 419 (660)
.++|...+.||+|+||.||++.. .+++.||||.++.. .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688889999999999999985 46899999998642 233345678899999999999999999988654 34
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++++||+. ++|.+++. ..+.+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68888884 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH---h--------
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLW---N-------- 567 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~---~-------- 567 (660)
........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+. .
T Consensus 157 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 65433211 122357889999998875 468999999999999999999999987544222111110 0
Q ss_pred ---cCccccccccc--CCCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH--hcC
Q 006125 568 ---EGNVLELVDPL--LTDT---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM--LKG 619 (660)
Q Consensus 568 ---~~~~~~~~d~~--~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~ 619 (660)
.....+.+... .... ...+.....+.+++.+||+.+|++||++.|+++- ++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00000000000 0000 0011233557899999999999999999999854 554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.78 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=198.3
Q ss_pred CCCCCcccccCCcccEEeeee----cCCcEEEEEEccCCC----hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCee
Q 006125 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 420 (660)
+|+..+.||+|++|.||+++. .+++.+|||.++... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 356678999999999999874 357889999986421 23345688999999999 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++|+|.+++. ....+++..+..++.|++++|.|||+.+ ++||||+|+||++++++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999984 3345889999999999999999999988 99999999999999999999999999876
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCC--CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
+....... .....|+..|++||.+.+.. .+.++||||||+++|||++|+.|+...........+... ... ....
T Consensus 155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~-~~~~ 230 (288)
T cd05583 155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR--ILK-SKPP 230 (288)
T ss_pred cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH--HHc-cCCC
Confidence 54432221 12246788999999987655 788999999999999999999998533211111111100 000 0011
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
. +......+.+++.+||+.||++|||+.++.+.|+..
T Consensus 231 ~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 231 F-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred C-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1 111223467888999999999999999998888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=319.91 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=189.1
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe----------
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD---------- 416 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 416 (660)
.+|+..+.||+|+||.|||++.+ ||+.||||++.-. +......+.+|+..+++|+|||||+++....+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 45677778999999999999954 8999999999743 44556678999999999999999998631100
Q ss_pred --------------------------------------------------------------------C-----------
Q 006125 417 --------------------------------------------------------------------G----------- 417 (660)
Q Consensus 417 --------------------------------------------------------------------~----------- 417 (660)
+
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ------------------------------CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC
Q 006125 418 ------------------------------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467 (660)
Q Consensus 418 ------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 467 (660)
.-+||-||||+..+|.+++.+..-. -.....++++++|++||.|+|+.
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhC
Confidence 1136788999998888888432211 14677899999999999999999
Q ss_pred CCCCeEecCCCCCceEeCCCCCEEEeecccccccc----c------------cCCccceeeeeccCCcCCHhhhhcC---
Q 006125 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA----E------------SEGEANTVRIVGTYGYMAPEYAMEG--- 528 (660)
Q Consensus 468 ~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~--- 528 (660)
+ ||||||||.||++|++..|||+|||++.... . .......+..+||.-|+|||++.+.
T Consensus 717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred c---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 8 9999999999999999999999999998722 0 0111123446899999999999754
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006125 529 LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP 608 (660)
Q Consensus 529 ~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 608 (660)
.|+.|+|+|||||||+||+. ||+..-.........+.+.+... +.+..+....=..+|.++++.||.+||
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-------~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-------ADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-------cccccccchHHHHHHHHHhcCCCccCC
Confidence 49999999999999999995 35433222222233333332221 133444455556889999999999999
Q ss_pred CHHhHHH
Q 006125 609 TMSSVAP 615 (660)
Q Consensus 609 t~~evl~ 615 (660)
|+.|++.
T Consensus 864 tA~eLL~ 870 (1351)
T KOG1035|consen 864 TATELLN 870 (1351)
T ss_pred CHHHHhh
Confidence 9999874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=285.48 Aligned_cols=242 Identities=20% Similarity=0.252 Sum_probs=185.1
Q ss_pred cCCCCCCccc--ccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNIL--GQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~l--G~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|+..+.+ |+|+||.||++.. .+++.+++|.+........ |+.....+ +||||+++++.+...+..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3456666665 9999999999985 4688899999865321111 22222222 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-CEEEeecccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFA 502 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~ 502 (660)
|||+++++|.+++.. ...+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 88 MDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999943 236899999999999999999999998 99999999999999998 99999999987553
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
... ...++..|+|||++.+..++.++||||||+++|||++|+.||............+.... ....
T Consensus 162 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~--- 227 (267)
T PHA03390 162 TPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-----QKKL--- 227 (267)
T ss_pred CCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-----cccC---
Confidence 221 23578899999999988899999999999999999999999874322111111111110 0000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCC-HHhHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPT-MSSVA 614 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl 614 (660)
.........+.+++.+||+.+|.+||+ ++|++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 111123345778888999999999996 68887
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=330.37 Aligned_cols=253 Identities=28% Similarity=0.387 Sum_probs=199.9
Q ss_pred cCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
+-++....+||.|.||.||-+. ..+|+..|+|-++.. .......+.+|..++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4456677899999999999999 668999999988643 3444567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
|||++|+|.+++. ..+..++.....+..|++.|++|||++| ||||||||.||+|+.+|.+|++|||.+......
T Consensus 1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999994 3334566666778899999999999999 999999999999999999999999999887655
Q ss_pred CCc--cceeeeeccCCcCCHhhhhcC---CCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCccccccccc
Q 006125 505 EGE--ANTVRIVGTYGYMAPEYAMEG---LYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 505 ~~~--~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~d~~ 578 (660)
... .......||+.|||||++.+. ....+.||||||||++||+||++||..-+ ..+..++.-- +.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-gh-------- 1458 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-GH-------- 1458 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-cC--------
Confidence 322 122345899999999999753 35679999999999999999999996432 2222222211 11
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
.|.++......=.+++..||+.||++|.++.|+++.=
T Consensus 1459 --~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1459 --KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred --CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 1122333333345667799999999999999887643
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=285.50 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=196.4
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-----ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
+|...+.||+|+||.||++... .+..+++|.++.. ......++..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4677889999999999999854 3455666655431 223344577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 424 YEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
+||+++++|.+++... .....+++..++.++.|+++||.|||+.+ ++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988532 23456899999999999999999999988 999999999999975 569999999987664
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
..... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.|+............... . . +
T Consensus 157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~-----~-----~ 223 (260)
T cd08222 157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-P-----T-----P 223 (260)
T ss_pred CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-C-----C-----C
Confidence 33221 11235788999999998888899999999999999999999999766554443332221 1 0 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.........+.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 122233456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.31 Aligned_cols=267 Identities=24% Similarity=0.287 Sum_probs=208.1
Q ss_pred hhcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
+.-++|...++||+|.||+|.+++ ..+++.+|+|++++. ...+...-..|-++|+.-+||.+..+.-.|...+.+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 344678889999999999999998 457999999999863 3344555667889999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||..+|.|.-+|. ....+++......-..|+.+|.|||+.+ ||.||||.+|.|+|.||++||+||||++.-
T Consensus 245 FVMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999988883 4456889988999999999999999988 999999999999999999999999999743
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
-. ....+..++|||.|+|||++....|..++|+|.+||++|||++|+.||...+-.....-+..++ +
T Consensus 319 I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed---------~-- 385 (516)
T KOG0690|consen 319 IK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED---------L-- 385 (516)
T ss_pred cc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh---------c--
Confidence 22 2233456799999999999999999999999999999999999999997655333322222211 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHH--HHhcCC------CCCCCCCCCCce
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVA--PMLKGE------TGTLPQPQKPAF 632 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl--~~L~~~------~~~~~~p~~p~~ 632 (660)
.++.....+...|+...|.+||.+|. .+.||. +.+.++ .+.+++|=+|..
T Consensus 386 -kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 386 -KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred -cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 11111122244566689999999996 244443 222332 355666666654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=290.06 Aligned_cols=246 Identities=30% Similarity=0.435 Sum_probs=194.6
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccC---CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
|...+.||+|+||.||+|... +++.+++|.+.. .......++.+|+++++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 555688999999999999954 678899998863 2233445688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+. |+|.+++.. ....+++.++..++.|++.+|.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 97 CL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred cC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 96 577776643 2345889999999999999999999988 999999999999999999999999998755322
Q ss_pred ccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+................. +...
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------~~~~--- 235 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------PALQ--- 235 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC------CCcC---
Confidence 1235788999999985 35678899999999999999999999865443333322222111 1111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
.......+.+++.+||+.+|.+||++.++++.--
T Consensus 236 -~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1122345778999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=295.73 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=197.8
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC------
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 418 (660)
.++|...+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46788889999999999999995 46899999998642 2233456889999999999999999999987543
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++|+||+.. +|..++. ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 7766651 24889999999999999999999998 999999999999999999999999998
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc-------
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN------- 570 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~------- 570 (660)
+...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.....
T Consensus 165 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 165 RHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred cCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 7543211 12357888999999876 4689999999999999999999999986654443333222100
Q ss_pred -------cccccc--ccCCCCCCC---HHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhcCCCC
Q 006125 571 -------VLELVD--PLLTDTSFS---DDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGETG 622 (660)
Q Consensus 571 -------~~~~~d--~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~~~ 622 (660)
....+. +........ +.....+.+++.+||+.||.+||++.|++ ..+++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000 000000000 01224577899999999999999999998 45766543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=288.27 Aligned_cols=247 Identities=25% Similarity=0.327 Sum_probs=193.5
Q ss_pred CCCCCcccccCCcccEEeeee----cCCcEEEEEEccCCC----hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCee
Q 006125 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 420 (660)
+|+..+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999985 368899999987522 22345678899999999 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++|+||+++++|.+++. ....+++..+..++.||++||.|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999984 3345889999999999999999999988 99999999999999999999999999976
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcC--CCCcchhHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHHhcCccccc
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGRRNAGSNQL----LAYAWHLWNEGNVLEL 574 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwslGvll~elltG~~p~~~~~~----~~~~~~~~~~~~~~~~ 574 (660)
....... ......|+..|+|||.+... .++.++||||||+++|+|++|+.|+..... ...........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-----
Confidence 5432221 12234688999999998753 468899999999999999999999863221 11111111110
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
+ ..+......+.+++.+||+.||.+|| ++.+++.
T Consensus 229 --~-----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --P-----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --C-----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1 11122234577888999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=287.13 Aligned_cols=257 Identities=26% Similarity=0.358 Sum_probs=198.3
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
|+..+.||+|.+|.||+++.. +++.+++|++.... ....+.+.+|+.+++.++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999964 58999999987642 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
+ ++|.+++.... ..+++..+..++.|++++|+|||+.+ |+||||+|+||++++++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58999985322 45899999999999999999999998 999999999999999999999999998765433221
Q ss_pred cceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc------c---ccc--c
Q 006125 508 ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN------V---LEL--V 575 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~------~---~~~--~ 575 (660)
. ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+..... . .++ .
T Consensus 155 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 Y--THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred c--CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 1 122457789999998776 789999999999999999999999876554333222211000 0 000 0
Q ss_pred cccCCC---C---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 576 DPLLTD---T---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 576 d~~~~~---~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+..... . ...+.....+.+++.+||+.||++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 0 000112356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=291.71 Aligned_cols=262 Identities=24% Similarity=0.321 Sum_probs=194.1
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC------
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 418 (660)
.++|+..++||+|+||.||+++.. +++.+++|++.... ......+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999954 68899999986432 222346778999999999999999999876543
Q ss_pred --eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecc
Q 006125 419 --EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 419 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 496 (660)
..++|+||+.. +|...+.. ....+++..+..++.||+++|.|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999975 66666643 2345999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCccc---------eeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 006125 497 MARIFAESEGEAN---------TVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLW 566 (660)
Q Consensus 497 la~~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~ 566 (660)
++........... .....+++.|+|||.+.+ ..++.++||||||+++|||++|++||............+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9976543221111 122356888999998865 458899999999999999999999987655433322222
Q ss_pred hcCc------------ccccc----cccCCCC--CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 567 NEGN------------VLELV----DPLLTDT--SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 567 ~~~~------------~~~~~----d~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.... ..... ....... .........+.+++.+||+.||.+|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1100 00000 0000000 000011245789999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=302.36 Aligned_cols=252 Identities=28% Similarity=0.380 Sum_probs=200.7
Q ss_pred CCCCcccccCCcccEEeee-ecCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------CeeEE
Q 006125 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DEKLL 422 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 422 (660)
+...+.||+|+||.||+|+ ..+|+.||||.++.. .....+...+|+++|++++|+|||+++++-... ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445789999999999999 558999999999763 344566788999999999999999999986543 35789
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC--CCCC--EEEeecccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMN--SKISDFGMA 498 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~--~~~~--~kl~DfGla 498 (660)
|||||.+|+|...|.++++...|++.+.+.++.++..||.|||+++ |+||||||.||++- ++|+ -||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999999888888999999999999999999999998 99999999999994 3344 699999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhh-cCCCCcchhHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHHhcCcccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSN----QLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwslGvll~elltG~~p~~~~----~~~~~~~~~~~~~~~~~ 573 (660)
+.+.++. .....+||..|++||+.. .+.|+..+|.|||||++||++||..||.+. ......|....+.+-.-
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9886654 344579999999999999 488999999999999999999999998632 23334555443322111
Q ss_pred c--ccccCC-----------CCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006125 574 L--VDPLLT-----------DTSFSDDEFSRYIHIGLLCVQEDAFDRP 608 (660)
Q Consensus 574 ~--~d~~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RP 608 (660)
. .+...+ .-..+.....++-.....+|..+|++|.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 111111 1123445556677777788999999998
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.37 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=196.5
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG- 417 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 417 (660)
.++...+++|...+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45566778999999999999999999984 57899999998753 223345688899999999999999999988643
Q ss_pred -----CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEE
Q 006125 418 -----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (660)
Q Consensus 418 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl 492 (660)
...+++++++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 2357788876 7899888732 34899999999999999999999998 999999999999999999999
Q ss_pred eeccccccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--
Q 006125 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG-- 569 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~-- 569 (660)
+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+....
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998754322 122367889999999876 568899999999999999999999986544322222111100
Q ss_pred cccccc---c-----------ccCCCCCCC---HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 NVLELV---D-----------PLLTDTSFS---DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 ~~~~~~---d-----------~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...++. . +......+. ......+.+++.+|++.||.+||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000000 0 000000000 011235778999999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=293.60 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=203.6
Q ss_pred CCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC-----eeE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL 421 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 421 (660)
+|...+.||+|+||.||+++.. +++.+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677889999999999999964 58999999987543 445567899999999999999999999998775 789
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
++|||++ ++|.+++.. ...+++..++.++.||++||.|||+.+ |+|+||||+|||+++++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 488888843 337999999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCc-cceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc---------
Q 006125 502 AESEGE-ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN--------- 570 (660)
Q Consensus 502 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~--------- 570 (660)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 543311 112223578899999999877 789999999999999999999999976654443332222100
Q ss_pred -----ccccccccCCCCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 571 -----VLELVDPLLTDTS-----FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 571 -----~~~~~d~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
..+.+........ ........+.+++.+||+.+|.+||++.+++. ++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0000000000000 01112345788999999999999999999996 35543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=292.04 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=195.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe-CCeeE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKL 421 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 421 (660)
..+++|...+.||+|+||.||++.. .+++.||+|++.. ......+.+.+|+.++..++||||+++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4577899999999999999999984 4789999998854 223345678899999999999999999999876 55788
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+++||+ +++|..++. ...+++.....++.||++||.|||+.+ ++||||+|+||++++++.+||+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568988883 234788888999999999999999998 999999999999999999999999998754
Q ss_pred cccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH--------------H
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL--------------W 566 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~--------------~ 566 (660)
.... ....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+ .
T Consensus 159 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 3211 12356888999998765 56899999999999999999999998654322111100 0
Q ss_pred hcCcccccccccCCCCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 567 NEGNVLELVDPLLTDTSFSD-----DEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 567 ~~~~~~~~~d~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
..+...+.+.........+. .....+.+++.+||+.+|++||++.|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00111111111000001111 123568889999999999999999999744
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=287.28 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=195.4
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh-hcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEEEec
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
|...+.||+|++|.||+|+.. +++.|++|++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999965 578999999865322 22334567899999998 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
+|+|.+++.... ...+++..+..++.|++++|.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 889988885422 246899999999999999999999988 999999999999999999999999999765432221
Q ss_pred cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-----------C-ccccc
Q 006125 508 ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-----------G-NVLEL 574 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-----------~-~~~~~ 574 (660)
....++..|+|||++.. ..++.++||||||++++||++|+.||......+..+..... . ...+.
T Consensus 156 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 156 ---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred ---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 12357889999998754 45789999999999999999999988655443333222110 0 00000
Q ss_pred ccccCCC---C---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 575 VDPLLTD---T---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 575 ~d~~~~~---~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
++..+.. . .........+.+++.+||+.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1100000 0 000111356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=314.87 Aligned_cols=259 Identities=25% Similarity=0.307 Sum_probs=214.7
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEE
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 415 (660)
...+++...++|.+.++||+|+||.|..++.+ +++.||+|++.+. ...+...|.+|..+|..-+.+.|+.++-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 45678888899999999999999999999964 6889999999863 3456678999999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeec
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 495 (660)
+...+|+|||||+||+|-.++. +.+.+++..+..++..|+-||.-||+.| +|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999994 3346999999999999999999999998 999999999999999999999999
Q ss_pred cccccccccCCccceeeeeccCCcCCHhhhh----c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc
Q 006125 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAM----E-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 570 (660)
|.+..+..+ +.......+|||.|++||++. + +.|+..+|+||+||++|||+.|..||..+.+++-..++.+...
T Consensus 220 GsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 220 GSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE 298 (1317)
T ss_pred hhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh
Confidence 998766532 223333458999999999995 3 6799999999999999999999999999998888877776644
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHhHH
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT---MSSVA 614 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl 614 (660)
...+.+.. . .++ ...+||.+.+ -+|+.|.. ++++-
T Consensus 299 ~l~FP~~~----~-VSe---eakdLI~~ll-~~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 299 SLSFPDET----D-VSE---EAKDLIEALL-CDREVRLGRNGIEDIK 336 (1317)
T ss_pred hcCCCccc----c-cCH---HHHHHHHHHh-cChhhhcccccHHHHH
Confidence 43332111 1 122 3444555544 46788887 88875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=279.63 Aligned_cols=236 Identities=28% Similarity=0.352 Sum_probs=193.4
Q ss_pred cccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 357 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
||+|+||.||++... +++.+++|++.... ......+.+|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 58999999987532 22456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceee
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (660)
.+++.. ...+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence 999943 335899999999999999999999987 99999999999999999999999999977644321 1223
Q ss_pred eeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 513 ~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
..++..|++||...+...+.++|+||||+++|||++|+.||...+........... . . ..+......+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~--------~---~~~~~~~~~l 220 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-P--------L---RFPEFLSPEA 220 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-C--------C---CCCCCCCHHH
Confidence 46788999999998888999999999999999999999999766543332222211 0 0 1111123457
Q ss_pred HHHHhhcccCCCCCCCCHHh
Q 006125 593 IHIGLLCVQEDAFDRPTMSS 612 (660)
Q Consensus 593 ~~li~~cl~~dP~~RPt~~e 612 (660)
.+++.+||+.||++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 78999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.93 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=193.2
Q ss_pred CCC-CCcccccCCcccEEeeeec-CCcEEEEEEccCCChhc--------------HHHHHHHHHHHhhcCCCCcceEeEE
Q 006125 350 NFS-DSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQG--------------TAEFTNEVLLILKLQHKNLVKLLGF 413 (660)
Q Consensus 350 ~~~-~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~ 413 (660)
+|. ..+.||+|+||.||++... +++.||+|+++...... ...+.+|+.+++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 444 3467999999999999954 68999999986432111 1247789999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEe
Q 006125 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (660)
Q Consensus 414 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 493 (660)
+..++..++||||+. |+|.+++. ....+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 999999999999996 68988884 3445899999999999999999999988 9999999999999999999999
Q ss_pred eccccccccccCC------------ccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 006125 494 DFGMARIFAESEG------------EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA 560 (660)
Q Consensus 494 DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~ 560 (660)
|||++........ ........++..|+|||++.+. .++.++||||||+++|||++|+.||...+..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999976541110 0111123467889999998764 46899999999999999999999987554333
Q ss_pred HHHHHHh---cCc---cccc--------ccccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 561 YAWHLWN---EGN---VLEL--------VDPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 561 ~~~~~~~---~~~---~~~~--------~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....+.. ... +... ....... ..........+.+++.+||+.+|++||+++|++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2222111 100 0000 0000000 0000112345778999999999999999999984
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=275.03 Aligned_cols=202 Identities=28% Similarity=0.434 Sum_probs=168.9
Q ss_pred CCCCCCcccccCCcccEEeeeec---C--CcEEEEEEccCCCh--hcHHHHHHHHHHHhhcCCCCcceEeEEEEe-CCee
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS---D--GKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEK 420 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~---~--g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 420 (660)
..|+....||+|.||.||+++-. + .+.+|+|+++...+ ......-+|+.+++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 35777889999999999999733 2 23789999975322 334567799999999999999999999987 6778
Q ss_pred EEEEEecCCCChhhhhcC--CCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC----CCEEEee
Q 006125 421 LLVYEFMPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD----MNSKISD 494 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~----~~~kl~D 494 (660)
+|++||.++ +|..+++. ..+...++-..+..|+.||+.|+.|||++- |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988 78787753 223356899999999999999999999999 9999999999999877 9999999
Q ss_pred ccccccccccCCcc-ceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 006125 495 FGMARIFAESEGEA-NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAG 554 (660)
Q Consensus 495 fGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~ 554 (660)
+|+++.+...-... .....+-|..|.|||++.+ ..||.+.|||+.|||+.||++-++.|.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 99999887554333 3344678999999999986 469999999999999999999887664
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=294.13 Aligned_cols=260 Identities=26% Similarity=0.352 Sum_probs=198.4
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe----
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE---- 419 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 419 (660)
..++|...+.||+|++|.||++... +++.||+|++... .......+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999964 6889999998642 23344567789999999999999999998876554
Q ss_pred --eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 420 --KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 420 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
.++|+||+ +++|.+++.. ..+++..+..++.||+++|+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6699998842 45899999999999999999999988 99999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--ccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG--NVLEL 574 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~--~~~~~ 574 (660)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ...++
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9765432 112357888999999865 367899999999999999999999987555433332222110 00000
Q ss_pred ------------ccccCCC--CCC---CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 575 ------------VDPLLTD--TSF---SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 575 ------------~d~~~~~--~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
+...... ..+ .......+.+++.+||+.||.+|||+.||++ +++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 0000000 000 0012346889999999999999999999975 4444
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.67 Aligned_cols=258 Identities=24% Similarity=0.328 Sum_probs=190.5
Q ss_pred CCCCCcccccCCcccEEeeeec-C--CcEEEEEEccCC--ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC----Ce
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS-D--GKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG----DE 419 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~-~--g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 419 (660)
+|+..+.||+|+||.||++... + ++.+|+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667789999999999999954 4 779999998642 222345678899999999 599999999976432 34
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++++||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 68888884 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCc--cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh---------
Q 006125 500 IFAESEGE--ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN--------- 567 (660)
Q Consensus 500 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~--------- 567 (660)
.+...... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...+..........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432221 11223468999999998865 4689999999999999999999999875543222211111
Q ss_pred -----cCcccccccc--cCCC---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 568 -----EGNVLELVDP--LLTD---TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 568 -----~~~~~~~~d~--~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.......+.. .... ..........+.+++.+||+.||.+||++.|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 0000 000011134578899999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=265.15 Aligned_cols=254 Identities=27% Similarity=0.449 Sum_probs=197.8
Q ss_pred cccChHHHHhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccC-CChhcHHHHHHHHHHHhhc-CCCCcceEeEE
Q 006125 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLGF 413 (660)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 413 (660)
...|..+++. ...||.|.-|.||+...+ .|..+|||.+.+ .+..+.+.+...+.++.+- ++|.||+.+|+
T Consensus 87 ~~~dindl~~-------l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy 159 (391)
T KOG0983|consen 87 YQADINDLEN-------LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY 159 (391)
T ss_pred cccChHHhhh-------HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE
Confidence 3445555544 467999999999999954 689999999975 3455566777777777666 48999999999
Q ss_pred EEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEe
Q 006125 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (660)
Q Consensus 414 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 493 (660)
|......++.||.|.. .++.+|. +..+++++.-+=++...++++|.||.++. +|+|||+||+|||+|+.|++||+
T Consensus 160 Fi~n~dV~IcMelMs~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 160 FITNTDVFICMELMST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred EeeCchHHHHHHHHHH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence 9999999999998843 5666664 33455888888899999999999998876 69999999999999999999999
Q ss_pred eccccccccccCCccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcC
Q 006125 494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEG 569 (660)
Q Consensus 494 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~ 569 (660)
|||++-.+.++... .+..|-+.|||||.+. ...|...+||||||+.|+||.||+.|+.... ..+..-.+.+++
T Consensus 235 DFGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e 311 (391)
T KOG0983|consen 235 DFGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE 311 (391)
T ss_pred cccccceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC
Confidence 99999877654433 3347889999999986 3468899999999999999999999997532 223333333322
Q ss_pred cccccccccCCCCC-CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 NVLELVDPLLTDTS-FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 ~~~~~~d~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
. +.+.... +++ .+.+++..||++|+.+||...++++
T Consensus 312 P------P~L~~~~gFSp----~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 312 P------PLLPGHMGFSP----DFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred C------CCCCcccCcCH----HHHHHHHHHhhcCcccCcchHHHhc
Confidence 2 2332222 343 3777888999999999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=309.62 Aligned_cols=145 Identities=25% Similarity=0.392 Sum_probs=130.0
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|...++||+|+||.||++... +++.||||+++... ......+.+|+.++..++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56778899999999999999965 68999999987532 333467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
||+.+++|.+++.. .+.+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999843 345889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.81 Aligned_cols=261 Identities=27% Similarity=0.438 Sum_probs=217.4
Q ss_pred ccChHHHHhhcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEE
Q 006125 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (660)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 415 (660)
.++++.+...++.|++.++||+|.+|.||+++ .++++.+|+|++... ....++++.|.++++.+ .|||++.++|++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 34566666778889999999999999999999 568999999998763 34556788899999988 7999999999987
Q ss_pred e-----CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCE
Q 006125 416 D-----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (660)
Q Consensus 416 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~ 490 (660)
. ++++|||||||.+|+..+++++.. ...+.|..+.-|++.++.||.+||... ++|||||-.|||++.++.+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence 4 568999999999999999997655 677999999999999999999999988 9999999999999999999
Q ss_pred EEeeccccccccccCCccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 006125 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL 565 (660)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~ 565 (660)
||.|||++..+........ ...||+.|||||++. +..|+..+|+||||++..||.-|.+|+-+.......+.+
T Consensus 163 KLvDFGvSaQldsT~grRn--T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I 240 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRN--TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 240 (953)
T ss_pred EEeeeeeeeeeeccccccc--CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence 9999999987765444433 358999999999985 334778999999999999999999998776655555444
Q ss_pred HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 566 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.+..+ +.+.+ +..-.+.+.+.|..||.+|-++||++.+++
T Consensus 241 pRNPP------PkLkr---p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 241 PRNPP------PKLKR---PKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred CCCCC------ccccc---hhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 44322 12222 334556788999999999999999999987
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-33 Score=275.27 Aligned_cols=272 Identities=25% Similarity=0.304 Sum_probs=212.8
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCe
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 419 (660)
.+...+|....+||+|+||.|.++..+ +.+.+|||++++.- +.+.+--+.|-++|... +-|.++++..+|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 344567888999999999999999854 56789999998642 22333345677777766 56889999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
+|+||||+.+|+|--.+ +.-+.+.+..+...+..||-||-|||+++ |+.||||.+|||+|.+|++||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999997777 45566888899999999999999999999 9999999999999999999999999997
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
.-.- ....+.+.+||+.|+|||++.-.+|+..+|+|||||+||||+.|++||++++..+....+....-
T Consensus 499 Eni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--------- 567 (683)
T KOG0696|consen 499 ENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--------- 567 (683)
T ss_pred cccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---------
Confidence 5332 22334567999999999999999999999999999999999999999998887666554443221
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCH----H-hHH--------HHhcCCCCCCCCCCCCceeccc
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTM----S-SVA--------PMLKGETGTLPQPQKPAFSIGR 636 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~-evl--------~~L~~~~~~~~~p~~p~~~~~~ 636 (660)
.++.....+...|+...|.+.|.+|... + +|. .+-+-+..+.++|=+|....++
T Consensus 568 ---syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r 634 (683)
T KOG0696|consen 568 ---SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGR 634 (683)
T ss_pred ---cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCC
Confidence 2222333446677888999999999532 2 221 1222234567778888875444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=286.80 Aligned_cols=238 Identities=27% Similarity=0.328 Sum_probs=188.7
Q ss_pred cCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+..|.....+|.|+|+.|-.+. ..+++..++|++.+.. .+-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5667778889999999999998 4578899999997641 2334667666555 89999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe-CCCCCEEEeecccccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL-DSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl-~~~~~~kl~DfGla~~~~~~ 504 (660)
.+.++-|.+.+. ....+. .++..|+.+|+.++.|||++| ++||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999988777663 223233 778889999999999999998 9999999999999 58899999999999876554
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
....+-|..|.|||++....|++++||||||++||+||+|+.|+....-..........+ .+
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~-------------~~ 531 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP-------------KF 531 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC-------------cc
Confidence 122356889999999999999999999999999999999999986433222222222221 12
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
+........+|+.+||+.||.+||+|.++.
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 222223356778899999999999999996
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=280.93 Aligned_cols=243 Identities=28% Similarity=0.397 Sum_probs=196.5
Q ss_pred CcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCC
Q 006125 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 430 (660)
.++||+|.||+||-|+. ++|+.||||++.+ .......++.+|+.+|++++||.||.+-..|+..+..++|||.+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999995 5899999999964 44555678999999999999999999999999999999999999665
Q ss_pred ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC---CCEEEeeccccccccccCCc
Q 006125 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfGla~~~~~~~~~ 507 (660)
-|+-+|. ...+.|++..-..++.||+.+|.|||.++ |+|+||||+|||+.+. -++||+|||+++...+....
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 5666663 34566999999999999999999999998 9999999999999754 57999999999998765443
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
. ..+||+.|+|||++.++.|...-|+||.|||+|--++|.-||..++.... .+.+. .++-+. +.-.+
T Consensus 724 r---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---QIQNA---aFMyPp----~PW~e 790 (888)
T KOG4236|consen 724 R---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---QIQNA---AFMYPP----NPWSE 790 (888)
T ss_pred h---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH---Hhhcc---ccccCC----Cchhh
Confidence 3 35899999999999999999999999999999999999999975542211 11111 111111 11122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.....+++|...||..-++|-+.++-+
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 233467788889999999999887765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=242.82 Aligned_cols=258 Identities=24% Similarity=0.303 Sum_probs=194.5
Q ss_pred CCCCCcccccCCcccEEeee-ecCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+|...++||+|.+|+||+++ ..+++.||+|+++- .++.-.....+|+.+++.++|.|||+++++...+..+.||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45556899999999999999 45688999999864 3444456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
|.. +|..+.. .-++.++.+.+..++.|+++||.|.|++. +.||||||.|.||+.+|..||+|||+++.+.-...
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 7877773 34566899999999999999999999998 99999999999999999999999999997754321
Q ss_pred ccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHh------cCcccc---cc
Q 006125 507 EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWN------EGNVLE---LV 575 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~------~~~~~~---~~ 575 (660)
- ....+-|..|.+|.++.+. -|+...|+||-|||+.|+.. |++.|.+.+..+...+++. ++.+.. +-
T Consensus 157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 1 1223568899999999875 48999999999999999998 5555666555554444432 111111 11
Q ss_pred cccC---CCCCCCH-HHH----HHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 576 DPLL---TDTSFSD-DEF----SRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 576 d~~~---~~~~~~~-~~~----~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
|-.. -.+..+. +.. .+=.++....+.-+|.+|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1000 0001111 111 12245666777789999999988764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=268.97 Aligned_cols=221 Identities=20% Similarity=0.149 Sum_probs=174.4
Q ss_pred CCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCChhhhhcC
Q 006125 360 GGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD 438 (660)
Q Consensus 360 G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 438 (660)
|.+|.||++.. .+++.+|+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 478999999997533 233455555666899999999999999999999999999999998843
Q ss_pred CCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCC
Q 006125 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518 (660)
Q Consensus 439 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 518 (660)
...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.++|+|||.+....... ....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 345899999999999999999999988 9999999999999999999999999876543321 11245677
Q ss_pred cCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhh
Q 006125 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLL 598 (660)
Q Consensus 519 y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~ 598 (660)
|+|||.+....++.++||||+|+++|||++|+.++...... . .......+ +......+.+++.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~-----~~~~~~~~-----~~~~~~~~~~li~~ 211 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------I-----NTHTTLNI-----PEWVSEEARSLLQQ 211 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------c-----ccccccCC-----cccCCHHHHHHHHH
Confidence 99999998888999999999999999999999776422110 0 00000011 11122457788999
Q ss_pred cccCCCCCCCCHHh
Q 006125 599 CVQEDAFDRPTMSS 612 (660)
Q Consensus 599 cl~~dP~~RPt~~e 612 (660)
|++.||++||++.+
T Consensus 212 ~l~~dp~~R~~~~~ 225 (237)
T cd05576 212 LLQFNPTERLGAGV 225 (237)
T ss_pred HccCCHHHhcCCCc
Confidence 99999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=263.36 Aligned_cols=238 Identities=29% Similarity=0.374 Sum_probs=193.8
Q ss_pred CcccEEeeeec-CCcEEEEEEccCCChhc-HHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCChhhhhcC
Q 006125 361 GFGPVYKGVLS-DGKEVAVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD 438 (660)
Q Consensus 361 ~fg~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 438 (660)
+||.||+++.. +|+.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 58999999997654444 67899999999999999999999999999999999999999999999853
Q ss_pred CCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCC
Q 006125 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518 (660)
Q Consensus 439 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 518 (660)
. ..+++..++.++.++++++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 2 22889999999999999999999998 9999999999999999999999999998765432 1223467889
Q ss_pred cCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhh
Q 006125 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLL 598 (660)
Q Consensus 519 y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~ 598 (660)
|++||.+....++.++|||+||+++++|++|..|+..................... .........+.+++.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP--------PPEWKISPEAKDLIRK 223 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc--------cccccCCHHHHHHHHH
Confidence 99999999888999999999999999999999998763322323333322211110 0000033468889999
Q ss_pred cccCCCCCCCCHHhHHH
Q 006125 599 CVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 599 cl~~dP~~RPt~~evl~ 615 (660)
|+..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-33 Score=265.94 Aligned_cols=255 Identities=27% Similarity=0.332 Sum_probs=191.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+++.....||.|.||+|+|-.+ +.|+..|||+++.. .+.+.+++..|.+...+- ++||||+++|.+..++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 4445567899999999999885 47999999999853 346677788888766555 79999999999999999999999
Q ss_pred ecCCCChhhhhcC--CCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 426 FMPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 426 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
.|. .+|+.+... ..+...+++.-.-+|....+.||.||...- .|+|||+||+|||||..|.+||+|||++-.+.+
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 994 477655421 123345788888888889999999998764 699999999999999999999999999977655
Q ss_pred cCCccceeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCcccccccccCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
+.... ...|-..|||||.+.. ..|..+|||||||+.|+|+.||+-|+..-+ ..+........+. ..+.. ...
T Consensus 221 SiAkT---~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp-p~l~~-~~~ 295 (361)
T KOG1006|consen 221 SIAKT---VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP-PILLF-DKE 295 (361)
T ss_pred HHHhh---hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC-CeecC-ccc
Confidence 43322 2367888999999863 348999999999999999999999986422 3333333332221 11111 110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.......+...+..|+.+|-++||...++.+
T Consensus 296 ----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 296 ----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1112234667777899999999999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-33 Score=282.68 Aligned_cols=245 Identities=23% Similarity=0.305 Sum_probs=208.6
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCc-EEEEEEccC---CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~-~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
+.-.+++....||-|+||.|-+...+... .+|+|.+++ .+..+.+.+..|-.+|...+.|.||+++--|.+....|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 33455666778999999999999875433 488888865 34556677889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+.||-|-+|.|+.+| ++++.++......++..+.+|++|||.++ ||.|||||+|.|+|.+|-+||.|||+++.+
T Consensus 497 mLmEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 497 MLMEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhHHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 999999999999999 67778999999999999999999999998 999999999999999999999999999987
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
... ..+++++||+.|.|||++.++....++|.|+||++++||++|++||...+.......+.+.-+..
T Consensus 571 ~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--------- 638 (732)
T KOG0614|consen 571 GSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------- 638 (732)
T ss_pred ccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------
Confidence 654 34667899999999999999999999999999999999999999999877666555554432221
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPT 609 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt 609 (660)
.++....+.-.+++++.+..+|.+|..
T Consensus 639 -~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 234444555678888999999999986
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=274.11 Aligned_cols=258 Identities=28% Similarity=0.386 Sum_probs=200.1
Q ss_pred hcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccC-------CChhcHHHHHHHHHHHhhcCCCCcceEeEEEE-eC
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS-------CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV-DG 417 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~ 417 (660)
..++|-..++||+|+|+.||++. +...+.||+|+-.- ..+...+...+|..+.+.|+||.||++++++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34556667899999999999998 55678899997532 12233455778999999999999999999986 55
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC---CCEEEee
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISD 494 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~---~~~kl~D 494 (660)
+..|-|+|||++.+|+-+|. ....++++++..|+.||+.+|.||.+.. +||||-||||.|||+.+. |.+||+|
T Consensus 541 dsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 67889999999999999994 4556899999999999999999999875 789999999999999654 7899999
Q ss_pred ccccccccccCCcc-----ceeeeeccCCcCCHhhhhc----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 006125 495 FGMARIFAESEGEA-----NTVRIVGTYGYMAPEYAME----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL 565 (660)
Q Consensus 495 fGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~ 565 (660)
|||++......... -+....||.+|++||.+.- ...+.|+||||.|||+|+.+.|++||+.+.... ++
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dI 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DI 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HH
Confidence 99999876544331 1234579999999998853 347889999999999999999999998765433 34
Q ss_pred HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 566 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
+.+..+.....-.++... ........+|++||+..-++|....++.
T Consensus 694 LqeNTIlkAtEVqFP~KP---vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 LQENTILKATEVQFPPKP---VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HhhhchhcceeccCCCCC---ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 444444443332222211 1222345677899999999998877765
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=260.97 Aligned_cols=265 Identities=25% Similarity=0.297 Sum_probs=198.3
Q ss_pred cCCCCC-CcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEe----CCee
Q 006125 348 TSNFSD-SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD----GDEK 420 (660)
Q Consensus 348 ~~~~~~-~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 420 (660)
+++|.+ .++||-|-.|.|-.+.. .+++.+|+|++.. .....+|+++.-.. .|||||++++++.+ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 344544 36899999999999985 4789999999864 23566888877666 79999999999865 3456
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC---CCCEEEeeccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGM 497 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGl 497 (660)
++|||.|+||.|.+.+.+ +....+++.++..|++||..++.|||+.+ |.||||||+|+|... |-.+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 899999999999999965 34456999999999999999999999998 999999999999964 45699999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHHHhcCccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA---YAWHLWNEGNVLEL 574 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~ 574 (660)
++.-.. .......+-|+-|.|||++...+|....|+||+||++|-|++|.+||....-.. -....+..+.
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq---- 283 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ---- 283 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC----
Confidence 986443 222334578999999999999999999999999999999999999996433110 0111111111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCCCCCCCCCceec
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGTLPQPQKPAFSI 634 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~p~~p~~~~ 634 (660)
-.+..+++ +...+...++|+.+|..+|++|.|++|++. ++.. .-..|+.|.+..
T Consensus 284 --y~FP~pEW-s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~---~~~vp~tpl~t~ 339 (400)
T KOG0604|consen 284 --YEFPEPEW-SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ---YEAVPQTPLSTS 339 (400)
T ss_pred --ccCCChhH-hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc---cccCCCCCchhh
Confidence 01111111 122344578899999999999999999973 3332 333455555443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=267.37 Aligned_cols=257 Identities=22% Similarity=0.265 Sum_probs=198.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-C-CC----cceEeEEEEeCCe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-H-KN----LVKLLGFCVDGDE 419 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~n----iv~l~~~~~~~~~ 419 (660)
.+++|....++|+|.||.|-++... .+..||||+++.- ....+..+-|+++++++. + |+ ++++.+||.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3788999999999999999999843 5789999999863 334455677999999993 3 22 7888899999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-------------
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS------------- 486 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~------------- 486 (660)
.+||+|.+ |-++.++|.. .+..+++...+..|+.|++++++|||+.+ ++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 6689999954 34456899999999999999999999998 999999999999932
Q ss_pred -------CCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH
Q 006125 487 -------DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL 559 (660)
Q Consensus 487 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~ 559 (660)
+..+||+|||.++.-.... ..++.|..|.|||++.+-.++..+||||+||||.|+.+|...|...+-.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 2348999999998644332 3468899999999999999999999999999999999999887633311
Q ss_pred H---HHHHHH-----------------hcCcccccccccCCC---------------CCCCHHHHHHHHHHHhhcccCCC
Q 006125 560 A---YAWHLW-----------------NEGNVLELVDPLLTD---------------TSFSDDEFSRYIHIGLLCVQEDA 604 (660)
Q Consensus 560 ~---~~~~~~-----------------~~~~~~~~~d~~~~~---------------~~~~~~~~~~l~~li~~cl~~dP 604 (660)
+ ....+. ..+ ..++-+....+ -...+.+...|++|+.+||..||
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 1 111111 111 01100000000 01244667889999999999999
Q ss_pred CCCCCHHhHHH
Q 006125 605 FDRPTMSSVAP 615 (660)
Q Consensus 605 ~~RPt~~evl~ 615 (660)
.+|+|+.|++.
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=291.38 Aligned_cols=260 Identities=19% Similarity=0.216 Sum_probs=168.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-C----CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEE------EE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-D----GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF------CV 415 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 415 (660)
..++|...++||+|+||.||+|++. + +..||+|++...... +...+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678899999999999999999964 4 689999998653221 111111 1122222222222211 24
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCCCC-----------------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPRKR-----------------GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK 478 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLk 478 (660)
.+...+||+||+++++|.+++...... .......+..++.||++||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999998542210 01123345679999999999999988 9999999
Q ss_pred CCceEeCC-CCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcC----------------------CCCcchh
Q 006125 479 ASNVLLDS-DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG----------------------LYSKKSD 535 (660)
Q Consensus 479 p~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksD 535 (660)
|+|||+++ ++.+||+|||+++.+....... .....+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5899999999997654322211 2235789999999976422 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc----ccccccccCCC-----CCCCHHHHHHHHHHHhhcccCCCCC
Q 006125 536 VFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN----VLELVDPLLTD-----TSFSDDEFSRYIHIGLLCVQEDAFD 606 (660)
Q Consensus 536 VwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~----~~~~~d~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~ 606 (660)
||||||+||||+++..+.+.. .......+...+. +...+.+.... ....+.......+|+.+||+.||++
T Consensus 362 VwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999977654422 1111111111000 00011111000 0000111223457999999999999
Q ss_pred CCCHHhHHH
Q 006125 607 RPTMSSVAP 615 (660)
Q Consensus 607 RPt~~evl~ 615 (660)
|||+.|+++
T Consensus 441 R~ta~e~L~ 449 (566)
T PLN03225 441 RISAKAALA 449 (566)
T ss_pred CCCHHHHhC
Confidence 999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=282.30 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=178.5
Q ss_pred hcCCCCCCcccccCCcccEEeeee-----------------cCCcEEEEEEccCCChhcHHH--------------HHHH
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL-----------------SDGKEVAVKRLSSCSEQGTAE--------------FTNE 395 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 395 (660)
..++|+..++||+|+||.||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235679999987543322223 3346
Q ss_pred HHHHhhcCCCCc-----ceEeEEEEe--------CCeeEEEEEecCCCChhhhhcCCCC---------------------
Q 006125 396 VLLILKLQHKNL-----VKLLGFCVD--------GDEKLLVYEFMPNGSLDAILFDPRK--------------------- 441 (660)
Q Consensus 396 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------- 441 (660)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766654 677887753 3567999999999999999864211
Q ss_pred CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCC
Q 006125 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521 (660)
Q Consensus 442 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 521 (660)
...+++..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||++.......... .....+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence 123567888999999999999999988 9999999999999999999999999997543322111 111234789999
Q ss_pred HhhhhcCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCCcHHHH----------HHHHHhc
Q 006125 522 PEYAMEGLY----------------------SKKSDVFSFGVLLIEIITGRR-NAGSNQLLAY----------AWHLWNE 568 (660)
Q Consensus 522 PE~~~~~~~----------------------t~ksDVwslGvll~elltG~~-p~~~~~~~~~----------~~~~~~~ 568 (660)
||.+..... ..+.||||+||+++||++|.. |+........ .|+.+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998854321 235799999999999999875 5542211111 1111111
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCC---CCCCCHHhHHH
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDA---FDRPTMSSVAP 615 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~ 615 (660)
.. .+-. ..+.......+++.++|..+| .+|+|++|+++
T Consensus 459 ~~----~~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QK----YDFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cC----CCcc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11 0101 111223446678888888765 78999999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=256.64 Aligned_cols=261 Identities=24% Similarity=0.390 Sum_probs=192.7
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-------
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------- 417 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 417 (660)
.+.|+...+||+|.||.||++.. ++|+.||+|++-. ..+.-.....+|+++|..++|+|++.++.+|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 34566678899999999999994 4678899987632 2334455678999999999999999999988542
Q ss_pred -CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecc
Q 006125 418 -DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 418 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 496 (660)
...+|||.+|++ +|.-+|.+. ...++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 347899999977 788888543 234899999999999999999999988 9999999999999999999999999
Q ss_pred ccccccccCCcc--ceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHH----------
Q 006125 497 MARIFAESEGEA--NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAW---------- 563 (660)
Q Consensus 497 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~---------- 563 (660)
+++.+....... ..+..+-|..|.+||.+.+ ..|+.+.|||.-|||+.||++|.+-+..+.......
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 998776443322 2233467999999999875 579999999999999999999998876543222111
Q ss_pred -HHHhc---Cccccccccc-CCCCCC--CHHHHH------HHHHHHhhcccCCCCCCCCHHhHH
Q 006125 564 -HLWNE---GNVLELVDPL-LTDTSF--SDDEFS------RYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 564 -~~~~~---~~~~~~~d~~-~~~~~~--~~~~~~------~l~~li~~cl~~dP~~RPt~~evl 614 (660)
+.|.+ -.+.+.+... +....+ ..+..+ .-++|+..++..||.+|+++++++
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 11111 1111111100 111000 011111 456777889999999999999987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=273.49 Aligned_cols=214 Identities=25% Similarity=0.412 Sum_probs=183.2
Q ss_pred ccChHHHHhhcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEE
Q 006125 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGF 413 (660)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~ 413 (660)
++.++.-+...+-|...+.||-|+||+|-++. .++...+|+|.|++.+ ..+....+.|..||...+.+.||+|+-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44556666777889999999999999999997 5567789999998643 3456678899999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEe
Q 006125 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (660)
Q Consensus 414 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 493 (660)
|.+.+.+|+||+|++||++-++| -.-+.+.+..+..++..+..++++.|..| +|||||||+|||||.||++||+
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeee
Confidence 99999999999999999999998 45677999999999999999999999998 9999999999999999999999
Q ss_pred ecccccccc---------ccCCccc-------------------------------eeeeeccCCcCCHhhhhcCCCCcc
Q 006125 494 DFGMARIFA---------ESEGEAN-------------------------------TVRIVGTYGYMAPEYAMEGLYSKK 533 (660)
Q Consensus 494 DfGla~~~~---------~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~t~k 533 (660)
||||+.-+. ..+.... ....+||+.|+|||++....++..
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 999996431 1000000 012479999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCc
Q 006125 534 SDVFSFGVLLIEIITGRRNAGSNQ 557 (660)
Q Consensus 534 sDVwslGvll~elltG~~p~~~~~ 557 (660)
+|+||.|||||||+-|+.||-.+.
T Consensus 852 cdwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCC
Confidence 999999999999999999997544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=252.69 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=196.3
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC---CChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCee
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 420 (660)
+.-.+|....+||+|+|.+|..+.+ ++.+.+|+|++++ ..+.+....+.|-.+..+. +||.+|.+..+|..+..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3456788899999999999999985 4688999999975 3445566677777777766 799999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++|.||+++|+|--.+ +.+..++++.+......|.-+|.|||+.| |+.||||.+|||+|..|++||+|+|+++.
T Consensus 327 ffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999996666 44556999999999999999999999999 99999999999999999999999999975
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCC-------CCcHHHHHHHHHhcCcccc
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG-------SNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~-------~~~~~~~~~~~~~~~~~~~ 573 (660)
--... ..+.+++||+.|+|||++.+..|...+|+|+|||+++||+.|+.||+ +.+..++.++++-+..+
T Consensus 401 ~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-- 476 (593)
T KOG0695|consen 401 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-- 476 (593)
T ss_pred CCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--
Confidence 43222 22345799999999999999999999999999999999999999997 22334444444433221
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP 608 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 608 (660)
.+ +.....+...++..-|.+||.+|.
T Consensus 477 ----ri-----prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ----RI-----PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----cc-----cceeehhhHHHHHHhhcCCcHHhc
Confidence 11 111122344667788999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=280.54 Aligned_cols=245 Identities=28% Similarity=0.390 Sum_probs=188.8
Q ss_pred CCCCcccccCCccc-EEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 351 FSDSNILGQGGFGP-VYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 351 ~~~~~~lG~G~fg~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
|...+.+|.|+.|+ ||+|.. +|+.||||++-. .......+|+..|+.- +|||||++++.-.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 55567899999876 799998 689999999854 2334567999999988 79999999999999999999999994
Q ss_pred CCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC---C--CCEEEeecccccccc
Q 006125 429 NGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---D--MNSKISDFGMARIFA 502 (660)
Q Consensus 429 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~---~--~~~kl~DfGla~~~~ 502 (660)
.+|++++... ...........+.++.|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999999653 11111222456788999999999999988 999999999999975 3 579999999999887
Q ss_pred ccCCccc-eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 503 ESEGEAN-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG-RRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 503 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
....... .....||.+|+|||++....-+.++|||||||++|+.++| ..||++.-. ....+.........+.+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~--- 737 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEP--- 737 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeecc---
Confidence 5544322 3345799999999999998889999999999999999997 788875422 11222222221111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
..++ .-.+||.+|+.++|..||++.+|+
T Consensus 738 ----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 ----LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ----CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111 566888999999999999999997
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=232.28 Aligned_cols=208 Identities=27% Similarity=0.399 Sum_probs=171.6
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC-CChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCC
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 418 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 418 (660)
..+++..+++.....||+|++|.|-+-++ .+|+..|+|+++. -..+..++..+|+.+..+- .+|.+|.++|....+.
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 34566667777788999999999988874 5899999999974 3445566778888876554 8999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcC-CCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 419 EKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
..++.||.|. .+|+.+... ....+.+++.-.=+|+..+.+||.|||++- .++|||+||+||||+.+|++|++|||.
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence 9999999994 478776643 234556888888899999999999999964 699999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhh----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAM----EGLYSKKSDVFSFGVLLIEIITGRRNAGS 555 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~t~ksDVwslGvll~elltG~~p~~~ 555 (660)
+-.+.++.... -..|-..|||||.+. ...|+.|+||||||+.+.||.+++.|+..
T Consensus 196 sG~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 196 SGYLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ceeehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 98776543322 125778899999985 34689999999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-28 Score=234.47 Aligned_cols=211 Identities=37% Similarity=0.589 Sum_probs=182.7
Q ss_pred cccCCcccEEeeeecC-CcEEEEEEccCCChh-cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCChhh
Q 006125 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA 434 (660)
Q Consensus 357 lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 434 (660)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999764332 35679999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEEeeccccccccccCCccceeee
Q 006125 435 ILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESEGEANTVRI 513 (660)
Q Consensus 435 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~ 513 (660)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985322 45899999999999999999999998 999999999999999 89999999999986654321 11223
Q ss_pred eccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Q 006125 514 VGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592 (660)
Q Consensus 514 ~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 592 (660)
.+...|++||..... ..+.+.|+|++|+++++| ..+
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~ 190 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PEL 190 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHH
Confidence 577889999999887 889999999999999999 347
Q ss_pred HHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 593 IHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 593 ~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
.+++.+|++.+|++||++.++++.+
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 7888999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=231.75 Aligned_cols=202 Identities=21% Similarity=0.430 Sum_probs=169.2
Q ss_pred ccChHHHHhhc---CCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeE
Q 006125 338 FIDLETLNLAT---SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLG 412 (660)
Q Consensus 338 ~~~~~~~~~~~---~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~ 412 (660)
.++++...+.. ++|++.+++|+|-++.||.|. ..+.+.++||++++. ..+.+.+|+.+|+.|. ||||+++++
T Consensus 24 YWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 24 YWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred hcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhh
Confidence 34555544433 567888999999999999998 567899999999863 3467889999999996 999999999
Q ss_pred EEEeCC--eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-CC
Q 006125 413 FCVDGD--EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MN 489 (660)
Q Consensus 413 ~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~ 489 (660)
+..+.. .+.||+||+.+.+...+. ..++...+...+.+++++|.|+|+.| |+|||+||.|++||.. -.
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rk 171 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRK 171 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhce
Confidence 998764 457999999998887766 34788889999999999999999999 9999999999999975 56
Q ss_pred EEEeeccccccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 006125 490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAG 554 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~ 554 (660)
++|+|||++..+....... ..+.+.-|..||++.. ..|...-|+|||||+|..|+-.+.||-
T Consensus 172 LrlIDWGLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred eeeeecchHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 9999999999876554332 1355677889999876 568999999999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=240.96 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=189.2
Q ss_pred CCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-----CeeEEE
Q 006125 352 SDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DEKLLV 423 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 423 (660)
+..+.||.|+||.||..+. ++|+.|++|++... +-...+.+.+|+.++..++|.|++..+++..-. .+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999985 47999999998752 333456789999999999999999998886543 246788
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
.|.| ..+|+.++- ....++-..+.-++.||++||.|||+.+ |.||||||.|.|++++-.+||+|||+++.-..
T Consensus 136 TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8888 458888883 4456888889999999999999999998 99999999999999999999999999986543
Q ss_pred cCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHHH-----------hc
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAY---AWHLW-----------NE 568 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~---~~~~~-----------~~ 568 (660)
.+. ...+..+-|.-|.|||++++ ..|+.+.||||.|||+.||+..+-.|......+. +.++. .+
T Consensus 209 d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 332 22333466888999999987 4699999999999999999988776653322211 11111 11
Q ss_pred CcccccccccCCCCCC--------CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 569 GNVLELVDPLLTDTSF--------SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
+...-++......+++ ....-.+-+++...++..||++|.+.++.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111111111111 112223345566679999999999999887544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-27 Score=230.91 Aligned_cols=210 Identities=32% Similarity=0.466 Sum_probs=176.3
Q ss_pred CCCCcccccCCcccEEeeeecC-CcEEEEEEccCCChh-cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecC
Q 006125 351 FSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556889999999999999764 889999999865444 57789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+++|.+++..... .+++.....++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999999853221 1789999999999999999999997 999999999999999999999999999876554311
Q ss_pred ceeeeeccCCcCCHhhh-hcCCCCcchhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHH
Q 006125 509 NTVRIVGTYGYMAPEYA-MEGLYSKKSDVFSFGVLLIEIITGRRNAGS-NQLLAYAWHLW 566 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwslGvll~elltG~~p~~~-~~~~~~~~~~~ 566 (660)
......++..|++||.+ ....++.++|||+||++++||++|+.||.. .+......+.+
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 12234678889999998 666788899999999999999999999966 34333343333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=243.20 Aligned_cols=133 Identities=26% Similarity=0.378 Sum_probs=109.9
Q ss_pred hcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-----C---CCcceEeEEEEe-
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----H---KNLVKLLGFCVD- 416 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~- 416 (660)
...+|...++||.|.|++||++. ..+.+.||+|+.+.. ....+....||++|++++ | .+||+|++.|..
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 34788899999999999999999 456789999999863 334556788999999883 3 369999999975
Q ss_pred ---CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe
Q 006125 417 ---GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484 (660)
Q Consensus 417 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl 484 (660)
+.+.+||+|++.. +|-.+|... ....++...+.+|++||+.||.|||.+. +|||.||||+|||+
T Consensus 155 GpNG~HVCMVfEvLGd-nLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGD-NLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhhhh-HHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 5578999999954 666666433 3334899999999999999999999987 69999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=247.82 Aligned_cols=197 Identities=28% Similarity=0.390 Sum_probs=166.5
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcH-----HHHHHHHHHHhhcC---CCCcceEeEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGT-----AEFTNEVLLILKLQ---HKNLVKLLGFCV 415 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~-----~~~~~E~~~l~~l~---h~niv~l~~~~~ 415 (660)
..+|...+.+|+|+||.|+.++++ +...|+||.+.+.. +.+. -.+..|+.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 345888899999999999999965 46689999886521 1121 23667999999997 999999999999
Q ss_pred eCCeeEEEEEec-CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 416 DGDEKLLVYEFM-PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 416 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
+.+..||++|-. ++.+|.+++ .....+++.++.-|++||+-|+++||+.+ |+|||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999975 456888888 34456999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccCCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAG 554 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~ 554 (660)
||.+....... ...++||.+|.|||++.+..| ...-|||++|++||.++....|+.
T Consensus 714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987654332 234689999999999998776 677899999999999998877764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=250.57 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=203.1
Q ss_pred cCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|+...++|.|.+|.|||++ ...++..|+|+++-.......-+.+|+-+++.-+||||+.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4578888999999999999999 457999999999876666777788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
|.+|+|+++. ...+++++.++...++...+||.|||+.+ -+|||||-.|||+++.|.+|+.|||.+-.+.....
T Consensus 94 cgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred cCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999999988 35677999999999999999999999998 89999999999999999999999999876543332
Q ss_pred ccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccc-cCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDP-LLTDT 582 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~ 582 (660)
. ...+.||+-|||||+.. .+.|..++|||++|+...|+-.-++|..+.......+ +... ..+++ .+.+
T Consensus 168 K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-LmTk----S~~qpp~lkD- 239 (829)
T KOG0576|consen 168 K--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-LMTK----SGFQPPTLKD- 239 (829)
T ss_pred h--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-Hhhc----cCCCCCcccC-
Confidence 2 23468999999999874 5679999999999999999987777644333222211 1111 11222 1111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
...-...|-++++.++.++|.+||+++.++
T Consensus 240 --k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 240 --KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred --CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 222334567788899999999999998876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=221.67 Aligned_cols=250 Identities=20% Similarity=0.351 Sum_probs=186.9
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEE-EEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGF-CVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e 425 (660)
+.|.+.+.||+|.||.+-++.++ +.+.+++|-+.. .....++|.+|...--.| .|.||+.-+++ |...+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45778899999999999999965 567889998865 345567899998877667 68999988775 455567778999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC--CCCCEEEeeccccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMNSKISDFGMARIFAE 503 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DfGla~~~~~ 503 (660)
|++.|+|.+-+.. ..+-+....+++.|+++++.|+|++. +||||||.+||||- +..++||+|||+.+....
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999988832 33667778899999999999999998 99999999999993 346899999999875432
Q ss_pred cCCccceeeeeccCCcCCHhhhhcC-----CCCcchhHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHHHhcCcccccc
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEG-----LYSKKSDVFSFGVLLIEIITGRRNAGS---NQLLAYAWHLWNEGNVLELV 575 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwslGvll~elltG~~p~~~---~~~~~~~~~~~~~~~~~~~~ 575 (660)
.... ..-+..|.+||+.... ...+.+|||.||++++.++||+.||.. .+..-|.|..|..+.....-
T Consensus 176 tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 176 TVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred eehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 2211 2235679999987543 246789999999999999999999973 34445566666665543221
Q ss_pred cccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 576 DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 576 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
+. . + .+++ +.+.+.++-+..+|++|-...++.++.+
T Consensus 251 ~~-F-~-~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 251 KK-F-N-PFSE----KALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred hh-h-c-ccCH----HHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 11 1 1 1222 3455666789999999966666655543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-27 Score=240.62 Aligned_cols=263 Identities=21% Similarity=0.233 Sum_probs=203.0
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC------CCCcceEeEEEEe
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ------HKNLVKLLGFCVD 416 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~ 416 (660)
-++..++|......|+|-|++|.+|.. ..|+.||||++++.. .-.+.=..|+++|++|+ .-|+++++-.|.+
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 456678899999999999999999984 458899999998743 33344568999999994 3589999999999
Q ss_pred CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-CCEEEeec
Q 006125 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDF 495 (660)
Q Consensus 417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~Df 495 (660)
..++|||+|-+ .-+|.++|.....+-.|....+..++.|+.-+|..|...+ |+|.||||.||||++. ..+|||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 99999999987 5589999977666667999999999999999999999988 9999999999999986 56899999
Q ss_pred cccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCC---cHHHHHH--------H
Q 006125 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN---QLLAYAW--------H 564 (660)
Q Consensus 496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~---~~~~~~~--------~ 564 (660)
|.|......+..+. .-+..|.|||++.+..|....|+||.||.||||.||+-.|.+. ++..... +
T Consensus 582 GSA~~~~eneitPY----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 582 GSASFASENEITPY----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred ccccccccccccHH----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 99987665544332 3466799999999999999999999999999999999877532 2222111 1
Q ss_pred HHhcCccc---------------------------ccccc-------cCCCCCCC---HHHHHHHHHHHhhcccCCCCCC
Q 006125 565 LWNEGNVL---------------------------ELVDP-------LLTDTSFS---DDEFSRYIHIGLLCVQEDAFDR 607 (660)
Q Consensus 565 ~~~~~~~~---------------------------~~~d~-------~~~~~~~~---~~~~~~l~~li~~cl~~dP~~R 607 (660)
+++.+.+. ..+.| .+..+.++ ......|.+|+..|+..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 11111100 00111 01111122 3345678889999999999999
Q ss_pred CCHHhHHH
Q 006125 608 PTMSSVAP 615 (660)
Q Consensus 608 Pt~~evl~ 615 (660)
.|..+.|.
T Consensus 738 it~nqAL~ 745 (752)
T KOG0670|consen 738 ITVNQALK 745 (752)
T ss_pred CCHHHHhc
Confidence 99998874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=225.14 Aligned_cols=254 Identities=26% Similarity=0.285 Sum_probs=186.8
Q ss_pred CCCCCCcccccCCcccEEeee-ecCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------Ce
Q 006125 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DE 419 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 419 (660)
.+|.....+|.|.- .|-.+. .-.++.||+|++.. ......+...+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888877 444444 23688999998753 2344566788999999999999999999998643 35
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.|+|||+|. .+|...++ -.++-+....|+.|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 689999994 58888874 23777889999999999999999998 9999999999999999999999999997
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcC---------
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEG--------- 569 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~--------- 569 (660)
.-... -..+..+.+.-|.|||++.+..+.+.+||||+||++.||++|+-.|.+.+ +.+|..-.-.-+
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 54332 12233577888999999998889999999999999999999997765332 222211100000
Q ss_pred ------------------cccccccccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 ------------------NVLELVDPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 ------------------~~~~~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+.+-..+.. .+.+.-......+++.+||..||++|-+++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 011111111100 0111122344678889999999999999999984
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=228.74 Aligned_cols=200 Identities=24% Similarity=0.418 Sum_probs=166.4
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeeec----CCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCC
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 418 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 418 (660)
+....+.|...++||+|.|++||++++. .++.||+|.+... .....+.+|+++|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344567888999999999999999953 4678999998753 3345688999999999 6999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-CCEEEeeccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGM 497 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGl 497 (660)
...+|+||+++....+++.. ++...+...++.+..+|.++|..| ||||||||.|+|.+.. ++-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999998832 678889999999999999999999 9999999999999865 6789999999
Q ss_pred cccccccC------C-------c-----------------------------cceeeeeccCCcCCHhhhhc-CCCCcch
Q 006125 498 ARIFAESE------G-------E-----------------------------ANTVRIVGTYGYMAPEYAME-GLYSKKS 534 (660)
Q Consensus 498 a~~~~~~~------~-------~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~ks 534 (660)
+....... . . .......||++|.|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 98321100 0 0 00011369999999999986 4578999
Q ss_pred hHHHHHHHHHHHHhCCCCCC
Q 006125 535 DVFSFGVLLIEIITGRRNAG 554 (660)
Q Consensus 535 DVwslGvll~elltG~~p~~ 554 (660)
||||-|||++-+++++.||-
T Consensus 260 Diws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ceeeccceeehhhccccccc
Confidence 99999999999999999974
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=263.05 Aligned_cols=196 Identities=20% Similarity=0.209 Sum_probs=138.3
Q ss_pred hcCC-CCcceEeEEE-------EeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006125 401 KLQH-KNLVKLLGFC-------VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472 (660)
Q Consensus 401 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 472 (660)
.++| +||++++++| .+.+..++++|++ +++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5888888877 2334567788987 66999999532 345999999999999999999999998 9
Q ss_pred EecCCCCCceEeCC-------------------CCCEEEeeccccccccccCC--------------ccceeeeeccCCc
Q 006125 473 VHRDLKASNVLLDS-------------------DMNSKISDFGMARIFAESEG--------------EANTVRIVGTYGY 519 (660)
Q Consensus 473 vH~DLkp~NILl~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y 519 (660)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566666666653211000 0001113578889
Q ss_pred CCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhc
Q 006125 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLC 599 (660)
Q Consensus 520 ~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~c 599 (660)
||||++.+..++.++|||||||+||||++|.+|+..... .... .... .+.+. ..........++.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~-~~~~----~~~~~------~~~~~~~~~~~~~~~ 248 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSS-LRHR----VLPPQ------ILLNWPKEASFCLWL 248 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHH-HHHh----hcChh------hhhcCHHHHHHHHHh
Confidence 999999999999999999999999999999887643211 1111 1100 01110 011123356778899
Q ss_pred ccCCCCCCCCHHhHHH
Q 006125 600 VQEDAFDRPTMSSVAP 615 (660)
Q Consensus 600 l~~dP~~RPt~~evl~ 615 (660)
|++||.+||+|.||++
T Consensus 249 L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 249 LHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCChhhCcChHHHhh
Confidence 9999999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=208.10 Aligned_cols=165 Identities=20% Similarity=0.152 Sum_probs=124.3
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
|+|.+++.. ....+++.+++.|+.||++||.|||+.+ ||+|||+++++.+|+ ||++.......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999953 2345999999999999999999999875 999999999999999 99987654321
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHHhcCcccccccccCCCCCCCHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL-LAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 588 (660)
..|++.|+|||++.+..++.++|||||||++|||++|+.|+..... ............. . ++.. . ......
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~--~~~~-~-~~~~~~ 135 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-D--DPRD-R-SNLESV 135 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-C--Cccc-c-ccHHHH
Confidence 2578999999999999999999999999999999999999864432 2222222111110 0 0000 0 011112
Q ss_pred H--HHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 589 F--SRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 589 ~--~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
. ..+.+++.+||+.||.+||++.|+++.+..
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 2 258899999999999999999999987753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=209.00 Aligned_cols=245 Identities=20% Similarity=0.352 Sum_probs=188.5
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEcc--CCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCC
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 431 (660)
..+|.+...|..|+|+++ |..+++|++. ........+|.+|.-.++.+.||||++++|.|....++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 457899999999999994 6677778775 3455566789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeE-ecCCCCCceEeCCCCCEEEeeccccccccccCCccce
Q 006125 432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV-HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510 (660)
Q Consensus 432 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv-H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (660)
|..+|+. ...-..+..++.+++.+|++|++|||+.. +++ ---|.++.|+||++.+++|+- +-.++.....
T Consensus 274 lynvlhe-~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarism-ad~kfsfqe~----- 344 (448)
T KOG0195|consen 274 LYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEV----- 344 (448)
T ss_pred HHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheec-ccceeeeecc-----
Confidence 9999975 34445788999999999999999999987 344 346899999999999988852 1111111111
Q ss_pred eeeeccCCcCCHhhhhcCC---CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 511 VRIVGTYGYMAPEYAMEGL---YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 511 ~~~~gt~~y~aPE~~~~~~---~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
...-.+.||+||.+...+ .-+++|+|||.+++|||.|...||.+-...+.-.++.-++- ...+.+ . ...
T Consensus 345 -gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl-----rv~ipp-g-is~ 416 (448)
T KOG0195|consen 345 -GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL-----RVHIPP-G-ISR 416 (448)
T ss_pred -ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc-----cccCCC-C-ccH
Confidence 113467899999998665 34689999999999999999999987766655544443332 122211 2 222
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
. +.+|+.-|+..||.+||.++.|+..|+.
T Consensus 417 h---m~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 417 H---MNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred H---HHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 3 4455556999999999999999998875
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-24 Score=183.21 Aligned_cols=101 Identities=36% Similarity=0.692 Sum_probs=78.0
Q ss_pred CCCCC-CCCCcc-CCCChHHHHHHHHHHHhhhcccc---CCcccccccCCCCcEEEEEecCCCCChhchHHHHHHHHHHH
Q 006125 29 YNICS-TSTAGS-ARASTIDDNLQNVLTSLASNANA---AKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDI 103 (660)
Q Consensus 29 ~~~C~-~~~~~~-~~~s~~~~nl~~l~~~l~~~~~~---~~~~~~~~g~~~~~vyg~~~Cr~d~~~~~C~~C~~~a~~~~ 103 (660)
|+.|+ +..+.+ +.+++|++||+.|++.|...++. .+|+++..|.++++|||++||++|+++++|..||+.|...+
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 67899 444433 57888999999999999999776 37999988999999999999999999999999999999999
Q ss_pred hhhCCCcccceEEcCeeEEEecCccc
Q 006125 104 SKLCPNKTEAIVWEEVCQLRYAYQNF 129 (660)
Q Consensus 104 ~~~C~~~~~a~~~~~~C~~ry~~~~f 129 (660)
.+.|+.+++|+||++.|+|||++++|
T Consensus 81 ~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHhCCCCceEEEECCCEEEEEECCCC
Confidence 99999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=213.93 Aligned_cols=167 Identities=20% Similarity=0.241 Sum_probs=129.6
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec--CCcEEEEEEccCC-----ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS--DGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 417 (660)
....++|...+.||+|+||+||++... +++.+|||++... .......+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999864 5778899987532 22235568999999999999999853322 2
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCceEeCCCCCEEEeecc
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL-KASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL-kp~NILl~~~~~~kl~DfG 496 (660)
+..+|||||+++++|.... ..+ ...++.+++++|.|||+.+ |+|||| ||+|||++.++++||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4679999999999996321 111 1467889999999999998 999999 9999999999999999999
Q ss_pred ccccccccCCccc------eeeeeccCCcCCHhhhhc
Q 006125 497 MARIFAESEGEAN------TVRIVGTYGYMAPEYAME 527 (660)
Q Consensus 497 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 527 (660)
+++.+........ .....+++.|++||++..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9987654321111 123567888999999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-22 Score=207.14 Aligned_cols=259 Identities=21% Similarity=0.274 Sum_probs=191.9
Q ss_pred CCCCCcccccCCcccEEeeeecCC--cEEEEEEccCCChhcHHHHHHHHHHHhhcCC----CCcceEeEEE-EeCCeeEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLSDG--KEVAVKRLSSCSEQGTAEFTNEVLLILKLQH----KNLVKLLGFC-VDGDEKLL 422 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 422 (660)
+|...++||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999996543 4788887765433333378889999998863 6899999998 47778899
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-----CCEEEeeccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-----MNSKISDFGM 497 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-----~~~kl~DfGl 497 (660)
||+.+ +.+|.++..... .+.++..+...|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 779999875433 567999999999999999999999999 9999999999999754 4699999999
Q ss_pred cc--cccccCCc----c-c-eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC
Q 006125 498 AR--IFAESEGE----A-N-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG 569 (660)
Q Consensus 498 a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~ 569 (660)
++ .+...... . . .....||..|.+++.+.+...+.+.|+||++.++.|++.|..||................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 43222211 1 1 123469999999999999999999999999999999999999986433211111111110
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 570 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
....... .....+.+...+.. .+-..+..++|....+...|+..
T Consensus 254 -~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 254 -RKLLTDR---FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred -hhhcccc---ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHH
Confidence 0011111 11223344444444 34447889999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-20 Score=196.95 Aligned_cols=259 Identities=30% Similarity=0.397 Sum_probs=198.3
Q ss_pred CCCCcccccCCcccEEeeeecCCcEEEEEEccCCChh---cHHHHHHHHHHHhhcCCC-CcceEeEEEEeCCeeEEEEEe
Q 006125 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ---GTAEFTNEVLLILKLQHK-NLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 426 (660)
|...+.||.|+|+.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999976 88999998753322 467899999999999988 799999999777778999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-CEEEeeccccccccccC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAESE 505 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~~~ 505 (660)
+.++++.+++........++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .+++.|||.+..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977743211135889999999999999999999998 99999999999999988 79999999998655433
Q ss_pred Ccc----ceeeeeccCCcCCHhhhhc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHHhcCcccccc
Q 006125 506 GEA----NTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSNQL---LAYAWHLWNEGNVLELV 575 (660)
Q Consensus 506 ~~~----~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwslGvll~elltG~~p~~~~~~---~~~~~~~~~~~~~~~~~ 575 (660)
... ......|+..|++||.+.. .......|+|++|++++++++|..|+..... ....+......... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 221 2244689999999999987 5789999999999999999999999765542 23333333222211 00
Q ss_pred cccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 576 DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 576 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
...... .........+.+++..++..+|..|.++.+....
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCc-cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000 0001223456788889999999999999987753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=226.47 Aligned_cols=259 Identities=25% Similarity=0.309 Sum_probs=188.8
Q ss_pred CCCcccccCCcccEEeeee-cCCcEEEEEEcc----C-CChh-cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 352 SDSNILGQGGFGPVYKGVL-SDGKEVAVKRLS----S-CSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~----~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
.....+|.|.+|.|+.... ...+..+.|... . ..+. ....+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998777763 334434444332 1 1111 1222667888888899999988888777776666669
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++ +|..++. ..+.++..++..++.|+..|+.|||+.| |.|||||++|++++.++.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999983 3356888999999999999999999999 999999999999999999999999999877655
Q ss_pred CCc--cceeeeeccCCcCCHhhhhcCCCC-cchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 505 EGE--ANTVRIVGTYGYMAPEYAMEGLYS-KKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 505 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
... ......+|+..|+|||++....|. ...||||.|+++..|++|+.||......+.-.............. ..
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~---~~ 550 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFE---GP 550 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccccc---Ch
Confidence 443 334457899999999999988875 579999999999999999998863321111000000000000000 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhcCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGE 620 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~ 620 (660)
.......+.+...++.+||+.||.+|-|+++|+ .+++.+
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 122334556678899999999999999999998 345444
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.4e-22 Score=171.29 Aligned_cols=97 Identities=37% Similarity=0.699 Sum_probs=77.4
Q ss_pred cccC-CChhHHHHHHHHHHHHHHHHhccCCCCcceeeeeccCCCCCceEEEeeccCCCCccchHHHHHHHHHhhhhhccC
Q 006125 144 RLNI-SEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYF 222 (660)
Q Consensus 144 ~~~~-~~~~~~~~~~~~~l~~l~~~~~~~~~~~~f~~~~~~~~~~~~vygl~QC~~Dls~~~C~~CL~~a~~~~~~~c~~ 222 (660)
..++ +++..|..++..+|.+|...++...+ .+|++++.+ .++++||||+||++||++++|..||+.++..++.+|+.
T Consensus 9 ~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~-~~f~~~~~~-~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~ 86 (106)
T PF01657_consen 9 NNNYTTDNSTFEQNLNSLLSSLVSNAASSSS-KGFATGSAG-SGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPG 86 (106)
T ss_dssp SB----TT-THHHHHHHHHHHHHHHGGGTT--TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTS
T ss_pred CCCcCCCCchHHHHHHHHHHHHHHHHhhccc-cCcEEeecC-CCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCC
Confidence 3444 55666999999999999999886543 689999875 68889999999999999999999999999999999999
Q ss_pred CCCcEEEcccccchhhhchh
Q 006125 223 SRGARLLSRNCYLRYELYAF 242 (660)
Q Consensus 223 ~~g~~~~~~~C~lry~~~~f 242 (660)
++||+|++++|+||||+|+|
T Consensus 87 ~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 87 SRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp BSSEEEEESSEEEEEESS--
T ss_pred CceEEEECCCEEEEEECCCC
Confidence 99999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-22 Score=222.02 Aligned_cols=252 Identities=21% Similarity=0.225 Sum_probs=186.2
Q ss_pred CCCCCcccccCCcccEEeeeecCCcEEEEEEccCC-ChhcHHHHHHHHHHH--hhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC-SEQGTAEFTNEVLLI--LKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~-~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++...+.||.+.|=+|.+++.++|. |+||++-+. .......+.++++-+ ..++|||++++.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 889988543 344555555554444 445999999998887777778899999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+.+ +|.+.| ..+..+...+...|+.|++.||..+|..+ |+|||||.+||||+.-..+.|+||..-+...-.+.
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 966 888888 46667888999999999999999999998 99999999999999999999999987654332222
Q ss_pred ccc-eeeee----ccCCcCCHhhhhcC-----------CCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC
Q 006125 507 EAN-TVRIV----GTYGYMAPEYAMEG-----------LYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEG 569 (660)
Q Consensus 507 ~~~-~~~~~----gt~~y~aPE~~~~~-----------~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 569 (660)
.+. ...+. .-..|+|||.+... ..+++-||||+||++.||++ |+++|.-.++..+-.. +.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~---~~ 252 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG---NA 252 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc---Cc
Confidence 211 11122 23359999998541 16789999999999999998 5777865544433211 01
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 570 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
...+.+-..+.+ ..+.++++.|++.||++|.++++.++.-++.
T Consensus 253 ~~~e~~Le~Ied--------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 253 DDPEQLLEKIED--------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred cCHHHHHHhCcC--------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111111111111 1477899999999999999999999875554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=185.03 Aligned_cols=200 Identities=20% Similarity=0.334 Sum_probs=170.7
Q ss_pred cCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.-+|...++||+|.||.++.|+ +-+++.||||.-... .+..++..|....+.| ..++|...+-+..++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4578899999999999999999 668999999976543 3345788899998888 57999999999888888899999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-----CCEEEeecccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-----MNSKISDFGMARI 500 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-----~~~kl~DfGla~~ 500 (660)
.+ +-+|+++..- -...++.+++..++.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+++.
T Consensus 105 LL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 88 7799998843 2345999999999999999999999998 9999999999999643 4589999999998
Q ss_pred ccccCCcc-----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006125 501 FAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS 555 (660)
Q Consensus 501 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~ 555 (660)
+.+..... ......||.+||+-....+...+...|+-|||-+++..|-|..||.+
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 77654432 22335799999999999999999999999999999999999999974
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=178.98 Aligned_cols=203 Identities=21% Similarity=0.320 Sum_probs=170.1
Q ss_pred hcCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCC-CCcceEeEEEEeCCeeEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 424 (660)
-.++|...++||.|+||.+|.|. ..+|+.||||.-+.. ....++.-|..+...|++ ..|..+..+..++..-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35788999999999999999999 678999999986542 223467789999999975 77888888888899999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC---CCEEEeeccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIF 501 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfGla~~~ 501 (660)
+.. +-+|++++.-.. ..++.++++-++-|++.-++|+|.++ ++||||||+|+|+.-+ .++.|+|||+++.+
T Consensus 91 dLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 779999885433 34899999999999999999999998 9999999999999654 56899999999987
Q ss_pred cccCCcc-----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 006125 502 AESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557 (660)
Q Consensus 502 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~ 557 (660)
.+..... ......||.+|.+-..+.+...+...|+-|+|.+|..+..|..||.+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 6543322 2233579999999888888888999999999999999999999998644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=184.24 Aligned_cols=172 Identities=15% Similarity=0.188 Sum_probs=134.8
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHH---H------HHHHHHHHhhcCCCCcceEeEEEEe
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA---E------FTNEVLLILKLQHKNLVKLLGFCVD 416 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~ 416 (660)
+..++|...++||.|+||.||+... ++..+|+|.+++....... . +.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578899999999999999999655 5778999999753222222 2 6789999999999999999988664
Q ss_pred C--------CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC
Q 006125 417 G--------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (660)
Q Consensus 417 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~ 488 (660)
. ...+|+|||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||++|+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999988741 222 24568999999999998 99999999999999988
Q ss_pred CEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHH
Q 006125 489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547 (660)
Q Consensus 489 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ell 547 (660)
++|+|||.......... -..++....+..++|+|+||+.+.-+.
T Consensus 173 -i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998865421111 011445556778999999999987665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=179.58 Aligned_cols=139 Identities=20% Similarity=0.198 Sum_probs=108.7
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChh--c------------------------HHHHHHHHHHHhhcCCCCc
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ--G------------------------TAEFTNEVLLILKLQHKNL 407 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 407 (660)
...||+|+||.||+|...+|+.||||+++..... . .....+|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999878999999999753211 1 1123459999999988877
Q ss_pred ceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCceEeCC
Q 006125 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL-HEDSRLRIVHRDLKASNVLLDS 486 (660)
Q Consensus 408 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~DLkp~NILl~~ 486 (660)
.....+.. ...+|||||++++++...+. ....+++.+...++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333322 23489999999987765431 234688999999999999999999 6877 99999999999998
Q ss_pred CCCEEEeeccccccc
Q 006125 487 DMNSKISDFGMARIF 501 (660)
Q Consensus 487 ~~~~kl~DfGla~~~ 501 (660)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-20 Score=197.62 Aligned_cols=216 Identities=25% Similarity=0.360 Sum_probs=164.0
Q ss_pred HhhcCCCCcceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006125 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK 478 (660)
Q Consensus 399 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLk 478 (660)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ..-.++|.....++++|++||+|||... -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4578999999999999999999999999999999999965 3445899999999999999999999875 23999999
Q ss_pred CCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcC-------CCCcchhHHHHHHHHHHHHhCCC
Q 006125 479 ASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-------LYSKKSDVFSFGVLLIEIITGRR 551 (660)
Q Consensus 479 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwslGvll~elltG~~ 551 (660)
++|+++|..+.+||+|||+.................-...|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999999877531111111112345679999998753 25788999999999999999999
Q ss_pred CCCCCcH----HHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCC
Q 006125 552 NAGSNQL----LAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGT 623 (660)
Q Consensus 552 p~~~~~~----~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 623 (660)
||..... .+.+..+.+ ...+.+.|.+... .+....+..++..||..+|.+||++++|-..++.....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHHHHh--cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9874221 122222222 1112222222211 13333688999999999999999999999988876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=173.67 Aligned_cols=140 Identities=22% Similarity=0.225 Sum_probs=111.0
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChh---------------------c-----HHHHHHHHHHHhhcCCCCc
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ---------------------G-----TAEFTNEVLLILKLQHKNL 407 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 407 (660)
...||+|+||.||+|...+|+.||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999998753211 0 1224678999999999987
Q ss_pred ceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEeCC
Q 006125 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDS 486 (660)
Q Consensus 408 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~DLkp~NILl~~ 486 (660)
.....+... ..+|||||++++++..... ....++......++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444333 3489999999886543321 22457788999999999999999999 87 99999999999998
Q ss_pred CCCEEEeecccccccc
Q 006125 487 DMNSKISDFGMARIFA 502 (660)
Q Consensus 487 ~~~~kl~DfGla~~~~ 502 (660)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-20 Score=198.00 Aligned_cols=225 Identities=24% Similarity=0.276 Sum_probs=178.5
Q ss_pred ccccCCcccEEeee----ecCCcEEEEEEccCCChh--cHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEEEecC
Q 006125 356 ILGQGGFGPVYKGV----LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~----~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
++|+|.||.|++.. .+.|..+|+|.+++.... .......|..++...+ ||.++++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999865 235778899988753221 1124556788888886 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+|.|...+. +...++..........++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++........
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988873 4455777778888889999999999998 999999999999999999999999999876544332
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 588 (660)
+||..|||||++. ....++|.||||++++||+||..||.. +....+.+.. ...+.+.
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~------------~~~p~~l 210 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE------------LEMPREL 210 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc------------cCCchhh
Confidence 8999999999988 567899999999999999999999976 2222222211 1234444
Q ss_pred HHHHHHHHhhcccCCCCCCCCH
Q 006125 589 FSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 589 ~~~l~~li~~cl~~dP~~RPt~ 610 (660)
.....+++..++..+|..|.-.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhcc
Confidence 4455667778888999999765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=163.95 Aligned_cols=183 Identities=17% Similarity=0.113 Sum_probs=137.8
Q ss_pred CCcccccCCcccEEeeeecCCcEEEEEEccCCCh----hcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEEEec
Q 006125 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE----QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 353 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
....|++|+||+||.+.. .+.+++.+.+..... .....+.+|+++|++|. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997665 678888887765322 11225789999999995 5889999886 3469999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCceEeCCCCCEEEeeccccccccccCC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL-KASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL-kp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
.+.+|...+. . ....++.|++++|.++|+.+ |+|||| ||+|||+++++.++|+|||++........
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999865431 1 11347789999999999998 999999 79999999999999999999985443221
Q ss_pred c----c-c------eeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 006125 507 E----A-N------TVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNA 553 (660)
Q Consensus 507 ~----~-~------~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~ 553 (660)
. . . ......++.|++|+...- ..--...++++-|..+|.++|++.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 0 0 001235788899986542 22236789999999999999999764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=173.15 Aligned_cols=230 Identities=21% Similarity=0.243 Sum_probs=146.9
Q ss_pred CCcccccCCcccEEeeeec-CCcEEEEEEccC---CChhcHHHHHHHHHHHhhcCC----------CCcceEeEEEE---
Q 006125 353 DSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH----------KNLVKLLGFCV--- 415 (660)
Q Consensus 353 ~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~--- 415 (660)
....||.|+++.||.++.. +|+++|+|++.. ......+++++|......+.+ -.++-.++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3578999999999999965 589999998742 233446677777766665432 12222222221
Q ss_pred ------eC---C-----eeEEEEEecCCCChhhhhcC----CCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 006125 416 ------DG---D-----EKLLVYEFMPNGSLDAILFD----PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL 477 (660)
Q Consensus 416 ------~~---~-----~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL 477 (660)
.. . ..+++|+-+ .++|..++.- ......+....++.+..|+++.+++||+.| ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 11 1 235677777 5688877631 112233445566778899999999999999 999999
Q ss_pred CCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcC--------CCCcchhHHHHHHHHHHHHhC
Q 006125 478 KASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG--------LYSKKSDVFSFGVLLIEIITG 549 (660)
Q Consensus 478 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~t~ksDVwslGvll~elltG 549 (660)
+|+|++++.+|.++|+||+........... ...+..|.+||..... .++.+.|.|+||+++|.|++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999877654332211 1235679999987542 478999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCC
Q 006125 550 RRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDR 607 (660)
Q Consensus 550 ~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 607 (660)
+.|++........ ...+. ... +.++.+..||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~---------~~~f~------~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADP---------EWDFS------RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTS---------GGGGT------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccc---------cccch------hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999744311100 00111 233 556678889999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.3e-19 Score=176.47 Aligned_cols=197 Identities=22% Similarity=0.283 Sum_probs=137.5
Q ss_pred CCCCcceEeEEEEeC---------------------------CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHH
Q 006125 403 QHKNLVKLLGFCVDG---------------------------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455 (660)
Q Consensus 403 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 455 (660)
+|||||++.++|.+. ..+|+||.-.+. +|..++.. ...+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence 599999999887531 235888887754 88888842 2356677778999
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCceEeC--CCC--CEEEeecccccccccc----CCccceeeeeccCCcCCHhhhhc
Q 006125 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDM--NSKISDFGMARIFAES----EGEANTVRIVGTYGYMAPEYAME 527 (660)
Q Consensus 456 ~ia~~L~~LH~~~~~~ivH~DLkp~NILl~--~~~--~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 527 (660)
|+++|+.|||.++ |.|||||++||||. +|+ .+.|+|||.+-.-... .........-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999994 443 4788999987532211 11111122346677899999864
Q ss_pred CC------CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhccc
Q 006125 528 GL------YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQ 601 (660)
Q Consensus 528 ~~------~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~ 601 (660)
.+ .-.|+|.|+.|-+.||+++...||......-.....+++..+ +..++..+..+.+++...|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL----------Palp~~vpp~~rqlV~~lL~ 495 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL----------PALPSRVPPVARQLVFDLLK 495 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC----------CCCcccCChHHHHHHHHHhc
Confidence 32 236999999999999999999998653211111111222111 12344445567889999999
Q ss_pred CCCCCCCCHHhHHHHh
Q 006125 602 EDAFDRPTMSSVAPML 617 (660)
Q Consensus 602 ~dP~~RPt~~evl~~L 617 (660)
.||++||+..-....|
T Consensus 496 r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVL 511 (598)
T ss_pred CCccccCCccHHHhHH
Confidence 9999999876655444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-18 Score=165.09 Aligned_cols=137 Identities=18% Similarity=0.226 Sum_probs=106.5
Q ss_pred CCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-----CCCCcceEeEEEEeCC---e-eE
Q 006125 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-----QHKNLVKLLGFCVDGD---E-KL 421 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 421 (660)
+...+.||+|+||.||. .-.++.. +||++........+.+.+|+.++..+ +||||++++|++.... . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 3223444 79988765445567899999999999 5799999999998864 3 33
Q ss_pred EEEEe--cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCceEeCC----CCCEEEee
Q 006125 422 LVYEF--MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM-LYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISD 494 (660)
Q Consensus 422 lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~DLkp~NILl~~----~~~~kl~D 494 (660)
+|+|| +++|+|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +.+++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 558999999943 235554 35677888777 9999998 999999999999974 34899999
Q ss_pred cccc
Q 006125 495 FGMA 498 (660)
Q Consensus 495 fGla 498 (660)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=194.74 Aligned_cols=252 Identities=18% Similarity=0.232 Sum_probs=179.5
Q ss_pred HHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC---CCCcceEeEEEEeCCe
Q 006125 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDE 419 (660)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~ 419 (660)
++++....|.+.+.||+|+||.||+|...+|+.||+|+-++... .+|---.+++.+|+ -+.|..+.....-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 45566777888899999999999999988899999998765322 11111122333333 2345555555566778
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC-------CCCCEEE
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-------SDMNSKI 492 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~-------~~~~~kl 492 (660)
.+||+||.+.|+|.+++. ..+..+|...+.++.|+++.+++||..+ |||+||||+|+||. +.-.++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999994 5566999999999999999999999998 99999999999994 2345899
Q ss_pred eeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccc
Q 006125 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVL 572 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 572 (660)
+|||.+-.+.--.........++|-.+--+|...+..+++++|.|.|.-+++-||-|+.. . .+.+..+
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------q-~~~g~~~- 910 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------E-VKNGSSW- 910 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------H-hcCCcce-
Confidence 999998654432222333445788899999999999999999999999999999999831 1 1111111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.++..+.+ -+..+...+++++ +|..|-..=|...++...|+++
T Consensus 911 -~~~~~~~R-y~~~~~W~~~F~~---lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 911 -MVKTNFPR-YWKRDMWNKFFDL---LLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred -eccccchh-hhhHHHHHHHHHH---HhCcCcccchhHHHHHHHHHHH
Confidence 11111111 2223334444443 4445555567777777776654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9e-17 Score=158.01 Aligned_cols=134 Identities=19% Similarity=0.292 Sum_probs=113.4
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCCh--------hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+.||+|++|.||+|.. +|..+++|+...... .....+.+|+.++..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899998654221 1124577899999999999998888888778889999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998421 12 78899999999999999998 99999999999999 78999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.8e-17 Score=160.16 Aligned_cols=142 Identities=22% Similarity=0.210 Sum_probs=111.1
Q ss_pred CCCCCcccccCCcccEEeee--ecCCcEEEEEEccCCChh------------------------cHHHHHHHHHHHhhcC
Q 006125 350 NFSDSNILGQGGFGPVYKGV--LSDGKEVAVKRLSSCSEQ------------------------GTAEFTNEVLLILKLQ 403 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 403 (660)
.|...+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999998743210 0123568999999997
Q ss_pred CCC--cceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 006125 404 HKN--LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (660)
Q Consensus 404 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~N 481 (660)
+.+ +.+++++ ...++||||+++++|..... ....+...+...++.||+.+|.+||+.+ .++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 533 4445543 23589999999988876542 2234566677899999999999999986 49999999999
Q ss_pred eEeCCCCCEEEeeccccccc
Q 006125 482 VLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 482 ILl~~~~~~kl~DfGla~~~ 501 (660)
|+++ +++++|+|||.+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999998643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.2e-18 Score=177.24 Aligned_cols=124 Identities=29% Similarity=0.454 Sum_probs=109.7
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
.+++.|+++...+|.++|...+.....++.....++.|++.++.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999776777778999999999999999999 55 999999999999999999999999998
Q ss_pred ccccccC----CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh
Q 006125 499 RIFAESE----GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548 (660)
Q Consensus 499 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt 548 (660)
....... .........||..||+||.+.+..|+.|+|||+||+||+|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7655443 1223445689999999999999999999999999999999997
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=154.83 Aligned_cols=144 Identities=21% Similarity=0.217 Sum_probs=111.7
Q ss_pred HHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCCh----------------------hcHHHHHHHHHHHh
Q 006125 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE----------------------QGTAEFTNEVLLIL 400 (660)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~ 400 (660)
++......|...+.||+|+||.||++..++|+.||||+++.... ........|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 33333334777899999999999999988899999998753210 01123667888999
Q ss_pred hcCCCC--cceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006125 401 KLQHKN--LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK 478 (660)
Q Consensus 401 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLk 478 (660)
.+.|++ ++..++. ...++||||+++++|..+... .....++.++++++.++|+.+ ++|||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 4455442 355899999999998776420 235678899999999999987 9999999
Q ss_pred CCceEeCCCCCEEEeecccccccc
Q 006125 479 ASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 479 p~NILl~~~~~~kl~DfGla~~~~ 502 (660)
|+||++++++.++|+|||++..+.
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=154.32 Aligned_cols=130 Identities=23% Similarity=0.356 Sum_probs=106.8
Q ss_pred ccccCCcccEEeeeecCCcEEEEEEccCCCh--------hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.||+|+||.||+|.+ +|..+++|+...... .....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 678899998653211 11356778999999999887766666666677789999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++++|.+++... . . .++.+++++|.+||+.+ ++|+|++|+||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~---~-~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc---H-H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887321 1 0 78999999999999998 99999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=176.35 Aligned_cols=136 Identities=22% Similarity=0.341 Sum_probs=111.3
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEE-ccC-CC------hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR-LSS-CS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~-l~~-~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
..|...+.||+|+||.||++.+.+.. +++|+ +.. .. ....+.+.+|++++..++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34466789999999999999875443 44443 221 11 11235688999999999999999888888887788
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999883 35678999999999999998 9999999999999 678999999999865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-16 Score=176.95 Aligned_cols=211 Identities=22% Similarity=0.270 Sum_probs=146.7
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|+.++.|..|++|.||...++ ..+.+|+|+-+. .. -+.+ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch----hhhc---cccccCCccee------------------
Confidence 367888899999999999999865 467788853221 10 0001 22222333333
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
|+-..++. .-+.++... +.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+.......
T Consensus 136 ---gDc~tllk---~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 44444442 223344332 78899999998 99999999999999999999999999875432211
Q ss_pred c-------------cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc-cc
Q 006125 507 E-------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN-VL 572 (660)
Q Consensus 507 ~-------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~-~~ 572 (660)
. ......+||+.|.|||++....|..-+|+|++|+|+||.+-|..||..+...+.+...+.+.- +.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 1 112335899999999999999999999999999999999999999988766665555444321 11
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHH
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMS 611 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 611 (660)
|- ......+..+++...|+.+|..|--..
T Consensus 279 E~----------dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 279 EE----------DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred cc----------CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 11 122233466777889999999996433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.3e-15 Score=135.47 Aligned_cols=135 Identities=23% Similarity=0.259 Sum_probs=114.7
Q ss_pred CCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCC--CCcceEeEEEEeCCeeEEEEEecCCC
Q 006125 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNG 430 (660)
Q Consensus 353 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 430 (660)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999754 7899999865433 5678899999999976 58999999988888899999999887
Q ss_pred ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
.+..+ +......++.+++++|.+||.....+++|+||+|+||++++++.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 4566778899999999999997555699999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.7e-15 Score=141.74 Aligned_cols=136 Identities=26% Similarity=0.304 Sum_probs=98.4
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChh--cHHH----------------------HHHHHHHHhhcCCCC--c
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ--GTAE----------------------FTNEVLLILKLQHKN--L 407 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 407 (660)
.+.||+|+||.||++...+|+.||||+++..... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999988653211 1111 135566666664433 4
Q ss_pred ceEeEEEEeCCeeEEEEEecCCCChhhh-hcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEeC
Q 006125 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAI-LFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLD 485 (660)
Q Consensus 408 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~DLkp~NILl~ 485 (660)
.+.++. ...++||||++++.+... +... . .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-h---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 455543 246899999999554221 1110 0 11 5678899999999999999 77 99999999999999
Q ss_pred CCCCEEEeecccccccc
Q 006125 486 SDMNSKISDFGMARIFA 502 (660)
Q Consensus 486 ~~~~~kl~DfGla~~~~ 502 (660)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.7e-14 Score=142.57 Aligned_cols=135 Identities=20% Similarity=0.237 Sum_probs=105.3
Q ss_pred Ccccc-cCCcccEEeeeecCCcEEEEEEccCCC-------------hhcHHHHHHHHHHHhhcCCCCc--ceEeEEEEeC
Q 006125 354 SNILG-QGGFGPVYKGVLSDGKEVAVKRLSSCS-------------EQGTAEFTNEVLLILKLQHKNL--VKLLGFCVDG 417 (660)
Q Consensus 354 ~~~lG-~G~fg~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 417 (660)
...|| .|+.|+||+... ++..++||++.... ......+.+|+.++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 899999999887 47789999875311 1233567889999999998875 6777775443
Q ss_pred Ce----eEEEEEecCC-CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEE
Q 006125 418 DE----KLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (660)
Q Consensus 418 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl 492 (660)
.. .++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 3599999997 689888843 234443 3578999999999998 999999999999999999999
Q ss_pred eecccccc
Q 006125 493 SDFGMARI 500 (660)
Q Consensus 493 ~DfGla~~ 500 (660)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.8e-16 Score=172.91 Aligned_cols=255 Identities=23% Similarity=0.287 Sum_probs=188.1
Q ss_pred CCCCCCcccccCCcccEEeeeecC--CcEEEEEEccCC--ChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSD--GKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 423 (660)
..|...+.||+|+|+.|-...... ...+++|.+... ..........|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345666779999999998877533 345677766543 2334445566777777786 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCceEeCCCC-CEEEeeccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH-EDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIF 501 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~ 501 (660)
.+|..++++.+.+.... ....+.......+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||++..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999988873211 113556667788999999999999 776 99999999999999999 9999999999988
Q ss_pred cc-cCCccceeeeec-cCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 502 AE-SEGEANTVRIVG-TYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 502 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............|.+.+.. ..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~-- 251 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR--FT-- 251 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc--cc--
Confidence 77 444444445678 9999999998874 56789999999999999999999987544333221112111100 00
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
. ...........++..+++..+|..|.+.+++-
T Consensus 252 ~---~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 Q---LPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred c---CccccCChhhhhcccccccCCchhcccccccc
Confidence 0 00111222355667788889999999988874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.1e-13 Score=145.64 Aligned_cols=141 Identities=23% Similarity=0.269 Sum_probs=100.3
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhcH----------------------------------------HHHH
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT----------------------------------------AEFT 393 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 393 (660)
.+.||.|++|.||+|++++|+.||||+.++...... -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999875321110 0244
Q ss_pred HHHHHHhhc----CCCCcceEeEEEE-eCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHH-HHHHHHhC
Q 006125 394 NEVLLILKL----QHKNLVKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK-GMLYLHED 467 (660)
Q Consensus 394 ~E~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~ 467 (660)
+|...+.++ +|.+-+.+-.++. .....+|||||+++++|.++...... .. ....++..+++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 455555554 2333333333332 24457999999999999887632111 12 23456666666 47888988
Q ss_pred CCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 468 ~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
+ ++|+|+||.||+++++++++|.|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-13 Score=135.27 Aligned_cols=205 Identities=21% Similarity=0.276 Sum_probs=139.3
Q ss_pred HHHHHhhcCCCCcceEeEEEEeC-----CeeEEEEEecCCCChhhhhcCCCC-CCccCHHHHHHHHHHHHHHHHHHHhCC
Q 006125 395 EVLLILKLQHKNLVKLLGFCVDG-----DEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDS 468 (660)
Q Consensus 395 E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~ 468 (660)
-...+-++.|.|||+++.+..+. ....++.|||..|+|..+|+...+ ...+......+|+.||..||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34456667899999999887653 346789999999999999965333 334778888899999999999999976
Q ss_pred CCCeEecCCCCCceEeCCCCCEEEeecccc--ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHH
Q 006125 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMA--RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546 (660)
Q Consensus 469 ~~~ivH~DLkp~NILl~~~~~~kl~DfGla--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~el 546 (660)
|+|+|+++.-+-|++..++-+||.----. ................+-++|.+||+-.....+-++|||+||+..+||
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 78999999999999999999988521111 001111111112223567899999987777778899999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 547 ITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 547 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.-+.--.....-. ...+..+...+-. +.+ . .=...+..|++.+|..||+|.+++
T Consensus 276 ailEiq~tnseS~-----~~~ee~ia~~i~~-len---~-----lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 276 AILEIQSTNSESK-----VEVEENIANVIIG-LEN---G-----LQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHheeccCCCcce-----eehhhhhhhheee-ccC---c-----cccCcCcccccCCCCCCcchhhhh
Confidence 8776322111100 0001111111000 000 0 012456689999999999999986
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=139.97 Aligned_cols=247 Identities=23% Similarity=0.266 Sum_probs=179.3
Q ss_pred CCCCCccccc--CCcccEEeeee---cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeE
Q 006125 350 NFSDSNILGQ--GGFGPVYKGVL---SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 350 ~~~~~~~lG~--G~fg~Vy~~~~---~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 421 (660)
.|...+.+|. |.+|.+|.+.. .++..+|+|+-+. ........-.+|+....++ .|+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4555678999 99999999986 3578899998442 2233344455677777777 5999999888899999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCceEeCCC-CCEEEeecc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK----GMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFG 496 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfG 496 (660)
+-.|++. .+|.++.+. ....++....+..+.+..+ ||.++|+.. ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999885 677777743 2333777788888888888 999999998 9999999999999999 889999999
Q ss_pred ccccccccCCccc---eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccc
Q 006125 497 MARIFAESEGEAN---TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 497 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
+...+........ ..+..|...|++||.+ .+.++.+.|+|++|.++.|..++.......-...| ...+...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W--~~~r~~~--- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW--SQLRQGY--- 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCc--ccccccc---
Confidence 9988776543221 1223577889999975 55678999999999999999998865543211111 1111111
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
+-+ ++......++...+..|++.+|..|++.+.+.
T Consensus 343 ip~------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 343 IPL------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred Cch------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 111 11111112233477789999999999888775
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.9e-12 Score=117.51 Aligned_cols=130 Identities=24% Similarity=0.189 Sum_probs=97.5
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcc-eEeEEEEeCCeeEEEEEecCCCCh
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
.+.|+.|.++.||+.... ++.+++|+...... ....+..|+.++..+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999999874 78899998765322 233567899999998665554 455443 3346899999999887
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.... . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5431 0 11245678999999999987 23469999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.7e-11 Score=133.03 Aligned_cols=144 Identities=19% Similarity=0.226 Sum_probs=95.0
Q ss_pred CCCCCCcccccCCcccEEeeeecC-CcEEEEEEccCCChhc----------------------------------HH---
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQG----------------------------------TA--- 390 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~~--- 390 (660)
..|+. +.||+|++|.||++++++ |+.||||++++..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999887 9999999997542110 11
Q ss_pred ---HHHHHHHHHhhc----CCCCcceEeEEEEe-CCeeEEEEEecCCCChhhhhcCCCCC---CccCHHHHHHHHHHHHH
Q 006125 391 ---EFTNEVLLILKL----QHKNLVKLLGFCVD-GDEKLLVYEFMPNGSLDAILFDPRKR---GILCWRKRTNIVNGIAK 459 (660)
Q Consensus 391 ---~~~~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~ 459 (660)
++.+|...+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++..-.... ..+....+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 133444444444 24444444444443 45678999999999997753111111 12333333333333
Q ss_pred HHHHHHhCCCCCeEecCCCCCceEeCCCC----CEEEeeccccccccc
Q 006125 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGMARIFAE 503 (660)
Q Consensus 460 ~L~~LH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfGla~~~~~ 503 (660)
++..| ++|+|+||.||+++.++ ++++.|||+...+..
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34456 99999999999999988 999999999976644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-10 Score=125.59 Aligned_cols=166 Identities=19% Similarity=0.221 Sum_probs=128.3
Q ss_pred ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHH
Q 006125 370 LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449 (660)
Q Consensus 370 ~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 449 (660)
..++.+|.|+..+...........+-++.|+.++||||++++......+..|||.|-+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 44788899888876555556667888999999999999999999999999999999874 46666632 33566
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCC
Q 006125 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529 (660)
Q Consensus 450 ~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 529 (660)
....+.||+.+|.|||+.+ .++|++|.-..|+|++.|..||++|.+............ ...--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~--~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK--SLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc--cchhhhcccChhhcCccc
Confidence 7778899999999999776 599999999999999999999999988865433221110 111223466777543322
Q ss_pred CCcchhHHHHHHHHHHHHhC
Q 006125 530 YSKKSDVFSFGVLLIEIITG 549 (660)
Q Consensus 530 ~t~ksDVwslGvll~elltG 549 (660)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.7e-10 Score=108.00 Aligned_cols=135 Identities=19% Similarity=0.151 Sum_probs=98.9
Q ss_pred cccccCCcccEEeeeecC-------CcEEEEEEccCC-------------C---------hhcHHHH----HHHHHHHhh
Q 006125 355 NILGQGGFGPVYKGVLSD-------GKEVAVKRLSSC-------------S---------EQGTAEF----TNEVLLILK 401 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~l~~~-------------~---------~~~~~~~----~~E~~~l~~ 401 (660)
..||.|--+.||.|...+ +..+|||+.+.. + ....+.+ .+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 479999986410 0 1112223 389999999
Q ss_pred cCC--CCcceEeEEEEeCCeeEEEEEecCCCChhh-hhcCCCCCCccCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCC
Q 006125 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDA-ILFDPRKRGILCWRKRTNIVNGIAKGMLYL-HEDSRLRIVHRDL 477 (660)
Q Consensus 402 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~DL 477 (660)
+.. -++.+++++ ...+|||||+.+..+.. .+. ...++..+...+..+++.+|..| |+.+ ++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 466777765 46789999997754422 221 22345566778889999999999 7887 999999
Q ss_pred CCCceEeCCCCCEEEeeccccccc
Q 006125 478 KASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 478 kp~NILl~~~~~~kl~DfGla~~~ 501 (660)
++.|||++ ++.+.|+|||.+...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 468999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.2e-10 Score=111.21 Aligned_cols=141 Identities=21% Similarity=0.278 Sum_probs=111.2
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCCh-hcHHHHHHHHHHHhhcCC--CCcceEeEEEEeCC---eeEEEEEecC
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGD---EKLLVYEFMP 428 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 428 (660)
+.|+.|..+.+|++...+|+.+++|+...... .....+..|..+++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999765322 235578899999999965 44677888776543 5689999999
Q ss_pred CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 006125 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS---------------------------------------- 468 (660)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------- 468 (660)
+.++...+.. ..++..+...++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776521 34777888889999999999998531
Q ss_pred -------------CCCeEecCCCCCceEeCC--CCCEEEeeccccc
Q 006125 469 -------------RLRIVHRDLKASNVLLDS--DMNSKISDFGMAR 499 (660)
Q Consensus 469 -------------~~~ivH~DLkp~NILl~~--~~~~kl~DfGla~ 499 (660)
...++|+|++|.||++++ ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245899999999999998 6678999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.5e-09 Score=111.09 Aligned_cols=170 Identities=22% Similarity=0.308 Sum_probs=132.6
Q ss_pred CcccEEeee-ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEE----eCCeeEEEEEecCC-CChhh
Q 006125 361 GFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV----DGDEKLLVYEFMPN-GSLDA 434 (660)
Q Consensus 361 ~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~ 434 (660)
.-.+.||+. ..||..|++|+++............-+++++++.|.|||++.+++. ....+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 346789988 4589999999996544444445566788999999999999999887 23457899999986 56776
Q ss_pred hhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 435 ILFDPR------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 435 ~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
+..... .+...++...|.++.|+..||.++|+.| +..+-|.+++||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 654321 2234778999999999999999999999 9999999999999999999999998877655
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN 552 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p 552 (660)
.+.. |.+++ -.+-|.=-||.+++.|.||...
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 4331 11111 2367888999999999999755
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-10 Score=125.19 Aligned_cols=247 Identities=21% Similarity=0.173 Sum_probs=174.8
Q ss_pred hhcCCCCCCcccccCCcccEEeeee--cCCcEEEEEEccCCChhcHHH--HHHHHHHHhhc-CCCCcceEeEEEEeCCee
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL--SDGKEVAVKRLSSCSEQGTAE--FTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 420 (660)
....+|..+..||.|.|+.|++... .++..+++|.+.+.......+ -..|+.+...+ .|.++++....+..-+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788899999999999999874 367889999886533322222 33566666666 688888888777777788
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-CCEEEeeccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMAR 499 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~ 499 (660)
++--||++++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||...
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999887665 23344777888999999999999999887 9999999999999886 888999999986
Q ss_pred cccccCCccceeeeeccCCcC--CHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccc
Q 006125 500 IFAESEGEANTVRIVGTYGYM--APEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~ 577 (660)
.+...... ....-++. +|+......+-.+.|++|||.-+.|.++|......... | ..+...
T Consensus 416 ~~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~--------~~i~~~ 478 (524)
T KOG0601|consen 416 RLAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----S--------LTIRSG 478 (524)
T ss_pred ccceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccCccccc----c--------eeeecc
Confidence 53221111 11222333 55555667788999999999999999998864322110 1 111111
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
.+.. .......+..+...++.+++..||.+.++....+
T Consensus 479 ~~p~---~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 479 DTPN---LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccC---CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1111 1111144556667799999999999988876544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.5e-09 Score=98.82 Aligned_cols=131 Identities=23% Similarity=0.367 Sum_probs=101.2
Q ss_pred cccccCCcccEEeeeecCCcEEEEEE-ccC-C--C----hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKR-LSS-C--S----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~-l~~-~--~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
..+++|+-+.+|.+.+. |.++++|. +++ . . ......-.+|..++.+++--.|.-.+=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999764 44466664 222 1 1 11123466899999999777776666677788888999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
+++-.|.+.+... ...++..+-+-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888432 2557888888899999999 99999999999997665 99999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.8e-11 Score=131.58 Aligned_cols=251 Identities=17% Similarity=0.182 Sum_probs=167.9
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCCh---hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
...+.+.+.+-+-+|.++.++...- ..|...+.|....... .+.+....+-.++-..+||-+++..--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3455677777888999999988763 2343344443332111 11222222323333334566665554455667889
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
|+++|..+++|...|+. .+..+.+-....+..+...+++||... +.|+|++|.|+|+..++..++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999999854 334566666667778889999999976 899999999999999999999999843321
Q ss_pred cc------c---------------CCc--------cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCC
Q 006125 502 AE------S---------------EGE--------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN 552 (660)
Q Consensus 502 ~~------~---------------~~~--------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p 552 (660)
.. . ... .......+|+.|.+||.+.+......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0 000 001235789999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHH
Q 006125 553 AGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMS 611 (660)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 611 (660)
|........+..+. ...-++... +........+++...+..+|.+|-.|.
T Consensus 1035 ~na~tpq~~f~ni~------~~~~~~p~g---~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENIL------NRDIPWPEG---PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhccc------cCCCCCCCC---ccccChhhhhhhhhhhccCchhccCcc
Confidence 98665444332221 112222222 222333445666678889999997766
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.7e-09 Score=96.41 Aligned_cols=144 Identities=20% Similarity=0.285 Sum_probs=106.8
Q ss_pred CCcccccCCcccEEeeeecCCcEEEEEE-ccC-------CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 353 DSNILGQGGFGPVYKGVLSDGKEVAVKR-LSS-------CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 353 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~-l~~-------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
....|-+|+-+.|+++.+ .|+...||. +.+ ..........+|++.+.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457889999999999998 577766664 322 11223446778999999987666665556667777788999
Q ss_pred EecCC-CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC---CEEEeecccccc
Q 006125 425 EFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARI 500 (660)
Q Consensus 425 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DfGla~~ 500 (660)
||+++ .++.+++....... ........++..|-+.+.-||..+ |+|+||..+||+|.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 47788775433322 222333678899999999999998 99999999999997654 358999999865
Q ss_pred c
Q 006125 501 F 501 (660)
Q Consensus 501 ~ 501 (660)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.7e-08 Score=99.56 Aligned_cols=140 Identities=17% Similarity=0.118 Sum_probs=100.7
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCChh-----------cHHHHHHHHHHHhhcCCCCc--ceEeEEEEe-----
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ-----------GTAEFTNEVLLILKLQHKNL--VKLLGFCVD----- 416 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~----- 416 (660)
+.+-+-....|.+..+ +|+.+.||+.....-. ....+.+|...+.++...+| ++++.+...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344444455667666 6788999977542211 11137789999988854443 455556543
Q ss_pred CCeeEEEEEecCCC-ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-------CC
Q 006125 417 GDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-------DM 488 (660)
Q Consensus 417 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-------~~ 488 (660)
....+||+|++++. +|.+++.+.. ....+...+..++.+++..+.-||+.| |+|+||+++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23468999999986 8999884321 233556677899999999999999999 999999999999975 46
Q ss_pred CEEEeeccccc
Q 006125 489 NSKISDFGMAR 499 (660)
Q Consensus 489 ~~kl~DfGla~ 499 (660)
.+.|+||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 89999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=3e-08 Score=94.56 Aligned_cols=125 Identities=26% Similarity=0.296 Sum_probs=83.7
Q ss_pred cEEeeeecCCcEEEEEEccCC--------------Ch------------hcHHHHHHHHHHHhhcCCC--CcceEeEEEE
Q 006125 364 PVYKGVLSDGKEVAVKRLSSC--------------SE------------QGTAEFTNEVLLILKLQHK--NLVKLLGFCV 415 (660)
Q Consensus 364 ~Vy~~~~~~g~~vavK~l~~~--------------~~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 415 (660)
.||.|...+|+.+|||+.+.. .. .......+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999889999999986421 00 0123467899999999765 566676552
Q ss_pred eCCeeEEEEEecC--CCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCceEeCCCCCEEE
Q 006125 416 DGDEKLLVYEFMP--NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY-LHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (660)
Q Consensus 416 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~DLkp~NILl~~~~~~kl 492 (660)
...|||||++ +..+..+... .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 6555554421 12234556678888886555 56877 9999999999999988 9999
Q ss_pred eeccccccc
Q 006125 493 SDFGMARIF 501 (660)
Q Consensus 493 ~DfGla~~~ 501 (660)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.5e-07 Score=95.07 Aligned_cols=192 Identities=17% Similarity=0.189 Sum_probs=124.8
Q ss_pred CCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEE----E--eCCe-eEEEE
Q 006125 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFC----V--DGDE-KLLVY 424 (660)
Q Consensus 353 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~----~--~~~~-~~lv~ 424 (660)
....||+|+-+.+|-.- +-...+-|+...-......+. +..|.+. .||-+-.-+.|= . ++.. .-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35679999999998533 112234576654333322222 2333333 565443311111 1 1111 34566
Q ss_pred EecCCCC-hhhhhc---CCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 425 EFMPNGS-LDAILF---DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 425 e~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
+.+++.- ...++. ..+.....+|...++.++.++.+.+.||..| .+-+|++++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 6665532 233331 1233345889999999999999999999999 99999999999999999999998544333
Q ss_pred ccccCCccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITG-RRNAGS 555 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG-~~p~~~ 555 (660)
..+. ....-.+|...|.+||... +..-+...|-|.||+++++++.| +.|+.+
T Consensus 167 ~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 NANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 2111 1122347899999999865 23356789999999999999987 788863
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.6e-07 Score=92.02 Aligned_cols=134 Identities=21% Similarity=0.233 Sum_probs=98.7
Q ss_pred CCCCcccccCCcccEEeeeecCCcEEEEEEcc----------CCC------------hhcHHHHHHHHHHHhhcCCC--C
Q 006125 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLS----------SCS------------EQGTAEFTNEVLLILKLQHK--N 406 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~----------~~~------------~~~~~~~~~E~~~l~~l~h~--n 406 (660)
....+.||.|--+.||.|..++|.++|||.=+ ... .-.....++|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34568899999999999999999999999522 100 01123467899999999654 7
Q ss_pred cceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC
Q 006125 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (660)
Q Consensus 407 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~ 486 (660)
|.+.+++ +.-.+||||+++-.|...- ++.+....|+..|++-+.-+-..| ++|+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777776 3557999999886654332 234444455666666665555666 999999999999999
Q ss_pred CCCEEEeeccccc
Q 006125 487 DMNSKISDFGMAR 499 (660)
Q Consensus 487 ~~~~kl~DfGla~ 499 (660)
||.+.++||-.+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.8e-07 Score=87.34 Aligned_cols=106 Identities=22% Similarity=0.292 Sum_probs=84.0
Q ss_pred HHHHHHHHHHHhhcCCC--CcceEeEEEEeCC----eeEEEEEecCCC-ChhhhhcCCCCCCccCHHHHHHHHHHHHHHH
Q 006125 389 TAEFTNEVLLILKLQHK--NLVKLLGFCVDGD----EKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461 (660)
Q Consensus 389 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L 461 (660)
.....+|...+..+... .+++.+++..... ..+||+|++++. +|.+++.... .++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 34677888888888543 3566777766532 358999999884 7999984321 256677889999999999
Q ss_pred HHHHhCCCCCeEecCCCCCceEeCCCC---CEEEeecccccc
Q 006125 462 LYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARI 500 (660)
Q Consensus 462 ~~LH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DfGla~~ 500 (660)
.-||+.| |+|+|+++.|||++.+. .+.|+||+-++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.3e-07 Score=98.70 Aligned_cols=141 Identities=18% Similarity=0.244 Sum_probs=93.4
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCChhcHH----------------------------------------HHHH
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA----------------------------------------EFTN 394 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~----------------------------------------~~~~ 394 (660)
+-|+.++-|.||+|++++|+.||||+.++.-..... ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999998653211110 1333
Q ss_pred HHHHHhhc----CCCCcceEeEEEEe-CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHH-HHHHHhCC
Q 006125 395 EVLLILKL----QHKNLVKLLGFCVD-GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG-MLYLHEDS 468 (660)
Q Consensus 395 E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~~~ 468 (660)
|...+.++ ++..-+++=.++.+ .....|+|||++|..+.++..... ..++.+. ++..++++ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 44444443 22333334344443 456789999999999888852211 2244333 33333332 33333345
Q ss_pred CCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 469 ~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.4e-08 Score=107.64 Aligned_cols=151 Identities=21% Similarity=0.375 Sum_probs=101.1
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccce-------eeeeccCCcCCHhhhh
Q 006125 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGYMAPEYAM 526 (660)
Q Consensus 454 ~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~ 526 (660)
+.+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+............ .-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344558999999875 6999999999999999999999999987654331111100 0012355799999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCC-CCCC-cHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCC
Q 006125 527 EGLYSKKSDVFSFGVLLIEIITGRRN-AGSN-QLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDA 604 (660)
Q Consensus 527 ~~~~t~ksDVwslGvll~elltG~~p-~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP 604 (660)
....+.++|+||+|+++|-+..|+.+ +... ........... .+.... ..+.+.+.++.+=+.+++..++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~-------~~~~~~--~~s~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL-------LNAGAF--GYSNNLPSELRESLKKLLNGDS 253 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc-------cccccc--cccccCcHHHHHHHHHHhcCCc
Confidence 98899999999999999999965554 2211 11111111110 111111 2223344456666667899999
Q ss_pred CCCCCHHhHHH
Q 006125 605 FDRPTMSSVAP 615 (660)
Q Consensus 605 ~~RPt~~evl~ 615 (660)
..||++.++..
T Consensus 254 ~~rp~~~~l~~ 264 (700)
T KOG2137|consen 254 AVRPTLDLLLS 264 (700)
T ss_pred ccCcchhhhhc
Confidence 99998888763
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.9e-06 Score=81.51 Aligned_cols=138 Identities=20% Similarity=0.182 Sum_probs=102.2
Q ss_pred cccCCcccEEeeeecCCcEEEEEEccCC---C---hhcHHHHHHHHHHHhhcCCC--CcceEeEEEE-eC----CeeEEE
Q 006125 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSC---S---EQGTAEFTNEVLLILKLQHK--NLVKLLGFCV-DG----DEKLLV 423 (660)
Q Consensus 357 lG~G~fg~Vy~~~~~~g~~vavK~l~~~---~---~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~~----~~~~lv 423 (660)
-|.||-+-|++-.+ +|+.+-+|+-... + +.....|.+|+..+.+|... .+.+++ ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46688888998776 4557888986521 1 33567899999999998532 355555 332 21 235799
Q ss_pred EEecCC-CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC--EEEeecccccc
Q 006125 424 YEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--SKISDFGMARI 500 (660)
Q Consensus 424 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DfGla~~ 500 (660)
+|-+++ -+|.+++.+. ...+.+...+..++.++++.+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 5888888432 2234677788899999999999999999 999999999999986667 99999976653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.9e-06 Score=82.36 Aligned_cols=132 Identities=17% Similarity=0.190 Sum_probs=86.6
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC--cceEeEEEEeCCeeEEEEEecCCCC-
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNGS- 431 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 431 (660)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-+ +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 25567888876532 3455789999999986443 4778888877778889999998863
Q ss_pred hhhhhcCCCCCCccCHHHHHHHHHHHHHH---------------------------------------HHHHHhC-CCCC
Q 006125 432 LDAILFDPRKRGILCWRKRTNIVNGIAKG---------------------------------------MLYLHED-SRLR 471 (660)
Q Consensus 432 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~---------------------------------------L~~LH~~-~~~~ 471 (660)
+...+.. +......++..+++. ..+|... ..+.
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2211110 001111111111111 1222211 2345
Q ss_pred eEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 472 IVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 472 ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999998774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.4e-06 Score=80.53 Aligned_cols=138 Identities=15% Similarity=0.157 Sum_probs=92.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHH---------HHHHHHHHhhcCC---CCcceEeEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE---------FTNEVLLILKLQH---KNLVKLLGF 413 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~l~~~ 413 (660)
+...+|...+++-......|.+-.. +|+.+++|..++......+. ..+++..+.+++. .....++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4567777778888777777777666 67899999887543332222 2334444444433 223333332
Q ss_pred EEe-----CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC
Q 006125 414 CVD-----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (660)
Q Consensus 414 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~ 488 (660)
... ....+|+|||++|..|.++.. ++. .+...|.+.+..||+.| ++|+|.+|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 221 234568999999988766541 222 24566778899999999 99999999999998654
Q ss_pred CEEEeeccccc
Q 006125 489 NSKISDFGMAR 499 (660)
Q Consensus 489 ~~kl~DfGla~ 499 (660)
+++.||+..+
T Consensus 173 -i~iID~~~k~ 182 (229)
T PF06176_consen 173 -IRIIDTQGKR 182 (229)
T ss_pred -EEEEECcccc
Confidence 9999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-05 Score=78.88 Aligned_cols=151 Identities=24% Similarity=0.232 Sum_probs=98.3
Q ss_pred HHHHhhcCCCCCCc---ccccCCcccEEeeeecCCcEEEEEEccCCChh-------------------c-----HHHHHH
Q 006125 342 ETLNLATSNFSDSN---ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ-------------------G-----TAEFTN 394 (660)
Q Consensus 342 ~~~~~~~~~~~~~~---~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-------------------~-----~~~~~~ 394 (660)
+.+....++..+.. .|.+|--+.||+|...++..+|+|+.+..... . ......
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k 117 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK 117 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence 33433334443333 46678888899999878999999997531100 0 112455
Q ss_pred HHHHHhhcC--CCCcceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006125 395 EVLLILKLQ--HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472 (660)
Q Consensus 395 E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 472 (660)
|...|.++. +=.+.+.+.+. .-.|||||+....+-.-. .+.-.+..++...+..++++.+.-|-... ++
T Consensus 118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~L 188 (268)
T COG1718 118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA--GL 188 (268)
T ss_pred HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc--Cc
Confidence 777777763 34455555553 457999999664211111 11122333367777888888888887733 39
Q ss_pred EecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 473 VHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 473 vH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||+||+.=|||+. ++.+.|+|||.+....
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccC
Confidence 9999999999999 8899999999886543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.5e-05 Score=80.06 Aligned_cols=139 Identities=17% Similarity=0.131 Sum_probs=85.7
Q ss_pred cccCCc-ccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEEEecCCCChhh
Q 006125 357 LGQGGF-GPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA 434 (660)
Q Consensus 357 lG~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 434 (660)
|..|.. ..||+.... +..+.+|+..... ..++.+|+.++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 788988764 4788889876533 345778999988883 4456678888777667899999999987764
Q ss_pred hhc-------------------CCCC-CCccCH--HHHHHHHH--------------------HHHHHHHHHHh----CC
Q 006125 435 ILF-------------------DPRK-RGILCW--RKRTNIVN--------------------GIAKGMLYLHE----DS 468 (660)
Q Consensus 435 ~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~ia~~L~~LH~----~~ 468 (660)
... .... ...+.. ........ .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 421 1000 000100 00000000 01111122211 12
Q ss_pred CCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 469 ~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3569999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=2e-05 Score=78.20 Aligned_cols=142 Identities=20% Similarity=0.235 Sum_probs=85.0
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCC--CcceEeEEEEeC---CeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK--NLVKLLGFCVDG---DEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~~ 429 (660)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++...... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999866 68999987653 4556788899999888533 356777655433 346899999999
Q ss_pred CChhh----------------hhc---CC-CCCCccCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 006125 430 GSLDA----------------ILF---DP-RKRGILCWRK---------RTNI------------VNGIAK-GMLYLHE- 466 (660)
Q Consensus 430 gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~~LH~- 466 (660)
..+.. .+. .. .....+.+.. .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 110 00 0000011000 0000 111222 3333332
Q ss_pred ---CCCCCeEecCCCCCceEeC-CCCCEEEeeccccc
Q 006125 467 ---DSRLRIVHRDLKASNVLLD-SDMNSKISDFGMAR 499 (660)
Q Consensus 467 ---~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~ 499 (660)
.....++|+|+.|+|||++ +++.+-|.||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345699999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.18 E-value=8.3e-06 Score=78.13 Aligned_cols=104 Identities=25% Similarity=0.268 Sum_probs=83.4
Q ss_pred HHHHHHHhhcCC-CCcceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 006125 393 TNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471 (660)
Q Consensus 393 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 471 (660)
.+|..+++.+++ +++++++|.| ..+++.||...+++...-..-..-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468888998976 6999999999 45789999988766432100011223689999999999999999999866556
Q ss_pred eEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 472 IVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 472 ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
+...|++++|+-+++++++|+.|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999986643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.7e-05 Score=86.73 Aligned_cols=141 Identities=18% Similarity=0.278 Sum_probs=89.6
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhc-------------------------------HH------HHHHHH
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG-------------------------------TA------EFTNEV 396 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------~~------~~~~E~ 396 (660)
.+.||..+.|.||++++++|+.||||+-++.-+.. .+ +|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999876421111 00 244444
Q ss_pred HHHhhc----CCCCc---ceEeEEEEe-CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHH-HHHhC
Q 006125 397 LLILKL----QHKNL---VKLLGFCVD-GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML-YLHED 467 (660)
Q Consensus 397 ~~l~~l----~h~ni---v~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~ 467 (660)
+...+. .|-++ |.+=.++++ .....|+||||+|..+.++..- ....++... |+..+.++.. .|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~---i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHD---ILNKLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 443333 45451 223333333 3467899999999888776432 112244443 3333333321 22223
Q ss_pred CCCCeEecCCCCCceEeCC----CCCEEEeecccccccc
Q 006125 468 SRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFA 502 (660)
Q Consensus 468 ~~~~ivH~DLkp~NILl~~----~~~~kl~DfGla~~~~ 502 (660)
| ++|.|=+|.||++.. ++.+.+-|||+...+.
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 4 999999999999984 6789999999987554
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.05 E-value=8.3e-05 Score=71.58 Aligned_cols=130 Identities=22% Similarity=0.297 Sum_probs=91.7
Q ss_pred CCCcccccCCcccEEeeeecCCcEEEEEEccCCC----------------hhcHHHHHHHHHHHhhcC------CCCcce
Q 006125 352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS----------------EQGTAEFTNEVLLILKLQ------HKNLVK 409 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~ 409 (660)
+....||+|+.-.||. +++.....||+..... .....+..+|+.....+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3456799999999996 4456677888887544 223456677777666665 788999
Q ss_pred EeEEEEeCCeeEEEEEecCC------CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceE
Q 006125 410 LLGFCVDGDEKLLVYEFMPN------GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (660)
Q Consensus 410 l~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 483 (660)
++|+.......-+|+|.+.+ -+|.+++. .+.++. ...+.+. +-..||-+.. |+.+||+|+||+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEE
Confidence 99999999889999998653 25777773 233554 3333444 4455666666 999999999999
Q ss_pred eCCC--C--CEEEee
Q 006125 484 LDSD--M--NSKISD 494 (660)
Q Consensus 484 l~~~--~--~~kl~D 494 (660)
+... + .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9643 2 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00011 Score=86.85 Aligned_cols=79 Identities=16% Similarity=0.357 Sum_probs=58.4
Q ss_pred CcccccCCcccEEeeeecCC---cEEEEEEccCCC-hhcHHHHHHHHHHHhhcC-CCCc--ceEeEEEEeC---CeeEEE
Q 006125 354 SNILGQGGFGPVYKGVLSDG---KEVAVKRLSSCS-EQGTAEFTNEVLLILKLQ-HKNL--VKLLGFCVDG---DEKLLV 423 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 423 (660)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|..+++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876554 467888765422 123457889999999995 6665 7888888764 457899
Q ss_pred EEecCCCCh
Q 006125 424 YEFMPNGSL 432 (660)
Q Consensus 424 ~e~~~~gsL 432 (660)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=9.7e-07 Score=95.33 Aligned_cols=185 Identities=19% Similarity=0.123 Sum_probs=132.9
Q ss_pred CCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC-cceEeEEEEeCCeeEEEEEecCC
Q 006125 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
+...+-+++++.++++|.+-...+....+.+.. .....-++++|.+.+||| .++.++-+..++..+++++++..
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 334466889999999998732233333554432 144567899999999999 77777777777888999999987
Q ss_pred C-ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc
Q 006125 430 G-SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 430 g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 508 (660)
+ +-.... ......+...+...+.+.-.+++++||+.. -+|+| ||+..+ +..|..||+....+....
T Consensus 319 ~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 319 GRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred CccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence 7 221111 011122444455567777888999999874 58998 777755 678999999887765543
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCC
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA 553 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~ 553 (660)
......+++.|+|||+.....+..+.|+|++|+-..++.-|-+|.
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 222347899999999999999999999999998777777776654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=74.94 Aligned_cols=78 Identities=13% Similarity=0.101 Sum_probs=57.8
Q ss_pred CCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCC---CCcceEeEEEEeC---CeeEEEEE
Q 006125 352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH---KNLVKLLGFCVDG---DEKLLVYE 425 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e 425 (660)
...+.||+|..+.||+....++ .+++|..+. ......+..|...++.|.. -.+.++++++..+ +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3356799999999999876555 466676433 1133578899999998843 3688899888653 56899999
Q ss_pred ecCCCCh
Q 006125 426 FMPNGSL 432 (660)
Q Consensus 426 ~~~~gsL 432 (660)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=72.67 Aligned_cols=73 Identities=16% Similarity=0.262 Sum_probs=46.3
Q ss_pred cccccCCcc-cEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCC---CcceEeEEEEeCC---eeEEEEEec
Q 006125 355 NILGQGGFG-PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK---NLVKLLGFCVDGD---EKLLVYEFM 427 (660)
Q Consensus 355 ~~lG~G~fg-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~e~~ 427 (660)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... .+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766665 48874 235777865542 2345788999999888532 3444554433322 347899999
Q ss_pred CCCChh
Q 006125 428 PNGSLD 433 (660)
Q Consensus 428 ~~gsL~ 433 (660)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00034 Score=69.72 Aligned_cols=74 Identities=22% Similarity=0.244 Sum_probs=49.4
Q ss_pred cccccCCcccEEeeeecC--CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc-ceEeEEEEeCCeeEEEEEecCCCC
Q 006125 355 NILGQGGFGPVYKGVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGS 431 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 431 (660)
+.|..|-...+|+....+ ++.+++|+....... ..+..+|+.++..+...++ +++++.+. ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 557778888999988654 678999977643221 2234578888888854444 44544332 248999999877
Q ss_pred hh
Q 006125 432 LD 433 (660)
Q Consensus 432 L~ 433 (660)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00037 Score=70.58 Aligned_cols=139 Identities=16% Similarity=0.092 Sum_probs=80.2
Q ss_pred ccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc-ceEeEEEEeCCeeEEEEEecCCCChhh
Q 006125 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGSLDA 434 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 434 (660)
.+..|-...+|+... +++.+++|+..........+..+|..+++.+...++ .+++... ...+|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 355677888998874 577888987654322221245788999998864434 4444443 2368999999876542
Q ss_pred h-----------------hcCCC-CCCccCHHHH-HHHHH---------HHHHHHHHHHhC-----CCCCeEecCCCCCc
Q 006125 435 I-----------------LFDPR-KRGILCWRKR-TNIVN---------GIAKGMLYLHED-----SRLRIVHRDLKASN 481 (660)
Q Consensus 435 ~-----------------l~~~~-~~~~l~~~~~-~~i~~---------~ia~~L~~LH~~-----~~~~ivH~DLkp~N 481 (660)
. ++... ....++.... ..... .+.+.+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 0111221111 11111 111112222211 13458999999999
Q ss_pred eEeCCCCCEEEeecccccc
Q 006125 482 VLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 482 ILl~~~~~~kl~DfGla~~ 500 (660)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00026 Score=65.43 Aligned_cols=127 Identities=20% Similarity=0.241 Sum_probs=87.0
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcce-EeEEEEeCCeeEEEEEecCCCCh
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK-LLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
.+.|++|.+|.||++.+. |..+|+|+-+. +.....+..|.+++..+.-.++.+ ++.+- .-++.|||+.|-.|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence 467999999999999985 55888887664 344567889999999998766644 55443 33456999998888
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-CCceEeCCCCCEEEeecccccc
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK-ASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLk-p~NILl~~~~~~kl~DfGla~~ 500 (660)
.+.-.. .+-++ +..+++.---|...| |-|+.|+ |..++|-.+..+.|+||.-++.
T Consensus 100 ~~~~~~------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIG------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhc------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 766521 11222 333444433444445 9999986 4444444555999999998873
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00033 Score=81.24 Aligned_cols=199 Identities=20% Similarity=0.221 Sum_probs=138.4
Q ss_pred HHHHHHHHHHHhhcCCCCcceEeEEEEeCCee----EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHH
Q 006125 389 TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464 (660)
Q Consensus 389 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L 464 (660)
.....-|...+.++.|+|+++++.|..+.... .+..|++..-++...+ ..-+.++....+.+..++.+||.|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHH
Confidence 34455677888889999999999998765332 2445778777887777 3455688899999999999999999
Q ss_pred HhCCCCCeEecCCCCC---ceEeCCCCCEEEe--eccccccccccCCccceeeeeccCCcCCHhhhhcCCCCc--chhHH
Q 006125 465 HEDSRLRIVHRDLKAS---NVLLDSDMNSKIS--DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK--KSDVF 537 (660)
Q Consensus 465 H~~~~~~ivH~DLkp~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--ksDVw 537 (660)
|+.. ..|.-|..+ +.-++.++...++ ||+....+........ ..-+..|.+||......+.. ..|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHH
Confidence 9986 666655555 5556677777777 9988876654433221 23455678888877665544 47999
Q ss_pred HHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 538 SFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 538 slGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
.+|.++..+..|..+........ .+++. .... ...+....|+..++++|++..+++...
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~~~------------~~l~~-----~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAVPV------------SLLDV-----LSTS----ELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HHHHHHhhhhhcCcccccccchh------------hhhcc-----ccch----hhhhhhhhhcchhhhhccchhhhhhch
Confidence 99999999999886432111100 01110 1111 345566789999999999999998654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.001 Score=63.59 Aligned_cols=125 Identities=26% Similarity=0.379 Sum_probs=89.1
Q ss_pred CCCCCCcccccCCc-ccEEeeeecCCcEEEEEEccC---C---------Ch---------hcHHHHHHHHHHHhhcC---
Q 006125 349 SNFSDSNILGQGGF-GPVYKGVLSDGKEVAVKRLSS---C---------SE---------QGTAEFTNEVLLILKLQ--- 403 (660)
Q Consensus 349 ~~~~~~~~lG~G~f-g~Vy~~~~~~g~~vavK~l~~---~---------~~---------~~~~~~~~E~~~l~~l~--- 403 (660)
.+++..+.||.|.- |.||+..+ +|+.+|+|.++. . .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67788899999999 99999998 678999999321 0 00 12235888988888874
Q ss_pred CCCc--ceEeEEEEeCC------------------eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHH
Q 006125 404 HKNL--VKLLGFCVDGD------------------EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463 (660)
Q Consensus 404 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~ 463 (660)
+.++ |+.+||..-.. ...||.||++... .++. .-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4466 89999874221 1246777765432 1222 235567777889
Q ss_pred HHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 464 LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99998 999999999985 3489999854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00058 Score=70.70 Aligned_cols=142 Identities=17% Similarity=0.118 Sum_probs=86.0
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC--cceEeEE------EEeCCeeEEEEE
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGF------CVDGDEKLLVYE 425 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 425 (660)
.+.|..|....+|+....+ ..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999987644 4788898764 23456777888888884332 4454432 223445689999
Q ss_pred ecCCCChhh----hh----------cC----CCC----CCccCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 006125 426 FMPNGSLDA----IL----------FD----PRK----RGILCWRKRT----------NIVNGIAKGMLYLHE----DSR 469 (660)
Q Consensus 426 ~~~~gsL~~----~l----------~~----~~~----~~~l~~~~~~----------~i~~~ia~~L~~LH~----~~~ 469 (660)
|++|..+.. .. +. ... .....|.... .....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 00 10 000 0111222111 011123334455543 122
Q ss_pred CCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 470 ~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
..++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 459999999999999998778899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0018 Score=69.11 Aligned_cols=75 Identities=17% Similarity=0.189 Sum_probs=54.0
Q ss_pred cccccCCcccEEeeeecCC-cEEEEEEccCC----C---hhcHHHHHHHHHHHhhcC---CCCcceEeEEEEeCCeeEEE
Q 006125 355 NILGQGGFGPVYKGVLSDG-KEVAVKRLSSC----S---EQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g-~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 423 (660)
+.||.|.+..||+....+| +.++||.-.+. . ....+....|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999998777 58999985421 1 123456677888887762 2456777777 44567899
Q ss_pred EEecCCCC
Q 006125 424 YEFMPNGS 431 (660)
Q Consensus 424 ~e~~~~gs 431 (660)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0019 Score=67.05 Aligned_cols=140 Identities=24% Similarity=0.334 Sum_probs=83.3
Q ss_pred cccccCCcccEEeeeecC-------CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc-ceEeEEEEeCCeeEEEEEe
Q 006125 355 NILGQGGFGPVYKGVLSD-------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 426 (660)
+.|..|-...+|+....+ ++.+++|+..... ....+..+|..++..+...++ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345556667888887654 5789999876533 223456788888888854333 455665532 368999
Q ss_pred cCCCChhhh-h----------------cCCCCCC------cc--CHHHHHH--------------------------HHH
Q 006125 427 MPNGSLDAI-L----------------FDPRKRG------IL--CWRKRTN--------------------------IVN 455 (660)
Q Consensus 427 ~~~gsL~~~-l----------------~~~~~~~------~l--~~~~~~~--------------------------i~~ 455 (660)
++|..+... + |...... .. -|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776431 1 1110000 00 0111111 112
Q ss_pred HHHHHHHHHHh------CCCCCeEecCCCCCceEeCCC----CCEEEeeccccc
Q 006125 456 GIAKGMLYLHE------DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMAR 499 (660)
Q Consensus 456 ~ia~~L~~LH~------~~~~~ivH~DLkp~NILl~~~----~~~kl~DfGla~ 499 (660)
.+..-+..|.. ..+..++|+|+.+.|||++++ +.++|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233344432 234579999999999999985 889999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.004 Score=64.26 Aligned_cols=130 Identities=16% Similarity=0.261 Sum_probs=81.0
Q ss_pred ccEEeeeecCCcEEEEEEcc-CCChhcHHHHHHHHHHHhhcCC--CCcceEeEEEEeCC--eeEEEEEecCCCChhhhhc
Q 006125 363 GPVYKGVLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGD--EKLLVYEFMPNGSLDAILF 437 (660)
Q Consensus 363 g~Vy~~~~~~g~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~ 437 (660)
-.+|.... +++.+++.+-. ...........+|..+++.+.- --+.+.+++|.++. ..+.||+|+++..+.+.+.
T Consensus 39 n~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 39 NDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred cceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 33444333 37788888221 1233345567788888888743 34456677777665 6699999998854433331
Q ss_pred CCCCCCccCHHHHHHHH-HHHHHHHHHHHh--------------------------------------------------
Q 006125 438 DPRKRGILCWRKRTNIV-NGIAKGMLYLHE-------------------------------------------------- 466 (660)
Q Consensus 438 ~~~~~~~l~~~~~~~i~-~~ia~~L~~LH~-------------------------------------------------- 466 (660)
.. ... .+++ ..+++.|.-||+
T Consensus 118 ~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 118 PE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred cc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 10 000 1112 244444555543
Q ss_pred C-----CCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 467 D-----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 467 ~-----~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+ +++.++|+|+++.|++++++.-+=|.||+++..-
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2 2456999999999999999988999999998754
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0005 Score=49.21 Aligned_cols=41 Identities=44% Similarity=0.754 Sum_probs=33.0
Q ss_pred CCCCCCCCCCCceeccccCCCC--C-CC---CCCCCCceeeccccCC
Q 006125 620 ETGTLPQPQKPAFSIGRVTDGH--C-NN---NNCSANGLTISNLSPR 660 (660)
Q Consensus 620 ~~~~~~~p~~p~~~~~~~~~~~--~-~~---~~~~~~~~~~~~~~~~ 660 (660)
....+|+|.+|+|+..+...+. + +. ...|.|+||+|.|++|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 3568999999999999886443 2 22 4689999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0054 Score=62.72 Aligned_cols=30 Identities=30% Similarity=0.555 Sum_probs=25.3
Q ss_pred CCeEecCCCCCceEeCCCCC-EEEeeccccc
Q 006125 470 LRIVHRDLKASNVLLDSDMN-SKISDFGMAR 499 (660)
Q Consensus 470 ~~ivH~DLkp~NILl~~~~~-~kl~DfGla~ 499 (660)
+.++|+|+++.|||++++++ .-|.||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 45899999999999997555 4699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0081 Score=62.55 Aligned_cols=143 Identities=18% Similarity=0.186 Sum_probs=82.7
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC--cceEeEE------EEeCCeeEEEEE
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGF------CVDGDEKLLVYE 425 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 425 (660)
.+.++.|....+|+....+| .+++|+.+... ....+..|..++..|...+ +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876544 57788775421 2344566777777774322 3444432 122456789999
Q ss_pred ecCCCChhhh--------------hcCCCC----C-----CccCHHHHH------------HHHHHHHHHHHHHHh----
Q 006125 426 FMPNGSLDAI--------------LFDPRK----R-----GILCWRKRT------------NIVNGIAKGMLYLHE---- 466 (660)
Q Consensus 426 ~~~~gsL~~~--------------l~~~~~----~-----~~l~~~~~~------------~i~~~ia~~L~~LH~---- 466 (660)
|++|..+... ++.... . ....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988654210 111000 0 011121110 011223344555543
Q ss_pred CCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 467 ~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.-+..++|+|+++.||++++++.+.|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999988877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.003 Score=64.66 Aligned_cols=74 Identities=24% Similarity=0.324 Sum_probs=48.8
Q ss_pred CCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC---CCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 353 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
..+.++.|....+|+.. .+++.+.||.-. ......|..|..-|+.|. --.+++++++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34668889999999877 578889999865 233456788888888883 45678899998888888999999987
Q ss_pred C
Q 006125 430 G 430 (660)
Q Consensus 430 g 430 (660)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0075 Score=63.13 Aligned_cols=142 Identities=17% Similarity=0.197 Sum_probs=78.4
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC--cceEeE------EEEeCCeeEEEEE
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLG------FCVDGDEKLLVYE 425 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e 425 (660)
.+.|+.|....+|+....+| .+++|+.... ..+.+..|+.++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35577787789999886555 6888987521 2334445666666653222 334332 1223556789999
Q ss_pred ecCCCChhh-----------hh---cCCC--------CCCccCH-HHHHH------------HHHH-HHHHHHHHHhC--
Q 006125 426 FMPNGSLDA-----------IL---FDPR--------KRGILCW-RKRTN------------IVNG-IAKGMLYLHED-- 467 (660)
Q Consensus 426 ~~~~gsL~~-----------~l---~~~~--------~~~~l~~-~~~~~------------i~~~-ia~~L~~LH~~-- 467 (660)
|++|..+.. .| +... ....+.| ..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998875421 11 1100 0001112 11111 1111 11222333211
Q ss_pred --CCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 468 --SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 468 --~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
-+..++|+|++|.|||++++...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999876656899999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.01 Score=61.17 Aligned_cols=139 Identities=22% Similarity=0.223 Sum_probs=97.4
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCC----------------------Chh----cHHHHHHHHHHHhhcCCCCc
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC----------------------SEQ----GTAEFTNEVLLILKLQHKNL 407 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~----------------------~~~----~~~~~~~E~~~l~~l~h~ni 407 (660)
..-|..|--+.||.+.-.+|..+|||+.+.. ... -.-....|+..|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3468889999999999889999999986420 000 01235668888888865554
Q ss_pred ceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC
Q 006125 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487 (660)
Q Consensus 408 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~ 487 (660)
.-.--+... .-.|||+|+.....-.- ..+...++...+..+-.+++.-|.-|.+.+ ++||.||+--|+|+ .+
T Consensus 229 P~PePIlLk--~hVLVM~FlGrdgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 229 PCPEPILLK--NHVLVMEFLGRDGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HD 300 (520)
T ss_pred CCCCceeee--cceEeeeeccCCCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-EC
Confidence 322222111 24699999864322111 123445777788889999999999998877 59999999999999 56
Q ss_pred CCEEEeecccccc
Q 006125 488 MNSKISDFGMARI 500 (660)
Q Consensus 488 ~~~kl~DfGla~~ 500 (660)
|.+.|+|-+.+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 7899999987754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.012 Score=62.35 Aligned_cols=141 Identities=21% Similarity=0.267 Sum_probs=82.5
Q ss_pred cccccCCcccEEeeeecC-----CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc-ceEeEEEEeCCeeEEEEEecC
Q 006125 355 NILGQGGFGPVYKGVLSD-----GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 428 (660)
+.|-.|-.-.+|+....+ ++.+++|+.....+.. -+-.+|..++..+...++ .++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345457777888876532 3678999886644322 234688999998865444 3566665332 5899998
Q ss_pred CCChhhh-----------------hcCCCCC--C-ccCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 006125 429 NGSLDAI-----------------LFDPRKR--G-ILCWRKRTNIVNGI-----------------AKGMLYL----HE- 466 (660)
Q Consensus 429 ~gsL~~~-----------------l~~~~~~--~-~l~~~~~~~i~~~i-----------------a~~L~~L----H~- 466 (660)
+.+|..- +|..... . ...+.+..++..++ ..-+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 1111100 1 11123332332211 1112222 22
Q ss_pred CCCCCeEecCCCCCceEeCC-CCCEEEeecccccc
Q 006125 467 DSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARI 500 (660)
Q Consensus 467 ~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~ 500 (660)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 47899999988753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.0038 Score=63.23 Aligned_cols=133 Identities=17% Similarity=0.170 Sum_probs=91.9
Q ss_pred CCCCcccccCCcccEEeeeecCCcEEEEEEcc----------C--------CChhc----HHHHHHHHHHHhhcC-C-CC
Q 006125 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLS----------S--------CSEQG----TAEFTNEVLLILKLQ-H-KN 406 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~----------~--------~~~~~----~~~~~~E~~~l~~l~-h-~n 406 (660)
+...+.||-|--+.||.+...+|++.++|.=+ . .+..| .-...+|...|+.|. | =-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56688999999999999999899999998421 0 01111 113557888888884 3 23
Q ss_pred cceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC
Q 006125 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (660)
Q Consensus 407 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~ 486 (660)
|.+.+++. ..++|||++.+-.|...-+ ..+..+ +...+..-+--|-.+| +||+|..-=||+|++
T Consensus 174 VPkpiD~~----RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPIDHN----RHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCccccc----ceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEec
Confidence 55556553 5579999998877755431 122233 3333333444555666 999999999999999
Q ss_pred CCCEEEeeccccc
Q 006125 487 DMNSKISDFGMAR 499 (660)
Q Consensus 487 ~~~~kl~DfGla~ 499 (660)
+..++++||-...
T Consensus 238 d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 238 DDKIVVIDFPQMV 250 (465)
T ss_pred CCCEEEeechHhh
Confidence 9999999997554
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.045 Score=58.49 Aligned_cols=80 Identities=15% Similarity=0.112 Sum_probs=52.1
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCC----Ch---hcHHHHHHHHHHHhhcC---CCCcceEeEEEEeCCeeEEE
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SE---QGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 423 (660)
.+.||.|..-.||+... +++.++||+-... +. .....-..|...|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 45789999999999876 4567999986521 11 12333344556665553 357888888876 456889
Q ss_pred EEecCC--CChhhhh
Q 006125 424 YEFMPN--GSLDAIL 436 (660)
Q Consensus 424 ~e~~~~--gsL~~~l 436 (660)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3444443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.037 Score=57.66 Aligned_cols=31 Identities=29% Similarity=0.365 Sum_probs=27.7
Q ss_pred CCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 469 ~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
+..++|+|+.++|||+++++.+.|+||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 3469999999999999999999999998774
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.019 Score=56.16 Aligned_cols=122 Identities=20% Similarity=0.264 Sum_probs=60.3
Q ss_pred CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc-ceEeEEEEeCCeeEEEEEecCCCChhhh-h--------------
Q 006125 373 GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGSLDAI-L-------------- 436 (660)
Q Consensus 373 g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l-------------- 436 (660)
++.|+||+.... ....-.-.+|..+++.+...++ .++++.+.+ .+|+||+++..|..- +
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 457888887664 3344567788999998865454 556665422 257799876654321 1
Q ss_pred --cC--C--CCCCccCHHHHHHH----------------------HHHHHHHHHHHHh----C-CCCCeEecCCCCCceE
Q 006125 437 --FD--P--RKRGILCWRKRTNI----------------------VNGIAKGMLYLHE----D-SRLRIVHRDLKASNVL 483 (660)
Q Consensus 437 --~~--~--~~~~~l~~~~~~~i----------------------~~~ia~~L~~LH~----~-~~~~ivH~DLkp~NIL 483 (660)
|. . .....--|.....+ ...+.+-+..+.+ . ....++|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 00 0 00111112222222 0111111222211 1 1235889999999999
Q ss_pred e-CCCCCEEEeeccccc
Q 006125 484 L-DSDMNSKISDFGMAR 499 (660)
Q Consensus 484 l-~~~~~~kl~DfGla~ 499 (660)
+ +.++.++|+||..+.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.16 Score=52.76 Aligned_cols=29 Identities=24% Similarity=0.368 Sum_probs=25.2
Q ss_pred CCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 470 ~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46999999999999987 678999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.075 Score=55.91 Aligned_cols=140 Identities=15% Similarity=0.199 Sum_probs=78.8
Q ss_pred ccccCCcccEEeeeecC----CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc-ceEeEEEEeCCeeEEEEEecCCC
Q 006125 356 ILGQGGFGPVYKGVLSD----GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNG 430 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 430 (660)
.|..|-.-.+|+....+ +..|++|+.....+ ..-+-.+|..+++.+..-++ .++++++. .+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 44446667788876533 23788998765433 22344688889988866555 45666653 22 589998776
Q ss_pred Chhhh-------h----------cCCC--CCC-ccCHHHHHHHHHHH----------------------HHHHHH----H
Q 006125 431 SLDAI-------L----------FDPR--KRG-ILCWRKRTNIVNGI----------------------AKGMLY----L 464 (660)
Q Consensus 431 sL~~~-------l----------~~~~--~~~-~l~~~~~~~i~~~i----------------------a~~L~~----L 464 (660)
.|..- + |... ... .--|....++..++ .+-+.. +
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 55320 1 1111 000 11122222222111 111111 1
Q ss_pred Hh-CCCCCeEecCCCCCceEeCC-CCCEEEeecccccc
Q 006125 465 HE-DSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARI 500 (660)
Q Consensus 465 H~-~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~ 500 (660)
.. ..+..++|+||.+.|||+++ ++.++++||..+..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 12235789999999999975 57899999988754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.0017 Score=77.26 Aligned_cols=160 Identities=13% Similarity=-0.032 Sum_probs=109.7
Q ss_pred HHHHHHHHhhcCCCCcceEeEEEEe--CCeeEEEEEecCCCChhhhhcCCCCC-CccCHHHHHHHHHHHHHHHHHHHhCC
Q 006125 392 FTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNGIAKGMLYLHEDS 468 (660)
Q Consensus 392 ~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~ 468 (660)
...|....+...|+++.....-... ..+.+..++|+..|.+.+.+-...+. ..++..-+.....+......-.|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555666688887665444332 34568899999999999988554333 23333333333333244444444432
Q ss_pred --CCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHH
Q 006125 469 --RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546 (660)
Q Consensus 469 --~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~el 546 (660)
....+|++||+-|.+|..+.++|+.++|+.+...+..... ....+++-|+.|++...-.++.++|+|..|+-+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~--Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF--GLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhh--hhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 3457899999999999999999999999998333222211 224677889999999888999999999999999998
Q ss_pred HhCCCCC
Q 006125 547 ITGRRNA 553 (660)
Q Consensus 547 ltG~~p~ 553 (660)
--|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8877654
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.19 Score=48.91 Aligned_cols=59 Identities=25% Similarity=0.315 Sum_probs=44.8
Q ss_pred CCcEEEEEEccCCChhcHHHHHHHHHHHhhcC---CCCcceEeEEEEeCCeeEEEEEecCCCChh
Q 006125 372 DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (660)
Q Consensus 372 ~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 433 (660)
+..++.||+-. ......|..|+.-|..|. .-++.+++.+-.+.++.|||+||++-|.++
T Consensus 38 g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 38 GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 45678888643 234456888888877774 356788888888999999999999987775
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.2 Score=52.34 Aligned_cols=140 Identities=23% Similarity=0.272 Sum_probs=82.6
Q ss_pred ccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC------cceEeEE----EEeCCeeEEEEE
Q 006125 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN------LVKLLGF----CVDGDEKLLVYE 425 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~----~~~~~~~~lv~e 425 (660)
.|.+ .--.+|+....+|+. ++|+.+.. ....++..|...+..|.-.+ +..+-|- ...+...+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556788888777766 88887764 44566778888888773211 2222222 111236778999
Q ss_pred ecCCCChhh-hh--------------c----CC-----CCCCccCHHH-------------HHHHHHHHHHHHHHHHhCC
Q 006125 426 FMPNGSLDA-IL--------------F----DP-----RKRGILCWRK-------------RTNIVNGIAKGMLYLHEDS 468 (660)
Q Consensus 426 ~~~~gsL~~-~l--------------~----~~-----~~~~~l~~~~-------------~~~i~~~ia~~L~~LH~~~ 468 (660)
|++|..+.. .. + +. .......|.. ......++...+..+++.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988772 10 0 00 0011233320 0112233444444444331
Q ss_pred ----C---CCeEecCCCCCceEeCCCCC-EEEeeccccc
Q 006125 469 ----R---LRIVHRDLKASNVLLDSDMN-SKISDFGMAR 499 (660)
Q Consensus 469 ----~---~~ivH~DLkp~NILl~~~~~-~kl~DfGla~ 499 (660)
+ ..+||+|+.|.||+++++.. +-+.|||-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 22999999999999999875 8999999764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.17 Score=53.17 Aligned_cols=79 Identities=15% Similarity=0.168 Sum_probs=49.0
Q ss_pred ccccCCcccEEeeeecCC-cEEEEEEccCC----C---hhcHHHHHHHHHHHhhcC--CC-CcceEeEEEEeCCeeEEEE
Q 006125 356 ILGQGGFGPVYKGVLSDG-KEVAVKRLSSC----S---EQGTAEFTNEVLLILKLQ--HK-NLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~~~~g-~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 424 (660)
.||.|-...||++..++| +.|+||.-.+. . +.......-|...|.... .| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478899999999997654 68999975421 1 233444556666666552 34 34444443 455567999
Q ss_pred EecCCC-Chhhhh
Q 006125 425 EFMPNG-SLDAIL 436 (660)
Q Consensus 425 e~~~~g-sL~~~l 436 (660)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998553 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.12 Score=53.52 Aligned_cols=106 Identities=15% Similarity=0.137 Sum_probs=72.1
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..|++|++. ++++... ....+++...|+.+-+..+.-+..+- +.-||||.-.||||+ +|++-|+||-++
T Consensus 300 y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 456777765 4444322 22568899999999998888887764 699999999999999 999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHH
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll 543 (660)
+......... ....--|-.+. +.-+.+-|||-+--.|
T Consensus 369 Rl~~~q~~is-------y~rldhp~lF~-G~dd~QFeIYrlMr~l 405 (488)
T COG5072 369 RLSYSQGIIS-------YNRLDHPDLFN-GVDDYQFEIYRLMRRL 405 (488)
T ss_pred ecccCCceee-------ccccCchhhhc-CccceeeeHHHHHHHH
Confidence 8543221111 11223344444 4447778888754443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.41 Score=50.22 Aligned_cols=72 Identities=18% Similarity=0.146 Sum_probs=45.3
Q ss_pred CCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC--cceEe---E--EEEeCCeeEEEEEecCCCCh
Q 006125 360 GGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLL---G--FCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 360 G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~---~--~~~~~~~~~lv~e~~~~gsL 432 (660)
+.-..||+....+|+.+++|+.+.. .....++..|+..+..|.... ++..+ | +...++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 4456789888778888999987642 234556777888887773211 22211 2 22234567789999987643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.29 Score=59.28 Aligned_cols=141 Identities=21% Similarity=0.258 Sum_probs=77.5
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc--C-----CCCcceEe-E----EEEe-CC--e
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL--Q-----HKNLVKLL-G----FCVD-GD--E 419 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~-----h~niv~l~-~----~~~~-~~--~ 419 (660)
+.|+ |..-.+|+....+|+.+++|+.+... .......|...+..| + -|.+++-. | .... .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 45577888887788899999998642 223344455555544 2 22333211 1 1111 22 3
Q ss_pred eEEEEEecCCCChhhhhc---------------------C---CCCCCccCHHH-----------------HHHHHHHHH
Q 006125 420 KLLVYEFMPNGSLDAILF---------------------D---PRKRGILCWRK-----------------RTNIVNGIA 458 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~---------------------~---~~~~~~l~~~~-----------------~~~i~~~ia 458 (660)
.+-+++|+++..|.+... + ......+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 567899999987755110 0 00011122321 122233333
Q ss_pred HHHH-----HHHhCCCCCeEecCCCCCceEeCCCC--CEE-Eeeccccc
Q 006125 459 KGML-----YLHEDSRLRIVHRDLKASNVLLDSDM--NSK-ISDFGMAR 499 (660)
Q Consensus 459 ~~L~-----~LH~~~~~~ivH~DLkp~NILl~~~~--~~k-l~DfGla~ 499 (660)
+... .|.+ -+..+||+|+.+.|||++.+. ++. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3222 1211 134599999999999999875 555 99999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.18 Score=48.69 Aligned_cols=139 Identities=14% Similarity=0.149 Sum_probs=85.3
Q ss_pred EEEEEEccCCChh-cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHH
Q 006125 375 EVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453 (660)
Q Consensus 375 ~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i 453 (660)
+..+|+++.-.-. ...-+.++..++++++ .|+++..- +....-++.|+|..-.. .. ..+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHH
Confidence 4556666543333 4456788888888774 56666622 33345588998843211 11 112
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcc
Q 006125 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533 (660)
Q Consensus 454 ~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k 533 (660)
+.-=++.|.-.|+.. ...+|+|-.|+|||-|.+|.+||.|-+.-.. . +..|.--| -...|.+
T Consensus 147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~------------~V~~vN~~---Y~~lT~~ 208 (308)
T PF07387_consen 147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N------------QVNMVNIE---YESLTQE 208 (308)
T ss_pred HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--h------------eeeEEeee---ccccChH
Confidence 222246778888653 4699999999999999999999999764321 0 11122211 1235677
Q ss_pred hhHHHHHHHHHHHHhCCC
Q 006125 534 SDVFSFGVLLIEIITGRR 551 (660)
Q Consensus 534 sDVwslGvll~elltG~~ 551 (660)
+.+-+|=.-++++....+
T Consensus 209 aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 209 AEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred HHHHHHHHHHHHHHHHHh
Confidence 888777777777776544
|
The function of this family is unknown. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.071 Score=57.53 Aligned_cols=47 Identities=30% Similarity=0.392 Sum_probs=36.4
Q ss_pred HHHHHHHHHHhhcCCCCcceEeEEEEeCCe-eEEEEEecCCCChhhhhc
Q 006125 390 AEFTNEVLLILKLQHKNLVKLLGFCVDGDE-KLLVYEFMPNGSLDAILF 437 (660)
Q Consensus 390 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~ 437 (660)
.++.-...+++.+.|+|+...+.+...... ..+|+|++ +.+|++++.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 345566788899999999999998765433 57889988 568888883
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 660 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-38 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-25 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-23 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-23 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-23 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-22 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-22 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-22 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-22 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-22 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-22 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-22 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-22 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-22 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-22 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-22 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-22 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-21 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-21 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-21 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-21 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-21 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-21 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-21 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-21 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-21 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-21 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-21 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-20 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-20 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-20 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-20 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-20 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-20 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-20 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-20 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-20 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-20 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-20 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-20 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-20 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-20 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-20 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-20 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-20 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-20 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-20 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-20 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-20 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-20 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-20 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-19 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-143
Identities = 108/298 (36%), Positives = 158/298 (53%), Gaps = 22/298 (7%)
Query: 341 LETLNLATSNFSD------SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SEQGTA 390
L T+NF + N +G+GGFG VYKG + + VAVK+L++ +E+
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR 450
+F E+ ++ K QH+NLV+LLGF DGD+ LVY +MPNGSL L L W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I G A G+ +LHE+ +HRD+K++N+LLD +KISDFG+AR + T
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ----LLAYAWHLW 566
RIVGT YMAPE + G + KSD++SFGV+L+EIITG ++ LL +
Sbjct: 193 SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251
Query: 567 NE-GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGT 623
+E + + +D + D + C+ E RP + V +L+ T +
Sbjct: 252 DEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 417 bits (1074), Expect = e-142
Identities = 120/290 (41%), Positives = 174/290 (60%), Gaps = 12/290 (4%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLI 399
L L +A+ NFS+ NILG+GGFG VYKG L+DG VAVKRL QG +F EV +I
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIA 458
H+NL++L GFC+ E+LLVY +M NGS+ + L + + + L W KR I G A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
+G+ YLH+ +I+HRD+KA+N+LLD + + + DFG+A++ + T + GT G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIG 200
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--------LLAYAWHLWNEGN 570
++APEY G S+K+DVF +GV+L+E+ITG+R + LL + L E
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260
Query: 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620
+ LVD L ++ D+E + I + LLC Q +RP MS V ML+G+
Sbjct: 261 LEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-125
Identities = 102/286 (35%), Positives = 160/286 (55%), Gaps = 11/286 (3%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLIL 400
L L AT+NF ++G G FG VYKGVL DG +VA+KR + S QG EF E+ +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAK 459
+H +LV L+GFC + +E +L+Y++M NG+L L+ + W +R I G A+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
G+ YLH + I+HRD+K+ N+LLD + KI+DFG+++ E + + + GT GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ------LLAYAWHLWNEGNVLE 573
+ PEY ++G ++KSDV+SFGV+L E++ R + L +A N G + +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619
+VDP L D + ++ + C+ + DRP+M V L+
Sbjct: 268 IVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 6e-98
Identities = 74/307 (24%), Positives = 128/307 (41%), Gaps = 33/307 (10%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
+ E L + + +G FG V+K L + VAVK +Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 399 ILKLQHKNLVKLLGFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
+ ++H+N+++ +G G + L+ F GSL L K ++ W + +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 455 NGIAKGMLYLHED-------SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
+A+G+ YLHED + I HRD+K+ NVLL +++ + I+DFG+A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 508 ANTVRIVGTYGYMAPEYAMEGL-----YSKKSDVFSFGVLLIEIITGRRNAGSN---QLL 559
+T VGT YMAPE + + D+++ G++L E+ + A +L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 560 AYAWHLWNEGN--------VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMS 611
+ + + V + P+L D + C DA R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 612 SVAPMLK 618
V +
Sbjct: 308 CVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 1e-79
Identities = 75/333 (22%), Positives = 127/333 (38%), Gaps = 48/333 (14%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--V 396
+L N ++G+G +G VYKG L D + VAVK S + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 397 LLILKLQHKNLVKLLGFCVDGD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
+ ++H N+ + + E LLV E+ PNGSL L W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 452 NIVNGIAKGMLYLHED------SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES- 504
+ + + +G+ YLH + + I HRDL + NVL+ +D ISDFG++ +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 505 -----EGEANTVRIVGTYGYMAPEYAMEGL-------YSKKSDVFSFGVLLIEIITGRRN 552
E + + VGT YMAPE + K+ D+++ G++ EI +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 553 AGSNQ-----LLAYAWHLWNEGNVLELVD--------PLLTDTSFSDDEFSRYI-HIGLL 598
+ +A+ + N ++ P + + R +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 599 CVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPA 631
C +DA R T + + + +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 5e-70
Identities = 83/309 (26%), Positives = 142/309 (45%), Gaps = 34/309 (11%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGT 389
+ D I LN+ +G G FG V++ G +VAVK L +
Sbjct: 27 MDGDDMDIPWCDLNI-------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV 78
Query: 390 AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449
EF EV ++ +L+H N+V +G +V E++ GSL +L R L R+
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
R ++ +AKGM YLH IVHR+LK+ N+L+D K+ DFG++R+ ++ +
Sbjct: 139 RLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLS 195
Query: 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR---RNAGSNQLLAYAWHLW 566
+ GT +MAPE + ++KSDV+SFGV+L E+ T + N Q+ +
Sbjct: 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---VAAVG 252
Query: 567 NEGNVLELVDPLLTDTSFSDDEFSRYIHIGLL--CVQEDAFDRPTMSSVAPMLKG-ETGT 623
+ LE+ P + + ++ C + + RP+ +++ +L+
Sbjct: 253 FKCKRLEI--PRNLNPQVAA----------IIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
Query: 624 LPQPQKPAF 632
+P P +
Sbjct: 301 VPPPNRSDL 309
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 8e-68
Identities = 73/286 (25%), Positives = 119/286 (41%), Gaps = 45/286 (15%)
Query: 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+LG+G FG K G+ + +K L E+ F EV ++ L+H N++K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+ E++ G+L I+ + W +R + IA GM YLH + I+
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR------------IVGTYGYMA 521
HRDL + N L+ + N ++DFG+AR+ + + + +R +VG +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVD----- 576
PE Y +K DVFSFG++L EII A + + ++
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------ADPDYLPRTMDFGLNVRGFL 240
Query: 577 ----PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
P SF I + C D RP+ + L+
Sbjct: 241 DRYCPPNCPPSFFP--------ITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 4e-67
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
ID + + + ++G+G FG V K K+VA+K++ S E F E+
Sbjct: 5 IDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQ 54
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
+ ++ H N+VKL G C++ LV E+ GSL +L + +
Sbjct: 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
+G+ YLH ++HRDLK N+LL + KI DFG A + + + G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSA 167
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR--NAGSNQLLAYAWHLWNEGNVLELV 575
+MAPE YS+K DVFS+G++L E+IT R+ + W + + G L
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPL- 225
Query: 576 DPLLTDTSFSDDEFSRYIHIGLL--CVQEDAFDRPTMSSVAPMLKGETGTLPQPQKP 630
L+ C +D RP+M + ++ P +P
Sbjct: 226 -IKNLPKPIES----------LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-65
Identities = 87/295 (29%), Positives = 132/295 (44%), Gaps = 44/295 (14%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA----EFTN 394
ID L L I+G GGFG VY+ G EVAVK ++ +
Sbjct: 4 IDFAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
E L L+H N++ L G C+ LV EF G L+ +L R + N
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWA 111
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--------KISDFGMARIFAESEG 506
IA+GM YLH+++ + I+HRDLK+SN+L+ + + KI+DFG+AR + +
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR---RNAGSNQLLAYAW 563
+ G Y +MAPE ++SK SDV+S+GVLL E++TG R + A+
Sbjct: 172 MSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV---AY 224
Query: 564 HLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ L + P F+ + C D RP+ +++ L
Sbjct: 225 GVAMNKLALPI--PSTCPEPFAK--------LMEDCWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-64
Identities = 78/298 (26%), Positives = 128/298 (42%), Gaps = 46/298 (15%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA------- 390
+ + +G+GGFG V+KG + D VA+K L +G
Sbjct: 16 LADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68
Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR 450
EF EV ++ L H N+VKL G + +V EF+P G L L D + W +
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVK 124
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGMARIFAESE 505
++ IA G+ Y+ + IVHRDL++ N+ L S + +K++DFG+++ S
Sbjct: 125 LRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS- 182
Query: 506 GEANTVRIVGTYGYMAPE--YAMEGLYSKKSDVFSFGVLLIEIITGR---RNAGSNQLLA 560
++G + +MAPE A E Y++K+D +SF ++L I+TG + +
Sbjct: 183 ----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IK 237
Query: 561 YAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ + EG + P + + LC D RP S + L
Sbjct: 238 FINMIREEGLRPTI--PEDCPPRLRN--------VIELCWSGDPKKRPHFSYIVKELS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 3e-64
Identities = 82/307 (26%), Positives = 142/307 (46%), Gaps = 38/307 (12%)
Query: 323 QHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL- 381
H + A D+ I + + +G G FG VYKG +VAVK L
Sbjct: 5 HHHHHHGSRDAADDWEIPDGQITVG-------QRIGSGSFGTVYKGKWHG--DVAVKMLN 55
Query: 382 -SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDP 439
++ + Q F NEV ++ K +H N++ +G+ +L +V ++ SL L
Sbjct: 56 VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHAS 113
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ +K +I A+GM YLH I+HRDLK++N+ L D KI DFG+A
Sbjct: 114 ETK--FEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168
Query: 500 IFAESEGEANTVRIVGTYGYMAPE---YAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
+ G ++ G+ +MAPE YS +SDV++FG++L E++TG+
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------ 222
Query: 557 QLLAYAWHLWNEGNVLELVD-----PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMS 611
L Y+ ++ N ++E+V P L+ + + R + C+++ +RP+
Sbjct: 223 --LPYS-NINNRDQIIEMVGRGSLSPDLSKVRSNCPK--RMKRLMAECLKKKRDERPSFP 277
Query: 612 SVAPMLK 618
+ ++
Sbjct: 278 RILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-63
Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 38/289 (13%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEV 396
ID + LN L + G ++KG G ++ VK L S + + +F E
Sbjct: 7 IDFKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
+ H N++ +LG C + +MP GSL +L + ++ +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFA 117
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
+A+GM +LH L I L + +V++D DM ++IS + F +
Sbjct: 118 LDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------M 169
Query: 515 GTYGYMAPEYAMEG----LYSKKSDVFSFGVLLIEIITGRR-NAGSNQLLAYAWHLWNEG 569
++APE A++ + +D++SF VLL E++T A + + + EG
Sbjct: 170 YAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-MEIGMKVALEG 227
Query: 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ S+ + I C+ ED RP + P+L+
Sbjct: 228 LRPTI-------PPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-61
Identities = 72/307 (23%), Positives = 124/307 (40%), Gaps = 39/307 (12%)
Query: 326 QGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SS 383
+ + Q++ I E L + ++G+G FG VY G EVA++ +
Sbjct: 17 KASQTSIFLQEWDIPFEQLEI-------GELIGKGRFGQVYHGRWHG--EVAIRLIDIER 67
Query: 384 CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG 443
+E F EV+ + +H+N+V +G C+ ++ +L +++ D +
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV- 126
Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
L K I I KGM YLH I+H+DLK+ NV D + I+DFG+ I
Sbjct: 127 -LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181
Query: 504 SEGEANTVRI---VGTYGYMAPE---------YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
+ ++ G ++APE + +SK SDVF+ G + E+
Sbjct: 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
Query: 552 NAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMS 611
+ A W + + + + SD I L C + +RPT +
Sbjct: 242 PFKTQPAEAIIWQMGT--GMKPNLSQIGMGKEISD--------ILLFCWAFEQEERPTFT 291
Query: 612 SVAPMLK 618
+ ML+
Sbjct: 292 KLMDMLE 298
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-59
Identities = 66/293 (22%), Positives = 121/293 (41%), Gaps = 37/293 (12%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--VLLILKLQHKNLVKLLG 412
+G+G +G V++G G+ VAVK SS + + E + + L+H+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 413 FCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ L+ + GSL L + L IV IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 469 RLR-----IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI--VGTYGYMA 521
I HRDLK+ N+L+ + I+D G+A + ++S + + VGT YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 522 PE------YAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN----- 570
PE K+ D+++FG++L E+ + G + ++ +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 571 VLELVD-----PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ ++V P + + FSD + + C ++ R T + L
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-58
Identities = 63/309 (20%), Positives = 119/309 (38%), Gaps = 44/309 (14%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--V 396
+ + + +G+G +G V+ G G++VAVK + A + E +
Sbjct: 34 TIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEI 82
Query: 397 LLILKLQHKNLVKLLGFCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
+ ++H+N++ + + G L+ ++ NGSL L K L +
Sbjct: 83 YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLK 138
Query: 453 IVNGIAKGMLYLHEDSRLR-----IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
+ G+ +LH + I HRDLK+ N+L+ + I+D G+A F E
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 508 ANTVRI--VGTYGYMAPE------YAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL 559
+ VGT YM PE +D++SFG++L E+ + G +
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 560 AYAWH--LWNEGNVLELVD--------PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT 609
+H + ++ + ++ + P + SD+ + + C + R T
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 610 MSSVAPMLK 618
V L
Sbjct: 319 ALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-56
Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 39/294 (13%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--VLLILKLQHKNLVKLLG 412
+G+G FG V++G G+EVAVK SS E+ + E + + L+H+N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103
Query: 413 FCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED- 467
+ LV ++ +GSL L R + + A G+ +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 468 ----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI--VGTYGYMA 521
+ I HRDLK+ N+L+ + I+D G+A + + VGT YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 522 PEYAMEGL-------YSKKSDVFSFGVLLIEIITGRRNAGSNQ--LLAYAWHLWNEGNVL 572
PE ++ K++D+++ G++ EI G ++ L Y + ++ +V
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 573 ELVD--------PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
E+ P + + S + I C + R T + L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 4e-53
Identities = 67/201 (33%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
+G+G FG V+ G L +D VAVK + A+F E ++ + H N+V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+V E + G L R G L + +V A GM YL +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT------VRIVGTYGYMAPEYAME 527
HRDL A N L+ KISDFGM+R A+ A+ V+ + APE
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK------WTAPEALNY 289
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
G YS +SDV+SFG+LL E +
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-50
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG V + G+ VAVK+L +E+ +F E+ ++ LQH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G C + L+ E++P GSL L + + + K + I KGM YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGYM 520
R +HRDL N+L++++ KI DFG+ ++ + + + +
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF------WY 184
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIIT 548
APE E +S SDV+SFGV+L E+ T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-50
Identities = 79/288 (27%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+ LG+G FG V + G VAVK+L +F E+ ++ L +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G + LV E++P+G L L R R L + + I KGM YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAP 522
R VHRDL A N+L++S+ + KI+DFG+A++ + +V G + AP
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEG----NVLELVD- 576
E + ++S++SDV+SFGV+L E+ T ++ + + +LEL++
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 577 ------PLLTDTSFSDDEFSRYIH-IGLLCVQEDAFDRPTMSSVAPML 617
P +H + LC DRP+ S++ P L
Sbjct: 260 GQRLPAP---------PACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-50
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 355 NILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
+LG G FG VYKG+ E VA+K L + S + E +E ++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+LLG C+ L+ + MP G L + + + + + N IAKGM YL
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL---E 134
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT------VRIVGTYGYMAP 522
R+VHRDL A NVL+ + + KI+DFG+A++ E E + ++ +MA
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK------WMAL 188
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
E + +Y+ +SDV+S+GV + E++T G +
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-50
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V G +VA+K + S EF E +++ L H+ LV+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
++ E+M NG L L R ++ + + + M YL + +H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEGL 529
RDL A N L++ K+SDFG++R + E ++ VR + PE M
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSK 197
Query: 530 YSKKSDVFSFGVLLIEIIT-GRR 551
+S KSD+++FGVL+ EI + G+
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKM 220
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-50
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG V + G+ VAVK+L +E+ +F E+ ++ LQH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G C + L+ E++P GSL L + + + K + I KGM YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAP 522
R +HRDL N+L++++ KI DFG+ ++ + + V G + AP
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAP 217
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
E E +S SDV+SFGV+L E+ T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-50
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 30/230 (13%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQ 387
+ +D I E + ++G+G FG VY G D + A+K L Q
Sbjct: 10 EVKDVLIPHERVVT-----HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64
Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-KLLVYEFMPNGSLDAILFDPRKRGILC 446
F E LL+ L H N++ L+G + + ++ +M +G L + P++
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PT 122
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE- 505
+ + +A+GM YL + + VHRDL A N +LD K++DFG+AR + E
Sbjct: 123 VKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179
Query: 506 --GEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+ + V+ + A E ++ KSDV+SFGVLL E++T
Sbjct: 180 YSVQQHRHARLPVK------WTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-49
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
+G G FG V+ G + +VA+K + + +F E +++KL H LV+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
++ LV EFM +G L L R RG+ + + +GM YL ++
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEG 528
HRDL A N L+ + K+SDFGM R + + ++T V+ + +PE
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPEVFSFS 180
Query: 529 LYSKKSDVFSFGVLLIEIIT-GRR 551
YS KSDV+SFGVL+ E+ + G+
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-49
Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 48/291 (16%)
Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
LG+G FG V + G++VAVK L A+ E+ ++ L H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 409 KLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
K G C + L+ EF+P+GSL L P+ + + +++ I KGM YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGY 519
+ VHRDL A NVL++S+ KI DFG+ + + V +
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------W 195
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEG----NVLEL 574
APE M+ + SDV+SFGV L E++T ++ L + ++
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 575 VD-------PLLTDTSFSDDEFSRYIH-IGLLCVQEDAFDRPTMSSVAPML 617
+ P ++ + C + +R + ++
Sbjct: 256 LKEGKRLPCP---------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-49
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 25/210 (11%)
Query: 356 ILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G G FG VYKG+L VA+K L + +E+ +F E ++ + H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L G +++ E+M NG+LD L + + ++ GIA GM YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL---AN 165
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGYMAP 522
+ VHRDL A N+L++S++ K+SDFG++R+ + T +R + AP
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR------WTAP 219
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
E ++ SDV+SFG+++ E++T G R
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 34/217 (15%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG V+ + VAVK L + +F E L+ LQH+++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKRTNIVNGI 457
G C DGD ++V+E+M +G L+ L + +G L + +I + I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE---GEANT---V 511
A GM+YL + VHRDL N L+ +++ KI DFGM+R ++ +T +
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
R +M PE M ++ +SDV+SFGV+L EI T
Sbjct: 200 R------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 24/210 (11%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
I+G G G V G L + VA+K L + +E+ +F +E ++ + H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L G G ++V E+M NGSLD L + + ++ G+ GM YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SD 169
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGYMAP 522
L VHRDL A NVL+DS++ K+SDFG++R+ + A T +R + AP
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR------WTAP 223
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
E +S SDV+SFGV++ E++ G R
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-49
Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQ 387
Q I +L + + ++G+G FG VY G L D AVK L
Sbjct: 14 AVQHVVIGPSSLIV-----HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68
Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMPNGSLDAILFDPRKRGILC 446
++F E +++ H N++ LLG C+ + L V +M +G L + +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PT 126
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
+ +AKGM YL + VHRDL A N +LD K++DFG+AR + E
Sbjct: 127 VKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE- 182
Query: 507 EANTVRIVGTYG------YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+ G +MA E ++ KSDV+SFGVLL E++T
Sbjct: 183 ---YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 3e-49
Identities = 66/203 (32%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
LG G FG V G +VAVK + S EF E ++KL H LVK G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+V E++ NG L L R G L + + + +GM +L + +H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEGL 529
RDL A N L+D D+ K+SDFGM R + + ++ V+ + APE
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------WSAPEVFHYFK 181
Query: 530 YSKKSDVFSFGVLLIEIIT-GRR 551
YS KSDV++FG+L+ E+ + G+
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKM 204
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-49
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 33/218 (15%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
LG+G FG V+ + VAVK L SE +F E L+ LQH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAIL------------FDPRKRGILCWRKRTNIVNG 456
+ G C +G L+V+E+M +G L+ L + G L + + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-----GEANT- 510
+A GM+YL + L VHRDL N L+ + KI DFGM+R ++ G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+R +M PE + ++ +SDV+SFGV+L EI T
Sbjct: 224 IR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 32/233 (13%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGK---EVAVKRL--SSCSE 386
++ ++ ++D + L L LG G FG V KG K VAVK L +
Sbjct: 6 IRPKEVYLDRKLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 59
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC 446
E E ++ +L + +V+++G C + + +LV E G L+ L ++ +
Sbjct: 60 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVK 115
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
+ +V+ ++ GM YL VHRDL A NVLL + +KISDFG+++ E
Sbjct: 116 DKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 507 EANT-------VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
V+ + APE +S KSDV+SFGVL+ E + G++
Sbjct: 173 YYKAQTHGKWPVK------WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 355 NILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+ LG G +G VY+GV VAVK L + + EF E ++ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
C ++ EFM G+L L + R + + I+ M YL + +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEG 528
HRDL A N L+ + K++DFG++R+ A+ ++ + APE
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYN 187
Query: 529 LYSKKSDVFSFGVLLIEIIT-GRR 551
+S KSDV++FGVLL EI T G
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-48
Identities = 83/303 (27%), Positives = 125/303 (41%), Gaps = 47/303 (15%)
Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
LG+G FG V G+ VAVK L + Q + + E+ ++ L H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 409 KLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
K G C D LV E++P GSL L + + + I +GM YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHS-IGLAQLLLFAQQICEGMAYLHA 152
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMA 521
+HRDL A NVLLD+D KI DFG+A+ E V G + A
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYA 205
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEG----NVLELVD 576
PE E + SDV+SFGV L E++T + + + EL++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 577 -------PLLTDTSFSDDEFSRYIH-IGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQ 628
P D+ ++ + C + +A RPT ++ P+LK Q Q
Sbjct: 266 RGERLPRP---------DKCPAEVYHLMKNCWETEASFRPTFENLIPILK-TVHEKYQGQ 315
Query: 629 KPA 631
P+
Sbjct: 316 APS 318
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 356 ILGQGGFGPVYKGVLSDGK--------EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
LGQG F ++KGV + EV +K L + F ++ KL HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
V G CV GDE +LV EF+ GSLD L + + + + + +A M +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL--- 129
Query: 468 SRLRIVHRDLKASNVLLDSDMNS--------KISDFGMARIFAESEGEANTVRIVGTYGY 519
++H ++ A N+LL + + K+SD G++ + + +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------W 183
Query: 520 MAPEYAMEG-LYSKKSDVFSFGVLLIEIIT-GRR 551
+ PE + +D +SFG L EI + G +
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 68/220 (30%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LG+ FG VYKG L VA+K L EF +E +L +LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKRTNIV 454
V LLG +++ + +G L L D + L ++V
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT--- 510
IA GM YL S +VH+DL NVL+ +N KISD G+ R ++A +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 511 --VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+R +MAPE M G +S SD++S+GV+L E+ +
Sbjct: 192 LPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-48
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G G FG V G L + VA+K L +E+ +F E ++ + H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDS 468
L G ++V E+M NGSLD+ L RK + ++ GIA GM YL S
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGYMA 521
+ VHRDL A N+L++S++ K+SDFG+ R+ + A T +R + +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR------WTS 218
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
PE ++ SDV+S+G++L E+++ G R
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-48
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 30/229 (13%)
Query: 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE---VAVKRL-SSCSEQGTA 390
+ F+ + L + LG G FG V +GV K+ VA+K L + T
Sbjct: 2 KKLFLKRDNLLI------ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 55
Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR 450
E E ++ +L + +V+L+G C + +LV E G L L R+ +
Sbjct: 56 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNV 112
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+++ ++ GM YL VHRDL A NVLL + +KISDFG+++ +
Sbjct: 113 AELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169
Query: 511 -------VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
++ + APE +S +SDV+S+GV + E ++ G++
Sbjct: 170 RSAGKWPLK------WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-48
Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 29/248 (11%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----V 376
H+ H +++ LE + + + ILG+G FG V +G L V
Sbjct: 6 HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 377 AVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKLLVYEFMPN 429
AVK + + S++ EF +E + H N+++LLG C++ + +++ FM
Sbjct: 66 AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125
Query: 430 GSLDAILFDPRKRG---ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
G L L R + + + IA GM YL S +HRDL A N +L
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRD 182
Query: 487 DMNSKISDFGMAR-IFAESEGEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFG 540
DM ++DFG+++ I++ V+ ++A E + +Y+ KSDV++FG
Sbjct: 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWAFG 236
Query: 541 VLLIEIIT 548
V + EI T
Sbjct: 237 VTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-48
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLV 408
+LG+G FG V + L VAVK L + EF E + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 409 KLLGFCVDGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAK 459
KL+G + K +++ FM +G L A L R L + + IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT-----VRI 513
GM YL S +HRDL A N +L DM ++DFG++R I++ V+
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK- 204
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
++A E + LY+ SDV++FGV + EI+T
Sbjct: 205 -----WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-48
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 355 NILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
+LG G FG VYKG+ E VA+K L + S + E +E ++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+LLG C+ L+ + MP G L + + + + + N IAKGM YL
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL---E 134
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT------VRIVGTYGYMAP 522
R+VHRDL A NVL+ + + KI+DFG+A++ E E + ++ +MA
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK------WMAL 188
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
E + +Y+ +SDV+S+GV + E++T G +
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 30/231 (12%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSE 386
+D+ I E + L +G+G FG V++G+ + VA+K + S+
Sbjct: 5 SSTRDYEIQRERIEL-------GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD 57
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC 446
+F E L + + H ++VKL+G + ++ E G L + L + L
Sbjct: 58 SVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LD 114
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
++ + YL R VHRD+ A NVL+ S+ K+ DFG++R +S
Sbjct: 115 LASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171
Query: 507 EANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
+ ++ +MAPE ++ SDV+ FGV + EI+ G +
Sbjct: 172 YKASKGKLPIK------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-47
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQ 387
Q I +L + + ++G+G FG VY G L D AVK L
Sbjct: 78 AVQHVVIGPSSLIV-----HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 132
Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMPNGSLDAILFDPRKRGILC 446
++F E +++ H N++ LLG C+ + L V +M +G L + +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PT 190
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
+ +AKGM +L + + VHRDL A N +LD K++DFG+AR + E
Sbjct: 191 VKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247
Query: 507 EANT--------VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
++ V+ +MA E ++ KSDV+SFGVLL E++T
Sbjct: 248 DSVHNKTGAKLPVK------WMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 70/203 (34%), Positives = 106/203 (52%), Gaps = 18/203 (8%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V+ G + +VAVK L S F E L+ +LQH+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYA-V 76
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
V + ++ E+M NGSL L L K ++ IA+GM ++ +H
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEGL 529
RDL+A+N+L+ ++ KI+DFG+AR+ ++E A ++ + APE G
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPEAINYGT 186
Query: 530 YSKKSDVFSFGVLLIEIIT-GRR 551
++ KSDV+SFG+LL EI+T GR
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LGQG FG VY+GV + VA+K + + S + EF NE ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDPRKRGILCWRKRTNIVNGIAKG 460
V+LLG G L++ E M G L + L + K + IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-----GEANT-VRIV 514
M YL+ + VHRDL A N ++ D KI DFGM R E++ G+ VR
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 205
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+M+PE +G+++ SDV+SFGV+L EI T
Sbjct: 206 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-47
Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 43/228 (18%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LG+G FG V K K VAVK L + S + +E ++ ++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG----------- 456
+KL G C LL+ E+ GSL L + RK G + +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 457 ----------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESE 505
I++GM YL + +++VHRDL A N+L+ KISDFG++R ++ E
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 506 GEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+ V+ +MA E + +Y+ +SDV+SFGVLL EI+T
Sbjct: 206 YVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G FG V G G +VAVK + + + Q F E ++ +L+H NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGV 82
Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
V+ L +V E+M GSL L R R +L + + M YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-VRIVGTYGYMAPEYAMEGLYS 531
VHRDL A NVL+ D +K+SDFG+ + + ++ V+ + APE E +S
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 192
Query: 532 KKSDVFSFGVLLIEIIT-GRR 551
KSDV+SFG+LL EI + GR
Sbjct: 193 TKSDVWSFGILLWEIYSFGRV 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 67/235 (28%), Positives = 95/235 (40%), Gaps = 34/235 (14%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL--SDGKE--VAVKRL---SSC 384
L++ I + L L LG G FG V +G GK VAVK L
Sbjct: 8 LQSLTCLIGEKDLRL-------LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
+ +F EV + L H+NL++L G + +V E P GSL L +
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH-- 117
Query: 445 LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
+ +A+GM YL R +HRDL A N+LL + KI DFG+ R ++
Sbjct: 118 FLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
Query: 505 EGEANT-------VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
+ + APE +S SD + FGV L E+ T G+
Sbjct: 175 DDHYVMQEHRKVPFA------WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 355 NILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
+LG G FG V+KGV E V +K + Q T+ +L I L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+LLG C G LV +++P GSL + RG L + N IAKGM YL
Sbjct: 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL---E 132
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT------VRIVGTYGYMAP 522
+VHR+L A NVLL S +++DFG+A + + + ++ +MA
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK------WMAL 186
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
E G Y+ +SDV+S+GV + E++T G
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-47
Identities = 71/213 (33%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 355 NILGQGGFGPVYKGVLSDGK------EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LG G FG VY+G +S +VAVK L CSEQ +F E L+I K H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLY 463
V+ +G + + ++ E M G L + L + R + L ++ IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 464 LHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAESEGEANTVRIVGTYGY- 519
L +HRD+ A N LL +KI DFGMAR + G
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAML 207
Query: 520 ----MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
M PE MEG+++ K+D +SFGVLL EI +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-47
Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 289 FFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLN--- 345
TK+I +R+ T + + + D + A +L
Sbjct: 18 HKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWE 77
Query: 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKE--------VAVKRL-SSCSEQGTAEFTNEV 396
+ LG+G FG V + VAVK L +E+ ++ +E+
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 397 LLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
++ + +HKN++ LLG C ++ E+ G+L L R G+ +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 456 G-------------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IF 501
+A+GM YL + + +HRDL A NVL+ + KI+DFG+AR I
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 502 AESEGEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+ T V+ +MAPE + +Y+ +SDV+SFGVL+ EI T
Sbjct: 255 NIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-47
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 38/223 (17%)
Query: 355 NILGQGGFGPVYKGVLSDGKE--------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QH 404
LG+G FG V + VAVK L +E+ ++ +E+ ++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-------- 456
KN++ LLG C ++ E+ G+L L R G+ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT 510
+A+GM YL + + +HRDL A NVL+ + KI+DFG+AR I + T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 511 -----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
V+ +MAPE + +Y+ +SDV+SFGVL+ EI T
Sbjct: 218 NGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-47
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
ILG+G FG VY+GV ++ K VAVK C+ +F +E +++ L H ++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+G + + ++ E P G L L + L I K M YL +
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYL---ESI 132
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYA 525
VHRD+ N+L+ S K+ DFG++R + + + ++ +M+PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------WMSPESI 186
Query: 526 MEGLYSKKSDVFSFGVLLIEIIT-GRR 551
++ SDV+ F V + EI++ G++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 71/213 (33%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 355 NILGQGGFGPVYKGVLSDGK------EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LG G FG VY+G +S +VAVK L CSEQ +F E L+I K H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLY 463
V+ +G + + ++ E M G L + L + R + L ++ IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 464 LHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAESEGEANTVRIVGTYGY- 519
L +HRD+ A N LL +KI DFGMAR + G
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAML 248
Query: 520 ----MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
M PE MEG+++ K+D +SFGVLL EI +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 43/228 (18%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
+G+G FG V++ VAVK L S A+F E L+ + + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG----------- 456
VKLLG C G L++E+M G L+ L +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 457 ----------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESE 505
+A GM YL S + VHRDL N L+ +M KI+DFG++R I++
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 506 GEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+A+ +R +M PE Y+ +SDV+++GV+L EI +
Sbjct: 230 YKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 355 NILGQGGFGPVYKGVLSDGKE---VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
+++G+G FG V K + A+KR+ S+ +F E+ ++ KL H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKRTNIVNG 456
LLG C L E+ P+G+L L L ++ +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT---VRI 513
+A+GM YL S+ + +HRDL A N+L+ + +KI+DFG++R + VR
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 206
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+MA E +Y+ SDV+S+GVLL EI++
Sbjct: 207 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-46
Identities = 71/201 (35%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G FG V G G +VAVK + + + Q F E ++ +L+H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGV 254
Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
V+ L +V E+M GSL L R R +L + + M YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
VHRDL A NVL+ D +K+SDFG+ + + + V+ + APE E +S
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 364
Query: 532 KKSDVFSFGVLLIEIIT-GRR 551
KSDV+SFG+LL EI + GR
Sbjct: 365 TKSDVWSFGILLWEIYSFGRV 385
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 355 NILGQGGFGPVYKGVL------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
LG+G FG V + + + VAVK L + +E+ +++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 407 LVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--------- 456
+V LLG C L+V EF G+L L R + ++
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 457 ----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT- 510
+AKGM +L + + +HRDL A N+LL KI DFG+AR I+ + +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 511 ----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
++ +MAPE + +Y+ +SDV+SFGVLL EI +
Sbjct: 210 ARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-46
Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 7/195 (3%)
Query: 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+ LG G +G VY+GV VAVK L + + EF E ++ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
C ++ EFM G+L L + ++ + + I+ M YL + +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
HR+L A N L+ + K++DFG++R+ A+ + APE +S K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399
Query: 534 SDVFSFGVLLIEIIT 548
SDV++FGVLL EI T
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-46
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
LG G FG V + + VAVK L S+ +E+ ++ L QH+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSL-----------DAILFDPRKRGILCWRKRTNIVN 455
+V LLG C G L++ E+ G L + R + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT---- 510
+A+GM +L + +HRD+ A NVLL + +KI DFG+AR I +S
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 511 -VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
V+ +MAPE + +Y+ +SDV+S+G+LL EI +
Sbjct: 229 PVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-46
Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
LG G FG V + + VAVK L S +E+ ++ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---------- 456
+V LLG C G L++ E+ G L L R I + +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT 510
+AKGM +L + +HRDL A N+LL +KI DFG+AR I +S
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 511 -----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
V+ +MAPE +Y+ +SDV+S+G+ L E+ +
Sbjct: 206 NARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-46
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V+ + +VAVK + S F E ++ LQH LVKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ ++ EFM GSL L + K + IA+GM ++ + +H
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEGL 529
RDL+A+N+L+ + + KI+DFG+AR+ ++E A ++ + APE G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFGS 361
Query: 530 YSKKSDVFSFGVLLIEIIT-GRR 551
++ KSDV+SFG+LL+EI+T GR
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRI 384
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-45
Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 30/242 (12%)
Query: 322 YQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE---VAV 378
++ +LK + F+ + L +A LG G FG V +GV K+ VA+
Sbjct: 315 FESPFSDPEELKDKKLFLKRDNLLIA------DIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 379 KRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF 437
K L + T E E ++ +L + +V+L+G C + +LV E G L L
Sbjct: 369 KVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV 427
Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
R+ + +++ ++ GM YL VHR+L A NVLL + +KISDFG+
Sbjct: 428 GKREE--IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 498 ARIFAESEGEANT-------VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-G 549
++ + ++ + APE +S +SDV+S+GV + E ++ G
Sbjct: 483 SKALGADDSYYTARSAGKWPLK------WYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536
Query: 550 RR 551
++
Sbjct: 537 QK 538
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 78/286 (27%), Positives = 120/286 (41%), Gaps = 53/286 (18%)
Query: 297 RKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNI 356
K++ Q+Q+ ++ ++D ++ Y + + DLK + E L +
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLK---WEFPRENLEFG-------KV 52
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKNLV 408
LG G FG V + VAVK L +E+ ++ +L H+N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG------------ 456
LLG C L++E+ G L L R++ + N
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 457 --------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGE 507
+AKGM +L VHRDL A NVL+ KI DFG+AR I ++S
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 508 ANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
V+ +MAPE EG+Y+ KSDV+S+G+LL EI +
Sbjct: 230 VRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-45
Identities = 68/221 (30%), Positives = 106/221 (47%), Gaps = 38/221 (17%)
Query: 357 LGQGGFGPVYKGVL--------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
LG+G FG V + +VAVK L S +E+ ++ +E+ ++ + +HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---------- 456
++ LLG C ++ E+ G+L L R G+ ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 457 ---IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT-- 510
+A+GM YL + + +HRDL A NVL+ D KI+DFG+AR I + T
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 511 ---VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
V+ +MAPE + +Y+ +SDV+SFGVLL EI T
Sbjct: 254 RLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-45
Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LGQG FG V+ G + VA+K L + F E ++ KL+H+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ + +V E+M GSL L L + ++ IA GM Y+ R+ VH
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
RDL+A+N+L+ ++ K++DFG+AR+ ++E A + APE A+ G ++ KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362
Query: 535 DVFSFGVLLIEIIT 548
DV+SFG+LL E+ T
Sbjct: 363 DVWSFGILLTELTT 376
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-44
Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LGQG FG V+ G + VA+K L + F E ++ KL+H+ LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ + +V E+M GSL L L + ++ IA GM Y+ R+ VH
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
RDL+A+N+L+ ++ K++DFG+AR+ ++E A + APE A+ G ++ KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445
Query: 535 DVFSFGVLLIEIIT 548
DV+SFG+LL E+ T
Sbjct: 446 DVWSFGILLTELTT 459
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-43
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
+G+G FG V++G+ + VA+K + S+ +F E L + + H ++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+G + + ++ E G L + L ++ L ++ + YL
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYA 525
R VHRD+ A NVL+ S+ K+ DFG++R +S + ++ +MAPE
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAPESI 564
Query: 526 MEGLYSKKSDVFSFGVLLIEIIT-GRR 551
++ SDV+ FGV + EI+ G +
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 69/274 (25%), Positives = 127/274 (46%), Gaps = 42/274 (15%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G+G F VY+ L DG VA+K++ + A+ E+ L+ +L H N++K
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAKGMLYLHED 467
++ +E +V E G L ++ +K+ L W + + ++H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSALEHMHSR 155
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
R++HRD+K +NV + + K+ D G+ R F+ A+++ VGT YM+PE E
Sbjct: 156 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHE 210
Query: 528 GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELV--------DPLL 579
Y+ KSD++S G LL E+ + ++ ++ N+ L PL
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQS----------PFYG-DKMNLYSLCKKIEQCDYPPLP 259
Query: 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613
+D +S +E + ++ +C+ D RP ++ V
Sbjct: 260 SD-HYS-EELRQLVN---MCINPDPEKRPDVTYV 288
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 67/262 (25%), Positives = 112/262 (42%), Gaps = 26/262 (9%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G+G F VYKG+ EVA + ++ F E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 413 FCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ +LV E M +G+L L ++ ++ + + I KG+ +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 469 RLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
I+HRDLK N+ + S KI D G+A + S A V +GT +MAPE E
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAV--IGTPEFMAPEMYEE 204
Query: 528 GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587
Y + DV++FG+ ++E+ T Q A + G D +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD------KVAIP 257
Query: 588 EFSRYIHIGLLCVQEDAFDRPT 609
E I C++++ +R +
Sbjct: 258 EVKEIIE---GCIRQNKDERYS 276
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 51/238 (21%), Positives = 101/238 (42%), Gaps = 21/238 (8%)
Query: 320 FHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAV 378
H+ H DL ++ +++ + +G+G FG DG++ +
Sbjct: 1 MHHHHHHSSGVDLGTENL--YFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVI 54
Query: 379 K--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL 436
K +S S + E EV ++ ++H N+V+ + +V ++ G L +
Sbjct: 55 KEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114
Query: 437 FDPRKRGI---LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493
+ I + ++H+ +I+HRD+K+ N+ L D ++
Sbjct: 115 NAQKGVLFQEDQILD----WFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLG 167
Query: 494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
DFG+AR+ + A +GT Y++PE Y+ KSD+++ G +L E+ T +
Sbjct: 168 DFGIARVLNSTVELARAC--IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 59/251 (23%), Positives = 100/251 (39%), Gaps = 27/251 (10%)
Query: 315 ANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDS-------NILGQGGFGPVYK 367
A +Q + + + + E L + + +G+G FG V++
Sbjct: 17 AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHR 76
Query: 368 GV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424
G + AVK RL + E++ L +V L G +G +
Sbjct: 77 MKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFM 129
Query: 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
E + GSL ++ ++ G L + + +G+ YLH RI+H D+KA NVLL
Sbjct: 130 ELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLL 183
Query: 485 DSDMNS-KISDFGMARIFAESEGEANTVR---IVGTYGYMAPEYAMEGLYSKKSDVFSFG 540
SD + + DFG A + + I GT +MAPE M K D++S
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243
Query: 541 VLLIEIITGRR 551
+++ ++ G
Sbjct: 244 CMMLHMLNGCH 254
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-41
Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 29/247 (11%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR 380
H+ H DL ++ + ++ +S +G GG V++ + + A+K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVK--GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY 59
Query: 381 --LSSCSEQGTAEFTNEVLLILKLQHKNL--VKLLGFCVDGDEKLLVYEFMPNGSLDAIL 436
L Q + NE+ + KLQ + ++L + + +V E N L++ L
Sbjct: 60 VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL 118
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
+K+ + +R + + + + +H+ IVH DLK +N L+ D K+ DFG
Sbjct: 119 ---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFG 171
Query: 497 MARIFAESEGEANTVR--IVGTYGYMAPE-----------YAMEGLYSKKSDVFSFGVLL 543
+A + V+ VGT YM PE + S KSDV+S G +L
Sbjct: 172 IANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 544 IEIITGR 550
+ G+
Sbjct: 230 YYMTYGK 236
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
+LG+G +G VY G LS+ +A+K + + + E+ L L+HKN+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ + E +P GSL A+L + I +G+ YLH++ +IVH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 475 RDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPE---YAMEGLY 530
RD+K NVL+++ KISDFG ++ A T GT YMAPE G Y
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMAPEIIDKGPRG-Y 202
Query: 531 SKKSDVFSFGVLLIEIITGRR 551
K +D++S G +IE+ TG+
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 44/282 (15%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
+F + ++G GGFG V+K DGK +KR+ +E + EV + KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 408 VKLLGFCVDGDEKL----------------LVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
V G D + EF G+L+ + + R+ L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
+ I KG+ Y+H ++++RDLK SN+ L KI DFG+ +++G+
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRS 181
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV 571
GT YM+PE Y K+ D+++ G++L E++ +
Sbjct: 182 --KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD------------TAFETSKF 227
Query: 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613
+ + F + + + + DRP S +
Sbjct: 228 FTDLRDGIISDIFD-KKEKTLLQ---KLLSKKPEDRPNTSEI 265
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-40
Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G G +G K SDGK + K S +E +EV L+ +L+H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 413 FCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAKGMLYLH 465
+D L V E+ G L +++ K R T + + H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK----ECH 128
Query: 466 E--DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
D ++HRDLK +NV LD N K+ DFG+ARI A T VGT YM+PE
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF--VGTPYYMSPE 186
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
Y++KSD++S G LL E+
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNL--VKL 410
+G GG V++ + + A+K L Q + NE+ + KLQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ + +V E N L++ L +K+ + +R + + + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGTYGYMAPE----- 523
IVH DLK +N L+ D K+ DFG+A + V+ VGT YM PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 524 ------YAMEGLYSKKSDVFSFGVLLIEIITGR 550
+ S KSDV+S G +L + G+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-39
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 27/213 (12%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNL--VKL 410
+G GG V++ + + A+K L Q + NE+ + KLQ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ + +V E N L++ L +K+ + +R + + + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGTYGYMAPE----- 523
IVH DLK +N L+ D K+ DFG+A + V+ VG YM PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 524 ------YAMEGLYSKKSDVFSFGVLLIEIITGR 550
+ S KSDV+S G +L + G+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 62/270 (22%), Positives = 95/270 (35%), Gaps = 37/270 (13%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKL-QH 404
+F + LG G +G V+K DG+ AVK + A EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAK 459
V+L +G L E SL G W +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVW----GYLRDTLL 168
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
+ +LH +VH D+K +N+ L K+ DFG+ + G G Y
Sbjct: 169 ALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQ--EGDPRY 222
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579
MAPE ++G Y +DVFS G+ ++E+ L + W + L
Sbjct: 223 MAPE-LLQGSYGTAADVFSLGLTILEVACNME-------LPHGGEGWQQLRQGYLPPEFT 274
Query: 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPT 609
S E + ++ ++ D R T
Sbjct: 275 AGLS---SELRSVL---VMMLEPDPKLRAT 298
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-38
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 37/231 (16%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
S+F + +LGQG FG V K D + A+K++ +E+ + +EV+L+ L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 407 LVKLLGFCVDGDEKL-------------LVYEFMPNGSL-DAILFDPRKRGILCWRKRT- 451
+V+ ++ + + E+ NG+L D I + R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
+ I + + Y+H I+HRDLK N+ +D N KI DFG+A+ S
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 512 RI------------VGTYGYMAPE-YAMEGLYSKKSDVFSFGVLLIEIITG 549
+GT Y+A E G Y++K D++S G++ E+I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGF 413
ILGQG V++G G A+K ++ S + E ++ KL HKN+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 414 CVDGDEKL--LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
+ + L+ EF P GSL +L +P L + ++ + GM +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 472 IVHRDLKASNVLL----DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE---- 523
IVHR++K N++ D K++DFG AR + E + + + GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYER 189
Query: 524 ----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
+ Y D++S GV TG
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKN 406
++F LG+GGFG V++ D A+KR+ E + EV + KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 407 LVKLLGFCVDGDE---------KLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
+V+ ++ + K+ +Y + +L + +I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-- 512
IA+ + +LH ++HRDLK SN+ D K+ DFG+ + E E +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 513 --------IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
VGT YM+PE YS K D+FS G++L E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-37
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV-LLILKLQHKNLV 408
+F ++LG G G + + D ++VAVKR+ + + EV LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ D + + E +L + +K + ++ G+ +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 469 RLRIVHRDLKASNVLL-----DSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYMAP 522
L IVHRDLK N+L+ + + ISDFG+ + A + + GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 523 EY---AMEGLYSKKSDVFSFGVLLIEIITG 549
E + + D+FS G + +I+
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 55/203 (27%), Positives = 107/203 (52%), Gaps = 10/203 (4%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
++ +GQG G VY + ++ G+EVA+++++ + NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+V L + GDE +V E++ GSL ++ + + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
+ +++HRD+K+ N+LL D + K++DFG + + +T+ VGT +MAPE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVT 189
Query: 527 EGLYSKKSDVFSFGVLLIEIITG 549
Y K D++S G++ IE+I G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG 212
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGF 413
ILGQG V++G G A+K ++ S + E ++ KL HKN+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 414 CVDGDEKL--LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
+ + L+ EF P GSL +L +P L + ++ + GM +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 472 IVHRDLKASNVLL----DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE---- 523
IVHR++K N++ D K++DFG AR + E + ++ GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSL--YGTEEYLHPDMYER 189
Query: 524 ----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
+ Y D++S GV TG
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 10/203 (4%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
+G+G G V G++VAVK + +Q NEV+++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+V++ + G+E ++ EF+ G+L I+ + L + + + + + YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
++HRD+K+ ++LL D K+SDFG ++ + ++ VGT +MAPE
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVIS 214
Query: 527 EGLYSKKSDVFSFGVLLIEIITG 549
LY+ + D++S G+++IE++ G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 64/228 (28%), Positives = 112/228 (49%), Gaps = 10/228 (4%)
Query: 323 QHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL 381
+ VQ R+ + + F LG+G +G VYK + G+ VA+K++
Sbjct: 3 ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62
Query: 382 SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK 441
E E E+ ++ + ++VK G + +V E+ GS+ I+ +
Sbjct: 63 PV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLR 118
Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
L + I+ KG+ YLH R +HRD+KA N+LL+++ ++K++DFG+A
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
++ + NTV +GT +MAPE E Y+ +D++S G+ IE+ G
Sbjct: 176 TDTMAKRNTV--IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHK 405
F+ +G+G FG V+KG+ K VA+K + +E + E+ ++ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ K G + + ++ E++ GS +L + G L + I+ I KG+ YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH 136
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
+ + +HRD+KA+NVLL K++DFG+A +++ + NT VGT +MAPE
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVI 191
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
+ Y K+D++S G+ IE+ G
Sbjct: 192 KQSAYDSKADIWSLGITAIELARG 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 60/287 (20%), Positives = 103/287 (35%), Gaps = 48/287 (16%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKL-Q 403
T+ F + +G G FG V+K V DG A+KR EV L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGML 462
H ++V+ + D L+ E+ GSL DAI + R + +++ + +G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSD-------------------MNSKISDFGMARIFAE 503
Y+H +VH D+K SN+ + + KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182
Query: 504 SEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYA 562
G ++A E E + K+D+F+ + ++ +
Sbjct: 183 RISSPQVE--EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236
Query: 563 WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT 609
WH +G + P + S EF+ + + + D RP+
Sbjct: 237 WHEIRQGRL-----PRIPQ-VLS-QEFTELLK---VMIHPDPERRPS 273
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 5e-35
Identities = 64/207 (30%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL-- 411
LG GGFG V + + G++VA+K+ E + E+ ++ KL H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 412 ----GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
D LL E+ G L L L +++ I+ + YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 468 SRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
RI+HRDLK N++L KI D G A+ + E VGT Y+APE
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEF--VGTLQYLAPEL 194
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGRR 551
+ Y+ D +SFG L E ITG R
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-34
Identities = 72/243 (29%), Positives = 106/243 (43%), Gaps = 23/243 (9%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLET-LNLATSNFSD----SNILGQGGFGPVYKGV-LSDGK 374
H+ H GR+N D + + S+ LG G +G V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 375 EVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
E A+K + +S S ++ EV ++ L H N++KL F D LV E G L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 433 -DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DM 488
D I+ R I+ + G+ YLH+ IVHRDLK N+LL+S D
Sbjct: 124 FDEII----HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDA 176
Query: 489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
KI DFG++ +F + +GT Y+APE + Y +K DV+S GV+L ++
Sbjct: 177 LIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232
Query: 549 GRR 551
G
Sbjct: 233 GYP 235
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G+G F V + + G++ AVK + +S T + E + L+H ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
LL +V+EFM L I+ + ++ + I + + Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 469 RLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
I+HRD+K VLL S NS K+ FG+A ES A VGT +MAPE
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVV 205
Query: 526 MEGLYSKKSDVFSFGVLL 543
Y K DV+ GV+L
Sbjct: 206 KREPYGKPVDVWGCGVIL 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 71/284 (25%), Positives = 121/284 (42%), Gaps = 41/284 (14%)
Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLIL 400
++ + + LG+G +G V K + G+ +AVKR+ ++ + Q ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 401 KL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG------ILCWRKRTNI 453
+ V G + + E M + SLD +G IL I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KI 114
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
I K + +LH S+L ++HRD+K SNVL+++ K+ DFG++ + +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDID-- 169
Query: 514 VGTYGYMAPE----YAMEGLYSKKSDVFSFGVLLIEIITGR----RNAGSNQLLAYAWHL 565
G YMAPE + YS KSD++S G+ +IE+ R Q L
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ---- 225
Query: 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT 609
V+E P L FS EF + C+++++ +RPT
Sbjct: 226 -----VVEEPSPQLPADKFS-AEFVDFTS---QCLKKNSKERPT 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 49/291 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLI 399
+ + + D +G+G +G V K V G+ +AVKR+ S+ E+ + ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 400 LKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN------ 452
++ +V+ G + + E M + S D K
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGK 129
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
I K + +L E+ L+I+HRD+K SN+LLD N K+ DFG++ +S +
Sbjct: 130 ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-- 185
Query: 513 IVGTYGYMAPE----YAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE 568
G YMAPE A Y +SDV+S G+ L E+ TGR + + WN
Sbjct: 186 -AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR----------FPYPKWN- 233
Query: 569 GNVLELVD-------PLLTDTS---FSDDEFSRYIHIGLLCVQEDAFDRPT 609
+V + + P L+++ FS F +++ LC+ +D RP
Sbjct: 234 -SVFDQLTQVVKGDPPQLSNSEEREFS-PSFINFVN---LCLTKDESKRPK 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+ LG G FG VYK G A K + + SE+ ++ E+ ++ H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
LLG + ++ EF P G++DAI+ L + + + + + +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHSK-- 136
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-----Y 524
RI+HRDLKA NVL+ + + +++DFG++ ++ + ++ +GT +MAPE
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF--IGTPYWMAPEVVMCET 193
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
+ Y K+D++S G+ LIE+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 35/232 (15%)
Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK 401
+ + ++ LG+GGF V L DG A+KR+ +Q E E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 402 LQHKNLVKLLGFCVD----GDEKLLVYEFMPNGSLDAILFDPRKRG-------ILCWRKR 450
H N+++L+ +C+ E L+ F G+L + + +G IL
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL----- 137
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-------AE 503
++ GI +G+ +H HRDLK +N+LL + + D G +
Sbjct: 138 -WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSK-----KSDVFSFGVLLIEIITGR 550
+ + T Y APE + + S ++DV+S G +L ++ G
Sbjct: 194 ALTLQDWAAQRCTISYRAPE--LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 13/216 (6%)
Query: 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLS-SCSEQGTAEFTNE 395
+ L +F + LG G G V+K G +A K + + E
Sbjct: 22 TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 81
Query: 396 VLLILK-LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
L +L +V G E + E M GSLD +L + K +
Sbjct: 82 -LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 137
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
+ KG+ YL E +I+HRD+K SN+L++S K+ DFG++ +S AN+ V
Sbjct: 138 IAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF--V 191
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
GT YM+PE YS +SD++S G+ L+E+ GR
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 6e-34
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLIL 400
++ FSD LG+G F V + V + G E A K + S + + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
KLQH N+V+L + LV++ + G L + I+ R ++ + I +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILE 116
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGT 516
+ Y H IVHR+LK N+LL S K++DFG+A +SE + GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHG--FAGT 170
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLL 543
GY++PE + YSK D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 347 ATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLS--------SCSEQGTAEFT 393
A F +++G+G V + V + G E AVK + E+
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 394 NEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRT 451
E ++ ++ H +++ L+ LV++ M G L D + ++ L ++
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETR 203
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
+I+ + + + +LH IVHRDLK N+LLD +M ++SDFG + E +
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRE- 258
Query: 512 RIVGTYGYMAPE------YAMEGLYSKKSDVFSFGVLL 543
+ GT GY+APE Y K+ D+++ GV+L
Sbjct: 259 -LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 347 ATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLS---------SCSEQGTAEF 392
+T F + ILG+G V + + KE AVK + ++
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 393 TNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKR 450
EV ++ K+ H N+++L LV++ M G L D + ++ L ++
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKET 126
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I+ + + + LH+ L IVHRDLK N+LLD DMN K++DFG + E +
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLRE 182
Query: 511 VRIVGTYGYMAPE------YAMEGLYSKKSDVFSFGVLL 543
+ GT Y+APE Y K+ D++S GV++
Sbjct: 183 --VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 69/207 (33%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLIL 400
F++ +LG+G FG V K +E AVK + +S + T+ EV L+
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
KL H N++KL D +V E G L D I+ KR I+ +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFS 132
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGT 516
G+ Y+H+ IVHRDLK N+LL+S D + KI DFG++ F ++ +GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGT 186
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLL 543
Y+APE + G Y +K DV+S GV+L
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-33
Identities = 75/238 (31%), Positives = 112/238 (47%), Gaps = 28/238 (11%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
H+ H GR+N F ++ +LG+G FG V K +E AVK
Sbjct: 4 HHHHSSGRENLYFQGTF----------AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK 53
Query: 380 RL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAIL 436
+ +S + T+ EV L+ KL H N++KL D +V E G L D I+
Sbjct: 54 VINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII 113
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKIS 493
KR I+ + G+ Y+H+ IVHRDLK N+LL+S D + KI
Sbjct: 114 ----KRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKII 166
Query: 494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
DFG++ F ++ +GT Y+APE + G Y +K DV+S GV+L +++G
Sbjct: 167 DFGLSTCFQQNT---KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 34/222 (15%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV-LLILKLQHKNLVKLLGF 413
ILG G G V G+ VAVKR+ E+ LL H N+++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCS 77
Query: 414 CVDGDEKLLVYEFMPNGSL-DAIL---FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
+ E N +L D + + +++ IA G+ +LH
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 470 LRIVHRDLKASNVLLDS-------------DMNSKISDFGMARIFAESEGEANTVR--IV 514
L+I+HRDLK N+L+ + ++ ISDFG+ + + T
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 515 GTYGYMAPE-------YAMEGLYSKKSDVFSFGVLLIEIITG 549
GT G+ APE + ++ D+FS G + I++
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 345 NLATSNFSDS----NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLI 399
++ T+N + +LG G F V+ GK A+K + + NE+ ++
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIA 458
K++H+N+V L LV + + G L D IL +RG+ + + ++ +
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQVL 116
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAESEGEANTVRIVG 515
+ YLHE IVHRDLK N+L + + NS I+DFG++++ G +T G
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMST--ACG 169
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
T GY+APE + YSK D +S GV+
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 342 ETLNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV 396
+ L+ + F+D +G G + + + + E AVK + T E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EEI 66
Query: 397 LLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIV 454
++L+ QH N++ L DG +V E M G L D IL ++ R+ + ++
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVL 122
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS----KISDFGMARIFAESEGEANT 510
I K + YLH +VHRDLK SN+L + + +I DFG A+ G T
Sbjct: 123 FTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
T ++APE Y D++S GVLL
Sbjct: 180 P--CYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-33
Identities = 68/254 (26%), Positives = 107/254 (42%), Gaps = 34/254 (13%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLET-LNLATSNFSD----SNILGQGGFGPVYKGV-LSDGK 374
H+ H +L Q I+ + + LG G +G V +
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHS 62
Query: 375 EVAVKRLS-------------SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421
E A+K + E+ E NE+ L+ L H N++KL D
Sbjct: 63 EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122
Query: 422 LVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480
LV EF G L + I+ R NI+ I G+ YLH+ IVHRD+K
Sbjct: 123 LVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPE 175
Query: 481 NVLLDS-DMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVF 537
N+LL++ + KI DFG++ F++ +GT Y+APE ++ Y++K DV+
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE-VLKKKYNEKCDVW 231
Query: 538 SFGVLLIEIITGRR 551
S GV++ ++ G
Sbjct: 232 SCGVIMYILLCGYP 245
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 23/229 (10%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
H+ H GR+N F LG G FG V+ S G E +K
Sbjct: 4 HHHHSSGRENLYFQGTI----------DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK 53
Query: 380 RLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILF 437
++ S+ + E+ ++ L H N++K+ D +V E G L + I+
Sbjct: 54 TINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVS 113
Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISD 494
+ L ++ + + Y H +VH+DLK N+L KI D
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
FG+A +F E + GT YMAPE + + K D++S GV++
Sbjct: 171 FGLAELFKSDE-HSTN--AAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 25/211 (11%)
Query: 346 LATSNFSD-------SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVL 397
+ S F LG+G F K V + AVK +S E T E+
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEIT 57
Query: 398 LILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
+ + H N+VKL D LV E + G L + I K+ + + I+
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMR 113
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVR 512
+ + ++H+ + +VHRDLK N+L + ++ KI DFG AR+ T
Sbjct: 114 KLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-- 168
Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
T Y APE + Y + D++S GV+L
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-33
Identities = 73/219 (33%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 344 LNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNE 395
+ +T+ FSD +LG+G FG V G+E AVK +S + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIV 454
V L+ +L H N++KL F D LV E G L D I+ R I+
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARII 132
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTV 511
+ G+ Y+H+ +IVHRDLK N+LL+S D N +I DFG++ F S+
Sbjct: 133 RQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMK 186
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
+GT Y+APE + G Y +K DV+S GV+L +++G
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 20/224 (8%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVL 397
IDL L F ++G G +G VYKG + G+ A+K + + E E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEIN 72
Query: 398 LILKL-QHKNLVKLLG-----FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKR 450
++ K H+N+ G D++L LV EF GS+ ++ K L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWI 131
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I I +G+ +LH+ +++HRD+K NVLL + K+ DFG++ + G NT
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 511 VRIVGTYGYMAPE-----YAMEGLYSKKSDVFSFGVLLIEIITG 549
+GT +MAPE + Y KSD++S G+ IE+ G
Sbjct: 189 F--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 16/223 (7%)
Query: 340 DLETLNLATSNFSDSNILGQG--GFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTN 394
+ + + ++G+G V G+ V V+R L +CS +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
E+ + H N+V + +E +V FM GS ++ + I+
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYIL 134
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI- 513
G+ K + Y+H VHR +KAS++L+ D +S V
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 514 ----VGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGR 550
V +++PE + L Y KSD++S G+ E+ G
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 14/213 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKN 406
++ ++G G V ++VA+KR++ + E E+ + + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT-----NIVNGIAKGM 461
+V V DE LV + + GS+ I+ +G I+ + +G+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVR--IVGTYG 518
YLH++ +HRD+KA N+LL D + +I+DFG+ A + + N VR VGT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 519 YMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
+MAPE + Y K+D++SFG+ IE+ TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 342 ETLNLATSNFSDS----NILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTN 394
E + A++ FSD+ LG+G F V + V + G E A K + S + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNI 453
E + KLQH N+V+L + LV++ + G L + I+ R ++
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHC 133
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANT 510
+ I + + Y H IVHR+LK N+LL S K++DFG+A +SE
Sbjct: 134 IQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AW 187
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
GT GY++PE + YSK D+++ GV+L
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
LG+GGF ++ + A K + S + E + E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
F D D +V E SL + ++R L + + I G YLH R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 162
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
+HRDLK N+ L+ D+ KI DFG+A + GT Y+APE + +S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220
Query: 533 KSDVFSFGVLLIEIITGR 550
+ DV+S G ++ ++ G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
LG+GGF ++ + A K + S + E + E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
F D D +V E SL + ++R L + + I G YLH R R+
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 136
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
+HRDLK N+ L+ D+ KI DFG+A + GT Y+APE + +S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194
Query: 533 KSDVFSFGVLLIEIITGR 550
+ DV+S G ++ ++ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
LG GG VY +VA+K + E+ F EV +L H+N+V ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
+ D LV E++ +L + G L N N I G+ + H +RI
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
VHRD+K N+L+DS+ KI DFG+A+ +E+ T ++GT Y +PE A +
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 533 KSDVFSFGVLLIEIITGRR 551
+D++S G++L E++ G
Sbjct: 192 CTDIYSIGIVLYEMLVGEP 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 28/217 (12%)
Query: 348 TSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK 401
+ F D ++LG+G V + L +E AVK + + EV ++ +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 402 LQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
Q H+N+++L+ F + D LV+E M GS+ I KR + + +V +A
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVAS 122
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVR---- 512
+ +LH I HRDLK N+L + KI DF + + +
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 513 -IVGTYGYMAPE-----YAMEGLYSKKSDVFSFGVLL 543
G+ YMAPE +Y K+ D++S GV+L
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-32
Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 37/248 (14%)
Query: 312 IGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-L 370
+ + + F + + D + + + S LG G G V
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKAL----------RDEYIMSKTLGSGACGEVKLAFER 157
Query: 371 SDGKEVAVKRLS--------SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422
K+VA++ +S + E+ ++ KL H ++K+ F D ++ +
Sbjct: 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYI 216
Query: 423 VYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481
V E M G L D ++ L + + YLHE I+HRDLK N
Sbjct: 217 VLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPEN 269
Query: 482 VLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE---YAMEGLYSKKSD 535
VLL S D KI+DFG ++I E+ T+ GT Y+APE Y++ D
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETS-LMRTL--CGTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 536 VFSFGVLL 543
+S GV+L
Sbjct: 327 CWSLGVIL 334
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 348 TSNFSDS----NILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLIL 400
+ F++ LG+G F V + V + G+E A + S + + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
L+H N+V+L + L+++ + G L + I+ R ++ + I +
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILE 121
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGT 516
+L+ H+ + +VHR+LK N+LL S K++DFG+A E E +A GT
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWF-GFAGT 176
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLL 543
GY++PE + Y K D+++ GV+L
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT---NEVLLILKLQ 403
FSD +G G FG VY + + + VA+K++S +Q ++ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
H N ++ G + LV E+ + D + L + + +G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAY 169
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
LH ++HRD+KA N+LL K+ DFG A AN+ VGT +MAPE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANSF--VGTPYWMAPE 220
Query: 524 ---YAMEGLYSKKSDVFSFGVLLIEIITG 549
EG Y K DV+S G+ IE+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 43/299 (14%)
Query: 329 DNDLKAQDF-FIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCS 385
+ K + I + ++ + +G G G V+K G +AVK++ S +
Sbjct: 4 GSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63
Query: 386 EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-- 442
++ ++ ++LK +V+ G + + + E M + + +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP 122
Query: 443 -GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
IL + I K + YL E ++HRD+K SN+LLD K+ DFG++
Sbjct: 123 ERILG-----KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 502 AESEGEANTVRIVGTYGYMAPE-----YAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
+ + + + G YMAPE + Y ++DV+S G+ L+E+ TG+
Sbjct: 176 VDDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ------ 226
Query: 557 QLLAYA-WHLWNEGNVLELV---DP--LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT 609
Y + VL V +P L FS +F ++ C+ +D RP
Sbjct: 227 --FPYKNCK--TDFEVLTKVLQEEPPLLPGHMGFS-GDFQSFVK---DCLTKDHRKRPK 277
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL 402
+ + N +G+G +G V V A K++ + F E+ ++ L
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
H N+++L D + LV E G L + ++ + + I+ + +
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAV 119
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
Y H+ L + HRDLK N L + D K+ DFG+A F + T VGT
Sbjct: 120 AYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRT--KVGTPY 173
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLL 543
Y++P+ +EGLY + D +S GV++
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 53/229 (23%), Positives = 94/229 (41%), Gaps = 17/229 (7%)
Query: 323 QHVQGRDNDLKAQDFFIDLETLNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVA 377
+ D + + + + + D LG G FG V++ V + G+
Sbjct: 21 PKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFV 80
Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAIL 436
K +++ NE+ ++ +L H L+ L D E +L+ EF+ G L D I
Sbjct: 81 AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--KISD 494
+ + + N + +G+ ++HE IVH D+K N++ ++ S KI D
Sbjct: 141 ---AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIID 194
Query: 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
FG+A + E V T + APE +D+++ GVL
Sbjct: 195 FGLATKL--NPDEIVKV-TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 349 SNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAE-FTNEVL 397
S D LG G F V K GKE A K RLSS + E EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNG 456
++ +++H N++ L + + +L+ E + G L D + ++ L + T +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA----EKESLTEDEATQFLKQ 116
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTVR 512
I G+ YLH RI H DLK N++L + K+ DFG+A G
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKN- 170
Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
I GT ++APE ++D++S GV+
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
LG+G F VY+ + G EVA+K + + + G + NEV + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDP--RKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ D + LV E NG + + + + ++ I GMLYLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
I+HRDL SN+LL +MN KI+DFG+A + T + GT Y++PE A +
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAH 189
Query: 531 SKKSDVFSFGVLLIEIITGR 550
+SDV+S G + ++ GR
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK----RLSSCSEQGT--AEFTNEV 396
D LG G F V K S G E A K R S S +G E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
++ ++ H N++ L + + +L+ E + G L D + ++ L + T+ +
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIK 122
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTV 511
I G+ YLH +I H DLK N++L + K+ DFG+A +G
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN 177
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
I GT ++APE ++D++S GV+
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 31/238 (13%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSD-----SNILGQGGFGPVYKGV-LSDGK 374
H+ H DL ++ + + NF++ S LG+G F V + + S G+
Sbjct: 2 HHHHHHSSGVDLGTENLYFQ------SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQ 55
Query: 375 EVAVK--RLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYEFMPNGS 431
E A K + + AE +E+ ++ + ++ L + E +L+ E+ G
Sbjct: 56 EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115
Query: 432 LDAILFD---PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---D 485
+ F P ++ ++ I +G+ YLH+ IVH DLK N+LL
Sbjct: 116 I----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIY 168
Query: 486 SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
+ KI DFGM+R I+GT Y+APE + +D+++ G++
Sbjct: 169 PLGDIKIVDFGMSRKI--GHACELRE-IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 39/222 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEVLL--------------IL 400
L QG F + D K A+K+ S ++ +N + I+
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 401 K-LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
++++ + G + DE ++YE+M N S+ +L I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNYTCFIPIQVI 153
Query: 459 K--------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
K Y+H + I HRD+K SN+L+D + K+SDFG + + +
Sbjct: 154 KCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG 209
Query: 511 VRIVGTYGYMAPE-YAMEGLYS-KKSDVFSFGVLLIEIITGR 550
GTY +M PE ++ E Y+ K D++S G+ L +
Sbjct: 210 --SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 44/191 (23%), Positives = 85/191 (44%), Gaps = 14/191 (7%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
LG+G FG V++ V S K K + E+ ++ +H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 416 DGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+E ++++EF+ + + I L R+ + V+ + + + +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 475 RDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
D++ N++ + +S KI +FG AR G+ + + Y APE + S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRL-LFTAPEYYAPEVHQHDVVST 182
Query: 533 KSDVFSFGVLL 543
+D++S G L+
Sbjct: 183 ATDMWSLGTLV 193
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK----RLSSCSEQGT--AEFTNEV 396
D LG G F V K S G E A K R S S +G E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
++ ++ H N++ L + + +L+ E + G L D + ++ L + T+ +
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIK 122
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTV 511
I G+ YLH +I H DLK N++L + K+ DFG+A +G
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN 177
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
I GT ++APE ++D++S GV+
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 17/210 (8%)
Query: 342 ETLNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV 396
+ + + + D LG G FG V++ + G A K + + E E+
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI 205
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
+ L+H LV L D +E +++YEFM G L + + + + + +
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMR 262
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRI 513
+ KG+ ++HE VH DLK N++ + ++ K+ DFG+ ++ V
Sbjct: 263 QVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKV-T 316
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
GT + APE A +D++S GVL
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK----RLSSCSEQGT--AEFTNEV 396
N D LG G F V K S G + A K R + S +G + EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
++ ++QH N++ L + + +L+ E + G L D + ++ L + T +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLK 121
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTV 511
I G+ YLH L+I H DLK N++L KI DFG+A G
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
I GT ++APE ++D++S GV+
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 33/213 (15%)
Query: 348 TSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK 401
+D +LG G G V + G++ A+K L + EV +
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ 77
Query: 402 LQ-HKNLVKLLGFCVDGDEK----LLVYEFMPNGSL-DAILFDPRKRGILCW--RKRTNI 453
++V +L + L++ E M G L I +RG + R+ I
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEI 133
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAESEGEANT 510
+ I + +LH I HRD+K N+L S + ++ K++DFG A+ ++ T
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQT 188
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
T Y+APE Y K D++S GV++
Sbjct: 189 --PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
S + ILG G FG V+K + G ++A K + + + E NE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
+L ++ +LV E++ G L D I+ + L + I +G+ ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 468 SRLRIVHRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
+ I+H DLK N+L + KI DFG+AR + E V GT ++APE
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKV-NFGTPEFLAPEVV 260
Query: 526 MEGLYSKKSDVFSFGVLL 543
S +D++S GV+
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 69/316 (21%), Positives = 118/316 (37%), Gaps = 48/316 (15%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFC 414
L +GGF VY+ + G+E A+KRL S E+ EV + KL H N+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 415 V-------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G + L+ + G L L RG L I + + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----------VGTY 517
+ I+HRDLK N+LL + K+ DFG A + + + + T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 518 GYMAPEYAMEGLYSK-----KSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVL 572
Y PE + LYS K D+++ G +L + + H + +G L
Sbjct: 215 MYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQ-------------HPFEDGAKL 259
Query: 573 ELVD---PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLP-QPQ 628
+V+ + + F I +Q + +R +++ V L+ P+
Sbjct: 260 RIVNGKYSIPPHDTQYTV-FHSLIRA---MLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315
Query: 629 KPAFSIGRVTDGHCNN 644
P + G+ +
Sbjct: 316 SPITELLEQNGGYGSA 331
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 27/204 (13%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS--------SCSEQGTAEFTNEVLLILKLQHKN 406
LG G G V K+VA+K +S + E+ ++ KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
++K+ F D ++ +V E M G L D ++ L + + YLH
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 466 EDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
E I+HRDLK NVLL S D KI+DFG ++I E+ T+ GT Y+AP
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTL--CGTPTYLAP 185
Query: 523 E---YAMEGLYSKKSDVFSFGVLL 543
E Y++ D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 55/243 (22%), Positives = 83/243 (34%), Gaps = 52/243 (21%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
+GQG +G V + A+K ++ + + EV L+ KL H N+ +L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 411 LGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRT------------------ 451
D LV E G L D + C
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 452 ------------------NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--K 491
NI+ I + YLH I HRD+K N L ++ + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 492 ISDFGMARIFAESEGEANTVR--IVGTYGYMAPE--YAMEGLYSKKSDVFSFGVLLIEII 547
+ DFG+++ F + GT ++APE Y K D +S GVLL ++
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 548 TGR 550
G
Sbjct: 271 MGA 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 31/303 (10%), Positives = 61/303 (20%), Gaps = 66/303 (21%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
L G V+ + ++ A+K + S +L ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 412 GFC--------------------------VDGDEKLLVYEFMPNGSL----DAILFDPRK 441
LL+ + L + F
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
RG + + + L +VH N+ + D + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-- 242
Query: 502 AESEGEANTVRIVGTYGYMAPEYAM--EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL 559
G Y E+ ++ + + G+ + +
Sbjct: 243 --KVGTRGPA-SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF--------- 290
Query: 560 AYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHI---------GLLCVQEDAFDRPTM 610
+ L G P L F + L D R
Sbjct: 291 -LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF--DRRRRLLP 347
Query: 611 SSV 613
Sbjct: 348 LEA 350
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G+GG G VY+ + VA+K +S S E +LQ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
F + + + L A+L R++G L + IV I + H
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
HRD+K N+L+ +D + + DFG+A + VGT YMAPE E +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESHATY 214
Query: 533 KSDVFSFGVLLIEIITGRR 551
++D+++ +L E +TG
Sbjct: 215 RADIYALTCVLYECLTGSP 233
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
LG+G FG VY +A+K L + + G EV + L+H N+++L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
+ D L+ E+ P G++ L +K ++ + +A + Y H R+
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SKRV 130
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMAPEYAMEGLYS 531
+HRD+K N+LL S KI+DFG + + + GT Y+ PE ++
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTD--LCGTLDYLPPEMIEGRMHD 185
Query: 532 KKSDVFSFGVLLIEIITGR 550
+K D++S GVL E + G+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 59/193 (30%), Positives = 88/193 (45%), Gaps = 17/193 (8%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG+G VY+ K A+K L ++ E+ ++L+L H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 415 VDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
E LV E + G L D I+ ++G R + V I + + YLHE IV
Sbjct: 118 ETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE---NGIV 170
Query: 474 HRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
HRDLK N+L D KI+DFG+++I + GT GY APE Y
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAY 227
Query: 531 SKKSDVFSFGVLL 543
+ D++S G++
Sbjct: 228 GPEVDMWSVGIIT 240
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 32/218 (14%)
Query: 343 TLNLATSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV 396
L + + D S +LG G G V + ++ A+K L C + EV
Sbjct: 51 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREV 105
Query: 397 LLILKLQ-HKNLVKLLGFCVDGDEK----LLVYEFMPNGSL-DAILFDPRKRGILCW--R 448
L + ++V+++ + L+V E + G L I RG + R
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTER 161
Query: 449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAESE 505
+ + I+ I + + YLH + I HRD+K N+L S N+ K++DFG A+ S
Sbjct: 162 EASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSH 217
Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
T T Y+APE Y K D++S GV++
Sbjct: 218 NSLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 60/232 (25%), Positives = 95/232 (40%), Gaps = 53/232 (22%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS-----------------SCSEQGTAEFTNEVLL 398
+G+G +G V +D A+K LS +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 399 --------ILK-LQHKNLVKLLGFCV---DGDEKL-LVYEFMPNGSLDAILFDPRKRGIL 445
ILK L H N+VKL V ++ L +V+E + G + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPL 134
Query: 446 ----CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+++ GI YLH +I+HRD+K SN+L+ D + KI+DFG++ F
Sbjct: 135 SEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 502 AESEGEANTVRIVGTYGYMAPE--YAMEGLYS-KKSDVFSFGVLLIEIITGR 550
S+ + VGT +MAPE ++S K DV++ GV L + G+
Sbjct: 188 KGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVKLL- 411
LG GG V+ L D ++VAVK L + F E L H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 412 -GFCVDGDEKLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G + L Y E++ +L I+ G + ++ ++ + + + H
Sbjct: 80 TG-EAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMAPEYAM 526
+ I+HRD+K +N+++ + K+ DFG+AR A+S T ++GT Y++PE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR 551
+SDV+S G +L E++TG
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-29
Identities = 45/328 (13%), Positives = 86/328 (26%), Gaps = 76/328 (23%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQ-------- 403
+LGQ + G+ V + + EVL + L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 404 --------------HKNLVKLLGFCVDGDEKLLVYEFM----PNGSL----DAILFDPRK 441
K++ +D + ++ F +L + +L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
L R + + + + LH +VH L+ +++LD ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 502 AESEGEANTVRIVGTYGYMAPEY----------AMEGLYSKKSDVFSFGVLLIEIITGRR 551
+G + G+ PE L + D ++ G+ + I
Sbjct: 260 --RDGASAVSP--IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 552 -NAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQ-------ED 603
N L W + N+ + V LL G L
Sbjct: 316 PNTDDAALGGSEWIFRSCKNIPQPVRALLE---------------GFLRYPKEDRLLPLQ 360
Query: 604 AFDRPTMSSVAPMLKGETGTLPQPQKPA 631
A + P + L +P
Sbjct: 361 AMETPEYEQLRTELSAALPLYQTDGEPT 388
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 40/203 (19%), Positives = 75/203 (36%), Gaps = 24/203 (11%)
Query: 357 LGQGGFGPVYKGV--LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGF 413
+ GG G +Y + +G+ V +K L + E + ++ H ++V++ F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 414 CVDGDEKL-----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
D +V E++ SL L + + I + YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH--- 199
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
+ +V+ DLK N++L + K+ D G + GT G+ APE
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV-RT 251
Query: 529 LYSKKSDVFSFGVLLIEIITGRR 551
+ +D+++ G L +
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLP 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 31/231 (13%), Positives = 66/231 (28%), Gaps = 28/231 (12%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQGTAEFTNE 395
L + ++LG+G F VY+ D ++ +K + T
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN--- 452
+ + +K + + +LV E G+L + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI---NLYKNTPEKVMPQGLV 174
Query: 453 --IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-----------KISDFGMAR 499
+ + +H+ I+H D+K N +L + + D G +
Sbjct: 175 ISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
T G+ E ++ + D F + ++ G
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 7e-28
Identities = 40/304 (13%), Positives = 77/304 (25%), Gaps = 72/304 (23%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE----------------------- 391
+LGQ + G+ V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 392 -----FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM-PNGSL----DAILFDPRK 441
F L+ Q K ++++ D + + +L + +L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
L R + + + + LH +VH L+ +++LD ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE----H 252
Query: 502 AESEGEANTVRIVGTYGYMAPEY-----------AMEGLYSKKSDVFSFGVLLIEIITGR 550
+G + G+ PE L + D ++ G+++ I
Sbjct: 253 LVRDGARVVS--SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 551 R-NAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT 609
L W + N+ + V LL G L DR
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLE---------------GFLRY--PKEDRLL 353
Query: 610 MSSV 613
Sbjct: 354 PLQA 357
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN-EVLLILKLQHKN 406
+++ ++G G FG V++ L + EVA+K++ F N E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPN 93
Query: 407 LVKLLGF-----CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---- 456
+V L F + L LV E++P ++ R + K +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TV--------YRASRHYAKLKQTMPMLLIK 144
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANT 510
+ + + Y+H + I HRD+K N+LLD K+ DFG A+I GE N
Sbjct: 145 LYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNV 199
Query: 511 VRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGR 550
I Y Y APE + G Y+ D++S G ++ E++ G+
Sbjct: 200 SYICSRY-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 30/210 (14%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILKLQHK--NL 407
LG GGFG VY G+ +SD VA+K + E N EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGIL----CWRKRTNIVNGIAKGML 462
++LL + D +L+ E P D LFD +RG L ++ +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVR---- 163
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
+ H ++HRD+K N+L+D + K+ DFG + + GT Y
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSP 216
Query: 522 PEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
PE+ Y + + V+S G+LL +++ G
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 32/212 (15%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLL-----ILKL-----QHK 405
LG+GGFG V+ G L+D +VA+K + G + ++ V +L H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGIL----CWRKRTNIVNGIAKG 460
+++LL + + +LV E D LFD ++G L +V I
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQ-D--LFDYITEKGPLGEGPSRCFFGQVVAAIQ-- 153
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGY 519
+ H +VHRD+K N+L+D K+ DFG + + GT Y
Sbjct: 154 --HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDF--DGTRVY 204
Query: 520 MAPEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
PE+ Y + V+S G+LL +++ G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
LG+G FG VY + +A+K L S ++G E+ + L+H N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
+ D L+ EF P G L L +K G ++ + +A + Y H ++
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH---ERKV 135
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMAPEYAMEGLYS 531
+HRD+K N+L+ KI+DFG + + T + GT Y+ PE +
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRT--MCGTLDYLPPEMIEGKTHD 190
Query: 532 KKSDVFSFGVLLIEIITGR 550
+K D++ GVL E + G
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 28/209 (13%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--------RLSSCSEQGTAEFTNEVLLILKLQHKNL 407
LG G FG V+ V KEV VK + + T E+ ++ +++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-----PRKRGILCWRKRTNIVNGIAKGML 462
+K+L + LV E +G LD LF PR L +V+ +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQLVSAVG---- 144
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
YL I+HRD+K N+++ D K+ DFG A E T GT Y AP
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTF--CGTIEYCAP 198
Query: 523 EYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
E M Y + +++S GV L ++
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-26
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 41/223 (18%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTN-EVLLILKLQHK 405
+++D+ ++G G FG VY+ L D G+ VA+K++ F N E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107
Query: 406 NLVKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--- 456
N+V+L F EK LV +++P ++ R + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TV--------YRVARHYSRAKQTLPVIYV 158
Query: 457 ------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEAN 509
+ + + Y+H I HRD+K N+LLD D K+ DFG A+ GE N
Sbjct: 159 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPN 213
Query: 510 TVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGR 550
I Y Y APE + G Y+ DV+S G +L E++ G+
Sbjct: 214 VSYICSRY-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 8e-26
Identities = 58/267 (21%), Positives = 94/267 (35%), Gaps = 66/267 (24%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKN 406
++F +G+GGFG V++ D A+KR+ E + EV + KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 407 LVKLLGFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKR-----------T 451
+V+ ++ ++ + ++ + S D L P + R
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 452 NIVNGIAKGMLYLH-----------------------EDSRLRI---------------- 472
+ K LY+ L I
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV----------RIVGTYGYMAP 522
+HRDLK SN+ D K+ DFG+ + E E + VGT YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITG 549
E YS K D+FS G++L E++
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILK-LQHKNLVK 409
LG+G +G V V + VAVK R C E E I K L H+N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-----INKMLNHENVVK 69
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
G +G+ + L E+ G L FD + ++ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGEL----FD-----RIEPDIGMPEPDAQRFFHQLMAGVV- 119
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
YLH + I HRD+K N+LLD N KISDFG+A +F + E ++ GT Y
Sbjct: 120 ---YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 520 MAPEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
+APE + + DV+S G++L ++ G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 68/212 (32%), Positives = 110/212 (51%), Gaps = 16/212 (7%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKL 402
++S F LG G + VYKG+ + G VA+K + SE+G TA E+ L+ +L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKEL 60
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPN---GSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
+H+N+V+L ++ LV+EFM N +D+ RG+ + + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY-FQWQLLQ 119
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
G+ + HE+ +I+HRDLK N+L++ K+ DFG+AR F + +V T Y
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-TLWY 174
Query: 520 MAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
AP+ M YS D++S G +L E+ITG+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKN 406
+ +G+G +G VYK S G+ VA+KR+ +E T E+ L+ +L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 407 LVKLLGFCVDGDEKLLVYEFMPN---GSLDA--ILFDPRKRGILCWRKRTNIVNGIAKGM 461
+V L+ LV+EFM LD + I ++ + +G+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ--------LLRGV 132
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
+ H+ RI+HRDLK N+L++SD K++DFG+AR F + T +V T Y A
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYRA 187
Query: 522 PEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
P+ M YS D++S G + E+ITG+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILK-LQHKNLVK 409
LG+G +G V V + VAVK R C E E I K L H+N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-----INKMLNHENVVK 69
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
G +G+ + L E+ G L FD + ++ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGEL----FD-----RIEPDIGMPEPDAQRFFHQLMAGVV- 119
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
YLH + I HRD+K N+LLD N KISDFG+A +F + E ++ GT Y
Sbjct: 120 ---YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 520 MAPEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
+APE + + DV+S G++L ++ G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 37/218 (16%)
Query: 357 LGQGGFGPVYKGV---LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G +G VYK D K+ A+K++ +A E+ L+ +L+H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 86
Query: 414 CVD-GDEKL-LVYEFM-------------PNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
+ D K+ L++++ + + L ++ I
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ--------IL 138
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS----KISDFGMARIF-AESEGEANTVRI 513
G+ YLH + ++HRDLK +N+L+ + KI+D G AR+F + + A+ +
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 514 VGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
V T+ Y APE + Y+K D+++ G + E++T
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS----SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
LG+G +G V + + AVK L G A E+ L+ +L+HKN+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71
Query: 412 GFCVDGDE---KL-LVYEFMPNGSLDAILFDPRKRGIL----CWRKRTNIVNGIAKGMLY 463
V +E K+ +V E+ G + + D +++G+ Y
Sbjct: 72 -VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----Y 124
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV-GTYGYMAP 522
LH IVH+D+K N+LL + KIS G+A +T R G+ + P
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL-HPFAADDTCRTSQGSPAFQPP 180
Query: 523 EYAM-EGLYS-KKSDVFSFGVLLIEIITGR 550
E A +S K D++S GV L I TG
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 12/216 (5%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEV 396
LE + F D +LG+GGFG V+ + ++ A K+L+ +G E
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNI-V 454
++ K+ + +V L + + L LV M G + +++ + R
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
I G+ +LH+ I++RDLK NVLLD D N +ISD G+A + +
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YA 350
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
GT G+MAPE + Y D F+ GV L E+I R
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G F V + G+EVA+K + + + + EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81
Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFD-PRKRGIL----CWRKRTNIVNGIAKGMLYLHED 467
++ ++ L L+ E+ G + FD G + K IV+ + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH-- 131
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA-NTVRIVGTYGYMAPEYAM 526
+ RIVHRDLKA N+LLD+DMN KI+DFG + F + G + G Y APE
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAF--CGAPPYAAPELFQ 186
Query: 527 EGLYS-KKSDVFSFGVLLIEIITGR 550
Y + DV+S GV+L +++G
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 26/237 (10%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
H+ H G D + F +++ + + ++G+G +G V K G+ VA+K
Sbjct: 5 HHHHSSGVDLGTENLYF----QSME----KYENLGLVGEGSYGMVMKCRNKDTGRIVAIK 56
Query: 380 RLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN---GSLDA 434
+ + + E+ L+ +L+H+NLV LL C LV+EF+ + L+
Sbjct: 57 KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE- 115
Query: 435 ILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494
L ++ + I G+ + H I+HRD+K N+L+ K+ D
Sbjct: 116 -----LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCD 167
Query: 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
FG AR A + GE + T Y APE + + Y K DV++ G L+ E+ G
Sbjct: 168 FGFARTLA-APGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 43/227 (18%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKL---- 402
F + GQG FG V G G VA+K++ F N L I++
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76
Query: 403 QHKNLVKLL------GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
H N+V+L G D L +V E++P+ +L R + +R
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TL--------HRCCRNYYRRQVAPP 127
Query: 456 G---------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESE 505
+ + + LH S + + HRD+K NVL++ + K+ DFG A+ S
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SP 184
Query: 506 GEANTVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGR 550
E N I Y Y APE + G Y+ D++S G + E++ G
Sbjct: 185 SEPNVAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNL 407
+ +G+G +G VYK + G+ A+K++ E T E+ ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLD-AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
VKL +LV+E + D L D + G+ ++ + + G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKS-FLLQLLNGIAYCHD 118
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
R++HRDLK N+L++ + KI+DFG+AR F T IV T Y AP+ M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWYRAPDVLM 173
Query: 527 -EGLYSKKSDVFSFGVLLIEIITGR 550
YS D++S G + E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 350 NFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKLQHK 405
+ + LG+G + VYKG VA+K + E+G TA EV L+ L+H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHA 60
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPN---GSLD--AILFDPRKRGILCWRKRTNIVNGIAKG 460
N+V L LV+E++ LD + + + ++ + +G
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------LLRG 112
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
+ Y H +++HRDLK N+L++ K++DFG+AR + + +V T Y
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWYR 167
Query: 521 APEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
P+ + YS + D++ G + E+ TGR
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHK 405
S + +GQG FG V+K G++VA+K++ +E+ T E+ ++ L+H+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 406 NLVKLLGFCVDGDEKL--------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
N+V L+ C LV++F + L +L + + L K ++ +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK--RVMQML 133
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN---TVRIV 514
G+ Y+H + +I+HRD+KA+NVL+ D K++DFG+AR F+ ++ T R+V
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 515 GTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
T Y PE + E Y D++ G ++ E+ T
Sbjct: 191 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE---FTN--EVLLILKL 402
+ + LG+G F VYK + + VA+K++ + T E+ L+ +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 403 QHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGI 457
H N++ LL + LV++FM L+ I+ D I +
Sbjct: 70 SHPNIIGLLD-AFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM------T 121
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
+G+ YLH+ I+HRDLK +N+LLD + K++DFG+A+ F S A T ++V T
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TR 176
Query: 518 GYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
Y APE +Y D+++ G +L E++
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKN 406
+ +G+G +G V+K + VA+KR+ + + E+ L+ +L+HKN
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 407 LVKLLGFCVDGDEKL-LVYEFMPN---GSLD--AILFDPRKRGILCWRKRTNIVNGIAKG 460
+V+L D+KL LV+EF D DP ++ + KG
Sbjct: 63 IVRLHDVLH-SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ--------LLKG 113
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
+ + H ++HRDLK N+L++ + K+++FG+AR F + +V T Y
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLWYR 168
Query: 521 APEYAM-EGLYSKKSDVFSFGVLLIEIITGRR 551
P+ LYS D++S G + E+ R
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 13/215 (6%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEV 396
LE + + F +LG+GGFG V + ++ A K+L +G A NE
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
++ K+ + +V L + + + L LV M G L ++ + G R
Sbjct: 236 QILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
I G+ LH RIV+RDLK N+LLD + +ISD G+A E + VG
Sbjct: 295 -ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKG--RVG 347
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
T GYMAPE Y+ D ++ G LL E+I G+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTN-EVLLILKLQH 404
+F ILG+G F V + +E A+K L ++ + E ++ +L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 405 KNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILC-WRKR---TNIVNGIAK 459
VKL D DEKL + NG L L RK G R IV+ +
Sbjct: 90 PFFVKLYFTFQD-DEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVSALE- 144
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
YLH I+HRDLK N+LL+ DM+ +I+DFG A++ + +A VGT Y
Sbjct: 145 ---YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
++PE E K SD+++ G ++ +++ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLL 411
+G+G +G V+K G+ VA+K+ + + E+ ++ +L+H NLV LL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
LV+E+ + ++ L D +RG+ + +I + + + H +
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVK-SITWQTLQAVNFCH---KHN 122
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLY 530
+HRD+K N+L+ K+ DFG AR+ + + T Y +PE + + Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA-TRWYRSPELLVGDTQY 180
Query: 531 SKKSDVFSFGVLLIEIITGR 550
DV++ G + E+++G
Sbjct: 181 GPPVDVWAIGCVFAELLSGV 200
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSC---SEQGTAEFTNE--VL-LILK 401
++FS I+G+GGFG VY +D ++ A+K L +QG NE +L L+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 402 LQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
+V + + +KL + + M G L + + G+ I G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL---HYHLSQHGVFSEADMRFYAAEIILG 304
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
+ ++H +V+RDLK +N+LLD + +ISD G+A F S+ + + VGT+GYM
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHA--SVGTHGYM 357
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
APE +G+ Y +D FS G +L +++ G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 8e-23
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN-----EVLLIL 400
ATS + +G G +G VYK G VA+K + + G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 401 KLQ---HKNLVKLLGFCV----DGDEKL-LVYEFMPNGSLD-AILFDPRKRGILCWRKRT 451
+L+ H N+V+L+ C D + K+ LV+E + D D L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIK 123
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
+++ +G+ +LH + IVHRDLK N+L+ S K++DFG+ARI+ S A T
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTP 178
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
+V T Y APE ++ Y+ D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHK 405
+ LG+G +G VYK + + VA+KR+ E+ T EV L+ +LQH+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPN---GSLDA-ILFDPRKRGILCWRKRTNIVNGIAKGM 461
N+++L L++E+ N +D R ++ + G+
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ--------LINGV 145
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-----KISDFGMARIFAESEGEANTVRIVGT 516
+ H R +HRDLK N+LL S KI DFG+AR F T I+ T
Sbjct: 146 NFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEII-T 200
Query: 517 YGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
Y PE + YS D++S + E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKG--VLSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQ- 403
+ +G+G +G V+K + + G+ VA+KR+ + + + EV ++ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 404 --HKNLVKLL----GFCVDGDEKL-LVYEFMPNGSLD-AILFDPRKRGILCWRKRTNIVN 455
H N+V+L D + KL LV+E + D D + +++
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
+ +G+ +LH R+VHRDLK N+L+ S K++DFG+ARI+ S A T +V
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVV- 181
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
T Y APE ++ Y+ D++S G + E+ +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 15/113 (13%)
Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-I 500
+ L +AKGM +L + + +HRDL A N+LL KI DFG+AR I
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 501 FAESEGEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
+ + + ++ +MAPE + +Y+ +SDV+SFGVLL EI +
Sbjct: 244 YKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 19/160 (11%)
Query: 355 NILGQGGFGPVYKGVL------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
LG+G FG V + + + VAVK L + +E+ +++ + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 407 LVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+V LLG C L+V EF G+L L KR V KG +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ + DLK + S +S S F + ++ E
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKL-QHKNLVKLLG 412
LG G FG V G G +VAVK L + LKL +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAKGML 462
+ +V E++ G L FD +C R I++ +
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FD-----YICKHGRVEEMEARRLFQQILSAVD---- 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
Y H R +VHRDLK NVLLD+ MN+KI+DFG++ + T G+ Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTS--CGSPNYAAP 179
Query: 523 EYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
E LY+ + D++S GV+L ++ G
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-21
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 53/219 (24%)
Query: 342 ETLNLATSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNE 395
L + + D S +LG G G V + ++ A+K L C + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 396 VLLILKL-QHKNLVKLLGFCVDGDEK----LLVYEFMPNGSL-DAILFDPRKRGILCW-- 447
V L + Q ++V+++ + L+V E + G L I RG +
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTE 116
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAES 504
R+ + I+ I + + YLH + I HRD+K N+L S N+ K++DFG
Sbjct: 117 REASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG-------- 165
Query: 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
A E E Y K D++S GV++
Sbjct: 166 ---------------FAKETTGEK-YDKSCDMWSLGVIM 188
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 63/255 (24%), Positives = 100/255 (39%), Gaps = 58/255 (22%)
Query: 316 NDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GK 374
D +F+ + F + + + +G G G V + +
Sbjct: 7 RDNNFYSVEIGD-------STFTVL--------KRYQNLKPIGSGAQGIVCAAYDAILER 51
Query: 375 EVAVKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLLG-FCVDGDEKL--- 421
VA+K+LS F N E++L+ + HKN++ LL F +
Sbjct: 52 NVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104
Query: 422 --LVYEFMPNGSLDAI----LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+V E M +L + L R +L + G+ +LH I+HR
Sbjct: 105 VYIVMELMDA-NLCQVIQMELDHERMSYLLY---------QMLCGIKHLHSAG---IIHR 151
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSD 535
DLK SN+++ SD KI DFG+AR S V T Y APE + Y + D
Sbjct: 152 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILGMGYKENVD 208
Query: 536 VFSFGVLLIEIITGR 550
++S G ++ E+I G
Sbjct: 209 IWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 57/247 (23%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTN-EVLLILKLQHK 405
+ +S LG G FG V + + GK A+K++ + N E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60
Query: 406 NLVKLL-GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK--------------- 449
N++KL+ F GDE+ + + + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 450 --------RTNIVNG--------------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487
++ I +G + + + ++H L I HRD+K N+L++S
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 488 MNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEY---AMEGLYSKKSDVFSFGVLL 543
N+ K+ DFG A+ E + I + Y APE A E Y+ D++S G +
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATE--YTPSIDLWSIGCVF 232
Query: 544 IEIITGR 550
E+I G+
Sbjct: 233 GELILGK 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 37/221 (16%)
Query: 350 NFSDSNIL---GQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFTNEVLLILK-L 402
NF IL G+G FG V +D K++ A+K ++ C E+ + L I++ L
Sbjct: 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 403 QHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK-- 459
+H LV L + +E + +V + + G L L ++ + K
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-----------QQNVHFKEETVKLF 120
Query: 460 ------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
+ YL RI+HRD+K N+LLD + I+DF +A + + T+
Sbjct: 121 ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITTM-- 174
Query: 514 VGTYGYMAPE---YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
GT YMAPE YS D +S GV E++ GRR
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 40/212 (18%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
LG G FG V G G +VAVK ++ S G E+ LKL +H +++K
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQ-NLKLFRHPHIIK 80
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
L + +V E++ G L FD +C R + I++G+
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGEL----FD-----YICKNGRLDEKESRRLFQQILSGVD- 130
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
Y H R +VHRDLK NVLLD+ MN+KI+DFG++ + T G+ Y
Sbjct: 131 ---YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTS--CGSPNY 181
Query: 520 MAPEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
APE LY+ + D++S GV+L ++ G
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 38/226 (16%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE--FTN---------EV 396
S ++ + G +G V GV S+G VA+KR+ + G ++ E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 397 LLILKLQHKNLVKLLG-FCVDGDEKL----LVYEFMPN------GSLDAILFDPRKRGIL 445
L+ H N++ L F + + LV E M ++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ--- 137
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ I G+ LHE +VHRDL N+LL + + I DF +AR
Sbjct: 138 ------YFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
N V Y APE M+ ++K D++S G ++ E+ +
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 34/208 (16%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G FG + VAVK + E++ L+H N+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAKGMLYLH 465
++ E+ G L ++ +C R + +++G++ Y H
Sbjct: 87 TPTHLAIIMEYASGGEL----YE-----RICNAGRFSEDEARFFFQQLLSGVS----YCH 133
Query: 466 EDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
++I HRDLK N LLD KI DFG ++ + + VGT Y+APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST--VGTPAYIAPE 187
Query: 524 YAMEGLYS-KKSDVFSFGVLLIEIITGR 550
+ Y K +DV+S GV L ++ G
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 61/254 (24%), Positives = 96/254 (37%), Gaps = 56/254 (22%)
Query: 316 NDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGK 374
D F+ V F + + + +G G G V +
Sbjct: 44 VDNQFYSVEVGD-------STFTVL--------KRYQNLKPIGSGAQGIVCAAYDAVLDR 88
Query: 375 EVAVKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLL------GFCVDGDE 419
VA+K+LS F N E++L+ + HKN++ LL + +
Sbjct: 89 NVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141
Query: 420 KLLVYEFMP---NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
LV E M + L R +L + G+ +LH I+HRD
Sbjct: 142 VYLVMELMDANLCQVIQMELDHERMSYLLY---------QMLCGIKHLHS---AGIIHRD 189
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDV 536
LK SN+++ SD KI DFG+AR S V T Y APE + Y + D+
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILGMGYKENVDI 246
Query: 537 FSFGVLLIEIITGR 550
+S G ++ E++ +
Sbjct: 247 WSVGCIMGEMVRHK 260
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 25/201 (12%), Positives = 56/201 (27%), Gaps = 45/201 (22%)
Query: 357 LGQGGFGPVYKGVLSD---GKEVAVKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
G ++ + D ++VA+ + + E + L + ++ + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
L L+V E++ GSL + + +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RA 148
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
+ S V + D G+ ++ M
Sbjct: 149 GVALSIDHPSRVRVSID------------------GDV----VLAYPATMPDA------- 179
Query: 531 SKKSDVFSFGVLLIEIITGRR 551
+ + D+ G L ++ R
Sbjct: 180 NPQDDIRGIGASLYALLVNRW 200
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 41/212 (19%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
LG+G FG V ++VA+K L E E+ LKL +H +++K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REIS-YLKLLRHPHIIK 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
L + ++V E+ G L FD + +KR I+ I
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGEL----FD-----YIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
Y H R +IVHRDLK N+LLD ++N KI+DFG++ I T G+ Y
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTS--CGSPNY 173
Query: 520 MAPEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
APE LY+ + DV+S G++L ++ GR
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 36/211 (17%)
Query: 357 LGQGGFGPVY---KGVLSDGKEV-AVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LGQG FG V+ K SD +++ A+K L + + E +++++ H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 411 LGFCVDGDEKL-LVYEFMPNGSL-----DAILFD-PRKR----GILCWRKRTNIVNGIAK 459
+ + KL L+ +F+ G L ++F + +
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------------- 137
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
+ +LH L I++RDLK N+LLD + + K++DFG+++ + E +A + GT Y
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
MAPE +++ +D +SFGVL+ E++TG
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 53/249 (21%)
Query: 319 DFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVA 377
F+ Q V + + + +G G +G V + G++VA
Sbjct: 9 GFYKQDVNK-------TAWEL--------PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVA 53
Query: 378 VKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLL-----GFCVDGDEKL-L 422
+K+LS F + E+LL+ +QH+N++ LL + L
Sbjct: 54 IKKLSRP-------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106
Query: 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482
V FM L I+ K +V + KG+ Y+H +VHRDLK N+
Sbjct: 107 VMPFMQT-DLQKIM-----GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNL 157
Query: 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGV 541
++ D KI DFG+AR V T Y APE + Y++ D++S G
Sbjct: 158 AVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGC 212
Query: 542 LLIEIITGR 550
++ E++TG+
Sbjct: 213 IMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHK 405
+++ + +G+G +G V + VA+K++S Q + T E+ ++L+ +H+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 406 NLVKLLG-FCVDGDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
N++ + E++ +V + M L +L K L + I +G
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRG 140
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV-RIVGTYGY 519
+ Y+H + ++HRDLK SN+LL++ + KI DFG+AR+ + V T Y
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
APE + Y+K D++S G +L E+++ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 44/230 (19%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTN---------EVL 397
S + D LG GG G V+ V +D K VA+K++ T+ E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 398 LILKLQHKNLVKLL--------------GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG 443
+I +L H N+VK+ G + + +V E+M L +L ++G
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL----EQG 115
Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFA 502
L + + +G+ Y+H + ++HRDLK +N+ +++ D+ KI DFG+ARI
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 503 ESEGEANTV-RIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
+ + T Y +P + Y+K D+++ G + E++TG+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 29/235 (12%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS--EQGT 389
A+ + L+ + L +F ++G+G F V + +V A+K ++ ++G
Sbjct: 45 WAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE 104
Query: 390 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCW 447
E +L + + +L F + L LV E+ G L L K G
Sbjct: 105 VSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL---LTLLSKFGERIP 160
Query: 448 RKRTN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
+ IV I +H L VHRD+K N+LLD + +++DFG
Sbjct: 161 AEMARFYLAEIVMAID----SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKL- 212
Query: 503 ESEGEANTVRIVGTYGYMAPE-------YAMEGLYSKKSDVFSFGVLLIEIITGR 550
++G ++ VGT Y++PE G Y + D ++ GV E+ G+
Sbjct: 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV--------LL 398
+ + D +G G +G V V G +VA+K+L F +E+ L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76
Query: 399 ILK-LQHKNLVKLLG-FCVDGDEKL-----LVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
+LK ++H+N++ LL F D LV FM L ++ K L +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEKLGEDRIQ 131
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
+V + KG+ Y+H I+HRDLK N+ ++ D KI DFG+AR
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--- 185
Query: 512 RIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
V T Y APE + Y++ D++S G ++ E+ITG+
Sbjct: 186 --VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 33/236 (13%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS--EQGT 389
A+ F ++ + L +F ++G+G FG V L + +V A+K L+ ++
Sbjct: 58 WAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE 117
Query: 390 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCW 447
E +L K + L + D L LV ++ G L +L
Sbjct: 118 TACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS---------- 166
Query: 448 RKRTNIVNGIAK--------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ + +A+ + +H+ L VHRD+K N+L+D + + +++DFG
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 500 IFAESEGEANTVRIVGTYGYMAPE-----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
E +G + VGT Y++PE +G Y + D +S GV + E++ G
Sbjct: 224 KLME-DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 57/231 (24%), Positives = 102/231 (44%), Gaps = 26/231 (11%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS--EQGT 389
+ +D + L + ++ ++G+G FG V ++V A+K LS ++
Sbjct: 53 RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 112
Query: 390 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCW 447
+ F E I+ +V+L + D L +V E+MP G L ++ +
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEK 168
Query: 448 RKR---TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAE 503
R +V + +H + +HRD+K N+LLD + K++DFG ++ E
Sbjct: 169 WARFYTAEVVLALD----AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221
Query: 504 SEGEANTVRIVGTYGYMAPE----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
+T VGT Y++PE +G Y ++ D +S GV L E++ G
Sbjct: 222 GMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHK 405
+S+F ++LG+G +G V G+ VA+K++ + A T E+ ++ +H+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 406 NLVKLLG-FCVDGDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
N++ + D E ++ E M L ++ +L + +
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI------- 513
+ LH + ++HRDLK SN+L++S+ + K+ DFG+ARI ES + +
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 514 -VGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
V T Y APE + YS+ DV+S G +L E+ R
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 5e-18
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAEFTNEV--------LLI 399
++F+ +LG+G FG V E+ AVK L + ++V +L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK----KDVVIQDDDVECTMVEKRVLA 396
Query: 400 LKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
L + L +L C ++L V E++ G L ++ ++ G IA
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIA 452
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
G+ +L I++RDLK NV+LDS+ + KI+DFGM + T GT
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPD 507
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
Y+APE Y K D ++FGVLL E++ G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLLG 412
LG+G FG V A+K L + T E ++ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 413 FCVDGDEKL-LVYEFMPNGSL------DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ ++L V E+ G L + + + R R I + YLH
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA---------EIVSALDYLH 265
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
S +V+RDLK N++LD D + KI+DFG+ + + T GT Y+APE
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVL 321
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
+ Y + D + GV++ E++ GR
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 42/215 (19%)
Query: 357 LGQGGFGPVY---KGVLSDGKEV-AVKRLSS---CSEQGTAEFT---NEVLLILKLQHKN 406
LG+GG+G V+ K ++ ++ A+K L T +L +++H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE--EVKHPF 82
Query: 407 LVKLLGFCVDGDEKL-LVYEFMPNGSL------DAILFDPRKR----GILCWRKRTNIVN 455
+V L+ + KL L+ E++ G L + I + I
Sbjct: 83 IVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM--------- 132
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
+ +LH+ I++RDLK N++L+ + K++DFG+ + +T G
Sbjct: 133 ----ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCG 183
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
T YMAPE M +++ D +S G L+ +++TG
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 60/257 (23%), Positives = 96/257 (37%), Gaps = 45/257 (17%)
Query: 306 QIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPV 365
Q + + DF + N + F + T LG G FG V
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDR------IKT--------LGTGSFGRV 57
Query: 366 YKGVLSDGKEV-AVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKL 421
+ A+K L + E T NE ++ + LVKL D
Sbjct: 58 MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK--------GMLYLHEDSRLRIV 473
+V E++ G + + L R+ A+ YLH L ++
Sbjct: 118 MVMEYVAGGEMFSHL-----------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
+RDLK N+L+D +++DFG A+ +G T + GT +APE + Y+K
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT--LCGTPEALAPEIILSKGYNKA 218
Query: 534 SDVFSFGVLLIEIITGR 550
D ++ GVL+ E+ G
Sbjct: 219 VDWWALGVLIYEMAAGY 235
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 52/229 (22%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 338 FIDLETLNLA---TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT 393
+ D E+ + ++ LG+G + V++ + +++ ++V VK L ++ +
Sbjct: 22 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 78
Query: 394 NEVLLILKLQ-HKNLVKLLGFCVDGDEK--LLVYEFMPNGSLDAI---LFDPRKRGILCW 447
E+ ++ L+ N++ L D + LV+E + N + L D R +
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-- 136
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEG 506
I K + Y H S I+HRD+K NV++D + ++ D+G+A + G
Sbjct: 137 -------YEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPG 184
Query: 507 EANTVRIVGTYGYMAPE----YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
+ VR+ Y + PE Y M Y D++S G +L +I +
Sbjct: 185 QEYNVRVASRY-FKGPELLVDYQM---YDYSLDMWSLGCMLASMIFRKE 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 20/202 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
LG+G FG V A+K L + T + VL +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ--NTRHPFLTAL 70
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHEDS 468
+ ++L V E+ G L F + + +R I + YLH
Sbjct: 71 K-YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHS-- 123
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
+V+RD+K N++LD D + KI+DFG+ + T GT Y+APE +
Sbjct: 124 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDN 180
Query: 529 LYSKKSDVFSFGVLLIEIITGR 550
Y + D + GV++ E++ GR
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 62/249 (24%), Positives = 106/249 (42%), Gaps = 52/249 (20%)
Query: 319 DFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVA 377
F+ Q + + + + + + +G G +G V + G VA
Sbjct: 14 TFYRQELNK-------TIWEVP--------ERYQNLSPVGSGAYGSVCAAFDTKTGLRVA 58
Query: 378 VKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLL-----GFCVDGDEKL-L 422
VK+LS F + E+ L+ ++H+N++ LL ++ + L
Sbjct: 59 VKKLSRP-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111
Query: 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482
V M L+ I+ K L ++ I +G+ Y+H I+HRDLK SN+
Sbjct: 112 VTHLMGA-DLNNIV----KCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNL 163
Query: 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGV 541
++ D KI DFG+AR A+ V T Y APE + Y++ D++S G
Sbjct: 164 AVNEDCELKILDFGLARHTADEMTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGC 218
Query: 542 LLIEIITGR 550
++ E++TGR
Sbjct: 219 IMAELLTGR 227
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
LG+G FG V + + ++ AVK L + E T +L L H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS-LARNHPFLTQL 89
Query: 411 LGFCVDGDEKL-LVYEFMPNGSL-----DAILFD-PRKRGILCWRKRTNIVNGIAKGMLY 463
C ++L V EF+ G L + FD R R I +++
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA---------EIISALMF 139
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
LH+ I++RDLK NVLLD + + K++DFGM + + T GT Y+APE
Sbjct: 140 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPE 194
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITGR 550
E LY D ++ GVLL E++ G
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFTNEVLLILKLQHKN--LVKLL 411
LG+G FG V+ + A+K L E T +L L ++ L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 412 GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
E L V E++ G L ++ + + T I G+ +LH
Sbjct: 85 -CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHS---K 137
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
IV+RDLK N+LLD D + KI+DFGM + + + NT GT Y+APE + Y
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKY 195
Query: 531 SKKSDVFSFGVLLIEIITGR 550
+ D +SFGVLL E++ G+
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQ 215
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
+G+G FG V + AVK L + ++ + VLL ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL-KNVKHPFLVGL 104
Query: 411 LGFCVDGDEKL-LVYEFMPNGSL-----DAILFD-PRKRGILCWRKRTNIVNGIAKGMLY 463
F +KL V +++ G L F PR R IA + Y
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA---------EIASALGY 154
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
LH L IV+RDLK N+LLDS + ++DFG+ + E +T GT Y+APE
Sbjct: 155 LHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPE 209
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITGR 550
+ Y + D + G +L E++ G
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVK 409
++G+G + V L + A+K + ++ ++ V H LV
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE-QASNHPFLVG 74
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHED 467
L C + +L V E++ G L +F +++ L + + I+ + YLHE
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP-EEHARFYSAEISLALNYLHE- 128
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
I++RDLK NVLLDS+ + K++D+GM + +T GT Y+APE
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRG 184
Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
Y D ++ GVL+ E++ GR
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGR 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
LG+G FG V E+ AVK L + E T VL L + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPGKPPFLTQL 86
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
C ++L V E++ G L ++ ++ G IA G+ +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS--- 139
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
I++RDLK NV+LDS+ + KI+DFGM + T GT Y+APE
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQP 197
Query: 530 YSKKSDVFSFGVLLIEIITGR 550
Y K D ++FGVLL E++ G+
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQ 218
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 51/251 (20%), Positives = 99/251 (39%), Gaps = 55/251 (21%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV--------LL 398
+ +++G G +G V + + + VA+K++ F + + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 399 ILK-LQHKNLVKLLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
IL L H ++VK+L + + ++L +V E + + R L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF---RTPVYLTELHIKT 160
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
++ + G+ Y+H S I+HRDLK +N L++ D + K+ DFG+AR E + +
Sbjct: 161 LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 513 IVGTYG-------------------------YMAPEYAM-EGLYSKKSDVFSFGVLLIEI 546
I Y APE + + Y++ DV+S G + E+
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 547 ITGRRNAGSNQ 557
+ + +
Sbjct: 278 LNMIKENVAYH 288
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVK 409
++G+G + V L + A++ + ++ ++ V H LV
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE-QASNHPFLVG 117
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHED 467
L C + +L V E++ G L +F +++ L + + I+ + YLHE
Sbjct: 118 LH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP-EEHARFYSAEISLALNYLHE- 171
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
I++RDLK NVLLDS+ + K++D+GM + +T GT Y+APE
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRG 227
Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
Y D ++ GVL+ E++ GR
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGR 250
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 55/272 (20%), Positives = 107/272 (39%), Gaps = 55/272 (20%)
Query: 324 HVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS 382
H + + +F ++ +++ N+ +++G+G +G VY + K VA+K+++
Sbjct: 2 HHHHHHSSGRENLYFQGIKNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 383 SCSEQGTAEFTNEV--------LLILK-LQHKNLVKLLG-FCVDGDEKL----LVYEFMP 428
F + + + IL L+ +++L D K +V E
Sbjct: 61 RM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113
Query: 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488
+ L + + L I+ + G ++HE I+HRDLK +N LL+ D
Sbjct: 114 S-DLKKLF---KTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDC 166
Query: 489 NSKISDFGMARIFAESEGEANTVRI--------------------VGTYGYMAPE---YA 525
+ K+ DFG+AR + + V T Y APE
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557
Y+K D++S G + E++ ++ ++
Sbjct: 227 EN--YTKSIDIWSTGCIFAELLNMLQSHINDP 256
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 349 SNFSDSNILGQGGFGPVY----KGVLSDGKEVAVKRLS--SCSEQGTAEFT-NEVLLILK 401
+F LG G FG V+ + +G+ A+K L E T +E L++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 402 LQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK- 459
+ H ++++ G D +++ ++ +++ G L ++L RK N +AK
Sbjct: 63 VTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLL---RKSQRF--------PNPVAKF 110
Query: 460 -------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
+ YLH I++RDLK N+LLD + + KI+DFG A+ T
Sbjct: 111 YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT-- 162
Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
+ GT Y+APE Y+K D +SFG+L+ E++ G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 48/236 (20%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV--------LL 398
+ LG+G +G V+K + G+ VAVK++ F N ++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 399 ILKL--QHKNLVKLLG-FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
IL H+N+V LL D D + LV+++M L A++ + IL + +V
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVV 115
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI- 513
+ K + YLH S ++HRD+K SN+LL+++ + K++DFG++R F N + +
Sbjct: 116 YQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 514 ------------------VGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
V T Y APE + Y+K D++S G +L EI+ G+
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 357 LGQGGFGPVY---KGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEVLLILKLQHKN--L 407
LG G +G V+ K D ++ A+K L + T E T +L+ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 408 VKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLH 465
V L + + KL L+ +++ G L +R I G I + +LH
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL---FTHLSQRERFT-EHEVQIYVGEIVLALEHLH 176
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMAPE- 523
+ L I++RD+K N+LLDS+ + ++DFG+++ F E E A GT YMAP+
Sbjct: 177 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPDI 231
Query: 524 --YAMEGLYSKKSDVFSFGVLLIEIITGR 550
G + K D +S GVL+ E++TG
Sbjct: 232 VRGGDSG-HDKAVDWWSLGVLMYELLTGA 259
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILK---------LQH 404
LG G F V+ + + VA+K + AE ++L + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 405 KNLVKLLG-FCVDGDEKL---LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
+++KLL F G + +V+E + +L A++ RGI V I+K
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI-----PLIYVKQISKQ 139
Query: 461 ML----YLHEDSRLRIVHRDLKASNVLLDSDMNS------KISDFGMARIFAESEGEANT 510
+L Y+H R I+H D+K NVL++ + KI+D G A + +
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----CWYDEHY 192
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
+ T Y +PE + + +D++S L+ E+ITG
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 3e-12
Identities = 39/257 (15%), Positives = 75/257 (29%), Gaps = 67/257 (26%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--------SSCSEQGTAEFTNEV 396
L T +G+G FG V++ + D VA+K + + ++ E E+
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 397 LLILKLQ---------HKNLVKLLGFCV------------------------------DG 417
++ +L + + L
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL 477
D+ +V EF G + + + +I++ + + LR HRDL
Sbjct: 135 DQLFIVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDL 188
Query: 478 KASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP--EYAMEGLYSKKSD 535
NVLL K+ + + + G +Y + L
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIV 237
Query: 536 VFSFGVLLIEIITGRRN 552
VF + ++ TG +
Sbjct: 238 VFCDVSMDEDLFTGDGD 254
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 60/282 (21%)
Query: 290 FATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATS 349
T+ + + + +K+ +++ G +D ++ Y G E
Sbjct: 13 LGTENLYFQSMSSHKKERKVYNDG-YDDDNYDYIVKNG--------------EKWM---D 54
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQ-- 403
+ +++G+G FG V K + + VA+K + Q E +L ++
Sbjct: 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEV--RLLELMNKHDT 112
Query: 404 --HKNLVKLLGF-------CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
+V L C LV+E + + +L +L + RG+ N+
Sbjct: 113 EMKYYIVHLKRHFMFRNHLC-------LVFEML-SYNLYDLLRNTNFRGV-----SLNLT 159
Query: 455 NGIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEA 508
A+ M +L L I+H DLK N+LL + S KI DFG + G+
Sbjct: 160 RKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQR 214
Query: 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
I + Y +PE + Y D++S G +L+E+ TG
Sbjct: 215 IYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 36/214 (16%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G FG + G L + VA+K S L + ++ F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFGP 75
Query: 416 DGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRK---RTNIVNGIAKGML----YLHED 467
G +V E + G SL+ LFD LC R +T V IA ++ Y+H
Sbjct: 76 CGKYNAMVLELL--GPSLED-LFD------LCDRTFSLKT--VLMIAIQLISRMEYVHSK 124
Query: 468 SRLRIVHRDLKASNVLLDSDMNSK-----ISDFGMARIFAESEGEA-----NTVRIVGTY 517
+ +++RD+K N L+ N I DF +A+ + + E + + GT
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 518 GYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
YM+ G S++ D+ + G + + + G
Sbjct: 182 RYMSI-NTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 30/210 (14%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G FG +Y G ++ G+EVA+K ++ +++ +++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-GGVGIPTIRWCGA 75
Query: 416 DGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRT-NIVNGIAKGML----YLHEDSR 469
+GD ++V E + G SL+ LF+ C RK + V +A M+ Y+H +
Sbjct: 76 EGDYNVMVMELL--GPSLED-LFN------FCSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 470 LRIVHRDLKASNVLLDSDMNSK---ISDFGMARIFAESEGEA-----NTVRIVGTYGYMA 521
+HRD+K N L+ I DFG+A+ + ++ + GT Y A
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
G+ S++ D+ S G +L+ G
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 52/220 (23%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQ----HKNL 407
++G+G FG V K + VA+K + + Q E +L L+ Q N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI--RILEHLRKQDKDNTMNV 161
Query: 408 VKLLGF-------CVDGDEKLL---VYEFMPNG-----SLDAILFDPRKRGILCWRKRTN 452
+ +L C+ + LL +YE + SL + RK
Sbjct: 162 IHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLV------------RK--- 204
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANT 510
+ I + + LH + RI+H DLK N+LL S K+ DFG + E +
Sbjct: 205 FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVY 257
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
I + Y APE + Y D++S G +L E++TG
Sbjct: 258 TYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV-KLLGFC 414
+G G FG +Y G + +EVA+K + ++ + E + LQ + + F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72
Query: 415 VDGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRT-NIVNGIAKGML----YLHEDS 468
V+GD +LV + + G SL+ LF+ C RK + V +A M+ ++H S
Sbjct: 73 VEGDYNVLVMDLL--GPSLED-LFN------FCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 469 RLRIVHRDLKASNVLLDSDMNSK---ISDFGMARIFAESEGEA-----NTVRIVGTYGYM 520
+HRD+K N L+ + I DFG+A+ + ++ + GT Y
Sbjct: 124 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY- 179
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
A G+ S++ D+ S G +L+ + G
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 36/214 (16%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G+G FG +++G L + ++VA+K S+ +L + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-GCTGIPNVYYFGQ 76
Query: 416 DGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRK---RTNIVNGIAKGML----YLHED 467
+G +LV + + G SL+ L D LC RK +T V AK ML +HE
Sbjct: 77 EGLHNVLVIDLL--GPSLED-LLD------LCGRKFSVKT--VAMAAKQMLARVQSIHEK 125
Query: 468 SRLRIVHRDLKASNVLLDSDMNSK-----ISDFGMARIFAESEGEA-----NTVRIVGTY 517
S +V+RD+K N L+ + + DFGM + + + + + GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 518 GYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
Y G S++ D+ + G + + + G
Sbjct: 183 RY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 53/264 (20%), Positives = 91/264 (34%), Gaps = 86/264 (32%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILK------LQHKNLV 408
LG G F V+ + K VA+K + S+ TA +L ++ + +V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 409 KLLG-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN-------IVNGIAKG 460
+LL F + G NG+ ++F+ +L W ++N V I +
Sbjct: 105 QLLDDFKISG----------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 461 ML----YLHEDSRLRIVHRDLKASNVLL-------------------------------- 484
+L YLH ++ RI+H D+K N+LL
Sbjct: 155 VLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 485 -----------------DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
+ KI+D G A + E + T Y + E +
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVLIG 267
Query: 528 GLYSKKSDVFSFGVLLIEIITGRR 551
Y+ +D++S + E+ TG
Sbjct: 268 SGYNTPADIWSTACMAFELATGDY 291
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 32/175 (18%), Positives = 66/175 (37%), Gaps = 37/175 (21%)
Query: 357 LGQGGFGPVYKGV---------LSDGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQ 403
+ G +Y+ ++ ++K + +EQ + + L + K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 404 HKNLVKLLGF-------CVDGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVN 455
LL + LV + G SL + D + +L +R+ V
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLS--ERS--VL 162
Query: 456 GIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKI--SDFGMARIFAES 504
+A +L +LHE+ VH ++ A N+ +D + S++ + +G A + S
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 47/231 (20%), Positives = 85/231 (36%), Gaps = 52/231 (22%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSC-----------SEQGTAEFTNEVLLILKLQHK 405
+GQGGFG +Y ++ + V +E + + I K
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 406 NLVKLLGFCV-----DGDEKLLVYEFM------PNGSLDAILFDPRKRGILCWRK---RT 451
+K LG D+ Y FM L +++ ++ +T
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQK-IYE------ANAKRFSRKT 153
Query: 452 NIVNGIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKI--SDFGMARIFAESE 505
V ++ +L Y+HE VH D+KASN+LL+ ++ D+G+A +
Sbjct: 154 --VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 506 G-----EANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
GT + + + A G+ S++ D+ G +I+ +TG
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSID-AHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 83/558 (14%), Positives = 152/558 (27%), Gaps = 185/558 (33%)
Query: 19 HDLAFGDS---PPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSD 75
D + D+ YN+ R L+ L L N
Sbjct: 116 RDRLYNDNQVFAKYNVS--------RLQPYL-KLRQALLELRPAKNVL------------ 154
Query: 76 RVYGLYM------CLNYISAETCNDCITTASQDISKLCPNKTEAIVW------------- 116
+ G + + + + C + K I W
Sbjct: 155 -IDG--VLGSGKTWV---ALDVCLS------YKVQCKMDFK---IFWLNLKNCNSPETVL 199
Query: 117 EEVCQLRY-AYQNFFGQLDVSGNIP-----------------KYNR-L----NISEPE-- 151
E + +L Y N+ + D S NI Y L N+ +
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 152 -------------RYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCT- 197
R++ V + + T +S + T + L++
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH-------SMTLTPDEVKSLLLKYLD 312
Query: 198 ---KDLPADDCITCLHNATADILSCCYFSRGARL---LSRNCYLRYELYAFYKGATEPSI 251
+DLP + T + + L+ ++ E S+
Sbjct: 313 CRPQDLPREVL-------TTNPRRLSII--AESIRDGLATWDNWKHVNCDKLTTIIESSL 363
Query: 252 LAGNQASGGGKQRKMWMIIVL---ASVVALLLVVFASTGYFFATKKITRK--RKGTARKQ 306
N ++ + V A + +LL + + K + KQ
Sbjct: 364 ---NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 307 -----IQLH------KIGDANDTDFH------YQHVQGRDNDLKAQDFFIDLETLNLATS 349
I + K+ N+ H Y + D+D D
Sbjct: 421 PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD----DLIPPYL------D 470
Query: 350 NFSDSNI------LGQGGFGPVYKGVLSDGKEVAVK-RLSSCSEQGTAEFTNEVLLILKL 402
+ S+I + +++ V D + + K R S + + N L LK
Sbjct: 471 QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-TLQQLKF 529
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-FDPRKRGILCWRKRTNIVNGIA--- 458
+ D D K YE + ++AIL F P+ L K T+++ IA
Sbjct: 530 YKP-------YICDNDPK---YERL----VNAILDFLPKIEENLICSKYTDLLR-IALMA 574
Query: 459 -KGMLYLHEDSRLRIVHR 475
++ E++ + V R
Sbjct: 575 EDEAIF--EEA-HKQVQR 589
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 52/237 (21%), Positives = 84/237 (35%), Gaps = 70/237 (29%)
Query: 356 ILGQGGFGPVYKGV--LSDGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQ----HKN 406
LG+G FG V + + +VA+K + E E VL +K +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEI--NVLKKIKEKDKENKFL 83
Query: 407 LVKLLGF-------CVDGDEKLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVN 455
V + + C + +E L F+ K + V
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKENNFQPY-----PLPHVR 126
Query: 456 GIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNS-------------------KI 492
+A + +LHE ++ H DLK N+L + ++
Sbjct: 127 HMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
+DFG A F + E +T IV T Y PE +E +++ DV+S G +L E G
Sbjct: 184 ADFGSA-TF---DHEHHT-TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 47/236 (19%), Positives = 78/236 (33%), Gaps = 64/236 (27%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQH---KNLV 408
+G G FG V + + K AVK + + E ++L ++ N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEA--DILKKIQNDDINNNNIV 99
Query: 409 KLLGF-------CVDGDEKLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVNGI 457
K G C L++E L L++ G +
Sbjct: 100 KYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRNNYNGF-----HIEDIKLY 142
Query: 458 AKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA----N 509
+L YL + + + H DLK N+LLD K +
Sbjct: 143 CIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 510 TVRI------------VGTY----GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
+++ G+ Y APE + + SD++SFG +L E+ TG
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 54/238 (22%), Positives = 89/238 (37%), Gaps = 72/238 (30%)
Query: 356 ILGQGGFGPVYKGV--LSDGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQ----HKN 406
LG+G FG V + + + G+ VAVK + E +E +VL L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI--QVLEHLNTTDPNSTFR 78
Query: 407 LVKLLGF-------CVDGDEKLLVYEFM-PNGSLDAILFDPRK----RGILCWRKRTNIV 454
V++L + C +V+E + + +D K R + +
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFELLGLS------TYDFIKENGFLPF-----RLDHI 120
Query: 455 NGIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNS-------------------K 491
+A + +LH ++ H DLK N+L + K
Sbjct: 121 RKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
+ DFG A + + E + +V T Y APE + +S+ DV+S G +LIE G
Sbjct: 178 VVDFGSA-TY-DDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 32/176 (18%), Positives = 61/176 (34%), Gaps = 40/176 (22%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV------- 408
+G GGFG +Y + ++ A + Q +E+ ++ K+ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 409 --------KLLGF----CVDGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVN 455
G + +V E + G L I V
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKST-------VL 154
Query: 456 GIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKI--SDFGMARIFAESE 505
+ ML Y+HE+ VH D+KA+N+LL ++ +D+G++ + +
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A Length = 304 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 19/109 (17%), Positives = 35/109 (32%), Gaps = 32/109 (29%)
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKIS---DFGMARI------------FAESEGEA 508
++ ++H D + ++L D++ + I DFG A I E G
Sbjct: 185 IYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243
Query: 509 NTVRIVGTYG----------------YMAPEYAMEGLYSKKSDVFSFGV 541
+I+ Y Y + E + G D + G+
Sbjct: 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEGL 292
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 660 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.92 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.9 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.96 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.58 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.3 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.18 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.05 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.76 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.56 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.3 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.85 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.43 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.97 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.47 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-55 Score=449.69 Aligned_cols=261 Identities=29% Similarity=0.411 Sum_probs=217.8
Q ss_pred cCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
.++|...+.||+|+||.||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 356677889999999999999863 47789999998877777889999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCC----------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEE
Q 006125 422 LVYEFMPNGSLDAILFDP----------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
||||||++|+|.++|+.. .....++|.+++.|+.||++||+|||+++ |+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 999999999999999642 22346999999999999999999999988 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCc
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 570 (660)
|+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||......+....+.....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999987655443333333579999999999999999999999999999999999 8999987766555544433221
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
.+ .+......+.+|+.+||+.||++|||++||+++|++...
T Consensus 249 -~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 249 -LQ----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 111223457889999999999999999999999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=451.05 Aligned_cols=261 Identities=29% Similarity=0.399 Sum_probs=210.9
Q ss_pred cCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
.++|...++||+|+||.||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 345666789999999999999864 47889999998877777889999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC
Q 006125 422 LVYEFMPNGSLDAILFDPR------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~ 489 (660)
||||||++|+|.++++... ..+.++|.+++.|+.||++||+|||+.+ |+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999996532 2346999999999999999999999988 999999999999999999
Q ss_pred EEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhc
Q 006125 490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNE 568 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 568 (660)
+||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||......+....+...
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999987655444333444679999999999999999999999999999999999 89999877655544444332
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
.+ .+ .+......+.+|+.+||+.||++||||+||+++|+....
T Consensus 277 ~~-~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 277 RE-LE----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp CC-CC----------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-CC----------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 21 11 111223457889999999999999999999999987643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=443.99 Aligned_cols=257 Identities=29% Similarity=0.387 Sum_probs=214.0
Q ss_pred CCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
+++..++||+|+||+||+|.+. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3445688999999999999863 4678999999753 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC
Q 006125 423 VYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~ 489 (660)
|||||++|+|.++|..... ...++|.++++|+.||++||+|||+.+ |+||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999964321 245999999999999999999999998 999999999999999999
Q ss_pred EEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhc
Q 006125 490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNE 568 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 568 (660)
+||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+....+..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~- 262 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN- 262 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT-
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-
Confidence 99999999987765444433444579999999999999999999999999999999999 8999987766555444332
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
+.... .+...+..+.+|+.+||+.||++||||.||++.|+..
T Consensus 263 ~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 263 RQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22111 1222334578899999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=440.13 Aligned_cols=267 Identities=27% Similarity=0.412 Sum_probs=210.2
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
+..+++...++||+|+||+||+|+++ ..||||+++. .+....+.|.+|+.++++++|||||+++|++.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 34567777899999999999999874 3699999874 344556789999999999999999999998864 568999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
||||++|+|.++|+.. ...++|.++..|+.||++||+|||+.+ |+||||||+||||++++++||+|||+++....
T Consensus 110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999643 345999999999999999999999988 99999999999999999999999999987655
Q ss_pred cCCccceeeeeccCCcCCHhhhhc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
..........+||+.|||||++.. +.|+.++|||||||+||||+||+.||...............+... +.+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~----p~~~ 260 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS----PDLS 260 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC----CCST
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----CCcc
Confidence 444434445689999999999964 468999999999999999999999998655444444444333211 1111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQ 626 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 626 (660)
.........+.+|+.+||+.||++||||.||++.|+....++|+
T Consensus 261 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 261 --KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp --TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred --cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 11222344578899999999999999999999998866555543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=431.06 Aligned_cols=250 Identities=20% Similarity=0.343 Sum_probs=207.5
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..++||+|+||+||+++. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5788999999999999999995 47999999999643 44556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++|+|.++|.. ++...+++.+++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+....
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999953 23445789999999999999999999998 9999999999999999999999999998764322
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+....+...... .+. ..++
T Consensus 180 ~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------~~~-~~~s 250 (350)
T 4b9d_A 180 E--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP------PVS-LHYS 250 (350)
T ss_dssp H--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC------CCC-TTSC
T ss_pred c--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC------CCC-ccCC
Confidence 1 122357999999999999999999999999999999999999999988877766666544321 111 1233
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+.+|+.+||+.||++|||++|+++
T Consensus 251 ----~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 251 ----YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34778899999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=433.90 Aligned_cols=272 Identities=27% Similarity=0.382 Sum_probs=223.8
Q ss_pred cccChHHHHhhcCCCCCCcccccCCcccEEeeeecC------CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCC-CCcc
Q 006125 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQH-KNLV 408 (660)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h-~niv 408 (660)
+..+..+.++..++|+..+.||+|+||.||+|.+.. ++.||||+++.. .....+.|.+|+.+|.+++| ||||
T Consensus 52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 445667778888999999999999999999998542 368999999753 34456779999999999965 8999
Q ss_pred eEeEEEEeC-CeeEEEEEecCCCChhhhhcCCCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 006125 409 KLLGFCVDG-DEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474 (660)
Q Consensus 409 ~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 474 (660)
+++|+|.+. +..+||||||++|+|.++|+.... ...+++.++..++.||++||+|||+++ |+|
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence 999999764 568999999999999999964221 345899999999999999999999998 999
Q ss_pred cCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 006125 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNA 553 (660)
Q Consensus 475 ~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~ 553 (660)
|||||+||||++++.+||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987765544444445689999999999999999999999999999999998 89999
Q ss_pred CCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 554 GSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
......+........+..... +......+.+++.+||+.||++|||+.||++.|++..
T Consensus 289 ~~~~~~~~~~~~i~~g~~~~~----------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 289 PGVKIDEEFCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp TTCCCSHHHHHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCCCC----------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 866544445555544432211 1112335778899999999999999999999987653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=427.77 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=212.9
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+.|+..++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45778899999999999999964 79999999997655555667899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.+++.. +.+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+......
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999942 45999999999999999999999998 999999999999999999999999999876543322
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+..... +.+.. ...
T Consensus 227 --~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------~~~~~---~~~ 295 (346)
T 4fih_A 227 --RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------PRLKN---LHK 295 (346)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC------CCCSC---GGG
T ss_pred --ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC------CCCCc---ccc
Confidence 2346899999999999999999999999999999999999999987776655544433211 11111 111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
....+.+|+.+||+.||++|||+.|+++ ++++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 2234778899999999999999999985 5554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-52 Score=424.94 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=213.3
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..++||+|+||+||+++. .+|+.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688899999999999999995 57999999999642 3345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. +.+.+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999994 4466999999999999999999999998 999999999999999999999999999987654
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.........+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+..... .+.. .+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-------~~p~-~~ 257 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-------DFPE-KF 257 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------CCCT-TC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------CCCc-cc
Confidence 444444456899999999999999999999999999999999999999988776666555544321 1111 23
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
+ ..+.+|+.+||+.||++|||++|++
T Consensus 258 s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 F----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp C----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred C----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 3 3477889999999999999999963
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=412.55 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=199.2
Q ss_pred CCCcccccCCcccEEeeeec-CCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe----CCeeEEEE
Q 006125 352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVY 424 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 424 (660)
+..++||+|+||.||+|... +++.||+|++.. ......+.|.+|+.++++++|||||++++++.+ +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999964 688999999864 244556779999999999999999999999875 34579999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEEeeccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAE 503 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~ 503 (660)
|||++|+|.+++. ..+.+++..+..|+.||++||+|||+++ ++|+||||||+||||+. ++.+||+|||+++....
T Consensus 109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999994 3456999999999999999999999975 46999999999999984 79999999999975432
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...............+.....++. .
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~-----~ 254 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK-----V 254 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG-----C
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCc-----c
Confidence 2 2334689999999998864 6999999999999999999999999765444444444333221111111 2
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+ ..+.+|+.+||+.||++|||++|+++
T Consensus 255 ~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 255 AI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 24778899999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=425.08 Aligned_cols=252 Identities=22% Similarity=0.244 Sum_probs=204.4
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+.|...++||+|+||.||+++. .+|+.||||+++.... ..+|+.+++.++|||||++++++.+++..||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577788999999999999995 4699999999975321 247999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-CEEEeeccccccccccCC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAESEG 506 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 506 (660)
++|+|.++|. ..+.+++.++..++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+++.+.....
T Consensus 133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999994 4456999999999999999999999998 99999999999999987 699999999987654322
Q ss_pred cc---ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 507 EA---NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 507 ~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+........ .+ .+.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~-~~~ 281 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR----EI-PPS 281 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG----GS-CTT
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch----hc-Ccc
Confidence 11 12235799999999999999999999999999999999999999976543333333333321111 11 112
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
. ...+.+++.+||+.||.+|||+.||++.|...
T Consensus 282 ~----s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 282 C----APLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2 23477889999999999999999999887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=428.97 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=214.1
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+.|+..++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4688889999999999999996 479999999997665566677999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.+++. .+.+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 231 ~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 9999999994 245999999999999999999999998 999999999999999999999999999876543322
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC-CCCCH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD-TSFSD 586 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~ 586 (660)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+..... +.+.. ..++
T Consensus 304 --~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------~~~~~~~~~s- 374 (423)
T 4fie_A 304 --RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------PRLKNLHKVS- 374 (423)
T ss_dssp --BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------CCCSCTTSSC-
T ss_pred --ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC------CCCcccccCC-
Confidence 2346899999999999999999999999999999999999999987776655544433221 11111 1222
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
..+.+|+.+||+.||++|||+.|+++ ++++
T Consensus 375 ---~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 375 ---PSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp ---HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ---HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 34778889999999999999999986 5554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=406.39 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=195.9
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||+||++.. .+|+.||||++++. .......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999995 57999999999643 2344567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+ +|+|.+++. ..+.+++.++..++.||+.||+|||+++ |+||||||+||||++++++||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 679999884 4456999999999999999999999998 999999999999999999999999999865433
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.. ....+||+.|||||++.+..+ +.++|||||||++|||++|+.||...+.......+..... .+.. .
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-------~~p~-~ 234 (275)
T 3hyh_A 166 NF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-------TLPK-F 234 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------CCCT-T
T ss_pred Cc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-------CCCC-C
Confidence 22 224589999999999988775 6899999999999999999999988776655544433221 1111 2
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--Hhc
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLK 618 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~ 618 (660)
.+ ..+.+++.+||+.||++|||++|+++ +++
T Consensus 235 ~s----~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 235 LS----PGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp SC----HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred CC----HHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 22 34678899999999999999999986 554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=420.27 Aligned_cols=261 Identities=24% Similarity=0.308 Sum_probs=199.1
Q ss_pred CCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC----eeEEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKLLVYE 425 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e 425 (660)
+|...++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++++++.+.+ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 456678999999999999998 689999999975322 2223445666777899999999999998754 5799999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
||++|+|.++|+. ..++|..+.+|+.|+++||+|||++ ..++|+||||||+||||++++++||+|||+++.
T Consensus 82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999943 3589999999999999999999987 234599999999999999999999999999987
Q ss_pred ccccCCcc--ceeeeeccCCcCCHhhhhcC------CCCcchhHHHHHHHHHHHHhCCCCCCCCc--------------H
Q 006125 501 FAESEGEA--NTVRIVGTYGYMAPEYAMEG------LYSKKSDVFSFGVLLIEIITGRRNAGSNQ--------------L 558 (660)
Q Consensus 501 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwslGvll~elltG~~p~~~~~--------------~ 558 (660)
........ .....+||+.|||||++.+. .++.++|||||||+||||+||++|+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 65443221 22345799999999999764 36789999999999999999987654211 1
Q ss_pred HHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 559 LAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 559 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.........++ .+++.+.......+....+.+|+.+||+.||++||||.||++.|+..
T Consensus 238 ~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 238 VEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11111221111 12222222112335667788999999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=414.90 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=202.0
Q ss_pred CCCCCCcccccCCcccEEeeeec----CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
++|+..+.||+|+||+||+++.. +++.||||+++.. .......+.+|+.++++++|||||++++++.+.+..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56888999999999999999852 4778999999753 22334468899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++|+|.+++. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999994 4456999999999999999999999998 9999999999999999999999999998654
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
..... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+..... .+. .
T Consensus 178 ~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-------~~p-~ 247 (304)
T 3ubd_A 178 DHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-------GMP-Q 247 (304)
T ss_dssp ---CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------CCC-T
T ss_pred CCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-------CCC-C
Confidence 43322 2235899999999999999999999999999999999999999988777666555544321 111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCH-----HhHHH--HhcC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTM-----SSVAP--MLKG 619 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~--~L~~ 619 (660)
..+ ..+.+|+.+||+.||++|||+ +|+++ ++++
T Consensus 248 ~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 248 FLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred cCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 223 347788999999999999984 67763 4444
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=401.59 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=192.8
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC---------
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--------- 418 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------- 418 (660)
+|+..+.||+|+||.||+++. .+|+.||||+++.. .+...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 577889999999999999995 47999999999643 3445567999999999999999999999987644
Q ss_pred ---eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeec
Q 006125 419 ---EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (660)
Q Consensus 419 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 495 (660)
..|+||||+++|+|.+++.........++..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999975444445677788999999999999999998 999999999999999999999999
Q ss_pred cccccccccCCcc----------ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 006125 496 GMARIFAESEGEA----------NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL 565 (660)
Q Consensus 496 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~ 565 (660)
|+++.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||............
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 9998765432221 1223579999999999999999999999999999999996 66533211111111
Q ss_pred HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 566 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
....... .........+.+|+.+||+.||++|||+.|+++ ++++.
T Consensus 240 ~~~~~~p----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 240 VRNLKFP----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHTTCCC----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HhcCCCC----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 2111110 111223344678999999999999999999986 56543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=394.75 Aligned_cols=266 Identities=20% Similarity=0.303 Sum_probs=206.5
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe------CCe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD------GDE 419 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 419 (660)
++|+..++||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5788899999999999999995 47999999999753 33445678899999999999999999999764 356
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.|||||||+ |+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 68999984 4567999999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCC--ccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-Ccc-ccc
Q 006125 500 IFAESEG--EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-GNV-LEL 574 (660)
Q Consensus 500 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~~~-~~~ 574 (660)
.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|++||...+..+....+... +.. .+.
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 7654321 1223346899999999998875 5799999999999999999999999877665554444321 100 000
Q ss_pred c------------cccCCCCCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCC
Q 006125 575 V------------DPLLTDTSFSDD-----EFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGET 621 (660)
Q Consensus 575 ~------------d~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 621 (660)
. ...........+ ....+.+|+.+||+.||.+|||+.|+++ ++++..
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0 000000000111 1234778999999999999999999985 666543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=379.19 Aligned_cols=278 Identities=37% Similarity=0.645 Sum_probs=237.3
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
.+.++...+++|...+.||+|+||.||++...+++.||||++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34455567899999999999999999999988899999999987666667889999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
.++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999964332 235899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCC------cHHHHHHHHHhcCccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN------QLLAYAWHLWNEGNVL 572 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~------~~~~~~~~~~~~~~~~ 572 (660)
+...............||+.|+|||++.+..++.++||||||+++|||++|+.||... ....+.......+...
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 8654433333333456899999999999999999999999999999999999998632 3444544555556666
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
+.+++.+.. ....+....+.+++.+||+.||++||++.||++.|+...
T Consensus 267 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 267 QIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSSSCTT-CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcChhhcc-ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 666666554 567788889999999999999999999999999998653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=382.97 Aligned_cols=197 Identities=22% Similarity=0.342 Sum_probs=169.7
Q ss_pred hcCCCCCCcccccCCcccEEeeeec----CCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 421 (660)
-.++|+..++||+|+||+||+|+.+ .++.||+|++... .....+.+|++++..+ +||||+++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3578999999999999999999843 4678999998653 3345688999999998 6999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-CCEEEeecccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARI 500 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~~ 500 (660)
|||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999982 3899999999999999999999998 9999999999999877 7999999999986
Q ss_pred ccccCCc--------------------------cceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 006125 501 FAESEGE--------------------------ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNA 553 (660)
Q Consensus 501 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~ 553 (660)
....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432211 111234799999999999875 5899999999999999999999998
Q ss_pred C
Q 006125 554 G 554 (660)
Q Consensus 554 ~ 554 (660)
.
T Consensus 248 ~ 248 (361)
T 4f9c_A 248 Y 248 (361)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=375.89 Aligned_cols=283 Identities=42% Similarity=0.726 Sum_probs=237.5
Q ss_pred cccChHHHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEE
Q 006125 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415 (660)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 415 (660)
..+++.++.+..++|...+.||+|+||.||++...+|+.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 3567899999999999999999999999999998889999999997532 223346899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
..+..++||||+++|+|.+++.... ....+++..+..|+.||+.||+|||+...++|+||||||+|||+++++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999996543 334599999999999999999999999222399999999999999999999999
Q ss_pred ccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCC--------CCcHHHHHHHHH
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG--------SNQLLAYAWHLW 566 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~--------~~~~~~~~~~~~ 566 (660)
||++.......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||. ......+.....
T Consensus 178 fg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99998765433222 223468999999999999999999999999999999999999985 223444444445
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 567 NEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 567 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.........+..+.. ....+....+.+++.+||+.||.+|||+.||++.|++..
T Consensus 257 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 555555556655544 667888899999999999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=403.84 Aligned_cols=255 Identities=23% Similarity=0.296 Sum_probs=215.0
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
++|+..+.||+|+||.||++.. .+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+....+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5788899999999999999995 479999999998766667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC--CCEEEeeccccccccccC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARIFAESE 505 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~--~~~kl~DfGla~~~~~~~ 505 (660)
++|+|.++|.. ..+.+++.++..++.||++||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999853 3456999999999999999999999998 9999999999999865 899999999998765432
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+...... + ..... ...+
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~--~-~~~~~-~~~s 384 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--M-DDSAF-SGIS 384 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--C-CSGGG-TTSC
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--C-Ccccc-cCCC
Confidence 233468999999999999999999999999999999999999999887766655554433211 0 11111 1223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
..+.+|+.+||+.||.+|||+.|+++ +++.
T Consensus 385 ----~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 385 ----EDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 34678899999999999999999987 5554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=397.10 Aligned_cols=245 Identities=28% Similarity=0.350 Sum_probs=197.1
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHH---HHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTN---EVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
-++|+..++||+|+||.||+++. .+|+.||||++++. .......+.+ ++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 46789999999999999999995 47999999999642 1122233333 45667778999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
||||||+++|+|.++|. ..+.+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+++.
T Consensus 268 ylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999994 4466999999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCccccccc
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ---LLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~---~~~~~~~~~~~~~~~~~~d 576 (660)
+.... ....+||+.|||||++.. ..|+.++|||||||++|||++|+.||.... ........... ..
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~----- 411 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AV----- 411 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CC-----
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CC-----
Confidence 65432 223589999999999975 579999999999999999999999996432 22222222211 10
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHhHH
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT-----MSSVA 614 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl 614 (660)
.+. ..++ ..+.+|+.+||+.||.+|++ ++||+
T Consensus 412 -~~p-~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 412 -ELP-DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp -CCC-TTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred -CCC-ccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 111 1233 34778899999999999998 67776
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=370.34 Aligned_cols=271 Identities=28% Similarity=0.421 Sum_probs=210.9
Q ss_pred hHHHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
...+.+..++|+..+.||+|+||.||++.. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 344456677888899999999999999987 6889999998753 3444567899999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+++|+|.+++........+++..++.++.||++||+|||+.+ ++|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999999965443445999999999999999999999975 35999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+............+
T Consensus 187 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----- 259 (309)
T 3p86_A 187 RLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE----- 259 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC-----
T ss_pred cccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----
Confidence 75443221 12235789999999999999999999999999999999999999987765554443322221111
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCC
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLP 625 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 625 (660)
.+......+.+++.+||+.||.+||++.||++.|+.......
T Consensus 260 -----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 260 -----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred -----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 111222347889999999999999999999999998755443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.95 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=211.7
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|...+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45788899999999999999984 57899999999765556677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999943 35899999999999999999999998 99999999999999999999999999986654332
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||................... + ..+.
T Consensus 172 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------~---~~~~ 240 (297)
T 3fxz_A 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE------L---QNPE 240 (297)
T ss_dssp C--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC------C---SCGG
T ss_pred c--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------C---CCcc
Confidence 2 223579999999999999999999999999999999999999998776655554444332211 1 1111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.....+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 22344778999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=354.84 Aligned_cols=278 Identities=38% Similarity=0.613 Sum_probs=228.1
Q ss_pred cccChHHHHhhcCCCCCC------cccccCCcccEEeeeecCCcEEEEEEccCC----ChhcHHHHHHHHHHHhhcCCCC
Q 006125 337 FFIDLETLNLATSNFSDS------NILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKLQHKN 406 (660)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h~n 406 (660)
..+.++++...+++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 456778888889998877 8999999999999987 6889999998642 2334667999999999999999
Q ss_pred cceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC
Q 006125 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (660)
Q Consensus 407 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~ 486 (660)
|+++++++.+.+..++||||+++++|.+++........+++..++.++.||++||.|||+.+ |+||||||+|||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence 99999999999999999999999999999975555567999999999999999999999998 999999999999999
Q ss_pred CCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc----HHHHH
Q 006125 487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ----LLAYA 562 (660)
Q Consensus 487 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~----~~~~~ 562 (660)
++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|||++|+.||.... ...+.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 99999999999987654333322333578999999998865 58899999999999999999999987432 12222
Q ss_pred HHHHhc-CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 563 WHLWNE-GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 563 ~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
...... ..+.+.+++.+. .........+.+++.+||+.||.+||++.||++.|++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 222221 122334444442 346677788999999999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=369.75 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=212.3
Q ss_pred hcCCCCCCcccccCCcccEEeeeec--------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD 416 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 416 (660)
..++|...+.||+|+||.||++... ++..||||+++.. .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4467888899999999999999852 3557999999754 344567899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhcCCCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceE
Q 006125 417 GDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (660)
Q Consensus 417 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 483 (660)
.+..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999964321 235899999999999999999999998 999999999999
Q ss_pred eCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q 006125 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYA 562 (660)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~ 562 (660)
|+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999987654433222233456789999999999999999999999999999999 99998765544433
Q ss_pred HHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 563 WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 563 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+.. +... ..+......+.+++.+||+.||.+||++.|+++.|+.+
T Consensus 316 ~~~~~-~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 316 KLLKE-GHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHHT-TCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhc-CCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 32222 2111 11112234578899999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=368.72 Aligned_cols=271 Identities=27% Similarity=0.385 Sum_probs=221.3
Q ss_pred cccChHHHHhhcCCCCCCcccccCCcccEEeeee------cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcc
Q 006125 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLV 408 (660)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv 408 (660)
..++....++..++|...+.||+|+||.||++.+ .+++.||||+++.. .....+.+.+|+.++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 4456777888899999999999999999999973 24678999999763 344556799999999999 899999
Q ss_pred eEeEEEEeCCe-eEEEEEecCCCChhhhhcCCCC----------------------------------------------
Q 006125 409 KLLGFCVDGDE-KLLVYEFMPNGSLDAILFDPRK---------------------------------------------- 441 (660)
Q Consensus 409 ~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------- 441 (660)
++++++.+.+. .++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999987654 8999999999999999965432
Q ss_pred -----------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 442 -----------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 442 -----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999998 999999999999999999999999999876544
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
..........||+.|+|||++.+..++.++||||||+++|||++ |+.||...............+..... . ..
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~-~~ 320 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-----P-DY 320 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC-----C-TT
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC-----C-CC
Confidence 43333344578999999999999999999999999999999998 99999765544444444443322111 1 12
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
. ...+.+++.+||+.||.+||++.||++.|+..
T Consensus 321 ~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 321 T----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 2 23477889999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=361.86 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=208.8
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
.++|...+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788899999999999999996 58999999998643 4445667889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999984 3356999999999999999999999998 999999999999999999999999999765433
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCC-cchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYS-KKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.. ....+||+.|+|||++.+..+. .++|||||||++|||++|+.||...........+...... +. ..
T Consensus 168 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------~p-~~ 236 (328)
T 3fe3_A 168 GK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-------IP-FY 236 (328)
T ss_dssp CG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------CC-TT
T ss_pred Cc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------CC-CC
Confidence 22 2234799999999999887765 8999999999999999999999887766655544433211 11 01
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
. ...+.+++.+||+.||.+|||++|+++
T Consensus 237 ~----s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 237 M----STDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp S----CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred C----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2 234778899999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.58 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=207.5
Q ss_pred CCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
|...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 555678999999999999965 7999999999876666778899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 127 ~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-- 197 (321)
T 2c30_A 127 GALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-- 197 (321)
T ss_dssp CBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--
Confidence 99999984 235899999999999999999999998 999999999999999999999999999876543222
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHH
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEF 589 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 589 (660)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+..... +.+.. .....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------~~~~~---~~~~~ 268 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP------PKLKN---SHKVS 268 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC------CCCTT---GGGSC
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------CCcCc---cccCC
Confidence 2235799999999999999999999999999999999999999987665544433332211 11110 11122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 590 SRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 590 ~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+.+++.+||+.||++||++.|+++
T Consensus 269 ~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 269 PVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 34778899999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=362.36 Aligned_cols=259 Identities=29% Similarity=0.425 Sum_probs=211.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeec----CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
..++|...+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 4567888899999999999999964 3456999999753 4455678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 127 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999954 2345999999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 502 AESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 502 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+......
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------- 273 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-------- 273 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC--------
Confidence 5432221 1122345778999999999999999999999999999999 99999876655544433322111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.........+.+|+.+||+.||.+||++.||+++|+...
T Consensus 274 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 274 ---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011122345788999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=364.34 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=206.1
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC----eeE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKL 421 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 421 (660)
+..++|...++||+|+||.||+|+.. ++.||||+++.. .........|+.++.+++||||+++++++.... ..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34567888999999999999999874 799999999753 333445677999999999999999999998754 369
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCceEeCCCCCEE
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED----------SRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
+||||+++|+|.+++.. ..+++..++.++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 99999999999999943 3499999999999999999999998 6 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhhcC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCcH--------
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-----LYSKKSDVFSFGVLLIEIITGRRNAGSNQL-------- 558 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwslGvll~elltG~~p~~~~~~-------- 558 (660)
|+|||+++...............||+.|+|||++.+. .++.++||||||+++|||++|+.||.....
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999876654443333335789999999999863 456789999999999999999999863210
Q ss_pred -------HHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 559 -------LAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 559 -------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
............. .+.+............+.+|+.+||+.||++|||+.||++.|+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111111111111 111111011224556789999999999999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=359.90 Aligned_cols=261 Identities=28% Similarity=0.458 Sum_probs=209.2
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|...++||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 456778899999999999999964 6899999999877777788899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++|+|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999542 345999999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccc------------eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccc
Q 006125 507 EAN------------TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLEL 574 (660)
Q Consensus 507 ~~~------------~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 574 (660)
... .....||+.|+|||++.+..++.++||||||+++|||++|..|+.......... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----~~~~~~~ 239 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----GLNVRGF 239 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----SBCHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----hhhhhcc
Confidence 211 113478999999999999999999999999999999999998875321000000 0000000
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
.+.... +.. ...+.+++.+||+.||++||++.|++++|+....
T Consensus 240 ~~~~~~-~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 240 LDRYCP-PNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHTCC-TTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCC-CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001111 111 2347789999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=363.69 Aligned_cols=269 Identities=28% Similarity=0.418 Sum_probs=218.9
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEE
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 414 (660)
..+.+..++|...+.||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344566788999999999999999999964 3478999999754 344567799999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCChhhhhcCCCC---------------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 006125 415 VDGDEKLLVYEFMPNGSLDAILFDPRK---------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 473 (660)
.+.+..++||||+++|+|.+++..... ...+++.+++.++.||++||.|||+.+ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999999999999964221 256899999999999999999999998 99
Q ss_pred ecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCC
Q 006125 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRN 552 (660)
Q Consensus 474 H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p 552 (660)
||||||+|||+++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999987654433233334567899999999999999999999999999999999 9999
Q ss_pred CCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 553 AGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
|......+....+.. +.... .+......+.+++.+||+.||++||++.||++.|++.....
T Consensus 277 ~~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 277 YYGMAHEEVIYYVRD-GNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTSCHHHHHHHHHT-TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCCChHHHHHHHhC-CCcCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 987665544433332 22111 11112345788999999999999999999999999876544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.05 Aligned_cols=259 Identities=28% Similarity=0.376 Sum_probs=210.1
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
+..++|...+.||+|+||.||+|... +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 44567778899999999999999975 7899999999753 233445688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999953 2345899999999999999999999998 99999999999999999999999999986443
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
...........++..|+|||++....++.++||||||+++|||++ |+.||......+..... ..+....
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~--------- 335 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLP--------- 335 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-HTTCCCC---------
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCC---------
Confidence 221111112245778999999999999999999999999999998 99998766544333222 2221110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.+......+.+|+.+||+.||++|||+.||++.|+++
T Consensus 336 -~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 336 -CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111234577899999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=349.27 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=212.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
..++|+..+.||+|+||.||++...+++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 345778889999999999999998889999999997532 3456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999954 3345899999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+...... .. ....
T Consensus 162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------~~-~~~~- 232 (269)
T 4hcu_A 162 TS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------YK-PRLA- 232 (269)
T ss_dssp HS-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------CC-CTTS-
T ss_pred cc-ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC------CC-CCcC-
Confidence 11 112346778999999999999999999999999999999 99999877665554443332110 11 1112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
...+.+++.+||+.||++||++.|+++.|++.
T Consensus 233 ---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 233 ---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 23477889999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=365.41 Aligned_cols=258 Identities=29% Similarity=0.444 Sum_probs=200.5
Q ss_pred hcCCCCCCcccccCCcccEEeeeec----CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
..++|...+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 4568899999999999999999864 5678999999753 4455678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+++|+|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999964 3345999999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 502 AESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 502 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+.. +.. .
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-~~~-------~ 269 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYR-------L 269 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-TEE-------C
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCC-------C
Confidence 5432221 1112245778999999999999999999999999999998 9999976655444333221 110 0
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.........+.+++.+||+.||.+||++.||+++|+..
T Consensus 270 ---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 270 ---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 01112334588899999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=348.83 Aligned_cols=259 Identities=27% Similarity=0.358 Sum_probs=214.1
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+..++|+..+.||+|+||.||++...++..||+|+++... ...+++.+|+.++.+++||||+++++++.+....++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3456788889999999999999998888899999997633 345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred ccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999953 2345899999999999999999999998 9999999999999999999999999998654432
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.................. ......
T Consensus 159 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~ 230 (268)
T 3sxs_A 159 YVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-------YRPHLA 230 (268)
T ss_dssp EEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------CCCTTS
T ss_pred hhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-------CCCCcC
Confidence 211 122345678999999999899999999999999999999 99999876655544443332211 001111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
...+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 231 ----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 231 ----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 2347789999999999999999999999988643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.47 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=202.5
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999965 78999999986432 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++|+|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999994 3455999999999999999999999998 99999999999999999999999999987654333
Q ss_pred ccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
........||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+...... ..+ .
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~-------~ 231 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNP-------W 231 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--STT-------G
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--CCc-------c
Confidence 332334579999999999987765 789999999999999999999997544322222222221110 000 0
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 112234678899999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=359.70 Aligned_cols=248 Identities=23% Similarity=0.276 Sum_probs=207.9
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|+..+.||+|+||.||++... +|+.||+|+++.. .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888899999999999999964 6899999999752 234566789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|..++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999984 3456899999999999999999999998 99999999999999999999999999976432
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+.......+..... .+.. .
T Consensus 158 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------~~p~-~ 227 (337)
T 1o6l_A 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------RFPR-T 227 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------CCCT-T
T ss_pred CCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------CCCC-C
Confidence 222 22345899999999999999999999999999999999999999987765555444433211 1111 2
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
.+ ..+.+++.+||+.||.+|| ++.||++
T Consensus 228 ~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 228 LS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 22 3477888999999999999 8999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=362.86 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=201.1
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCc----EEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
.++|+..++||+|+||.||+|... +++ .||+|.++. ......+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 456888899999999999999953 444 368888864 33455678999999999999999999999998764 78
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+|+||+++|+|.+++.. ....+++..++.|+.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999954 2345999999999999999999999998 999999999999999999999999999877
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------- 238 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 238 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---------
Confidence 55444333334467889999999999999999999999999999999 99999765543332222221110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.........+.+++.+||+.||.+||++.||++.|+..
T Consensus 239 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 239 --PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11122234578899999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=361.69 Aligned_cols=269 Identities=29% Similarity=0.403 Sum_probs=215.1
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeee------cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEE
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 415 (660)
.++..++|...+.||+|+||.||++.. .+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445667889999999999999999985 24568999999753 334557899999999999 9999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCCCC--------------------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPRKR--------------------GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 475 (660)
..+..++||||+++|+|.+++...... ..+++..++.++.||++||+|||+.+ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999999653321 34899999999999999999999998 9999
Q ss_pred CCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 006125 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAG 554 (660)
Q Consensus 476 DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~ 554 (660)
||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987655443333334567889999999999999999999999999999998 999997
Q ss_pred CCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCC
Q 006125 555 SNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLP 625 (660)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 625 (660)
..............+.... .+......+.+|+.+||+.||.+||++.||++.|+......+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cCCcHHHHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 6554444444443321111 111123457889999999999999999999999988765544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=347.90 Aligned_cols=262 Identities=25% Similarity=0.354 Sum_probs=211.4
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC---CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|+..+.||+|+||.||++.. .+++.||+|++.. ......+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46788899999999999999995 4689999999853 2334456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++++|.+++. ..+.+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999994 3456999999999999999999999998 99999999999999999999999999986643
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.................. .. ....
T Consensus 164 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~-~~~~---- 236 (294)
T 4eqm_A 164 TSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP-NV-TTDV---- 236 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC-CH-HHHS----
T ss_pred cccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC-Cc-chhc----
Confidence 3222 122357899999999999999999999999999999999999999877766555444433211 10 0011
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-CHHhHHHHhcCCCCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRP-TMSSVAPMLKGETGT 623 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~ 623 (660)
.......+.+++.+||+.||.+|| +++++.+.|+.....
T Consensus 237 -~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 237 -RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 111234578899999999999998 999999999886544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=361.18 Aligned_cols=267 Identities=25% Similarity=0.319 Sum_probs=211.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCee
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 420 (660)
+..++|+..++||+|+||.||+++.. +|+.||||+++.. .....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578899999999999999999964 6899999999752 334556788999999988 799999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++|+|..++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999994 3456999999999999999999999998 99999999999999999999999999975
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+...... .
T Consensus 174 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-------~- 243 (353)
T 3txo_A 174 GICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-------Y- 243 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------C-
T ss_pred cccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------C-
Confidence 432221 223458999999999999989999999999999999999999999887766655555443211 1
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCH------HhHHH--HhcCC------CCCCCCCCCCce
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTM------SSVAP--MLKGE------TGTLPQPQKPAF 632 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~--~L~~~------~~~~~~p~~p~~ 632 (660)
....+ ..+.+++.+||+.||.+||++ .|+++ +++++ .....+|-.|..
T Consensus 244 p~~~~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~ 305 (353)
T 3txo_A 244 PTWLH----EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRI 305 (353)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred CCCCC----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCC
Confidence 11222 347788899999999999998 67763 44443 234445555543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=367.41 Aligned_cols=268 Identities=28% Similarity=0.384 Sum_probs=218.2
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec--------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEE
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFC 414 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 414 (660)
++..++|...++||+|+||.||++... .++.||||+++.. .......+.+|+.+++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 345577888899999999999999852 2357999999753 344567899999999999 999999999999
Q ss_pred EeCCeeEEEEEecCCCChhhhhcCCCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 006125 415 VDGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~N 481 (660)
...+..++||||+++|+|.+++..... ...+++..++.|+.||++||+|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999964321 245999999999999999999999998 9999999999
Q ss_pred eEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 006125 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLA 560 (660)
Q Consensus 482 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~ 560 (660)
|||++++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987654433333333467889999999999999999999999999999999 999998766554
Q ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCC
Q 006125 561 YAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQ 626 (660)
Q Consensus 561 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 626 (660)
....+.. +..... .... ...+.+++.+||+.||++||++.||++.|++.....+.
T Consensus 302 ~~~~~~~-~~~~~~------~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 302 LFKLLKE-GHRMDK------PSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHHHT-TCCCCC------CSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHHHc-CCCCCC------CccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 4433322 211111 1122 23578899999999999999999999999887544433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=365.71 Aligned_cols=260 Identities=31% Similarity=0.436 Sum_probs=212.5
Q ss_pred hcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
..++|...++||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3467788899999999999999843 4678999999753 44556678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCC----CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC---CEEE
Q 006125 420 KLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKI 492 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~---~~kl 492 (660)
.++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+||||+.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999996422 2245899999999999999999999998 99999999999999554 5999
Q ss_pred eeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcc
Q 006125 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNV 571 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 571 (660)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986644433333333467899999999999999999999999999999998 99999877665554444332211
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
. ........+.+|+.+||+.||.+||++.||++.|+..
T Consensus 306 -~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 306 -D----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp -C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C----------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 1111223477899999999999999999999999754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=376.28 Aligned_cols=264 Identities=28% Similarity=0.394 Sum_probs=215.9
Q ss_pred HHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
..++..++|...+.||+|+||.||+|.+.+++.||||+++... ...+.+.+|+.++++++||||+++++++. .+..++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3455667888899999999999999999888999999998643 45778999999999999999999999986 567899
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 260 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999999532 2235889999999999999999999998 9999999999999999999999999998764
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
...... .....++..|+|||++....++.++||||||+++|||++ |+.||......+....+...... ..
T Consensus 336 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------~~ 406 (454)
T 1qcf_A 336 DNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM--------PR 406 (454)
T ss_dssp CHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC--------CC
T ss_pred CCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------CC
Confidence 322111 112246778999999999999999999999999999999 99999876655444333322111 01
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
+......+.+|+.+||+.||++|||+.+|+++|++.....
T Consensus 407 ---~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 407 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 1122345788999999999999999999999999875443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=345.84 Aligned_cols=254 Identities=32% Similarity=0.487 Sum_probs=201.8
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCC----hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
..++|+..+.||+|+||.||++.. .++.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 456788889999999999999997 48999999987532 2335678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC--------CCCEEEee
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--------DMNSKISD 494 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~--------~~~~kl~D 494 (660)
||||+++++|.+++. ...+++..++.++.||++||.|||+.+..+|+||||||+|||++. ++.+||+|
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999993 346899999999999999999999988666999999999999986 67899999
Q ss_pred ccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccc
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLEL 574 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 574 (660)
||++........ ....|++.|+|||++.+..++.++||||||+++|||++|+.||....................
T Consensus 160 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 234 (271)
T 3dtc_A 160 FGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP- 234 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC-
T ss_pred CCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC-
Confidence 999976543322 134689999999999999999999999999999999999999987665555444433322111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
........+.+++.+||+.||.+||++.|+++.|++
T Consensus 235 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 235 ---------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ---------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111223457889999999999999999999999976
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=354.68 Aligned_cols=251 Identities=22% Similarity=0.258 Sum_probs=207.0
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh------hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
.++|...+.||+|+||.||++... +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356888899999999999999964 689999999875322 2357899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC----CEEEeecc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFG 496 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfG 496 (660)
++||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999994 3456999999999999999999999998 99999999999998877 79999999
Q ss_pred ccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccc
Q 006125 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||......+....+...... ++
T Consensus 165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~ 238 (361)
T 2yab_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD---FD 238 (361)
T ss_dssp SCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC---CC
T ss_pred CceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---CC
Confidence 9987654322 22357999999999999999999999999999999999999999877655544443322110 00
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+.... .. ...+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~-~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 239 EEFFS-QT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHT-TS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcc-CC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 11 234778999999999999999999984
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=355.83 Aligned_cols=262 Identities=29% Similarity=0.416 Sum_probs=213.3
Q ss_pred HhhcCCCCCCcccccCCcccEEeeee------cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 417 (660)
++..++|...+.||+|+||.||++.. .+++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34567788889999999999999985 24578999999753 345567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCCCC---------------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRK---------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 476 (660)
+..++||||+++|+|.+++..... ...+++.+++.++.||++||.|||+.+ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999964332 234899999999999999999999998 99999
Q ss_pred CCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 006125 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGS 555 (660)
Q Consensus 477 Lkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~ 555 (660)
|||+|||+++++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654433332333467888999999999999999999999999999999 9999876
Q ss_pred CcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 556 NQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
........ ....+... .........+.+++.+||+.||++||++.||++.|++.
T Consensus 256 ~~~~~~~~-~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 256 IPPERLFN-LLKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CCGGGHHH-HHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHH-HhhcCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 55433322 22222111 11112234578899999999999999999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=358.43 Aligned_cols=266 Identities=26% Similarity=0.391 Sum_probs=198.9
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeeecC-Cc---EEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEE
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GK---EVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 415 (660)
+++.+..++|+..+.||+|+||.||++.... ++ .||||+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3444667789999999999999999999643 32 7999999753 3445678999999999999999999999998
Q ss_pred eCCee------EEEEEecCCCChhhhhcCCC---CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC
Q 006125 416 DGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (660)
Q Consensus 416 ~~~~~------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~ 486 (660)
..... ++||||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||+++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcC
Confidence 87665 99999999999999985321 2225899999999999999999999998 999999999999999
Q ss_pred CCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 006125 487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHL 565 (660)
Q Consensus 487 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~ 565 (660)
++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 99999999999987654443333333456788999999999999999999999999999999 89998765544443333
Q ss_pred HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 566 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
...... .........+.+++.+||+.||++||++.|+++.|++..
T Consensus 253 ~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 253 IGGNRL-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HTTCCC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCC-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 322211 111122345788999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=374.22 Aligned_cols=268 Identities=27% Similarity=0.399 Sum_probs=212.3
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++..++|...++||+|+||.||+|.+.++..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34566788889999999999999999888889999998643 345789999999999999999999999876 6789999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999421 2245899999999999999999999998 999999999999999999999999999876533
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.... .....++..|+|||++....++.++||||||+++|||++ |+.||......+....+...... .
T Consensus 334 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-----------~ 401 (452)
T 1fmk_A 334 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------P 401 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----------C
T ss_pred ceec-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------C
Confidence 2211 122356788999999999999999999999999999999 89999766554443333222110 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCCCCCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKP 630 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p 630 (660)
.+......+.+|+.+||+.||++|||+++|++.|++......+...|
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 11122345788999999999999999999999999986655443333
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=350.40 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=207.0
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|+..+.||+|+||.||+++.. +|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 356788899999999999999964 7899999999752 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999994 3456899999999999999999999998 99999999999999999999999999986543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
. ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+.......+..... .+. ..
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------~~p-~~ 225 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-------RFP-PF 225 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-------CCC-TT
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------CCC-CC
Confidence 2 2235799999999999999999999999999999999999999987776655555443321 011 12
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVA 614 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl 614 (660)
++ ..+.+++.+||+.||++|| +++||+
T Consensus 226 ~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 226 FN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp SC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 22 3477888999999999999 889988
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=357.87 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=206.8
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCe
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 419 (660)
.+..++|...+.||+|+||.||+++.+ +|+.||+|+++.. .......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 455678999999999999999999964 6899999999753 134456788899999887 99999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++||||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999994 3356899999999999999999999998 9999999999999999999999999997
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..... .+
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------~~ 237 (345)
T 1xjd_A 167 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-------FY 237 (345)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------CC
T ss_pred hcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-------CC
Confidence 5433222 22345899999999999999999999999999999999999999987766555444433221 11
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHH-hHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMS-SVA 614 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 614 (660)
.. ..+ ..+.+++.+||+.||++||++. ||+
T Consensus 238 p~-~~s----~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 PR-WLE----KEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CT-TSC----HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred Cc-ccC----HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 222 3477889999999999999998 775
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=349.26 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=202.4
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
++..++|+..++||+|+||.||+++.. ..+|+|+++.. .....+.+.+|+.++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 355678999999999999999999863 35999998643 345567899999999999999999999965 5567899
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999953 3455999999999999999999999998 9999999999999999999999999998655
Q ss_pred ccCCccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
............||+.|+|||++. ...++.++||||||+++|||++|+.||...............+.....+..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 249 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK-- 249 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS--
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh--
Confidence 433333333457899999999986 567899999999999999999999999865544444444444332221111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
........+.+++.+||+.||.+||++.|++++|++...
T Consensus 250 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 ----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111223458889999999999999999999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=353.37 Aligned_cols=258 Identities=26% Similarity=0.340 Sum_probs=200.3
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhh--cCCCCcceEeEEEEeC----CeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDG----DEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 421 (660)
.++|...+.||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788899999999999999988 6899999998653 33455666666665 7999999999997653 4578
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCceEeCCCCCEEEe
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH--------EDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~DLkp~NILl~~~~~~kl~ 493 (660)
+||||+++|+|.+++. ...+++..++.++.||++||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 345999999999999999999999 666 9999999999999999999999
Q ss_pred eccccccccccCCcc--ceeeeeccCCcCCHhhhhcC------CCCcchhHHHHHHHHHHHHhC----------CCCCCC
Q 006125 494 DFGMARIFAESEGEA--NTVRIVGTYGYMAPEYAMEG------LYSKKSDVFSFGVLLIEIITG----------RRNAGS 555 (660)
Q Consensus 494 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwslGvll~elltG----------~~p~~~ 555 (660)
|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997655433221 11224789999999999876 455799999999999999999 777753
Q ss_pred C----cHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 556 N----QLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 556 ~----~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
. .............. ..+.+............+.+++.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2 11122222221111 1111111112335667899999999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=349.44 Aligned_cols=256 Identities=19% Similarity=0.236 Sum_probs=210.8
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|...+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 357888899999999999999964 6889999998753 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC--CCCEEEeecccccccccc
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--DMNSKISDFGMARIFAES 504 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DfGla~~~~~~ 504 (660)
+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||++......
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999943 2345999999999999999999999998 999999999999987 789999999999876433
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+........ .... +..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~-~~~ 230 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD---EEAF-KEI 230 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---HHHH-TTS
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC---hhhh-ccC
Confidence 2 22345799999999999988899999999999999999999999987766555544443321100 0000 011
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
...+.+++.+||+.||.+|||+.|+++ ++++.
T Consensus 231 ----s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 231 ----SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 235788999999999999999999985 55543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.26 Aligned_cols=257 Identities=27% Similarity=0.376 Sum_probs=209.9
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+..++|+..+.||+|+||.||++...++..||+|+++... ...+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4456788889999999999999999888899999997633 345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999999542 345999999999999999999999998 9999999999999999999999999998654322
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...........+..... ... ....
T Consensus 175 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------~~~-~~~~ 246 (283)
T 3gen_A 175 YTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------LYR-PHLA 246 (283)
T ss_dssp HHS-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------CCC-CTTC
T ss_pred ccc-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC------CCC-CCcC
Confidence 111 112246778999999999999999999999999999998 9999987665554444332211 011 1111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
...+.+++.+||+.||.+||++.|+++.|++.
T Consensus 247 ----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 247 ----SEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 23577899999999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.90 Aligned_cols=267 Identities=29% Similarity=0.433 Sum_probs=217.1
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEE
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 414 (660)
+++++..++|...+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344566788999999999999999999854 3678999999753 334456789999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCChhhhhcCCC-------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC
Q 006125 415 VDGDEKLLVYEFMPNGSLDAILFDPR-------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~ 487 (660)
.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999985321 1245789999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 006125 488 MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLW 566 (660)
Q Consensus 488 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~ 566 (660)
+.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+......
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999999986654433222233467889999999999999999999999999999999 888887766554443333
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 567 NEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 567 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
.. .... ........+.+++.+||+.||.+||++.|+++.|++...
T Consensus 255 ~~-~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 EG-GLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TT-CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cC-CcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 22 1111 111223447789999999999999999999999988643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=376.14 Aligned_cols=261 Identities=27% Similarity=0.372 Sum_probs=213.0
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
++..++|...++||+|+||.||+|.+. ++..||||+++.. ....+.+.+|+.++++++||||+++++++.+.+..+||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 344567788899999999999999976 4889999999763 33567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++... ....+++..++.|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999542 2345899999999999999999999998 99999999999999999999999999987643
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
..... .....++..|+|||++....++.++||||||+++|||++ |+.||......+.... ...+.. +
T Consensus 371 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~-------~--- 438 (495)
T 1opk_A 371 DTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYR-------M--- 438 (495)
T ss_dssp CCEEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCC-------C---
T ss_pred Cceee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCC-------C---
Confidence 22111 112345778999999999999999999999999999999 8899876554433222 222111 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
..+......+.+|+.+||+.||.+||++.||++.|+....
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111223457889999999999999999999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=355.46 Aligned_cols=269 Identities=27% Similarity=0.376 Sum_probs=205.8
Q ss_pred hcCCCCCCcccccCCcccEEeeee-----cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--Ce
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DE 419 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 419 (660)
..++|+..+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 346778889999999999999984 36889999999877777778899999999999999999999998654 45
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999999542 335899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc--------
Q 006125 500 IFAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN-------- 570 (660)
Q Consensus 500 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~-------- 570 (660)
......... ......++..|+|||++.+..++.++||||||+++|||++|..|+...... .........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHHCTTCCTHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhhcCccccchhHHH
Confidence 765432221 112234677899999999999999999999999999999999887643211 001111000
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCC
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGT 623 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 623 (660)
..+.+...... ..+......+.+++.+||+.||++|||+.||++.|+.....
T Consensus 241 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 241 LIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhccCcC-CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00000000000 11222334588899999999999999999999999875433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=351.99 Aligned_cols=264 Identities=27% Similarity=0.395 Sum_probs=215.5
Q ss_pred HhhcCCCCCCcccccCCcccEEeeee------cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEe
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD 416 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 416 (660)
++..++|...+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 44567788899999999999999984 356789999997543 34567799999999999 99999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhcCCCC---------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 006125 417 GDEKLLVYEFMPNGSLDAILFDPRK---------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (660)
Q Consensus 417 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~N 481 (660)
.+..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 9999999999999999999964322 224899999999999999999999998 9999999999
Q ss_pred eEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 006125 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLA 560 (660)
Q Consensus 482 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~ 560 (660)
||+++++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999987655443322333467889999999999999999999999999999999 999987655444
Q ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 561 YAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 561 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
........... ... ... ....+.+++.+||+.||.+||++.|+++.|++..
T Consensus 256 ~~~~~~~~~~~-----~~~-~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 256 KFYKMIKEGFR-----MLS-PEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHHHHTCC-----CCC-CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCC-----CCC-ccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 44444333211 111 112 2345788999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.76 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=205.8
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh------hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
++|...+.||+|+||.||++... +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45777899999999999999964 689999999864321 24678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC----CEEEeeccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM 497 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfGl 497 (660)
+||||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999994 3456999999999999999999999998 99999999999999887 899999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~ 577 (660)
+........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+...... ....
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~ 239 (326)
T 2y0a_A 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--FEDE 239 (326)
T ss_dssp CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC--CCHH
T ss_pred CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC--cCcc
Confidence 987643322 12347999999999999899999999999999999999999999876655444333322110 0000
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
... .. ...+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~--~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 240 YFS--NT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHT--TS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccc--cC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 11 234778899999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=349.54 Aligned_cols=265 Identities=28% Similarity=0.413 Sum_probs=205.6
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.++|+..+.||+|+||.||++.. .++.||+|++... ...+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 35677789999999999999997 4789999999743 34567899999999999999999999876 4589999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC-EEEeeccccccccccCC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-SKISDFGMARIFAESEG 506 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~-~kl~DfGla~~~~~~~~ 506 (660)
++|+|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~- 160 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM- 160 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence 99999999976544445889999999999999999999943234999999999999998886 7999999997553321
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHHhcCcccccccccCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--LLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
....||+.|+|||++.+..++.++||||||+++|||++|+.||.... .....+....... . .... ..
T Consensus 161 ----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~-----~~~~-~~ 229 (307)
T 2eva_A 161 ----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-P-----PLIK-NL 229 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-C-----CCBT-TC
T ss_pred ----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-C-----Cccc-cc
Confidence 22368999999999999999999999999999999999999997432 2222222222111 1 1111 22
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCCCCCCcee
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFS 633 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~ 633 (660)
...+.+++.+||+.||.+|||+.|+++.|+.....++.+..|...
T Consensus 230 ----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 274 (307)
T 2eva_A 230 ----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274 (307)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCC
T ss_pred ----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcccc
Confidence 234778999999999999999999999998876666655555443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=349.26 Aligned_cols=265 Identities=26% Similarity=0.323 Sum_probs=202.9
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.++|...++||+|+||.||++...+|+.||+|+++.. .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4678888999999999999999888999999998743 22335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++ +|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 77777753 3345899999999999999999999998 9999999999999999999999999998664322
Q ss_pred CccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHH---HHHHhcCcccccc------
Q 006125 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYA---WHLWNEGNVLELV------ 575 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~------ 575 (660)
.. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ..........+..
T Consensus 174 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 RS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred cc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 22 223468999999999876 56899999999999999999999999754322222 2222111100000
Q ss_pred ---c---ccCCCCC---CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 576 ---D---PLLTDTS---FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 576 ---d---~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
+ ....... ........+.+++.+||+.||++|||+.|+++ ++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0 0000000 00011235778999999999999999999986 55554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.46 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=214.6
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC--eeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 423 (660)
.++|...++||+|+||.||++... +++.||||+++... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356788899999999999999965 58999999997533 344677889999999999999999999998765 67999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe----CCCCCEEEeeccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMAR 499 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DfGla~ 499 (660)
|||+++++|.+++........+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976545455999999999999999999999998 9999999999999 788889999999998
Q ss_pred cccccCCccceeeeeccCCcCCHhhhh--------cCCCCcchhHHHHHHHHHHHHhCCCCCCC----CcHHHHHHHHHh
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAM--------EGLYSKKSDVFSFGVLLIEIITGRRNAGS----NQLLAYAWHLWN 567 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDVwslGvll~elltG~~p~~~----~~~~~~~~~~~~ 567 (660)
........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||.. ....+....+..
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 76543322 2346899999999987 46789999999999999999999999863 222333333333
Q ss_pred cCccc--c-----------cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 568 EGNVL--E-----------LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 568 ~~~~~--~-----------~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
..... . +.................+.+++.+||+.||++|||++|+++-..+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 22110 0 000111112445677778899999999999999999999999887653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=353.44 Aligned_cols=263 Identities=26% Similarity=0.386 Sum_probs=213.3
Q ss_pred HhhcCCCCCCcccccCCcccEEeeee--------cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEE
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVL--------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFC 414 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 414 (660)
.+..++|...+.||+|+||.||++.. .+++.||+|+++.. .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34567888899999999999999985 24678999999753 344567799999999999 999999999999
Q ss_pred EeCCeeEEEEEecCCCChhhhhcCCCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 006125 415 VDGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~N 481 (660)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999965332 234899999999999999999999998 9999999999
Q ss_pred eEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 006125 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLA 560 (660)
Q Consensus 482 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~ 560 (660)
||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999999987654433222333456888999999999899999999999999999999 999998766554
Q ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 561 YAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 561 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
....+..... .. ........+.+++.+||+.||.+||++.||++.|++..
T Consensus 268 ~~~~~~~~~~-~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 268 LFKLLKEGHR-MD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHHHHTCC-CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCC-CC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 4433322211 11 11112345788999999999999999999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=349.75 Aligned_cols=272 Identities=27% Similarity=0.388 Sum_probs=219.8
Q ss_pred cccChHHHHhhcCCCCCCcccccCCcccEEeeee------cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcc
Q 006125 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLV 408 (660)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv 408 (660)
..++..+..+..++|...+.||+|+||.||++.. .+++.||||+++.. .....+.+.+|+.++.++ +||||+
T Consensus 15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence 3455667777888999999999999999999974 35689999999753 334556789999999999 799999
Q ss_pred eEeEEEEeCC-eeEEEEEecCCCChhhhhcCCCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 006125 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474 (660)
Q Consensus 409 ~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 474 (660)
++++++...+ ..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+|
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H 171 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 171 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999998755 48999999999999999965332 223899999999999999999999998 999
Q ss_pred cCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 006125 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNA 553 (660)
Q Consensus 475 ~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~ 553 (660)
|||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654433333334567899999999999999999999999999999998 99999
Q ss_pred CCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 554 GSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
...............+..... .. .. ...+.+++.+||+.||.+||++.||++.|+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~-----~~-~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 252 PGVKIDEEFCRRLKEGTRMRA-----PD-YT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp TTCCCSHHHHHHHHHTCCCCC-----CT-TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccchhHHHHHHhccCccCCC-----CC-CC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 765544434333333321111 11 12 234778899999999999999999999998653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=345.16 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=198.9
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCCh--------------------------hcHHHHHHHHHHHh
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE--------------------------QGTAEFTNEVLLIL 400 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 400 (660)
.++|...+.||+|+||.||++.. .+++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46788899999999999999985 4688999999864321 12356889999999
Q ss_pred hcCCCCcceEeEEEEe--CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006125 401 KLQHKNLVKLLGFCVD--GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK 478 (660)
Q Consensus 401 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLk 478 (660)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||++||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998876 3346999999999999999999999998 9999999
Q ss_pred CCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 006125 479 ASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL---YSKKSDVFSFGVLLIEIITGRRNAGS 555 (660)
Q Consensus 479 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwslGvll~elltG~~p~~~ 555 (660)
|+|||++.++.+||+|||+++........ .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999876543221 22347899999999987655 47899999999999999999999987
Q ss_pred CcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 556 NQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.........+...... . + ..+..+ ..+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~--~--~--~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALE--F--P--DQPDIA----EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHHHHHHHHHCCCC--C--C--SSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHHHHHHHhcccCC--C--C--CccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 7655544333322110 0 0 011222 34778999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.03 Aligned_cols=268 Identities=22% Similarity=0.291 Sum_probs=216.0
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEE
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 415 (660)
.+.++++..++|+..++||+|+||.||+++.. +++.||+|+++.. .......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45667788899999999999999999999965 5789999998642 1222334889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeec
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 495 (660)
+.+..+|||||+++|+|.+++.. ..+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999954 2356999999999999999999999998 999999999999999999999999
Q ss_pred cccccccccCCccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc
Q 006125 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 570 (660)
|+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 999766443222 122357999999999997 45689999999999999999999999988776665555543211
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHhHHH--HhcCC
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFD--RPTMSSVAP--MLKGE 620 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~--~L~~~ 620 (660)
...+ +... ...+ ..+.+|+.+||+.+|++ ||+++|+++ +++++
T Consensus 299 ~~~~--p~~~-~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 299 RFQF--PTQV-TDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HCCC--CSSC-CCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred cccC--Cccc-ccCC----HHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 1111 1100 1222 34678888999888888 999999984 55543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=352.42 Aligned_cols=271 Identities=28% Similarity=0.402 Sum_probs=205.8
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeeec----CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEE
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGF 413 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 413 (660)
.++++.+..++|...+.||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34555667788999999999999999999854 3458999998743 34456779999999999999999999999
Q ss_pred EEeCCe-----eEEEEEecCCCChhhhhcCC---CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC
Q 006125 414 CVDGDE-----KLLVYEFMPNGSLDAILFDP---RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD 485 (660)
Q Consensus 414 ~~~~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~ 485 (660)
+.+.+. .++||||+++|+|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc
Confidence 987653 49999999999999998432 23456999999999999999999999998 99999999999999
Q ss_pred CCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 006125 486 SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWH 564 (660)
Q Consensus 486 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~ 564 (660)
+++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||...........
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 999999999999987654433222333467889999999999999999999999999999999 8888876554443333
Q ss_pred HHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 565 LWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 565 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
....... .........+.+++.+||+.||.+||++.|+++.|++....+
T Consensus 262 ~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 262 LLHGHRL-----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHTTCCC-----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHcCCCC-----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 3222110 111122345788999999999999999999999998765444
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.60 Aligned_cols=256 Identities=22% Similarity=0.253 Sum_probs=211.4
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
++|...+.||+|+||.||++... +|+.||+|++..........+.+|+.++..++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 57888999999999999999964 68999999998765556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC--CCCEEEeeccccccccccC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--DMNSKISDFGMARIFAESE 505 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DfGla~~~~~~~ 505 (660)
++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 131 ~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 131 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999853 2345999999999999999999999998 999999999999974 4789999999998764432
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...... .+... .
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~---~~~~~-----~ 274 (387)
T 1kob_A 206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---FDEDA-----F 274 (387)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC---CCSST-----T
T ss_pred c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCccc-----c
Confidence 1 22347999999999999999999999999999999999999999877655544443332211 11111 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
......+.+++.+||+.||.+|||+.|+++ ++++.
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 112234778999999999999999999986 35443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.65 Aligned_cols=257 Identities=31% Similarity=0.417 Sum_probs=204.6
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcE----EEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKE----VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
.++|+..+.||+|+||.||+|... +++. |++|.+... .......+.+|+.++.+++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 456788899999999999999954 4554 788887542 2334456788999999999999999999986 45688
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+++|+|.+++.. ..+.+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999954 2356999999999999999999999998 999999999999999999999999999887
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
.............++..|+|||++.+..++.++||||||+++|||++ |+.||...........+..... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~------ 238 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-LAQ------ 238 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-CCC------
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-CCC------
Confidence 65544433444578889999999999999999999999999999999 9999986554443333222211 110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
+......+.+++.+||+.||.+||++.|+++.|+...
T Consensus 239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 ----PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111223667889999999999999999999997653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=353.10 Aligned_cols=244 Identities=24% Similarity=0.283 Sum_probs=206.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||+++.. +|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56788899999999999999964 6899999998642 2244567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999994 3345899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... .+. ..+
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------~~p-~~~ 261 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-------RFP-SHF 261 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------CCC-TTC
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-------CCC-CCC
Confidence 2235799999999999999999999999999999999999999987776555544443321 111 122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCC-----HHhHHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPT-----MSSVAP 615 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 615 (660)
+ ..+.+++.+||+.||.+||+ ++||++
T Consensus 262 ~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 S----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C----HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 2 34778999999999999998 888873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=355.14 Aligned_cols=265 Identities=28% Similarity=0.409 Sum_probs=214.6
Q ss_pred HHHhhcCCCCCCcccccCCcccEEeeeecC-C-----cEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEE
Q 006125 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSD-G-----KEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFC 414 (660)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 414 (660)
+.++..++|...+.||+|+||.||++.... + +.||+|+++.. .....+.+.+|+.++.++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345667889999999999999999998532 2 47999999754 334566799999999999 899999999999
Q ss_pred EeCCeeEEEEEecCCCChhhhhcCCC-----------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceE
Q 006125 415 VDGDEKLLVYEFMPNGSLDAILFDPR-----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 483 (660)
.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999985321 1345899999999999999999999998 999999999999
Q ss_pred eCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q 006125 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYA 562 (660)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~ 562 (660)
++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999987654433322333467889999999999999999999999999999999 88898765544444
Q ss_pred HHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 563 WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 563 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
........... . +......+.+++.+||+.||.+||++.||++.|+..
T Consensus 277 ~~~~~~~~~~~-----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 YKLVKDGYQMA-----Q-----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCC-----C-----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 44443322110 0 111124577899999999999999999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.20 Aligned_cols=259 Identities=22% Similarity=0.346 Sum_probs=201.8
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe----
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE---- 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 419 (660)
.++|+..+.||+|+||.||++.. .+++.||||+++.. .......+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788899999999999999995 57899999999753 23345678899999999999999999999876543
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++||||+++++|.+++. ..+.+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 499999999999999994 3346899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCc-cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 500 IFAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 500 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+...........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 240 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS---- 240 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH----
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc----
Confidence 66543222 1223357899999999999999999999999999999999999999887776666655544322110
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH-HHhcCC
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA-PMLKGE 620 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl-~~L~~~ 620 (660)
...... ...+.+++.+||+.||.+||++.+++ ..|...
T Consensus 241 ~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 ARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 000112 23477899999999999999666554 455443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=366.00 Aligned_cols=252 Identities=31% Similarity=0.386 Sum_probs=206.2
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC-eeEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLVY 424 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 424 (660)
+..++|...+.||+|+||.||+|... |+.||||+++... ..+.+.+|+.++++++||||+++++++.+.+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 44567788899999999999999984 7899999997643 5578999999999999999999999988765 789999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999999542 2234789999999999999999999998 999999999999999999999999999854322
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+..... . .
T Consensus 343 ~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~----------~ 406 (450)
T 1k9a_A 343 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-M----------D 406 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-C----------C
T ss_pred c-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C----------C
Confidence 1 12256889999999999999999999999999999999 9999876544333332222111 0 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.+......+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1122234578899999999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.35 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=199.1
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..++||+|+||.||++... +++.||+|+++.. .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46788899999999999999964 6899999998643 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|++++ |.+.+.. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99864 4444422 3456999999999999999999999998 9999999999999999999999999998664332
Q ss_pred CccceeeeeccCCcCCHhhhhcCC-CCcchhHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHHHhc---Cccc---ccc--
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNA-GSNQLLAYAWHLWNE---GNVL---ELV-- 575 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwslGvll~elltG~~p~-~~~~~~~~~~~~~~~---~~~~---~~~-- 575 (660)
.. .....||+.|+|||++.+.. ++.++||||||+++|||++|+.|+ ...+..+....+... .... ...
T Consensus 156 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 22 22347899999999998765 899999999999999999988874 444433333333221 0000 000
Q ss_pred -c--c------cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 576 -D--P------LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 576 -d--~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+ + ..............+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0 00000111122345778999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=362.53 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=210.6
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|...+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888899999999999999964 79999999996421 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999994 4456999999999999999999999998 99999999999999999999999999987644
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
... ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...........+..... .. ..
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------~~-p~ 237 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-------YT-PQ 237 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-------CC-CT
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-------CC-Cc
Confidence 322 223479999999999988765 7899999999999999999999987766555444433211 00 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGET 621 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 621 (660)
..+ ..+.+++.+||+.||.+|||+.|+++ +++...
T Consensus 238 ~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 238 YLN----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp TCC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred cCC----HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 222 34778899999999999999999985 666543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=344.86 Aligned_cols=258 Identities=31% Similarity=0.438 Sum_probs=209.9
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+..++|+..+.||+|+||.||++...+++.||+|+++... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 4456788889999999999999998888899999997533 34678999999999999999999999986 456899999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 99999999999431 1225899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+..... ...
T Consensus 164 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------~~~----- 231 (279)
T 1qpc_A 164 YTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------MVR----- 231 (279)
T ss_dssp EEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------CCC-----
T ss_pred ccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC------CCC-----
Confidence 111 112346788999999998899999999999999999999 8999876665444333322211 011
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.......+.+++.+||+.||++||++.++++.|++..
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1112245788999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.12 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=206.2
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
.++|...+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356888899999999999999964 6899999999643 3445667899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC---CCEEEeeccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIF 501 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfGla~~~ 501 (660)
||+++|+|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||++...
T Consensus 108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999884 3456899999999999999999999998 9999999999999865 45999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+...... ...+.
T Consensus 182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~--- 253 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPE--- 253 (362)
T ss_dssp TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTG---
T ss_pred cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--CCccc---
Confidence 53322 12347999999999999989999999999999999999999999876655444333322110 00000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.......+.+++.+||+.||++||++.|+++
T Consensus 254 ---~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 254 ---WDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0112234778999999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.79 Aligned_cols=259 Identities=25% Similarity=0.335 Sum_probs=201.5
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|+..+.||+|+||.||++...+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4677889999999999999998889999999986532 23356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++ +|.+++.. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 89888854 2345899999999999999999999998 99999999999999999999999999976543221
Q ss_pred ccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---Cccc--------cc
Q 006125 507 EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---GNVL--------EL 574 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~~~~--------~~ 574 (660)
. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+... .... ..
T Consensus 156 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 1 123468999999999976 45899999999999999999999999876655444433321 0000 00
Q ss_pred ccccCCC------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 575 VDPLLTD------TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 575 ~d~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.++.... ..........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111000 0001112345778999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=362.38 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=205.7
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
.++|...+.||+|+||.||++.. .+|+.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45688889999999999999985 47899999998653 2344567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC---CCCCEEEeeccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIF 501 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DfGla~~~ 501 (660)
||+++|+|.+.+. ..+.+++..+..++.||++||.|||+.+ |+||||||+|||++ +++.+||+|||++...
T Consensus 90 E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999884 3456999999999999999999999998 99999999999998 4688999999999766
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... ...+..
T Consensus 164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~-- 237 (444)
T 3soa_A 164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD--FPSPEW-- 237 (444)
T ss_dssp CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--CCTTTT--
T ss_pred cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--CCcccc--
Confidence 543222 22357999999999999989999999999999999999999999877655544443332210 101110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
... ...+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 238 DTV----TPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 122 234778899999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.08 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=204.8
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CC-------cEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DG-------KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
..++|...+.||+|+||.||++... ++ ..||+|++........+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3457788899999999999999854 33 479999998766677788999999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC--------E
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--------S 490 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~--------~ 490 (660)
..++||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999953 2334899999999999999999999998 999999999999998887 9
Q ss_pred EEeeccccccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHHhc
Q 006125 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRN-AGSNQLLAYAWHLWNE 568 (660)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p-~~~~~~~~~~~~~~~~ 568 (660)
||+|||++...... ....|++.|+|||++.+ ..++.++||||||+++|||++|..| +......... .....
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYED 233 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHT
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhc
Confidence 99999998654322 12357899999999987 7799999999999999999996554 4443333222 22222
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
... +.. .. ...+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 234 ~~~-------~~~-~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 234 RHQ-------LPA-PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TCC-------CCC-CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred cCC-------CCC-CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 110 000 11 1236788999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=341.74 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=211.4
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
..++|...+.||+|+||.||++...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 346777889999999999999998888999999997633 3446799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++.. ....+++..++.++.||++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 85 MEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999953 2345899999999999999999999998 99999999999999999999999999986543211
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. .....++..|+|||++.+..++.++||||||+++|||++ |+.||...........+...... .. ...
T Consensus 160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~------~~-~~~-- 229 (267)
T 3t9t_A 160 TS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------YK-PRL-- 229 (267)
T ss_dssp HS-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------CC-CTT--
T ss_pred cc-cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC------CC-Ccc--
Confidence 11 112346778999999999999999999999999999999 89999876655544443322110 01 111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
....+.+++.+||+.||++||++.|+++.|++.
T Consensus 230 --~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 230 --ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 223477899999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=354.89 Aligned_cols=250 Identities=24% Similarity=0.275 Sum_probs=202.6
Q ss_pred CcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
.+.||+|+||.||++.. .+|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999985 46899999999876666777899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe--CCCCCEEEeeccccccccccCCccce
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL--DSDMNSKISDFGMARIFAESEGEANT 510 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl--~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (660)
.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||+++........
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~--- 245 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--- 245 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---
Confidence 988853 2345899999999999999999999998 9999999999999 56789999999999876543222
Q ss_pred eeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHH
Q 006125 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFS 590 (660)
Q Consensus 511 ~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 590 (660)
....||+.|+|||++....++.++|||||||++|||++|+.||......+....+....... ..... ... ..
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--~~~~~--~~~----~~ 317 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL--EDEEF--QDI----SE 317 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS--CSGGG--TTS----CH
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--Chhhh--ccC----CH
Confidence 22468999999999998899999999999999999999999998777665555444332110 00111 122 23
Q ss_pred HHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 591 RYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 591 ~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
.+.+++.+||+.||.+||++.|+++ ++++
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 4788999999999999999999985 5543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=356.27 Aligned_cols=271 Identities=18% Similarity=0.212 Sum_probs=207.6
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC------CcEEEEEEccCCChhc-----------HHHHHHHHHHHhhcCCCCcc
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQG-----------TAEFTNEVLLILKLQHKNLV 408 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv 408 (660)
...++|...+.||+|+||.||++...+ ++.||||++....... ...+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 345688899999999999999998754 4789999987543211 11234566677788899999
Q ss_pred eEeEEEEeC----CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe
Q 006125 409 KLLGFCVDG----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484 (660)
Q Consensus 409 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl 484 (660)
++++++... ...+|||||+ +++|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+||||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 999999875 4579999999 9999999954 2356999999999999999999999998 9999999999999
Q ss_pred C--CCCCEEEeeccccccccccCCcc-----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 006125 485 D--SDMNSKISDFGMARIFAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557 (660)
Q Consensus 485 ~--~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~ 557 (660)
+ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998765432211 1123459999999999999999999999999999999999999997421
Q ss_pred -HHHHH--HHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCC
Q 006125 558 -LLAYA--WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQ 626 (660)
Q Consensus 558 -~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 626 (660)
..... ........+.+++++.+.....+ ..+.+++..||+.||.+||++.+|+++|++.......
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 11111 11111123344445444332333 3477888899999999999999999999876544433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=357.92 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=197.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 421 (660)
..++|+..++||+|+||.||+++.+ +++.||+|++++. .......+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4467888999999999999999964 6889999999753 233345688899999887 8999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+++|+|..++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999984 3456999999999999999999999998 999999999999999999999999999753
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHHHhcCcccc
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--------LLAYAWHLWNEGNVLE 573 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~--------~~~~~~~~~~~~~~~~ 573 (660)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 204 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 204 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred ccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 32222 2234589999999999999999999999999999999999999996321 11222222222111
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 610 (660)
.++......+.+|+.+||+.||.+||++
T Consensus 280 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ---------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111122347788999999999999996
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.85 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=197.1
Q ss_pred hcCCCCCCcccccCCcccEEeeee----cCCcEEEEEEccCCC----hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
..++|+..+.||+|+||.||++.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 346788889999999999999986 478999999997532 234556889999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999994 3456899999999999999999999998 999999999999999999999999998
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
+........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+..... .
T Consensus 169 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------~ 239 (327)
T 3a62_A 169 KESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-------N 239 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-------C
T ss_pred cccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-------C
Confidence 754322211 1234789999999999999999999999999999999999999987766555444443211 0
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHHH
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP 615 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 615 (660)
+. +.. ...+.+++.+||+.||.+|| ++.|+++
T Consensus 240 ~p-~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 LP-PYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CC-TTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CC-CCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11 122 23477889999999999999 7778874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=347.38 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=199.4
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC--------
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-------- 418 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 418 (660)
++|+..+.||+|+||.||+++.. +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45778899999999999999965 7999999999743 3445678999999999999999999999987654
Q ss_pred -------------------------------------------------eeEEEEEecCCCChhhhhcCCCCCCccCHHH
Q 006125 419 -------------------------------------------------EKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449 (660)
Q Consensus 419 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 449 (660)
..++||||+++|+|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2789999999999999997765556677888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc----------cceeeeeccCCc
Q 006125 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE----------ANTVRIVGTYGY 519 (660)
Q Consensus 450 ~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~y 519 (660)
++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 9999999999999999998 999999999999999999999999999876543221 111234689999
Q ss_pred CCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhc
Q 006125 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLC 599 (660)
Q Consensus 520 ~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~c 599 (660)
+|||++.+..++.++||||||+++|||++|..|+... ............ +.........+.+++.+|
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---VRIITDVRNLKF----------PLLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---HHHHHHHHTTCC----------CHHHHHHCHHHHHHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---HHHHHHhhccCC----------CcccccCChhHHHHHHHH
Confidence 9999999999999999999999999999987654211 111111111110 011123345578899999
Q ss_pred ccCCCCCCCCHHhHHH
Q 006125 600 VQEDAFDRPTMSSVAP 615 (660)
Q Consensus 600 l~~dP~~RPt~~evl~ 615 (660)
|+.||++||++.|+++
T Consensus 310 l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 310 LSPSPTERPEATDIIE 325 (332)
T ss_dssp HCSSGGGSCCHHHHHH
T ss_pred ccCCCCcCCCHHHHhh
Confidence 9999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=343.54 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=197.6
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC----CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
+..++|+..+.||+|+||.||++.... +..||+|+++.. .....+.+.+|+.++++++||||+++++++ ..+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCcc
Confidence 345678888999999999999998642 457999998753 344566799999999999999999999997 45678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999999532 335899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
........ .....+++.|+|||++....++.++||||||+++|||++ |..||......+....+......
T Consensus 166 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~-------- 236 (281)
T 1mp8_A 166 MEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------- 236 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------
T ss_pred cCcccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC--------
Confidence 65432221 222356788999999999999999999999999999997 89998765544433333222110
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+......+.+++.+||+.||++||++.|+++.|+..
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01112234577899999999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.93 Aligned_cols=249 Identities=24% Similarity=0.272 Sum_probs=206.0
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCee
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 420 (660)
+..++|+..+.||+|+||.||++... +++.||+|+++.. .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578889999999999999999965 5789999999753 234556788999999988 899999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++|+|.+++. ..+.+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999994 3346999999999999999999999998 99999999999999999999999999975
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..... .+.
T Consensus 171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------~~p 241 (353)
T 2i0e_A 171 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-------AYP 241 (353)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------CCC
T ss_pred cccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-------CCC
Confidence 432221 22345799999999999999999999999999999999999999987776655554443221 111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHhHH
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPT-----MSSVA 614 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl 614 (660)
... ...+.+++.+||+.||.+||+ +.||+
T Consensus 242 -~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 242 -KSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp -TTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred -CCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 122 234778899999999999995 46665
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=354.29 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=200.8
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcE----EEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKE----VAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~----vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
.++|+..++||+|+||.||++... +++. |++|.+.. ......+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467888999999999999999953 4553 57777754 34456778999999999999999999999998765 78
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+|+||+++|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999542 345899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--------- 238 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 238 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 54443333333456888999999999999999999999999999999 99999865544433322222110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.........+.+++.+||+.||.+||++.|+++.|+...
T Consensus 239 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 --PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011112334788999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=344.42 Aligned_cols=260 Identities=27% Similarity=0.371 Sum_probs=213.5
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
.++..++|+..+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3455677888999999999999999965 5889999999753 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999542 3355899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |..||................. .
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~------~---- 231 (288)
T 3kfa_A 163 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------M---- 231 (288)
T ss_dssp SSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------C----
T ss_pred CCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC------C----
Confidence 43322 2223457889999999999999999999999999999999 8899876554433322222111 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+......+.+++.+||+.||.+||++.|+++.|+..
T Consensus 232 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 232 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11112234578899999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=342.18 Aligned_cols=262 Identities=25% Similarity=0.330 Sum_probs=191.0
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.++|+..+.||+|+||.||++.. .+|+.||+|+++.. .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45788899999999999999985 46899999998753 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCC---CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 426 FMPNGSLDAILFDP---RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 426 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
|++ |+|.+++... .....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5998888432 12245899999999999999999999998 9999999999999999999999999998764
Q ss_pred ccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-Ccc-----cc--
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-GNV-----LE-- 573 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~~~-----~~-- 573 (660)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+... +.. ..
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 32221 123478999999999976 46899999999999999999999999876654444333221 000 00
Q ss_pred ---cccccCCC--CC---------CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 574 ---LVDPLLTD--TS---------FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 574 ---~~d~~~~~--~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+.+.. +. ........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000 00 00011235788999999999999999999984
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.69 Aligned_cols=257 Identities=18% Similarity=0.241 Sum_probs=206.4
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.++|...+.||+|+||.||++.. .+|+.||||++.... ....+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46788899999999999999995 578999999987532 234588999999999 99999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC-----EEEeecccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-----SKISDFGMARI 500 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~DfGla~~ 500 (660)
|+ +++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999542 356999999999999999999999998 999999999999998887 99999999987
Q ss_pred ccccCCcc-----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHHHhcCccc
Q 006125 501 FAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS---NQLLAYAWHLWNEGNVL 572 (660)
Q Consensus 501 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~---~~~~~~~~~~~~~~~~~ 572 (660)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.. ....+....+..... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-A 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-H
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-c
Confidence 65433221 12345799999999999999999999999999999999999999975 333332222211100 0
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
... ..+.. . . + .+.+++..||+.||.+||++++|++.|++.
T Consensus 239 ~~~-~~~~~-~-~---p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPI-EVLCE-N-F---P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCH-HHHTT-T-C---H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCH-HHHhc-c-C---h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000 00000 1 1 1 688899999999999999999999988653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=363.31 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=213.8
Q ss_pred hHHHHhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe
Q 006125 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416 (660)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 416 (660)
+.++++..++|...++||+|+||.||+++.. +++.||+|+++.. .....+.+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4566677889999999999999999999965 6889999998642 12233458899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecc
Q 006125 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 496 (660)
.+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999943 34899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCccceeeeeccCCcCCHhhhhcCC----CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccc
Q 006125 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGL----YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVL 572 (660)
Q Consensus 497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 572 (660)
+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.......
T Consensus 214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292 (410)
T ss_dssp TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence 9986543321 1122357999999999998655 7899999999999999999999998877666555554322111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHhHHH--HhcCC
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFD--RPTMSSVAP--MLKGE 620 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~--~L~~~ 620 (660)
.... ....+ ..+.+|+.+||+.+|.+ ||+++||++ +++++
T Consensus 293 ~~p~----~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 293 TFPD----DNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp CCCT----TCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred cCCC----ccccc----HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 1100 01222 34678888999999988 999999984 44543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.41 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=197.4
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCC--CCcceEeEEEEeCCeeE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~ 421 (660)
+..++|+..+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++.+++| |||+++++++......+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 45667888999999999999999988899999999864 234455778999999999976 99999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||| +.+++|.+++. ....+++.++..++.||++||.|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 86 lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 56889999995 3456899999999999999999999998 99999999999997 678999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAME-----------GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEG 569 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~ 569 (660)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ............
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence 54433333334579999999999975 678999999999999999999999997532 222222222111
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
... .++......+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~----------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 238 HEI----------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp SCC----------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccc----------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 110 111111234778899999999999999999984
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=376.39 Aligned_cols=264 Identities=27% Similarity=0.397 Sum_probs=214.4
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++..++|...++||+|+||.||+|.+.++..||||+++... ...+.+.+|+.+|++++||||+++++++.+ +..+||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 345566788889999999999999999888899999998643 345789999999999999999999999876 678999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++... ....+++.+++.|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999421 2245899999999999999999999998 99999999999999999999999999986643
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
..... .....++..|+|||++....++.++||||||++||||++ |+.||......+....+..... .
T Consensus 416 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~---------- 483 (535)
T 2h8h_A 416 NEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M---------- 483 (535)
T ss_dssp HHHHT-TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-C----------
T ss_pred Cceec-ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C----------
Confidence 21111 112246778999999999999999999999999999999 8999976655444333322211 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLP 625 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 625 (660)
.........+.+|+.+||+.||++||++.+|+++|+.......
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 0111223457889999999999999999999999998765544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=348.75 Aligned_cols=267 Identities=16% Similarity=0.180 Sum_probs=201.0
Q ss_pred hcCCCCCCcccccCCcccEEeeeec----CCcEEEEEEccCCChh-----------cHHHHHHHHHHHhhcCCCCcceEe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSCSEQ-----------GTAEFTNEVLLILKLQHKNLVKLL 411 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~ 411 (660)
..++|...+.||+|+||.||++... ++..+|+|++...... ....+.+|+..+..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3467888999999999999999965 5778999998753321 123466788899999999999999
Q ss_pred EEEEe----CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC
Q 006125 412 GFCVD----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487 (660)
Q Consensus 412 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~ 487 (660)
+++.. ....++||||+ +++|.+++.. .+.+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 99988 67889999999 9999999943 337999999999999999999999998 9999999999999988
Q ss_pred C--CEEEeeccccccccccCCcc-----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCC--cH
Q 006125 488 M--NSKISDFGMARIFAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN--QL 558 (660)
Q Consensus 488 ~--~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~--~~ 558 (660)
+ .+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 99999999998765432211 112347899999999999999999999999999999999999999532 11
Q ss_pred HHH--HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCC
Q 006125 559 LAY--AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLP 625 (660)
Q Consensus 559 ~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 625 (660)
... ....... .....+......... ...+.+++.+||+.||++||++.+|++.|++....++
T Consensus 268 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 331 (345)
T 2v62_A 268 VAVQTAKTNLLD-ELPQSVLKWAPSGSS----CCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG 331 (345)
T ss_dssp HHHHHHHHHHHH-TTTHHHHHHSCTTSC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred HHHHHHHHhhcc-cccHHHHhhcccccc----HHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence 111 1111111 111111111111122 2357888899999999999999999999998765443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.96 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=191.3
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
..++|+..+.||+|+||.||++... +++.||||+++... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567888999999999999999965 57899999997532 34568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC---CCCEEEeecccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFA 502 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla~~~~ 502 (660)
|+++|+|.+++. ..+.+++.++..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999994 3456899999999999999999999998 999999999999975 8999999999998654
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||................... ...+.
T Consensus 203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-~~~~~---- 274 (349)
T 2w4o_A 203 HQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-FISPW---- 274 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-CCTTT----
T ss_pred cccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-cCCch----
Confidence 3221 223578999999999999999999999999999999999999997655444333333222111 11111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.......+.+++.+||+.||++|||+.|+++
T Consensus 275 --~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 275 --WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122345778999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.34 Aligned_cols=250 Identities=24% Similarity=0.282 Sum_probs=197.4
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHH-HhhcCCCCcceEeEEEEeCCeeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLL-ILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
.++|+..+.||+|+||.||+++.+ +++.||+|+++... ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457888999999999999999965 68899999996532 2334456677776 567899999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999994 3456899999999999999999999998 9999999999999999999999999998643
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..... .+ .+
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------~~-~~ 260 (373)
T 2r5t_A 191 EHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-------QL-KP 260 (373)
T ss_dssp CCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-------CC-CS
T ss_pred cCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-------CC-CC
Confidence 3222 22345899999999999999999999999999999999999999987776655544443311 01 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHh
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 617 (660)
..+ ..+.+|+.+||+.||.+||++.+.++.+
T Consensus 261 ~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 261 NIT----NSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp SSC----HHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred CCC----HHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 222 3477889999999999999986544433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=349.84 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=202.0
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-----ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
++|+..+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4678889999999999999985 46899999998531 22246789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC---EEEeecccc
Q 006125 423 VYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMA 498 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DfGla 498 (660)
||||+++|+|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988774322 2335899999999999999999999998 999999999999987654 999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .......+... ..+.
T Consensus 181 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~-~~~~i~~~~~~--~~~~ 254 (351)
T 3c0i_A 181 IQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-R-LFEGIIKGKYK--MNPR 254 (351)
T ss_dssp EECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-H-HHHHHHHTCCC--CCHH
T ss_pred eEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-H-HHHHHHcCCCC--CCcc
Confidence 876543221 2234799999999999999999999999999999999999999976532 1 12222111110 0000
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. ... ...+.+++.+||+.||++||++.|+++
T Consensus 255 ~~-~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 255 QW-SHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HH-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cc-ccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 011 235778999999999999999999984
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.10 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=197.9
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 423 (660)
++|+..+.||+|+||.||+++.. +++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56778899999999999999964 6889999999753 334456788999999988 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++. ..+.+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999994 3356999999999999999999999998 99999999999999999999999999975432
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHHHhcCcccccc
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--------LLAYAWHLWNEGNVLELV 575 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~--------~~~~~~~~~~~~~~~~~~ 575 (660)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 163 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 221 2234589999999999999999999999999999999999999996421 11122222222111
Q ss_pred cccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006125 576 DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 576 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 610 (660)
.+.. .. ...+.+++.+||+.||.+||++
T Consensus 237 --~~p~-~~----s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --RIPR-SL----SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CCCT-TS----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CCCC-CC----CHHHHHHHHHHhcCCHhHCCCC
Confidence 1111 22 2347788999999999999996
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=344.52 Aligned_cols=262 Identities=26% Similarity=0.380 Sum_probs=210.0
Q ss_pred cCCCCCCc-ccccCCcccEEeeeec---CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 348 TSNFSDSN-ILGQGGFGPVYKGVLS---DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 348 ~~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
.++|...+ .||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34455555 8999999999999853 5788999999764 345567899999999999999999999999 5567899
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999953 3445999999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 503 ESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 503 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+.. +...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-~~~~-------- 232 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRM-------- 232 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCC--------
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-CCcC--------
Confidence 332211 1122356789999999998899999999999999999999 9999976654443333222 1111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQ 626 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 626 (660)
..+......+.+++.+||+.||++||++.|+++.|+....+...
T Consensus 233 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 233 --ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp --CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 11112234578899999999999999999999999876544433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=337.68 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=208.2
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 423 (660)
.++|...+.||+|+||.||+++. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 45688889999999999999998 4899999998753 344566799999999999999999999999887 778999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++... ....+++..++.++.||++||.|||+.+ ++++||||||+|||+++++.++|+|||+......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999642 2335899999999999999999999875 4599999999999999999999999988754322
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCC---cchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYS---KKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t---~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
. ...||+.|+|||++.+..++ .++||||||+++|||++|+.||.................... +.
T Consensus 166 ~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~ 233 (271)
T 3kmu_A 166 P-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT-----IP 233 (271)
T ss_dssp T-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC-----CC
T ss_pred c-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC-----CC
Confidence 1 23678999999999875544 489999999999999999999987766655554444332111 11
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
. .. ...+.+++.+||+.||++|||+.|+++.|+...
T Consensus 234 ~-~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 234 P-GI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp T-TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C-CC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 22 334788999999999999999999999998653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.43 Aligned_cols=268 Identities=20% Similarity=0.254 Sum_probs=213.8
Q ss_pred cChHHHHhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEE
Q 006125 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (660)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 414 (660)
+.++++++..++|+..++||+|+||.||+++.+ +|+.||+|++++. .....+.+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345667778899999999999999999999964 7999999999642 222344588999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
.+.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999999532 236999999999999999999999998 99999999999999999999999
Q ss_pred ccccccccccCCccceeeeeccCCcCCHhhhh-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAM-------EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN 567 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~ 567 (660)
||+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+..
T Consensus 206 FGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 206 FGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred chhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 9999876443221 122357999999999997 35689999999999999999999999987776655544443
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCC---CCHHhHHH--HhcCC
Q 006125 568 EGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDR---PTMSSVAP--MLKGE 620 (660)
Q Consensus 568 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~--~L~~~ 620 (660)
....... +.. ....+ ..+.+++.+||+ +|.+| |+++||++ +++++
T Consensus 285 ~~~~~~~--p~~-~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 285 YKEHLSL--PLV-DEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp HHHHCCC--C-----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred cccCcCC--Ccc-ccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 2111000 111 01222 347788899999 99998 58999973 45543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=339.43 Aligned_cols=253 Identities=32% Similarity=0.515 Sum_probs=201.5
Q ss_pred hcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhc-------HHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQG-------TAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
..++|+..+.||+|+||.||++.. .+++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 456788889999999999999996 478999999986432211 267899999999999999999999986554
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC-----EEEe
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-----SKIS 493 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~ 493 (660)
++||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ ++|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999888854 3346999999999999999999999985 35999999999999988776 9999
Q ss_pred eccccccccccCCccceeeeeccCCcCCHhhhh--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHHHhcC
Q 006125 494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAM--EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAY--AWHLWNEG 569 (660)
Q Consensus 494 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~--~~~~~~~~ 569 (660)
|||+++.... ......|++.|+|||++. ...++.++||||||+++|||++|+.||........ ........
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 9999974432 223357899999999984 45678999999999999999999999975432222 21222111
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 570 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
. .+. ........+.+++.+||+.||.+||++.||++.|++
T Consensus 247 ~-----~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 247 L-----RPT-----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp C-----CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred C-----CCC-----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1 111 112223457889999999999999999999999976
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=339.40 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=203.1
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
..++|...+.||+|+||.||++... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467888899999999999999854 5779999998642 22335678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999984 3345899999999999999999999988 9999999999999999999999999986543
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||...........+..... ..
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~--- 226 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------TF--- 226 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-------CC---
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-------CC---
Confidence 322 1234789999999999999999999999999999999999999987765554443332211 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+......+.+++.+||+.||.+||++.|+++
T Consensus 227 --~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 227 --PDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1112234778899999999999999999984
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=335.51 Aligned_cols=249 Identities=20% Similarity=0.284 Sum_probs=205.8
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
++|...++||+|+||.||++... ++..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 46778899999999999999964 57799999998765566788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe---CCCCCEEEeecccccccccc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~~~ 504 (660)
++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 89 TGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999884 3445899999999999999999999998 9999999999999 78899999999999866543
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
... ....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+....+........ .... ..
T Consensus 163 ~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~--~~- 233 (277)
T 3f3z_A 163 KMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP--EKDW--LN- 233 (277)
T ss_dssp SCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--HHHH--TT-
T ss_pred cch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--chhh--hc-
Confidence 322 23468999999998865 489999999999999999999999987665554444433221100 0000 01
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....+.+++.+||+.||.+||++.|+++
T Consensus 234 ---~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 234 ---VSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1245788999999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=365.35 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=200.6
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
+..++|+..++||+|+||.||++.. .+|+.||||+++.. .......+.+|+.+++.++||||+++++++...+..+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 3456788899999999999999995 47899999999742 3344566789999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
+||||+++|+|.+++. ....+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.+||+|||+++.
T Consensus 225 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 225 FVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999984 34568999999999999999999998 77 99999999999999999999999999975
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... .+.
T Consensus 299 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------~~p 369 (446)
T 4ejn_A 299 GIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------RFP 369 (446)
T ss_dssp TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------CCC
T ss_pred ccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-------CCC
Confidence 4332222 2235799999999999999999999999999999999999999987766555444443221 011
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHHH--HhcC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP--MLKG 619 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~--~L~~ 619 (660)
. ..+ ..+.+++.+||+.||.+|| ++.|+++ ++++
T Consensus 370 ~-~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 370 R-TLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp T-TSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred c-cCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 1 222 3477899999999999999 9999984 4444
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.02 Aligned_cols=265 Identities=22% Similarity=0.236 Sum_probs=208.8
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-----ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
...++|...+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3456788999999999999999995 46889999998642 34456789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCC-------------------------------------CCCccCHHHHHHHHHHHHHHHH
Q 006125 420 KLLVYEFMPNGSLDAILFDPR-------------------------------------KRGILCWRKRTNIVNGIAKGML 462 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~L~ 462 (660)
.++||||+++|+|.+++.... ....+++..++.++.||++||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 999999999999999984100 0223467788899999999999
Q ss_pred HHHhCCCCCeEecCCCCCceEeCCCC--CEEEeeccccccccccCCcc--ceeeeeccCCcCCHhhhhc--CCCCcchhH
Q 006125 463 YLHEDSRLRIVHRDLKASNVLLDSDM--NSKISDFGMARIFAESEGEA--NTVRIVGTYGYMAPEYAME--GLYSKKSDV 536 (660)
Q Consensus 463 ~LH~~~~~~ivH~DLkp~NILl~~~~--~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~t~ksDV 536 (660)
|||+.+ |+||||||+|||++.++ .+||+|||++..+....... ......||+.|+|||++.+ ..++.++||
T Consensus 183 ~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 999998 99999999999998776 89999999998764432221 1234578999999999975 678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH-
Q 006125 537 FSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP- 615 (660)
Q Consensus 537 wslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~- 615 (660)
||||+++|||++|+.||......+.............. +.. ......+.+++.+||+.||.+||++.|+++
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN--PNY------NVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS--GGG------GGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC--ccc------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999877766666555544321110 110 011234778999999999999999999985
Q ss_pred -HhcCCC
Q 006125 616 -MLKGET 621 (660)
Q Consensus 616 -~L~~~~ 621 (660)
++++..
T Consensus 332 p~~~~~~ 338 (345)
T 3hko_A 332 PWISQFS 338 (345)
T ss_dssp HHHHTTS
T ss_pred hhhccCh
Confidence 455543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=345.24 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=209.8
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|...+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356778899999999999999964 5789999998643 334567789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++++|.+++. ....+++.+++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999884 3346899999999999999999999998 99999999999999999999999999987643
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.... .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+....+..... .+.. .
T Consensus 194 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~-~ 263 (335)
T 2owb_A 194 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------SIPK-H 263 (335)
T ss_dssp TTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-------CCCT-T
T ss_pred Cccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-------CCCc-c
Confidence 2222 2234789999999999999999999999999999999999999987765554443332211 1111 2
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
.+ ..+.+++.+||+.||++||++.|+++ ++.+.
T Consensus 264 ~~----~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 264 IN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred CC----HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 22 34778899999999999999999985 56553
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=340.46 Aligned_cols=262 Identities=22% Similarity=0.267 Sum_probs=201.0
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
-++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367888999999999999999964 78899999997532 23356789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++++|.+++. ..+.+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999994 3346899999999999999999999998 99999999999999999999999999976544
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......... ........ .+....+.
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~----~~~~~~~~ 260 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-AHINQAIP----RPSTVRPG 260 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-HHHHSCCC----CGGGTSTT
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-HHhccCCC----CccccCCC
Confidence 3221 122346899999999999999999999999999999999999999876544222 22221110 00001112
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-CHHhHHHHhcCCCCCCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRP-TMSSVAPMLKGETGTLP 625 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~ 625 (660)
. ...+.+++.+||+.||++|| +++++++.|+.......
T Consensus 261 ~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 261 I----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp C----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred C----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 2 23477889999999999999 99999999988655443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.75 Aligned_cols=263 Identities=16% Similarity=0.221 Sum_probs=208.5
Q ss_pred hcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 424 (660)
..++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+|+.++..+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 356788899999999999999995 579999999986432 234578899999999 8999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC-----EEEeeccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-----SKISDFGMAR 499 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~DfGla~ 499 (660)
||+ +++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999999532 335999999999999999999999998 999999999999987776 9999999998
Q ss_pred cccccCCcc-----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCcc
Q 006125 500 IFAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ---LLAYAWHLWNEGNV 571 (660)
Q Consensus 500 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~---~~~~~~~~~~~~~~ 571 (660)
......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 765443221 1233579999999999999999999999999999999999999997532 22222111111000
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
... +.+. ... ...+.+++.+||+.||++||++.+|++.|++....+
T Consensus 240 -~~~-~~~~-~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 240 -TPL-RELC-AGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp -SCH-HHHT-TTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -ccH-HHHH-hhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 000 0000 012 245788999999999999999999999998764433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=349.05 Aligned_cols=266 Identities=30% Similarity=0.357 Sum_probs=204.9
Q ss_pred CCCCcccccCCcccEEeeee-----cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEE
Q 006125 351 FSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 422 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 422 (660)
|+..+.||+|+||.||++.+ .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 47789999999999988764 26889999999753 344567799999999999999999999999884 57899
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++|+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999943 34899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-----HHhcCccccccc
Q 006125 503 ESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWH-----LWNEGNVLELVD 576 (660)
Q Consensus 503 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~-----~~~~~~~~~~~d 576 (660)
...... ......++..|+|||++.+..++.++||||||+++|||++|+.||........... ........+.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 433211 12234578889999999999999999999999999999999999864321110000 000000111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
..... ..+......+.+|+.+||+.||.+||++.|+++.|+......
T Consensus 266 ~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 266 RGERL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccCC-CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11110 112223345888999999999999999999999998764333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.76 Aligned_cols=272 Identities=27% Similarity=0.352 Sum_probs=209.0
Q ss_pred cCCCCCCcccccCCcccEEeeee-----cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEE--eCCee
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV--DGDEK 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 420 (660)
.++|+..+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46778889999999999999984 368899999998777777788999999999999999999999987 45568
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 899999999999999953 2345999999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH-hc----Cccccc
Q 006125 501 FAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLW-NE----GNVLEL 574 (660)
Q Consensus 501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~-~~----~~~~~~ 574 (660)
........ ......|+..|+|||++.+..++.++||||||+++|||++|+.|+............. .. ....+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 65432211 1122357888999999999999999999999999999999999886432211000000 00 000000
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCC
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLP 625 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 625 (660)
+...... .........+.+++.+||+.||.+||++.||++.|+.......
T Consensus 257 ~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LEEGQRL-PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hhcccCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 0110000 1122233457889999999999999999999999988754443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.63 Aligned_cols=265 Identities=24% Similarity=0.247 Sum_probs=207.8
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-----CCCcceEeEE
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----HKNLVKLLGF 413 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~ 413 (660)
.+++..+..++|...++||+|+||.||++.. .+++.||||+++. .......+..|+.++..++ ||||++++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 3444556678999999999999999999996 5788999999975 3445566788999999986 9999999999
Q ss_pred EEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-------
Q 006125 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS------- 486 (660)
Q Consensus 414 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~------- 486 (660)
+...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccc
Confidence 99999999999999 99999999542 2235899999999999999999999998 999999999999976
Q ss_pred ------------------CCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh
Q 006125 487 ------------------DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548 (660)
Q Consensus 487 ------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt 548 (660)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 7899999999998644322 23478999999999999999999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-c-------------ccccccc-----cCCCCCCCHHH---------------HHHHHH
Q 006125 549 GRRNAGSNQLLAYAWHLWNEG-N-------------VLELVDP-----LLTDTSFSDDE---------------FSRYIH 594 (660)
Q Consensus 549 G~~p~~~~~~~~~~~~~~~~~-~-------------~~~~~d~-----~~~~~~~~~~~---------------~~~l~~ 594 (660)
|+.||......+....+.... . ....++. ........... ...+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 999998655443332221110 0 0000000 00000000110 145779
Q ss_pred HHhhcccCCCCCCCCHHhHHH
Q 006125 595 IGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 595 li~~cl~~dP~~RPt~~evl~ 615 (660)
++.+||+.||++|||+.|+++
T Consensus 335 li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCChhhCCCHHHHhc
Confidence 999999999999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=341.25 Aligned_cols=257 Identities=29% Similarity=0.383 Sum_probs=205.3
Q ss_pred hhcCCCCCCc-ccccCCcccEEeeee---cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 346 LATSNFSDSN-ILGQGGFGPVYKGVL---SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 346 ~~~~~~~~~~-~lG~G~fg~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
+..++|...+ .||+|+||.||++.. .+++.||||+++... ....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3445666667 899999999999964 346889999997532 33356799999999999999999999999 5667
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++||||+++++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 8999999999999999953 345899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccc-eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccc
Q 006125 500 IFAESEGEAN-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 500 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~ 577 (660)
.......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~----- 239 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERM----- 239 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCC-----
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCC-----
Confidence 7654332211 122346788999999998889999999999999999999 999998766544333222 22111
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+......+.+++.+||+.||.+||++.||++.|++.
T Consensus 240 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 240 -----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11112234578899999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=351.42 Aligned_cols=247 Identities=23% Similarity=0.298 Sum_probs=201.4
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|...+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888899999999999999954 6889999998642 234567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999995 3456999999999999999999999998 99999999999999999999999999987643
Q ss_pred cCCccceeeeeccCCcCCHhhhhc---CCCCcchhHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHHhcCcccccccc
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSN---QLLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwslGvll~elltG~~p~~~~---~~~~~~~~~~~~~~~~~~~d~ 577 (660)
... ....+||+.|+|||++.. ..++.++|||||||++|||++|+.||... .......... ....
T Consensus 168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~------ 237 (384)
T 4fr4_A 168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-TTVV------ 237 (384)
T ss_dssp TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-HCCC------
T ss_pred CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-hccc------
Confidence 322 234579999999999974 45899999999999999999999999632 2222222211 1110
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCC-HHhHHH
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPT-MSSVAP 615 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 615 (660)
.++......+.+|+.+||+.||.+||+ +++|.+
T Consensus 238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111112245788999999999999998 777763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=354.16 Aligned_cols=269 Identities=20% Similarity=0.252 Sum_probs=205.9
Q ss_pred hcCCCCCCcccccC--CcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 347 ATSNFSDSNILGQG--GFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 347 ~~~~~~~~~~lG~G--~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
..++|+..++||+| +||.||++... +|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35678889999999 99999999965 7999999999743 3445567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+++|+|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999999542 2345899999999999999999999998 999999999999999999999999998654
Q ss_pred cccCCc-----cceeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccc
Q 006125 502 AESEGE-----ANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLEL 574 (660)
Q Consensus 502 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 574 (660)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||................ ...+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~ 257 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT-VPCL 257 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-CCcc
Confidence 322111 11112368899999999987 679999999999999999999999997543322222211110 0000
Q ss_pred cccc-----------------------------------CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--Hh
Q 006125 575 VDPL-----------------------------------LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--ML 617 (660)
Q Consensus 575 ~d~~-----------------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L 617 (660)
++.. .............+.+|+.+||+.||++|||+.|+++ ++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 0000 0000011122345888999999999999999999984 35
Q ss_pred cCC
Q 006125 618 KGE 620 (660)
Q Consensus 618 ~~~ 620 (660)
++.
T Consensus 338 ~~~ 340 (389)
T 3gni_B 338 KQI 340 (389)
T ss_dssp GGC
T ss_pred HHH
Confidence 543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=354.59 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=201.9
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
-++|...+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35788899999999999999995 57899999998642 123345789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+ +|+|.+++. ..+.+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 688888884 3356999999999999999999999998 99999999999999999999999999986654
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.... ...+||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... ..+.+.....
T Consensus 161 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------~~~~i~~~~~-- 225 (336)
T 3h4j_B 161 GNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------LFKKVNSCVY-- 225 (336)
T ss_dssp SBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------CBCCCCSSCC--
T ss_pred Cccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------HHHHHHcCCC--
Confidence 3322 23479999999999987775 789999999999999999999997543211 1111111110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
..+......+.+++.+||+.||.+|||+.|+++ +++.
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 111122345778999999999999999999974 4443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=344.57 Aligned_cols=259 Identities=28% Similarity=0.453 Sum_probs=203.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC-----CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
+..++|...+.||+|+||.||+|.... +..||+|+++.. .......+.+|+.++.+++||||+++++++.+.+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 345667778999999999999998642 235999999753 34455678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999953 2346999999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccc
Q 006125 500 IFAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 500 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~ 577 (660)
......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+......
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~------ 269 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL------ 269 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC------
Confidence 765432211 1122345778999999999999999999999999999999 99999766554443333222111
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.........+.+++.+||+.||.+||++.||++.|+..
T Consensus 270 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 270 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01112234578899999999999999999999999764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.39 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=199.5
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhh--cCCCCcceEeEEEEeC----Ce
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDG----DE 419 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~ 419 (660)
...++|...+.||+|+||.||+++.. ++.||||++... ....+..|.+++.. ++||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34568999999999999999999974 899999998642 23344555555554 4999999999999987 67
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCceEeCCCCCEEEee
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS-----RLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
.++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. +++|+||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 8999999999999999942 35899999999999999999999981 12399999999999999999999999
Q ss_pred ccccccccccCCccc--eeeeeccCCcCCHhhhhcCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCC
Q 006125 495 FGMARIFAESEGEAN--TVRIVGTYGYMAPEYAMEGLYSKK------SDVFSFGVLLIEIITG----------RRNAGSN 556 (660)
Q Consensus 495 fGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~k------sDVwslGvll~elltG----------~~p~~~~ 556 (660)
||++........... .....||+.|+|||++.+...+.+ +|||||||++|||++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999976644332211 123478999999999987766654 9999999999999999 5555421
Q ss_pred ----cHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 557 ----QLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 557 ----~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
.............. ..+..............+.+++.+||+.||.+||++.||++.|+....
T Consensus 266 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SCSSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCchhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 11111112111111 111111101123567779999999999999999999999999987543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.74 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=208.1
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888999999999999999964 6899999998642 3445677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC---EEEeeccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMARIF 501 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DfGla~~~ 501 (660)
||+++++|.+.+. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999988884 3356899999999999999999999998 999999999999987655 999999999765
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
...... ....|++.|+|||++.+..++.++||||||+++|||++|+.||.................. ...+..
T Consensus 159 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~-- 231 (284)
T 3kk8_A 159 NDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPEW-- 231 (284)
T ss_dssp CSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTTT--
T ss_pred ccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc--CCchhh--
Confidence 433221 2346899999999999999999999999999999999999999876655544433322111 000000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
... ...+.+++.+||+.||++|||+.|+++ ++++
T Consensus 232 ~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 232 DTV----TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp TTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred ccc----CHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 122 234778999999999999999999985 4544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.17 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=197.9
Q ss_pred CCCCCC-cccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDS-NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+.|... +.||+|+||.||++.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456553 7899999999999994 57899999999876666678899999999985 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC---EEEeecccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMARIFA 502 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DfGla~~~~ 502 (660)
|+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999943 346899999999999999999999998 999999999999998776 9999999997654
Q ss_pred ccCC-----ccceeeeeccCCcCCHhhhhc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcH--------------
Q 006125 503 ESEG-----EANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQL-------------- 558 (660)
Q Consensus 503 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwslGvll~elltG~~p~~~~~~-------------- 558 (660)
.... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111123468999999999975 5588999999999999999999999975321
Q ss_pred HHHHHHHHhcCcccccccccCCCCCCCHH----HHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 559 LAYAWHLWNEGNVLELVDPLLTDTSFSDD----EFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 559 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
..........+.. .++.. ....+.+++.+||+.||.+|||+.|+++ ++++.
T Consensus 246 ~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 246 QNMLFESIQEGKY-----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHCCC-----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHhccCc-----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 1111122222111 11111 1245788999999999999999999987 55543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=334.02 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=203.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46778899999999999999964 7899999998643 234457789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++. ....+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999984 3456899999999999999999999998 99999999999999999999999999986654332
Q ss_pred ccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
........|++.|+|||++.+..+ +.++||||||+++|||++|+.||............+...... ... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~-------~ 231 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNP-------W 231 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STT-------G
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCc-------h
Confidence 222233578999999999987665 789999999999999999999997544322222222221110 000 0
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 112234778999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=337.23 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=208.2
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|...+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 456888899999999999999964 6789999998642 223356789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++.. .+.+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999843 345899999999999999999999998 99999999999999999999999999875543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.. .....|++.|+|||++.+..++.++||||||+++|||++|+.||...........+..... .+. ..
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------~~~-~~ 234 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-------KFP-PF 234 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------CCC-TT
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-------CCC-Cc
Confidence 22 1234689999999999999999999999999999999999999987665554433332211 111 12
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGET 621 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 621 (660)
. ...+.+++.+||+.||.+||++.|+++ +++...
T Consensus 235 ~----~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 235 L----SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp S----CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred C----CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 2 234778999999999999999999984 565443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.43 Aligned_cols=250 Identities=22% Similarity=0.261 Sum_probs=206.2
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh------hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
++|...+.||+|+||.||++... +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45778899999999999999964 689999999865321 23678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC----CEEEeeccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM 497 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfGl 497 (660)
+||||+++++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999953 456899999999999999999999998 99999999999999887 799999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~ 577 (660)
+......... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+...... .++
T Consensus 166 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---~~~ 239 (321)
T 2a2a_A 166 AHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD---FDE 239 (321)
T ss_dssp CEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC---CCH
T ss_pred ceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc---cCh
Confidence 9876543221 2346899999999999999999999999999999999999999876655444333322110 000
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.... .. ...+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~-~~----~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 240 EFFS-HT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHT-TC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hhhc-cc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 11 234778999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=345.19 Aligned_cols=261 Identities=30% Similarity=0.437 Sum_probs=206.6
Q ss_pred hhcCCCCCCcccccCCcccEEeeee------cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
+..++|...+.||+|+||.||++.. .+++.||||++... .......+.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3457788899999999999999984 24678999999743 4455667899999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCC----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC---CCCEE
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSK 491 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~---~~~~k 491 (660)
..++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999964321 245899999999999999999999998 999999999999984 45699
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCc
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 570 (660)
|+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||...........+.....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 999999976544333222233467889999999999999999999999999999998 8899876655444333322211
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.. ........+.+++.+||+.||.+||++.||++.|+..
T Consensus 264 -~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 -MD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp -CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 10 1111223578899999999999999999999998754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=337.29 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=209.1
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|...+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356778899999999999999965 5889999998643 334566789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++++|.+++. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999884 3346899999999999999999999998 99999999999999999999999999986543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.... .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+.......... .+.. .
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~-~ 237 (294)
T 2rku_A 168 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------SIPK-H 237 (294)
T ss_dssp TTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------CCCT-T
T ss_pred Cccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC-------CCcc-c
Confidence 2222 1234689999999999998999999999999999999999999987765554433332211 1111 2
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
. ...+.+++.+||+.||++||++.|+++ ++.+.
T Consensus 238 ~----~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 238 I----NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred c----CHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 2 234778899999999999999999985 45543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.78 Aligned_cols=245 Identities=31% Similarity=0.459 Sum_probs=202.6
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
+.|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477788999999999999995 57899999998643 2334467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+. |+|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 678777742 2346899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
....||+.|+|||++. ...++.++||||||+++|||++|+.||...........+..... +....
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------~~~~~ 275 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------PALQS 275 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------CCCCC
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------CCCCC
Confidence 1247899999999985 56789999999999999999999999987766655555444322 11111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..++ ..+.+++.+||+.||++|||+.|+++
T Consensus 276 ~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 276 GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC----HHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1222 34778889999999999999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=351.12 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=197.4
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcC--CCCcceEeEEEEeCCeeEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 422 (660)
...+|...+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34568889999999999999999878999999998642 3455678999999999996 5999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||| +.+++|.+++.. ...+++.++..++.||++||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 134 v~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 678899999953 346899999999999999999999998 99999999999995 5899999999998765
Q ss_pred ccCCccceeeeeccCCcCCHhhhhc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCc
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAME-----------GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEGN 570 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~~ 570 (660)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence 4433222334579999999999875 468999999999999999999999997532 2222222222111
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
... . +... ...+.+|+.+||+.||.+||++.|+++
T Consensus 286 ~~~-----~--~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 286 EIE-----F--PDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CCC-----C--CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCC-----C--Cccc---hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 100 1 1111 234778899999999999999999984
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=339.69 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=198.8
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 46788899999999999999964 5899999998653 23335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999884 3345899999999999999999999998 9999999999999999999999999998765332
Q ss_pred CccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh--------------cCc
Q 006125 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN--------------EGN 570 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~--------------~~~ 570 (660)
.. .....|++.|+|||++.+ ..++.++||||||+++|||++|+.||......+....... ...
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 DY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22 123478999999999976 6789999999999999999999999986654443322211 000
Q ss_pred ccccccccCCCC-CC-C-----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VLELVDPLLTDT-SF-S-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~~~~d~~~~~~-~~-~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..... .+..+ .. . ......+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGV--KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTC--CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccC--cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00000 00 0 112234788999999999999999999984
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=370.18 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=202.7
Q ss_pred CCCCCc-ccccCCcccEEeeeec---CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 350 NFSDSN-ILGQGGFGPVYKGVLS---DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 350 ~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++...+ .||+|+||.||+|.+. ++..||||+++.. .....+.+.+|+.++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333344 7999999999999864 4667999999864 33467789999999999999999999999976 5689999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++.. ....+++..+..|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999953 3456999999999999999999999998 999999999999999999999999999876433
Q ss_pred CCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 505 EGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 505 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.. +...
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~---------- 558 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRM---------- 558 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-TCCC----------
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCC----------
Confidence 2211 1112345689999999999999999999999999999998 9999986655444333322 2111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
..+......+.+|+.+||+.||++||++.+|++.|+...
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111223345888999999999999999999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=349.04 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=192.8
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
..++|...+.||+|+||.||++... +++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3567888999999999999999965 78999999997533 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC--EEEeeccccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--SKISDFGMARIFAE 503 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DfGla~~~~~ 503 (660)
|+++|+|.+++. ..+.+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999984 3446999999999999999999999998 999999999999987765 99999999974332
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHHhcCccccccccc
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKK-SDVFSFGVLLIEIITGRRNAGSNQ----LLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDVwslGvll~elltG~~p~~~~~----~~~~~~~~~~~~~~~~~~d~~ 578 (660)
... .....||+.|+|||++.+..+..+ +|||||||++|||++|+.||.... ............. . .
T Consensus 171 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~----~ 241 (361)
T 3uc3_A 171 HSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY--S----I 241 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC--C----C
T ss_pred cCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC--C----C
Confidence 221 223479999999999988877655 999999999999999999997532 2222222221110 0 0
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+ ..+.+|+.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~s----~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 PDDIRIS----PECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CTTSCCC----HHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcCCCC----HHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0000122 34778999999999999999999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=352.66 Aligned_cols=259 Identities=29% Similarity=0.423 Sum_probs=195.3
Q ss_pred CCCCCcccccCCcccEEeeeec--CC--cEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe-CCeeEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLS--DG--KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLV 423 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 423 (660)
.|...+.||+|+||.||+|... ++ ..||+|.++.. .....+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556789999999999999853 22 36899998753 34556789999999999999999999999765 4578999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999954 3345889999999999999999999998 99999999999999999999999999986643
Q ss_pred cCCcc--ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 504 SEGEA--NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 504 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |.+||......+........... ..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~-------~~ 317 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-------LQ 317 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC-------CC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC-------CC
Confidence 32211 1122456788999999999999999999999999999999 66677644333222222222110 01
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
.... ...+.+++.+||+.||++||++.|+++.|+.....+
T Consensus 318 p~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 318 PEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1122 235788899999999999999999999998765444
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=335.71 Aligned_cols=257 Identities=25% Similarity=0.331 Sum_probs=203.3
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC----CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
+..++|...+.||+|+||.||++...+ +..||+|+++.. .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 345678888999999999999998543 336999999764 34456789999999999999999999999765 457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 899999999999999953 2345899999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.................. . .
T Consensus 163 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-~-----~ 235 (281)
T 3cc6_A 163 IEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-P-----K 235 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-C-----C
T ss_pred cccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-C-----C
Confidence 65432211 122356788999999999999999999999999999998 99998754433332222221110 0 0
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.... ...+.+++.+||+.||++||++.|+++.|++.
T Consensus 236 -~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 236 -PDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 1112 23477899999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=333.71 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=200.8
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-----ChhcHHHHHHHHHHHhhc---CCCCcceEeEEEEe
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKL---QHKNLVKLLGFCVD 416 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~ 416 (660)
+..++|+..++||+|+||.||++.. .+++.||+|+++.. .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999995 57899999998632 122234677788877776 49999999999987
Q ss_pred CC-----eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEE
Q 006125 417 GD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 417 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
.. ..++||||+. ++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 4789999997 5999998643 2334899999999999999999999998 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG-- 569 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~-- 569 (660)
|+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....
T Consensus 161 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999866433222 23478999999999999999999999999999999999999998776555544433210
Q ss_pred -c---ccccc---cccCCCC-CC-----CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 -N---VLELV---DPLLTDT-SF-----SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 -~---~~~~~---d~~~~~~-~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
. +.... ....... .. ..+....+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 00000 0000000 00 0112245788999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.83 Aligned_cols=253 Identities=28% Similarity=0.381 Sum_probs=200.7
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|.....||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 34566667999999999999995 56889999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEEeeccccccccccC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESE 505 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~~~ 505 (660)
+++++|.+++........+++..+..++.||+.||.|||+.+ |+|+||||+|||++. ++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999965444445778999999999999999999998 999999999999987 8999999999998654322
Q ss_pred CccceeeeeccCCcCCHhhhhcCC--CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHHHhcCcccccccccCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAY-AWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwslGvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.. .....|++.|+|||++.+.. ++.++||||||+++|||++|+.||........ ........ ..+.+
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~--- 247 (295)
T 2clq_A 178 PC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-----VHPEI--- 247 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC-----CCCCC---
T ss_pred Cc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc-----ccccc---
Confidence 11 22346899999999997654 89999999999999999999999864322221 11111111 11111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+......+.+++.+||+.||++||++.|+++
T Consensus 248 --~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 --PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122345778899999999999999999984
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=339.03 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=203.8
Q ss_pred CCCCCCcccccCCcccEEeeeecC----CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe-CCeeEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLL 422 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 422 (660)
.+|...++||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 456777999999999999998542 235899998753 34456789999999999999999999999754 557899
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999964 3345899999999999999999999998 9999999999999999999999999998665
Q ss_pred ccCCc--cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 503 ESEGE--ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 503 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+......+........... .
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 252 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-------L 252 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-------C
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-------C
Confidence 43221 11223467889999999999999999999999999999999 55566544433333322222110 1
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
..... ...+.+++.+||+.||.+||++.|+++.|++....+
T Consensus 253 ~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 253 QPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11122 234788999999999999999999999998765443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=335.47 Aligned_cols=247 Identities=26% Similarity=0.429 Sum_probs=206.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+.|...+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4577889999999999999985 46899999998753 244567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++. .+.+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999994 246899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||...........+..... +.+.. ..+
T Consensus 175 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~-~~~- 244 (303)
T 3a7i_A 175 K--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------PTLEG-NYS- 244 (303)
T ss_dssp C--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------CCCCS-SCC-
T ss_pred c--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC------CCCcc-ccC-
Confidence 2 2234789999999999999999999999999999999999999987665544433322211 11111 222
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+.+++.+||+.||.+||++.|+++
T Consensus 245 ---~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 245 ---KPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp ---HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 34778999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.51 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=200.2
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|...++||+|+||.||++.. .+++.+|+|++... .....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4577789999999999999995 46889999998653 334567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe---CCCCCEEEeecccccccc
Q 006125 427 MPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA 502 (660)
Q Consensus 427 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~ 502 (660)
+++|+|.+++... .....+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988432 12356999999999999999999999998 9999999999999 456889999999997654
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.... .....|++.|+|||++. +.++.++||||||+++|||++|+.||..................... ...
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~ 249 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-----ECR 249 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-------C
T ss_pred Cccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc-----ccC
Confidence 4322 22347899999999875 56899999999999999999999999877655544433322211110 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+ ..+.+++.+||+.||++||++.||++
T Consensus 250 ~~~----~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 250 PLT----PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122 34778899999999999999999984
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=333.62 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=204.0
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC----hhcHHHHHHHHHHHhhcCCCCcceEeEEEEe--CCeeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 421 (660)
++|...+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 6789999999999999999995 468899999987432 2345679999999999999999999999854 45789
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||++++ |.+++... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 999999877 66666432 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCC--CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
.............|++.|+|||++.+.. ++.++||||||+++|||++|+.||...........+..... .+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-------~~ 232 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-------AI 232 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------CC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-------CC
Confidence 5433333333456899999999997644 47899999999999999999999987766554433332211 11
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
. ... ...+.+++.+||+.||.+||++.|+++ ++++.
T Consensus 233 ~-~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 233 P-GDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp C-SSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred C-Ccc----CHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 1 122 234778899999999999999999994 56554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=336.96 Aligned_cols=248 Identities=28% Similarity=0.416 Sum_probs=182.2
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|...+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4677889999999999999996 57899999998642 1233567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999964 2346899999999999999999999998 999999999999999999999999999866432
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||............ ...... .
T Consensus 166 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~---~ 231 (278)
T 3cok_A 166 HEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV---------VLADYE---M 231 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---------CSSCCC---C
T ss_pred CCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---------hhcccC---C
Confidence 221 12346899999999999888999999999999999999999999755432221111 111111 1
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+......+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1112235778999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=342.90 Aligned_cols=258 Identities=27% Similarity=0.402 Sum_probs=205.9
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEE--EEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEV--AVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~v--avK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 422 (660)
.++|...+.||+|+||.||++... ++..+ ++|+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 467888899999999999999954 56644 99988752 334556789999999999 99999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC
Q 006125 423 VYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~ 489 (660)
||||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999996532 2346899999999999999999999998 999999999999999999
Q ss_pred EEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhc
Q 006125 490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNE 568 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 568 (660)
+||+|||+++....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...........+...
T Consensus 181 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 99999999874332211 122356889999999998889999999999999999998 99999876655443332221
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
.. . .........+.+++.+||+.||.+||++.|+++.|+....
T Consensus 258 ~~------~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 258 YR------L-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp CC------C-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC------C-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11 0 1111223457889999999999999999999999876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=343.98 Aligned_cols=269 Identities=21% Similarity=0.252 Sum_probs=207.3
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe----CCee
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEK 420 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 420 (660)
+..++|+..+.||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4567899999999999999999996 5789999999977666777889999999999999999999999973 3467
Q ss_pred EEEEEecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 421 LLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
++||||+++|+|.+++... .....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 8999999999999988532 12456999999999999999999999998 9999999999999999999999999987
Q ss_pred cccccCCcc-------ceeeeeccCCcCCHhhhhcCC---CCcchhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHHhc
Q 006125 500 IFAESEGEA-------NTVRIVGTYGYMAPEYAMEGL---YSKKSDVFSFGVLLIEIITGRRNAGSNQLLA-YAWHLWNE 568 (660)
Q Consensus 500 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwslGvll~elltG~~p~~~~~~~~-~~~~~~~~ 568 (660)
......... ......|++.|+|||++.... ++.++||||||+++|||++|+.||....... ........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 553211110 001235689999999987543 6899999999999999999999984210000 00011111
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCCC
Q 006125 569 GNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQP 627 (660)
Q Consensus 569 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 627 (660)
.. ... ........+.+++.+||+.||.+||++.||++.|+......+.+
T Consensus 263 ~~-------~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 263 QL-------SIP---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp C---------CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred cC-------CCC---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 00 000 01112345788999999999999999999999999876554443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.15 Aligned_cols=258 Identities=26% Similarity=0.351 Sum_probs=203.2
Q ss_pred CCCCcccccCCcccEEeeeec-CC---cEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee-EEEE
Q 006125 351 FSDSNILGQGGFGPVYKGVLS-DG---KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK-LLVY 424 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~ 424 (660)
|...++||+|+||.||+|... ++ ..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 445688999999999999853 22 37999998753 344567899999999999999999999999876665 9999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+.+|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 103 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 103 PYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999964 3455899999999999999999999998 999999999999999999999999999865433
Q ss_pred CC--ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 505 EG--EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN-AGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 505 ~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
.. ........+++.|+|||.+.+..++.++||||||+++|||++|+.| +...+............. .. ..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~------~~ 250 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-LP------QP 250 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-CC------CC
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-CC------CC
Confidence 21 1112234678899999999999999999999999999999996555 444433332222222111 00 01
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
... ...+.+++.+||+.||.+|||+.|+++.|++....+
T Consensus 251 ~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 251 EYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccc----hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 122 235788999999999999999999999998764443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.60 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=193.8
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCC--eeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGD--EKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~ 421 (660)
.++|...+.||+|+||.||++.. .+|+.||||++.. ........+.+|+.++..+. ||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46788899999999999999985 4789999999864 23455667889999999997 999999999998654 689
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||++ ++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999997 689998842 46899999999999999999999998 999999999999999999999999999865
Q ss_pred cccCC-------------------ccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 006125 502 AESEG-------------------EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAY 561 (660)
Q Consensus 502 ~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~ 561 (660)
..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 43111 111223579999999999986 6799999999999999999999999987665544
Q ss_pred HHHHHhcCc--ccccccc--------------------cCCCCCCCH-------------HHHHHHHHHHhhcccCCCCC
Q 006125 562 AWHLWNEGN--VLELVDP--------------------LLTDTSFSD-------------DEFSRYIHIGLLCVQEDAFD 606 (660)
Q Consensus 562 ~~~~~~~~~--~~~~~d~--------------------~~~~~~~~~-------------~~~~~l~~li~~cl~~dP~~ 606 (660)
...+...-. ..+.+.. ......... .....+.+|+.+||+.||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 433321100 0000000 000000000 11235788999999999999
Q ss_pred CCCHHhHHHH
Q 006125 607 RPTMSSVAPM 616 (660)
Q Consensus 607 RPt~~evl~~ 616 (660)
|||+.|+++-
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999853
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=345.77 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=181.1
Q ss_pred CcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEEEecCCCC
Q 006125 354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 431 (660)
.+.||+|+||.||++... +++.||||++.. .....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 689999999964 24467789999999996 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC---CEEEeeccccccccccCCcc
Q 006125 432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIFAESEGEA 508 (660)
Q Consensus 432 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DfGla~~~~~~~~~~ 508 (660)
|.+++. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+++........
T Consensus 93 L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 93 LFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 999994 3456999999999999999999999998 99999999999997765 8999999999865433222
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHHHhcCcccccccccCCCC
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL------LAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~------~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..........+... ...
T Consensus 166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~- 237 (325)
T 3kn6_A 166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEG- 237 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCS-
T ss_pred -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCc-
Confidence 2234789999999999999999999999999999999999999974321 11112222221110 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhcCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGE 620 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~ 620 (660)
.........+.+|+.+||+.||.+|||+.|++ .++++.
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 00011234578899999999999999999998 455554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.48 Aligned_cols=244 Identities=25% Similarity=0.279 Sum_probs=192.2
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..++||+|+||+||+|... +|+.||||++... ..........|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888899999999999999965 7999999998642 233344555666666555 9999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 67888888532 345999999999999999999999998 999999999999999999999999998765433
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.. .....||+.|+|||++.+ .++.++||||||+++|||++|..++..... +.....+.... .+.. .
T Consensus 211 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~~~~~~----~~~~-~- 276 (311)
T 3p1a_A 211 GA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQGYLPP----EFTA-G- 276 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTTTCCCH----HHHT-T-
T ss_pred CC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhccCCCc----cccc-C-
Confidence 22 223468999999998875 789999999999999999999876654322 22222211111 0000 1
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....+.+++.+||+.||++|||+.|+++
T Consensus 277 ---~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 277 ---LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2245788999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=338.07 Aligned_cols=258 Identities=27% Similarity=0.387 Sum_probs=202.9
Q ss_pred cCCCCCCcccccCCcccEEeeee-----cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--Ce
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DE 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 419 (660)
...|+..+.||+|+||.||++.+ .+++.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34577789999999999999983 36889999999753 344567899999999999999999999999876 56
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999999999999953 2345899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCc-cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--------------HHHHHHH
Q 006125 500 IFAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--------------LLAYAWH 564 (660)
Q Consensus 500 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~--------------~~~~~~~ 564 (660)
........ .......||..|+|||++.+..++.++||||||+++|||++|+.|+.... .......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 76543321 11122357888999999999999999999999999999999998754221 1111111
Q ss_pred HHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 565 LWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 565 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
....+.. . ..+......+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 255 ~~~~~~~-------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 TLKEGKR-------L---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHTTCC-------C---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCC-------C---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111110 0 11122234578899999999999999999999999753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=341.57 Aligned_cols=277 Identities=26% Similarity=0.390 Sum_probs=208.3
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 417 (660)
..++..+..++|+..+.||+|+||.||++...+ .+|+|+++.. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345556677889999999999999999998743 5999998642 233445678899999999999999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
+..++||||+++++|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999953 2345899999999999999999999998 99999999999998 67999999999
Q ss_pred cccccccCC---ccceeeeeccCCcCCHhhhhc---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 006125 498 ARIFAESEG---EANTVRIVGTYGYMAPEYAME---------GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL 565 (660)
Q Consensus 498 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~ 565 (660)
+........ ........|++.|+|||++.. ..++.++||||||+++|||++|+.||.........+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 876532211 111223468999999999874 45789999999999999999999999877665555444
Q ss_pred HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCCCCCCceec
Q 006125 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSI 634 (660)
Q Consensus 566 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~ 634 (660)
..... +.......+ ..+.+++.+||+.||.+||++.||+++|+...........|..+.
T Consensus 256 ~~~~~------~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 256 GTGMK------PNLSQIGMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp HTTCC------CCCCCSSCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred ccCCC------CCCCcCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 33211 111111111 237789999999999999999999999999877666555555543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.53 Aligned_cols=267 Identities=24% Similarity=0.293 Sum_probs=213.2
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC--eeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 423 (660)
.++|...++||+|+||.||++... +|+.||||+++... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356788899999999999999965 58999999997533 344667889999999999999999999998765 67999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe----CCCCCEEEeeccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMAR 499 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DfGla~ 499 (660)
|||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965444445999999999999999999999998 9999999999999 778889999999998
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhc--------CCCCcchhHHHHHHHHHHHHhCCCCCCC----CcHHHHHHHHHh
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAME--------GLYSKKSDVFSFGVLLIEIITGRRNAGS----NQLLAYAWHLWN 567 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDVwslGvll~elltG~~p~~~----~~~~~~~~~~~~ 567 (660)
........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....+....+..
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 76543222 23468999999999875 5678899999999999999999999853 222333333333
Q ss_pred cCcccc-------------cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 568 EGNVLE-------------LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 568 ~~~~~~-------------~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
...... +.................+.+++.+||+.||++||++.|+++.++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 221100 00011111234567778889999999999999999999999888764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.74 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=202.4
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC------hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
++|...+.||+|+||.||++... +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45778899999999999999965 68999999986432 124678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC----CEEEeeccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM 497 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfGl 497 (660)
+||||+++++|.+++. ....+++..++.++.||++||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999994 3446899999999999999999999998 99999999999999877 899999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~ 577 (660)
+........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||...........+...... ...
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 232 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD---FDE 232 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---CCH
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC---Ccc
Confidence 986543322 12346899999999999999999999999999999999999999876654443333221110 000
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.... . ....+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~-~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 233 EYFS-N----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHT-T----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhcc-c----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000 1 1234788999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=340.97 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=199.3
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|...+.||+|+||.||++.. .+|+.||+|+++.. .......+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688889999999999999995 57899999998742 3445667899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 425 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
||+++++|.+++... .....+++..++.++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998532 12345899999999999999999999998 99999999999999999999999999976543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHHhcCcccccccccCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ--LLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
.... .....|++.|+|||++.+..++.++||||||+++|||++|+.||.... ....... ....... ....
T Consensus 189 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~-----~~~~ 260 (310)
T 2wqm_A 189 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-IEQCDYP-----PLPS 260 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH-HHTTCSC-----CCCT
T ss_pred CCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH-hhcccCC-----CCcc
Confidence 3221 123468999999999999999999999999999999999999986432 2222222 2221111 1111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLP 625 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 625 (660)
... ...+.+++.+||+.||.+||++.||++.|++.....+
T Consensus 261 ~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 261 DHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 122 2347788999999999999999999999987654433
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=342.79 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=199.9
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56788899999999999999964 5899999998643 23345568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999998874 3345899999999999999999999998 9999999999999999999999999997654332
Q ss_pred CccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh--------------cCc
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWN--------------EGN 570 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~--------------~~~ 570 (660)
.. .....|++.|+|||++.+. .++.++||||||+++|||++|+.||......+....+.. ...
T Consensus 179 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 EV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred cc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 22 1234689999999999875 789999999999999999999999986654443332221 111
Q ss_pred cc-ccccccCCCCCC----CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VL-ELVDPLLTDTSF----SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~-~~~d~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. ....+.+..... .......+.+++.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 10 001111111000 0012345889999999999999999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.37 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=205.3
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
++|...+.||+|+||.||++... +|+.||+|+++.......+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46778899999999999999964 78999999998655555567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe---CCCCCEEEeecccccccccc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~~~ 504 (660)
++++|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||++......
T Consensus 89 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 89 SGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999884 3346899999999999999999999998 9999999999999 78899999999998754332
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||...........+..... .. ... .
T Consensus 163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~-~~~-----~ 230 (304)
T 2jam_A 163 I----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY--EF-ESP-----F 230 (304)
T ss_dssp T----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC--CC-CTT-----T
T ss_pred c----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--CC-Ccc-----c
Confidence 1 1223689999999999999999999999999999999999999987665444333332211 00 001 1
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
.......+.+++.+||+.||++||++.|+++ ++++.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 1122345788999999999999999999985 56553
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.22 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=192.6
Q ss_pred HhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEe------
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVD------ 416 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~------ 416 (660)
++...+|...++||+|+||.||++.. .+++.||+|++........+.+.+|+.++.++. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 44556788899999999999999995 478999999997766667778999999999995 9999999999953
Q ss_pred --CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 417 --GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 417 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
....++||||+. |+|.+++......+.+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 334789999996 789888854344566999999999999999999999875 3599999999999999999999999
Q ss_pred ccccccccccCCcc----------ceeeeeccCCcCCHhhh---hcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 006125 495 FGMARIFAESEGEA----------NTVRIVGTYGYMAPEYA---MEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAY 561 (660)
Q Consensus 495 fGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~ 561 (660)
||++.......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 99998765432211 11134689999999998 566789999999999999999999999965433221
Q ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCC
Q 006125 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTL 624 (660)
Q Consensus 562 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 624 (660)
..... .... .... ...+.+|+.+||+.||.+||++.|+++.|+......
T Consensus 262 ~~~~~---------~~~~-~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 262 VNGKY---------SIPP-HDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ----C---------CCCT-TCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hcCcc---------cCCc-cccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11100 0000 0011 123678899999999999999999999998765443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.54 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=202.4
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
.++|+..+.||+|+||.||++... +++.||+|++........+.+.+|+.++..++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 457888899999999999999965 5899999999876666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++++|.+++.. ....+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 999999998853 2345899999999999999999999998 99999999999999999999999998764322111
Q ss_pred ccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
......|++.|+|||++. ...++.++||||||+++|||++|+.|+................... . ..
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~----~~- 244 (302)
T 2j7t_A 173 --KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-L----LT- 244 (302)
T ss_dssp --C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-C----SS-
T ss_pred --ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-c----CC-
Confidence 112346899999999984 5678999999999999999999999998776655544444332211 0 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.......+.+++.+||+.||.+|||+.|+++
T Consensus 245 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 ---PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112235778999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=354.25 Aligned_cols=256 Identities=24% Similarity=0.291 Sum_probs=196.9
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------C
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 418 (660)
.++|...++||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46788999999999999999985 46899999999753 444567788999999999999999999999754 3
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..+|||||++++ |.+.+. . .+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~---~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ---M--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT---S--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh---h--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999765 555552 1 3899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-C-cccc---
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-G-NVLE--- 573 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~-~~~~--- 573 (660)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+... + ...+
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8664322 123357999999999999999999999999999999999999999876655444333221 0 0000
Q ss_pred --------ccc---------------ccCCCCC--CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 574 --------LVD---------------PLLTDTS--FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 574 --------~~d---------------~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+. ..+.... ........+.+|+.+||+.||++|||++|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000000 00112456889999999999999999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=369.25 Aligned_cols=267 Identities=23% Similarity=0.276 Sum_probs=215.5
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCee
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 420 (660)
+..++|+..++||+|+||.||++... +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 45578999999999999999999954 6889999998742 234456788899999988 799999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
+|||||+++|+|..++. ..+.+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 418 ~lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999994 3356999999999999999999999998 99999999999999999999999999985
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------- 559 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------- 559 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC----------
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 433222 23345899999999999999999999999999999999999999988776665555543321
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCH-----HhHHH--HhcCC------CCCCCCCCCCce
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTM-----SSVAP--MLKGE------TGTLPQPQKPAF 632 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~--~L~~~------~~~~~~p~~p~~ 632 (660)
.++......+.+|+.+||+.||++||++ +||++ +++++ ...+.+|-.|..
T Consensus 560 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~ 622 (674)
T 3pfq_A 560 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 622 (674)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBC
T ss_pred --CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcC
Confidence 1111122347788999999999999998 67762 33332 234555555654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=344.33 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=205.7
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhh--cCCCCcceEeEEEEeCC----
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDGD---- 418 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---- 418 (660)
....++|...+.||+|+||.||+++. +|+.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44457899999999999999999998 5899999998642 34567788888887 79999999999998876
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCceEeCCCCCE
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH--------EDSRLRIVHRDLKASNVLLDSDMNS 490 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~DLkp~NILl~~~~~~ 490 (660)
..++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+||||+.++++
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999942 35899999999999999999999 666 9999999999999999999
Q ss_pred EEeeccccccccccCCcc--ceeeeeccCCcCCHhhhhcCC------CCcchhHHHHHHHHHHHHhC----------CCC
Q 006125 491 KISDFGMARIFAESEGEA--NTVRIVGTYGYMAPEYAMEGL------YSKKSDVFSFGVLLIEIITG----------RRN 552 (660)
Q Consensus 491 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~t~ksDVwslGvll~elltG----------~~p 552 (660)
||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765433221 112347899999999997653 34789999999999999999 667
Q ss_pred CCCCc----HHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 553 AGSNQ----LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 553 ~~~~~----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
|.... ............. ..+.+.......+....+.+|+.+||+.||++||++.||++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCcCcccHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 65321 1122222222111 11111110112356678899999999999999999999999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=337.88 Aligned_cols=266 Identities=26% Similarity=0.384 Sum_probs=189.5
Q ss_pred HhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
.+..++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 35567899999999999999999984 478999999986432 3445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcC-----CCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 423 VYEFMPNGSLDAILFD-----PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
||||+++++|.+++.. ......+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999853 123456899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCc---cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccc
Q 006125 498 ARIFAESEGE---ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 498 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
+......... .......|++.|+|||++.+ ..++.++||||||+++|||++|+.||.................. .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~ 246 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP-S 246 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC-C
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC-c
Confidence 9765432211 11223478999999999876 57899999999999999999999999865544333333222111 1
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
. ................+.+++.+||+.||.+||++.|+++
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 L-ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp T-TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c-ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 0000000111112235778999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=341.48 Aligned_cols=270 Identities=27% Similarity=0.371 Sum_probs=201.4
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC------
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 418 (660)
.++|...+.||+|+||.||++.. .+|+.||||++.. ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788889999999999999996 4799999999964 23444567899999999999999999999998653
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999843 45899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-Cc-ccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-GN-VLELV 575 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~~-~~~~~ 575 (660)
+..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...+..+....+... +. ..+.+
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 865432 123478999999999987 67999999999999999999999999876655444333221 00 00000
Q ss_pred c--------------ccCCCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCCCCCCCCC
Q 006125 576 D--------------PLLTDT---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGTLPQPQKP 630 (660)
Q Consensus 576 d--------------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~p~~p 630 (660)
. +..... .........+.+|+.+||+.||.+|||+.|+++ ++++......+|..+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~ 324 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ 324 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC
Confidence 0 000000 011112345788999999999999999999997 676654444444433
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.84 Aligned_cols=251 Identities=30% Similarity=0.368 Sum_probs=198.4
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-CeeEEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYE 425 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 425 (660)
..++|+..+.||+|+||.||++.. +|+.||+|+++.. ...+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 346788889999999999999987 5889999999753 3456789999999999999999999997655 46899999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++... ....+++..++.++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999999431 2223789999999999999999999998 9999999999999999999999999987554321
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+........ .. . ..
T Consensus 172 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~-----~-----~~ 235 (278)
T 1byg_A 172 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YK-----M-----DA 235 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CC-----C-----CC
T ss_pred -----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CC-----C-----CC
Confidence 12357889999999999999999999999999999998 99999766544333222211 10 1 11
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.......+.+++.+||+.||.+||++.|+++.|+.+
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 112234578899999999999999999999999764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=368.87 Aligned_cols=248 Identities=29% Similarity=0.377 Sum_probs=199.5
Q ss_pred cccccCCcccEEeeeec---CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLS---DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
++||+|+||.||+|.+. .++.||||+++.. .....+++.+|+.++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 4678999999753 33446789999999999999999999999964 558899999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc-c
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-A 508 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 508 (660)
|+|.+++. ....+++..++.|+.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999994 3456999999999999999999999998 999999999999999999999999999876543322 1
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+... .... .+..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~----------~p~~ 596 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMG----------CPAG 596 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCC----------CCTT
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCC----------CCCC
Confidence 1222356788999999999999999999999999999998 99999876655443333322 1111 1112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
....+.+|+.+||+.||++||++.+|++.|++.
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 234578899999999999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=330.35 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=200.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
..++|...+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3467888999999999999999965 7899999998642 22345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999943 345899999999999999999999998 9999999999999999999999999998664
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
.... .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...........+..... .+.
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~- 231 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-------YIP- 231 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------CCC-
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-------cCc-
Confidence 4321 123468999999999987765 6899999999999999999999987665544333322211 011
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
... ...+.+++.+||+.||.+||++.|+++ ++++
T Consensus 232 ~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 232 EYL----NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhc----CHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 112 234778899999999999999999986 3544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=343.31 Aligned_cols=264 Identities=20% Similarity=0.298 Sum_probs=197.5
Q ss_pred hcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
..++|...++||+|+||.||++.. .+++.||||+++... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346788899999999999999984 478999999997532 23345678999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe-----CCCCCEEEeecccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL-----DSDMNSKISDFGMA 498 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl-----~~~~~~kl~DfGla 498 (660)
|||++ |+|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99997 59999884 3345899999999999999999999998 9999999999999 45566999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccc-----
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVL----- 572 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~----- 572 (660)
+........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.......
T Consensus 185 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 866433222 2234689999999999874 58999999999999999999999998776555554443210000
Q ss_pred -cc--cc---ccCCC-CCCCHH------HHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 573 -EL--VD---PLLTD-TSFSDD------EFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 573 -~~--~d---~~~~~-~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
.. .. ..... ...... ....+.+++.+||+.||.+|||+.|+++ ++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 00 00 00000 000000 1245788999999999999999999986 5544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=329.93 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=199.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe----CCeeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 421 (660)
..|...+.||+|+||.||+|.. .++..||+|++.. ......+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3466678899999999999985 4678999999864 244556779999999999999999999999875 35589
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC-CCCCEEEeecccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARI 500 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~ 500 (660)
+||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999994 3356899999999999999999999975 3599999999999998 789999999999975
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
..... .....|++.|+|||++. +.++.++||||||+++|||++|+.||...............+......+.
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 253 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK--- 253 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG---
T ss_pred ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCC---
Confidence 43321 22346899999999876 45899999999999999999999999764444333333333221111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+ ..+.+++.+||+.||.+||++.|+++
T Consensus 254 --~~~----~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 254 --VAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCC----HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112 34788999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=333.84 Aligned_cols=259 Identities=25% Similarity=0.339 Sum_probs=205.0
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe--CCeeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLL 422 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 422 (660)
.++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 356788899999999999999964 7899999998743 34456779999999999999999999998864 567899
Q ss_pred EEEecCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 423 VYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||+++++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999995422 2334899999999999999999999976 2349999999999999999999999999997
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+....+.. +.... +
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~-----~ 236 (279)
T 2w5a_A 165 ILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRR-----I 236 (279)
T ss_dssp HC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCC-----C
T ss_pred eecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-ccccc-----C
Confidence 65432211 1124689999999999999999999999999999999999999987665444333322 22111 1
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
.. .. ...+.+++.+||+.||.+||++.||++.+..
T Consensus 237 ~~-~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 PY-RY----SDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CT-TS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred Cc-cc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 22 2457889999999999999999999987644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=334.80 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=202.1
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe-----------
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----------- 416 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------- 416 (660)
.+|+..+.||+|+||.||++... +++.||+|+++... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 46788899999999999999975 79999999997543 356789999999999999999999864
Q ss_pred -----CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEE
Q 006125 417 -----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 417 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
....++||||+++++|.+++... ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence 34578999999999999999532 2346899999999999999999999998 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV 571 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 571 (660)
|+|||++......... ....|++.|+|||++.+..++.++||||||+++|||++|..|+.... ..+.......
T Consensus 163 l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~- 235 (284)
T 2a19_B 163 IGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---KFFTDLRDGI- 235 (284)
T ss_dssp ECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHHHTTC-
T ss_pred ECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---HHHHHhhccc-
Confidence 9999999876543221 22468999999999999999999999999999999999998763211 1111121111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCC
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLP 625 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 625 (660)
+. ..++ ..+.+++.+||+.||.+||++.|+++.|+.......
T Consensus 236 -------~~-~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 236 -------IS-DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp -------CC-TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred -------cc-ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11 1222 346788899999999999999999999987654443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.88 Aligned_cols=242 Identities=24% Similarity=0.325 Sum_probs=199.9
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC--------hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 418 (660)
.++|...+.||+|+||.||++.. .+++.||||+++... ......+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45788899999999999999984 578999999987532 113345778999999999999999999999999
Q ss_pred eeEEEEEecCCC-ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 419 EKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 419 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
..++||||+..| +|.+++. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999777 9999994 3445999999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
+........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... +.+.
T Consensus 177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---------------~~~~ 238 (335)
T 3dls_A 177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE---------------ETVE 238 (335)
T ss_dssp CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG---------------GGTT
T ss_pred ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH---------------HHHh
Confidence 987654322 223579999999999988776 889999999999999999999986421 1111
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHH
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPM 616 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 616 (660)
.....+.. ....+.+++.+||+.||++||++.|+++-
T Consensus 239 ~~~~~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIHPPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccCCCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 12347788999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=341.03 Aligned_cols=262 Identities=27% Similarity=0.351 Sum_probs=194.3
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHH--HHhhcCCCCcceEeEEEEe-----CC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVL--LILKLQHKNLVKLLGFCVD-----GD 418 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~-----~~ 418 (660)
+..++|+..+.||+|+||.||+|+. +++.||||++.... ...+..|.+ .+..++||||+++++.+.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3456788899999999999999987 68999999986532 233444444 4556899999999986643 23
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCceEeCCCCC
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED---------SRLRIVHRDLKASNVLLDSDMN 489 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------~~~~ivH~DLkp~NILl~~~~~ 489 (660)
..++||||+++|+|.+++.. ...++..+..++.||++||.|||+. + |+||||||+||||+.++.
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred eEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 56899999999999999942 3358999999999999999999998 6 999999999999999999
Q ss_pred EEEeeccccccccccCCc------cceeeeeccCCcCCHhhhhc-------CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006125 490 SKISDFGMARIFAESEGE------ANTVRIVGTYGYMAPEYAME-------GLYSKKSDVFSFGVLLIEIITGRRNAGSN 556 (660)
Q Consensus 490 ~kl~DfGla~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwslGvll~elltG~~p~~~~ 556 (660)
+||+|||+++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999876533211 11123468999999999976 45678999999999999999997765321
Q ss_pred c-----------------HHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 557 Q-----------------LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 557 ~-----------------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
. .................+.... .........+.+|+.+||+.||++|||+.||++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 1 0001111111111111111111 1123456678999999999999999999999999987
Q ss_pred CC
Q 006125 620 ET 621 (660)
Q Consensus 620 ~~ 621 (660)
..
T Consensus 316 ll 317 (336)
T 3g2f_A 316 LM 317 (336)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.97 Aligned_cols=251 Identities=28% Similarity=0.355 Sum_probs=205.3
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
+..++|...++||+|+||.||++... +|+.||+|++... .......+.+|+.++..++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 44567888899999999999999964 7999999998642 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999999643 2334899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCccccccccc
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ---LLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~---~~~~~~~~~~~~~~~~~~d~~ 578 (660)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............. ..
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~------~~ 407 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP------EE 407 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC------CC
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc------cc
Confidence 43322 223479999999999999899999999999999999999999997542 1122222222111 01
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHH
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVA 614 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl 614 (660)
+. ..++ ..+.+|+.+||+.||.+|| ++.||+
T Consensus 408 ~p-~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil 443 (576)
T 2acx_A 408 YS-ERFS----PQARSLCSQLLCKDPAERLGCRGGSAREVK 443 (576)
T ss_dssp CC-TTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred CC-ccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHH
Confidence 11 1222 3477889999999999999 788887
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.51 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=204.6
Q ss_pred hhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh--------hcHHHHHHHHHHHhhc-CCCCcceEeEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 415 (660)
...++|...+.||+|+||.||++... +|+.||||+++.... ...+.+.+|+.++.++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 33467888899999999999999975 799999999865321 1245678999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeec
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 495 (660)
.....++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred eCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence 9999999999999999999994 3346899999999999999999999998 999999999999999999999999
Q ss_pred cccccccccCCccceeeeeccCCcCCHhhhhc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC
Q 006125 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAME------GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG 569 (660)
Q Consensus 496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~ 569 (660)
|++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+....
T Consensus 245 G~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 321 (365)
T 2y7j_A 245 GFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321 (365)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 99987654322 223578999999999864 358899999999999999999999998765444433332221
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. ...+... .. ...+.+++.+||+.||++||++.|+++
T Consensus 322 ~~--~~~~~~~--~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 322 YQ--FSSPEWD--DR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CC--CCHHHHS--SS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC--CCCcccc--cC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 0000000 11 234788999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.89 Aligned_cols=266 Identities=21% Similarity=0.284 Sum_probs=198.4
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh-hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|...+.||+|+||.||++... +++.||+|+++.... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46778899999999999999965 789999999864322 1222455799999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 588888853 2345899999999999999999999998 99999999999999999999999999976543222
Q ss_pred ccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---C---cccccccc--
Q 006125 507 EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---G---NVLELVDP-- 577 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~---~~~~~~d~-- 577 (660)
. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+... . .+......
T Consensus 156 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 156 T--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred c--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 2 223468999999999876 56899999999999999999999999876655443333221 0 00000000
Q ss_pred -------cCCCCC---CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCC
Q 006125 578 -------LLTDTS---FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETG 622 (660)
Q Consensus 578 -------~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 622 (660)
...... ........+.+++.+||+.||.+|||+.|+++ ++.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 000000 00011235778999999999999999999985 5655433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=342.99 Aligned_cols=267 Identities=27% Similarity=0.386 Sum_probs=207.1
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-----cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC--
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-- 418 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 418 (660)
+..++|+..+.||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3456678889999999999999983 368899999998766667788999999999999999999999987654
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+++++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 679999999999999999542 345899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccc-eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc-------
Q 006125 499 RIFAESEGEAN-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN------- 570 (660)
Q Consensus 499 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~------- 570 (660)
........... .....++..|+|||++.+..++.++||||||+++|||++|..|+..... ..........
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHHHHHCTTCCTHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHHHhhccccchhhhHH
Confidence 87654332111 1123567789999999998899999999999999999999988753210 0001000000
Q ss_pred -ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 571 -VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 571 -~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
+.+.+...... ..+......+.+++.+||+.||++||++.||++.|+..
T Consensus 271 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 271 HLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00111100000 11122234588899999999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.41 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=197.5
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.++|+..+.||+|+||.||++..+ +|+.||+|+++.... ...+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 356888899999999999999964 689999999975432 234688888888 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC----CCEEEeeccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARIF 501 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~----~~~kl~DfGla~~~ 501 (660)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999853 356999999999999999999999998 9999999999998543 35999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHHHhcCcccccccccC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN--QLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~--~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||... ............+... . ..
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~-~~-- 244 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS-L-SG-- 244 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC-C-CS--
T ss_pred cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc-c-Cc--
Confidence 543322 22347899999999998888999999999999999999999999742 2222222222222211 0 00
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.........+.+|+.+||+.||++||++.|+++
T Consensus 245 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 ---GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011112234778899999999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.48 Aligned_cols=259 Identities=25% Similarity=0.331 Sum_probs=203.5
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
..++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3467888899999999999999964 6899999998753 3445677999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
||+++++|.+++. ..+.+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 111 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999994 334589999999999999999999996 7 99999999999999999999999999976543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---------------
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE--------------- 568 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~--------------- 568 (660)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...............
T Consensus 185 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred cc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 22 12347899999999999999999999999999999999999999765433321111000
Q ss_pred --------------Ccccccccc---cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 569 --------------GNVLELVDP---LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 569 --------------~~~~~~~d~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....+.++. ..............+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000 00000000112235788999999999999999999983
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=346.97 Aligned_cols=262 Identities=15% Similarity=0.157 Sum_probs=204.0
Q ss_pred cCCCCCCcccccCCcccEEeeeecC---------CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcce---------
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSD---------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK--------- 409 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 409 (660)
.++|...+.||+|+||.||++.... ++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4678889999999999999999653 789999998753 35789999999999999887
Q ss_pred ------EeEEEEe-CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 006125 410 ------LLGFCVD-GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (660)
Q Consensus 410 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 482 (660)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||++||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778876 67889999999 99999999532 2356999999999999999999999998 99999999999
Q ss_pred EeCCCC--CEEEeeccccccccccCCcc-----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006125 483 LLDSDM--NSKISDFGMARIFAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS 555 (660)
Q Consensus 483 Ll~~~~--~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~ 555 (660)
|++.++ .+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 99999999998765432211 11224789999999999999999999999999999999999999975
Q ss_pred Cc-HHHHHHHHHh--cCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCC
Q 006125 556 NQ-LLAYAWHLWN--EGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGT 623 (660)
Q Consensus 556 ~~-~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 623 (660)
.. .......... ......+.+........+ ..+.+++.+||+.||++||+++||+++|++....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 42 1111111111 111112222111111122 3477888999999999999999999999876433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=336.68 Aligned_cols=258 Identities=21% Similarity=0.272 Sum_probs=205.4
Q ss_pred cCCCCCC-cccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEE
Q 006125 348 TSNFSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 348 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 422 (660)
.++|... +.||+|+||.||++... +++.||+|+++.. .......+.+|+.++..+ +||||+++++++.+.+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 4455555 78999999999999964 6899999998752 334467899999999999 56999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC---CCCEEEeeccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMAR 499 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla~ 499 (660)
||||+++|+|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 107 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred EEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 9999999999999843 23456999999999999999999999998 999999999999998 7899999999998
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+...... ...
T Consensus 183 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~--- 254 (327)
T 3lm5_A 183 KIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD--YSE--- 254 (327)
T ss_dssp EC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCT---
T ss_pred ccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc--cCc---
Confidence 7643322 22347899999999999999999999999999999999999999876655544433322110 000
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
.........+.+++.+||+.||.+|||++|+++ ++++.
T Consensus 255 ---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 255 ---ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp ---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred ---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 111122344778999999999999999999985 45543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.59 Aligned_cols=256 Identities=16% Similarity=0.161 Sum_probs=204.8
Q ss_pred HHHhhcCCCCCCcccccCCcccEEeee------ecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC---CCCcceEeEE
Q 006125 343 TLNLATSNFSDSNILGQGGFGPVYKGV------LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGF 413 (660)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~ 413 (660)
++++..++|...++||+|+||.||+|. ..+++.||||+++... ..++..|+.++..++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 345667889999999999999999994 4568899999997643 456777777777775 9999999999
Q ss_pred EEeCCeeEEEEEecCCCChhhhhcCC--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-----
Q 006125 414 CVDGDEKLLVYEFMPNGSLDAILFDP--RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----- 486 (660)
Q Consensus 414 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~----- 486 (660)
+...+..+|||||+++|+|.+++... .....+++..++.|+.||++||+|||+.+ |+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 99999999999999999999999531 13456999999999999999999999998 999999999999998
Q ss_pred ------CCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 006125 487 ------DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA 560 (660)
Q Consensus 487 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~ 560 (660)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-- 290 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-- 290 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET--
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC--
Confidence 899999999999765533333333445799999999999999999999999999999999999999853221
Q ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCC-CCHHhHHHHhcCC
Q 006125 561 YAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDR-PTMSSVAPMLKGE 620 (660)
Q Consensus 561 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~ 620 (660)
+ ...+...+.. ....+ .+.+++..|++.+|.+| |++.++.+.|++.
T Consensus 291 --------~--~~~~~~~~~~-~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 291 --------G--ECKPEGLFRR-LPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------T--EEEECSCCTT-CSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------C--ceeechhccc-cCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0 0111122222 12233 45567778999999999 6888888877764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=356.30 Aligned_cols=247 Identities=27% Similarity=0.353 Sum_probs=202.0
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
..++|...++||+|+||.||+++.. +|+.||+|++... .......+.+|+.++++++||||+++++++...+..++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3467888899999999999999964 6999999999642 22345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 423 VYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
||||+++|+|..++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999986532 2446999999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHHhcCcccccccc
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ----LLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~----~~~~~~~~~~~~~~~~~~d~ 577 (660)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+... ..
T Consensus 340 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~------ 410 (543)
T 3c4z_A 340 KAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AV------ 410 (543)
T ss_dssp CTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CC------
T ss_pred cCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-cc------
Confidence 543222 223479999999999999999999999999999999999999997542 22222222221 10
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTM 610 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 610 (660)
.++......+.+++.+||+.||.+||++
T Consensus 411 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 -----TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 1111122347788899999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=336.30 Aligned_cols=263 Identities=26% Similarity=0.442 Sum_probs=204.9
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEe-
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD- 416 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 416 (660)
++.++....++|+..+.||+|+||.||++.. .+++.||+|++... ......+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344455678899999999999999999996 47899999998753 23456789999999999 89999999999987
Q ss_pred -----CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEE
Q 006125 417 -----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (660)
Q Consensus 417 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~k 491 (660)
.+..++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 46789999999999999999542 2356899999999999999999999998 99999999999999999999
Q ss_pred EeeccccccccccCCccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 006125 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLW 566 (660)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~ 566 (660)
|+|||++......... .....|++.|+|||++. +..++.++||||||+++|||++|+.||...........+.
T Consensus 170 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred EeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 9999999765432221 22346899999999987 5678999999999999999999999998766555444433
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 567 NEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 567 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
.... +......++ ..+.+++.+||+.||.+||++.|+++ ++++
T Consensus 248 ~~~~------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 248 RNPA------PRLKSKKWS----KKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HSCC------CCCSCSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred cCcc------ccCCccccC----HHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 3221 111111222 34778899999999999999999986 4543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.62 Aligned_cols=259 Identities=28% Similarity=0.389 Sum_probs=201.3
Q ss_pred hcCCCCCCcccccCCcccEEeeeec--CCc--EEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS--DGK--EVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
..++|+..+.||+|+||.||++.+. +++ .||+|+++.. .....+.+.+|+.++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3457888899999999999999853 333 6899998753 3345678899999999999999999999998765
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++|+||+++++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 8899999999999999953 2345899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccc
Q 006125 500 IFAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 500 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~ 577 (660)
......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 245 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---- 245 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC----
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC----
Confidence 765433221 1122457788999999998889999999999999999999 9999987766555444433322111
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
........+.+++.+||+.||.+||++.++++.|++..
T Consensus 246 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 246 ------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 11122345788999999999999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.84 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=201.8
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh-----hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-----QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
..++|...+.||+|+||.||++... +|+.||||+++.... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3467899999999999999999964 689999999974221 1234688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++ +|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 88888843 3345899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---Cccccccc
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---GNVLELVD 576 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~~~~~~~d 576 (660)
....... .....||+.|+|||++.+ ..++.++||||||+++|||++|.+||......+....+... .....+.+
T Consensus 162 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 162 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred ccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 6433222 223478999999999975 45899999999999999999999999877655554444331 00000000
Q ss_pred -----ccCC---CCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 577 -----PLLT---DTSFS-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 577 -----~~~~---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
.... .+..+ ......+.+++.+||+.||++|||+.|+++ ++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 0000 00111 112256888999999999999999999985 44443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=348.58 Aligned_cols=247 Identities=24% Similarity=0.305 Sum_probs=187.3
Q ss_pred CCCCC-cccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhh-cCCCCcceEeEEEEe----CCeeEE
Q 006125 350 NFSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILK-LQHKNLVKLLGFCVD----GDEKLL 422 (660)
Q Consensus 350 ~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~l 422 (660)
+|... ++||+|+||.||++... +|+.||||+++.. ..+.+|+.++.+ .+||||+++++++.. ....+|
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 44444 68999999999999964 6899999998642 456788888754 489999999999875 556899
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC---CCCEEEeeccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMAR 499 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla~ 499 (660)
||||+++|+|.+++... ....+++..+..|+.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 137 v~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999642 2345999999999999999999999998 999999999999998 7899999999998
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHHHhcCccccccc
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA---YAWHLWNEGNVLELVD 576 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~~d 576 (660)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.. ....
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-~~~~ 288 (400)
T 1nxk_A 213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 288 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-CCCT
T ss_pred ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-cCCC
Confidence 654322 1224578999999999999999999999999999999999999996443111 01111111111 0000
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+. .... ...+.+|+.+||+.||++|||+.|+++
T Consensus 289 ~~--~~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 289 PE--WSEV----SEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TT--TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc--cccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0122 234788999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.09 Aligned_cols=195 Identities=25% Similarity=0.434 Sum_probs=154.7
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-----Ce
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 419 (660)
.++|+..++||+|+||.||++... +++.||||++.. ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367889999999999999999854 789999999865 2344567789999999999999999999999543 56
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++||||+ +++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 578999884 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCc-------------------------cceeeeeccCCcCCHhhh-hcCCCCcchhHHHHHHHHHHHHhC
Q 006125 500 IFAESEGE-------------------------ANTVRIVGTYGYMAPEYA-MEGLYSKKSDVFSFGVLLIEIITG 549 (660)
Q Consensus 500 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwslGvll~elltG 549 (660)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76432211 112335789999999986 456799999999999999999993
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.52 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=202.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
..++|+..+.||+|+||.||++... +|+.||+|++... ...+.+.+|+.++..++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567888999999999999999965 5899999999753 245678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999842 2446899999999999999999999998 9999999999999999999999999997664432
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.. .....|++.|+|||++.+..++.++||||||+++|||++|+.||.................. .... .
T Consensus 180 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~---~ 248 (314)
T 3com_A 180 AK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP------TFRK---P 248 (314)
T ss_dssp SC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC------CCSS---G
T ss_pred cc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc------ccCC---c
Confidence 22 22346899999999999999999999999999999999999999876655444333222110 0100 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......+.+++.+||+.||.+||++.|+++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111245778999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=339.84 Aligned_cols=270 Identities=25% Similarity=0.331 Sum_probs=192.4
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------C
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 418 (660)
.++|...+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47888999999999999999984 57899999999652 344566788999999999999999999999754 4
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 7899998842 45999999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-C-ccccc-
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-G-NVLEL- 574 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~-~~~~~- 574 (660)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+... + ...+.
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 865432 223478999999999987 67899999999999999999999999876654444333221 0 00000
Q ss_pred -----------ccccCCCCCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCCCCCCCCC
Q 006125 575 -----------VDPLLTDTSFSDD-----EFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGTLPQPQKP 630 (660)
Q Consensus 575 -----------~d~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~p~~p 630 (660)
+......+..... ....+.+|+.+||+.||.+|||+.|+++ +++....+..+|..+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~ 328 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 328 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC
Confidence 0000000011111 1245788999999999999999999985 555544333334333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=332.12 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=197.7
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|+..+.||+|+||.||++... +++.||+|+++.. .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356788899999999999999965 7999999998753 334456788999999999 999999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC---------------
Q 006125 424 YEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD--------------- 487 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~--------------- 487 (660)
|||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999995321 1255899999999999999999999998 9999999999999844
Q ss_pred ----CCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q 006125 488 ----MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYA 562 (660)
Q Consensus 488 ----~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~ 562 (660)
..+||+|||++....... ...|++.|+|||++.+. .++.++||||||+++|||++|.+++......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence 479999999998664322 12589999999999865 5678999999999999999999877554322
Q ss_pred HHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 563 WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 563 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.....+... .+.. ..+ ..+.+++.+||+.||++||++.|+++
T Consensus 238 -~~~~~~~~~-----~~~~-~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 -HEIRQGRLP-----RIPQ-VLS----QEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HHHHTTCCC-----CCSS-CCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHcCCCC-----CCCc-ccC----HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 122222211 1111 222 34778899999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.56 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=204.2
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC---------hhcHHHHHHHHHHHhhcC-CCCcceEeEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---------EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVD 416 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 416 (660)
.++|...+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888899999999999999964 68999999986432 122456889999999995 9999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecc
Q 006125 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 496 (660)
....++||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999994 3356899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccCCccceeeeeccCCcCCHhhhh------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc
Q 006125 497 MARIFAESEGEANTVRIVGTYGYMAPEYAM------EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 570 (660)
++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||...........+.....
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 9986643322 22346899999999985 45688999999999999999999999987665444433333211
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
. ...+ ........+.+++.+||+.||.+||++.|+++
T Consensus 247 ~--~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 247 Q--FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C--CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c--cCcc------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 0000 01122345788999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.16 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=199.9
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEE-----------
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV----------- 415 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 415 (660)
.++|...+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367888899999999999999965 58999999998766677788999999999999999999999873
Q ss_pred ---eCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC-CCCCEE
Q 006125 416 ---DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSK 491 (660)
Q Consensus 416 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~-~~~~~k 491 (660)
+....++||||++ |+|.+++. .+.+++..++.++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999997 69999983 345899999999999999999999998 99999999999997 567999
Q ss_pred EeeccccccccccCCc-cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC
Q 006125 492 ISDFGMARIFAESEGE-ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG 569 (660)
Q Consensus 492 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~ 569 (660)
|+|||+++........ .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999876432211 11122357889999999876 678999999999999999999999998766554443333221
Q ss_pred cccc-------------cccccCCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCC
Q 006125 570 NVLE-------------LVDPLLTDTSFS-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGET 621 (660)
Q Consensus 570 ~~~~-------------~~d~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 621 (660)
.... .+......+... ......+.+++.+||+.||++||++.|+++ +++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 1000 000000000000 112345788999999999999999999985 666543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=333.48 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=200.1
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--------
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-------- 417 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 417 (660)
++|...+.||+|+||.||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688889999999999999996 57899999998643 233456788999999999999999999999873
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
+..++||||+++ +|...+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999985 67666643 2345999999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCc--cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-Ccc-c
Q 006125 498 ARIFAESEGE--ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-GNV-L 572 (660)
Q Consensus 498 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~~~-~ 572 (660)
++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+... +.. .
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9876532221 11223478999999999876 45899999999999999999999999876544433332211 000 0
Q ss_pred cc------------ccccCCCCCCCHHH------HHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 573 EL------------VDPLLTDTSFSDDE------FSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 573 ~~------------~d~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+. +...........+. ...+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00 00000000001111 234778999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.82 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=188.5
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
+..++|+..+.||+|+||.||++.. .+|+.||+|+++... ....+.+.++...++.++||||+++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 4457788899999999999999995 578999999997532 2223345556666888899999999999999999999
Q ss_pred EEEecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 423 VYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
||||++ |+|.+++... .....+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999997 5887776431 2345699999999999999999999998 7 99999999999999999999999999976
Q ss_pred ccccCCccceeeeeccCCcCCHhhh----hcCCCCcchhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHHhcCcccccc
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYA----MEGLYSKKSDVFSFGVLLIEIITGRRNAGSN-QLLAYAWHLWNEGNVLELV 575 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDVwslGvll~elltG~~p~~~~-~~~~~~~~~~~~~~~~~~~ 575 (660)
....... ....||+.|+|||++ .+..++.++||||||+++|||++|+.||... ...............
T Consensus 160 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 232 (290)
T 3fme_A 160 LVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP---- 232 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC----
T ss_pred ccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC----
Confidence 6443222 223689999999996 4667899999999999999999999999753 222222233222211
Q ss_pred cccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 576 DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 576 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....... ...+.+++.+||+.||++|||+.|+++
T Consensus 233 --~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 --QLPADKF----SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --CCCTTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CcccccC----CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111122 234788999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=348.76 Aligned_cols=252 Identities=24% Similarity=0.311 Sum_probs=190.5
Q ss_pred hcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC--------hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 417 (660)
..++|...+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 357899999999999999999985 468999999986421 112235789999999999999999999975 4
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC---CCEEEee
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISD 494 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~---~~~kl~D 494 (660)
+..++||||+++|+|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.+ ..+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 56899999999999999884 4456999999999999999999999998 9999999999999754 4599999
Q ss_pred ccccccccccCCccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV 571 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 571 (660)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||...............+..
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 99998764322 122357999999999985 366889999999999999999999999743321112222222211
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. .. .... . ....+.+++.+||+.||++||++.|+++
T Consensus 363 ~~-~~-~~~~-~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 NF-IP-EVWA-E----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CC-CH-HHHT-T----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC-Cc-hhhc-c----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 00 0000 1 1345788999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.68 Aligned_cols=199 Identities=26% Similarity=0.442 Sum_probs=166.5
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-----Ce
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 419 (660)
.++|...+.||+|+||.||++.. .+++.||||+++.. .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46788999999999999999995 46889999999752 344567789999999999999999999999776 56
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.++||||++ |+|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 59999994 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCc--------------------cceeeeeccCCcCCHhhh-hcCCCCcchhHHHHHHHHHHHHhCCCCC
Q 006125 500 IFAESEGE--------------------ANTVRIVGTYGYMAPEYA-MEGLYSKKSDVFSFGVLLIEIITGRRNA 553 (660)
Q Consensus 500 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwslGvll~elltG~~p~ 553 (660)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76543221 112345789999999986 5667999999999999999999854443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.12 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=199.6
Q ss_pred cCCCCCCcccccCCcccEEeeee----cCCcEEEEEEccCCC----hhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCC
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 418 (660)
.++|...+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+.++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788889999999999999986 378999999987421 23345677899999999 6999999999999999
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+++|+|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999994 3346899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHHhcCccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSN----QLLAYAWHLWNEGNVL 572 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~~~~----~~~~~~~~~~~~~~~~ 572 (660)
+.+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||... .............
T Consensus 207 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--- 282 (355)
T 1vzo_A 207 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--- 282 (355)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC---
T ss_pred eecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC---
Confidence 8654332221 223478999999999985 34789999999999999999999998632 2222222222111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHHHH
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAPM 616 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 616 (660)
+ ..+......+.+|+.+||+.||.+|| ++.|+++.
T Consensus 283 ----~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 ----P-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----C-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----C-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1 11112234477899999999999999 99999853
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=331.29 Aligned_cols=256 Identities=19% Similarity=0.283 Sum_probs=198.9
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEE-EeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC-VDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 425 (660)
.++|...+.||+|+||.||++.. .+++.||||++.... ....+.+|+.++..++|++++..++.+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46799999999999999999995 578999999875432 223578899999999988877766665 66778899999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe---CCCCCEEEeecccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA 502 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~ 502 (660)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 9999999953 2345999999999999999999999998 9999999999999 788999999999998765
Q ss_pred ccCCcc-----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHHHhcCcc
Q 006125 503 ESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ------LLAYAWHLWNEGNV 571 (660)
Q Consensus 503 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~------~~~~~~~~~~~~~~ 571 (660)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 443211 1223578999999999999999999999999999999999999996421 11111111100000
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
. ... ... ...+.+++.+||+.||++||+++||++.|++..
T Consensus 240 ~-----~~~-~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 240 E-----VLC-KGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp H-----HHT-TTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred h-----hhh-ccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0 000 012 235788999999999999999999999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.74 Aligned_cols=262 Identities=19% Similarity=0.229 Sum_probs=202.5
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhc------CCCCcceEeEEEEeCCee
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL------QHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 420 (660)
..+|+..++||+|+||.||++... +++.||||+++. .......+.+|+.++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457888999999999999999854 689999999975 334456778888888887 577999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC--EEEeecccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--SKISDFGMA 498 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DfGla 498 (660)
++||||+. ++|.+++... ....+++..+..|+.||++||+|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6898888542 2234899999999999999999999998 999999999999999987 999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc--C-------
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE--G------- 569 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~--~------- 569 (660)
....... ....||+.|+|||++.+..++.++|||||||++|||++|++||...+..+....+... .
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 7543321 2247899999999999999999999999999999999999999876654443322211 0
Q ss_pred ---ccccccccc---------------------------C--CCCCCCH------HHHHHHHHHHhhcccCCCCCCCCHH
Q 006125 570 ---NVLELVDPL---------------------------L--TDTSFSD------DEFSRYIHIGLLCVQEDAFDRPTMS 611 (660)
Q Consensus 570 ---~~~~~~d~~---------------------------~--~~~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~ 611 (660)
...+.++.. . ....... .....+.+++.+||+.||++|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 000000000 0 0000000 0124578999999999999999999
Q ss_pred hHHH--HhcCC
Q 006125 612 SVAP--MLKGE 620 (660)
Q Consensus 612 evl~--~L~~~ 620 (660)
|+++ ++++.
T Consensus 405 e~L~Hpw~~~~ 415 (429)
T 3kvw_A 405 QALRHPWLRRR 415 (429)
T ss_dssp HHHTSTTTC--
T ss_pred HHhCChhhccC
Confidence 9986 55543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=351.35 Aligned_cols=242 Identities=15% Similarity=0.149 Sum_probs=188.6
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC---CChhcHHHHHHHH---HHHhhcCCCCcceEe-------EE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEV---LLILKLQHKNLVKLL-------GF 413 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 413 (660)
.++|...+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45678889999999999999995 5799999999873 3344567899999 455566899999998 67
Q ss_pred EEeCCe-----------------eEEEEEecCCCChhhhhcCCC----CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006125 414 CVDGDE-----------------KLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472 (660)
Q Consensus 414 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 472 (660)
+...+. .+|||||+ +|+|.+++.... ....+++..++.|+.||++||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 689999995311 1223556888999999999999999998 9
Q ss_pred EecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcC-----------CCCcchhHHHHHH
Q 006125 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-----------LYSKKSDVFSFGV 541 (660)
Q Consensus 473 vH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDVwslGv 541 (660)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985322 2233467 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 542 LLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 542 ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
++|||++|+.||...... . ..+.+.... ...+ ..+.+++.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~---------~-~~~~~~~~~--~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAAL---------G-GSEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC---------------C-CSGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccc---------c-chhhhhhhc--cCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999998643211 1 111111111 1223 34778899999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=349.87 Aligned_cols=255 Identities=27% Similarity=0.355 Sum_probs=205.1
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-------------hhcHHHHHHHHHHHhhcCCCCcceEeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-------------EQGTAEFTNEVLLILKLQHKNLVKLLGF 413 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 413 (660)
.++|...++||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888999999999999999964 68899999986422 1335678999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC---CE
Q 006125 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NS 490 (660)
Q Consensus 414 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~---~~ 490 (660)
+.+....++||||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999884 3456999999999999999999999998 99999999999998775 69
Q ss_pred EEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc
Q 006125 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN 570 (660)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 570 (660)
||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|+.||......+....+.....
T Consensus 189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999987654322 22347999999999986 5689999999999999999999999987776655544433221
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 571 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
.... . .. ... ...+.+++.+||+.||.+|||+.|+++ ++++.
T Consensus 265 ~~~~-~-~~--~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 265 YFDF-N-DW--KNI----SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CCCH-H-HH--TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCCc-c-cc--CCC----CHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 1000 0 00 011 234788999999999999999999983 55544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=355.67 Aligned_cols=254 Identities=27% Similarity=0.367 Sum_probs=208.2
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|...++||+|+||.||++... +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356788899999999999999964 7899999998642 234567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe---CCCCCEEEeecccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARI 500 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~ 500 (660)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999998843 456999999999999999999999998 9999999999999 5678999999999986
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||......+....+......... +.
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~-- 250 (484)
T 3nyv_A 179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL--PQ-- 250 (484)
T ss_dssp BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--GG--
T ss_pred cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--cc--
Confidence 644322 123468999999999865 6999999999999999999999999877766555444433211110 00
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
.......+.+++.+||+.||.+|||+.|+++ +++.
T Consensus 251 ----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 251 ----WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp ----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred ----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 0112234778999999999999999999983 4544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.39 Aligned_cols=249 Identities=27% Similarity=0.357 Sum_probs=200.1
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|...++||+|+||.||++... +++.||+|+++.. .......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45788899999999999999964 7889999998753 23446778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC---CCEEEeecccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIFA 502 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfGla~~~~ 502 (660)
|+++|+|.+.+. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||++....
T Consensus 117 ~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999998884 3355899999999999999999999998 9999999999999764 559999999998765
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||......+....+....... ..+...
T Consensus 191 ~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~-- 262 (494)
T 3lij_A 191 NQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF--DSPEWK-- 262 (494)
T ss_dssp TTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CSGGGT--
T ss_pred CCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--Cchhcc--
Confidence 4322 22347999999999886 568999999999999999999999998777665554443322110 011110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~s----~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 263 NVS----EGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp TSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCC----HHHHHHHHHHCCCChhhCccHHHHhc
Confidence 122 34778899999999999999999983
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=326.66 Aligned_cols=258 Identities=19% Similarity=0.287 Sum_probs=202.7
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEE-EeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC-VDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 425 (660)
.++|+..+.||+|+||.||++.. .+++.||+|++.... ....+.+|+.++..++|++++..+..+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788899999999999999995 679999999986533 234688999999999988876666655 56778899999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe---CCCCCEEEeecccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA 502 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~ 502 (660)
|+ +++|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999953 2345999999999999999999999998 9999999999999 488999999999998765
Q ss_pred ccCCcc-----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHHHhcCcc
Q 006125 503 ESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ------LLAYAWHLWNEGNV 571 (660)
Q Consensus 503 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~------~~~~~~~~~~~~~~ 571 (660)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 443311 1223578999999999999999999999999999999999999987421 11111111100000
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCC
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGT 623 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 623 (660)
+.+. ...+ ..+.+++.+||+.||++||++.||++.|+.....
T Consensus 240 -----~~~~-~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 240 -----EVLC-KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -----HHHT-TTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----HHHH-hhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0000 1222 3478899999999999999999999999875433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=340.11 Aligned_cols=272 Identities=21% Similarity=0.283 Sum_probs=204.0
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCC-----------hhcHHHHHHHHHHHhhcCCCCcc
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS-----------EQGTAEFTNEVLLILKLQHKNLV 408 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~-----------~~~~~~~~~E~~~l~~l~h~niv 408 (660)
...++....++|...+.||+|+||.||++...+|+.||||++.... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3567788889999999999999999999998889999999986421 11236799999999999999999
Q ss_pred eEeEEEEeC-----CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceE
Q 006125 409 KLLGFCVDG-----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (660)
Q Consensus 409 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 483 (660)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998653 35799999998 578777753 3446999999999999999999999998 999999999999
Q ss_pred eCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q 006125 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYA 562 (660)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~ 562 (660)
++.++.+||+|||++........ .....|++.|+|||++.+ ..++.++||||||+++|||++|+.||......+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999975433222 223478999999999987 67999999999999999999999999876654444
Q ss_pred HHHHhc---Cccc-----------ccccccCCC-CCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 563 WHLWNE---GNVL-----------ELVDPLLTD-TSF-----SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 563 ~~~~~~---~~~~-----------~~~d~~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
..+... .... +.+...... +.. .......+.+++.+||+.||.+|||+.|+++ ++++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 333221 0000 000000000 000 0111245788999999999999999999985 45544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=338.54 Aligned_cols=259 Identities=23% Similarity=0.324 Sum_probs=204.6
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhc-----------------HHHHHHHHHHHhhcCCCCcceE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG-----------------TAEFTNEVLLILKLQHKNLVKL 410 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 410 (660)
.++|...+.||+|+||.||++.. +++.||+|++....... .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999999999 89999999986421111 1789999999999999999999
Q ss_pred eEEEEeCCeeEEEEEecCCCChhhh------hcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceE
Q 006125 411 LGFCVDGDEKLLVYEFMPNGSLDAI------LFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVL 483 (660)
Q Consensus 411 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~DLkp~NIL 483 (660)
++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.||+.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 532 225679999999999999999999999 77 999999999999
Q ss_pred eCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 006125 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSK-KSDVFSFGVLLIEIITGRRNAGSNQLLAY 561 (660)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDVwslGvll~elltG~~p~~~~~~~~~ 561 (660)
++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999875433 22234689999999999877 5666 99999999999999999999986554222
Q ss_pred HHHHHhcCcccccc------cccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 562 AWHLWNEGNVLELV------DPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 562 ~~~~~~~~~~~~~~------d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.......+...... .+.... ..........+.+++.+||+.||.+||++.|+++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 33333222211000 000000 0000122345788999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=354.13 Aligned_cols=254 Identities=27% Similarity=0.365 Sum_probs=205.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|...++||+|+||.||++... +++.||||++... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46788899999999999999964 7899999998642 23456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC---CCCCEEEeecccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFA 502 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DfGla~~~~ 502 (660)
|+++|+|.+.+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++...
T Consensus 102 ~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 102 LYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999998884 3356999999999999999999999998 99999999999995 45679999999998664
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+......... +..
T Consensus 176 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~--- 246 (486)
T 3mwu_A 176 QNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--PQW--- 246 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS--GGG---
T ss_pred CCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--ccc---
Confidence 3322 223479999999999875 5999999999999999999999999877665555444332211110 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
......+.+++.+||+.||.+|||+.|+++ ++++.
T Consensus 247 ---~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 247 ---RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp ---GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 111234778999999999999999999985 45543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=334.65 Aligned_cols=260 Identities=24% Similarity=0.276 Sum_probs=196.2
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC------
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 418 (660)
.++|...+.||+|+||.||++.. .+++.||||++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46788899999999999999985 4689999999865 23445567889999999999999999999998665
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 7877773 23889999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc--cc---
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV--LE--- 573 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~--~~--- 573 (660)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+...-.. .+
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8654322 122347899999999999999999999999999999999999999876654443333221000 00
Q ss_pred -----------------------cccccCCCCC--CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 574 -----------------------LVDPLLTDTS--FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 574 -----------------------~~d~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
.+........ ........+.+|+.+||+.||.+|||++|+++ +++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0000000000 01122456889999999999999999999984 4443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.99 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=198.3
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcC--CCCcceEeEEEEeC
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDG 417 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 417 (660)
..+.+..++|+..+.||+|+||.||++...+++.||+|++.. ......+.+.+|+.++.+++ |+||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 334456678999999999999999999988899999999864 23445678899999999997 59999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
+..++||| +.+++|.+++. ....+++..++.++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CEEEEEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 99999999 66889999995 3346899999999999999999999998 999999999999964 8999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHH
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAME-----------GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHL 565 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~ 565 (660)
+................|++.|+|||++.+ ..++.++||||||+++|||++|+.||.... ........
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 987654433322234578999999999875 468899999999999999999999997542 22222222
Q ss_pred HhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 566 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....... .... .. ...+.+++.+||+.||.+||++.|+++
T Consensus 253 ~~~~~~~-----~~~~-~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 253 IDPNHEI-----EFPD-IP----EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HCTTSCC-----CCCC-CS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Hhccccc-----CCcc-cc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 2111110 1111 11 235778889999999999999999984
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=333.86 Aligned_cols=266 Identities=22% Similarity=0.331 Sum_probs=203.9
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-----Cee
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DEK 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 420 (660)
.++|...+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457888999999999999999854 7889999999753 334457789999999999999999999999765 367
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||++ |+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 589998842 35899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCcc-ceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc--Ccccccc-
Q 006125 501 FAESEGEA-NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE--GNVLELV- 575 (660)
Q Consensus 501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~--~~~~~~~- 575 (660)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+... ....+.+
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 65432221 1233578999999998765 45899999999999999999999999765543333222210 0000000
Q ss_pred -----------cccCCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCC
Q 006125 576 -----------DPLLTDTSFS-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGET 621 (660)
Q Consensus 576 -----------d~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 621 (660)
.......... ......+.+++.+||+.||.+|||+.|+++ ++++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 0000000011 111245788999999999999999999985 555543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.46 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=196.4
Q ss_pred HhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------ 417 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 417 (660)
+...++|...+.||+|+||.||++.. .+|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45567899999999999999999985 5799999999865322 223799999999999999999998543
Q ss_pred --------------------------------CeeEEEEEecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHH
Q 006125 418 --------------------------------DEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYL 464 (660)
Q Consensus 418 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~L 464 (660)
...++||||++ |+|.+.+... .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999998 5777766421 2345699999999999999999999
Q ss_pred HhCCCCCeEecCCCCCceEeC-CCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHH
Q 006125 465 HEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVL 542 (660)
Q Consensus 465 H~~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvl 542 (660)
|+.+ |+||||||+|||++ +++.+||+|||+++........ ....+|+.|+|||++.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 99999999999998 6899999999999876443322 234689999999998865 48999999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHHhc---C----------cccccccccCCCCC----CCHHHHHHHHHHHhhcccCCCC
Q 006125 543 LIEIITGRRNAGSNQLLAYAWHLWNE---G----------NVLELVDPLLTDTS----FSDDEFSRYIHIGLLCVQEDAF 605 (660)
Q Consensus 543 l~elltG~~p~~~~~~~~~~~~~~~~---~----------~~~~~~d~~~~~~~----~~~~~~~~l~~li~~cl~~dP~ 605 (660)
+|||++|+.||......+....+... . ...+..-+...... ++......+.+|+.+||+.||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999876655544443321 0 00000000000000 1111234578899999999999
Q ss_pred CCCCHHhHH
Q 006125 606 DRPTMSSVA 614 (660)
Q Consensus 606 ~RPt~~evl 614 (660)
+|||+.|++
T Consensus 312 ~R~t~~e~l 320 (383)
T 3eb0_A 312 LRINPYEAM 320 (383)
T ss_dssp GSCCHHHHH
T ss_pred hCCCHHHHh
Confidence 999999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=344.09 Aligned_cols=262 Identities=22% Similarity=0.318 Sum_probs=198.3
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe------eE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------KL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 421 (660)
..+|...++||+|+||.||+++..++..+|+|++...... ..+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3467888999999999999999877777999988643221 2379999999999999999999975443 78
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC-CCCCEEEeecccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARI 500 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~ 500 (660)
+||||++++.+..+.........+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655544422233456999999999999999999999998 99999999999999 789999999999987
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---C-------
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---G------- 569 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~------- 569 (660)
....... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+... .
T Consensus 192 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6443322 234689999999998764 5899999999999999999999999877655444433321 0
Q ss_pred ---cccccccccCCCCC----CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 570 ---NVLELVDPLLTDTS----FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 570 ---~~~~~~d~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
...+..-+...... +.......+.+|+.+||+.||.+|||+.|+++ ++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 00000000000000 01112345889999999999999999999985 3544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=329.40 Aligned_cols=257 Identities=23% Similarity=0.289 Sum_probs=202.7
Q ss_pred cCCCCCCcccccCCcccEEeeee--cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCC------CcceEeEEEEeCCe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL--SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK------NLVKLLGFCVDGDE 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 419 (660)
.++|+..+.||+|+||.||++.. .+++.||||+++.. ....+.+.+|+.++..++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46788899999999999999985 36889999999753 34556788999999998765 49999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-------------
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS------------- 486 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~------------- 486 (660)
.++||||+ +++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999988542 2235899999999999999999999998 999999999999987
Q ss_pred ------CCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 006125 487 ------DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA 560 (660)
Q Consensus 487 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~ 560 (660)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6789999999997643321 22478999999999999999999999999999999999999998665443
Q ss_pred HHHHHHhc-Ccc----------cccc---------------------cccCCCCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006125 561 YAWHLWNE-GNV----------LELV---------------------DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP 608 (660)
Q Consensus 561 ~~~~~~~~-~~~----------~~~~---------------------d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 608 (660)
........ +.. .... .+..............+.+++.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 32221110 000 0000 000000011234566788999999999999999
Q ss_pred CHHhHHH
Q 006125 609 TMSSVAP 615 (660)
Q Consensus 609 t~~evl~ 615 (660)
|+.|+++
T Consensus 322 t~~ell~ 328 (339)
T 1z57_A 322 TLREALK 328 (339)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999983
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=338.95 Aligned_cols=257 Identities=22% Similarity=0.268 Sum_probs=199.1
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC--------CCCcceEeEEEE---
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ--------HKNLVKLLGFCV--- 415 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 415 (660)
.++|...++||+|+||.||+++. .+++.||||+++. .....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999985 4688999999975 3445667889999999985 788999999998
Q ss_pred -eCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCC-----
Q 006125 416 -DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDM----- 488 (660)
Q Consensus 416 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~----- 488 (660)
.....++||||+. ++|.+.+.. .....+++..++.++.||++||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 4567899999995 455554432 2234599999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------CEEEeeccccccccccCCccceeeeeccCCcCCHhh
Q 006125 489 --------------------------------------------NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524 (660)
Q Consensus 489 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 524 (660)
.+||+|||++....... ....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChh
Confidence 89999999998664332 22368999999999
Q ss_pred hhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc------HHHHH---HHHHhc--------Ccc-cccccc---------
Q 006125 525 AMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ------LLAYA---WHLWNE--------GNV-LELVDP--------- 577 (660)
Q Consensus 525 ~~~~~~t~ksDVwslGvll~elltG~~p~~~~~------~~~~~---~~~~~~--------~~~-~~~~d~--------- 577 (660)
+.+..++.++|||||||++|||++|+.||.... ..... ...... ... .+.+..
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999996432 11111 111100 000 000000
Q ss_pred ---------cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 578 ---------LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 578 ---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..............+.+|+.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00011235667778999999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.35 Aligned_cols=249 Identities=26% Similarity=0.328 Sum_probs=192.9
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC--------hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 419 (660)
++|...+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 56888899999999999999964 68899999986421 122345889999999999999999999987665
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC---EEEeecc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFG 496 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DfG 496 (660)
.++||||+++++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 899999999999999984 3456999999999999999999999998 999999999999987654 9999999
Q ss_pred ccccccccCCccceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccc
Q 006125 497 MARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLE 573 (660)
Q Consensus 497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 573 (660)
++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||...............+....
T Consensus 163 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 163 HSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp TCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred cceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 9986543211 12246899999999985 46789999999999999999999999864322111111222211100
Q ss_pred cccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 574 LVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 574 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
. +.... . ....+.+++.+||+.||++||++.|++
T Consensus 240 -~-~~~~~-~----~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 240 -I-PEVWA-E----VSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp -C-HHHHT-T----SCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred -C-chhhh-h----cCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 0 00000 1 124578899999999999999999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=328.36 Aligned_cols=257 Identities=18% Similarity=0.268 Sum_probs=199.3
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEe--CCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVD--GDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 423 (660)
.++|+..++||+|+||.||++.. .+++.||+|+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 35688889999999999999985 57899999999753 3467899999999997 9999999999998 6678999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-CEEEeecccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFA 502 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~ 502 (660)
|||+++++|.+++. .+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999983 3889999999999999999999998 99999999999999776 89999999998665
Q ss_pred ccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHHh---cCccccc---
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN-QLLAYAWHLWN---EGNVLEL--- 574 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~-~~~~~~~~~~~---~~~~~~~--- 574 (660)
..... ....|+..|+|||++.+ ..++.++||||||+++|||++|+.||... ...+....... .....+.
T Consensus 183 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 43322 22468999999999987 67999999999999999999999998532 11111111100 0000000
Q ss_pred --------------------ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 575 --------------------VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 575 --------------------~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
....... .........+.+++.+||+.||++|||++|+++ ++++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHS-ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCT-TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hccccccchhhhhhhccccchhhhccc-cccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 0000000 111112345788999999999999999999986 44443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.37 Aligned_cols=272 Identities=21% Similarity=0.223 Sum_probs=193.9
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe-
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE- 419 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 419 (660)
+......++|...+.||+|+||.||++.. .+|+.||||++... ........+|+..+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34456678899999999999999999996 46899999998653 2333456778888999999999999999976433
Q ss_pred ------eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCceEeCC-CCCE
Q 006125 420 ------KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH--EDSRLRIVHRDLKASNVLLDS-DMNS 490 (660)
Q Consensus 420 ------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~DLkp~NILl~~-~~~~ 490 (660)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987533333221234556899999999999999999999 777 999999999999997 8999
Q ss_pred EEeeccccccccccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC
Q 006125 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG 569 (660)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~ 569 (660)
||+|||+++........ ....||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+....
T Consensus 172 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 99999999876543322 224689999999998764 48999999999999999999999998766544443332210
Q ss_pred --ccccc---ccc-------cCCC--------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 570 --NVLEL---VDP-------LLTD--------TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 570 --~~~~~---~d~-------~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
...+. +++ .... ..........+.+|+.+||+.||.+|||+.|+++ ++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 00000 000 0000 0111123456889999999999999999999984 45544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=331.06 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=203.5
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-----Cee
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DEK 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 420 (660)
.++|...+.||+|+||.||++... +|+.||||++... .......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999964 6899999999753 334456788999999999999999999998764 568
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+. ++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689998843 45899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCcc--------ceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---
Q 006125 501 FAESEGEA--------NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE--- 568 (660)
Q Consensus 501 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~--- 568 (660)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+.......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 65332111 1122468999999998765 67899999999999999999999999876654433322211
Q ss_pred Ccccc------------cccccCCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCC
Q 006125 569 GNVLE------------LVDPLLTDTSFS-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGET 621 (660)
Q Consensus 569 ~~~~~------------~~d~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 621 (660)
..... .+......+... ......+.+++.+||+.||++|||+.|+++ ++++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00000 000000000000 112345778999999999999999999986 566543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.90 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=193.3
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC----C--eeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG----D--EKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~~ 421 (660)
.+|+..+.||+|+||.||+++.. +|+.||||++..... ...+|+++++.++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35777899999999999999974 689999999865322 234799999999999999999998642 2 257
Q ss_pred EEEEecCCCChhhhhcC-CCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-CCEEEeeccccc
Q 006125 422 LVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMAR 499 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~ 499 (660)
+||||+++ +|..++.. ......+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 55555432 123456999999999999999999999998 9999999999999965 678999999998
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---C------
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---G------ 569 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~------ 569 (660)
........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+... .
T Consensus 206 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 76443222 234789999999999764 7999999999999999999999999876654444333321 0
Q ss_pred ----cccccccccCCCCC----CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 ----NVLELVDPLLTDTS----FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 ----~~~~~~d~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+...+.+.... +.......+.+|+.+||+.||.+||++.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00011001110000 01112345889999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=360.14 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=208.1
Q ss_pred HHHhhcCCCCCCcccccCCcccEEeeeec----CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC
Q 006125 343 TLNLATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (660)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 417 (660)
..++..++|...+.||+|+||.||+|... .+..||+|+++.. .....+.+.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34455677888999999999999999864 2457999998753 3444577999999999999999999999984 4
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
+..++||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 568999999999999999953 2335899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+...... .
T Consensus 538 a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-~--- 612 (656)
T 2j0j_A 538 SRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-P--- 612 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-C---
T ss_pred CeecCCCccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-C---
Confidence 98764432221 222356789999999999999999999999999999997 99999876655544443332211 1
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 613 -------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 613 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112234578899999999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=323.24 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=203.4
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 357888999999999999999965 7899999998642 3345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC---CCEEEeeccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIF 501 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfGla~~~ 501 (660)
||+++++|.+++. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++...
T Consensus 101 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 101 ELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EccCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999998884 3345899999999999999999999998 9999999999999764 47999999999866
Q ss_pred cccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
...... ....|++.|+|||.+.+ .++.++||||||+++|||++|+.||......+....+......... +..
T Consensus 175 ~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-- 246 (287)
T 2wei_A 175 QQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--PQW-- 246 (287)
T ss_dssp CCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--GGG--
T ss_pred cCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--hhh--
Confidence 443221 22368999999998865 4899999999999999999999999877655544433322111000 000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 247 RTIS----DDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcC----HHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1222 34778999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=324.47 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=192.1
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe-----------
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----------- 416 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------- 416 (660)
++|+..+.||+|+||.||++.. .+++.||+|+++. .....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4677889999999999999995 4789999999965 34456778999999999999999999999865
Q ss_pred --CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 417 --GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 417 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
....++||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 3467899999999999999953 2345788999999999999999999998 99999999999999999999999
Q ss_pred ccccccccccCC------------ccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 006125 495 FGMARIFAESEG------------EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAY 561 (660)
Q Consensus 495 fGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~ 561 (660)
||++........ ........|++.|+|||++.+. .++.++||||||+++|||++ |+........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 999986543211 1112234689999999999864 78999999999999999998 4432221111
Q ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 562 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
......... ..+. +.+.......+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~------~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 237 ILKKLRSVS------IEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHSTT------CCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccccc------cccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 222222111 0111 1223333455788999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=343.46 Aligned_cols=258 Identities=20% Similarity=0.301 Sum_probs=202.7
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCC-CCcceEeEEEEeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 425 (660)
.++|...++||+|+||.||+++. .+++.||||++..... ..++.+|++++..++| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46788999999999999999995 5789999998764322 2357899999999977 566667777778888999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe---CCCCCEEEeecccccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA 502 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~ 502 (660)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999532 345999999999999999999999998 9999999999999 688999999999998765
Q ss_pred ccCCcc-----ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCccccc
Q 006125 503 ESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ---LLAYAWHLWNEGNVLEL 574 (660)
Q Consensus 503 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~---~~~~~~~~~~~~~~~~~ 574 (660)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.... .......+. .......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~-~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS-EKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH-HHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh-hcccccc
Confidence 443221 1224579999999999999999999999999999999999999997532 222221111 1111111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
+..... .+ ...+.+|+..||+.||++||++.+|+++|+..
T Consensus 237 ~~~l~~--~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 IEALCR--GY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHT--TS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhc--CC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111111 12 23578899999999999999999999988754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=327.14 Aligned_cols=266 Identities=23% Similarity=0.341 Sum_probs=203.5
Q ss_pred hcCCCCCCcccccCCcccEEeeee--cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhc---CCCCcceEeEEEE----
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVL--SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCV---- 415 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 415 (660)
..++|...+.||+|+||.||++.. .+|+.||+|+++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456788899999999999999996 468899999986422 22234566788777766 8999999999997
Q ss_pred -eCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 416 -DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 416 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
.....++||||++ |+|.+++... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 6999998542 2334899999999999999999999998 99999999999999999999999
Q ss_pred ccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---Ccc
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---GNV 571 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~~~ 571 (660)
||++....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...........+... ...
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99998654322 122346899999999999999999999999999999999999999876655444333321 000
Q ss_pred ccc----------ccccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH--HHhcCC
Q 006125 572 LEL----------VDPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGE 620 (660)
Q Consensus 572 ~~~----------~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl--~~L~~~ 620 (660)
..+ +...... ..........+.+++.+||+.||.+||++.|++ .++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 000 0000000 001112234577899999999999999999999 455543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=333.27 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=202.1
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-----------CCCcceEeEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----------HKNLVKLLGFCV 415 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 415 (660)
.++|...+.||+|+||.||+++. .+++.||||++.. .......+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46788899999999999999995 5789999999975 3345567889999999886 899999999998
Q ss_pred eCC----eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeC-----
Q 006125 416 DGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLD----- 485 (660)
Q Consensus 416 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~----- 485 (660)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+. + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 88999998542 234589999999999999999999998 7 99999999999994
Q ss_pred -CCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH-----
Q 006125 486 -SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL----- 559 (660)
Q Consensus 486 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~----- 559 (660)
..+.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 44589999999998664322 2236899999999999999999999999999999999999999743311
Q ss_pred -HHHHHHHh---c--------Cc----------cccccccc---------CCCCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006125 560 -AYAWHLWN---E--------GN----------VLELVDPL---------LTDTSFSDDEFSRYIHIGLLCVQEDAFDRP 608 (660)
Q Consensus 560 -~~~~~~~~---~--------~~----------~~~~~d~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 608 (660)
.....+.. . .. ....+... .....++......+.+|+.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111110 0 00 00000000 001134566778899999999999999999
Q ss_pred CHHhHHH--HhcCC
Q 006125 609 TMSSVAP--MLKGE 620 (660)
Q Consensus 609 t~~evl~--~L~~~ 620 (660)
|+.|+++ ++++.
T Consensus 327 t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 327 DAGGLVNHPWLKDT 340 (373)
T ss_dssp CHHHHHTCGGGTTC
T ss_pred CHHHHhhChhhhcc
Confidence 9999986 66654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.20 Aligned_cols=258 Identities=26% Similarity=0.354 Sum_probs=199.8
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee----
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK---- 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 420 (660)
.++|...+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46788899999999999999985 46899999999753 344467788999999999999999999999877655
Q ss_pred --EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 421 --LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 421 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68888872 23899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--cccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG--NVLELV 575 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~--~~~~~~ 575 (660)
+...... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.... ...+..
T Consensus 192 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 192 RHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 7654321 22468999999999987 789999999999999999999999998766554444332210 000000
Q ss_pred c------------ccCCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 576 D------------PLLTDTSFS-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 576 d------------~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
. .....+... ......+.+|+.+||+.||++|||+.|+++ +++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 0 000000000 111345788999999999999999999984 4544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=328.85 Aligned_cols=260 Identities=20% Similarity=0.259 Sum_probs=202.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CC-----CcceEeEEEEeCCe
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HK-----NLVKLLGFCVDGDE 419 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 419 (660)
..++|...+.||+|+||.||++... +++.||||+++. ......++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578899999999999999999854 688999999975 3344567788999988884 55 49999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC--CCCCEEEeeccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMNSKISDFGM 497 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DfGl 497 (660)
.++||||++ |+|.+++... ....+++..+..++.||+.||.|||++. .+|+||||||+||||+ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 5999988543 2245899999999999999999999531 2499999999999995 478899999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCc--c----
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN--V---- 571 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~--~---- 571 (660)
++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..... .
T Consensus 208 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98764321 234789999999999999999999999999999999999999987665444433322100 0
Q ss_pred ------ccccccc----------------C------------------------CCCCCCHHHHHHHHHHHhhcccCCCC
Q 006125 572 ------LELVDPL----------------L------------------------TDTSFSDDEFSRYIHIGLLCVQEDAF 605 (660)
Q Consensus 572 ------~~~~d~~----------------~------------------------~~~~~~~~~~~~l~~li~~cl~~dP~ 605 (660)
.+.++.. . ........+...+.+|+.+||+.||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 0000000 0 00011233456789999999999999
Q ss_pred CCCCHHhHHH
Q 006125 606 DRPTMSSVAP 615 (660)
Q Consensus 606 ~RPt~~evl~ 615 (660)
+|||+.|+++
T Consensus 363 ~Rpta~e~L~ 372 (382)
T 2vx3_A 363 TRIQPYYALQ 372 (382)
T ss_dssp TSCCHHHHTT
T ss_pred hCCCHHHHhc
Confidence 9999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.66 Aligned_cols=254 Identities=9% Similarity=0.010 Sum_probs=179.3
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhc--CCCCcceEe-------EEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL--QHKNLVKLL-------GFC 414 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 414 (660)
..+|...+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345777899999999999999954 78999999997643 23455677886555555 699987754 555
Q ss_pred EeC-----------------CeeEEEEEecCCCChhhhhcCCCCCCccCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 006125 415 VDG-----------------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR------TNIVNGIAKGMLYLHEDSRLR 471 (660)
Q Consensus 415 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ 471 (660)
... ...+|||||++ |+|.+++... ...+.+..+ ..++.||++||+|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 33799999999 8999999542 223455556 788899999999999998
Q ss_pred eEecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhC
Q 006125 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITG 549 (660)
Q Consensus 472 ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG 549 (660)
|+||||||+||||+.++.+||+|||+++...... ....+++.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998653221 12356799999999987 6799999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 550 RRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 550 ~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+.||........ ..+...............+ ........+.+|+.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIK--GSWKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCT--TCCCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccc--cchhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999975421100 0000000000000111100 01122345788999999999999999999973
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=326.48 Aligned_cols=259 Identities=25% Similarity=0.332 Sum_probs=199.7
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe-----
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE----- 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 419 (660)
.++|...+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35788889999999999999996 46899999998652 33445678899999999999999999999987654
Q ss_pred -eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 420 -KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 420 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
.++||||++ ++|.+++. ..+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 68888772 23899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC-c-ccc--
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG-N-VLE-- 573 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~-~-~~~-- 573 (660)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+..+....+.... . ..+
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 765322 123478999999999987 678999999999999999999999998766544433322210 0 000
Q ss_pred ----------c---ccccCC--CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 574 ----------L---VDPLLT--DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 574 ----------~---~d~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
. +..... -..........+.+++.+||+.||++|||+.|+++ +++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 000000 00111223445788999999999999999999984 55543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.49 Aligned_cols=257 Identities=22% Similarity=0.238 Sum_probs=173.3
Q ss_pred cCCCCCC-cccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe----CCeeE
Q 006125 348 TSNFSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKL 421 (660)
Q Consensus 348 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 421 (660)
.++|... +.||+|+||.||++... +|+.||||++.... ....+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4567774 46999999999999965 68999999986521 222233344566799999999999976 44579
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC---CCCEEEeecccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMA 498 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla 498 (660)
+||||+++|+|.+++... ....+++.+++.++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999999643 2346999999999999999999999998 999999999999986 455999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...............-.... ..
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~ 251 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ---YG 251 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------C
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc---cc
Confidence 7654322 1234689999999999888899999999999999999999999965432221111110000000 00
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
... .........+.+++.+||+.||.+|||+.|+++ ++++.
T Consensus 252 ~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 252 FPN-PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CCT-TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cCc-hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000 001122345778999999999999999999996 66653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=338.28 Aligned_cols=196 Identities=27% Similarity=0.437 Sum_probs=151.4
Q ss_pred CcccccCCcccEEeeeec---CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe--CCeeEEEEEecC
Q 006125 354 SNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP 428 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 428 (660)
.++||+|+||.||++... +++.||||++... .....+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 468999999999999965 5789999999753 233568899999999999999999999965 667899999997
Q ss_pred CCChhhhhcCC------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe----CCCCCEEEeecccc
Q 006125 429 NGSLDAILFDP------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMA 498 (660)
Q Consensus 429 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DfGla 498 (660)
+ +|.+++... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 4 777776421 12234899999999999999999999998 9999999999999 67799999999999
Q ss_pred ccccccCCc-cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 006125 499 RIFAESEGE-ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGS 555 (660)
Q Consensus 499 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~ 555 (660)
+........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 876543221 12233578999999999987 4599999999999999999999999964
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=325.93 Aligned_cols=247 Identities=23% Similarity=0.390 Sum_probs=191.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCCh------hcHHHHHHHHHHHhhc----CCCCcceEeEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE------QGTAEFTNEVLLILKL----QHKNLVKLLGFC 414 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~~~ 414 (660)
...++|...+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 4457899999999999999999985 5788999999975322 1223466799999988 899999999999
Q ss_pred EeCCeeEEEEEe-cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC-CCCCEEE
Q 006125 415 VDGDEKLLVYEF-MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKI 492 (660)
Q Consensus 415 ~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~-~~~~~kl 492 (660)
...+..++|+|+ +.+++|.+++.. .+.+++..++.++.||++||+|||+.+ |+||||||+||+++ +++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 789999999943 345899999999999999999999998 99999999999999 8899999
Q ss_pred eeccccccccccCCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc
Q 006125 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV 571 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 571 (660)
+|||++........ ....|+..|+|||++.+..+ +.++||||||+++|||++|+.||..... .....
T Consensus 182 ~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~-- 249 (312)
T 2iwi_A 182 IDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE-- 249 (312)
T ss_dssp CCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC--
T ss_pred EEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc--
Confidence 99999987654322 23468999999999987766 4599999999999999999999965321 11110
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
. .+.......+.+++.+||+.||++||++.|+++ +++..
T Consensus 250 -------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 250 -------L---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp -------C---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred -------c---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 0 011112234778999999999999999999997 44443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=324.99 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=200.4
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CC-cEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC------cceEeEEEEeCCe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DG-KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN------LVKLLGFCVDGDE 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 419 (660)
.++|...+.||+|+||.||++... ++ +.||+|+++. .....+.+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467888999999999999999854 34 6899999975 3345567889999999997665 8999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEe---------------
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL--------------- 484 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl--------------- 484 (660)
.++||||+ +++|.+++.. .....+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 5566666533 22245899999999999999999999998 9999999999999
Q ss_pred ----CCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 006125 485 ----DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA 560 (660)
Q Consensus 485 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~ 560 (660)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999997643322 22478999999999999999999999999999999999999998655433
Q ss_pred HHHHHHhc-Ccc-cc---------c-cc--------------------ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006125 561 YAWHLWNE-GNV-LE---------L-VD--------------------PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP 608 (660)
Q Consensus 561 ~~~~~~~~-~~~-~~---------~-~d--------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 608 (660)
....+... +.. .. . .. +..............+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 22211110 000 00 0 00 00000011223455788999999999999999
Q ss_pred CHHhHH--HHhcC
Q 006125 609 TMSSVA--PMLKG 619 (660)
Q Consensus 609 t~~evl--~~L~~ 619 (660)
|+.|++ .++++
T Consensus 327 t~~e~l~hp~f~~ 339 (355)
T 2eu9_A 327 TLAEALLHPFFAG 339 (355)
T ss_dssp CHHHHTTSGGGGG
T ss_pred CHHHHhcChhhcC
Confidence 999998 34544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=334.27 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=186.8
Q ss_pred CCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
|...+.||+|+||+||.....+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 3445789999999998766668999999998642 245678999999887 89999999999999999999999995
Q ss_pred CChhhhhcCCCCCC----ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC-------------CCEEE
Q 006125 430 GSLDAILFDPRKRG----ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-------------MNSKI 492 (660)
Q Consensus 430 gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~-------------~~~kl 492 (660)
|+|.+++....... ..++..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 69999996432211 1234456789999999999999998 9999999999999754 48999
Q ss_pred eeccccccccccCCcc--ceeeeeccCCcCCHhhhhc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q 006125 493 SDFGMARIFAESEGEA--NTVRIVGTYGYMAPEYAME-------GLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYA 562 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~ 562 (660)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||........
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~- 248 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-
Confidence 9999998765433221 1223579999999999975 678999999999999999999 8999875433221
Q ss_pred HHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 563 WHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 563 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+........ .. ...........+.+++.+||+.||.+||++.||++
T Consensus 249 -~i~~~~~~~~----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 -NIIRGIFSLD----EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHHTCCCCC----CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHhcCCCCcc----cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1221111000 01 11123455677889999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.62 Aligned_cols=256 Identities=27% Similarity=0.372 Sum_probs=177.7
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC-ChhcHHHHHHHHH-HHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
..++|...+.||+|+||.||++... +|+.||||+++.. ......++..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4567888999999999999999964 7899999999753 3334445556665 77778999999999999999999999
Q ss_pred EEecCCCChhhhhcC--CCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 424 YEFMPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
|||+++ +|.+++.. ......+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999985 77777642 11245689999999999999999999998 7 99999999999999999999999999986
Q ss_pred ccccCCccceeeeeccCCcCCHhhh----hcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccc
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYA----MEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
...... .....|++.|+|||++ .+..++.++||||||+++|||++|+.||........ ... .......
T Consensus 176 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~--~~~~~~~ 247 (327)
T 3aln_A 176 LVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---QLT--QVVKGDP 247 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------C--CCCCSCC
T ss_pred cccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---HHH--HHhcCCC
Confidence 643322 1223689999999998 456789999999999999999999999875321110 000 0000000
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+.+.. .........+.+++.+||+.||++||++.||++
T Consensus 248 ~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSN-SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCC-CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCC-cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111 001112345788999999999999999999973
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=327.24 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=199.8
Q ss_pred HHhhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCCh------hcHHHHHHHHHHHhhcC--CCCcceEeEEE
Q 006125 344 LNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQ--HKNLVKLLGFC 414 (660)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 414 (660)
.....++|...+.||+|+||.||++.. .+++.||||+++.... .....+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344567888999999999999999985 5789999999865321 12245678999999996 59999999999
Q ss_pred EeCCeeEEEEEecCC-CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC-CCCCEEE
Q 006125 415 VDGDEKLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKI 492 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~-~~~~~kl 492 (660)
...+..++|+|++.+ ++|.+++. ..+.+++..++.++.||++||+|||+.+ |+||||||+|||++ +++.+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 999999999999976 89999984 3456899999999999999999999998 99999999999999 7899999
Q ss_pred eeccccccccccCCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc
Q 006125 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV 571 (660)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 571 (660)
+|||++........ ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ......
T Consensus 192 ~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~- 260 (320)
T 3a99_A 192 IDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQV- 260 (320)
T ss_dssp CCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCC-
T ss_pred eeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcccc-
Confidence 99999987653321 22468999999999987765 7899999999999999999999965321 111110
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
......+ ..+.+++.+||+.||++||++.||++ ++++
T Consensus 261 -------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 261 -------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp -------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -------cccccCC----HHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 0111222 34778999999999999999999986 4444
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.94 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=180.2
Q ss_pred hcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCCh-h-cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-Q-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
..++|+..+.||+|+||.||++... +|+.||||++..... . ..+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3457788899999999999999964 789999999975322 2 233445555678888999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
|||+ ++.+..+... ....+++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 5566655532 235689999999999999999999995 7 9999999999999999999999999997654
Q ss_pred ccCCccceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHHhcCccccccc
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSN-QLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~-~~~~~~~~~~~~~~~~~~~d 576 (660)
.... .....|++.|+|||++. ...++.++||||||+++|||++|+.||... .............. .
T Consensus 177 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~---- 248 (318)
T 2dyl_A 177 DDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-P---- 248 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-C----
T ss_pred CCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-C----
Confidence 4322 12346899999999994 556899999999999999999999999753 22233333332211 1
Q ss_pred ccCCC-CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 577 PLLTD-TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 577 ~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+.. ...+ ..+.+++.+||+.||.+||++.|+++
T Consensus 249 -~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 -LLPGHMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -CCCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCCccCCCC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111 1122 34778889999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=331.73 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=187.6
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 424 (660)
+...+|...++||+|+||+||.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....+|||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 44556888899999999997655556899999999965332 2356899999999 8999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-----CCCEEEeeccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGMAR 499 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DfGla~ 499 (660)
||+. |+|.+++.... ..+.+..++.++.||++||.|||+.+ |+||||||+||||+. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 69999996432 23555567889999999999999998 999999999999953 3468899999998
Q ss_pred cccccCCc-cceeeeeccCCcCCHhhhh---cCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccc
Q 006125 500 IFAESEGE-ANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLEL 574 (660)
Q Consensus 500 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 574 (660)
........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||......... ... ......
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~-~~~~~~- 248 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILL-GACSLD- 248 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHT-TCCCCT-
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHh-ccCCcc-
Confidence 76543221 1223357999999999997 4567889999999999999999 88888654332221 111 111111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.. .........+.+|+.+||+.||.+||++.||+
T Consensus 249 ---~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 249 ---CL---HPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp ---TS---CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ---cc---CccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 11 11123344577899999999999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=344.85 Aligned_cols=259 Identities=27% Similarity=0.337 Sum_probs=200.3
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe------CCee
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD------GDEK 420 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 420 (660)
++|...++||+|+||.||++.. .+|+.||||+++.. .....+.+.+|+.++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999996 46899999998753 44556779999999999999999999999765 6678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCC---EEEeeccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGM 497 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DfGl 497 (660)
++||||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976555556999999999999999999999998 999999999999997765 99999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHHhcCc----cc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA-YAWHLWNEGN----VL 572 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~-~~~~~~~~~~----~~ 572 (660)
+......... ....|++.|+|||++.+..++.++||||||+++|||++|+.||....... |......... ..
T Consensus 171 a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 9876543322 23478999999999999999999999999999999999999997543221 1100000000 00
Q ss_pred ccc------cccCC-CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhH
Q 006125 573 ELV------DPLLT-DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613 (660)
Q Consensus 573 ~~~------d~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 613 (660)
+.. ...+. ...........+.+++.+||+.||++|||+.|+
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 01111 112344556778999999999999999999773
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=342.98 Aligned_cols=237 Identities=21% Similarity=0.316 Sum_probs=191.1
Q ss_pred cCCCCCCcccccCCcccEEeeeec--CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCe-----
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS--DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE----- 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 419 (660)
.++|...+.||+|+||.||++... +|+.||||++... .......+.+|+.++.+++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478899999999999999999964 6899999998653 34455678999999999999999999999987655
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.+|||||+++++|.+++.. .+++.+++.|+.||++||.|||+.+ |+||||||+|||++++ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987732 5999999999999999999999998 9999999999999886 99999999998
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
..... ....||+.|+|||++.+.. +.++||||||+++|||++|.+|+..... +. +
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~-----------------~~-~ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV-----------------DG-L 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----------------SS-C
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----------------cc-c
Confidence 65432 2347899999999987654 8999999999999999999887653210 00 0
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCC-HHhHHHHhc
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPT-MSSVAPMLK 618 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~ 618 (660)
............+.+|+.+||+.||.+||+ ++++...|.
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 010111223356889999999999999995 555655554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=300.52 Aligned_cols=230 Identities=13% Similarity=0.075 Sum_probs=181.2
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
.++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467888999999999999999964 58999999997532 33457799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++++|.+++.. + ....++.+|+.||++||+|||+.+ |+||||||+|||+++++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999932 2 355678899999999999999998 9999999999999999999997543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCC-C
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD-T 582 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~ 582 (660)
|++| ++.++||||||+++|||++|+.||.......... .....+...... .
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------PAERDTAGQPIEPA 226 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------ECCBCTTSCBCCHH
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------HHHHHhccCCCChh
Confidence 3333 6889999999999999999999997543110000 000000100000 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.........+.+++.+||+.||++| |+.|+++.|+...
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0001123457889999999999999 9999999998754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.66 Aligned_cols=232 Identities=23% Similarity=0.306 Sum_probs=178.2
Q ss_pred CCCCCC-cccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHH-hhcCCCCcceEeEEEEe----CCeeE
Q 006125 349 SNFSDS-NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLI-LKLQHKNLVKLLGFCVD----GDEKL 421 (660)
Q Consensus 349 ~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 421 (660)
++|... +.||+|+||.||++.. .+++.||+|+++. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 345555 7799999999999995 5789999999864 24567888888 55599999999999987 66789
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC---CCCEEEeecccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMA 498 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla 498 (660)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999642 2346999999999999999999999998 999999999999998 789999999998
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
.... +..++.++||||||+++|||++|+.||......... ...........
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----~~~~~~~~~~~ 218 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMKTRIRMGQ 218 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSCCSSCTTC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----HHHHHHHhhcc
Confidence 6432 234678999999999999999999999654322110 00000000000
Q ss_pred CCCCCCCH----HHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCC
Q 006125 579 LTDTSFSD----DEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGET 621 (660)
Q Consensus 579 ~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 621 (660)
. ..+. .....+.+++.+||+.||.+||++.|+++ ++.+..
T Consensus 219 ~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 219 Y---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp C---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred c---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0 1111 12345788999999999999999999985 555543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.94 Aligned_cols=241 Identities=16% Similarity=0.149 Sum_probs=178.2
Q ss_pred cCCCCCCcccccCCcccEEeee-ecCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCC-CCc---------ceEe--
Q 006125 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQH-KNL---------VKLL-- 411 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h-~ni---------v~l~-- 411 (660)
...|...+.||+|+||.||++. ..+|+.||||+++.. .....+.+.+|+.++..++| +|. +..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3446667899999999999999 457999999998732 22346789999999999987 321 1111
Q ss_pred ----------EEEEe-----CCeeEEEEEecCCCChhhhhcC----CCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006125 412 ----------GFCVD-----GDEKLLVYEFMPNGSLDAILFD----PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472 (660)
Q Consensus 412 ----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 472 (660)
.++.. ....+++|+++ +++|.+++.. ......+++..++.|+.||++||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 12346666655 6899988831 123456889999999999999999999998 9
Q ss_pred EecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhh----------hcCCCCcchhHHHHHHH
Q 006125 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA----------MEGLYSKKSDVFSFGVL 542 (660)
Q Consensus 473 vH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDVwslGvl 542 (660)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998765433 223467 999999999 44558889999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 543 LIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 543 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
+|||++|+.||....... .....+... ...+ ..+.+|+.+||+.||++||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~---------~~~~~~~~~---~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG---------GSEWIFRSC---KNIP----QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS---------CSGGGGSSC---CCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhh---------hHHHHHhhc---ccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999997543211 111111111 1223 4578889999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=309.22 Aligned_cols=242 Identities=15% Similarity=0.164 Sum_probs=184.1
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCC--------hhcHHHHHHHHHHHhhcC---------CCCcce
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQ---------HKNLVK 409 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~ 409 (660)
..++|...+.||+|+||.||+++. +|+.||||+++... ....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345677789999999999999998 78999999997532 233478899999999885 888888
Q ss_pred EeEEEE------------------------------eCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHH
Q 006125 410 LLGFCV------------------------------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459 (660)
Q Consensus 410 l~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~ 459 (660)
+.+++. ..+..+|||||+++|++.+.+.. ..+++..+..++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence 887753 26789999999999976666522 45899999999999999
Q ss_pred HHHHHH-hCCCCCeEecCCCCCceEeCCCC--------------------CEEEeeccccccccccCCccceeeeeccCC
Q 006125 460 GMLYLH-EDSRLRIVHRDLKASNVLLDSDM--------------------NSKISDFGMARIFAESEGEANTVRIVGTYG 518 (660)
Q Consensus 460 ~L~~LH-~~~~~~ivH~DLkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 518 (660)
||+||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 888 99999999999999887 8999999999866432 3479999
Q ss_pred cCCHhhhhcCCCCcchhHHHHHHH-HHHHHhCCCCCCCCcHHHHHH-HHHhcCcccccccccCCCCCCCHHHHHHHHHHH
Q 006125 519 YMAPEYAMEGLYSKKSDVFSFGVL-LIEIITGRRNAGSNQLLAYAW-HLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIG 596 (660)
Q Consensus 519 y~aPE~~~~~~~t~ksDVwslGvl-l~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li 596 (660)
|+|||++.+.. +.++||||||++ .+++++|..||.......... ........ ...............+.+|+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF-----KTKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC-----SSCCCSHHHHHHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc-----CcccchhhhhhcCHHHHHHH
Confidence 99999998666 899999998766 788888998874311101111 11111000 00001111234567789999
Q ss_pred hhcccCCCCCCCCHHhHH
Q 006125 597 LLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 597 ~~cl~~dP~~RPt~~evl 614 (660)
.+||+.| |+.|++
T Consensus 317 ~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 317 RTMLNFS-----SATDLL 329 (336)
T ss_dssp HHGGGSS-----SHHHHH
T ss_pred HHHhccC-----CHHHHH
Confidence 9999976 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-29 Score=279.80 Aligned_cols=183 Identities=16% Similarity=0.127 Sum_probs=129.3
Q ss_pred ccccCCcccEEeee-ecCCcEEEEEEccCC----------ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEE
Q 006125 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSC----------SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 356 ~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 423 (660)
.++.|++|.+..+. .--|+.+++|++... .+...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666655 335889999998642 123456799999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||++|++|.++|. ..+.++.. +|+.||+.||+|||++| |+||||||+||||++++++||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999995 34456654 58999999999999999 99999999999999999999999999987654
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~ 550 (660)
.... ....+||+.|||||++.+ .+..++|+|++|++++++.++.
T Consensus 392 ~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 392 DCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp --CC--SHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 3322 223589999999999865 4677899999999988876654
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-26 Score=195.83 Aligned_cols=103 Identities=23% Similarity=0.430 Sum_probs=91.9
Q ss_pred CCCCCCCCCCCCCccCCCChHHHHHHHHHHHhhhccccC--Cccccccc-CCCCcEEEEEecCCCCChhchHHHHHHHHH
Q 006125 25 DSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAA--KFSNASFG-NDSDRVYGLYMCLNYISAETCNDCITTASQ 101 (660)
Q Consensus 25 ~~~~~~~C~~~~~~~~~~s~~~~nl~~l~~~l~~~~~~~--~~~~~~~g-~~~~~vyg~~~Cr~d~~~~~C~~C~~~a~~ 101 (660)
+.++++.|++ +++ +++|+|++||+.|++.|+++++.. +|+++..| .++++|||++|||+|+++++|..||+.|+.
T Consensus 3 t~~v~~~Cn~-~~~-t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~ 80 (108)
T 3a2e_A 3 TAFVSSACNT-QKI-PSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVN 80 (108)
T ss_dssp CCEEEEEECS-SBC-CTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHT
T ss_pred cceeeeecCC-Ccc-CCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHH
Confidence 4578889975 455 899999999999999999998874 45565554 456899999999999999999999999999
Q ss_pred HHhhhCCCcccceEEcCeeEEEecCccc
Q 006125 102 DISKLCPNKTEAIVWEEVCQLRYAYQNF 129 (660)
Q Consensus 102 ~~~~~C~~~~~a~~~~~~C~~ry~~~~f 129 (660)
++.+.||++++|+||++.|+||||+++|
T Consensus 81 ~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 81 RIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp THHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 9999999999999999999999999998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-26 Score=253.69 Aligned_cols=185 Identities=18% Similarity=0.211 Sum_probs=145.5
Q ss_pred CCCcccccCCcccEEeeeecCCcEEEEEEccCCCh--------hcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
...++||+|+||.||++.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 578899988643211 1234589999999999999999777777788888999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||+++ ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999943 5579999999999999998 999999999999998 999999999987754
Q ss_pred cCCcc-----ceeeeeccCCcCCHhhhhc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 006125 504 SEGEA-----NTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNA 553 (660)
Q Consensus 504 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwslGvll~elltG~~p~ 553 (660)
..... ......||+.|||||++.. ..|+.++|+|+..+-.++.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 1123579999999999986 56888999999999999888777554
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=183.56 Aligned_cols=105 Identities=24% Similarity=0.404 Sum_probs=95.3
Q ss_pred CCceeccccccCCChhHHHHHHHHHHHHHHHHhccCCCCcceeeeeccCCCCCceEEEeeccCCCCccchHHHHHHHHHh
Q 006125 136 SGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATAD 215 (660)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~f~~~~~~~~~~~~vygl~QC~~Dls~~~C~~CL~~a~~~ 215 (660)
...+..||..+++.++.|+.+++.+|..|...++.+. .+|+++..+..++++||||+||+||+++++|+.||+.++.+
T Consensus 4 ~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~--~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~ 81 (108)
T 3a2e_A 4 AFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSG--YDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNR 81 (108)
T ss_dssp CEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTT--SEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTT
T ss_pred ceeeeecCCCccCCCChHHHHHHHHHHHHHhhCcccc--CCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHH
Confidence 3445678899999999999999999999999987653 57888877766789999999999999999999999999999
Q ss_pred hhhhccCCCCcEEEcccccchhhhchh
Q 006125 216 ILSCCYFSRGARLLSRNCYLRYELYAF 242 (660)
Q Consensus 216 ~~~~c~~~~g~~~~~~~C~lry~~~~f 242 (660)
++++|++++||+||+++|+||||+++|
T Consensus 82 ~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 82 IFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 999999999999999999999999987
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-23 Score=208.84 Aligned_cols=152 Identities=18% Similarity=0.112 Sum_probs=122.0
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCCh------------------hcHHHHHHHHHHHhhcC
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE------------------QGTAEFTNEVLLILKLQ 403 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~ 403 (660)
..+......|...+.||+|+||.||++...+|+.||+|+++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344445566777799999999999999997799999999864221 13456889999999999
Q ss_pred CCCcceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceE
Q 006125 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (660)
Q Consensus 404 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 483 (660)
| +++.+++.. +..++||||+++++|.+ +.. .....++.||++||.|||+.+ |+||||||+|||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 666665433 55699999999999988 421 224469999999999999998 999999999999
Q ss_pred eCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhh
Q 006125 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526 (660)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 526 (660)
++ ++.+||+|||+++ .+..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSV---------------EVGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence 99 9999999999985 244578999885
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=174.92 Aligned_cols=136 Identities=19% Similarity=0.193 Sum_probs=106.7
Q ss_pred CCCCcccccCCcccEEeeee-cCCcE--EEEEEccCCChh------------------------cHHHHHHHHHHHhhcC
Q 006125 351 FSDSNILGQGGFGPVYKGVL-SDGKE--VAVKRLSSCSEQ------------------------GTAEFTNEVLLILKLQ 403 (660)
Q Consensus 351 ~~~~~~lG~G~fg~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 403 (660)
|...+.||+|+||.||++.. .+|+. ||||+++..... ....+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999997 78999 999987542111 1136889999999998
Q ss_pred CCCc--ceEeEEEEeCCeeEEEEEecCC-C----ChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH-hCCCCCeEec
Q 006125 404 HKNL--VKLLGFCVDGDEKLLVYEFMPN-G----SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH-EDSRLRIVHR 475 (660)
Q Consensus 404 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~ 475 (660)
|+++ +.++.. ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8864 444443 356899999942 4 66665421 235567889999999999999 887 9999
Q ss_pred CCCCCceEeCCCCCEEEeeccccccc
Q 006125 476 DLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 476 DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-16 Score=167.42 Aligned_cols=139 Identities=13% Similarity=0.144 Sum_probs=100.6
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCC--------------hhcHH--------HHHHHHHHHhhcCCC
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--------------EQGTA--------EFTNEVLLILKLQHK 405 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--------------~~~~~--------~~~~E~~~l~~l~h~ 405 (660)
..-|+..+.||+|+||.||+|...+|+.||||+++... ..... ....|...|.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34478889999999999999998899999999875310 00111 123466666666544
Q ss_pred CcceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC
Q 006125 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD 485 (660)
Q Consensus 406 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~ 485 (660)
++.-..-+... ..+|||||+++++|..+.. ......++.||+.+|.+||+.+ ||||||||.||||+
T Consensus 174 gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 174 GFPVPEPIAQS--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp TCSCCCEEEEE--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCCeeeecc--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 43221111111 2479999999998876542 1234568899999999999998 99999999999998
Q ss_pred CCC----------CEEEeecccccc
Q 006125 486 SDM----------NSKISDFGMARI 500 (660)
Q Consensus 486 ~~~----------~~kl~DfGla~~ 500 (660)
+++ .+.|+||+.+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 876 389999998753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=7.9e-12 Score=125.66 Aligned_cols=142 Identities=18% Similarity=0.106 Sum_probs=112.0
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
..|.....++.|+.+.||+... +++.+++|+...........+.+|+.+++.+. +.++.++++++.+.+..++||||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 4576677788888899999875 46889999986522223346889999999984 677889999999989999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS--------------------------------------- 468 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 468 (660)
+|.+|.+.+. +......++.+++++|..||+..
T Consensus 93 ~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 93 DGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp SSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred CCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999987641 12234478899999999999821
Q ss_pred -----------------CCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 469 -----------------RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 469 -----------------~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1449999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=5.9e-11 Score=118.75 Aligned_cols=128 Identities=19% Similarity=0.144 Sum_probs=98.4
Q ss_pred ccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC--cceEeEEEEeCCeeEEEEEecCCCChhhh
Q 006125 358 GQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNGSLDAI 435 (660)
Q Consensus 358 G~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 435 (660)
+.|..+.||+....+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998777888999997653 2245788999999985544 566899888888889999999998884
Q ss_pred hcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------
Q 006125 436 LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS----------------------------------------------- 468 (660)
Q Consensus 436 l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------------------- 468 (660)
... .+ ...++.++++.|..||+..
T Consensus 104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 211 11 2357788888888888753
Q ss_pred --------CCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 469 --------RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 469 --------~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
+..++|+|++|.|||++++..+.|+|||.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=2.2e-09 Score=112.96 Aligned_cols=142 Identities=16% Similarity=0.246 Sum_probs=107.2
Q ss_pred CCcccccCCcccEEeeeecCCcEEEEEEcc--CCCh-hcHHHHHHHHHHHhhcC--CCCcceEeEEEEeC---CeeEEEE
Q 006125 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLS--SCSE-QGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDG---DEKLLVY 424 (660)
Q Consensus 353 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 424 (660)
..+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999998875 4678888876 3221 22346888999999996 45678899988776 4489999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS------------------------------------ 468 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------ 468 (660)
||+++..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874422 123678888999999999999999831
Q ss_pred -------------------CCCeEecCCCCCceEeCCCCC--EEEeecccccc
Q 006125 469 -------------------RLRIVHRDLKASNVLLDSDMN--SKISDFGMARI 500 (660)
Q Consensus 469 -------------------~~~ivH~DLkp~NILl~~~~~--~kl~DfGla~~ 500 (660)
...++|+|+++.|||+++++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.5e-09 Score=111.46 Aligned_cols=187 Identities=17% Similarity=0.224 Sum_probs=123.3
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCC--cceEeEEEEeCC---eeEEEEEec
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKN--LVKLLGFCVDGD---EKLLVYEFM 427 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~ 427 (660)
.+.++.|....||+.. ..+++|+... ......+.+|..+++.+ .+.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999864 5688998653 23456788999999888 3333 345555443333 348999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS--------------------------------------- 468 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 468 (660)
+|.+|..... ..++..++..++.++++.|..||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865431 23677788888999999999998621
Q ss_pred ----------------CCCeEecCCCCCceEeCC--CCCEEEeeccccccccccCCcccee------------eeeccCC
Q 006125 469 ----------------RLRIVHRDLKASNVLLDS--DMNSKISDFGMARIFAESEGEANTV------------RIVGTYG 518 (660)
Q Consensus 469 ----------------~~~ivH~DLkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~------------~~~gt~~ 518 (660)
.+.++|+|++|.||++++ +..+.|+||+.+............. ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 245899999999999998 4567899999886432210000000 0001111
Q ss_pred cCC-HhhhhcCCCCcchhHHHHHHHHHHHHhCCCCC
Q 006125 519 YMA-PEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA 553 (660)
Q Consensus 519 y~a-PE~~~~~~~t~ksDVwslGvll~elltG~~p~ 553 (660)
... |+..... ....+.|++|.++|++.+|..++
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 222 3322211 12368999999999999998643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.2e-06 Score=87.89 Aligned_cols=134 Identities=19% Similarity=0.195 Sum_probs=98.2
Q ss_pred ccccCCcc-cEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEEEecCCCCh
Q 006125 356 ILGQGGFG-PVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (660)
Q Consensus 356 ~lG~G~fg-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 432 (660)
.+..|..+ .||+.... ++..+++|+-.. .....+.+|...|+.+. +-.+.+++.++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455555 58987754 567899998654 23456888999998884 33477899999999999999999999888
Q ss_pred hhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 006125 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS-------------------------------------------- 468 (660)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------------- 468 (660)
.+.... .......+..++++.|..||...
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 776521 12233456777777777777521
Q ss_pred -----------CCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 469 -----------RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 469 -----------~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1238999999999999988777899998874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.5e-06 Score=87.45 Aligned_cols=136 Identities=21% Similarity=0.189 Sum_probs=97.4
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCC---CcceEeEEEE-eCCeeEEEEEecCC
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK---NLVKLLGFCV-DGDEKLLVYEFMPN 429 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 429 (660)
.+.++.|....||+. |..+++|+.. .......+.+|..+++.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 5678888853 233456789999999999653 3567777765 34557899999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS----------------------------------------- 468 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------------- 468 (660)
..|...... .++..+...++.++++.|..||+..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 1345556666666666666666532
Q ss_pred ----------------CCCeEecCCCCCceEeCC---CCC-EEEeecccccc
Q 006125 469 ----------------RLRIVHRDLKASNVLLDS---DMN-SKISDFGMARI 500 (660)
Q Consensus 469 ----------------~~~ivH~DLkp~NILl~~---~~~-~kl~DfGla~~ 500 (660)
++.++|+|+++.|||+++ ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 235799999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.2e-06 Score=89.68 Aligned_cols=80 Identities=5% Similarity=-0.014 Sum_probs=56.7
Q ss_pred ccc-ccCCcccEEeeeec-------CCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcC-C--CCcceEeEEEEeC---
Q 006125 355 NIL-GQGGFGPVYKGVLS-------DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQ-H--KNLVKLLGFCVDG--- 417 (660)
Q Consensus 355 ~~l-G~G~fg~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 417 (660)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999988764 26789999875422 111245778888888884 3 3577888887655
Q ss_pred CeeEEEEEecCCCChhh
Q 006125 418 DEKLLVYEFMPNGSLDA 434 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~ 434 (660)
+..++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=3.2e-05 Score=82.17 Aligned_cols=75 Identities=11% Similarity=0.137 Sum_probs=50.0
Q ss_pred CcccccCCcccEEeeeec-CCcEEEEEEccCCCh-------hcHHHHHHHHHHHhhcCC--CC-cceEeEEEEeCCeeEE
Q 006125 354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-------QGTAEFTNEVLLILKLQH--KN-LVKLLGFCVDGDEKLL 422 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 422 (660)
.+.||.|..+.||++... +++.++||...+... .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 568899998653211 123456778888888742 33 4455543 4556789
Q ss_pred EEEecCCC
Q 006125 423 VYEFMPNG 430 (660)
Q Consensus 423 v~e~~~~g 430 (660)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=2.1e-05 Score=81.47 Aligned_cols=140 Identities=14% Similarity=0.227 Sum_probs=80.6
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCC--CCcceEeE------EEEeCCeeEEEEEe
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVKLLG------FCVDGDEKLLVYEF 426 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 426 (660)
+.|+.|..+.||+....+| .+++|+... . ...+..|..++..|.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-P---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-C---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-C---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999887554 589998875 2 2334455565555521 12334433 22346678999999
Q ss_pred cCCCChhh--------------hhc----CCC-C------CCccCHHHH-------------------------------
Q 006125 427 MPNGSLDA--------------ILF----DPR-K------RGILCWRKR------------------------------- 450 (660)
Q Consensus 427 ~~~gsL~~--------------~l~----~~~-~------~~~l~~~~~------------------------------- 450 (660)
+++..+.. .++ ... . .....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99865420 011 000 0 001123211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 451 TNIVNGIAKGMLYLHE----------DSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 451 ~~i~~~ia~~L~~LH~----------~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
..+...+.+.+.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445667763 124569999999999999888899999999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=3.2e-05 Score=78.22 Aligned_cols=80 Identities=20% Similarity=0.239 Sum_probs=59.0
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCC---CCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH---KNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e 425 (660)
......+.+|.|..+.||+.++.+|+.+++|+...........+..|...|+.|.. -.+++++++ +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 34455678999999999999999999999998765444444567889999998842 234555554 23578999
Q ss_pred ecCCCCh
Q 006125 426 FMPNGSL 432 (660)
Q Consensus 426 ~~~~gsL 432 (660)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=9.6e-05 Score=75.55 Aligned_cols=140 Identities=17% Similarity=0.127 Sum_probs=93.5
Q ss_pred CCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC---CCCcceEeEEEEeCCeeEEEEEecC
Q 006125 352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMP 428 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 428 (660)
...+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+++++.+....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3356789999999999876 5678889987542 3567889999998883 3568889999888888999999999
Q ss_pred CCChhh-----------hhcCCCC---C--------C--------ccCHHHHH---HHH----------------HHHHH
Q 006125 429 NGSLDA-----------ILFDPRK---R--------G--------ILCWRKRT---NIV----------------NGIAK 459 (660)
Q Consensus 429 ~gsL~~-----------~l~~~~~---~--------~--------~l~~~~~~---~i~----------------~~ia~ 459 (660)
+..+.. -|+.... - + .-+|.... ++. ..+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876521 1111111 0 0 12454321 111 11111
Q ss_pred H-HHHHHh-CCCCCeEecCCCCCceEeCCCCCEEEeecc
Q 006125 460 G-MLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (660)
Q Consensus 460 ~-L~~LH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 496 (660)
- ...|.. ..++.++|+|+.+.||+++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223432 2356799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00027 Score=75.59 Aligned_cols=73 Identities=18% Similarity=0.234 Sum_probs=46.4
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCC----Chh-----cHHHHHHHHHHHhh-cCCCCcceEeEEEEeCCeeEEE
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SEQ-----GTAEFTNEVLLILK-LQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~----~~~-----~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv 423 (660)
.+.||.|....||+... +++.++||...+. ... ....+..|+..+.. .....+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999865 5678999953221 111 22334444443332 2334566777665 5667999
Q ss_pred EEec-CC
Q 006125 424 YEFM-PN 429 (660)
Q Consensus 424 ~e~~-~~ 429 (660)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00072 Score=68.63 Aligned_cols=71 Identities=11% Similarity=0.142 Sum_probs=45.8
Q ss_pred CcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc-ceEeEEEEeCCeeEEEEEec-CCCC
Q 006125 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFM-PNGS 431 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 431 (660)
.+.|+.|....+|+. +.+++|+....... .....+|...++.+...++ .++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 577888999999998 56888887653221 1223568888887743333 455554 344567999999 6544
Q ss_pred h
Q 006125 432 L 432 (660)
Q Consensus 432 L 432 (660)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0019 Score=66.45 Aligned_cols=141 Identities=14% Similarity=0.105 Sum_probs=73.2
Q ss_pred cccccCCcc-cEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCC--CCcceEeEEEEeCCeeEEEEEecCCCC
Q 006125 355 NILGQGGFG-PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (660)
Q Consensus 355 ~~lG~G~fg-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 431 (660)
+.|+.|... .+|+....+|+.+++|....... ..+..|+.++..+.. -.+.+++.+... ..+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence 345555444 36676654467788887654321 234566777776632 235567766332 2378999997766
Q ss_pred hhhhhcC---------------------CCC--CCccCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 006125 432 LDAILFD---------------------PRK--RGILCWRKRT-------N-------------IVNGIAKGMLYLH--- 465 (660)
Q Consensus 432 L~~~l~~---------------------~~~--~~~l~~~~~~-------~-------------i~~~ia~~L~~LH--- 465 (660)
+.+.+.. ... ...++..... . ....+.+.+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6443311 000 0111111000 0 0001111222221
Q ss_pred hCCCCCeEecCCCCCceEeCCC----CCEEEeecccccc
Q 006125 466 EDSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARI 500 (660)
Q Consensus 466 ~~~~~~ivH~DLkp~NILl~~~----~~~kl~DfGla~~ 500 (660)
......++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999875 6799999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0033 Score=64.38 Aligned_cols=141 Identities=16% Similarity=0.158 Sum_probs=81.6
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCC--CcceEeEE-----EEeCCeeEEEEEec
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK--NLVKLLGF-----CVDGDEKLLVYEFM 427 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~ 427 (660)
..|+ |....||+....+|+.+++|+..... .....+..|..++..+... .+++++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77889999887778789999986421 2345677788888877422 23444432 22345668899999
Q ss_pred CCCChhh-----h---------hc----CCC--CCCccCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 006125 428 PNGSLDA-----I---------LF----DPR--KRGILCWRKR----TNI---------------VNGIAKGMLYLHED- 467 (660)
Q Consensus 428 ~~gsL~~-----~---------l~----~~~--~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~- 467 (660)
++..+.. + ++ ... ....+++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754421 0 11 000 0111222111 001 01111222333221
Q ss_pred ---CCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 468 ---SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 468 ---~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.+..++|+|+++.|||++ + .+.|+||+.+.
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 234589999999999999 4 89999998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0013 Score=68.87 Aligned_cols=141 Identities=17% Similarity=0.208 Sum_probs=83.5
Q ss_pred cccccCCcccEEeeeec--------CCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEEE
Q 006125 355 NILGQGGFGPVYKGVLS--------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 425 (660)
+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+. +.-..++++.+.+ -+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45767888889998864 2478999986432 224556778999998884 3333567766543 29999
Q ss_pred ecCCCChhhh-----------------hcCCC--CCCccC--HHHHHHHHHHHHH-------------------HHHH--
Q 006125 426 FMPNGSLDAI-----------------LFDPR--KRGILC--WRKRTNIVNGIAK-------------------GMLY-- 463 (660)
Q Consensus 426 ~~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia~-------------------~L~~-- 463 (660)
|+++..|..- |+... ...... +.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 11110 011122 3444555443321 2233
Q ss_pred --HHhC-CCCCeEecCCCCCceEeCCC----CCEEEeecccccc
Q 006125 464 --LHED-SRLRIVHRDLKASNVLLDSD----MNSKISDFGMARI 500 (660)
Q Consensus 464 --LH~~-~~~~ivH~DLkp~NILl~~~----~~~kl~DfGla~~ 500 (660)
|... ....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3222 23469999999999999876 7899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0016 Score=66.55 Aligned_cols=142 Identities=15% Similarity=0.098 Sum_probs=79.6
Q ss_pred cccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC--cceEeEE------EEeCCeeEEEEEe
Q 006125 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGF------CVDGDEKLLVYEF 426 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~ 426 (660)
+.|+.|....+|+....+| .+++|+.... .....+..|..++..+...+ +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788889999887555 6889988652 12234567777777763222 2333321 2234567899999
Q ss_pred cCCCChhh--------------hhc----CCCCC-----CccCHHHHHH------------HHHHHHHHHHHHHhC----
Q 006125 427 MPNGSLDA--------------ILF----DPRKR-----GILCWRKRTN------------IVNGIAKGMLYLHED---- 467 (660)
Q Consensus 427 ~~~gsL~~--------------~l~----~~~~~-----~~l~~~~~~~------------i~~~ia~~L~~LH~~---- 467 (660)
+++..+.. -++ ..... +...|..... +...+.+.++.++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865421 011 10000 1112322110 011234455555532
Q ss_pred CCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 468 ~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.+..++|+|+++.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23469999999999999987666899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0012 Score=70.63 Aligned_cols=72 Identities=18% Similarity=0.257 Sum_probs=49.1
Q ss_pred cccccCCcccEEeeeecC--------CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc-ceEeEEEEeCCeeEEEEE
Q 006125 355 NILGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 425 (660)
+.|+.|-...+|+....+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 567788889999988653 478999987431 112455689999988843344 667766532 38999
Q ss_pred ecCCCCh
Q 006125 426 FMPNGSL 432 (660)
Q Consensus 426 ~~~~gsL 432 (660)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0045 Score=63.93 Aligned_cols=68 Identities=13% Similarity=0.082 Sum_probs=43.6
Q ss_pred ccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC---CCCcceEeEE------EEeCCeeEEEEEecC
Q 006125 358 GQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGF------CVDGDEKLLVYEFMP 428 (660)
Q Consensus 358 G~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~ 428 (660)
|.|....||+....+| .+++|+...... ..|+..+..|. -|++++++.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3344678999987667 899998765331 35566666552 2224454432 234567899999999
Q ss_pred CCCh
Q 006125 429 NGSL 432 (660)
Q Consensus 429 ~gsL 432 (660)
+..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8766
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0027 Score=66.36 Aligned_cols=73 Identities=11% Similarity=0.081 Sum_probs=44.7
Q ss_pred cccccCCcccEEeeeecC---------CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCC-cceEeEEEEeCCeeEEEE
Q 006125 355 NILGQGGFGPVYKGVLSD---------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 424 (660)
+.|+.|..-.+|+....+ ++.+++|+....... ..+...|..+++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888899988643 267888887643221 123467888888884334 44666544 2 37899
Q ss_pred EecCCCCh
Q 006125 425 EFMPNGSL 432 (660)
Q Consensus 425 e~~~~gsL 432 (660)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.006 Score=65.64 Aligned_cols=74 Identities=18% Similarity=0.124 Sum_probs=48.3
Q ss_pred CcccccCCcccEEeeeecC-CcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc-ceEeEEEEeCCeeEEEEEecCCCC
Q 006125 354 SNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGS 431 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 431 (660)
.+.|+.|-...+|+....+ +..+++|+....... .-+..+|..++..|...++ .++++.+. + .+|+||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3567888889999988754 478889987543221 1123588999998865555 56777662 2 25999998755
Q ss_pred h
Q 006125 432 L 432 (660)
Q Consensus 432 L 432 (660)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.56 E-value=0.013 Score=55.60 Aligned_cols=103 Identities=12% Similarity=0.038 Sum_probs=66.6
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCccc
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 509 (660)
-+|.++|.. ...+++++++|.++.|.++.|.-+-.... + ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 378888853 45679999999999999999877622110 1 1223457899999999988764 1110
Q ss_pred eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCC
Q 006125 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN 552 (660)
Q Consensus 510 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p 552 (660)
.....+.+||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122356787653 3457899999999999999865543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.85 E-value=0.12 Score=54.75 Aligned_cols=74 Identities=8% Similarity=0.000 Sum_probs=49.0
Q ss_pred CcccccCCcccEEeeeecC--------CcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEE
Q 006125 354 SNILGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 424 (660)
.+.|..|-...+|+....+ ++.+++|+...... ..-+..+|..+++.+. +.-..++++.+ . .++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3457778888899988753 57899998754332 2223467888888884 33345666533 2 37899
Q ss_pred EecCCCCh
Q 006125 425 EFMPNGSL 432 (660)
Q Consensus 425 e~~~~gsL 432 (660)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.43 E-value=0.17 Score=53.17 Aligned_cols=30 Identities=23% Similarity=0.387 Sum_probs=25.4
Q ss_pred CeEecCCCCCceEe------CCCCCEEEeecccccc
Q 006125 471 RIVHRDLKASNVLL------DSDMNSKISDFGMARI 500 (660)
Q Consensus 471 ~ivH~DLkp~NILl------~~~~~~kl~DfGla~~ 500 (660)
.++|+|+.+.|||+ +++..++++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.97 E-value=4.8 Score=37.97 Aligned_cols=113 Identities=10% Similarity=0.039 Sum_probs=75.7
Q ss_pred CCCCcceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCCc
Q 006125 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML-YLHEDSRLRIVHRDLKASN 481 (660)
Q Consensus 403 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~DLkp~N 481 (660)
.||++ -..+-.+++...+.++.-+++.=..-+ ..++...+++++.+|+.... +++. -+|--|+|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 67887 444556777777777765443322233 23778899999999887777 5554 5788899999
Q ss_pred eEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHH-HHHHHHHHHHhCCCCC
Q 006125 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVF-SFGVLLIEIITGRRNA 553 (660)
Q Consensus 482 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVw-slGvll~elltG~~p~ 553 (660)
|++|.++.++|.-.|+-..+.+.. +.+| |.| .+=+++..++.++..|
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP~e--------------~~ee-----------~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPPDE--------------WDDE-----------RLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSSCS--------------CCHH-----------HHHHHHHHHHHHHTTCSSCH
T ss_pred EEEeCCCcEEEEEcCCcccCCCCC--------------CCHH-----------HHHHHHHHHHHHHHcCCCCH
Confidence 999999999998777643221100 1222 333 5678888888887655
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.47 E-value=3.6 Score=38.75 Aligned_cols=115 Identities=7% Similarity=-0.003 Sum_probs=76.9
Q ss_pred CCCCcceEeEEEEeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 006125 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (660)
Q Consensus 403 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 482 (660)
.||++++. .+-.+.+...+.++.-+ +...+- .-..++...+++++.+|+....+++. -+|--|+|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 68888877 56666666656555433 222222 12347889999999999988866654 47888999999
Q ss_pred EeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCC
Q 006125 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA 553 (660)
Q Consensus 483 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~ 553 (660)
+++.++.+++.-.|+-..+.+. =+.+|. =.-.+=+++..+++++..|
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P~--------------~~~ee~----------fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDPL--------------PVSEAE----------FLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EECTTSCEEESCCEETTTBSCC--------------CCCHHH----------HHHHHHHHHHHHHCTTCCH
T ss_pred EEcCCCCEEEEEccCccCCCCC--------------CCCHHH----------HHHHHHHHHHHHHcCCCCH
Confidence 9999999999877764322111 011221 1235778899999998765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 660 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-75 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-67 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-61 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-24 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 1e-75
Identities = 69/281 (24%), Positives = 128/281 (45%), Gaps = 15/281 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
+ +G G FG VYKG V + +++ + Q F NEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+G+ + +V ++ SL L + K +I A+GM YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-- 526
I+HRDLK++N+ L D+ KI DFG+A + + G ++ G+ +MAPE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 527 -EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585
+ YS +SDV++FG++L E++TG+ + + G + + + ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP-- 239
Query: 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQ 626
+ C+++ +RP + ++ +LP+
Sbjct: 240 ----KAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 4e-68
Identities = 81/270 (30%), Positives = 123/270 (45%), Gaps = 17/270 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
LG G FG V+ G + +VAVK L F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+L + ++ E+M NGSL L P L K ++ IA+GM ++ E +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
+HRDL+A+N+L+ ++ KI+DFG+AR+ ++E A + APE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 529 LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588
++ KSDV+SFG+LL EI+T R G +V P D+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--YRMVRP--------DNC 235
Query: 589 FSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ LC +E DRPT + +L+
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 3e-67
Identities = 78/276 (28%), Positives = 122/276 (44%), Gaps = 19/276 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
S + +G G FG V+ G + +VA+K + +F E +++KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+L G C++ LV+EFM +G L + +RG+ + + +GM YL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
++HRDL A N L+ + K+SDFGM R + + ++ + +PE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 177
Query: 529 LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588
YS KSDV+SFGVL+ E+ + + N+ + + G L P L T
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--FRLYKPRLASTHVYQ-- 233
Query: 589 FSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG--ETG 622
I C +E DRP S + L E+G
Sbjct: 234 ------IMNHCWKERPEDRPAFSRLLRQLAEIAESG 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-66
Identities = 76/283 (26%), Positives = 125/283 (44%), Gaps = 17/283 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
+ LGQG FG V+ G + VA+K L F E ++ KL+H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+L + +V E+M GSL L L + ++ IA GM Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVE--- 130
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
R+ VHRDL+A+N+L+ ++ K++DFG+AR+ ++E A + APE A+ G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 529 LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588
++ KSDV+SFG+LL E+ T R + VL+ V+ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV---------PYPGMVNREVLDQVERGY-RMPCPPEC 239
Query: 589 FSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPA 631
+ C +++ +RPT + L+ + +P
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 9e-66
Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 17/270 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
+ + LG G FG V G +VA+K + EF E +++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+L G C ++ E+M NG L L + R R ++ + + + M YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
+ +HRDL A N L++ K+SDFG++R + E ++V + PE M
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYS 176
Query: 529 LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDE 588
+S KSD+++FGVL+ EI + + + + E + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------MPYERFTNSETAEHIAQGL-RLYRPHLA 226
Query: 589 FSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ I C E A +RPT + +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-65
Identities = 63/289 (21%), Positives = 115/289 (39%), Gaps = 33/289 (11%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
+G+G FG V++G G+EVAVK SS E+ + E+ + L+H+N++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 417 GDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED----- 467
+ LV ++ +GSL L R + + A G+ +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV--RIVGTYGYMAPEYA 525
+ I HRDLK+ N+L+ + I+D G+A + + VGT YMAPE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 526 MEGL------YSKKSDVFSFGVLLIEIITGRRNAGSNQ----------LLAYAWHLWNEG 569
+ + K++D+++ G++ EI G ++ + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ + P + + S + I C + R T + L
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 215 bits (547), Expect = 4e-65
Identities = 76/307 (24%), Positives = 123/307 (40%), Gaps = 41/307 (13%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLS-SCSEQGTAEF 392
L +L +N +G+G FG V++ VAVK L S A+F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------- 444
E L+ + + N+VKLLG C G L++E+M G L+ L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 445 -------------LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491
L ++ I +A GM YL E + VHRDL N L+ +M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
I+DFG++R ++ +M PE Y+ +SDV+++GV+L EI +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 552 NAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMS 611
+ +GN+L ++ ++ LC + DRP+
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFC 290
Query: 612 SVAPMLK 618
S+ +L+
Sbjct: 291 SIHRILQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-64
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK 401
+ L +F + LG G G V+K G +A K + + + E+ ++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
+V G E + E M GSLD +L +K G + + + + KG+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
YL + +I+HRD+K SN+L++S K+ DFG++ +S VGT YM+
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMS 171
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
PE YS +SD++S G+ L+E+ GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 6e-64
Identities = 77/271 (28%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
+G+G FG V G G +VAVK + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 409 KLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
+LLG V+ L +V E+M GSL L R R +L + + M YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
VHRDL A NVL+ D +K+SDFG+ + + ++ + APE E
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 528 GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587
+S KSDV+SFG+LL EI + R L +G ++ D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA------ 228
Query: 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ C DA RP+ + L+
Sbjct: 229 ----VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (537), Expect = 9e-64
Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 35/301 (11%)
Query: 338 FID---LETLNLATSNFSDS---------NILGQGGFGPVYKGVLSDGKE----VAVKRL 381
FID E N A F+ ++G G FG V G L + VA+K L
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 382 -SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
S +E+ +F +E ++ + H N++ L G +++ EFM NGSLD+ F +
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQ 120
Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
G + ++ GIA GM YL + VHRDL A N+L++S++ K+SDFG++R
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 501 FAESEGEANTVRIVG---TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557
+ + +G + APE ++ SDV+S+G+++ E+++
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------ 231
Query: 558 LLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPML 617
+ +V+ ++ D S + L C Q+D RP + L
Sbjct: 232 ---RPYWDMTNQDVINAIEQDYR-LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 618 K 618
Sbjct: 288 D 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 1e-63
Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 17/271 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
++ + + LG G +G VY+GV VAVK L + + EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
V+LLG C ++ EFM G+L L + R + + I+ M YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
+ +HRDL A N L+ + K++DFG++R+ A+ + APE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 528 GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587
+S KSDV++FGVLL EI T + + + V EL++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS---------PYPGIDLSQVYELLEKDYRME-RPEG 240
Query: 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ + C Q + DRP+ + + +
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-63
Identities = 72/296 (24%), Positives = 124/296 (41%), Gaps = 32/296 (10%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGK----EVAVKRLSSCSEQG 388
Q I +L + +F+ ++G+G FG VY G L D AVK L+ ++ G
Sbjct: 16 AVQHVVIGPSSLIV---HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 70
Query: 389 -TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK-LLVYEFMPNGSLDAILFDPRKRGILC 446
++F E +++ H N++ LLG C+ + L+V +M +G L + + +
Sbjct: 71 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
+ + + + VHRDL A N +LD K++DFG+AR + E
Sbjct: 131 DLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 507 EANTVR--IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWH 564
++ + +MA E ++ KSDV+SFGVLL E++T
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA------------P 233
Query: 565 LWNEGNVLELVDPLLTDTSFSDDEF--SRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ + N ++ LL E+ + L C A RP+ S + +
Sbjct: 234 PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 7e-63
Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 32/309 (10%)
Query: 344 LNLATSNFSDSNI-LGQGGFGPVYKGVL---SDGKEVAVKRLSSCSEQG-TAEFTNEVLL 398
L L N ++I LG G FG V +GV +VA+K L +E+ T E E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
+ +L + +V+L+G C + +LV E G L L R+ + +++ ++
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVS 119
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-TVRIVGTY 517
GM YL VHRDL A NVLL + +KISDFG+++ +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDP 577
+ APE +S +SDV+S+GV + E ++ + +G +E
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---- 232
Query: 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSIGRV 637
+ + C DRP +V + + +S+
Sbjct: 233 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM----------RACYYSLASK 276
Query: 638 TDGHCNNNN 646
+GH ++++
Sbjct: 277 VEGHHHHHH 285
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 8e-63
Identities = 73/284 (25%), Positives = 129/284 (45%), Gaps = 22/284 (7%)
Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE-----VAVKRLS-SCSEQGTAEFTNEV 396
T + S + ++G G FG VYKG+L VA+K L +E+ +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
++ + H N+++L G +++ E+M NG+LD F K G + ++ G
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRG 118
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-VRIVG 515
IA GM YL + VHRDL A N+L++S++ K+SDFG++R+ + T
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELV 575
+ APE ++ SDV+SFG+++ E++T + + V++ +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE---------RPYWELSNHEVMKAI 226
Query: 576 DPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619
+ D S + + C Q++ RP + + +L
Sbjct: 227 NDGFRL-PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-62
Identities = 73/287 (25%), Positives = 117/287 (40%), Gaps = 29/287 (10%)
Query: 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD---GKEVAVKRL--SSCSEQGTAEF 392
++D + L L + LG G FG V KG K VAVK L + E
Sbjct: 2 YLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 55
Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
E ++ +L + +V+++G C + + +LV E G L+ L + + +
Sbjct: 56 LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIE 111
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-V 511
+V+ ++ GM YL VHRDL A NVLL + +KISDFG+++ E
Sbjct: 112 LVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV 571
+ APE +S KSDV+SFGVL+ E + + + V
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ---------KPYRGMKGSEV 219
Query: 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+++ + LC D +RP ++V L+
Sbjct: 220 TAMLEKGERM-GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (524), Expect = 1e-61
Identities = 73/273 (26%), Positives = 120/273 (43%), Gaps = 29/273 (10%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQ 403
FSD +G G FG VY + + + VA+K++S +Q + EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
H N ++ G + LV E+ + D + + L + + +G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
LH ++HRD+KA N+LL K+ DFG A I A + VGT +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWMAPE 181
Query: 524 YAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580
+ EG Y K DV+S G+ IE+ + + ++ +H+ P L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------SPALQ 235
Query: 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613
+S+ + + C+Q+ DRPT +
Sbjct: 236 SGHWSEY----FRNFVDSCLQKIPQDRPTSEVL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 8e-61
Identities = 74/299 (24%), Positives = 127/299 (42%), Gaps = 40/299 (13%)
Query: 322 YQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKR 380
Y+HV DL +DF+ + L G G FG VYK A K
Sbjct: 1 YEHVT---RDLNPEDFWEIIGEL-------------GDGAFGKVYKAQNKETSVLAAAKV 44
Query: 381 LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
+ + SE+ ++ E+ ++ H N+VKLL + ++ EF G++DA++
Sbjct: 45 IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--E 102
Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
L + + + YLH+ +I+HRDLKA N+L D + K++DFG++
Sbjct: 103 LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159
Query: 501 FAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRR-NAG 554
+ ++ +GT +MAPE M + Y K+DV+S G+ LIE+ +
Sbjct: 160 NTRTIQRRDSF--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217
Query: 555 SNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613
N + + + P L S F ++ C++++ R T S +
Sbjct: 218 LNPMRVLL-------KIAKSEPPTLAQPSRWSSNFKDFL---KKCLEKNVDARWTTSQL 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-60
Identities = 81/300 (27%), Positives = 126/300 (42%), Gaps = 29/300 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLS-SCSEQGTAEFTNEVLLILK 401
+ S LGQG FG VY+GV VA+K ++ + S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIV 454
++V+LLG G L++ E M G L + L R K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
IA GM YL+ + + VHRDL A N ++ D KI DFGM R E++ + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLEL 574
+M+PE +G+++ SDV+SFGV+L EI T EG +L+
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKPAFSI 634
D + +C Q + RP+ + +K E P ++ +F
Sbjct: 257 PDNCP----------DMLFELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFREVSFYY 304
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-60
Identities = 86/344 (25%), Positives = 138/344 (40%), Gaps = 52/344 (15%)
Query: 306 QIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPV 365
Q+Q+ ++ ++D ++ Y + + DLK + E N +LG G FG V
Sbjct: 4 QLQMVQVTGSSDNEYFYVDFREYEYDLK---WEFPRE-------NLEFGKVLGSGAFGKV 53
Query: 366 YKGVLSD------GKEVAVKRLSSCSEQGTAE-FTNEVLLILKL-QHKNLVKLLGFCVDG 417
+VAVK L ++ E +E+ ++ +L H+N+V LLG C
Sbjct: 54 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113
Query: 418 DEKLLVYEFMPNGSLDAILFDPRKR--------------------GILCWRKRTNIVNGI 457
L++E+ G L L R++ +L + +
Sbjct: 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
AKGM +L VHRDL A NVL+ KI DFG+AR
Sbjct: 174 AKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVD 576
+MAPE EG+Y+ KSDV+S+G+LL EI + G + A + L G ++
Sbjct: 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-- 288
Query: 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620
++ +E I C D+ RP+ ++ L +
Sbjct: 289 -----PFYATEEI---YIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 9e-60
Identities = 67/274 (24%), Positives = 111/274 (40%), Gaps = 25/274 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKN 406
++ +G G +G K SDGK + K L S +E +EV L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 407 LVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLY 463
+V+ +D L V E+ G L +++ K R L ++ + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 464 LHE--DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
H D ++HRDLK +NV LD N K+ DFG+ARI A T YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYMS 182
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELV--DPLL 579
PE Y++KSD++S G LL E+ + +++ + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM----------PPFTAFSQKELAGKIREGKFR 232
Query: 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613
DE + I + + RP++ +
Sbjct: 233 RIPYRYSDELNEII---TRMLNLKDYHRPSVEEI 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-59
Identities = 69/295 (23%), Positives = 109/295 (36%), Gaps = 35/295 (11%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQGTAE-FTNEVLLILK 401
+ S LG G FG V + VAVK L + E +E+ ++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 402 L-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI---------------L 445
L H N+V LLG C G L++ E+ G L L R I L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ +AKGM +L +HRDL A N+LL +KI DFG+AR
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL 565
+MAPE +Y+ +SDV+S+G+ L E+ + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------PYPGM 251
Query: 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620
+ +++ + + I C D RPT + +++ +
Sbjct: 252 PVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-59
Identities = 65/267 (24%), Positives = 114/267 (42%), Gaps = 26/267 (9%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
+G+G F VYKG+ ++ EVA L ++ F E ++ LQH N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 412 GFCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
+ +LV E M +G+L L ++ ++ + + I KG+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 468 SRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
+ I+HRDLK N+ + S KI D G+A + S ++GT +MAPE
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-Y 185
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586
E Y + DV++FG+ ++E+ T N + V + SF
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYP---------YSECQNAAQIYRRVTSGVKPASFDK 236
Query: 587 DEFSRYIHIGLLCVQEDAFDRPTMSSV 613
I C++++ +R ++ +
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-59
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 22/276 (7%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKE----VAVKRLS-SCSEQGTAEFTNEVLLILKL 402
+ F +LG G FG VYKG+ + +G++ VA+K L + S + E +E ++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+ ++ +LLG C+ L+ + MP G L + + + + N IAKGM
Sbjct: 69 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
YL R+VHRDL A NVL+ + + KI+DFG+A++ E E + +MA
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582
E + +Y+ +SDV+S+GV + E++T + + +++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS---------KPYDGIPASEISSILEKGERLP 233
Query: 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
I + C DA RP +
Sbjct: 234 -QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-58
Identities = 65/267 (24%), Positives = 109/267 (40%), Gaps = 18/267 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNL 407
++ LG+G +G V V + VAVK + + E+ + L H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
VK G +G+ + L E+ G L + + + + G++YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG- 121
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM- 526
+ I HRD+K N+LLD N KISDFG+A +F + E ++ GT Y+APE
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586
+++ DV+S G++L ++ G + W E L D
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------KTYLNPWKKID 233
Query: 587 DEFSRYIHIGLLCVQEDAFDRPTMSSV 613
+H + E+ R T+ +
Sbjct: 234 SAPLALLH---KILVENPSARITIPDI 257
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-57
Identities = 63/270 (23%), Positives = 106/270 (39%), Gaps = 28/270 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
+F LG+G FG VY +A+K L + EV + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
N+++L G+ D L+ E+ P G++ L +K ++ + +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
H R++HRD+K N+LL S KI+DFG + S + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGRR-NAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583
++ +K D++S GVL E + G+ + Y E + V D
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-- 233
Query: 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613
+ ++ + RP + V
Sbjct: 234 -----------LISRLLKHNPSQRPMLREV 252
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-57
Identities = 68/288 (23%), Positives = 120/288 (41%), Gaps = 34/288 (11%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDG---KEVAVKRLS-SCSEQGTAEFTNEVLLILKL-Q 403
++ +++G+G FG V K + + A+KR+ S+ +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKR 450
H N++ LLG C L E+ P+G+L L L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ +A+GM YL + + +HRDL A N+L+ + +KI+DFG++R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGN 570
+MA E +Y+ SDV+S+GVLL EI++ A + +G
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243
Query: 571 VLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
LE + + C +E ++RP+ + + L
Sbjct: 244 RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-57
Identities = 72/277 (25%), Positives = 108/277 (38%), Gaps = 23/277 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL 402
+ LG G FG V +G VAVK L + +F EV + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
H+NL++L G + K+ V E P GSL + +G + +A+GM
Sbjct: 69 DHRNLIRLYGVVLTPPMKM-VTELAPLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMA 521
YL R +HRDL A N+LL + KI DFG+ R +++ + + A
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581
PE +S SD + FGV L E+ T + W N +L +D
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQ---------EPWIGLNGSQILHKIDKEGER 233
Query: 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+D ++ + C DRPT ++ L
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 9e-57
Identities = 63/267 (23%), Positives = 123/267 (46%), Gaps = 19/267 (7%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
++ +GQG G VY + ++ G+EVA+++++ + NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+V L + GDE +V E++ GSL ++ + + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHS 134
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
+++HRD+K+ N+LL D + K++DFG + + +T +VGT +MAPE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586
Y K D++S G++ IE+I G + L + + G P L +
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT------PELQNPEKLS 243
Query: 587 DEFSRYIHIGLLCVQEDAFDRPTMSSV 613
F ++ C+ D R + +
Sbjct: 244 AIFRDFL---NRCLDMDVEKRGSAKEL 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-56
Identities = 75/293 (25%), Positives = 121/293 (41%), Gaps = 36/293 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL--------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLI 399
LG+G FG V + +VAVK L S +E+ ++ +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 400 LKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------L 445
+ +HKN++ LLG C ++ E+ G+L L R G+ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ + +A+GM YL + +HRDL A NVL+ D KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHL 565
T +MAPE + +Y+ +SDV+SFGVLL EI T + + + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
EG+ ++ + + + C RPT + L
Sbjct: 250 LKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-53
Identities = 75/293 (25%), Positives = 109/293 (37%), Gaps = 36/293 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGV------LSDGKEVAVKRLSSCSEQGTAE--FTNEVLLIL 400
LG+G FG V + + + VAVK L + + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 401 KLQHKNLVKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILC 446
H N+V LLG C G +++ EF G+L L R + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
+AKGM +L + +HRDL A N+LL KI DFG+AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHL 565
+MAPE + +Y+ +SDV+SFGVLL EI + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 566 WNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
EG + D ++ E L C + RPT S + L
Sbjct: 250 LKEGTRMRAPD-------YTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-53
Identities = 61/268 (22%), Positives = 102/268 (38%), Gaps = 22/268 (8%)
Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKL 410
+G+G FG V++G+ + VA+K +C+ E F E L + + H ++VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+G + + ++ E G L + F ++ L ++ + YL
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---K 127
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
R VHRD+ A NVL+ S+ K+ DFG++R E + +MAPE +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 531 SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFS 590
+ SDV+ FGV + EI+ G L +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-------PPTLY 239
Query: 591 RYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+ C D RP + + L
Sbjct: 240 SLM---TKCWAYDPSRRPRFTELKAQLS 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 7e-53
Identities = 66/267 (24%), Positives = 108/267 (40%), Gaps = 24/267 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHK 405
+F ILG+G F V L+ +E A+K L E T E ++ +L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
VKL D ++ + NG L + K G I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
I+HRDLK N+LL+ DM+ +I+DFG A++ + +A VGT Y++PE
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT-DTSF 584
E K SD+++ G ++ +++ G + GN + ++ + F
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL-------------PPFRAGNEYLIFQKIIKLEYDF 229
Query: 585 SDDEFSRYIHIGLLCVQEDAFDRPTMS 611
+ F + + + DA R
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRLGCE 256
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (459), Expect = 5e-52
Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 21/262 (8%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V++ + G A K + + E E+ + L+H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
D +E +++YEFM G L + + + + + + KG+ ++HE VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 475 RDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
DLK N++ + ++ K+ DFG+ + + GT + APE A
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGY 204
Query: 533 KSDVFSFGVLLIEIITGRR-NAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSR 591
+D++S GVL +++G G N + N+ + + ++
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI------SEDGKD 258
Query: 592 YIHIGLLCVQEDAFDRPTMSSV 613
+I + D R T+
Sbjct: 259 FI---RKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 2e-50
Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 23/277 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
LG G FG V++ V + G+ K +++ NE+ ++ +L H L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
D E +L+ EF+ G L + + + + N + +G+ ++HE IVH
Sbjct: 97 DKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 476 DLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
D+K N++ ++ S KI DFG+A E T + APE
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFY 208
Query: 534 SDVFSFGVLLIEIITGRRN-AGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRY 592
+D+++ GVL +++G AG + L + E + E +
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV------SPEAKDF 262
Query: 593 IHIGLLCVQEDAFDRPTMSSVA--PMLKGETGTLPQP 627
I +Q++ R T+ P LKG+ L
Sbjct: 263 IK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (425), Expect = 1e-47
Identities = 64/281 (22%), Positives = 109/281 (38%), Gaps = 20/281 (7%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLG 412
++LG G F V K VA+K ++ + +G NE+ ++ K++H N+V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
G L+ + + G L + ++G R + ++ + + YLH+ +
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
+ LD D ISDFG++++ GT GY+APE + YSK
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSK 188
Query: 533 KSDVFSFGVLLIEIITGRRN-AGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSR 591
D +S GV+ ++ G N + L E E P D S D
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE---YEFDSPYWDDIS---DSAKD 242
Query: 592 YIHIGLLCVQEDAFDRPTMSSVA--PMLKGETGTLPQPQKP 630
+I +++D R T P + G+T +
Sbjct: 243 FI---RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 2e-47
Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 33/277 (11%)
Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLS---SCSEQGTAEFTNEVLL 398
T+N +FS I+G+GGFG VY +D GK A+K L +QG NE ++
Sbjct: 2 TMN----DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 57
Query: 399 ILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
+ + +V + D+ + + M G L L + G+
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAA 114
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
I G+ ++H +V+RDLK +N+LLD + +ISD G+A F++ + VG
Sbjct: 115 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 167
Query: 516 TYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLEL 574
T+GYMAPE +G+ Y +D FS G +L +++ G + + E+
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH----------SPFRQHKTKDKHEI 217
Query: 575 VDPLLTDTSFSDDEFSR-YIHIGLLCVQEDAFDRPTM 610
LT D FS + +Q D R
Sbjct: 218 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (416), Expect = 1e-46
Identities = 68/282 (24%), Positives = 111/282 (39%), Gaps = 36/282 (12%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---------SCSEQGTAEFTNEVLLI 399
N+ ILG+G V + + KE AVK + ++ EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 400 LKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
K+ H N+++L LV++ M G L L ++ L ++ I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
+ + LH+ L IVHRDLK N+LLD DMN K++DFG + E + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174
Query: 519 YMAPEYAMEGL------YSKKSDVFSFGVLLIEIITGRR-NAGSNQLLAYAWHLWNEGNV 571
Y+APE + Y K+ D++S GV++ ++ G Q+L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN--- 231
Query: 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613
+ P D S D + + R T
Sbjct: 232 YQFGSPEWDDYS---DTVKDLV---SRFLVVQPQKRYTAEEA 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 7/207 (3%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHK 405
+++ + +G+G +G V + VA+K++S Q + E+ ++L+ +H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
N++ + + + ++ + A L+ K L + I +G+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV-RIVGTYGYMAPEY 524
++HRDLK SN+LL++ + KI DFG+AR+ + V T Y APE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 525 AMEG-LYSKKSDVFSFGVLLIEIITGR 550
+ Y+K D++S G +L E+++ R
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 7e-46
Identities = 64/269 (23%), Positives = 105/269 (39%), Gaps = 27/269 (10%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEV-LLILKLQH 404
+F +LG+G FG V+ + A+K L + E +L L +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
L + + V E++ G L + + + T I G+ +L
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFL 119
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
H IV+RDLK N+LLD D + KI+DFGM + + + NT GT Y+APE
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEI 174
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584
+ Y+ D +SFGVLL E++ G+ ++ + EL + D F
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQ-------------SPFHGQDEEELFHSIRMDNPF 221
Query: 585 SDDEFSR-YIHIGLLCVQEDAFDRPTMSS 612
+ + + + R +
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRG 250
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 9e-46
Identities = 51/265 (19%), Positives = 108/265 (40%), Gaps = 30/265 (11%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
LG+G FG V++ V S K K + E+ ++ +H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+E ++++EF+ + + L R+ + V+ + + + +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 476 DLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
D++ N++ + +S KI +FG AR + N + Y APE + S
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 534 SDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYI 593
+D++S G L+ +++G + + ++++ ++ D+E + I
Sbjct: 184 TDMWSLGTLVYVLLSGI-------------NPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 594 HIGLL-----CVQEDAFDRPTMSSV 613
I + + ++ R T S
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 1e-45
Identities = 50/272 (18%), Positives = 103/272 (37%), Gaps = 22/272 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC- 414
+G G FG +Y G ++ G+EVA+K C + + E + +Q + + +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+GD ++V E + D + + + + + Y+H +H
Sbjct: 73 AEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIH 126
Query: 475 RDLKASNVLLDSDMNSKI---SDFGMARIFAESEGEAN-----TVRIVGTYGYMAPEYAM 526
RD+K N L+ + DFG+A+ + ++ + + GT Y + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586
S++ D+ S G +L+ G A + + ++ P+
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPW-QGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
EF+ Y++ C D+P S + + +
Sbjct: 246 SEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (406), Expect = 2e-45
Identities = 60/263 (22%), Positives = 110/263 (41%), Gaps = 23/263 (8%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
ILG GG V+ L ++VAVK L + F E L H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 412 GFCVDGDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
+V E++ +L I+ G + ++ ++ + + + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSHQ- 129
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMAPEYAM 526
I+HRD+K +N+++ + K+ DFG+AR A+S T ++GT Y++PE A
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586
+SDV+S G +L E++TG + ++ A+ E + + P S
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE----DPIPPSARHEGLSA 243
Query: 587 DEFSRYIHIGLLCVQEDAFDRPT 609
D + L + ++ +R
Sbjct: 244 D----LDAVVLKALAKNPENRYQ 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (408), Expect = 4e-45
Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 16/238 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
+F LG G FG V+ +G+ A+K L + +E L++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
++++ G D + ++ +++ G L ++L ++ + V L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
I++RDLK N+LLD + + KI+DFG A+ + T + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEV 172
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGRR-NAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581
Y+K D +SFG+L+ E++ G SN + Y L E + + D
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
+++D+ ++G G FG VY+ L G+ VA+K++ E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 409 KLLGFCVDGDEK------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+L F EK LV +++P R + L + + + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
Y+H I HRD+K N+LLD D K+ DFG A+ E + + Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYRA 190
Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIITGRR 551
PE Y+ DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 4e-44
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-----FTNEVLLILKLQHKNLV 408
+ LG+G F VYK + + VA+K++ + E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
LL LV++FM +L + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME- 527
I+HRDLK +N+LLD + K++DFG+A+ F V T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
+Y D+++ G +L E++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 65/286 (22%), Positives = 116/286 (40%), Gaps = 30/286 (10%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGF 413
+LG G G V + ++ A+K L C + EV L + Q ++V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 414 CVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
+ L+V E + G L + + D R R+ + I+ I + + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS--- 129
Query: 470 LRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
+ I HRD+K N+L S + K++DFG A+ + T Y+APE
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLG 186
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586
Y K D++S GV++ ++ G SN LA + + + + P + S+
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGETGTLPQPQKP 630
+ + ++ + R T++ P + T PQ P
Sbjct: 247 E----VKMLIRNLLKTEPTQRMTITEFMNHPWIMQST---KVPQTP 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-43
Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 30/300 (10%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKN 406
NF +G+G +G VYK G+ VA+K RL + +E + E+ L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+VKLL ++ LV+EF+ D + + + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YA 525
R++HRDLK N+L++++ K++DFG+AR F V T Y APE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEILL 175
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRRN-AGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584
YS D++S G + E++T R G +++ G E+V P +T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 585 SDDEFSRYIHIGLL----------------CVQEDAFDRPTMSSVA--PMLKGETGTLPQ 626
F ++ + D R + + P + T +P
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (391), Expect = 5e-43
Identities = 43/274 (15%), Positives = 93/274 (33%), Gaps = 24/274 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFC 414
+G+G FG +++G L + ++VA+K + +E L + + F
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+G +LV + + D + + + + +HE +V+
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 475 RDLKASNVLLDSDMNS-----KISDFGMARIFAESEGEANTVR-----IVGTYGYMAPEY 524
RD+K N L+ + + DFGM + + + + + + GT YM+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584
+ S++ D+ + G + + + G + G + F
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 244
Query: 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618
+EF +Y+H P + +
Sbjct: 245 P-EEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (390), Expect = 5e-43
Identities = 65/284 (22%), Positives = 112/284 (39%), Gaps = 28/284 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNL 407
+ +G+G +G VYK + G+ A+K RL E + E+ ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
VKL +LV+E + + G L + + + G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD- 118
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM- 526
R++HRDLK N+L++ + KI+DFG+AR F + + T Y AP+ M
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLWYRAPDVLMG 174
Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR-NAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585
YS D++S G + E++ G G ++ G P +T+
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 586 DDEFSRYIHIGLL----------------CVQEDAFDRPTMSSV 613
D F+ Y + ++ D R T
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-42
Identities = 61/289 (21%), Positives = 113/289 (39%), Gaps = 44/289 (15%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE------FTNEVLLILKLQ--HKN 406
+LG GGFG VY G+ +SD VA+K + E EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+++LL + D +L+ E +RG L + + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 467 DSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
++HRD+K N+L+D + K+ DFG + ++ GT Y PE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 181
Query: 526 M-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584
+ + + V+S G+LL +++ G ++ ++ +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI------------PFEHDEEIIR--GQVFFRQRV 227
Query: 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVA--PMLKGETGTLPQPQKPA 631
S + H+ C+ DRPT + P ++ + PQ+ A
Sbjct: 228 SSE----CQHLIRWCLALRPSDRPTFEEIQNHPWMQD----VLLPQETA 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 64/269 (23%), Positives = 104/269 (38%), Gaps = 30/269 (11%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL------SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG G F V K S G + A K + SS + EV ++ ++QH N++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L + + +L+ E + G L ++ L + T + I G+ YLH
Sbjct: 78 LHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 470 LRIVHRDLKASNVLLDSDMNS----KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
L+I H DLK N++L KI DFG+A I GT ++APE
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIV 188
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRRN-AGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584
++D++S GV+ +++G G + A E D ++TS
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY---EFEDEYFSNTS- 244
Query: 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSV 613
+I + +D R T+
Sbjct: 245 --ALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-40
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 355 NILGQGGFGPVYKG--VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKL---QHKNL 407
+G+G +G V+K + + G+ VA+KR+ + E EV ++ L +H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 408 VKLLGFCVDGDEK-----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
V+L C LV+E + D + +++ + +G+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
+LH R+VHRDLK N+L+ S K++DFG+ARI++ +V T Y AP
Sbjct: 131 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAP 184
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
E ++ Y+ D++S G + E+ +
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKP 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 3e-39
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 20/217 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHK 405
S + +GQG FG V+K G++VA+K++ + E E+ ++ L+H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 406 NLVKLLGFCVDGDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
N+V L+ C LV++F + + ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQML 126
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVG 515
G+ Y+H + +I+HRD+KA+NVL+ D K++DFG+AR F+ ++ V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 516 TYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRR 551
T Y PE + E Y D++ G ++ E+ T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 10/200 (5%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
+G+G +G V+K + VA+K RL E + E+ L+ +L+HKN+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
+ LV+EF + G L + + + KG+ + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
++HRDLK N+L++ + K+++FG+AR F + +V + LYS
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 532 KKSDVFSFGVLLIEIITGRR 551
D++S G + E+ R
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 4e-38
Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 13/237 (5%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHK 405
+F +LG+G FG V + G+ A+K L ++ A E ++ +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
L L D V E+ G L L + + + I + YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH 122
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
+V+RD+K N++LD D + KI+DFG+ + A GT Y+APE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVL 177
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRR-NAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581
+ Y + D + GV++ E++ GR + + L E + P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 9e-37
Identities = 71/315 (22%), Positives = 121/315 (38%), Gaps = 44/315 (13%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHK 405
+ + D +G G +G V V G +VA+K+L SE E+ L+ ++H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 406 NLVKLLGFCVDGD------EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
N++ LL + + LV FM + K L + +V + K
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
G+ Y+H I+HRDLK N+ ++ D KI DFG+AR + ++ V T Y
Sbjct: 133 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 520 MAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR-----------RNAGSNQLLAYAWHLWN 567
APE + + Y++ D++S G ++ E+ITG+
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 568 EGNVLELVDPLLTDTSFSDDEFSRYIH------IGLL--CVQEDAFDRPTMSSVA--PML 617
E + + +F+ + + LL + DA R T P
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
Query: 618 KGETGTLPQPQKPAF 632
+ T +PQ +
Sbjct: 305 ESLHDTEDEPQVQKY 319
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (347), Expect = 2e-36
Identities = 56/237 (23%), Positives = 87/237 (36%), Gaps = 16/237 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHK 405
F LG G FG V G A+K L + NE ++ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
LVKL D +V E++ G + + L + G I YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
L +++RDLK N+L+D +++DFG A+ T + GT +APE
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEII 210
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRR-NAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581
+ Y+K D ++ GVL+ E+ G + Y + + L D
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 1e-33
Identities = 48/237 (20%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 324 HVQGRDNDLKAQDFFIDLETLNLATSNFSDSNI---LGQGGFGPVYKGV-LSDGKEVAVK 379
V N + ++++ D E+ + N D + LG+G + V++ + +++ ++V VK
Sbjct: 8 RVYTDVNTHRPREYW-DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK 66
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKL--LVYEFMPNGSLDAIL 436
L ++ + E+ ++ L+ N++ L D + LV+E + N +
Sbjct: 67 ILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDF 495
L + I K + Y H + I+HRD+K NV++D + ++ D+
Sbjct: 124 ------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDW 174
Query: 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRR 551
G+A + + V + + PE ++ +Y D++S G +L +I +
Sbjct: 175 GLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-32
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLS----SCSEQGTAEFTNEVLLILK 401
NF +LG G +G V+ GK A+K L + T E ++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 402 LQHK-NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
++ LV L + L+ +++ G L L + + + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGEI 138
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
+L L +L I++RD+K N+LLDS+ + ++DFG+++ F E E GT YM
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYM 197
Query: 521 APEYAMEGL--YSKKSDVFSFGVLLIEIITGRR 551
AP+ G + K D +S GVL+ E++TG
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G G G V + VA+K+LS ++ E++L+ + HKN++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 413 FCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+ + LV E M I + + + ++ + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
I+HRDLK SN+++ SD KI DFG+AR S V T Y APE +
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVIL 191
Query: 527 EGLYSKKSDVFSFGVLLIEIITGR 550
Y + D++S G ++ E++ +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 19/202 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G G +G V G VAVK+LS S E+ L+ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 414 CVDGD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ + + L+ I K L ++ I +G+ Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
I+HRDLK SN+ ++ D KI DFG+AR + T + +
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWM 194
Query: 529 LYSKKSDVFSFGVLLIEIITGR 550
Y++ D++S G ++ E++TGR
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 3e-29
Identities = 46/209 (22%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
LG G F V+ + + VA+K + + T +E+ L+ ++ + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 416 DGDEKLLVY--EFMPNGSLDAILFDPRKRGILCWRKRTN-----------IVNGIAKGML 462
+ KLL + PNG ++F+ +L K+ I + G+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 463 YLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
Y+H R I+H D+K NVL++ D + +A + + + + T Y +
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
PE + + +D++S L+ E+ITG
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.8 bits (240), Expect = 9e-24
Identities = 34/205 (16%), Positives = 63/205 (30%), Gaps = 33/205 (16%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRL----------SSCSEQGTAEFTNEVLLILKLQH 404
++G+G V+ E VK + G F+ + + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 405 KNLVKLLGFCV----DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
+ L KL G V + ++ E + R + +++ I +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDE--VLDMILEE 115
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
+ + IVH DL NVL+ + I DF + E R V
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV----RN 167
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIE 545
Y Y + D+ S +++
Sbjct: 168 IITY-FSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 660 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.61 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.05 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=421.29 Aligned_cols=266 Identities=27% Similarity=0.419 Sum_probs=210.2
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
+..++|+..++||+|+||+||+|+++ ..||||+++.. +....+.|.+|+.++++++|||||++++++.+ +..+||
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 45678899999999999999999864 36999998643 45566789999999999999999999998754 568999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++.. ....+++..+..|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 82 ~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999964 3345999999999999999999999988 99999999999999999999999999987665
Q ss_pred cCCccceeeeeccCCcCCHhhhhc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
...........||+.|||||++.. ..++.++|||||||++|||+||+.||...............+.....+..
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~--- 233 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--- 233 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG---
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh---
Confidence 444444445689999999999964 45899999999999999999999999865544444444443322111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCC
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLP 625 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 625 (660)
........+.+|+.+||+.||++|||++||++.|+.....+|
T Consensus 234 ---~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 234 ---VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ---SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 111223457889999999999999999999999987655544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-51 Score=410.57 Aligned_cols=255 Identities=28% Similarity=0.414 Sum_probs=201.9
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.++|+..+.||+|+||.||+|.+.+++.||||+++.. ....++|.+|++++++++||||++++|++.+.+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 4577888999999999999999988999999999763 345578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.+++.. ....+++..++.|+.||++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999854 3345899999999999999999999998 999999999999999999999999999876543322
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG-RRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
. .....||+.|+|||++.+..++.++|||||||++|||+|+ ++|+......+....+....+. .. +.
T Consensus 158 ~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~------~~-----p~ 225 (263)
T d1sm2a_ 158 S-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------YK-----PR 225 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC------CC-----CT
T ss_pred e-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC------CC-----cc
Confidence 2 2234789999999999999999999999999999999995 5555554444433333222111 01 11
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.....+.+|+.+||+.||++||||+||++.|+++
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1223577899999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=408.96 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=203.6
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|+..++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4688889999999999999996 478999999986532 33445689999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++|+|.+++. ..+.+++.++..++.||++||+|||+.+ |+||||||+|||+++++++||+|||+++.......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999994 4456999999999999999999999998 99999999999999999999999999987765443
Q ss_pred ccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
.......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..................... + ....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~--~---~~~~- 232 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--P---WKKI- 232 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTST--T---GGGS-
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--c---cccC-
Confidence 333445689999999999988775 68899999999999999999999754332222222222211100 0 0012
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+.+|+.+||+.||++|||++|+++
T Consensus 233 ---s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 233 ---DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 234678889999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=406.82 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=212.3
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
++|+..++||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.++++++||||+++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4688999999999999999985 579999999997655556778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+......
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999998842 35999999999999999999999998 999999999999999999999999999876543322
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+............ + ..+..
T Consensus 173 --~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------~---~~~~~ 241 (293)
T d1yhwa1 173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE------L---QNPEK 241 (293)
T ss_dssp --BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC------C---SSGGG
T ss_pred --ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC------C---CCccc
Confidence 234579999999999999999999999999999999999999998777666555555443211 1 01111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
....+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2234778999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-50 Score=413.00 Aligned_cols=262 Identities=27% Similarity=0.388 Sum_probs=214.9
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
++..++|+..++||+|+||+||+|.+. +++.||||+++.. ....+++.+|+.++++++|||||++++++.+++..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 345567788899999999999999965 5889999999753 34567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++... ....+++..+..|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 92 ~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 92 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999999998542 3456899999999999999999999998 99999999999999999999999999987654
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
..... .....|++.|+|||++.+..++.++|||||||++|||++|+.|+...............+...+ .
T Consensus 168 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~-----~---- 237 (287)
T d1opja_ 168 DTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-----R---- 237 (287)
T ss_dssp SSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-----C----
T ss_pred CCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC-----C----
Confidence 33222 2234688999999999999999999999999999999997776554333333444443332111 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
+......+.+|+.+||+.||++|||++||+++|+....
T Consensus 238 -~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 238 -PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223457889999999999999999999999987643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=411.24 Aligned_cols=256 Identities=30% Similarity=0.436 Sum_probs=207.2
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
+..++|+..++||+|+||.||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 345677778999999999999999988899999999753 3456789999999999999999999998754 56799999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++|+|.+++.. .....+++..++.|+.||++||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 88 y~~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999998843 22335899999999999999999999988 9999999999999999999999999998765432
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA-GSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
... .....||+.|+|||++.++.++.++|||||||++|||+||+.|+ ......+.. .....+.. +... ...
T Consensus 164 ~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-~~i~~~~~-----~~~p-~~~ 235 (272)
T d1qpca_ 164 YTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYR-----MVRP-DNC 235 (272)
T ss_dssp EEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCC-----CCCC-TTC
T ss_pred ccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcCC-----CCCc-ccC
Confidence 221 22346899999999999999999999999999999999976654 444433333 33322211 1111 122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
...+.+|+.+||+.||++||||+||+++|++
T Consensus 236 ----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 236 ----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2347789999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=400.63 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=216.1
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.++|+..++||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++||||++++|++.+.+..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 4688999999999999999999988899999999863 335578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|..++.. ....+++..+++|+.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999754 3445899999999999999999999988 999999999999999999999999999876544332
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+....+. .. +.
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--------~~---p~ 224 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------YR---PH 224 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC--------CC---CT
T ss_pred -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC--------CC---cc
Confidence 2233578999999999999999999999999999999998 78899877766555444432111 01 11
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.....+.+++.+||+.||++|||++||++.|.++
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1224578899999999999999999999998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=403.65 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=207.8
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||+++.+ +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46788899999999999999964 6899999998642 2344667899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999994 3456999999999999999999999998 999999999999999999999999999765432
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.+... .+.. ..
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------~~p~-~~ 227 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------TFPD-FV 227 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------CCCT-TS
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------CCCc-cC
Confidence 2 2345799999999999999999999999999999999999999987766555444333221 1111 22
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+ ..+.+++.+||+.||++|||++|+++
T Consensus 228 s----~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 228 T----EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2 34778889999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.4e-50 Score=409.71 Aligned_cols=257 Identities=29% Similarity=0.445 Sum_probs=200.7
Q ss_pred cCCCCCCcccccCCcccEEeeeec-CCc---EEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS-DGK---EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~---~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
.++|+..++||+|+||+||+|.++ +++ .||||++.. ......+.|.+|+.+|++++|||||+++|++.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 345677789999999999999964 332 589999865 345566789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
||||+++|+|.+++.. ..+.+++.++..|+.||++||+|||+.+ |+||||||+||||++++++||+|||+++...
T Consensus 105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998853 3446999999999999999999999988 9999999999999999999999999998765
Q ss_pred ccCCccc---eeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 503 ESEGEAN---TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 503 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+....+......
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------- 252 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL------- 252 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 4433221 122457899999999999999999999999999999998 89999876655544443322111
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+.+....+.+|+.+||+.||++||||.||++.|+..
T Consensus 253 ----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 253 ----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122334578899999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=406.50 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=206.5
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688889999999999999996 47899999998642 2345677999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999884 4456999999999999999999999998 999999999999999999999999999877654
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..... .+.. ..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-------~~p~-~~ 233 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-------DFPE-KF 233 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-------CCCT-TC
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-------CCCc-cC
Confidence 443333446899999999999999999999999999999999999999987766555544443211 1111 22
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
+ ..+.+|+.+||+.||++|||++|++
T Consensus 234 s----~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 234 F----PKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp C----HHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred C----HHHHHHHHHHccCCHhHCcCHHHHc
Confidence 3 3477899999999999999999964
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=405.34 Aligned_cols=265 Identities=27% Similarity=0.391 Sum_probs=208.0
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.++|+..+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||+++|++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3567788999999999999999988889999999753 345678999999999999999999999985 45689999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|..++... ....++|.+++.++.||++||+|||+.+ |+||||||+||||++++++||+|||+++........
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999988532 2345999999999999999999999998 999999999999999999999999999876543322
Q ss_pred cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHHHhcCcccccccccCCCCCCCH
Q 006125 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG-SNQLLAYAWHLWNEGNVLELVDPLLTDTSFSD 586 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 586 (660)
......||+.|+|||++.++.++.++|||||||++|||++|+.|+. .....+.. ..+..+... .. ..
T Consensus 170 -~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-~~i~~~~~~-----~~-----~~ 237 (285)
T d1fmka3 170 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVERGYRM-----PC-----PP 237 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCC-----CC-----CT
T ss_pred -eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcCCC-----CC-----Cc
Confidence 2233578999999999999999999999999999999999766654 34433333 333222111 11 11
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCCCCCCCCCC
Q 006125 587 DEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETGTLPQPQKP 630 (660)
Q Consensus 587 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p 630 (660)
.....+.+++.+||+.||++||+|++|+++|+......+++..|
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 22345788999999999999999999999999866555444434
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=404.32 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=207.5
Q ss_pred CCCCCCc-ccccCCcccEEeeeec---CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 349 SNFSDSN-ILGQGGFGPVYKGVLS---DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 349 ~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
++|...+ +||+|+||.||+|.++ ++..||||+++.. .....+.|.+|++++++++|||||+++|++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4455556 4999999999999853 3557999999754 44556789999999999999999999999865 568999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++.. .+..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999843 3356999999999999999999999998 99999999999999999999999999987654
Q ss_pred cCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 504 SEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 504 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
..... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+....+ ..+...+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-~~~~~~~-------- 232 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRME-------- 232 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-HTTCCCC--------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCC--------
Confidence 33221 1223468999999999999999999999999999999998 89999866554443333 2322111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.+......+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 233 --~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 233 --CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp --CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11122345778999999999999999999999997643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=411.71 Aligned_cols=260 Identities=30% Similarity=0.414 Sum_probs=211.4
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC-C-----cEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD-G-----KEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 417 (660)
+..++|+..++||+|+||+||+|+... + ..||+|++... .......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 445678889999999999999998642 2 36999998643 344556789999999998 899999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCCCC--------------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRK--------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL 477 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL 477 (660)
+..++||||+++|+|.++|..... ...+++..++.++.||++||+|||+.+ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999965332 245899999999999999999999998 999999
Q ss_pred CCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 006125 478 KASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN 556 (660)
Q Consensus 478 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~ 556 (660)
||+|||++.++.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987665544433344578999999999999999999999999999999998 89999765
Q ss_pred cHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhc
Q 006125 557 QLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLK 618 (660)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 618 (660)
........+...+...+ .+......+.+|+.+||+.||++|||++||++.|.
T Consensus 271 ~~~~~~~~~~~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 54444444444432111 11112345788999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=402.71 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=197.4
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--CeeEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV 423 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 423 (660)
++|+..+.||+|+||.||+++. .+|+.||+|+++.. ++...+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 4688889999999999999985 47899999998653 445567799999999999999999999999753 457899
Q ss_pred EEecCCCChhhhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 424 YEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
|||+++|+|.+++... .....+++..++.++.||++||.|||+.+ ..+|+||||||+||||++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998532 23456999999999999999999999865 23599999999999999999999999999987
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. +.... +.
T Consensus 164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~-----~~ 235 (269)
T d2java1 164 LNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRR-----IP 235 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCC-----CC
T ss_pred cccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCC-----CC
Confidence 6543322 2245899999999999999999999999999999999999999987766554444332 22211 11
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
..++ ..+.+|+.+||+.||.+|||++|+++
T Consensus 236 -~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 236 -YRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1233 34778889999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=403.59 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=209.4
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
+.|+..+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 3577789999999999999996 478999999998766677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.+++.. ..+.+++.++..++.||++||.|||+++ |+||||||+||||+.++++||+|||+++........
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 99999998743 2345999999999999999999999998 999999999999999999999999999765432211
Q ss_pred cceeeeeccCCcCCHhhhh-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 508 ANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||......+....+...... .+.
T Consensus 167 --~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~------~~~-- 236 (288)
T d2jfla1 167 --RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP------TLA-- 236 (288)
T ss_dssp --HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC------CCS--
T ss_pred --ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC------CCC--
Confidence 12357999999999984 456899999999999999999999999876655555554443221 111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+......+.+|+.+||+.||++|||++|+++
T Consensus 237 -~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 -QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112235778899999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=401.78 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=202.0
Q ss_pred hcCCCCCCcccccCCcccEEeeeecCC-----cEEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 347 ATSNFSDSNILGQGGFGPVYKGVLSDG-----KEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g-----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
..+.|+..++||+|+||.||+|.+++. ..||||+++. .......+|.+|+.++++++|||||+++|++.+.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 345677889999999999999996532 3699999965 3444556799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+.+|+|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 85 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999998853 3345999999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 501 FAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
........ ......||+.|+|||++.++.++.++|||||||++|||++|+.|+...............+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~------- 232 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL------- 232 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC-------
Confidence 65433222 2223468999999999999999999999999999999999766554332222233333332211
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..+......+.+|+.+||+.||++||||.||+++|+..
T Consensus 233 ---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 233 ---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11222335588899999999999999999999999764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=398.62 Aligned_cols=247 Identities=30% Similarity=0.389 Sum_probs=200.4
Q ss_pred cccccCCcccEEeeeecC---CcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEecCC
Q 006125 355 NILGQGGFGPVYKGVLSD---GKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 429 (660)
++||+|+||.||+|.+.+ ++.||||+++.. +....+.+.+|+.++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 468999999653 33345679999999999999999999999865 467899999999
Q ss_pred CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCcc-
Q 006125 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA- 508 (660)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~- 508 (660)
|+|.+++. ....+++..++.|+.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999994 4456999999999999999999999998 9999999999999999999999999998765433222
Q ss_pred ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCCHH
Q 006125 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDD 587 (660)
Q Consensus 509 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 587 (660)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+.. +...+ .+..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~----------~p~~ 234 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMG----------CPAG 234 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCC----------CCTT
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-CCCCC----------CCcc
Confidence 2223578999999999999999999999999999999998 8999987665544433332 22111 1112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 588 EFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 588 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
....+.+|+.+||+.||++|||++||+++|+.
T Consensus 235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 23457789999999999999999999998865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-49 Score=403.58 Aligned_cols=266 Identities=28% Similarity=0.413 Sum_probs=217.9
Q ss_pred HHHHhhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEE
Q 006125 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (660)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 414 (660)
.++++..++|+..+.||+|+||.||+|+.+ +++.||||+++.. .....++|.+|+.++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345566788999999999999999999864 3578999999753 344466799999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCChhhhhcCCC---------------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 006125 415 VDGDEKLLVYEFMPNGSLDAILFDPR---------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 473 (660)
...+..+++|||+++|+|.+++.... ....+++..++.|+.||+.||+|||+.+ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999995321 1234899999999999999999999998 99
Q ss_pred ecCCCCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCC-CC
Q 006125 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR-RN 552 (660)
Q Consensus 474 H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~-~p 552 (660)
||||||+||||+.++.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998765544444444557889999999999999999999999999999999996 56
Q ss_pred CCCCcHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 553 AGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
+......+....+. .+...+. +...+..+.+|+.+||+.||++||||.||+++|+++.
T Consensus 243 ~~~~~~~e~~~~v~-~~~~~~~----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEVIYYVR-DGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHHHHHHH-TTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHHHHHHH-cCCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 77666655554433 3322111 1122335788999999999999999999999998763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=392.53 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=198.4
Q ss_pred CCCcccccCCcccEEeeeec-CCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe----CCeeEEEE
Q 006125 352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVY 424 (660)
Q Consensus 352 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 424 (660)
+..++||+|+||+||+|... +++.||+|++.. ......+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34568999999999999964 688999999864 244556789999999999999999999999875 34578999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC-CCCCEEEeeccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARIFAE 503 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~~~~ 503 (660)
||+++|+|.+++. ....+++..+..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999994 3456999999999999999999999975 4599999999999996 578999999999975432
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
. .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...............+.....++ ..
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~-----~~ 237 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-----KV 237 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG-----GC
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccC-----cc
Confidence 2 2234589999999998865 699999999999999999999999976544444444333322111111 12
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.+ ..+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 238 AI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 22 23778899999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=408.11 Aligned_cols=201 Identities=30% Similarity=0.425 Sum_probs=178.4
Q ss_pred hhcCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
+..++|+..++||+|+||+||+|.. .+|+.||+|+++.. .......+.+|+.++++++|||||++++++.+.+..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4567899999999999999999995 47899999999753 344456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
|||+++|+|.+++. +.+.+++..+..++.||++||.|||+. + |+||||||+||||++++++||+|||+++...
T Consensus 83 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999994 345699999999999999999999974 7 9999999999999999999999999998764
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~ 556 (660)
.... ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 157 DSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp HHTC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CCcc----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4322 2358999999999999999999999999999999999999999654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-48 Score=398.19 Aligned_cols=248 Identities=29% Similarity=0.441 Sum_probs=206.7
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC---hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
.|+..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 477889999999999999995 578999999987532 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+++|+|..++. ....+++.++..++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 999999987763 3456999999999999999999999998 999999999999999999999999999865432
Q ss_pred CccceeeeeccCCcCCHhhhhc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDT 582 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 582 (660)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||......+....+..... +.+...
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~------~~~~~~ 237 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------PALQSG 237 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------CCCSCT
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------CCCCCC
Confidence 23479999999999863 4689999999999999999999999987766655555544322 111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 583 SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 583 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
.++ ..+.+++.+||+.||.+|||++|+++ ++.+
T Consensus 238 ~~s----~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 238 HWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCC----HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 233 34778889999999999999999985 4543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-47 Score=402.48 Aligned_cols=256 Identities=22% Similarity=0.291 Sum_probs=214.3
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
++|+..+.||+|+||.||+++. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4788899999999999999995 479999999998766677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC--CCCEEEeeccccccccccC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--DMNSKISDFGMARIFAESE 505 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DfGla~~~~~~~ 505 (660)
++|+|.+++.. ..+.+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999853 3456999999999999999999999998 999999999999964 5789999999998765432
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
......||+.|||||++.+..++.++|||||||++|||++|+.||...+..+....+........ .... +..+
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~-~~~s 253 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---DSAF-SGIS 253 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC---CGGG-GGCC
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---cccc-cCCC
Confidence 22346899999999999999999999999999999999999999987776665555443321110 0000 0122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
..+.+++.+||+.||++|||++|+++ ++...
T Consensus 254 ----~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 254 ----EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp ----HHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 34778899999999999999999997 35543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-48 Score=398.34 Aligned_cols=254 Identities=24% Similarity=0.336 Sum_probs=195.5
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCC-hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
+.|+..+.||+|+||+||++... +|+.||||++.... ......+.+|+.++++++||||+++++++.+++..+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45888899999999999999964 68999999997532 33345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC---CCCCEEEeeccccccccc
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAE 503 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DfGla~~~~~ 503 (660)
+++|+|.+++. ..+.+++.++..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++....
T Consensus 89 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999994 3456999999999999999999999998 99999999999994 578999999999986543
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....... ..... +.
T Consensus 163 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~-~~ 235 (307)
T d1a06a_ 163 GSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF---DSPYW-DD 235 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC---CTTTT-TT
T ss_pred CCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC---CCccc-cC
Confidence 322 223579999999999999999999999999999999999999998777665554444332111 01111 12
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
.+ ..+.+++.+||+.||++|||++|+++ ++++
T Consensus 236 ~s----~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 236 IS----DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp SC----HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 22 34788999999999999999999997 5654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-47 Score=399.92 Aligned_cols=259 Identities=23% Similarity=0.268 Sum_probs=216.0
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
++|+..+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+.++++++||||+++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688899999999999999995 579999999998766666678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeC--CCCCEEEeeccccccccccC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DfGla~~~~~~~ 505 (660)
++|+|.+++.. ....+++.+++.|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++......
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999888742 3345999999999999999999999998 99999999999998 67899999999998765432
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....... ..... +..+
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~-~~~s 256 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF---DEDAF-SSVS 256 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC---CSSTT-TTSC
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---Ccccc-cCCC
Confidence 2334579999999999999999999999999999999999999998877666555544332110 00110 1222
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGT 623 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~ 623 (660)
..+.+|+.+||+.||.+|||+.|+++ ++++....
T Consensus 257 ----~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 257 ----PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 34778999999999999999999987 57654433
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=395.09 Aligned_cols=268 Identities=27% Similarity=0.381 Sum_probs=207.5
Q ss_pred ChHHHHhhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccC-CChhcHHHHHHHHHHHhhc-CCCCcceEe
Q 006125 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLL 411 (660)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 411 (660)
+..+.++..++|+..++||+|+||.||+|... +++.||||+++. ......+.+.+|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 44556666778999999999999999999853 346899999975 3344556788888888877 689999999
Q ss_pred EEEEeCC-eeEEEEEecCCCChhhhhcCCC-------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 006125 412 GFCVDGD-EKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL 477 (660)
Q Consensus 412 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL 477 (660)
+++...+ ..++||||+++|+|.+++.... ....+++.++..++.||++||+|||+.+ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 9987654 6899999999999999995422 1245899999999999999999999998 999999
Q ss_pred CCCceEeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCC-CCCCCC
Q 006125 478 KASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR-RNAGSN 556 (660)
Q Consensus 478 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~-~p~~~~ 556 (660)
||+||||++++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. +||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765544443334457999999999999999999999999999999999975 567655
Q ss_pred cHHHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 557 QLLAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
............+...+. +......+.+++.+||+.||++|||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 241 KIDEEFCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCSHHHHHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 544444444444432211 111223478899999999999999999999999764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-47 Score=391.32 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=215.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||+||+++. .+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4678889999999999999996 46999999998642 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999984 4456889999999999999999999998 999999999999999999999999999876443
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
. ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..... .+ .+..
T Consensus 158 ~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-------~~-p~~~ 224 (316)
T d1fota_ 158 T-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-------RF-PPFF 224 (316)
T ss_dssp B-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-------CC-CTTS
T ss_pred c-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-------CC-CCCC
Confidence 2 235899999999999999999999999999999999999999988776666555544321 11 1122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCC-----CHHhHHH--HhcCC------CCCCCCCCCCcee
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP--MLKGE------TGTLPQPQKPAFS 633 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~--~L~~~------~~~~~~p~~p~~~ 633 (660)
+ ..+.+++.+||+.||.+|| |++|+++ +++++ ...+.+|-.|...
T Consensus 225 s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~ 282 (316)
T d1fota_ 225 N----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 282 (316)
T ss_dssp C----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred C----HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcC
Confidence 3 3477888999999999996 8999985 45543 2344445555443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=389.74 Aligned_cols=250 Identities=23% Similarity=0.272 Sum_probs=207.6
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC------ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC------SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
++|+..+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688889999999999999996 57999999998642 1224678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC----CEEEeeccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM 497 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfGl 497 (660)
|||||+++|+|.+++. ..+.+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999994 3456999999999999999999999998 99999999999998776 599999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDP 577 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~ 577 (660)
+......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+........ .
T Consensus 164 a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--~- 237 (293)
T d1jksa_ 164 AHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--D- 237 (293)
T ss_dssp CEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--H-
T ss_pred hhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--c-
Confidence 9876543222 234789999999999999999999999999999999999999987776655544433221000 0
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
... +.. ...+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~-~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 238 EYF-SNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHH-TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhc-CCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 011 234778999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=394.89 Aligned_cols=254 Identities=29% Similarity=0.453 Sum_probs=201.4
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCc----EEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 422 (660)
++|+..++||+|+||+||+|.+. +|+ .||+|+++. .+....+++.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888899999999999999854 444 589998865 3445677899999999999999999999999875 5678
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 502 (660)
++||+.+|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999988853 3456999999999999999999999998 9999999999999999999999999998876
Q ss_pred ccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCC
Q 006125 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTD 581 (660)
Q Consensus 503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 581 (660)
............||+.|+|||++.++.++.++|||||||++|||+| |++||......+... ....+...
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-~i~~~~~~--------- 232 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERL--------- 232 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-HHHHTCCC---------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCC---------
Confidence 5544444444578999999999999999999999999999999999 788887654433322 22222111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 582 TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 582 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
..+......+.+|+.+||+.||.+|||+.||++.|+.
T Consensus 233 -~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp -CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 1111223457889999999999999999999988754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=387.57 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=198.9
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC----CcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
+..++|+..+.||+|+||.||+|++.. +..||||+++.. .....+.+.+|+.++++++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 344678888999999999999998642 346899998753 4445677999999999999999999999985 4678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999998743 3446899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccC
Q 006125 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLL 579 (660)
Q Consensus 501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~ 579 (660)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |.+|+......+....+..... .. .
T Consensus 158 ~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-~~-----~ 230 (273)
T d1mp8a_ 158 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-LP-----M 230 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CC-----C
T ss_pred ccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC-----C
Confidence 6543322 2233578999999999999999999999999999999998 8888876655544443333221 11 1
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 580 TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 580 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.+.. ...+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 231 -~~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 231 -PPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122 34578899999999999999999999988754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=394.67 Aligned_cols=248 Identities=23% Similarity=0.274 Sum_probs=209.5
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 423 (660)
-++|+..+.||+|+||.||+++. .+|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35788899999999999999995 57999999999742 234567789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++. ..+.+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999984 4556899999999999999999999998 99999999999999999999999999986544
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|++||...+..+....+..... .+. ..
T Consensus 158 ~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~-------~~p-~~ 227 (337)
T d1o6la_ 158 DGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------RFP-RT 227 (337)
T ss_dssp TTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------CCC-TT
T ss_pred CCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC-------CCC-cc
Confidence 3222 2345899999999999999999999999999999999999999988776655444433221 111 12
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC-----HHhHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPT-----MSSVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 615 (660)
.++ .+.+|+.+||++||.+||+ ++|+++
T Consensus 228 ~s~----~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 LSP----EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SCH----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCH----HHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 333 4678899999999999995 778774
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=385.89 Aligned_cols=250 Identities=30% Similarity=0.374 Sum_probs=198.7
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-CeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 426 (660)
-++|+..++||+|+||.||+|.+ .|+.||||+++.. ...+.+.+|++++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 34566678999999999999998 5789999999753 3457799999999999999999999999654 567999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+++|+|.+++... ....+++..+++|+.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 9999999999532 2235899999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
....++..|+|||++.++.++.++||||||+++|||+| |+.|+......+....+.. +.. +. .+
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~-----~~-----~~ 222 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYK-----MD-----AP 222 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCC-----CC-----CC
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCC-----CC-----CC
Confidence 22367899999999999999999999999999999998 6777776555544444322 211 11 12
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
......+.+|+.+||+.||.+|||+.||+++|+.+
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 22234577899999999999999999999999753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=390.87 Aligned_cols=263 Identities=29% Similarity=0.425 Sum_probs=216.3
Q ss_pred HhhcCCCCCCcccccCCcccEEeeeec------CCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC
Q 006125 345 NLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (660)
Q Consensus 345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 417 (660)
++..++|...++||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 344567778899999999999999863 3578999999753 444556789999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCC-------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCE
Q 006125 418 DEKLLVYEFMPNGSLDAILFDP-------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~ 490 (660)
+..++||||+++|+|.+++... .....+++..+.+++.|+++||.|||+.+ |+||||||+||||++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence 9999999999999999988531 12234789999999999999999999988 9999999999999999999
Q ss_pred EEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHHHhcC
Q 006125 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR-RNAGSNQLLAYAWHLWNEG 569 (660)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~-~p~~~~~~~~~~~~~~~~~ 569 (660)
||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||+ +|+......+....+...
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~- 251 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG- 251 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-
Confidence 999999998776554444444457899999999999999999999999999999999985 667666655554444332
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 570 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
...+. +......+.+|+.+||+.||++||||+||+++|++..
T Consensus 252 ~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 252 GLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 21111 1112245888999999999999999999999998863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=385.21 Aligned_cols=256 Identities=28% Similarity=0.388 Sum_probs=202.1
Q ss_pred cCCCCCCcccccCCcccEEeeeec--CC--cEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCee
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLS--DG--KEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 420 (660)
.++|+..+.||+|+||.||+|++. ++ ..||||+++.. .....++|.+|+.++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 456778899999999999999853 23 36899998752 33445789999999999999999999999965 467
Q ss_pred EEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
++||||+++|+|.+++.. ..+.+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999988753 3456999999999999999999999988 99999999999999999999999999997
Q ss_pred ccccCCcc-ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 501 FAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
........ ......|+..|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+.+.+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~---- 236 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR---- 236 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC----
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC----
Confidence 65443322 2223467889999999999999999999999999999998 89999887777766665554322111
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcC
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKG 619 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 619 (660)
. ...+ ..+.+|+.+||+.||++|||+.||+++|++
T Consensus 237 -~-~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 237 -P-EDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -C-TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -c-cccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 1222 347789999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-47 Score=384.29 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=206.8
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC----e
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----E 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 419 (660)
.++|+..+.||+|+||.||+++. .+|+.||||+++.. +....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 45788899999999999999995 57999999999753 2334567999999999999999999999998654 3
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.+|||||+++|+|.+++. ..+.+++.+++.++.||++||+|||+.+ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999884 4456999999999999999999999998 9999999999999999999999999987
Q ss_pred cccccCCc-cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 500 IFAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 500 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+............. .
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~----~ 235 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP----S 235 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG----G
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC----c
Confidence 65433222 223345799999999999999999999999999999999999999998877776666665543221 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhcccCCCCCCC-CHHhHHHHhcC
Q 006125 579 LTDTSFSDDEFSRYIHIGLLCVQEDAFDRP-TMSSVAPMLKG 619 (660)
Q Consensus 579 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~ 619 (660)
...+..+ ..+.+++.+||+.||.+|| |++|++..|.+
T Consensus 236 ~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1111223 3477889999999999999 89999888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=387.14 Aligned_cols=261 Identities=29% Similarity=0.422 Sum_probs=210.7
Q ss_pred hhcCCCCCCcccccCCcccEEeeeecC--------CcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEE
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVLSD--------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 415 (660)
+..++|+..+.||+|+||.||+|+... +..||||+++.. ......++.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 445677788999999999999998532 347999999764 344567889999999888 8999999999999
Q ss_pred eCCeeEEEEEecCCCChhhhhcCCCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 006125 416 DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (660)
Q Consensus 416 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 482 (660)
+.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 99999999999999999999964331 245899999999999999999999998 99999999999
Q ss_pred EeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q 006125 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAY 561 (660)
Q Consensus 483 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~ 561 (660)
|++.++.+||+|||+++...............|++.|+|||.+.++.++.++|||||||++|||++ |.+||......+
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~- 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence 999999999999999998776555544445678999999999999999999999999999999998 677887666544
Q ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 562 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.+..+..+...+. . ...+ ..+.+|+.+||+.||++|||+.||+++|+++
T Consensus 246 ~~~~i~~~~~~~~-----p-~~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 246 LFKLLKEGHRMDK-----P-SNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHHHHTTCCCCC-----C-SSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCC-----C-ccch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 3344433322111 1 1222 3478899999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=391.17 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=214.8
Q ss_pred hhcCCCCCCcccccCCcccEEeeee------cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeC
Q 006125 346 LATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (660)
Q Consensus 346 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 417 (660)
+..++|+..++||+|+||.||+|++ .+++.||||+++.. .......+.+|+.++.++ +|||||++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4456777889999999999999985 24668999999753 344566799999999999 799999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCCC---------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPR---------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 482 (660)
+..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 99999999999999999986422 2235899999999999999999999998 99999999999
Q ss_pred EeCCCCCEEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q 006125 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAY 561 (660)
Q Consensus 483 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~ellt-G~~p~~~~~~~~~ 561 (660)
|++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |++++......+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987765544444445689999999999999999999999999999999999 5555655444444
Q ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 562 AWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 562 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.+.+...+.... . +......+.+|+.+||+.||++||||+||+++|++.
T Consensus 257 ~~~~i~~~~~~~-----~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 FYKMIKEGFRML-----S-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHTCCCC-----C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCCC-----C-----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 455544432111 1 111234578899999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-46 Score=390.70 Aligned_cols=248 Identities=23% Similarity=0.273 Sum_probs=210.1
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 424 (660)
++|+..+.||+|+||.||+++. .+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4688889999999999999996 47999999998642 2344667899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 504 (660)
||+.+|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999984 3456999999999999999999999998 999999999999999999999999999876432
Q ss_pred CCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCC
Q 006125 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 505 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
. ....||+.|||||++.+..++.++|||||||++|||++|+.||...+.......+...... . ....
T Consensus 195 ~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-------~-p~~~ 261 (350)
T d1rdqe_ 195 T-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-------F-PSHF 261 (350)
T ss_dssp B-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------C-CTTC
T ss_pred c-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC-------C-CccC
Confidence 2 2357999999999999999999999999999999999999999887766655554433211 1 1122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCC-----CHHhHHH--HhcC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP--MLKG 619 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~--~L~~ 619 (660)
+ ..+.+++.+||+.||.+|+ |++|+++ ++++
T Consensus 262 s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 262 S----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp C----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred C----HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 3 3477889999999999994 8999985 4544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=388.22 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=204.5
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHHHHHHHh-hcCCCCcceEeEEEEeCCeeEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 423 (660)
++|+..+.||+|+||+||+|+. .+|+.||||++++. .....+.+..|+.++. .++||||+++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4688889999999999999996 47999999999642 2344556677777665 68999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccc
Q 006125 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 503 (660)
|||+++|+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999994 4456899999999999999999999998 99999999999999999999999999986544
Q ss_pred cCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTS 583 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 583 (660)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..... .+.. .
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-------~~p~-~ 225 (320)
T d1xjda_ 156 GDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-------FYPR-W 225 (320)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------CCCT-T
T ss_pred cccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------CCCc-c
Confidence 3322 2335799999999999999999999999999999999999999987776554444432211 1111 2
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHH-hHHH
Q 006125 584 FSDDEFSRYIHIGLLCVQEDAFDRPTMS-SVAP 615 (660)
Q Consensus 584 ~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 615 (660)
.+ ..+.+|+.+||+.||.+||++. |+++
T Consensus 226 ~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 LE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp SC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 22 3477889999999999999996 7763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.3e-46 Score=376.97 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=206.3
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCCh---------hcHHHHHHHHHHHhhcC-CCCcceEeEEEEeC
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE---------QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDG 417 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 417 (660)
++|+..+.||+|+||+||+++. .+|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999995 5799999999864321 12345889999999996 99999999999999
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
+..+|||||+++|+|.+++. ..+.+++.++..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999994 4456999999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAME------GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV 571 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 571 (660)
++........ ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........+......
T Consensus 157 a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 157 SCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp CEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred eeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9876543322 23579999999999863 34788999999999999999999999887766555444443221
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 572 LELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 572 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+.. ...+ ..+.+++.+||+.||++|||++||++
T Consensus 234 --~~~~~~--~~~s----~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 234 --FGSPEW--DDYS----DTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --CCTTTG--GGSC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --CCCccc--ccCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000000 1222 35788999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=386.12 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=205.2
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCc--EEEEEEccCC-ChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEeCCeeEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 423 (660)
++|+..++||+|+||.||+|+++ +|. .||||+++.. .....+.+.+|++++.++ +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56777899999999999999965 444 4788887643 344566799999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCC-------------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCE
Q 006125 424 YEFMPNGSLDAILFDP-------------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (660)
Q Consensus 424 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~ 490 (660)
|||+++|+|.++|+.. .....+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999653 23456999999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCC-CCCCCcHHHHHHHHHhcC
Q 006125 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR-NAGSNQLLAYAWHLWNEG 569 (660)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~-p~~~~~~~~~~~~~~~~~ 569 (660)
||+|||+++........ ....||..|+|||.+.++.++.++|||||||++|||++|.. |+......+....+. .+
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~~ 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QG 242 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GT
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-hc
Confidence 99999999765433222 23468999999999999999999999999999999999765 566655544433332 22
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCC
Q 006125 570 NVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGET 621 (660)
Q Consensus 570 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 621 (660)
.. + ..+......+.+|+.+||+.||++||||+||++.|+++.
T Consensus 243 ~~-----~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 243 YR-----L-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp CC-----C-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-----C-----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 1 111122345788899999999999999999999987754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=377.70 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=202.9
Q ss_pred CcccccCCcccEEeeee-cCCcEEEEEEccCCChh-----cHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQ-----GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
.++||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 47899999999999995 46999999999643221 2346889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
.++++..++ .....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 998877776 34556899999999999999999999998 999999999999999999999999999876543322
Q ss_pred cceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---Cccccccc------c
Q 006125 508 ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---GNVLELVD------P 577 (660)
Q Consensus 508 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~~~~~~~d------~ 577 (660)
. ...+||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....+.+. .......+ .
T Consensus 157 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 157 Y--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp C--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred c--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 2 23479999999999875 46899999999999999999999999876655544443321 00000000 0
Q ss_pred -cC-CCCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCCC
Q 006125 578 -LL-TDTSFSD-----DEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGTL 624 (660)
Q Consensus 578 -~~-~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~ 624 (660)
.. ..+.... .....+.+|+.+||+.||++|||++|+++ ++++.-.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 00 0001111 11245788999999999999999999996 677654333
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=382.01 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=201.6
Q ss_pred CcccccCCcccEEeeeecCC----cEEEEEEccC-CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEe-CCeeEEEEEec
Q 006125 354 SNILGQGGFGPVYKGVLSDG----KEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYEFM 427 (660)
Q Consensus 354 ~~~lG~G~fg~Vy~~~~~~g----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 427 (660)
.++||+|+||+||+|.+.++ ..||||+++. .+....++|.+|++++++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36799999999999996432 2589999975 455567889999999999999999999999876 45889999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCCc
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 507 (660)
++|+|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999864 3345788999999999999999999998 999999999999999999999999999876543322
Q ss_pred c--ceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCcccccccccCCCCCC
Q 006125 508 A--NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ-LLAYAWHLWNEGNVLELVDPLLTDTSF 584 (660)
Q Consensus 508 ~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~ 584 (660)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.... ..+....+. .+... ..+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~-------~~p~- 257 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRL-------LQPE- 257 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCC-------CCCT-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCC-------CCcc-
Confidence 1 1223468999999999999999999999999999999999887765432 222222222 22211 1111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCCCC
Q 006125 585 SDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGETG 622 (660)
Q Consensus 585 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 622 (660)
.....+.+|+.+||+.||++||+|.||++.|+++..
T Consensus 258 --~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 258 --YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122357789999999999999999999999987643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=380.79 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=210.1
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEec
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 427 (660)
++|+..+.||+|+||+||+|... +|+.||||+++... .....+.+|+.+|+.++||||+++++++.+.+..||||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 57888999999999999999964 78899999997643 33456889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCC--CCEEEeeccccccccccC
Q 006125 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARIFAESE 505 (660)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~--~~~kl~DfGla~~~~~~~ 505 (660)
++|+|.+++.. ....+++.++..|+.||++||+|||+.+ |+||||||+|||++.+ .++||+|||+++......
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999943 2335999999999999999999999998 9999999999999854 589999999998654322
Q ss_pred CccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCCCCCCC
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLTDTSFS 585 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 585 (660)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+....... +.... +..+
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~-~~~s 231 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---DEEAF-KEIS 231 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---CHHHH-TTSC
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---Chhhc-cCCC
Confidence 2334578999999999999999999999999999999999999998877666555554432210 00000 0122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 586 DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 586 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
..+.+++.+||+.||.+|||++|+++ ++++
T Consensus 232 ----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 232 ----IEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 34778999999999999999999986 4543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=384.55 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=197.5
Q ss_pred CCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC----eeEEEEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKLLVYE 425 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e 425 (660)
+|...+.||+|+||.||+|++ +|+.||||+++... ........|+..+.+++||||+++++++.+.+ ..++|||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 455678899999999999997 68999999996532 22222344555666789999999999998654 5789999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCceEeCCCCCEEEeecccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS-----RLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 500 (660)
|+++|+|.++++. ..++|..+++++.|++.||+|||+.. .++|+||||||+||||++++++||+|||+++.
T Consensus 82 y~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999953 35899999999999999999999741 24599999999999999999999999999987
Q ss_pred ccccCCcc--ceeeeeccCCcCCHhhhhcCC------CCcchhHHHHHHHHHHHHhCCCCCCCCc--------------H
Q 006125 501 FAESEGEA--NTVRIVGTYGYMAPEYAMEGL------YSKKSDVFSFGVLLIEIITGRRNAGSNQ--------------L 558 (660)
Q Consensus 501 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~t~ksDVwslGvll~elltG~~p~~~~~--------------~ 558 (660)
........ ......||+.|+|||++.+.. ++.++|||||||+||||+||..|+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 75543322 223457999999999987543 5779999999999999999987764211 1
Q ss_pred HHHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 559 LAYAWHLWNEGNVLELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 559 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
..........+. +++.+.......+....+.+|+.+||+.||++|||+.||++.|+..
T Consensus 238 ~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111222221111 1222211111234556788999999999999999999999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=370.93 Aligned_cols=270 Identities=24% Similarity=0.343 Sum_probs=208.2
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCC--hhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..++||+|+||+||+|+. .+|+.||||+++... +...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788899999999999999995 579999999996432 3346789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
|+.++.+..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 997655544433 23445999999999999999999999998 9999999999999999999999999998765433
Q ss_pred CccceeeeeccCCcCCHhhhhcCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-Ccccccc--------
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-GNVLELV-------- 575 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~-------- 575 (660)
... ....||+.|+|||++.... ++.++|||||||++|||++|+.||...+..+....+... +...+..
T Consensus 157 ~~~--~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 RTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp BCT--TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccc--eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 222 2347999999999987655 589999999999999999999999876655544443321 1000000
Q ss_pred c--ccCCCC-CCC-----HHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCCCC
Q 006125 576 D--PLLTDT-SFS-----DDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGTLP 625 (660)
Q Consensus 576 d--~~~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~ 625 (660)
+ ...... ... ......+.+++.+||+.||++|||++|+++ ++++...+.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 0 000000 000 011245778899999999999999999997 5877755544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-45 Score=384.57 Aligned_cols=248 Identities=27% Similarity=0.320 Sum_probs=195.7
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC---ChhcHHHHHH---HHHHHhhcCCCCcceEeEEEEeCCeeE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTN---EVLLILKLQHKNLVKLLGFCVDGDEKL 421 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 421 (660)
++|+..+.||+|+||.||+|+. .+|+.||||++... .......+.+ |+.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5788899999999999999996 46999999998632 1122233334 466777778999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999994 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcccccccccCC
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPLLT 580 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 580 (660)
..... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.......... ....+
T Consensus 158 ~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~----~~~~~- 228 (364)
T d1omwa3 158 SKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MAVEL- 228 (364)
T ss_dssp SSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS----CCCCC-
T ss_pred CCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----CCCCC-
Confidence 54322 23479999999999975 5689999999999999999999999975432211111100000 00011
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHhHHH
Q 006125 581 DTSFSDDEFSRYIHIGLLCVQEDAFDRPT-----MSSVAP 615 (660)
Q Consensus 581 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 615 (660)
...++ ..+.+|+.+||+.||++||| ++|+++
T Consensus 229 ~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 229 PDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11223 34778999999999999999 688873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-44 Score=368.82 Aligned_cols=258 Identities=25% Similarity=0.333 Sum_probs=202.9
Q ss_pred CCCCCCcccccCCcccEEeeeecCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
++|+..++||+|+||+||+|+.++|+.||||+++.. .+...+.+.+|+.++++++||||+++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 478888999999999999999989999999999653 333467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccCC
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 506 (660)
+.++.+..+. ...+.+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988877776 34566999999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---Cc---cc---cc--
Q 006125 507 EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---GN---VL---EL-- 574 (660)
Q Consensus 507 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~~---~~---~~-- 574 (660)
. .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+........ .. .. +.
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2 223468999999999875 45799999999999999999999999876655444433221 00 00 00
Q ss_pred ccccCCC------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 575 VDPLLTD------TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 575 ~d~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.+..... ..........+.+++.+||+.||++|||++|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0000000 000111224577899999999999999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=380.24 Aligned_cols=250 Identities=23% Similarity=0.265 Sum_probs=195.4
Q ss_pred CCCCCCc-ccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhc-CCCCcceEeEEEEe----CCeeE
Q 006125 349 SNFSDSN-ILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD----GDEKL 421 (660)
Q Consensus 349 ~~~~~~~-~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~ 421 (660)
++|...+ .||+|+||.||+|.. .+++.||||+++. ...+.+|+.++.++ +||||+++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4676654 699999999999995 5799999999864 24577899887655 89999999999875 35689
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC---CCCEEEeecccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMA 498 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla 498 (660)
||||||++|+|.+++.. .....+++.++..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHS-CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHh-cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999964 22346999999999999999999999998 999999999999985 467999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVDPL 578 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d~~ 578 (660)
+........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... +....
T Consensus 162 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~-----i~~~~ 233 (335)
T d2ozaa1 162 KETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-----IRMGQ 233 (335)
T ss_dssp EECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C-----CCSCS
T ss_pred eeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH-----HhcCC
Confidence 876543322 2357999999999999999999999999999999999999999654322221111111 00001
Q ss_pred CCCCC-CCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 579 LTDTS-FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 579 ~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+. ........+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 10000 01123356889999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=367.76 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=197.2
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCCh------hcHHHHHHHHHHHhhcC--CCCcceEeEEEEeCCe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDE 419 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 419 (660)
++|+..++||+|+||.||+|+. .+|+.||||+++.... .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5688889999999999999995 5789999999864211 11234678999999996 8999999999999999
Q ss_pred eEEEEEecCC-CChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-CCCEEEeeccc
Q 006125 420 KLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGM 497 (660)
Q Consensus 420 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGl 497 (660)
.++||||+.+ +++.+++. ....+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 57777773 3456999999999999999999999998 999999999999985 47999999999
Q ss_pred cccccccCCccceeeeeccCCcCCHhhhhcCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCccccccc
Q 006125 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNVLELVD 576 (660)
Q Consensus 498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~d 576 (660)
++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+. +.....
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~~~------ 221 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQV------ 221 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCC------
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhccc------
Confidence 98654322 223579999999999987765 6789999999999999999999975421 111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 577 PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 577 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
.+ +...+ ..+.+++.+||+.||++|||++|+++ ++++.
T Consensus 222 -~~-~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 222 -FF-RQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -CC-SSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -CC-CCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11 11233 34778899999999999999999986 56554
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=365.39 Aligned_cols=265 Identities=22% Similarity=0.311 Sum_probs=200.6
Q ss_pred cCCCCCCcccccCCcccEEeeee-cC-CcEEEEEEccCC--ChhcHHHHHHHHHHHhhc---CCCCcceEeEEEEe----
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SD-GKEVAVKRLSSC--SEQGTAEFTNEVLLILKL---QHKNLVKLLGFCVD---- 416 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 416 (660)
.++|+..++||+|+||+||++.. .+ ++.||||+++.. .+.....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46788999999999999999986 34 667999998642 223334566788877766 79999999999863
Q ss_pred -CCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeec
Q 006125 417 -GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (660)
Q Consensus 417 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 495 (660)
....+++|||++++++..... .....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 245789999999887765553 23455899999999999999999999998 999999999999999999999999
Q ss_pred cccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc---Cccc
Q 006125 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE---GNVL 572 (660)
Q Consensus 496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~---~~~~ 572 (660)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+... ....
T Consensus 161 g~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 99876543322 23357999999999999999999999999999999999999999876655444333221 0000
Q ss_pred c----------cccccCCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCC
Q 006125 573 E----------LVDPLLTD--TSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGE 620 (660)
Q Consensus 573 ~----------~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 620 (660)
. ........ ..+.......+.+|+.+||+.||++|||+.|+++ +++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0 00000000 0011112234678899999999999999999985 45543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=361.49 Aligned_cols=270 Identities=27% Similarity=0.352 Sum_probs=198.8
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC------
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 418 (660)
.++|+..++||+|+||+||+|.. .+|+.||||+++. .++...+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46788899999999999999995 4799999999975 23445667899999999999999999999998655
Q ss_pred eeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeecccc
Q 006125 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (660)
Q Consensus 419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 498 (660)
..++||||+ +.+|..++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 567877763 345999999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--cccccc
Q 006125 499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG--NVLELV 575 (660)
Q Consensus 499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~--~~~~~~ 575 (660)
+...... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+............ ...+..
T Consensus 169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 8654322 23478999999999876 457999999999999999999999998665443332222100 000000
Q ss_pred --------------cccCCCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCCCCCCCCC
Q 006125 576 --------------DPLLTDT---SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGTLPQPQKP 630 (660)
Q Consensus 576 --------------d~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~p~~p 630 (660)
.+..... .........+.+|+.+||+.||.+|||+.|+++ ++++......+|..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~ 317 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ 317 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC
Confidence 0000000 000111234678999999999999999999996 577765444444443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=364.86 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=194.1
Q ss_pred CCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------CeeEE
Q 006125 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DEKLL 422 (660)
Q Consensus 350 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 422 (660)
+|+..++||+|+||+||+|+. .+|+.||||+++.... ...+|+.+|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 466778999999999999996 4799999999975432 234799999999999999999998653 24689
Q ss_pred EEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-CEEEeeccccccc
Q 006125 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIF 501 (660)
Q Consensus 423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~ 501 (660)
||||++++.+..+.........+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755555432234556999999999999999999999998 99999999999999775 8999999999876
Q ss_pred cccCCccceeeeeccCCcCCHhhhhc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc--C---------
Q 006125 502 AESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE--G--------- 569 (660)
Q Consensus 502 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~--~--------- 569 (660)
...... ....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+... .
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 543322 23479999999998875 56899999999999999999999999866544443332210 0
Q ss_pred --cccccccccCCCC----CCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 --NVLELVDPLLTDT----SFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 --~~~~~~d~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
...+..-+..... .........+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000 001112234778899999999999999999984
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=356.21 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=197.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccC--CChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC--------
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-------- 417 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 417 (660)
++|+..++||+|+||+||+|+. .+|+.||||++.. ..+.....+.+|+.+|++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6788899999999999999995 5799999999864 2344567789999999999999999999998653
Q ss_pred CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccc
Q 006125 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (660)
Q Consensus 418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 497 (660)
...++||||+.++.+..+. .....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4578999999888777665 34455889999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCcc--ceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-Cccc-
Q 006125 498 ARIFAESEGEA--NTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE-GNVL- 572 (660)
Q Consensus 498 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~-~~~~- 572 (660)
++......... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+... +...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 97665332221 12224799999999998764 6899999999999999999999999866544433322211 1000
Q ss_pred cc---c---------cccCCCCCCCHHH------HHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 573 EL---V---------DPLLTDTSFSDDE------FSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 573 ~~---~---------d~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
+. . ...........+. ...+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 0 0000000001111 234568999999999999999999984
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=362.96 Aligned_cols=273 Identities=21% Similarity=0.306 Sum_probs=202.9
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC-ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCC----eeE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKL 421 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 421 (660)
+++|+..++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688899999999999999985 58999999999753 3445667899999999999999999999997643 235
Q ss_pred EEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccc
Q 006125 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (660)
Q Consensus 422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 501 (660)
++++|+.+|+|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56677789999999942 35999999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCcc-ceeeeeccCCcCCHhhhh-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--ccccc---
Q 006125 502 AESEGEA-NTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEG--NVLEL--- 574 (660)
Q Consensus 502 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~--~~~~~--- 574 (660)
....... .....+||+.|+|||++. ...++.++||||+||++|||++|+.||...+..+..+...... ...+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 5433221 223457999999999985 4567899999999999999999999998665443333222110 00000
Q ss_pred ---------ccccCCCCCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCCCCCC
Q 006125 575 ---------VDPLLTDTSFSDD-----EFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGTLPQP 627 (660)
Q Consensus 575 ---------~d~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~p 627 (660)
..........+.. ....+.+++.+||+.||.+|||++|+++ +|+........|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~ 308 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 308 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc
Confidence 0000000000110 1134778999999999999999999996 365544433333
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-42 Score=349.97 Aligned_cols=263 Identities=21% Similarity=0.261 Sum_probs=204.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeCCeeEEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 425 (660)
++|+..++||+|+||+||+|+. .+|+.||||+++.. .......+.+|+.+++.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688899999999999999995 57899999998642 33456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccccccccC
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 505 (660)
++.+++|..++. ..+.+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988884 3456899999999999999999999998 9999999999999999999999999998765433
Q ss_pred CccceeeeeccCCcCCHhhhhcCC-CCcchhHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHHHh---cCc---c---ccc
Q 006125 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAG-SNQLLAYAWHLWN---EGN---V---LEL 574 (660)
Q Consensus 506 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwslGvll~elltG~~p~~-~~~~~~~~~~~~~---~~~---~---~~~ 574 (660)
... ....++..|+|||++.... ++.++|||||||++|||++|+.||. ..+..+....+.. ... . ...
T Consensus 156 ~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 RCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 222 2235778899999987654 6999999999999999999999864 3333333322211 100 0 000
Q ss_pred cc--------ccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcC
Q 006125 575 VD--------PLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKG 619 (660)
Q Consensus 575 ~d--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 619 (660)
.+ ...............+.+|+.+||+.||.+|||++||++ ++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 00 000000111122345778899999999999999999985 5544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-42 Score=351.51 Aligned_cols=259 Identities=18% Similarity=0.258 Sum_probs=194.0
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCcc-eEeEEEEeCCeeEEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 426 (660)
++|+..+.||+|+||.||+|+. .+|+.||||++..... ..++..|+++++.++|+|++ .+..+..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4688899999999999999995 5689999998865322 23578899999999877655 455566778889999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC---CCCEEEeeccccccccc
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAE 503 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla~~~~~ 503 (660)
+. ++|...+.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++. +..+||+|||+++.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 556555532 3345999999999999999999999998 999999999999863 56799999999997754
Q ss_pred cCCc-----cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc-cccccc
Q 006125 504 SEGE-----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV-LELVDP 577 (660)
Q Consensus 504 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~~d~ 577 (660)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.................. .....+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 4322 1223457999999999999999999999999999999999999999754322221111100000 000000
Q ss_pred cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 578 LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 578 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.+.. ..+ ..+.+++..||+.||++||+++++.+.|+..
T Consensus 239 ~~~~-~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 VLCK-GYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHTT-TSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred Hhcc-CCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1111 222 3477888899999999999999998888754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=359.79 Aligned_cols=265 Identities=25% Similarity=0.321 Sum_probs=205.4
Q ss_pred CCCCCCcccccCCcccEEeeee----cCCcEEEEEEccCC----ChhcHHHHHHHHHHHhhcCC-CCcceEeEEEEeCCe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDE 419 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 419 (660)
++|+..+.||+|+||+||++.. .+|+.||||+++.. +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688899999999999999984 24789999998642 22345668899999999966 899999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.+++|||+.+|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999994 4445788999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcC--CCCcchhHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHHhcCccccc
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGRRNAGSNQLL---AYAWHLWNEGNVLEL 574 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwslGvll~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~ 574 (660)
.+........ ....|++.|++||.+.+. .++.++|||||||+||||++|+.||...... ...........
T Consensus 178 ~~~~~~~~~~-~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~---- 252 (322)
T d1vzoa_ 178 EFVADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---- 252 (322)
T ss_dssp ECCGGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----
T ss_pred hhcccccccc-cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC----
Confidence 7654333222 234789999999999754 4788999999999999999999999654322 22221111111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHhHHH--HhcCC------CCCCCCCCCCc
Q 006125 575 VDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRP-----TMSSVAP--MLKGE------TGTLPQPQKPA 631 (660)
Q Consensus 575 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~--~L~~~------~~~~~~p~~p~ 631 (660)
+. .+......+.+++.+||++||.+|| |++|+++ +++++ ....++|-.|.
T Consensus 253 --~~-----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~ 315 (322)
T d1vzoa_ 253 --PP-----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 315 (322)
T ss_dssp --CC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred --CC-----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCC
Confidence 11 1112234577889999999999999 4788885 45553 23444454453
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-41 Score=352.54 Aligned_cols=272 Identities=23% Similarity=0.298 Sum_probs=205.2
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC-----Ce
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE 419 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 419 (660)
.++|+..++||+|+||+||+|.. .+|+.||||+++.. +....+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999995 57999999999753 334556788999999999999999999998643 34
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.+++++|+.+|+|.+++.. +.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5777888899999999932 35999999999999999999999998 9999999999999999999999999997
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhcCcc--ccc--
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNEGNV--LEL-- 574 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~~~~--~~~-- 574 (660)
...... ....|++.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+...... .+.
T Consensus 170 ~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 654322 234689999999987765 5689999999999999999999999866544443333221000 000
Q ss_pred ----------ccccCCCCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHhHHH--HhcCCCCCCCCCCCCc
Q 006125 575 ----------VDPLLTDTSFSD-----DEFSRYIHIGLLCVQEDAFDRPTMSSVAP--MLKGETGTLPQPQKPA 631 (660)
Q Consensus 575 ----------~d~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~p~~p~ 631 (660)
.......+.... .....+.+|+.+||+.||.+|||+.|+++ ++........+|..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~ 318 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 318 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCC
Confidence 000000000000 11234778999999999999999999997 7776554444444433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.6e-41 Score=348.96 Aligned_cols=252 Identities=18% Similarity=0.271 Sum_probs=194.1
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeC--CeeEEEE
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDG--DEKLLVY 424 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 424 (660)
++|+..++||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788899999999999999995 57999999999753 3567889999999995 99999999999854 4589999
Q ss_pred EecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCC-CEEEeeccccccccc
Q 006125 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAE 503 (660)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~ 503 (660)
||+++++|..+. ..+++..+..++.||++||.|||+.+ |+||||||+||||+.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999998765 24899999999999999999999998 99999999999998655 699999999987654
Q ss_pred cCCccceeeeeccCCcCCHhhhhcC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHH------------HHhcC
Q 006125 504 SEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQL-LAYAWH------------LWNEG 569 (660)
Q Consensus 504 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwslGvll~elltG~~p~~~~~~-~~~~~~------------~~~~~ 569 (660)
.... ....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||..... .+.... .....
T Consensus 183 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 3322 234789999999998765 479999999999999999999999864321 111110 11100
Q ss_pred cc---cc---cccc-------cCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHH
Q 006125 570 NV---LE---LVDP-------LLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAP 615 (660)
Q Consensus 570 ~~---~~---~~d~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 615 (660)
.. .. .... ..............+.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00 0000 00000011112235788999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-41 Score=346.21 Aligned_cols=258 Identities=16% Similarity=0.226 Sum_probs=201.9
Q ss_pred cCCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCC-CCcceEeEEEEeCCeeEEEEE
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 425 (660)
.++|+..++||+|+||.||+|+. .+|+.||||+++... ....+.+|++.+..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46788899999999999999995 478999999886532 22357789999999965 899999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCC-----CCCEEEeecccccc
Q 006125 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGMARI 500 (660)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DfGla~~ 500 (660)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6899988853 3345899999999999999999999998 999999999999974 57899999999987
Q ss_pred ccccCCc-----cceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCccc
Q 006125 501 FAESEGE-----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ---LLAYAWHLWNEGNVL 572 (660)
Q Consensus 501 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~---~~~~~~~~~~~~~~~ 572 (660)
+...... .......||+.|||||++.+..++.++|||||||++|||++|+.||.... .......+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~- 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS- 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC-
Confidence 6543222 12234579999999999999999999999999999999999999996432 22222111111000
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHhHHHHhcCC
Q 006125 573 ELVDPLLTDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMSSVAPMLKGE 620 (660)
Q Consensus 573 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 620 (660)
.... .+. +..+ ..+.+++..|++.+|++||+++.+.+.|++.
T Consensus 235 ~~~~-~l~-~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 235 TPLR-ELC-AGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp SCHH-HHT-TTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CChH-Hhc-CCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0000 011 1222 3477788899999999999999998887654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=349.87 Aligned_cols=254 Identities=23% Similarity=0.276 Sum_probs=190.7
Q ss_pred CCCCCCcccccCCcccEEeeeec-CCcEEEEEEccCC--ChhcHHHHHHHHHHHhhcCCCCcceEeEEEEeC------Ce
Q 006125 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DE 419 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 419 (660)
++|+..++||+|+||+||+|... +|+.||||+++.. +......+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888999999999999999954 7999999999743 344556789999999999999999999999643 57
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.|+||||+.++.+..+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999776555442 24899999999999999999999998 9999999999999999999999999987
Q ss_pred cccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhc-----------
Q 006125 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYAWHLWNE----------- 568 (660)
Q Consensus 500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~~~~~~~~~~----------- 568 (660)
....... .....+|+.|+|||++.+..++.++||||+||+++||++|+.||...+.......+...
T Consensus 168 ~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 6544322 22347899999999999999999999999999999999999999766544433322110
Q ss_pred ----------Cc-------ccccccccCCCCC--CCHHHHHHHHHHHhhcccCCCCCCCCHHhHH
Q 006125 569 ----------GN-------VLELVDPLLTDTS--FSDDEFSRYIHIGLLCVQEDAFDRPTMSSVA 614 (660)
Q Consensus 569 ----------~~-------~~~~~d~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 614 (660)
.. ....+........ ........+.+|+.+||+.||++|||++||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 00 0000000000000 1122345688999999999999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-37 Score=323.51 Aligned_cols=275 Identities=21% Similarity=0.247 Sum_probs=199.8
Q ss_pred CCCCCCcccccCCcccEEeeee-cCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-----------CCCcceEeEEEEe
Q 006125 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----------HKNLVKLLGFCVD 416 (660)
Q Consensus 349 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 416 (660)
++|+..++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4588899999999999999995 57999999999753 334567788999888875 5789999998865
Q ss_pred C--CeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEeCCCCC----
Q 006125 417 G--DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMN---- 489 (660)
Q Consensus 417 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~DLkp~NILl~~~~~---- 489 (660)
. ...+++++++..+..............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4567777777665543333333455668999999999999999999998 66 999999999999986653
Q ss_pred --EEEeeccccccccccCCccceeeeeccCCcCCHhhhhcCCCCcchhHHHHHHHHHHHHhCCCCCCCCcHH------HH
Q 006125 490 --SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL------AY 561 (660)
Q Consensus 490 --~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwslGvll~elltG~~p~~~~~~~------~~ 561 (660)
++|+|||.+....... ....||+.|+|||++....++.++||||+||+++||++|+.||...... +.
T Consensus 169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 8999999997654322 2347899999999999999999999999999999999999998643211 01
Q ss_pred HHH---HHh--------c-Cccccccc---------ccC---------CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHH
Q 006125 562 AWH---LWN--------E-GNVLELVD---------PLL---------TDTSFSDDEFSRYIHIGLLCVQEDAFDRPTMS 611 (660)
Q Consensus 562 ~~~---~~~--------~-~~~~~~~d---------~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 611 (660)
... ... . .......+ ... ............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 100 000 0 00000000 000 01133456677899999999999999999999
Q ss_pred hHHH--HhcCC--CCCCCCCCCCce
Q 006125 612 SVAP--MLKGE--TGTLPQPQKPAF 632 (660)
Q Consensus 612 evl~--~L~~~--~~~~~~p~~p~~ 632 (660)
|+++ ++++. ..+...|.+|.+
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred HHhcCcccCCCCCcccCCCCCcccC
Confidence 9986 46643 334444555544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.2e-22 Score=192.93 Aligned_cols=164 Identities=18% Similarity=0.172 Sum_probs=120.9
Q ss_pred CCcccccCCcccEEeeeecCCcEEEEEEccCCCh------------------hcHHHHHHHHHHHhhcCCCCcceEeEEE
Q 006125 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE------------------QGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (660)
Q Consensus 353 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~~ 414 (660)
..++||+|+||.||+|...+|+.||||+++.... ........|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4578999999999999988999999998753110 0122355688899999999999988663
Q ss_pred EeCCeeEEEEEecCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEeCCCCCEEEee
Q 006125 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (660)
Q Consensus 415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 494 (660)
..+++|||+++..+.. ++......++.|++++|.|||+.+ |+||||||+|||++++ .++|+|
T Consensus 84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 2479999998866543 334456789999999999999998 9999999999999865 589999
Q ss_pred ccccccccccCCccceeeeeccCCcCCH--h---hhhcCCCCcchhHHHHHHHHH
Q 006125 495 FGMARIFAESEGEANTVRIVGTYGYMAP--E---YAMEGLYSKKSDVFSFGVLLI 544 (660)
Q Consensus 495 fGla~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~t~ksDVwslGvll~ 544 (660)
||++......... .|... + ....+.|..++|+||..--++
T Consensus 146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 9998754322111 11111 1 012456788999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.61 E-value=8.2e-08 Score=93.57 Aligned_cols=143 Identities=19% Similarity=0.122 Sum_probs=100.9
Q ss_pred cCCCCCCcccccCCcccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC-CCCcceEeEEEEeCCeeEEEEEe
Q 006125 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEF 426 (660)
Q Consensus 348 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 426 (660)
-+.|...+..+-++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..++||++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 34555555544445578998765 56678889886544444556788888888773 43467888888888899999999
Q ss_pred cCCCChhhhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 006125 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS-------------------------------------- 468 (660)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 468 (660)
+++.++.+.... ......++.++++.|..||+..
T Consensus 92 l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred cccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999888665521 1123345666667777777421
Q ss_pred ------------------CCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 469 ------------------RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 469 ------------------~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
...++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987767799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.05 E-value=1e-05 Score=77.76 Aligned_cols=129 Identities=19% Similarity=0.156 Sum_probs=87.1
Q ss_pred cccCCc-ccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcC--CCCcceEeEEEEeCCeeEEEEEecCCCChh
Q 006125 357 LGQGGF-GPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (660)
Q Consensus 357 lG~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 433 (660)
+..|.. +.||+...+++..+++|....... ..+..|...++.+. .-.+.+++.+..+.+..++||+++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444443 678999887888899998765332 34667888887773 334677888888888899999999887654
Q ss_pred hhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 006125 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE----------------------------------------------- 466 (660)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~----------------------------------------------- 466 (660)
+.. +.. ..++.++.+.|.-||+
T Consensus 95 ~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 95 SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 321 111 1122333344444442
Q ss_pred ----C----CCCCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 467 ----D----SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 467 ----~----~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
. .++.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12338999999999999987777899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.49 E-value=0.00016 Score=74.09 Aligned_cols=75 Identities=12% Similarity=0.150 Sum_probs=47.9
Q ss_pred cccccCCcccEEeeeec-CCcEEEEEEccCC----C---hhcHHHHHHHHHHHhhc-CC--CCcceEeEEEEeCCeeEEE
Q 006125 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC----S---EQGTAEFTNEVLLILKL-QH--KNLVKLLGFCVDGDEKLLV 423 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~lv 423 (660)
+.||.|....||+.... +++.++||.-.+. . .........|...+..+ .+ ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999864 4678999975421 1 11233455677777766 23 335555544 55667899
Q ss_pred EEecCCCC
Q 006125 424 YEFMPNGS 431 (660)
Q Consensus 424 ~e~~~~gs 431 (660)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.91 E-value=0.0021 Score=63.48 Aligned_cols=135 Identities=16% Similarity=0.137 Sum_probs=78.0
Q ss_pred cccEEeeeecCCcEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc--ceEe-----EEEEeCCeeEEEEEecCCCChhh
Q 006125 362 FGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL--VKLL-----GFCVDGDEKLLVYEFMPNGSLDA 434 (660)
Q Consensus 362 fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL~~ 434 (660)
--.||+....+|+.+++|+.++. ....+++..|...+..|...++ +..+ .....++..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999999999999998753 2245668889888888743222 1111 12344566788999987643321
Q ss_pred -----h------h-------cC--CCCCCccCH-------------------HHHHHHHHHHHHHHHHHHh----CCCCC
Q 006125 435 -----I------L-------FD--PRKRGILCW-------------------RKRTNIVNGIAKGMLYLHE----DSRLR 471 (660)
Q Consensus 435 -----~------l-------~~--~~~~~~l~~-------------------~~~~~i~~~ia~~L~~LH~----~~~~~ 471 (660)
+ + .. ...+..+++ .....+...+.+.++.+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 0 00 001111111 1111122222233333322 22346
Q ss_pred eEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 472 IVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 472 ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
++|+|+.+.|||++++ ..+.||+-+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999754 4588998775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.34 E-value=0.0048 Score=62.61 Aligned_cols=72 Identities=18% Similarity=0.265 Sum_probs=48.0
Q ss_pred cccccCCcccEEeeeecCC--------cEEEEEEccCCChhcHHHHHHHHHHHhhcCCCCc-ceEeEEEEeCCeeEEEEE
Q 006125 355 NILGQGGFGPVYKGVLSDG--------KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYE 425 (660)
Q Consensus 355 ~~lG~G~fg~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 425 (660)
+.|+.|-.=.+|+...+++ +.|.+++... . .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5677788888999886543 4566666542 2 233456789999988843344 577777632 68999
Q ss_pred ecCCCCh
Q 006125 426 FMPNGSL 432 (660)
Q Consensus 426 ~~~~gsL 432 (660)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.07 E-value=0.061 Score=52.06 Aligned_cols=30 Identities=33% Similarity=0.379 Sum_probs=26.7
Q ss_pred CCeEecCCCCCceEeCCCCCEEEeeccccc
Q 006125 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (660)
Q Consensus 470 ~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 499 (660)
.+++|+|+.++||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 459999999999999988777899999874
|